0.08808324.12130565.html.plaintext.txt	0	eating elicited orexin melanin concentrating hormone opioid mediated deborah j
0.08808324.12130565.html.plaintext.txt	1	department psychiatry university cincinnati medical center d
0.08808324.12130565.html.plaintext.txt	2	cincinnati ohio num num department biomedical science cell biology neurobiology anatomy university cincinnati medical center e
0.08808324.12130565.html.plaintext.txt	3	address correspondence request reprint deborah j
0.08808324.12130565.html.plaintext.txt	4	department psychiatry university cincinnati medical center p
0.08808324.12130565.html.plaintext.txt	5	box num cincinnati ohio num num
0.08808324.12130565.html.plaintext.txt	6	neuron lha synthesize peptidergic transmitter stimulate feeding behavior specifically melanin concentrating hormone mch num orexins b also termed hypocretins num num
0.08808324.12130565.html.plaintext.txt	7	mch expressed predominately lha num num several line investigation implicate key regulator food intake body weight num num num num
0.08808324.12130565.html.plaintext.txt	8	first mch gene expression influenced change energy balance
0.08808324.12130565.html.plaintext.txt	9	adipocyte hormone leptin inhibits mch gene expression food restriction increase mch gene expression num
0.08808324.12130565.html.plaintext.txt	10	second intracerebroventricular administration exogenous mch stimulates food intake num num num mouse overexpress mch obese insulin resistant num
0.08808324.12130565.html.plaintext.txt	11	finally mouse targeted disruption mch gene reduced food intake body weight accompanied increased metabolic rate resulting little body fat num
0.08808324.12130565.html.plaintext.txt	12	orexin hypocretin system num num comprised two peptide termed orexin orexin b two associated receptor
0.08808324.12130565.html.plaintext.txt	13	intraventricular administration neutralizing antiorexin antibody suppresses spontaneous feeding fasted rat num intraventricular administration orexin dose dependently stimulates food consumption num num num num
0.08808324.12130565.html.plaintext.txt	14	change feeding administration orexin b inconsistent num num num stronger case made role orexin energy homeostasis
0.08808324.12130565.html.plaintext.txt	15	although orexin mch expressing neuron made within different neuron lha num num peptide increase energy intake
0.08808324.12130565.html.plaintext.txt	16	regard similar agouti related protein agrp neuropeptide y npy peptide made population neuron within arcuate nucleus
0.08808324.12130565.html.plaintext.txt	17	npy agrp administered exogenously increase food intake num num num num num num
0.08808324.12130565.html.plaintext.txt	18	axon lha project medial hypothalamus including arcuate agrpnpy neuron arcuate project lha num num num understanding functional interaction among peptide important
0.08808324.12130565.html.plaintext.txt	19	npy agrp induced increase food intake dependent opioid receptor activation action blocked nonspecific opioid receptor antagonist naloxone num num
0.08808324.12130565.html.plaintext.txt	20	activation opioid system turn associated increased intake preferred high fat containing diet num
0.08808324.12130565.html.plaintext.txt	21	consistent found agrp selectively increase intake high fat diet rat simultaneous access two diet differing relative amount carbohydrate fat num
0.08808324.12130565.html.plaintext.txt	22	hand administration npy reportedly increase consumption high carbohydrate diet num num although attributed stimulation whichever diet individual rat prefers num num
0.08808324.12130565.html.plaintext.txt	23	purpose present experiment determine whether orexigenic action mch orexin depends upon activity opioid receptor whether peptide influence diet selection
0.08808324.12130565.html.plaintext.txt	24	drug agrp num num orexin mch purchased phoenix pharmaceutical inc
0.08808324.12130565.html.plaintext.txt	25	naloxone hydrochloride nalx purchased sigma st
0.08808324.12130565.html.plaintext.txt	26	substance dissolved physiological saline also served control solution
0.08808324.12130565.html.plaintext.txt	27	agrp num num orexin mch saline administered inumvt num microl volume nalx control saline injected ip volume num
0.08808324.12130565.html.plaintext.txt	28	diet animal maintained pelleted rat chow harlan teklad indianapolis experiment num num
0.08808324.12130565.html.plaintext.txt	29	high fat hf low fat lf pelleted diet prepared dyets bethlehem pa used experiment num num
0.08808324.12130565.html.plaintext.txt	30	macronutrient composition diet given table num
0.08808324.12130565.html.plaintext.txt	31	macronutrient composition low fat high fat regular chow diet kilocalorie per gram percentage total kilocalorie
0.08808324.12130565.html.plaintext.txt	32	previously determined num
0.08808324.12130565.html.plaintext.txt	33	num mgkg nalx ip effect food intake
0.08808324.12130565.html.plaintext.txt	34	dose subthreshold num
0.08808324.12130565.html.plaintext.txt	35	however dose administered conjunction inumvt agrp reliably reduced increase food intake elicited agrp num
0.08808324.12130565.html.plaintext.txt	36	experiment num replication experiment confirm num
0.08808324.12130565.html.plaintext.txt	37	num mgkg nalx ip fact subthreshold cohort rat reconfirm attenuates agrp induced overeating
0.08808324.12130565.html.plaintext.txt	38	rat assigned one four treatment group n num numgroup matched preexperimental body weight food intake
0.08808324.12130565.html.plaintext.txt	39	test day food removed num h light
0.08808324.12130565.html.plaintext.txt	40	thirty minute light rat two group received ip injection num
0.08808324.12130565.html.plaintext.txt	41	num mgkg nalx rat two group received equal volume saline
0.08808324.12130565.html.plaintext.txt	42	ten minute later one naloxone one saline group received inumvt injection num nmol agrpnum microl two group received saline num microl
0.08808324.12130565.html.plaintext.txt	43	dose agrp elicits reliable long lasting increase food intake num num num
0.08808324.12130565.html.plaintext.txt	44	five minute light food returned cage intake measured num num num num num h
0.08808324.12130565.html.plaintext.txt	45	water available time
0.08808324.12130565.html.plaintext.txt	46	experiment paralleled experiment num except mch used instead agrp
0.08808324.12130565.html.plaintext.txt	47	body weight matched rat assigned one four treatment group n num numgroup
0.08808324.12130565.html.plaintext.txt	48	test day half rat received ip injection num
0.08808324.12130565.html.plaintext.txt	49	num mgkg nalx half received saline num min later half group received inumvt injection mch saline num microg num microl vol saline num microl vol
0.08808324.12130565.html.plaintext.txt	50	observed mch effective increasing food intake light dark period num experiment num repeated animal num d later except first injection occurred num h light phase
0.08808324.12130565.html.plaintext.txt	51	animal counterbalanced previous treatment reassigned one four new group ip nalx saline inumvt mch saline
0.08808324.12130565.html.plaintext.txt	52	orexin effective increasing food intake light dark period num experiment paralleled experiment num every way except orexin num ngnum microlrat substituted mch
0.08808324.12130565.html.plaintext.txt	53	group rat n num adapted two diet hf lf simultaneously available ad libitum separate food hopper cage num month
0.08808324.12130565.html.plaintext.txt	54	matched average daily food intake body weight assigned one two group receiving either saline num microg mch inumvt num microl injection volume following paradigm described experiment num
0.08808324.12130565.html.plaintext.txt	55	experiment paralleled experiment num except rat received either saline num ng orexin inumvt num microl
0.08808324.12130565.html.plaintext.txt	56	test day procedure identical described experiment num followed
0.08808324.12130565.html.plaintext.txt	57	intake diet recorded num num num num min
0.08808324.12130565.html.plaintext.txt	58	data analysis data analyzed parametric statistic repeated measure anova time repeated measure followed tukey hsd post hoc test
0.08808324.12130565.html.plaintext.txt	59	significance set p num
0.08808324.12130565.html.plaintext.txt	60	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	61	num mgkg nalx ip saline injected association inumvt injection saline num nmol agrp chow intake num h
0.08808324.12130565.html.plaintext.txt	62	different saline plus saline p num
0.08808324.12130565.html.plaintext.txt	63	num different agrp plus saline p num
0.08808324.12130565.html.plaintext.txt	64	experiment num mch num microg potently stimulated food intake level num greater produced saline dark
0.08808324.12130565.html.plaintext.txt	65	num mgkg nalx affect food intake
0.08808324.12130565.html.plaintext.txt	66	nalx reduce mch induced eating
0.08808324.12130565.html.plaintext.txt	67	two way repeated measure anova yielded reliable main effect drug fnumnum num
0.08808324.12130565.html.plaintext.txt	68	tukey post hoc test confirmed food intake mch plus nalx mch alone significantly higher saline saline plus nalx p num
0.08808324.12130565.html.plaintext.txt	69	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	70	num mgkg nalx ip saline administered association inumvt injection saline num microg mch chow intake num h
0.08808324.12130565.html.plaintext.txt	71	injection given num min onset dark phase
0.08808324.12130565.html.plaintext.txt	72	different saline plus saline p num
0.08808324.12130565.html.plaintext.txt	73	experiment num light period mch stimulated food intake level num greater saline
0.08808324.12130565.html.plaintext.txt	74	occurred beginning dark phase nalx neither suppressed food intake reduced mch induced hyperphagia fig
0.08808324.12130565.html.plaintext.txt	75	two way repeated measure anova yielded reliable interaction drug time fnumnum num
0.08808324.12130565.html.plaintext.txt	76	tukey post hoc test confirmed food intake mch plus nalx mch alone significantly higher intake saline saline plus nalx p num
0.08808324.12130565.html.plaintext.txt	77	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	78	num mgkg nalx ip saline administered association inumvt injection saline num microg mch chow intake num h
0.08808324.12130565.html.plaintext.txt	79	injection given light phase
0.08808324.12130565.html.plaintext.txt	80	different saline plus saline p num
0.08808324.12130565.html.plaintext.txt	81	experiment num orexin increased intake num relative saline nalx significantly reduced orexin induced eating second hour p num
0.08808324.12130565.html.plaintext.txt	82	two way repeated measure anova yielded reliable interaction drug time fnumnum num
0.08808324.12130565.html.plaintext.txt	83	tukey post hoc test confirmed food intake orexin plus saline orexin plus nalx different significantly higher intake saline saline plus nalx p num
0.08808324.12130565.html.plaintext.txt	84	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	85	num mgkg nalx ip saline administered association inumvt injection saline num ng orexin chow intake num h
0.08808324.12130565.html.plaintext.txt	86	injection given light phase
0.08808324.12130565.html.plaintext.txt	87	different saline plus saline p num
0.08808324.12130565.html.plaintext.txt	88	num different orexin plus saline p num
0.08808324.12130565.html.plaintext.txt	89	experiment num day test day animal preferred hf diet lf diet consuming average num intake weight hf diet
0.08808324.12130565.html.plaintext.txt	90	num mch increased total food intake well total caloric intake manifest significant increase diet
0.08808324.12130565.html.plaintext.txt	91	hence food intake food choice altered inumvt mch
0.08808324.12130565.html.plaintext.txt	92	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	93	intake hf lf diet num h light phase num microg mch inumvt saline
0.08808324.12130565.html.plaintext.txt	94	experiment num day test day animal preferred hf diet lf diet consuming average num hf diet
0.08808324.12130565.html.plaintext.txt	95	num orexin stimulated intake hf diet level num saline control intake significantly greater extent intake lf diet p num
0.08808324.12130565.html.plaintext.txt	96	therefore total caloric intake increased well proportion calorie derived hf diet
0.08808324.12130565.html.plaintext.txt	97	view larger version numk figure num
0.08808324.12130565.html.plaintext.txt	98	intake hf lf diet num h light phase num ng orexin inumvt saline
0.08808324.12130565.html.plaintext.txt	99	result consistent hypothesis regard energy homeostasis agrp orexin share common underlying mechanism whereas mch act different mechanism
0.08808324.12130565.html.plaintext.txt	100	opioid system long implicated regulation food intake increased opioid activity brain leading increased caloric consumption num num num num
0.08808324.12130565.html.plaintext.txt	101	particular opioids modulate incentive value food opioid agonist increasing opioid antagonist decreasing num num num
0.08808324.12130565.html.plaintext.txt	102	consistent opioids alter relative selection preference specific food
0.08808324.12130565.html.plaintext.txt	103	s endorphin example increase intake preferred hf diet num num
0.08808324.12130565.html.plaintext.txt	104	likewise present experiment orexin selectively increased consumption preferred hf diet orexin stimulated intake pelleted chow attenuated prior administration naloxone
0.08808324.12130565.html.plaintext.txt	105	hence conclude orexin like agrp us opioid mediated circuit orexigenic action
0.08808324.12130565.html.plaintext.txt	106	contrast comparably orexigenic dose mch alter diet selection mch elicited increase pelleted chow influenced naloxone
0.08808324.12130565.html.plaintext.txt	107	therefore conclude opioid system downstream mediator mch orexigenic action
0.08808324.12130565.html.plaintext.txt	108	considerable controversy surround contention macronutrient intake selectively regulated different central nervous system system num including opioids num num num
0.08808324.12130565.html.plaintext.txt	109	example drug treatment given easily ascertained whether increase decrease one particular food choice relative another reflects preference aversion specific macronutrient e
0.08808324.12130565.html.plaintext.txt	110	carbohydrate whether reflects magnified minimized preexisting preference based upon palatability num
0.08808324.12130565.html.plaintext.txt	111	regardless actual mechanism critical observation orexin mch influence food intake via distinct mechanism dissociated use opioid antagonist andor considering food selection
0.08808324.12130565.html.plaintext.txt	112	agrp orexigenic action also reduced naloxone agrp selectively increase intake preferred hf diet num conclude orexin agrp act common mechanism
0.08808324.12130565.html.plaintext.txt	113	recent data laboratory num num others num indicate orexigenic dose agrp increase fo activity lha dual label immunohistochemistry indicates increased activity orexin producing neuron
0.08808324.12130565.html.plaintext.txt	114	importantly agrp increase fo activity mch producing neuron num num
0.08808324.12130565.html.plaintext.txt	115	hence functional anatomical data consistent pharmacological behavioral data
0.08808324.12130565.html.plaintext.txt	116	agrp endogenous antagonist melanocortin num num receptor num found lha well projection site npyagrp neuron arcuate nucleus num num
0.08808324.12130565.html.plaintext.txt	117	present data allow determination whether agrp stimulates orexin neuron turn stimulate food intake acting via opioid receptor
0.08808324.12130565.html.plaintext.txt	118	additionally data determine whether pathway orexin agrp opioid circuit whether relay site involved integrate information agrp orexin input
0.08808324.12130565.html.plaintext.txt	119	added fact agrp neuron arcuate cosynthesize npy npy elicited food intake also naloxone dependent
0.08808324.12130565.html.plaintext.txt	120	hence npy agrp orexin appear share common circuit point
0.08808324.12130565.html.plaintext.txt	121	last several year number identified peptide involved control food intake energy balance grown enormously
0.08808324.12130565.html.plaintext.txt	122	much growth fueled application sophisticated molecular biological approach pressing clinical need treat exponential growth obesity
0.08808324.12130565.html.plaintext.txt	123	develop appropriate therapeutic strategy however alphabet soup peptide transmitter need organized functional circuit
0.08808324.12130565.html.plaintext.txt	124	identification functional circuit depend intensive effort delineate neuroanatomical relationship among system well functional interaction
0.08808324.12130565.html.plaintext.txt	125	present result demonstrate two peptide located within single hypothalamic subarea peptide appear regulated similarly energy balance stimulate food intake act via distinct behavioral neural mechanism
0.08808324.12130565.html.plaintext.txt	126	result point complexity homeostatic system designed much regulate intake rat ad libitum access single caloric source
0.08808324.12130565.html.plaintext.txt	127	rather existence two lha subsystem influence food intake different way emphasizes system great flexibility respond myriad environmental physiological challenge
0.08808324.12130565.html.plaintext.txt	128	footnote work supported nih grant dk num dk num dk num american diabetes association physician scientist training award e
0.08808324.12130565.html.plaintext.txt	129	obesity research center university cincinnati supported part procter gamble co
0.08808324.12130565.html.plaintext.txt	130	abbreviation agrp agouti related peptide hf high fat inumvt administered third ventricular lf low fat lha lateral hypothalamic area mch melanin concentrating hormone nalx naloxone hydrochloride npy neuropeptide y
0.08808324.12130565.html.plaintext.txt	131	accepted publication april num num
0.09531622.15591134.html.plaintext.txt	0	expression class ii major histocompatibility complex molecule thyrocytes cause spontaneous thyroiditis mildly increase severity immunization hiroaki kimura miho kimura shey cherng tzou yen chun chen koichi suzuki noel r
0.09531622.15591134.html.plaintext.txt	1	john hopkins medical institution baltimore maryland num department microbiology k
0.09531622.15591134.html.plaintext.txt	2	leprosy research center national institute infectious disease tokyo num num japan
0.09531622.15591134.html.plaintext.txt	3	address correspondence request reprint patrizio caturegli m
0.09531622.15591134.html.plaintext.txt	4	john hopkins medical institution department pathology ross building room num num rutland avenue baltimore maryland num
0.09531622.15591134.html.plaintext.txt	5	loss tolerance considered result combined effect environmental factor iodine gene variant
0.09531622.15591134.html.plaintext.txt	6	example individual g polymorphism noncoding num region cytotoxic lymphocyte antigen num gene num
0.09531622.15591134.html.plaintext.txt	7	num fold increased risk developing graf disease hashimoto thyroiditis respectively num
0.09531622.15591134.html.plaintext.txt	8	first described potent genetic influence known affect susceptibility autoimmune thyroiditis however major histocompatibility complex mhc
0.09531622.15591134.html.plaintext.txt	9	association mhc autoimmunity originally reported num first patient systemic lupus erythematosus num mouse experimental autoimmune thyroiditis num
0.09531622.15591134.html.plaintext.txt	10	mhc located short arm human chromosome num spanning num
0.09531622.15591134.html.plaintext.txt	11	num megabases complete annotated dna sequence num
0.09531622.15591134.html.plaintext.txt	12	main function guide intracellular processing antigen display antigenic peptide plasma membrane recognition lymphocyte num
0.09531622.15591134.html.plaintext.txt	13	gene dense region genome containing num locus num pseudogenes num expressed gene grouped three class
0.09531622.15591134.html.plaintext.txt	14	class ii mhc gene constitutively expressed hematopoietic cell involved antigen presentation dendritic cell macrophage b lymphocyte cortical thymic epithelial cell induced inflammatory stimulus many cell type endothelial cell hepatocytes s cell pancreas thyrocytes
0.09531622.15591134.html.plaintext.txt	15	little known biological significance observation although implicated allograft rejection num subsequently autoimmunity
0.09531622.15591134.html.plaintext.txt	16	field bottazzo feldman hypothesized class ii mhc molecule aberrantly expressed epithelial cell confer antigen presenting function favoring initiation autoimmune disease num num
0.09531622.15591134.html.plaintext.txt	17	mhc also region associated greatest number human disease ranging narcolepsy num primary immunodeficiency num autoimmune condition num num
0.09531622.15591134.html.plaintext.txt	18	strength association classically measured relative risk rr odds ratio varies low rr num
0.09531622.15591134.html.plaintext.txt	19	num myasthenia gravis person carrying drnum allele num medium rr num dqnum type num diabetes num high rr num anum birdshot retinochoroidopathy num
0.09531622.15591134.html.plaintext.txt	20	graf disease mhc drnum association mild rrs ranging num
0.09531622.15591134.html.plaintext.txt	21	hashimoto thyroiditis contribution mhc haplotype disease le definitive although may play role familial clustering thyroiditis diabetes num
0.09531622.15591134.html.plaintext.txt	22	given biological plausibility replication finding strength many association mhc molecule considered causal pathway lead autoimmune disease
0.09531622.15591134.html.plaintext.txt	23	however important factor could confound described association
0.09531622.15591134.html.plaintext.txt	24	first mhc locus found together frequency much higher would expected random combination frequency population
0.09531622.15591134.html.plaintext.txt	25	thus possible gene causing disease mhc gene per se rather gene travel mhc
0.09531622.15591134.html.plaintext.txt	26	example polymorphism lmpnum lmpnum gene embedded within class ii region associated ankylosing spondylitis num
0.09531622.15591134.html.plaintext.txt	27	addition allele associated particular disease also common normal unaffected population actually majority patient susceptible allele develop autoimmune disease
0.09531622.15591134.html.plaintext.txt	28	finally unknown whether initiate autoimmunity mhc molecule expressed professional antigen presenting cell within secondary lymphoid organ rather nonhematopoietic cell target organ thyroid follicular cell case autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	29	investigate whether mhc class ii molecule expressed thyrocytes play causal role autoimmune thyroiditis developed transgenic mouse express specifically thyroid gland mhc class ii transactivator ciita master regulator mhc class ii pathway num num
0.09531622.15591134.html.plaintext.txt	30	experimental model temporal relationship exposure
0.09531622.15591134.html.plaintext.txt	31	expression class ii mhc molecule thyrocytes disease
0.09531622.15591134.html.plaintext.txt	32	autoimmune thyroiditis clear defined ab initio
0.09531622.15591134.html.plaintext.txt	33	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	34	construction screening thyr ciita transgenic mouse
0.09531622.15591134.html.plaintext.txt	35	rat thyroglobulin promoter rat type iv ciita internal ribosomal entry site ire jellyfish gfp part human gh source splice donor acceptor sequence indicated rectangle different shade
0.09531622.15591134.html.plaintext.txt	36	primer used screening indicated arrow
0.09531622.15591134.html.plaintext.txt	37	b pcr screening using primer ciita region top gfp region bottom positive plasmid control lane num num bp dna marker lane num water control lane num wild type littermate lane num line c line d thyr ciita transgenic lane num num
0.09531622.15591134.html.plaintext.txt	38	c southern blot screening hindiii dna marker lane num positive plasmid control lane num wild type littermate lane num line c ciita transgenic lane num line d ciita transgenic lane num
0.09531622.15591134.html.plaintext.txt	39	founder identified southern hybridization
0.09531622.15591134.html.plaintext.txt	40	eight microgram tail genomic dna digested bamhi separated overnight electrophoresis transferred onto hybond n membrane amersham piscataway nj
0.09531622.15591134.html.plaintext.txt	41	num bp dna fragment gfp gene used generate nump labeled probe using random priming labeling kit invitrogen carlsbad ca
0.09531622.15591134.html.plaintext.txt	42	hybridization carried overnight num c num
0.09531622.15591134.html.plaintext.txt	43	num supplemented num sd num dextran sulfate containing num
0.09531622.15591134.html.plaintext.txt	44	num x num trichloroacetic acid precipitable count per minute probe per milliliter hybridization buffer
0.09531622.15591134.html.plaintext.txt	45	blot washed twice numx standard saline citrate ssc numx ssc num
0.09531622.15591134.html.plaintext.txt	46	num m sodium citrate washed num min num c numx sscnum
0.09531622.15591134.html.plaintext.txt	47	num sd num min room temperature num
0.09531622.15591134.html.plaintext.txt	48	blot wrapped plastic exposed overnight num c biomax m autoradiographic film eastman kodak rochester ny
0.09531622.15591134.html.plaintext.txt	49	establishment transgenic line mouse screened pcr tail genomic dna using one primer pair ciita region one gfp region
0.09531622.15591134.html.plaintext.txt	50	primer sequence follows ciita forward primer num gtcaagtgttcttgaacagtag num ciita reverse primer num agtatggccttgcaggtaag num gfp forward primer num tgaaccgcatcgagctgaag num gfp reverse primer num tccagcaggaccatgtgatc num
0.09531622.15591134.html.plaintext.txt	51	pcr product fractionated electrophoresis num
0.09531622.15591134.html.plaintext.txt	52	mouse contained ciita amplicon num bp gfp amplicon num bp labeled transgenic
0.09531622.15591134.html.plaintext.txt	53	analysis thyr ciita transgene expression thyroid specific expression ciita assessed fluorescent microscopy detect gfp rt pcr immunohistochemistry detect mch class ii
0.09531622.15591134.html.plaintext.txt	54	gfp expression measured freezing thyroid cutting num microm section microtome observing directly green fluorescence zeiss uv microscope
0.09531622.15591134.html.plaintext.txt	55	messenger rna extracted thyroid lobe using oligodt magnetic bead dynal lake success ny treated rnase free dnase invitrogen reverse transcribed superscript ii invitrogen cdna
0.09531622.15591134.html.plaintext.txt	56	cdna amplified pcr forward num gacattgaggccgaccacgtag num reverse num attggtagctggggtggaatttg num primer locus mouse h num complex
0.09531622.15591134.html.plaintext.txt	57	primer glyceraldehyde num phosphate dehydrogenase forward num gcatcttgggctacactgag num reverse num tctcttgctcagtgtccttg num used adjust amount loading
0.09531622.15591134.html.plaintext.txt	58	immunohistochemistry performed zinc fixed paraffin embedded thyroid specimen
0.09531622.15591134.html.plaintext.txt	59	five micrometer section cut mounted onto superfrost plus slide fisher scientific pittsburgh pa deparaffinized rehydrated
0.09531622.15591134.html.plaintext.txt	60	blocking antibody nonspecific binding num h num normal goat serum section incubated overnight humid chamber num c biotin conjugated monoclonal antibody recognizing ak clone num num
0.09531622.15591134.html.plaintext.txt	61	num pharmingen san diego ca
0.09531622.15591134.html.plaintext.txt	62	section washed pb incubated num hydrogen peroxide num min block endogenous peroxidase peroxidase conjugated streptavidin dako carpinteria ca num min humid chamber
0.09531622.15591134.html.plaintext.txt	63	reaction visualized addition diaminobenzidine substrate sigma chemical co
0.09531622.15591134.html.plaintext.txt	64	finally section rinsed distilled water counterstained mayer hematoxylin polyscientific bay shore ny washed running tap water dehydrated increasing concentration ethanol mounted cytoseal richard allan scientific kalamazoo mi
0.09531622.15591134.html.plaintext.txt	65	induction experimental autoimmune thyroiditis evaluation thyroid pathology study population included total num mouse cbaj background num wild type num female num male num thyr ciita transgenic num female num male
0.09531622.15591134.html.plaintext.txt	66	sixty three mouse num wild type num transgenic analyzed different time point num num month age basal condition without immunization d num table num
0.09531622.15591134.html.plaintext.txt	67	remaining num mouse num wild type num transgenic immunized twice d num num via sc injection gel purified murine thyroglobulin num microg emulsified complete freund adjuvant contains num mgml mycobacterium tuberculosis strain hnum ra difco laboratory detroit mi
0.09531622.15591134.html.plaintext.txt	68	mouse killed different time point immunization indicated table num
0.09531622.15591134.html.plaintext.txt	69	euthanasia trachea attached thyroid removed fixed num num d zinc based beckstead solution num
0.09531622.15591134.html.plaintext.txt	70	processing embedding paraffin six eight nonsequential section cut specimen stained hematoxylin eosin
0.09531622.15591134.html.plaintext.txt	71	section greatest surface area selected digital imaging performed described num
0.09531622.15591134.html.plaintext.txt	72	briefly acquisition image spot rt video camera mounted zeiss axioplot microscope image analyzed carnoy software
0.09531622.15591134.html.plaintext.txt	73	area corresponding entire thyroid gland marked measured used denominator b
0.09531622.15591134.html.plaintext.txt	74	area mononuclear cell infiltration marked summed used numerator
0.09531622.15591134.html.plaintext.txt	75	thyroid histopathology score expressed percentage total thyroid area infiltrated mononuclear cell ab x num
0.09531622.15591134.html.plaintext.txt	76	experimental protocol conformed john hopkins animal care use committee guideline
0.09531622.15591134.html.plaintext.txt	77	distribution mouse number wild type thyr ciita transgenic mouse according day killing immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	78	measurement mouse thyroglobulin specific igg antibody mouse bled retroorbital venous plexus beginning immunization num num num num num num num d first immunization
0.09531622.15591134.html.plaintext.txt	79	serum diluted pb numnum numnum incubated overnight immulonnum elisa plate dynex technology chantilly va precoated mouse thyroglobulin num ngwell
0.09531622.15591134.html.plaintext.txt	80	proper washing mouse thyroglobulin specific igg subclass detected using secondary antibody iggnum iggnuma iggnumb conjugated alkaline phosphatase
0.09531622.15591134.html.plaintext.txt	81	color change p nitrophenol phosphate measured num nm using emax microplate reader molecular device sunnyvale ca
0.09531622.15591134.html.plaintext.txt	82	plate included homemade standard curve derived serial dilution pool serum known mouse thyroglobulin antibody
0.09531622.15591134.html.plaintext.txt	83	standard curve allowed u express result arbitrary unit rather absorbance thus adjusting intra interassay variability
0.09531622.15591134.html.plaintext.txt	84	flow cytometry analysis draining cervical lymph node cervical lymph node isolated mechanically disrupted prepare single cell suspension
0.09531622.15591134.html.plaintext.txt	85	num min fc block num c lymphoid cell stained num min num c following monoclonal antibody pharmingen san diego ca fluorescein isothiocyanate conjugated anti bnum anti cdnum anti cdnum phycoerythrin conjugated anti cdnum anti cdnum cy chrome conjugated anti cdnum anti cdnum
0.09531622.15591134.html.plaintext.txt	86	data collected facscalibur cytometer becton dickinson san diego ca gated first forward side scatter cdnum compensated displayed using cellquest software becton dickinson
0.09531622.15591134.html.plaintext.txt	87	assessment thyroid function total tnum tsh level total tnum level measured commercial competitive ria gammacoat numitnum diasorin stillwater mn
0.09531622.15591134.html.plaintext.txt	88	mouse tsh measured highly sensitive double antibody ria developed
0.09531622.15591134.html.plaintext.txt	89	briefly assay employ highly purified rat tsh afpnumb iodinated ligand selected guinea pig antimouse tsh afpnum primary antibody partially purified extract mouse pituitary containing tsh afpnum
0.09531622.15591134.html.plaintext.txt	90	nummp reference preparation
0.09531622.15591134.html.plaintext.txt	91	cross reactivity either highly purified mouse fsh mouse lh mouse tsh ria le num
0.09531622.15591134.html.plaintext.txt	92	statistical analysis statistical analysis performed two phase
0.09531622.15591134.html.plaintext.txt	93	first phase analyzed cross sectionally whether mean severity thyroid lesion thyroid histopathology score differed wild type thyr ciita transgenic mouse
0.09531622.15591134.html.plaintext.txt	94	crude unadjusted effect covariate genotype outcome thyroid histopathology score calculated simple linear regression ignoring effect covariates
0.09531622.15591134.html.plaintext.txt	95	net adjusted effect genotype thyroid histopathology score holding covariates fixed calculated multiple linear regression
0.09531622.15591134.html.plaintext.txt	96	covariates relating thyroid histopathology score considered inclusion model addition genotype sex transgenic line day killing first immunization total tnum d num tsh d num thyroglobulin specific antibody d num
0.09531622.15591134.html.plaintext.txt	97	day killing immunization treated dummy variable d num chosen reference category
0.09531622.15591134.html.plaintext.txt	98	using stepwise backward selection removed sex total tnum d num tsh d num thyroglobulin specific antibody d num based p value greater num
0.09531622.15591134.html.plaintext.txt	99	final multiple linear regression model therefore included genotype transgenic line day killing covariates used estimate mean thyroid histopathology score
0.09531622.15591134.html.plaintext.txt	100	analysis residual fitting regression model indicated nonnormality heteroscedasticity
0.09531622.15591134.html.plaintext.txt	101	thus used bootstrapping num replication estimate se around regression coefficient perform valid hypothesis testing regression analysis nonnormal thyroid histopathology score
0.09531622.15591134.html.plaintext.txt	102	also analyzed cumulative incidence thyroiditis transgenic control labeling thyroiditis case mouse thyroid histopathology score greater num
0.09531622.15591134.html.plaintext.txt	103	rrs time point immunization expressed ratio incidence thyroiditis transgenic incidence wild type mouse
0.09531622.15591134.html.plaintext.txt	104	confidence interval around rrs calculated logarithmic scale result exponentiated
0.09531622.15591134.html.plaintext.txt	105	fisher exact test used test null hypothesis rrs equal num
0.09531622.15591134.html.plaintext.txt	106	second phase used multiple linear regression generalized estimating equation gee num analyze longitudinally thyroid function assessed total tnum tsh thyroglobulin antibody evolved immunization thyr ciita transgenic control
0.09531622.15591134.html.plaintext.txt	107	gee allows analysis multiple value tnum tsh mouse corrects fact characteristic single animal time likely correlated one another
0.09531622.15591134.html.plaintext.txt	108	gee analysis repeated measure participant clustered
0.09531622.15591134.html.plaintext.txt	109	furthermore gee analysis take account status changing value covariates time point
0.09531622.15591134.html.plaintext.txt	110	outcome used gee analysis total tnum tsh iggnum iggnuma iggnumb thyroglobulin specific antibody covariates addition genotype sex transgenic line day killing
0.09531622.15591134.html.plaintext.txt	111	statistical analysis performed using stata num stata corp
0.09531622.15591134.html.plaintext.txt	112	specific expression transgene thyroid gland assessed fluorescent microscopy showed characteristic green positivity gfp specifically within thyroid follicular cell fig
0.09531622.15591134.html.plaintext.txt	113	rt pcr revealed aberrant expression class ii mhc transcript thyrocytes thyr ciita transgenic thyrocytes wild type littermates fig
0.09531622.15591134.html.plaintext.txt	114	immunohistochemistry confirmed protein level expression class ii mhc molecule transgenic thyrocytes fig
0.09531622.15591134.html.plaintext.txt	115	numd wild type thyrocytes fig
0.09531622.15591134.html.plaintext.txt	116	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	117	thyroid expression function thyr ciita transgene
0.09531622.15591134.html.plaintext.txt	118	frozen section thyr ciita transgenic thyroid observed uv microscope direct green fluorescence xnum magnification num min exposure
0.09531622.15591134.html.plaintext.txt	119	inset represents background autofluorescence wild type thyroid xnum magnification num min exposure
0.09531622.15591134.html.plaintext.txt	120	b specific expression mhc class ii ak mrna transgenic thyroid assessed rt pcr
0.09531622.15591134.html.plaintext.txt	121	c control gel expression common housekeeping gene glyceraldehyde num phosphate dehydrogenase
0.09531622.15591134.html.plaintext.txt	122	b c gel minus sign indicates rt reaction performed absence reverse transcriptase control possible genomic dna contamination rna sample
0.09531622.15591134.html.plaintext.txt	123	lane num num bp dna marker lane num water control lane num num wild type littermate lane num num line c thyr ciita transgenic lane num num line d thyr ciita transgenic
0.09531622.15591134.html.plaintext.txt	124	d specific expression mhc class ii ak protein transgenic thyroid assessed immunohistochemistry
0.09531622.15591134.html.plaintext.txt	125	note diffuse cytosolic plasma membrane brown staining epithelial cell lining thyroid follicle thyr ciita transgenics
0.09531622.15591134.html.plaintext.txt	126	nucleus negative colored blue hematoxylin counterstain
0.09531622.15591134.html.plaintext.txt	127	e wild type control shown comparison
0.09531622.15591134.html.plaintext.txt	128	thyr ciita transgenic mouse developed normally normal litter size life span tnum level num
0.09531622.15591134.html.plaintext.txt	129	num microgdl plus minus num
0.09531622.15591134.html.plaintext.txt	130	none num mouse num wild type num transgenic analyzed histologically d num showed sign thyroid pathology fig
0.09531622.15591134.html.plaintext.txt	131	numa developed antibody mouse thyroglobulin fig
0.09531622.15591134.html.plaintext.txt	132	thus basal condition thyr ciita transgenic mouse despite ectopic expression mhc class ii molecule thyrocytes different wild type littermates develop spontaneous autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	133	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	134	thyroid histopathology different time point immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	135	d thyroid ciita transgenic mouse d num num b num c num d e f d num thyroid wild type e ciita transgenic f g h thyroid ciita transgenic mouse d num g num h
0.09531622.15591134.html.plaintext.txt	136	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	137	time series thyroglobulin specific antibody immunization
0.09531622.15591134.html.plaintext.txt	138	iggnuma isotype b iggnumb c iggnum
0.09531622.15591134.html.plaintext.txt	139	difference antibody level wild type transgenics therefore data represent pooled mean plus minus se genotype
0.09531622.15591134.html.plaintext.txt	140	number graph represent mouse analyzed time point
0.09531622.15591134.html.plaintext.txt	141	thyroid histopathology immunization mouse thyroglobulin immunized num mouse num wild type num transgenic mouse thyroglobulin assessed severity thyroid lesion thyroid histopathology score different time point thereafter
0.09531622.15591134.html.plaintext.txt	142	group mouse thyroid lesion already present although minimal num total thyroid area d num post immunization fig
0.09531622.15591134.html.plaintext.txt	143	increased num d num reached peak num d num fig
0.09531622.15591134.html.plaintext.txt	144	wild type mouse thyroid histopathology score decreased approximately num remained around value d num fig
0.09531622.15591134.html.plaintext.txt	145	thyr ciita transgenic instead score remained higher became significantly higher control d num
0.09531622.15591134.html.plaintext.txt	146	simple linear regression assessing crude effect genotype score revealed transgenic mouse tended severe disease average score num higher seen wild type although difference marked p num
0.09531622.15591134.html.plaintext.txt	147	multiple linear regression showed holding transgenic line day killing constant thyr ciita transgenic mouse average thyroid histopathology score num higher seen wild type num confidence interval num
0.09531622.15591134.html.plaintext.txt	148	overall result indicate thyr ciita transgenics developed thyroiditis moderately severe wild type control
0.09531622.15591134.html.plaintext.txt	149	pronounced separation transgenic wild type seen d num fig
0.09531622.15591134.html.plaintext.txt	150	num e f numb transgenics average thyroid histopathology score num compared wild type score num p num
0.09531622.15591134.html.plaintext.txt	151	group mouse score observed d num num num num num significantly higher observed d num num fig
0.09531622.15591134.html.plaintext.txt	152	num comparing d num num num num num d num num
0.09531622.15591134.html.plaintext.txt	153	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	154	distribution mean score thyr ciita transgenic wild type littermates d num several time point immunization b individual score thyr ciita transgenic wild type littermates d num immunization
0.09531622.15591134.html.plaintext.txt	155	addition severity also incidence thyroiditis tended greater thyr ciita transgenic mouse although time point difference reach statistical significance table num
0.09531622.15591134.html.plaintext.txt	156	incidence experimental autoimmune thyroiditis wild type thyr ciita transgenic mouse immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	157	antibody response thyroglobulin immunization mouse thyroglobulin longitudinal data regression analysis demonstrated iggnum iggnumb isotypes specific mouse thyroglobulin followed similar pattern reached similar level thyr ciita transgenic control
0.09531622.15591134.html.plaintext.txt	158	began increase d num post immunization became significantly higher d num reached peak d num p num
0.09531622.15591134.html.plaintext.txt	159	iggnum iggnumb gradually decreased d num num num still remaining significantly higher d num
0.09531622.15591134.html.plaintext.txt	160	iggnuma isotype attained higher level iggnum iggnumb isotypes showed different trend
0.09531622.15591134.html.plaintext.txt	161	also reached peak d num continued stay high d num
0.09531622.15591134.html.plaintext.txt	162	significant difference observed d num num num num although mean value looked higher d num fig
0.09531622.15591134.html.plaintext.txt	163	iggnuma level decreased d num still remaining significantly higher d num p num
0.09531622.15591134.html.plaintext.txt	164	iggnuma level differ thyr ciita transgenic control
0.09531622.15591134.html.plaintext.txt	165	lymphocyte activation draining cervical lymph node immunization mouse thyroglobulin shown experimental model type num diabetes mellitus activation islet specific cdnum cell precedes onset diabetes occurs draining pancreatic lymph node within islet num
0.09531622.15591134.html.plaintext.txt	166	observation also confirmed primate experimental allergic encephalomyelitis human multiple sclerosis num
0.09531622.15591134.html.plaintext.txt	167	therefore looked cdnum cell activation marker increased expression cdnum cdnum diminished display cdnuml cervical lymph node draining thyroid gland
0.09531622.15591134.html.plaintext.txt	168	immunization mouse thyroglobulin d num activated cdnum cell fig
0.09531622.15591134.html.plaintext.txt	169	numa thyr ciita transgenic wild type littermates
0.09531622.15591134.html.plaintext.txt	170	d num immunization significant increase d num p num
0.09531622.15591134.html.plaintext.txt	171	num percentage activated cdnum cell fig
0.09531622.15591134.html.plaintext.txt	172	numb difference however transgenic wild type
0.09531622.15591134.html.plaintext.txt	173	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	174	flow cytometry analysis draining cervical lymph node marker cell activation
0.09531622.15591134.html.plaintext.txt	175	expression cdnum cdnum gated cdnum cell num d b immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	176	four six lymph node collected mouse pooled analysis performed num thyr ciita transgenic mouse seven wild type control
0.09531622.15591134.html.plaintext.txt	177	thyroid function immunization mouse thyroglobulin longitudinal regression analysis showed total tnum significantly decreased average num
0.09531622.15591134.html.plaintext.txt	178	num microgdl d num average num
0.09531622.15591134.html.plaintext.txt	179	tnum remained significantly low d num difference among d num num num num increased normal level d num p num
0.09531622.15591134.html.plaintext.txt	180	holding covariates constant transgenic line sex day killing thyroglobulin specific antibody difference thyr ciita transgenic wild type total tnum level
0.09531622.15591134.html.plaintext.txt	181	total tnum poor predictor thyroid histopathology score p num
0.09531622.15591134.html.plaintext.txt	182	num multiple linear regression analysis
0.09531622.15591134.html.plaintext.txt	183	decrease total tnum d num present rise tsh suggesting decrease represents recovery phase euthyroid sick syndrome induced immunization procedure
0.09531622.15591134.html.plaintext.txt	184	view larger version numk fig
0.09531622.15591134.html.plaintext.txt	185	total tnum level tsh level b ciita transgenic wild type littermates several time point immunization mouse thyroglobulin
0.09531622.15591134.html.plaintext.txt	186	dotted line indicate normal reference range cbaj mouse numth numth percentile
0.09531622.15591134.html.plaintext.txt	187	num microgdl tnum num num uml tsh
0.09531622.15591134.html.plaintext.txt	188	tsh began increase num d immunization became significantly higher d num d num p num
0.09531622.15591134.html.plaintext.txt	189	num returned normal level d num fig
0.09531622.15591134.html.plaintext.txt	190	holding covariates constant thyr ciita transgenic tended higher tsh level although difference reach statistical significance p num
0.09531622.15591134.html.plaintext.txt	191	similarly observed thyroid pathology greatest distinction wild type thyr ciita transgenic observed d num post immunization fig
0.09531622.15591134.html.plaintext.txt	192	among humoral predictor measured study total tnum tsh iggnum iggnuma iggnumb thyroglobulin antibody tsh best predictor thyroid histopathology score
0.09531622.15591134.html.plaintext.txt	193	multiple linear regression showed every num u increase serum tsh score increased num
0.09531622.15591134.html.plaintext.txt	194	focused class ii mhc molecule used experimental autoimmune thyroiditis classical model organ specific autoimmunity
0.09531622.15591134.html.plaintext.txt	195	class ii molecule primarily expressed antigen presenting cell hematopoietic lineage also induced endothelial epithelial cell
0.09531622.15591134.html.plaintext.txt	196	observation raised question whether nonhematopoietic parenchymal cell function antigen presenting cell whether required damage target organ
0.09531622.15591134.html.plaintext.txt	197	much work come transplantation field generated conflicting result
0.09531622.15591134.html.plaintext.txt	198	num found mouse lacking secondary lymphoid organ spleen lymph node mucosa associated lymphoid tissue incapable rejecting either skin allograft primarily vascularized cardiac allograft suggesting secondary lymphoid organ required initiating immune response
0.09531622.15591134.html.plaintext.txt	199	num using model graft v
0.09531622.15591134.html.plaintext.txt	200	host disease bone marrow chimera expressing mhc molecule antigen presenting cell epithelial endothelial cell found graft capable inducing epithelial damage target organ skin gut liver host expressed mhc molecule host antigen presenting cell host target epithelium
0.09531622.15591134.html.plaintext.txt	201	study consistent recent direct visual evidence immune response indicating naive cell constantly roam secondary lymphoid organ encounter antigen presenting cell taken antigen target organ brought lymphoid organ num num num num
0.09531622.15591134.html.plaintext.txt	202	study also consistent notion naive cell posse receptor necessary homing secondary lymphoid organ rather nonlymphoid organ notion nonprofessional antigen presenting cell usually lack costimulatory molecule required complete cell activation
0.09531622.15591134.html.plaintext.txt	203	side however kreisel et al
0.09531622.15591134.html.plaintext.txt	204	num showed naive cdnum cell indeed activated vitro vivo nonprofessional antigen presenting cell likely endothelial cell lead prompt rejection cardiac allograft suggesting endothelial expression mhc molecule direct pathogenic immune response independently expression mhc molecule professional antigen presenting cell
0.09531622.15591134.html.plaintext.txt	205	expressed via transgenesis transcriptional regulator ciita specifically nonprofessional antigen presenting cell thyrocyte
0.09531622.15591134.html.plaintext.txt	206	ciita transcription factor defective cause severe primary immunodeficiency called bare lymphocyte syndrome num entirely attributable absence class ii mhc expression
0.09531622.15591134.html.plaintext.txt	207	ciita true coactivator bind directly dna mediates function class ii mhc promoter interaction protein num
0.09531622.15591134.html.plaintext.txt	208	considered master regulator necessary sufficient expression gene mhc class ii pathway num although recently shown control gene outside mhc num
0.09531622.15591134.html.plaintext.txt	209	ciita three different isoforms synthesized different cell specific promoter num promoter num used dendritic cell promoter num b lymphocyte promoter num nonhematopoietic cell
0.09531622.15591134.html.plaintext.txt	210	previously shown vitro promoter num mediates interferon induced transcription ciita thyrocytes num thus used type num isoform ciita present study
0.09531622.15591134.html.plaintext.txt	211	basal condition ciita transgenic mouse differ wild type littermates
0.09531622.15591134.html.plaintext.txt	212	develop spontaneously autoimmune thyroiditis despite aberrant expression class ii mhc molecule thyrocytes
0.09531622.15591134.html.plaintext.txt	213	finding agreement recent report li et al
0.09531622.15591134.html.plaintext.txt	214	num show thyroidal expression class ii molecule driven tsh receptor promoter lead apparent thyroid autoimmunity
0.09531622.15591134.html.plaintext.txt	215	phenomenon seem limited thyroid gland
0.09531622.15591134.html.plaintext.txt	216	num expressed ciita fact specifically central nervous system using promoter glial fibrillary protein herkel et al
0.09531622.15591134.html.plaintext.txt	217	num expressed liver using c reactive protein promoter
0.09531622.15591134.html.plaintext.txt	218	case despite aberrant expression class ii mhc molecule astrocyte hepatocytes mouse develop spontaneous autoimmunity
0.09531622.15591134.html.plaintext.txt	219	taken together observation strongly suggest expression class ii mhc molecule nonprofessional antigen presenting cell sufficient initiate autoimmune disease
0.09531622.15591134.html.plaintext.txt	220	postulate expression likely result inflammatory stimulus interferon lipopolysaccharide released immune cell infiltrate target organ rather initiating event recruit immune cell target organ
0.09531622.15591134.html.plaintext.txt	221	addition basal condition also interested analyzing role class ii molecule thyrocytes autoimmune response
0.09531622.15591134.html.plaintext.txt	222	upon immunization thyr ciita transgenic mouse developed thyroiditis moderately severe greater incidence observed wild type littermates
0.09531622.15591134.html.plaintext.txt	223	difference severity although higher transgenics time point became significantly higher d num immunization
0.09531622.15591134.html.plaintext.txt	224	result suggest thyrocytes expressing class ii mhc molecule play secondary role initiation phase serve better target facilitate greater immunopathology process already begun
0.09531622.15591134.html.plaintext.txt	225	lack significant difference thyroiditis severity earlier time point d num num explained fact immunization protocol used effective inducing thyroid lesion majority mouse incidence comprised num num wild type num transgenic
0.09531622.15591134.html.plaintext.txt	226	notion class ii mhc molecule epithelial cell modulatory role autoimmune attack begun intriguing may possible relevance hashimoto thyroiditis graf disease num
0.09531622.15591134.html.plaintext.txt	227	disease fact collectively referred autoimmune thyroiditis expression class ii molecule may indicate particularly severe stage disease
0.09531622.15591134.html.plaintext.txt	228	question difficult ass human use mouse model essential allows u analyze disease period time rather single time point
0.09531622.15591134.html.plaintext.txt	229	greater severity thyroid lesion displayed thyr ciita transgenic result greater number function activated cell considering cdnum cell cervical lymph node expressed similar level activation marker wild type transgenics
0.09531622.15591134.html.plaintext.txt	230	difference likely explained fact thyrocytes expressing class ii mhc molecule better recognized autoreactive cdnum cell cell already expanded
0.09531622.15591134.html.plaintext.txt	231	word thyrocytes may serve endogenous immunogen potentiate expand reactivity cell initially selected thyroglobulin immunization protocol
0.09531622.15591134.html.plaintext.txt	232	well established cell activation requires formation specialized cell cell junction antigen presenting cell called immunological synapse facilitates outcome immune recognition num
0.09531622.15591134.html.plaintext.txt	233	center synapse occupied cell receptorcdnum complex cdnum coreceptors cell side mhcpeptide complex antigen presenting side
0.09531622.15591134.html.plaintext.txt	234	also center costimulatory molecule cdnum cdnum ligand cell bnum cdnum antigen presenting cell
0.09531622.15591134.html.plaintext.txt	235	periphery synapse instead occupied integrins lymphocyte function associated antigen num cdnum cell intercellular adhesion molecule num cdnum antigen presenting cell
0.09531622.15591134.html.plaintext.txt	236	function efficiently antigen presenting cell thyrocytes aberrantly express mhc class ii molecule also express costimulatory molecule integrins
0.09531622.15591134.html.plaintext.txt	237	thyrocytes patient graf disease hashimoto thyroiditis shown express integrins intercellular adhesion molecule num cdnum num num costimulator cdnum num num
0.09531622.15591134.html.plaintext.txt	238	expression thyrocytes bnum probably potent costimulator le firmly established although reported hashimoto thyroiditis num differentiated thyroid tumor num
0.09531622.15591134.html.plaintext.txt	239	bnum costimulation could also supplied trans professional antigen presenting cell parenchymal cell num
0.09531622.15591134.html.plaintext.txt	240	thus theory thyrocytes aberrantly expressing class ii mhc molecule posse signal transduction circuitry necessary full cell activation although unknown whether individual component associate supramolecular activation complex
0.09531622.15591134.html.plaintext.txt	241	show expression thyrocytes class ii mhc insufficient initiate autoimmune thyroiditis
0.09531622.15591134.html.plaintext.txt	242	result emphasize importance location initiation immune response location likely requires interaction autoreactive cell antigen presenting cell within secondary lymphoid organ
0.09531622.15591134.html.plaintext.txt	243	conclusion study report expression class ii mhc molecule epithelial thyroid cell required initiation autoimmune attack thyroid
0.09531622.15591134.html.plaintext.txt	244	initiation seems mainly mediated professional antigen presenting cell secondary lymphoid organ
0.09531622.15591134.html.plaintext.txt	245	immune recognition begun however aberrant expression class ii nonprofessional antigen presenting cell facilitate disease progression yield severe disease
0.09531622.15591134.html.plaintext.txt	246	additional study required fully explain intriguing association mhc molecule autoimmune disease
0.09531622.15591134.html.plaintext.txt	247	acknowledgment grateful drs
0.09531622.15591134.html.plaintext.txt	248	baldwin james tonascia critical revision manuscript
0.09531622.15591134.html.plaintext.txt	249	footnote work supported national institute health grant dknum p
0.09531622.15591134.html.plaintext.txt	250	first published online december num num
0.09531622.15591134.html.plaintext.txt	251	abbreviation ciita class ii transactivator gee generalized estimating equation gfp green fluorescent protein mhc major histocompatibility complex rr relative risk
0.09531622.15591134.html.plaintext.txt	252	accepted publication december num num
0.09531622.15591134.html.plaintext.txt	253	home help feedback subscription archive search table content endocrinology endocrine review j
0.09531622.15591134.html.plaintext.txt	254	molecular endocrinology recent prog
0.0967214.12399421.html.plaintext.txt	0	combined blockade micro opioid receptor prevents acute orexigenic action agouti related protein
0.0967214.12399421.html.plaintext.txt	1	department animal physiology
0.0967214.12399421.html.plaintext.txt	2	university groningen num aa haren groningen netherlands department psychiatry d
0.0967214.12399421.html.plaintext.txt	3	university cincinnati cincinnati ohio num
0.0967214.12399421.html.plaintext.txt	4	address correspondence request reprint randy j
0.0967214.12399421.html.plaintext.txt	5	department psychiatry university cincinnati cincinnati ohio num num
0.0967214.12399421.html.plaintext.txt	6	given asp normally found cns role asp regulating mc receptor signaling brain unlikely
0.0967214.12399421.html.plaintext.txt	7	however homolog asp termed agouti related protein agrp made arcuate nucleus hypothalamus population neuron adjacent overlapping neuron produce msh num num num
0.0967214.12399421.html.plaintext.txt	8	agrp act antagonist mcnum mcnum receptor num num
0.0967214.12399421.html.plaintext.txt	9	hence agrp opposes action msh
0.0967214.12399421.html.plaintext.txt	10	consistent agrp msh precursor proopiomelanocortin regulated opposite direction energy balance leptin
0.0967214.12399421.html.plaintext.txt	11	food deprivation decrease proopiomelanocortin gene expression whereas increase agrp gene expression arcuate nucleus num num num
0.0967214.12399421.html.plaintext.txt	12	overexpression agrp result obese phenotype similar mouse overexpress asp num
0.0967214.12399421.html.plaintext.txt	13	biologically active fragment agrp administered third ventricle inumvt rat increase food intake last num d num num
0.0967214.12399421.html.plaintext.txt	14	although short term effect agrp seem depend antagonism identified mc receptor long term effect num
0.0967214.12399421.html.plaintext.txt	15	moreover like neuropeptide y npy orexigenic effect agrp blocked nonspecific opioid receptor antagonist naloxone num num
0.0967214.12399421.html.plaintext.txt	16	thus potent effect agrp increase food intake depend critically activation opioid receptor
0.0967214.12399421.html.plaintext.txt	17	opioid receptor come three identified subtypes micro num micro strongly implicated control food intake num
0.0967214.12399421.html.plaintext.txt	18	thus aim experiment ass role specific opioid receptor subtypes mediating effect agrp increase food intake
0.0967214.12399421.html.plaintext.txt	19	surgery guide sleeve plastic one guide num g catalog
0.0967214.12399421.html.plaintext.txt	20	cnumg obdurator num g catalog
0.0967214.12399421.html.plaintext.txt	21	cnum dc aimed third cerebral ventricle implanted
0.0967214.12399421.html.plaintext.txt	22	coordinate midline num
0.0967214.12399421.html.plaintext.txt	23	num mm ventral dura bregma vertical coordinate paxinos watson num
0.0967214.12399421.html.plaintext.txt	24	minimum num d recovery accuracy placement verified injection inumvt num ng angiotensin saline injector inserted guide sleeve
0.0967214.12399421.html.plaintext.txt	25	rat drank num ml hour injection used experiment
0.0967214.12399421.html.plaintext.txt	26	chemical agrpnum num purchased phoenix pharmaceutical inc
0.0967214.12399421.html.plaintext.txt	27	binaltorphimine norbni hydrochloride s funaltrexamine s fna hydrochloride purchased sigma st
0.0967214.12399421.html.plaintext.txt	28	norbni widely used selective antagonist opioid receptor num num s fna widely used selective micro opioid receptor antagonist num num
0.0967214.12399421.html.plaintext.txt	29	selective antagonist action s fna unique time course becoming selective action apparent num h administration num
0.0967214.12399421.html.plaintext.txt	30	thus experiment s fna actually administered num h food intake measurement
0.0967214.12399421.html.plaintext.txt	31	agrp dissolved physiological saline served control solution
0.0967214.12399421.html.plaintext.txt	32	norbni s fna dissolved num methanol served control solution
0.0967214.12399421.html.plaintext.txt	33	solution administered inumvt num microl vol
0.0967214.12399421.html.plaintext.txt	34	feeding schedule animal access high fat hf modified ain numm purified pelleted rodent diet dyets inc
0.0967214.12399421.html.plaintext.txt	35	bethlehem pa see table num diet composition num h day starting light
0.0967214.12399421.html.plaintext.txt	36	remaining num h rat access pelleted laboratory chow harlan teklad indianapolis
0.0967214.12399421.html.plaintext.txt	37	paradigm used produce reliable num h intake agrp ligand opioid receptor potently influence intake preferred hf diet diet num
0.0967214.12399421.html.plaintext.txt	38	consequently opioids important mediating effect agrp likely observed hf feeding alternative paradigm
0.0967214.12399421.html.plaintext.txt	39	water available ad libitum
0.0967214.12399421.html.plaintext.txt	40	body weight baseline food intake measured throughout experiment
0.0967214.12399421.html.plaintext.txt	41	macronutrient composition pelleted rodent chow hf diet
0.0967214.12399421.html.plaintext.txt	42	experiment num dose response determination opioid receptor antagonist first goal determine subthreshold dose opioid antagonist use subsequent experiment
0.0967214.12399421.html.plaintext.txt	43	end focused low end dose effect curve accurately determine highest dose norbni clearly subthreshold
0.0967214.12399421.html.plaintext.txt	44	effect food intake
0.0967214.12399421.html.plaintext.txt	45	four group naive rat n num numgroup administered norbni inumvt num h presentation hf diet num num num num nmol subsequent consumption hf diet chow measured
0.0967214.12399421.html.plaintext.txt	46	data analyzed one way anova followed dunnet test compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	47	experiment num dose response determination micro opioid receptor antagonist rat experiment num used experiment num num d experimental manipulation baseline intake body weight returned normal occurred within num h
0.0967214.12399421.html.plaintext.txt	48	analogous experiment num determined inumvt dose effect curve micro selective antagonist s fna administering num num
0.0967214.12399421.html.plaintext.txt	49	num num num nmol dos num h access hf diet measuring subsequent hf chow consumption
0.0967214.12399421.html.plaintext.txt	50	data analyzed one way anova followed dunnet test compare dose vehicle control
0.0967214.12399421.html.plaintext.txt	51	experiment num effect norbni agrpnum num induced food intake experimental day rat received two inumvt injection
0.0967214.12399421.html.plaintext.txt	52	first occurred num h second contained norbni highest subthreshold dose determined experiment num vehicle
0.0967214.12399421.html.plaintext.txt	53	second injection contained either saline agrp num nmol
0.0967214.12399421.html.plaintext.txt	54	second injection occurred num min light therefore num min access hf diet
0.0967214.12399421.html.plaintext.txt	55	rat n num tested twice num d apart two four condition num methanol saline num norbni num nmol saline num methanol agrp num nmol num norbni num nmol agrp num nmol
0.0967214.12399421.html.plaintext.txt	56	saline within subject factor whereas norbni v
0.0967214.12399421.html.plaintext.txt	57	methanol subject factor condition order counterbalanced across subject
0.0967214.12399421.html.plaintext.txt	58	food intake measured every num min access hf diet
0.0967214.12399421.html.plaintext.txt	59	num h hf diet replaced chow chow intake recorded remaining num h data analyzed using mixed model anova followed tukey post hoc test
0.0967214.12399421.html.plaintext.txt	60	experiment num effect s fna agrpnum num induced food intake experiment num used separate group naive animal n num design exactly parallel experiment num except selective opioid antagonist s fna maximally subthreshold dose determined experiment num num
0.0967214.12399421.html.plaintext.txt	61	num nmol methanol given num h agrp saline administration
0.0967214.12399421.html.plaintext.txt	62	food intake measured every num min access hf diet
0.0967214.12399421.html.plaintext.txt	63	num h hf diet replaced chow chow intake recorded remaining num h data analyzed using mixed model anova followed tukey post hoc test
0.0967214.12399421.html.plaintext.txt	64	experiment num effect combined norbni s fna agrpnum num induced food intake goal determine whether combined blockade micro opioid receptor attenuates agrp induced food intake
0.0967214.12399421.html.plaintext.txt	65	rat experiment num experiment num used experiment least num d rest food intake body weight returned baseline level
0.0967214.12399421.html.plaintext.txt	66	test day animal received three separate injection
0.0967214.12399421.html.plaintext.txt	67	twenty hour receiving either agrp saline rat received injection either methanol s fna num
0.0967214.12399421.html.plaintext.txt	68	methanol norbni num nmol injected num h final injection saline agrp num nmol
0.0967214.12399421.html.plaintext.txt	69	light animal given access hf diet num h
0.0967214.12399421.html.plaintext.txt	70	food intake measured every num min
0.0967214.12399421.html.plaintext.txt	71	num h hf diet replaced chow chow intake measured remaining num h
0.0967214.12399421.html.plaintext.txt	72	animal run one condition n num numgroup data analyzed two way anova followed tukey post hoc test
0.0967214.12399421.html.plaintext.txt	73	view larger version numk figure num
0.0967214.12399421.html.plaintext.txt	74	mean num h intake hf diet various dos norbni
0.0967214.12399421.html.plaintext.txt	75	num compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	76	experiment num effect s fna food intake dose effect curve s fna depicted fig
0.0967214.12399421.html.plaintext.txt	77	one way anova num h cumulative intake significant fnum num num
0.0967214.12399421.html.plaintext.txt	78	num post hoc analysis revealed injection num nmol s fna significantly suppressed num h intake hf diet compared vehicle p num
0.0967214.12399421.html.plaintext.txt	79	nonsignificant trend p num
0.0967214.12399421.html.plaintext.txt	80	num nmol dose inhibit food intake see fig
0.0967214.12399421.html.plaintext.txt	81	consequently chose use num
0.0967214.12399421.html.plaintext.txt	82	num nmol highest clearly subthreshold dose experiment
0.0967214.12399421.html.plaintext.txt	83	chow intake following num h reduced dose s fna
0.0967214.12399421.html.plaintext.txt	84	view larger version numk figure num
0.0967214.12399421.html.plaintext.txt	85	mean num h intake hf diet various dos s fna
0.0967214.12399421.html.plaintext.txt	86	num compared vehicle treatment
0.0967214.12399421.html.plaintext.txt	87	experiment num effect norbni agrpnum num induced food intake previously reported num agrp significantly increased intake hf diet fnum num num
0.0967214.12399421.html.plaintext.txt	88	num subsequent chow intake data shown
0.0967214.12399421.html.plaintext.txt	89	effect norbni influence food intake fnum num num
0.0967214.12399421.html.plaintext.txt	90	num significant interaction agrp norbni fnum num num
0.0967214.12399421.html.plaintext.txt	91	thus unlike subthreshold dos nonspecific opioid antagonist naloxone norbni reduce agrp orexigenic effect num h
0.0967214.12399421.html.plaintext.txt	92	noted baseline food intake uninjected day vehicle injected day lower experiment num num num experiment num num
0.0967214.12399421.html.plaintext.txt	93	experiment num num num run summer month ambient temperature ambient humidity higher february experiment num num run
0.0967214.12399421.html.plaintext.txt	94	despite vivarium temperature humidity controlled observed experiment animal room higher level humidity summer reduces consumption hf diet
0.0967214.12399421.html.plaintext.txt	95	importantly dose norbni determined subthreshold experiment num remained subthreshold experiment num despite lower baseline food intake
0.0967214.12399421.html.plaintext.txt	96	view larger version numk figure num
0.0967214.12399421.html.plaintext.txt	97	mean num h intake hf diet inumvt agrp vehicle pretreatment subthreshold dose num nmol selective opioid receptor antagonist norbni
0.0967214.12399421.html.plaintext.txt	98	num compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	99	experiment num effect s fna agrpnum num induced food intake similar occurred experiment num agrp significantly increased intake hf diet see fig
0.0967214.12399421.html.plaintext.txt	100	num subsequent chow intake data shown
0.0967214.12399421.html.plaintext.txt	101	s fna alter food intake fnum num num
0.0967214.12399421.html.plaintext.txt	102	num alter increase num h food intake caused agrp see fig
0.0967214.12399421.html.plaintext.txt	103	num act alter agrp effect time point data shown
0.0967214.12399421.html.plaintext.txt	104	thus unlike subthreshold dos nonspecific antagonist naloxone s fna reduce agrp orexigenic effect
0.0967214.12399421.html.plaintext.txt	105	view larger version numk figure num
0.0967214.12399421.html.plaintext.txt	106	mean num h intake hf diet inumvt agrp vehicle pretreatment subthreshold dose num
0.0967214.12399421.html.plaintext.txt	107	num nmol micro selective opioid receptor antagonist s fna
0.0967214.12399421.html.plaintext.txt	108	num compared vehiclevehicle condition
0.0967214.12399421.html.plaintext.txt	109	experiment num effect combined norbni s fna agrpnum num induced food intake vehicle treated rat two methanol injection one saline injection showed normal num h food consumption comparable baseline food intake experiment indicating complicated procedure stressful well handled animal
0.0967214.12399421.html.plaintext.txt	110	observed experiment num num agrp significantly increased hf diet fnum num num
0.0967214.12399421.html.plaintext.txt	111	num chow intake data shown compared baseline condition
0.0967214.12399421.html.plaintext.txt	112	combined administration norbni s fna significantly attenuated effect agrp increase intake hf diet interaction fnum num num
0.0967214.12399421.html.plaintext.txt	113	importantly occurred despite fact combined administration two opioid receptor antagonist dos effect food intake absence agrp fnum num num
0.0967214.12399421.html.plaintext.txt	114	effect agrp increase num h chow intake altered combined opioid receptor antagonist data shown
0.0967214.12399421.html.plaintext.txt	115	view larger version numk figure num
0.0967214.12399421.html.plaintext.txt	116	mean num h intake hf diet inumvt agrp vehicle pretreatment subthreshold dos combined norbni s fna
0.0967214.12399421.html.plaintext.txt	117	num compared vehiclevehicle treatment
0.0967214.12399421.html.plaintext.txt	118	data therefore consistent hypothesis acute effect agrp increase food intake depends activation opioid receptor
0.0967214.12399421.html.plaintext.txt	119	however data also indicate either micro opioid receptor activation sufficient mediate effect agrp receptor subtypes blocked agrp longer activate critical aspect cns circuitry necessary increase food intake acutely
0.0967214.12399421.html.plaintext.txt	120	result potentially analogous npy suprathreshold dos either micro receptor antagonist reduce orexigenic effect npy num
0.0967214.12399421.html.plaintext.txt	121	however experiment determined whether combined micro receptor blockade would inhibit npy induced feeding
0.0967214.12399421.html.plaintext.txt	122	npy agrp largely colocalized within arcuate nucleus hypothalamus num num num mrna elevated fasting also obob dbdb mouse num
0.0967214.12399421.html.plaintext.txt	123	moreover acute effect npy agrp associated recruitment many brain region num
0.0967214.12399421.html.plaintext.txt	124	consequently current data extend similarity npy agrp include recruiting opioid receptor subtypes
0.0967214.12399421.html.plaintext.txt	125	several line evidence implicate opioid system control food intake num
0.0967214.12399421.html.plaintext.txt	126	microinjection experiment identified numerous site every level neuroaxis opioid agonist antagonist affect food intake review see ref
0.0967214.12399421.html.plaintext.txt	127	particular whereas opioid agonist antagonist increase decrease food intake respectively also influence food choice
0.0967214.12399421.html.plaintext.txt	128	micro selective antagonist found decrease intake hf diet greater extent decrease intake high carbohydrate diet num
0.0967214.12399421.html.plaintext.txt	129	controversy exists however whether effect opioids alter animal choice macronutrients simply drive organism consume already preferred food num
0.0967214.12399421.html.plaintext.txt	130	regardless interpretation consistent important role opioid receptor subtypes mediating effect agrp
0.0967214.12399421.html.plaintext.txt	131	similar occurs manipulation opioid receptor signaling administration agrp selectively increase intake preferred hf diet num
0.0967214.12399421.html.plaintext.txt	132	additionally stimulation micro receptor nucleus accumbens preferentially enhances hf feeding num
0.0967214.12399421.html.plaintext.txt	133	strong parallel agrp opioid receptor ligand food intake food selection strengthen hypothesis two system interact important way influence food intake food choice
0.0967214.12399421.html.plaintext.txt	134	opioid system encompasses number distributed receptor population well number endogenous ligand receptor
0.0967214.12399421.html.plaintext.txt	135	experiment opioid receptor antagonist delivered third ventricle hence close hypothalamus
0.0967214.12399421.html.plaintext.txt	136	however given lipophyllic nature compound rostral caudal flow cerebrospinal fluid ventricular system likely antagonist could interact opioid receptor variety neuroanatomical site num
0.0967214.12399421.html.plaintext.txt	137	although experiment therefore determine exact location critical micro opioid receptor clue derived area show increase fo like immunoreactivity third ventricular administration agrp
0.0967214.12399421.html.plaintext.txt	138	two hour agrp administration fo increased accumbens shell lateral septum paraventricular dorsomedial nucleus hypothalamus
0.0967214.12399421.html.plaintext.txt	139	num h fo increased accumbens shell lateral septum central nucleus amygdala lateral hypothalamus nucleus solitary tract num
0.0967214.12399421.html.plaintext.txt	140	region show evidence micro receptor binding andor expression nucleus solitary tract lateral hypothalamus show high level binding receptor num num num
0.0967214.12399421.html.plaintext.txt	141	future research need address whether activation either micro receptor subtypes sufficient produce agrp effect neuroanatomical site occurs result activation disparate site
0.0967214.12399421.html.plaintext.txt	142	separate related question endogenous opioid ligand ligand blocked specific receptor antagonist increased release agrp administration
0.0967214.12399421.html.plaintext.txt	143	search specific function opioid ligand hampered fact interact multiple subtypes opioid receptor num num recent demonstration opioid receptor subtypes make heterodimers num
0.0967214.12399421.html.plaintext.txt	144	nevertheless s endorphin dynorphin high affinity micro opioid receptor num num num s endorphin made arcuate nucleus hypothalamus num cell hypothesized express mcnum receptor num num nucleus solitary tract region high mcnum receptor expression
0.0967214.12399421.html.plaintext.txt	145	thus possible agrp given third ventricle could exert direct effect one s endorphin population
0.0967214.12399421.html.plaintext.txt	146	food intake stimulated s endorphin significantly dose dependently attenuated pretreatment either micro selective antagonist num num
0.0967214.12399421.html.plaintext.txt	147	num antagonist worked high equimolar dos relative s fna conceivable could exerting effect multiple rather specific opioid receptor
0.0967214.12399421.html.plaintext.txt	148	none antagonist dos used silva study completely eliminated s endorphin induced feeding proposed analogous finding agrp blockade multiple opioid receptor might necessary produce effect
0.0967214.12399421.html.plaintext.txt	149	dynorphin made paraventricular nucleus lateral area hypothalamus region express high level mcnum receptor num
0.0967214.12399421.html.plaintext.txt	150	group berthoud colleague num shown agrp induced fo lateral hypothalamus colocalized orexin immunoreactivity
0.0967214.12399421.html.plaintext.txt	151	dynorphin heavily colocalized orexin lateral hypothalamus num provides direct evidence agrp activate dynorphin containing neuron
0.0967214.12399421.html.plaintext.txt	152	use either mouse targeted deletion s endorphin num num dynorphin could clarify role two opioid peptide orexigenic action agrp
0.0967214.12399421.html.plaintext.txt	153	exact role opioid system control food intake remains uncertain
0.0967214.12399421.html.plaintext.txt	154	given large number different receptor ligand however likely role one dimensional rather encompasses number aspect ingestive behavior num
0.0967214.12399421.html.plaintext.txt	155	present data point specific role micro opioid receptor mediating effect hypothalamic mc system
0.0967214.12399421.html.plaintext.txt	156	intimate relationship mc system point long term regulation energy balance one important role played opioid system
0.0967214.12399421.html.plaintext.txt	157	future research need address functional interaction opioid system hypothalamic peptide also explore potential involvement opioid system etiology treatment disorder energy balance regulation obesity
0.0967214.12399421.html.plaintext.txt	158	footnote work supported fund nih dk num dk num dk num fund procter amp gamble cincinnati oh
0.0967214.12399421.html.plaintext.txt	159	abbreviation agrp agouti related protein asp agouti signaling protein cns central nervous system s fna s funaltrexamine hf high fat inumvt administered third ventricle mc melanocortin norbni binaltorphine npy neuropeptide y
0.0967214.12399421.html.plaintext.txt	160	accepted publication july num num
0.09719374.15994572.html.plaintext.txt	0	modafinil modulates anterior cingulate function chronic schizophrenia sean
0.09719374.15994572.html.plaintext.txt	1	spence mrcpsych russell d
0.09719374.15994572.html.plaintext.txt	2	sheffield cognition neuroimaging laboratory scanlab academic clinical psychiatry division genomic medicine university sheffield
0.09719374.15994572.html.plaintext.txt	3	academic unit radiology university sheffield
0.09719374.15994572.html.plaintext.txt	4	scanlab academic clinical psychiatry division genomic medicine university sheffield sheffield uk
0.09719374.15994572.html.plaintext.txt	5	spence sheffield cognition neuroimaging scanlab academic clinical psychiatry division genomic medicine university sheffield longley centre norwood grange drive sheffield snum numjt uk
0.09719374.15994572.html.plaintext.txt	6	tel num num num num num fax num num num num num e mail
0.09719374.15994572.html.plaintext.txt	7	declaration interest study supported investigator led award
0.09719374.15994572.html.plaintext.txt	8	supported wellcome trust uk
0.09719374.15994572.html.plaintext.txt	9	aim study acute effect modafinil administration upon brain activity cognitive performance people chronic schizophrenia
0.09719374.15994572.html.plaintext.txt	10	method randomised double blind placebo controlled crossover design num patient received either modafinil num mg placebo prior undertaking working memory task functional magnetic resonance imaging
0.09719374.15994572.html.plaintext.txt	11	result seventeen patient completed study another underwent acute relapse num day post drug
0.09719374.15994572.html.plaintext.txt	12	modafinil administration associated significantly greater activation anterior cingulate cortex working memory task
0.09719374.15994572.html.plaintext.txt	13	anterior cingulate cortex signal correlated cognitive performance although subset patient exhibited enhancement
0.09719374.15994572.html.plaintext.txt	14	conclusion modafinil modulates anterior cingulate cortex function chronic schizophrenia beneficial cognitive effect may restricted subset patient requiring characterisation
0.09719374.15994572.html.plaintext.txt	15	participant right handed male aged num num year premorbid iq num national adult reading test nart nelson oconnell num dsm iv american psychiatric association num diagnosis schizophrenia prominent negative symptomatology rating num least one item scale assessment negative symptom sans andreasen num included
0.09719374.15994572.html.plaintext.txt	16	exclusion criterion prominent positive symptomatology marked delusion andor hallucination recent history mental state instability change psychotropic medication admission hospital within num month assessment significant history neurological endocrine cardiovascular disorder hypersensitivity modafinil concurrent prescription stimulant medication concurrent substance misuse contraindication magnetic resonance imaging scanning metallic implant foreign body claustrophobia
0.09719374.15994572.html.plaintext.txt	17	thirty two patient approached num agreed participate following full explanation study
0.09719374.15994572.html.plaintext.txt	18	nineteen satisfied detailed assessment inclusion exclusion criterion
0.09719374.15994572.html.plaintext.txt	19	participant underwent psychiatric brief psychiatric rating scale overall gorham num sans scale assessment positive symptom andreasen num beck depression inventory beck et al num mini mental state examination folstein et al num physical including electrocardiogram neuropsychological assessment simpson angus scale simpson angus num abnormal involuntary movement scale guy num barnes akathisia scale barnes num
0.09719374.15994572.html.plaintext.txt	20	written informed consent obtained patient
0.09719374.15994572.html.plaintext.txt	21	study approved north south sheffield research ethic committee also rotherham doncaster south humber research ethic committee
0.09719374.15994572.html.plaintext.txt	22	study funded investigator led award company sponsored trial research indemnity provided sheffield care trust reciprocally participating national health service trust clinical trial insurance provided university sheffield
0.09719374.15994572.html.plaintext.txt	23	procedure utilised randomised double blind placebo controlled crossover design
0.09719374.15994572.html.plaintext.txt	24	patient studied num day num week apart
0.09719374.15994572.html.plaintext.txt	25	day patient received oral modafinil num mg placebo num h prior functional magnetic resonance imaging fmri scanning
0.09719374.15994572.html.plaintext.txt	26	administration scanning time predicated drug pharmacokinetics human peak plasma level occur num num h post acute oral dosing cephalon num robertson hellriegel num
0.09719374.15994572.html.plaintext.txt	27	randomisation performed pharmacist member research team achieved drawing labelled counter ensured approximately equivalent number patient received modafinil placebo day num vice versa day num
0.09719374.15994572.html.plaintext.txt	28	patient required smoke consume caffeine prior scanning
0.09719374.15994572.html.plaintext.txt	29	admitted num h observation scanning procedure
0.09719374.15994572.html.plaintext.txt	30	outcome measure difference fmri signal working memory task modafinil placebo condition difference behavioural performance accuracy intra scanner task modafinil placebo condition patient wise bivariate correlation first two measure
0.09719374.15994572.html.plaintext.txt	31	psychological paradigm inside scanner patient performed standard working memory task num back callicott et al num
0.09719374.15994572.html.plaintext.txt	32	difficult task required subject monitor update temporally tag content working memory manoach num
0.09719374.15994572.html.plaintext.txt	33	series number num num presented visually pseudo random order one every num
0.09719374.15994572.html.plaintext.txt	34	colour coding stimulus cued patient indicate pressing button either number currently presented screen num back baseline condition number presented two trial earlier
0.09719374.15994572.html.plaintext.txt	35	num back active condition
0.09719374.15994572.html.plaintext.txt	36	stimulus delivered using presentation neurobehavioral system inc california usa software running personal computer via video projector mirror located inside scanner bore
0.09719374.15994572.html.plaintext.txt	37	patient responded pressing one four button intra scanner box optically connected computer system via interface new micros inc texas usa
0.09719374.15994572.html.plaintext.txt	38	alternating blocked num backnum back design num consecutive num back stimulus lasting num followed num consecutive num back stimulus also lasting num
0.09719374.15994572.html.plaintext.txt	39	sequence repeated six time hence functional scan lasted num min total
0.09719374.15994572.html.plaintext.txt	40	patient practised task prior entering scanner three time order minimise automation procedure
0.09719374.15994572.html.plaintext.txt	41	different performance level permitted previous study
0.09719374.15994572.html.plaintext.txt	42	incorporated wide range accuracy among patient schizophrenia callicott et al num performance relatively poor meyer lindenberg et al num bertolino et al num whereas others set stringent threshold callicott et al num num
0.09719374.15994572.html.plaintext.txt	43	comparison healthy control group necessarily requires comparable level performance across group study wished compare patient performance modafinil
0.09719374.15994572.html.plaintext.txt	44	hence allowed range performance accuracy
0.09719374.15994572.html.plaintext.txt	45	partly pragmatic given deliberately studying people chronic schizophrenia prominent negative symptomatology likely recipient putative cognitive enhancer also design led required range performance across group detect change performance within subject exposed modafinil hence avoiding ceiling effect allow post hoc correlation performance per se manoach et al num callicott et al num num
0.09719374.15994572.html.plaintext.txt	46	functional image acquisition analysis num functional imaging time point num mm contiguous tnum weighted slice acquired using echo planar imaging num
0.09719374.15994572.html.plaintext.txt	47	num system eclipse philip ohio sheffield university repetition timenum echo timenum m field view num mm plane matrixnum x num
0.09719374.15994572.html.plaintext.txt	48	image analysed using spmnum httpwww
0.09719374.15994572.html.plaintext.txt	49	blood oxygenation level dependent bold response measured fmri thought represent vascular marker neuronal activation logothetis et al num
0.09719374.15994572.html.plaintext.txt	50	following timing movement correction spatial normalisation smoothing gaussian kernel num mm full width half maximum friston et al num used boxcar wave convolved synthetic haemodynamic response function model bold response
0.09719374.15994572.html.plaintext.txt	51	patient two fmri data set modafinil placebo individual data set first level voxel wise contrast activation working memory v
0.09719374.15994572.html.plaintext.txt	52	generated contrast image used second order random effect group analysis
0.09719374.15994572.html.plaintext.txt	53	random effect analysis allow quantitative inference drawn regarding average behaviour population patient selected across different scanning session
0.09719374.15994572.html.plaintext.txt	54	analysis mandatory psychopharmacological design main effect interest exists distinct scanning session
0.09719374.15994572.html.plaintext.txt	55	individual contrast image entered data point whole group analysis covariance ancova compared brain activation working memory v
0.09719374.15994572.html.plaintext.txt	56	baseline condition modafinil activation working memory v
0.09719374.15994572.html.plaintext.txt	57	order scanning whether modafinil received day num day num comprised nuisance covariate
0.09719374.15994572.html.plaintext.txt	58	produced group parametric brain map statistic stereotactic space montreal neurological institute mni evans et al num showing brain area activated working memory baseline condition modafinil compared placebo
0.09719374.15994572.html.plaintext.txt	59	emphasise intra session effect working memory v
0.09719374.15994572.html.plaintext.txt	60	baseline modelled first level main inter session effect modafinil v
0.09719374.15994572.html.plaintext.txt	61	placebo modelled second level random effect analysis
0.09719374.15994572.html.plaintext.txt	62	also produced two subsidiary brain map demonstrating brain area activated working memory baseline placebo modafinil using two single group ancovas scanning order nuisance covariate
0.09719374.15994572.html.plaintext.txt	63	hence able ensure expected pattern cortical activation obtained num back irrespective drugplacebo condition
0.09719374.15994572.html.plaintext.txt	64	study hypothesis driven set significance threshold p num
0.09719374.15994572.html.plaintext.txt	65	num uncorrected height extent activation
0.09719374.15994572.html.plaintext.txt	66	also designated small volume sphere diameter num mm could used correct multiple comparison family wise error method activation priori region interest anterior cingulate cortex observed uncorrected threshold
0.09719374.15994572.html.plaintext.txt	67	purpose reporting neuroanatomical labelling stereotactic coordinate activated area transformed mni space system talairach tournoux num
0.09719374.15994572.html.plaintext.txt	68	brain activationbehavioural performance correlation patient calculated measure performance percentage accuracy working memory task study day hence difference score modafinil placebo condition
0.09719374.15994572.html.plaintext.txt	69	taking anterior cingulate cortex region interest also estimated magnitude fmri signal change derived beta parameter spmnum working memory task v
0.09719374.15994572.html.plaintext.txt	70	patient allowed u calculate difference anterior cingulate cortex signal change working memory task modafinil placebo condition
0.09719374.15994572.html.plaintext.txt	71	ran patient wise bivariate correlation difference behavioural performance modafinil v
0.09719374.15994572.html.plaintext.txt	72	placebo difference anterior cingulate cortex signal change modafinil v
0.09719374.15994572.html.plaintext.txt	73	demographic data patient predominantly middle aged male ill approximately num year table num
0.09719374.15994572.html.plaintext.txt	74	sixteen single none paid employment five performed voluntary work num received maximum disability living allowance eight lived accommodation three parent two supported group project four rehabilitation unit
0.09719374.15994572.html.plaintext.txt	75	patient receiving oral antipsychotic nnum atypical one case
0.09719374.15994572.html.plaintext.txt	76	four patient received intramuscular typical depot medication
0.09719374.15994572.html.plaintext.txt	77	num patient none changed medication study period
0.09719374.15994572.html.plaintext.txt	78	nine patient received modafinil day num placebo day num eight received reverse
0.09719374.15994572.html.plaintext.txt	79	view table table num demographic clinical characteristic included patient
0.09719374.15994572.html.plaintext.txt	80	behavioural measure statistical comparison prespecified except indicated
0.09719374.15994572.html.plaintext.txt	81	used non parametric test analyse group behavioural accuracy data working memory task placebo modafinil condition normally distributed
0.09719374.15994572.html.plaintext.txt	82	placebo condition response accuracy control num back condition num num median num differ significantly modafinil range num num median num wilcoxon signed rank test znum
0.09719374.15994572.html.plaintext.txt	83	placebo condition response accuracy num back task num num median num differ significantly modafinil range num num median num wilcoxon signed rank test znum
0.09719374.15994572.html.plaintext.txt	84	brain activation functional image analysis showed modafinil placebo day patient exhibited activation num back condition relative num back predicted brain region table num num specifically prefrontal anterior cingulate parietal cortex callicott et al num num meyer lindenberg et al num
0.09719374.15994572.html.plaintext.txt	85	view table table num brain area exhibiting greater activation working memory baseline placebo condition
0.09719374.15994572.html.plaintext.txt	86	view table table num brain area exhibiting greater activation working memory baseline modafinil condition
0.09719374.15994572.html.plaintext.txt	87	view larger version numk fig
0.09719374.15994572.html.plaintext.txt	88	num brain area anterior cingulate cortex exhibited greater activation working memory task modafinil placebo
0.09719374.15994572.html.plaintext.txt	89	group data displayed canonical tnum weighted image upper panel supra threshold voxels shown yellow pnum
0.09719374.15994572.html.plaintext.txt	90	order demonstrate regional specificity finding data also displayed statistical threshold within glass brain lower panel
0.09719374.15994572.html.plaintext.txt	91	functional image analysis comparing modafinil placebo condition revealed working memory task performance associated significantly greater activation solely anterior cingulate cortex fig
0.09719374.15994572.html.plaintext.txt	92	num talairach coordinate xnum mm ynum mm znum mm num supra threshold voxels peak z scorenum
0.09719374.15994572.html.plaintext.txt	93	num uncorrected height extent activation
0.09719374.15994572.html.plaintext.txt	94	activation remained significant correction multiple comparison within defined region interest p num
0.09719374.15994572.html.plaintext.txt	95	examining separate modafinil placebo brain map working memory v
0.09719374.15994572.html.plaintext.txt	96	baseline contrast confirmed focal difference due greater anterior cingulate cortex activation working memory baseline performance modafinil xnum mm ynum mm znum mm num voxels znum
0.09719374.15994572.html.plaintext.txt	97	num uncorrected height activation converse namely greater activation baseline working memory placebo
0.09719374.15994572.html.plaintext.txt	98	patient wise difference anterior cingulate cortex activation fig
0.09719374.15994572.html.plaintext.txt	99	num behavioural performance modafinil placebo condition positively significantly correlated fig
0.09719374.15994572.html.plaintext.txt	100	however correlation reflect straightforward relationship improved activation improved performance
0.09719374.15994572.html.plaintext.txt	101	rather reflected increased fmri signal majority patient modafinil session concomitant improvement memory performance half decreased signal minority patient response modafinil exhibited reduced performance drug fig
0.09719374.15994572.html.plaintext.txt	102	hence patient group whole relationship degree anterior cingulate cortex activation memory task modulated increaseddecreased drug level cognitive performance
0.09719374.15994572.html.plaintext.txt	103	although subgroup patient exhibited enhanced cognition association increased anterior cingulate cortex activation patient exhibiting reduced anterior cingulate cortex activity improved cognitively
0.09719374.15994572.html.plaintext.txt	104	view larger version numk fig
0.09719374.15994572.html.plaintext.txt	105	placebo working memory task correlation difference anterior cingulate activation behavioural performance
0.09719374.15994572.html.plaintext.txt	106	patient nnum x axis show difference accuracy intra scanner working memory task modafinil placebo condition y axis show corresponding difference estimated functional magnetic resonance imaging fmri signal change
0.09719374.15994572.html.plaintext.txt	107	positive value indicate greater accuracygreater fmri signal change modafinil placebo
0.09719374.15994572.html.plaintext.txt	108	post hoc examination data revealed five patient exhibiting improvement anterior cingulate cortex fmri signal num back performance four receiving typical neuroleptic depot sulpiride one receiving olanzapine
0.09719374.15994572.html.plaintext.txt	109	five patient received typicals majority responded positively modafinil physiologically cognitively
0.09719374.15994572.html.plaintext.txt	110	conversely num patient receiving atypicals one exhibited pattern
0.09719374.15994572.html.plaintext.txt	111	moreover post hoc analysis confirmed positive correlation anterior cingulate cortex signal performance change significant five patient receiving typical antipsychotic spearmans num
0.09719374.15994572.html.plaintext.txt	112	conversely patient excluded group analysis latter longer significant num patient receiving atypicals num
0.09719374.15994572.html.plaintext.txt	113	exclusion subject whose performance level chance placebo led exclusion three four subject receiving depot reduction anterior cingulate cortexperformance correlation trend significance num
0.09719374.15994572.html.plaintext.txt	114	hence possible receiving depot medication derived greatest benefit modafinil perhaps consequence greater initial deficit contributed finding
0.09719374.15994572.html.plaintext.txt	115	investigated post hoc deficitbenefit hypothesis found exhibiting improved working memory performance modafinil demonstrated significantly worse performance verbal fluency task initial assessment compared patient
0.09719374.15994572.html.plaintext.txt	116	responder generated num num word num min median num non responder generated num num word median num
0.09719374.15994572.html.plaintext.txt	117	correlation intra scanner working memory task performance specific symptom rating
0.09719374.15994572.html.plaintext.txt	118	finally way validating sample described successive report repeatedly described positive correlation num back accuracy right dorsolateral prefrontal cortex activity people schizophrenia compared normal callicott et al num num examined correlate performance per se num back task
0.09719374.15994572.html.plaintext.txt	119	found right dorsolateral prefrontal cortex implicated condition placebo xnum mm ynum mm znum mm num voxels znum
0.09719374.15994572.html.plaintext.txt	120	num uncorrected height activation modafinil xnum mm ynum mm znum mm num voxels znum
0.09719374.15994572.html.plaintext.txt	121	num uncorrected height activation
0.09719374.15994572.html.plaintext.txt	122	cognitive response despite enhanced anterior cingulate cortex activation group level working memory performance patient exhibit enhanced cognition
0.09719374.15994572.html.plaintext.txt	123	group whole effect modafinil upon working memory protocol
0.09719374.15994572.html.plaintext.txt	124	therefore might posited increased anterior cingulate cortex activation either unrelated cognition indicative reduced efficiency cognitive processing callicott et al num manoach num
0.09719374.15994572.html.plaintext.txt	125	greater anterior cingulate cortex activation occurs without increase cognitive performance brain function might said le efficient presence modafinil
0.09719374.15994572.html.plaintext.txt	126	however important note cognitive function improve minority patient although might posited expected statistically merely manifestation variation around mean feature data run counter interpretation
0.09719374.15994572.html.plaintext.txt	127	positive correlation anterior cingulate cortex activation cognitive improvement fig
0.09719374.15994572.html.plaintext.txt	128	modafinil simply made anterior cingulate cortex function le efficient expect correlation negative
0.09719374.15994572.html.plaintext.txt	129	positive correlation implies magnitude anterior cingulate cortex activation cognitive performance indeed related context modafinil exposure exhibiting greater anterior cingulate cortex response also exhibit greater cognitive enhancement working memory
0.09719374.15994572.html.plaintext.txt	130	accounting responder interest exhibiting greater physiological cognitive response modafinil tended receiving typical neuroleptic medication depot sulpiride
0.09719374.15994572.html.plaintext.txt	131	number small may rationale finding
0.09719374.15994572.html.plaintext.txt	132	neurotransmitter system implicated promotion wakefulness modafinil include dopaminergic serotonergic system
0.09719374.15994572.html.plaintext.txt	133	although antipsychotic share antagonism dopaminergic system especially dnum receptor typicals atypicals differ affinity receptor particularly numhtnuma keefe et al num
0.09719374.15994572.html.plaintext.txt	134	animal model modafinils effect increasing alertness attenuated numhtnuma antagonism shelton et al num hence possible atypical antipsychotic treatment antagonising numhtnuma might constrain cognotropic effect modafinil hypothesis deserving study
0.09719374.15994572.html.plaintext.txt	135	alternatively ability atypicals enhance cognition albeit limited extent keefe et al num might curtail improvement modafinil
0.09719374.15994572.html.plaintext.txt	136	safety number caveat study finding
0.09719374.15994572.html.plaintext.txt	137	first reason described deliberately utilised relatively low dose modafinil
0.09719374.15994572.html.plaintext.txt	138	may sub optimal
0.09719374.15994572.html.plaintext.txt	139	nevertheless one participant underwent psychotic relapse num day post drug
0.09719374.15994572.html.plaintext.txt	140	determine whether modafinil responsible
0.09719374.15994572.html.plaintext.txt	141	although covert non adherence concurrent medication excluded receiving oral antipsychotic must wary seeking exculpate test medication
0.09719374.15994572.html.plaintext.txt	142	however psychotic reaction single dose modafinil unprecedented knowledge although case psychosis emerging de novo receiving multiple dos
0.09719374.15994572.html.plaintext.txt	143	manufacturer prescribing information report one healthy male volunteer developed idea reference paranoid delusion auditory hallucination association multiple daily num mg dos modafinil sleep deprivation
0.09719374.15994572.html.plaintext.txt	144	evidence psychosis num hour drug discontinuation
0.09719374.15994572.html.plaintext.txt	145	british national formulary mention psychosis either contraindication consequence modafinil exposure
0.09719374.15994572.html.plaintext.txt	146	recent study num patient schizophrenia exposed single dose num mg modafinil drug elicited exacerbation psychosis turner et al num
0.09719374.15994572.html.plaintext.txt	147	however anecdotal account schizophrenic relapse following repeated dosing narendran et al num rosenthal bryant num
0.09719374.15994572.html.plaintext.txt	148	multi dosing study centre may help clarify magnitude putative risk
0.09719374.15994572.html.plaintext.txt	149	limitation many neuroimaging study number subject examined relatively small
0.09719374.15994572.html.plaintext.txt	150	impact memory improvement upon day day function outside scanner remains demonstrated
0.09719374.15994572.html.plaintext.txt	151	patient may derive cognitive benefit modafinil require characterisation
0.09719374.15994572.html.plaintext.txt	152	num scale assessment negative symptom sans
0.09719374.15994572.html.plaintext.txt	153	num scale assessment positive symptom sap
0.09719374.15994572.html.plaintext.txt	154	num rating scale drug induced akathisia
0.09719374.15994572.html.plaintext.txt	155	british journal psychiatry num num num
0.09719374.15994572.html.plaintext.txt	156	et al num inventory measuring depression
0.09719374.15994572.html.plaintext.txt	157	archive general psychiatry num num num
0.09719374.15994572.html.plaintext.txt	158	et al num working memory deficit level n acetylaspartate patient schizophreniform disorder
0.09719374.15994572.html.plaintext.txt	159	american journal psychiatry num num num
0.09719374.15994572.html.plaintext.txt	160	british medical association num british national formulary
0.09719374.15994572.html.plaintext.txt	161	london british medical associationroyal pharmaceutical society great britain
0.09719374.15994572.html.plaintext.txt	162	num cognitive emotional influence anterior cingulate cortex
0.09719374.15994572.html.plaintext.txt	163	trend cognitive science num num num
0.09719374.15994572.html.plaintext.txt	164	et al num functional magnetic resonance brain mapping psychiatry methodological issue illustrated study working memory schizophrenia
0.09719374.15994572.html.plaintext.txt	165	neuropsychopharmacology num num num
0.09719374.15994572.html.plaintext.txt	166	et al num physiological characteristic capacity constraint working memory revealed functional mri
0.09719374.15994572.html.plaintext.txt	167	et al num physiological dysfunction dorsolateral prefrontal cortex schizophrenia revisited
0.09719374.15994572.html.plaintext.txt	168	cerebral cortex num num num
0.09719374.15994572.html.plaintext.txt	169	et al num abnormal fmri response dorsolateral prefrontal cortex cognitively intact sibling patient schizophrenia
0.09719374.15994572.html.plaintext.txt	170	american journal psychiatry num num num
0.09719374.15994572.html.plaintext.txt	171	cephalon num prescribing information provigil modafinil tablet
0.09719374.15994572.html.plaintext.txt	172	west chester pa cephalon inc
0.09719374.15994572.html.plaintext.txt	173	et al num numd statistical neuroanatomical model num mri volume
0.09719374.15994572.html.plaintext.txt	174	ieee nuclear science symposium medical imaging conference proceeding num num num
0.09719374.15994572.html.plaintext.txt	175	num mini mental state practical method grading cognitive state patient clinician
0.09719374.15994572.html.plaintext.txt	176	journal psychiatric research num num num
0.09719374.15994572.html.plaintext.txt	177	et al num spatial registration normalisation image
0.09719374.15994572.html.plaintext.txt	178	human brain mapping num num num
0.09719374.15994572.html.plaintext.txt	179	num many subject constitute study neuroimage num num num
0.09719374.15994572.html.plaintext.txt	180	num early clinical drug evaluation unit assessment manual psychopharmacology revised edition
0.09719374.15994572.html.plaintext.txt	181	washington dc department health education welfare
0.09719374.15994572.html.plaintext.txt	182	et al num effect atypical antipsychotic drug neurocognitive impairment schizophrenia review meta analysis
0.09719374.15994572.html.plaintext.txt	183	schizophrenia bulletin num num num
0.09719374.15994572.html.plaintext.txt	184	num potential brain neuronal target amphetamine methylphenidate modafinil induced wakefulness evidenced c fo immunocytochemistry cat
0.09719374.15994572.html.plaintext.txt	185	proceeding national academy science usa num num num
0.09719374.15994572.html.plaintext.txt	186	et al num neurophysiological investigation basis fmri signal
0.09719374.15994572.html.plaintext.txt	187	num prefrontal cortex dysfunction working memory performance schizophrenia reconciling discrepant finding
0.09719374.15994572.html.plaintext.txt	188	schizophrenia research num num num
0.09719374.15994572.html.plaintext.txt	189	et al num num schizophrenic subject activate dorsolateral prefrontal cortex working memory task measured fmri
0.09719374.15994572.html.plaintext.txt	190	biological psychiatry num num num
0.09719374.15994572.html.plaintext.txt	191	et al num evidence abnormal cortical functional connectivity working memory schizophrenia
0.09719374.15994572.html.plaintext.txt	192	american journal psychiatry num num num
0.09719374.15994572.html.plaintext.txt	193	et al num psychosis exacerbated modafinil archive general psychiatry num num num
0.09719374.15994572.html.plaintext.txt	194	num dementia estimation premorbid intelligence level using national adult reading test
0.09719374.15994572.html.plaintext.txt	195	num brief psychiatric rating scale
0.09719374.15994572.html.plaintext.txt	196	psychological report num num num
0.09719374.15994572.html.plaintext.txt	197	num clinical pharmacokinetic profile modafinil
0.09719374.15994572.html.plaintext.txt	198	clinical pharmacokinetics num num num
0.09719374.15994572.html.plaintext.txt	199	num benefit adjunct modafinil open label pilot study patient schizophrenia
0.09719374.15994572.html.plaintext.txt	200	schizophrenia research num num
0.09719374.15994572.html.plaintext.txt	201	et al num hypothalamic arousal region activated modafinil induced wakefulness
0.09719374.15994572.html.plaintext.txt	202	journal neuroscience num num num
0.09719374.15994572.html.plaintext.txt	203	et al num comparative effect modafinil amphetamine daytime sleepiness cataplexy narcoleptic dog
0.09719374.15994572.html.plaintext.txt	204	num rating scale extrapyramidal side effect
0.09719374.15994572.html.plaintext.txt	205	acta psychiatrica scandinavica num suppl
0.09719374.15994572.html.plaintext.txt	206	num stereotactic co planar atlas human brain
0.09719374.15994572.html.plaintext.txt	207	et al num modafinil improves cognition attentional set shifting people schizophrenia
0.09719374.15994572.html.plaintext.txt	208	neuropsychopharmacology num num num
0.09719374.15994572.html.plaintext.txt	209	u modafinil narcolepsy multicenter study group num randomised trial modafinil treatment excessive daytime somnolence narcolepsy
0.09719374.15994572.html.plaintext.txt	210	et al num functional significance symptomatology cognitive function schizophrenia
0.09719374.15994572.html.plaintext.txt	211	schizophrenia research num num num
0.09719374.15994572.html.plaintext.txt	212	received publication may num num
0.09719374.15994572.html.plaintext.txt	213	revision received october num num
0.09719374.15994572.html.plaintext.txt	214	accepted publication october num num
0.09719374.15994572.html.plaintext.txt	215	article abstract full text pdf submit response alert article cited alert eletters posted alert correction posted citation map service email article friend similar article journal similar article pubmed alert new issue journal download citation manager google scholar article spence
0.09719374.15994572.html.plaintext.txt	216	article citing article pubmed pubmed citation article spence
0.09719374.15994572.html.plaintext.txt	217	home help feedback subscription archive search table content psychiatric bulletin advance psychiatric treatment rcpsych journal
0.09784351.9373235.html.plaintext.txt	0	evolving view major histocompatibility complex
0.09784351.9373235.html.plaintext.txt	1	department pediatrics yale child health research center yale university school medicine department genetics boyer center molecular medicine yale university school medicine new haven ct
0.09784351.9373235.html.plaintext.txt	2	major histocompatibility complex mhc extended cluster gene remarkable number importance immunological function encode
0.09784351.9373235.html.plaintext.txt	3	historically interest mhc emanated tissue transplantation experiment hence reference histocompatibility
0.09784351.9373235.html.plaintext.txt	4	know highly conserved region encodes gene many important varied function immune nonimmune nature
0.09784351.9373235.html.plaintext.txt	5	one family mhc gene human leukocyte antigen hla gene polymorphic yet discovered hundred allele described far
0.09784351.9373235.html.plaintext.txt	6	numnum serotyping polymorphism permitted genetic mapping locus early disease association study
0.09784351.9373235.html.plaintext.txt	7	addition polymorphism permitted extensive population study revealing number interesting mhc association phenomenon
0.09784351.9373235.html.plaintext.txt	8	recent cdna selectionsnum genomic sequencing cosmid screening shown existence large number gene mhc including number expressed selectively cell immune system
0.09784351.9373235.html.plaintext.txt	9	num num review discus recent data considerably expands number immune related gene encoded mhc review factor may underlie large scale organization
0.09784351.9373235.html.plaintext.txt	10	mhc includes coding region well known eponymous polymorphic surface antigen hla class class ii type respectively present antigen cdnum cdnum cell
0.09784351.9373235.html.plaintext.txt	11	intervening class ii class region human mhc class iii region includes gene several component complement system
0.09784351.9373235.html.plaintext.txt	12	numnum gene class ii region found encode component cytoplasmic proteasome degrades protein peptidesnum well peptide transporter loading peptide onto class protein
0.09784351.9373235.html.plaintext.txt	13	num class ii region also encodes dm gene facilitates loading assembly class ii protein
0.09784351.9373235.html.plaintext.txt	14	numnum centromeric class region cluster gene encoding three inflammation related protein tumor necrosis factor tnf lymphotoxin lta lymphotoxin ltb
0.09784351.9373235.html.plaintext.txt	15	num num remarkably list immune system related gene chromosome segment potentially derived duplication part mhc grown substantially within last year
0.09784351.9373235.html.plaintext.txt	16	mhc major biomedical interest contribution transplant rejection variation individual susceptibility variety autoimmune disorder
0.09784351.9373235.html.plaintext.txt	17	num num number case clear susceptibility determined variation protein sequence class ii molecule
0.09784351.9373235.html.plaintext.txt	18	however discussed possibility must still entertained polymorphism immune system related gene mhc also contribute disease
0.09784351.9373235.html.plaintext.txt	19	addition role influencing propensity known autoimmune disease insulin dependent diabetes mellitus multiple sclerosis systemic lupus erythematosus myasthenia gravis rheumatoid arthritis reviewed thomson num mhc contains gene contributing several hereditary disorder either autoimmune nature role autoimmunity uncertain
0.09784351.9373235.html.plaintext.txt	20	include ankylosing spondyloarthropathies clear association class allele hla bnum narcolepsy equally clearly associated certain class ii allele
0.09784351.9373235.html.plaintext.txt	21	mhc also includes gene steroid num hydroxylase hemochromatosis
0.09784351.9373235.html.plaintext.txt	22	deficiency num hydroxylase cause adrenogenital syndrome hemochromatosis one common simple mendelian disorder man
0.09784351.9373235.html.plaintext.txt	23	recently major quantitative trait locus dyslexia mapped distal mhc
0.09784351.9373235.html.plaintext.txt	24	actively pursued several group
0.09784351.9373235.html.plaintext.txt	25	mhc extensively studied large number excellent review exist range related topic
0.09784351.9373235.html.plaintext.txt	26	numnumnumnumnumnum num present review largely restricted newest development recognition complexity role human mhc immuno hematologic system relationship among segment mhc
0.09784351.9373235.html.plaintext.txt	27	subregion mhc contains unusual concentration gene related inflammation
0.09784351.9373235.html.plaintext.txt	28	convention mhc divided three contiguous region approximate location gene shared characteristic fig num
0.09784351.9373235.html.plaintext.txt	29	centromeric chromosome nump class ii region contains num known hla class ii gene pseudogenes
0.09784351.9373235.html.plaintext.txt	30	num contiguous class iii region encodes several component complement system
0.09784351.9373235.html.plaintext.txt	31	telomeric class iii region class region encodes num hla class related gene pseudogenes
0.09784351.9373235.html.plaintext.txt	32	recently number gene putatively involved inflammation identified central mhc telomeric end class iii region
0.09784351.9373235.html.plaintext.txt	33	presented group gene may role various aspect stress inflammation infection
0.09784351.9373235.html.plaintext.txt	34	suggest concentration gene sufficiently distinct designated class iv region
0.09784351.9373235.html.plaintext.txt	35	view larger version numk fig num
0.09784351.9373235.html.plaintext.txt	36	map mhc showing proposed class iv region
0.09784351.9373235.html.plaintext.txt	37	physical map organization human mhc selected gene
0.09784351.9373235.html.plaintext.txt	38	expressed hla class class ii gene rectangle positioned horizontal meridian
0.09784351.9373235.html.plaintext.txt	39	gene putative immune function triangle gene circle elevated horizontal meridian
0.09784351.9373235.html.plaintext.txt	40	blow view proposed class iv region shown beneath
0.09784351.9373235.html.plaintext.txt	41	physical distance approximate derived source referenced text unpublished data
0.09784351.9373235.html.plaintext.txt	42	symbol known gene conventional abbreviation defined text
0.09784351.9373235.html.plaintext.txt	43	num znf num znf num zinc finger gene map vicinity hla
0.09784351.9373235.html.plaintext.txt	44	cluster gene three related cytokine tnf lta ltb lie telomeric end class iii regionnum shortly centromeric class related gene
0.09784351.9373235.html.plaintext.txt	45	tnf extensively studiednum play important role inflammation bacterialnum viral infectionnum tumor cachexia immune response
0.09784351.9373235.html.plaintext.txt	46	produced variety cell including prominently monocyte macrophage cell subset
0.09784351.9373235.html.plaintext.txt	47	mouse variant tnf gene affect level tnf production associated variation level susceptibility renal disease lupus like syndrome
0.09784351.9373235.html.plaintext.txt	48	num polymorphism human tnf gene associated increased susceptibility fatal cerebral malarianum rheumatoid arthritis inflammatory bowel diseasenum perhaps autoimmune disorder
0.09784351.9373235.html.plaintext.txt	49	lta also called tnf action similar tnf cellular basis pattern expression considerably limited
0.09784351.9373235.html.plaintext.txt	50	remarkably deletion lta gene lead specific absence lymph node peyers patch splenic germinal center micenumnum whereas mouse lacking tnf develop lymph node peyers patch lack splenic primary b cell follicle
0.09784351.9373235.html.plaintext.txt	51	num deletion pnum tnf receptor result normal lymph node development architecture normal migration lymphocyte lamina propria epithelium small intestine organized peyers patch absence germinal center
0.09784351.9373235.html.plaintext.txt	52	num based observation speculated effect lta development lymphoid organ may mediated distinct receptor functioning organ specific context
0.09784351.9373235.html.plaintext.txt	53	ltb also called tnf c membrane bound molecule form heterotrimer lta
0.09784351.9373235.html.plaintext.txt	54	num lta ltb complex induce activation nf b certain cell line binding ltb receptor member tnf receptor family
0.09784351.9373235.html.plaintext.txt	55	numnum nf b pleiotropic transcription factor capable activating expression great variety gene critical immunoinflammatory response
0.09784351.9373235.html.plaintext.txt	56	num lta ltb complex also weakly cytotoxic tumor cell appear induce apoptosis
0.09784351.9373235.html.plaintext.txt	57	within num kb upstream human tnf cluster gene designated bnum lst num leukocyte specific transcriptnum homologue partial cdna first identified mouse
0.09784351.9373235.html.plaintext.txt	58	num transcript gene expressed exclusively monocyte macrophage cell
0.09784351.9373235.html.plaintext.txt	59	expression gene rna level increased various activating stimulus particular interferon ifn
0.09784351.9373235.html.plaintext.txt	60	probable gene product encoded open reading frame whose cognate amino acid sequence num identical human mouse
0.09784351.9373235.html.plaintext.txt	61	amino acid sequence contains long hydrophobic region near n terminus otherwise show apparent relationship protein known function
0.09784351.9373235.html.plaintext.txt	62	interpretation open reading frame regulation gene complicated remarkable degree alternative splicing seen mrna product
0.09784351.9373235.html.plaintext.txt	63	bnum rna actually ensemble related sequence derived four alternative num exon num internal exon well several form num exon
0.09784351.9373235.html.plaintext.txt	64	exon num num may associated num exon may separately jointly omitted final mrna product
0.09784351.9373235.html.plaintext.txt	65	result num form mrna may seen unum monocyte cell
0.09784351.9373235.html.plaintext.txt	66	form could encode altered form putative protein others affect num untranslated region
0.09784351.9373235.html.plaintext.txt	67	gene also peculiar one spliced form apparently ga dinucleotide first base num end intron
0.09784351.9373235.html.plaintext.txt	68	first two base intron generally gt occasional gc bnum splice site highly unusual perhaps unique
0.09784351.9373235.html.plaintext.txt	69	mouse gene also seems multiple alternative splice form cultured cell
0.09784351.9373235.html.plaintext.txt	70	amount bnum mrna cell quite substantial would surprising protein formed significant amount although presently publication characterizing putative protein
0.09784351.9373235.html.plaintext.txt	71	second gene numcnum preferentially expressed monocyte certain hematopoietic cell line lie immediately adjacent bnumnum num end two mrna template come within base overlapping
0.09784351.9373235.html.plaintext.txt	72	gene encodes least three differentially spliced mrna
0.09784351.9373235.html.plaintext.txt	73	mrna encodes potential leader sequence internal membrane anchor segment three form differ length sequence carboxy terminal intracytoplasmic domain
0.09784351.9373235.html.plaintext.txt	74	encoded product weak similarity surface antigen ctlanum
0.09784351.9373235.html.plaintext.txt	75	recently another mhc encoded monocyte lymphocyte specific cdna called aif num identified elevated level expression experimental cardiac transplant
0.09784351.9373235.html.plaintext.txt	76	num num separately gene characterized termed gnum
0.09784351.9373235.html.plaintext.txt	77	num gene transcript lie shortly centromeric bnum
0.09784351.9373235.html.plaintext.txt	78	highly conserved rodent human
0.09784351.9373235.html.plaintext.txt	79	mrna upregulated interferon expressed subset macrophage infiltrating allograft
0.09784351.9373235.html.plaintext.txt	80	putative amino acid translation lack hydrophobic leader sequence
0.09784351.9373235.html.plaintext.txt	81	however strong homology ef hand protein motif found calcium binding protein involved neutrophil activationnum also myeloid chemoattractant protein
0.09784351.9373235.html.plaintext.txt	82	num cytokine gene encode leader sequence remains possible aif num protein may secreted released injured cell
0.09784351.9373235.html.plaintext.txt	83	function gene remains unknown
0.09784351.9373235.html.plaintext.txt	84	region mhc telomeric tnf cluster gene protein contains certain motif similar seen b called b like ikbl
0.09784351.9373235.html.plaintext.txt	85	num role b negative regulation nf b hence inflammatory response well known paradigm transcriptional control involving regulation phosphorylation ubiquitination protein degradation
0.09784351.9373235.html.plaintext.txt	86	analogy mhc encoded ikbl molecule candidate regulator inflammatory response although described widely expressed
0.09784351.9373235.html.plaintext.txt	87	rather surprisingly functional data available molecule
0.09784351.9373235.html.plaintext.txt	88	centromeric hspnum genesnum lie skinumwnum num gene encoding protein substantial similarity yeast skinum superkiller num proteinnum including rna helicase motif
0.09784351.9373235.html.plaintext.txt	89	skinum make yeast cell resistant killer toxin rna virus virtue ability block translation nonpolyadenylated noncapped viral mrna targeted degradation
0.09784351.9373235.html.plaintext.txt	90	numnum gene play partially redundant essential role normal yeast growthnum antiviral effect well
0.09784351.9373235.html.plaintext.txt	91	homology yeast gene remains possible one role human gene mediator antiviral effect particularly rna virus use nonpolyadenylated rna life cycle
0.09784351.9373235.html.plaintext.txt	92	mic mhc class related familynumnum group homologous gene pseudogenes interspersed distal class iii class region mhc
0.09784351.9373235.html.plaintext.txt	93	structure gene predicted coding product resemble class gene clearly divergent family
0.09784351.9373235.html.plaintext.txt	94	also characterized large first intron
0.09784351.9373235.html.plaintext.txt	95	member group known expressed mrna mic b whose gene lie telomeric ikbl gene centromeric hla b
0.09784351.9373235.html.plaintext.txt	96	mic protein expressed properly folded independently num microglobulin preferentially expressed intestinal mucosa
0.09784351.9373235.html.plaintext.txt	97	num curiously transcription mic upregulated heat shock
0.09784351.9373235.html.plaintext.txt	98	thus gene share property class gene per se least one functional feature would relate heat shock gene located centromerically
0.09784351.9373235.html.plaintext.txt	99	overall central mhc complement region class iii class region least seven gene implicated degree inflammatory response
0.09784351.9373235.html.plaintext.txt	100	also eighth gene numcnum yet studied functionally whose pattern expression consistent similar role
0.09784351.9373235.html.plaintext.txt	101	addition ikbl molecule near one end cluster least potential candidate role inflammation
0.09784351.9373235.html.plaintext.txt	102	batnum gene dnumsnume also region encodes rna helicase conceivably could play role complex splicing bnum well gene
0.09784351.9373235.html.plaintext.txt	103	num centromeric end region number gene unknown function broad expression also gene three heat shock proteinsnum whose expression may elevated inflammation
0.09784351.9373235.html.plaintext.txt	104	heat shock protein also implicated mediating antiviral effect prostaglandin
0.09784351.9373235.html.plaintext.txt	105	num overall suggest segment mhc given separate designation class iv region recognition multiple potential role inflammation stress response
0.09784351.9373235.html.plaintext.txt	106	additional immune related gene distributed entire mhc
0.09784351.9373235.html.plaintext.txt	107	gene mentioned paragraph cited review encode substantial number structurally remotely related totally unrelated protein expressed specifically within function interacting cell immune system
0.09784351.9373235.html.plaintext.txt	108	gene linkage consequence duplication divergence seem adequate explanation clustering
0.09784351.9373235.html.plaintext.txt	109	ascertainment bias conceivable explanation intensity immune system gene cluster investigated
0.09784351.9373235.html.plaintext.txt	110	explanation seems progressively le likely immune system gene divergent structure discovered within cluster
0.09784351.9373235.html.plaintext.txt	111	recent finding distal mhc additional three four gene different family expressed selectively immunocytes seems make coincidence argument almost untenable
0.09784351.9373235.html.plaintext.txt	112	gene unknown function yet unknown degree polymorphism potential contribution association mhc haplotype propensity autoimmune disorder interest
0.09784351.9373235.html.plaintext.txt	113	recently detected immune system gene distal mhc include following
0.09784351.9373235.html.plaintext.txt	114	ubiquitin num amino acid peptide whose sequence remarkably conserved among eukaryote
0.09784351.9373235.html.plaintext.txt	115	expressed almost cell body generic function become attached protein target degradation proteasome system
0.09784351.9373235.html.plaintext.txt	116	ubiquitin play role diverse variety cellular process including chromatin structure cell cycle control modification cell receptor dna repair process gene silencing activation degradation nf b
0.09784351.9373235.html.plaintext.txt	117	num however curious ubiquitin initially studied peptide might transcellular effect modulating activity immunocytes
0.09784351.9373235.html.plaintext.txt	118	several gene encoding ubiquitin homologues discovered including least two non mhc gene implicated function immune system
0.09784351.9373235.html.plaintext.txt	119	one isgnumnum num encodes protein homologous ubiquitin dimer expressed unstimulated cell induced ifn variety cell type
0.09784351.9373235.html.plaintext.txt	120	interferon treatment newly synthesized isgnum found intracellularly
0.09784351.9373235.html.plaintext.txt	121	pulse chase experiment show num hour num labeled isgnum found extracellularly
0.09784351.9373235.html.plaintext.txt	122	question whether protein transcellular effect vivo remains unaddressed
0.09784351.9373235.html.plaintext.txt	123	primary product isgnum gene contains extension eight amino acid beyond c terminal diglycine characteristic ubiquitin
0.09784351.9373235.html.plaintext.txt	124	num c terminal extension rapidly removed intracellularly
0.09784351.9373235.html.plaintext.txt	125	primary translation product demonstrated effect cell
0.09784351.9373235.html.plaintext.txt	126	contrast processed product active low nanogram per milliliter level inducing ifn production cell
0.09784351.9373235.html.plaintext.txt	127	num peptide also induces remarkable proliferation activation natural killer nk cell b cell depleted mononuclear cell population
0.09784351.9373235.html.plaintext.txt	128	num effect nk cell requires presence cell accounted ifn interferon
0.09784351.9373235.html.plaintext.txt	129	nakamura et alnum investigating ubiquitin homologue synthesized cell act nonantigen specific suppresser factor b cell
0.09784351.9373235.html.plaintext.txt	130	isolation sequencing protein known mnsf monoclonal nonspecific suppressor factor followed cloning cdna showed protein ubiquitin homologue despite apparent larger molecular weight isolated cell
0.09784351.9373235.html.plaintext.txt	131	distal mhc encodes molecule known fatnum homologous ubiquitin divergent isgnum mnsf either two ubiquitin
0.09784351.9373235.html.plaintext.txt	132	homology ubiquitin extends preservation c terminal diglycine appears necessary transfer ubiquitin molecule well internal lysine flanking sequence ubiquitinylation occurs
0.09784351.9373235.html.plaintext.txt	133	molecule strongly expressed rna level b lymphoblastoid line ifn inducible others
0.09784351.9373235.html.plaintext.txt	134	vivo found thymus lesser degree spleen
0.09784351.9373235.html.plaintext.txt	135	expressed jurkat cell variety cell line
0.09784351.9373235.html.plaintext.txt	136	mouse homologue exists num conservation amino acid sequence
0.09784351.9373235.html.plaintext.txt	137	experimental investigation function fatnum beginning unpublished data
0.09784351.9373235.html.plaintext.txt	138	transcription factor like gene family
0.09784351.9373235.html.plaintext.txt	139	distal mhc encodes family least five gene share c terminal homology domain butyrophilinnumnum dubbed ctb box num extends num amino acid length
0.09784351.9373235.html.plaintext.txt	140	num butyrophilin protein coat fat globule milk encoded distal mhc
0.09784351.9373235.html.plaintext.txt	141	function conserved ctb box domain unknown although degree conservation suggests may motif interaction second protein family protein
0.09784351.9373235.html.plaintext.txt	142	protein family encoded gene strictly within mhc somewhat divergent n terminal structure
0.09784351.9373235.html.plaintext.txt	143	one generally expressed gene znfnum acid finger protein num several earmark transcription factor including paired zinc finger acidic domain
0.09784351.9373235.html.plaintext.txt	144	two member family znfnum num num encode protein resembling znfnum lacking acidic domain could potentially act transcriptional activator
0.09784351.9373235.html.plaintext.txt	145	one num num limited pattern expression including undefined cell type within spleen unpublished data august num
0.09784351.9373235.html.plaintext.txt	146	discussed telomeric boundary mhc recently extended include region around hemochromatosis locus
0.09784351.9373235.html.plaintext.txt	147	olfactory receptor cluster hemochromatosis locus fig num gene yet another orphan protein immune system whose mrna far found thymus unpublished data july num
0.09784351.9373235.html.plaintext.txt	148	aptly called thymus specific serine protease tssp
0.09784351.9373235.html.plaintext.txt	149	predicted protein hydrophobic leader sequence suggesting either membrane bound secreted
0.09784351.9373235.html.plaintext.txt	150	lack clear internal membrane anchor sequence latter likely interest immunologist learn function gene
0.09784351.9373235.html.plaintext.txt	151	recently rna transcript encoded fat num gene containing sequence one human mhc olfactory receptor like gene detected spleen mrna
0.09784351.9373235.html.plaintext.txt	152	closer examination showed olfactory receptor antisense sequence included probable num untranslated region novel fat num transcript
0.09784351.9373235.html.plaintext.txt	153	unpublished data june num transcript putatively encodes protein num amino acid
0.09784351.9373235.html.plaintext.txt	154	northern blot found predominantly lymph node compared spleen thymus bone marrow variety tissue organ
0.09784351.9373235.html.plaintext.txt	155	encoded protein obvious homology protein database
0.09784351.9373235.html.plaintext.txt	156	therefore fat num seems represent yet another example mhc gene function specifically immune system
0.09784351.9373235.html.plaintext.txt	157	gene within mhc may involved specifically immune process
0.09784351.9373235.html.plaintext.txt	158	homology murine class ii region human class ii striking except insertion num kb murine class ii region containing hnumk gene
0.09784351.9373235.html.plaintext.txt	159	num murine kenum gene lie centromeric hnumk reported expressed lymphatic tissue
0.09784351.9373235.html.plaintext.txt	160	num kenum lie within collagen gene mapping centromeric hnumk reported expressed lymphatic tissue functional significance unclear
0.09784351.9373235.html.plaintext.txt	161	recently described hcgviii transcriptnum reported expressed intestine lymphoid tissue yet another candidate gene specific function immune system
0.09784351.9373235.html.plaintext.txt	162	addition several gene whose expression limited immunocytes number broadly expressed gene mhc potential le specific role immune system
0.09784351.9373235.html.plaintext.txt	163	one example pbxnum also known gnum located approximately num kb telomeric hla dra
0.09784351.9373235.html.plaintext.txt	164	numnum although functional data available pbxnum non mhc pbx gene implicated human leukemia presumably formation oncogenic fusion product via chromosome numnum translocation
0.09784351.9373235.html.plaintext.txt	165	num experiment suggest pbx gene modify specificity clustered homeobox gene forming heterodimers directly bind dna
0.09784351.9373235.html.plaintext.txt	166	clustered homeobox gene expressed different pattern various stage lineage hematopoietic system may modulate expansion various hematopoietic precursor
0.09784351.9373235.html.plaintext.txt	167	view concentration immune related gene appears unlikely clustering immune function within mhc coincidence
0.09784351.9373235.html.plaintext.txt	168	partly discussed suggestion may regional subspecialization immune function within mhc beyond simply explained local gene duplication
0.09784351.9373235.html.plaintext.txt	169	description strikingly apt well studied antigen presentation function proximal mhc could also apply cluster complement component cluster inflammation stress response gene
0.09784351.9373235.html.plaintext.txt	170	large fraction immune system related gene mhc ifn responsive
0.09784351.9373235.html.plaintext.txt	171	although proposal concerning reason clustering quite speculative question arises whether clustering may promoted long range gene control perhaps level chromatin organization dna looping
0.09784351.9373235.html.plaintext.txt	172	alternative proposal cause clustering diverse gene immune system particular allelic form one locus create protein interact preferentially product one another allelic form second locus
0.09784351.9373235.html.plaintext.txt	173	num two allele would therefore preferentially co inherited
0.09784351.9373235.html.plaintext.txt	174	hypothesis simplest form difficulty evidence protein protein interaction product several relevant immune system gene
0.09784351.9373235.html.plaintext.txt	175	consideration population genetics mhc suggests alternative explanation clustering gene
0.09784351.9373235.html.plaintext.txt	176	class ii allele general show high rate accumulation various form mutation least peptide binding region
0.09784351.9373235.html.plaintext.txt	177	num extensively discussed others class inumnum class ii allele also subject gene conversion like eventsnum num well recombination point mutation
0.09784351.9373235.html.plaintext.txt	178	high degree polymorphism believed driven selection particular allele response rapidly evolving parasite kinship recognition see
0.09784351.9373235.html.plaintext.txt	179	certain allelic variant influence predisposition toward various disease including common autoimmune disorder
0.09784351.9373235.html.plaintext.txt	180	possible particular haplotype expanded population gene allele act either protect environmental stress modifier potential adverse effect particular class class ii allele also selected
0.09784351.9373235.html.plaintext.txt	181	example inconceivable class ii allele associated early onset severe autoimmune disease might become associated allele linked gene protective effect particular autoimmune disorder
0.09784351.9373235.html.plaintext.txt	182	consequence could even include paradoxical effect allele protective development disease would found higher incidence affected individual control
0.09784351.9373235.html.plaintext.txt	183	shortly distal hla f gene human mhc contains group gene encode num transmembrane segment receptor olfactory receptor familynum fig num
0.09784351.9373235.html.plaintext.txt	184	role receptor olfaction specific expression olfactory receptor epithelium yet directly shown although similarity gene receptor known expressed olfactory tissue make plausible suggestion
0.09784351.9373235.html.plaintext.txt	185	physiologically gene curiosity report urine odorants determine several type reproductive behavior including fetal retention mating type preference mouse difference odor determined gene linked mhc
0.09784351.9373235.html.plaintext.txt	186	study mouse congenic except mhc suggest num total difference odorant stimulus strain mouse may caused gene mhc mouse distinguish odor urine two strain differ mutation single class gene
0.09784351.9373235.html.plaintext.txt	187	num human also distinguish urine odor mouse different mhc haplotype
0.09784351.9373235.html.plaintext.txt	188	num cross breeding study mouse suggest preference mouse certain mhc determined odor may learned rather genetically irreversibly determined
0.09784351.9373235.html.plaintext.txt	189	num yet known mouse mhc also olfactory receptor gene
0.09784351.9373235.html.plaintext.txt	190	claimed human evidence preference particular mhc determined variation sweat odorsnum preference may change hormonal status individual
0.09784351.9373235.html.plaintext.txt	191	however clear data literature showing mhc determined mating type preference humansnum caution raised precise interpretation mouse experiment
0.09784351.9373235.html.plaintext.txt	192	num also curious subset olfactory receptor like gene expressed sperm number specie
0.09784351.9373235.html.plaintext.txt	193	num occurrence olfactory receptor within mhc may favor selection certain receptor allele matched subset mhc determined odorants haplotype carry certain matched allele would selective advantage population
0.09784351.9373235.html.plaintext.txt	194	odorant discrimination learned could implication population genetics mhc specie odorant attraction repulsion important
0.09784351.9373235.html.plaintext.txt	195	depending manner psychological imprinting social population structure specie imaginable learned haplotype discrimination could stronger driving force heterozygosity genetically determined haplotype discrimination
0.09784351.9373235.html.plaintext.txt	196	could individual might learn discriminate self haplotype also haplotype present early environment
0.09784351.9373235.html.plaintext.txt	197	also diversification mhc allele result selection kin recognition evolving parasite mutually exclusive mechanism
0.09784351.9373235.html.plaintext.txt	198	recurrent spontaneous abortion infertility reported associated sharing hla antigen husband wife although also number negative studiesnum num subject somewhat controversial
0.09784351.9373235.html.plaintext.txt	199	study difficult outbred nature human population polymorphism mhc
0.09784351.9373235.html.plaintext.txt	200	particular possible synergistic additive effect one locus within mhc would difficult detect population
0.09784351.9373235.html.plaintext.txt	201	recent investigator suggested different region mhc may affect different aspect fertilitynum including suggestion homozygosity dr may affect fertilization implantation homozygosity hla b may affect fetal loss
0.09784351.9373235.html.plaintext.txt	202	higher expected ratio heterozygosity homozygosity mhc locus seen several different populationsnum num suggested consequence loss mhc homozygote due increased susceptibility infection
0.09784351.9373235.html.plaintext.txt	203	alternatively may due undefined disadvantage pregnancy accruing fetus histocompatible mother
0.09784351.9373235.html.plaintext.txt	204	however reduction homozygotic individual seen even developed countriesnumnum current generation would expected show significant reduction homozygote due fetal wastage postnatal morbidity due infection
0.09784351.9373235.html.plaintext.txt	205	study reduced reproductive effectiveness couple sharing hla allele study homozygosity single mhc locus would fully reflect effect might seen comparison made entire haplotype
0.09784351.9373235.html.plaintext.txt	206	study south dakota hutterite population valuable regard
0.09784351.9373235.html.plaintext.txt	207	individual reproductively isolated group derived relatively small number individual north european origin apparently fewer num founder
0.09784351.9373235.html.plaintext.txt	208	num also traditionally large family
0.09784351.9373235.html.plaintext.txt	209	group reduction number individual sharing mhc haplotype one third statistically expected level quite remarkable
0.09784351.9373235.html.plaintext.txt	210	numnum suggests diversity mhc haplotype may favored reason parasite resistance perhaps mechanism avoiding inbred population
0.09784351.9373235.html.plaintext.txt	211	study limited population amerindian suggests production viable offspring discriminates mhc homozygosity rather concordance maternal fetal haplotype
0.09784351.9373235.html.plaintext.txt	212	num one study parent sharing mhc haplotype produced excess offspring heterozygous haploidentical mother le expected number mhc homozygous offspring
0.09784351.9373235.html.plaintext.txt	213	could occur zygote homozygous mhc region markedly le viable example recessive lethal allele mhc
0.09784351.9373235.html.plaintext.txt	214	effect would extend across number haplotype requiring unlikely occurrence mutually complementing set recessive lethals haplotype
0.09784351.9373235.html.plaintext.txt	215	num view absence comment contrary individual born homozygous mhc haplotype apparently show congenital abnormality suggest developmental difficulty
0.09784351.9373235.html.plaintext.txt	216	addition hedricknum presented quantitative argument likelihood recessive lethal allele explaining population deficit mhc homozygote
0.09784351.9373235.html.plaintext.txt	217	preferential occurrence heterozygosity would compatible principle kin recognition effect avoid breeding
0.09784351.9373235.html.plaintext.txt	218	could operative level mating type preference preferential fertilization ovum sperm different mhc haplotype decreased survival zygote embryo consequence homozygosity mhc locus
0.09784351.9373235.html.plaintext.txt	219	speculative explanation consistent hutterite amerindian data might selective failure fertilization ovum haplotype identical sperm
0.09784351.9373235.html.plaintext.txt	220	presumably would occur consequence gamete marking accomplished postmeiosis gene expression
0.09784351.9373235.html.plaintext.txt	221	immune attack fetal cell could consistent mechanism self recognition used nk cell
0.09784351.9373235.html.plaintext.txt	222	killing nk cell inhibited presence complete set self class antigen
0.09784351.9373235.html.plaintext.txt	223	therefore homozygous fetal cell would susceptible killing incomplete set maternal self antigen
0.09784351.9373235.html.plaintext.txt	224	however fetus histocompatible mother well cell killing would also inhibited recognition foreign antigen fetal cell
0.09784351.9373235.html.plaintext.txt	225	presumably recognition would mediated cell receptor
0.09784351.9373235.html.plaintext.txt	226	hemochromatosis gene example recombination suppression
0.09784351.9373235.html.plaintext.txt	227	hereditary hemochromatosis recognized num year ago recessive disorder linked mhc class region reviewed chu et alnum
0.09784351.9373235.html.plaintext.txt	228	prevalence rate num numnumnum white hemochromatosis counted among common autosomal recessive disease
0.09784351.9373235.html.plaintext.txt	229	underlying pathophysiology unknown von recklinghausennum others century ago originally described triad diabetes hepatomegaly skin hyperpigmentation
0.09784351.9373235.html.plaintext.txt	230	although know clinical manifestation caused iron overload resulting malregulated dietary iron absorption precise molecular pathway remains unknown
0.09784351.9373235.html.plaintext.txt	231	recent identification hla like gene mutation frequently associated diseasenum well observation num microglobulin deficient mouse develop similar iron overload syndromenum suggests immune system functionally linked iron metabolism
0.09784351.9373235.html.plaintext.txt	232	early genetic mapping study reproducibly independently showed genetic localization hemochromatosis gene vicinity distal mhc
0.09784351.9373235.html.plaintext.txt	233	study within pedigree linkage showed phenotype segregated hla gene
0.09784351.9373235.html.plaintext.txt	234	numnum study large population linkage disequilibrium showed strong association hla anum allele
0.09784351.9373235.html.plaintext.txt	235	num num additional study showed hla anum single marker extended haplotype span distance hla b beyond hla anum almost always associated phenotype
0.09784351.9373235.html.plaintext.txt	236	mapping study mendelian trait diastrophic dysplasia linkage disequilibrium study able pinpoint gene location le num kb
0.09784351.9373235.html.plaintext.txt	237	num surprising given linkage disequilibrium hla anum feder et alnum found hemochromatosis gene hfe candidate mutation num megabases mb telomeric hla considerable distance view genetic data
0.09784351.9373235.html.plaintext.txt	238	hfe gene share approximately num homology hla anum amino acid level le num similarity nucleotide level
0.09784351.9373235.html.plaintext.txt	239	retains many structural hallmark mhc class molecule signal sequence num num domain peptide binding ig like num domain transmembrane region cytoplasmic region
0.09784351.9373235.html.plaintext.txt	240	single mutation described cysnumtyr disrupts disulfide bridge num domain class gene posited associate num microglobulin
0.09784351.9373235.html.plaintext.txt	241	eighty three percent unrelated american patient found homozygous mutation feder report carrier frequency num
0.09784351.9373235.html.plaintext.txt	242	presumably cysnumtyr mutation interferes association hfe num microglobulin class molecule shown important intracellular transport protein endoplasmic reticulum cell surface
0.09784351.9373235.html.plaintext.txt	243	involvement class gene iron transport supported study showing iron overload mouse homozygous knockout num microglobulin
0.09784351.9373235.html.plaintext.txt	244	num however mechanistic connection intestinal iron absorption known function class gene obscure
0.09784351.9373235.html.plaintext.txt	245	although extensively searched autoimmunity part pathophysiology hemochromatosis
0.09784351.9373235.html.plaintext.txt	246	northern blot analysis show hfe num kb mrna weakly expressed many tissue
0.09784351.9373235.html.plaintext.txt	247	published cdna smaller mrna num
0.09784351.9373235.html.plaintext.txt	248	num kb num untranslated region
0.09784351.9373235.html.plaintext.txt	249	cysnumtyr mutation single described mutation consistently associated disease bearing chromosome
0.09784351.9373235.html.plaintext.txt	250	second much le common mutation described well appear increase risk disease
0.09784351.9373235.html.plaintext.txt	251	presumably mutation hfe yet discovered analysis region far proven elusive
0.09784351.9373235.html.plaintext.txt	252	interestingly feder et al find linkage disequilibrium numpnum
0.09784351.9373235.html.plaintext.txt	253	num marker hemochromatosis chromosome lacking cysnumtyr mutation
0.09784351.9373235.html.plaintext.txt	254	lack linkage disequilibrium interpreted evidence additional nonlinked locus causing hemochromatosis phenotype
0.09784351.9373235.html.plaintext.txt	255	follow study australia jazwinska et alnum recently reported severest phenotype found patient ancestral haplotype spanning region hla b beyond hla f fig num
0.09784351.9373235.html.plaintext.txt	256	patient homozygous cysnumtyr mutation suggested second modifier gene close hfe varied haplotype
0.09784351.9373235.html.plaintext.txt	257	contrast feder et al found united state hemochromatosis phenotype associated homozygote cysnumtyr heterozygote cysnumtyr homozygote non cysnumtyr mutation could differentiated clinical ground
0.09784351.9373235.html.plaintext.txt	258	although association cysnumtyr mutation hemochromatosis compelling argument causation explanation non cysnumtyr patient lacking
0.09784351.9373235.html.plaintext.txt	259	possible case non cysnumtyr hemochromatosis caused alternative mutation hfe
0.09784351.9373235.html.plaintext.txt	260	however proof awaits cloning remaining num
0.09784351.9373235.html.plaintext.txt	261	num kb hfe cdna identification alternative mutation
0.09784351.9373235.html.plaintext.txt	262	curiously new syndrome liver iron overload normal transferrin saturation recently described pippardnum moirand et al
0.09784351.9373235.html.plaintext.txt	263	num discovery add weight speculation feder et al mutation gene may cause clinical picture indistinguishable hemochromatosis
0.09784351.9373235.html.plaintext.txt	264	hemochromatosis phenotype cysnumtyr mutation common mhc haplotype anumbnum widespread distribution among white population including great britain france italy germany sweden norway australia united state
0.09784351.9373235.html.plaintext.txt	265	num high prevalence distribution strongly suggest mutation arose ancestral chromosome ancient event perhaps celtic scandinavian population
0.09784351.9373235.html.plaintext.txt	266	based estimated incidence hemochromatosis high carrier frequency frequency cysnumtyr mutation estimated cysnumtyr mutation may present least num num million individual
0.09784351.9373235.html.plaintext.txt	267	given plausible value coefficient selection mutation must occurred much num generation ago
0.09784351.9373235.html.plaintext.txt	268	physical distance hla hemochromatosis gene num megabases
0.09784351.9373235.html.plaintext.txt	269	rate recombination region comparable average rate genome one would expect num meiosis would result separation hla hfe marker
0.09784351.9373235.html.plaintext.txt	270	recombination frequency linkage disequilibrium dissipated relatively short period time yet
0.09784351.9373235.html.plaintext.txt	271	possible explanation preservation linkage disequilibrium num mb region include multiple identical hfe mutation haplotypic background recent origin hfe mutation recombination suppression perhaps simultaneous selection hla allele hla anum hemochromatosis mutation
0.09784351.9373235.html.plaintext.txt	272	first two explanation le likely
0.09784351.9373235.html.plaintext.txt	273	possibility identical hfe mutation could occur multiple time haplotypic background suggests might inherently unstable sequence hfe gene trinucleotide repeat known expand successive generation cpg dinucleotide
0.09784351.9373235.html.plaintext.txt	274	hfe mutation associated common haplotype anumbnum g transition nucleotide num open reading frame cause cysnumtyr missense mutation
0.09784351.9373235.html.plaintext.txt	275	furthermore work others shown mutation stable family yet example spontaneous mutation type reported
0.09784351.9373235.html.plaintext.txt	276	simultaneous selection allele multiple locus recombination suppression difficult explanation dismiss
0.09784351.9373235.html.plaintext.txt	277	possible certain genetic advantage offered combination allele gene distributed region including hla gene even perhaps extending hfe gene
0.09784351.9373235.html.plaintext.txt	278	however simultaneous coselection allele end region responsible maintenance linkage disequilibrium intervening allele might consistently retained haplotype
0.09784351.9373235.html.plaintext.txt	279	observed among hemochromatosis chromosome gene found distal region might interact proximal hla gene thereby promote selection
0.09784351.9373235.html.plaintext.txt	280	linkage disequilibrium portion mhc particularly region hla hla b suggest either recombination suppression coselection allele several locus may operative combination allele
0.09784351.9373235.html.plaintext.txt	281	num anumbnum haplotype long renowned high disequilibriumnum occurs num french family illustrating high association allele two locus may exhibit
0.09784351.9373235.html.plaintext.txt	282	investigator studying interpreted data suggestive selection although distinction made coselection operating several locus recombination suppression region
0.09784351.9373235.html.plaintext.txt	283	contrast anum show linkage disequilibrium hla b allele suggesting selection phenomenon low recombination rate apply possible haplotype
0.09784351.9373235.html.plaintext.txt	284	study syntenic region mouse suggest significant recombination suppression haplotype specific
0.09784351.9373235.html.plaintext.txt	285	linkage data distal hla somewhat limited
0.09784351.9373235.html.plaintext.txt	286	genethon sex averaged linkage mapnum show recombinant num meiosis derived eight ceph family studied marker adjacent interspersed hla hfe
0.09784351.9373235.html.plaintext.txt	287	major hemochromatosis mutation strong linkage disequilibrium marker near hla
0.09784351.9373235.html.plaintext.txt	288	anumbnum hemochromatosis haplotype comprises num hemochromatosis bearing chromosome
0.09784351.9373235.html.plaintext.txt	289	num compared genome wide average recombination region hemochromatosis mutation bearing chromosome suppressed
0.09784351.9373235.html.plaintext.txt	290	common extended haplotype described normal european control population associated anumbnum extends least num mb hla b
0.09784351.9373235.html.plaintext.txt	291	recombination suppression coselection favorable allele plausible explanation persistence linkage disequilibrium haplotype
0.09784351.9373235.html.plaintext.txt	292	three independent histone cluster mapping regionnum fig num unpublished data july num may also relevant recombination suppression
0.09784351.9373235.html.plaintext.txt	293	haplotype specific heterogeneity rate recombination tempting consider may modulated haplotype specific local sequence
0.09784351.9373235.html.plaintext.txt	294	preferred site recombination identified class ii class iii region mousenum human genomenum seem general feature throughout mhc
0.09784351.9373235.html.plaintext.txt	295	num case rate recombination within relatively short region le numnum base may elevated several order magnitude average rate genome whole
0.09784351.9373235.html.plaintext.txt	296	therefore mhc recombinant obtained laboratory cross particular pair strain may occur within hotspot
0.09784351.9373235.html.plaintext.txt	297	num hotspot thought resolution point joint molecule two dna duplex become separated
0.09784351.9373235.html.plaintext.txt	298	phenomenon complex particular hot spot operative certain haplotype genetic background may sex specific
0.09784351.9373235.html.plaintext.txt	299	num recombination maynum may require perfect homology across hotspotnum difference hotspot activity may due variation number copy relatively simple repetitive sequence present tandem array recombination site
0.09784351.9373235.html.plaintext.txt	300	num recombination occurs number copy least one set repeat chromosome
0.09784351.9373235.html.plaintext.txt	301	activity hotspot seems require instigator sequence present haplotype located distance region recombination actually occurs
0.09784351.9373235.html.plaintext.txt	302	recent work yeast mating type locus also shown chromosomal region may exhibit regulated activation recombination regulation may involve short region ci active dna sequence together trans acting protein
0.09784351.9373235.html.plaintext.txt	303	area recombination activated may several order magnitude larger ci active dna sequence interact relevant protein
0.09784351.9373235.html.plaintext.txt	304	particular num bp sequence identified activates recombination along numnum bp region yeast chromosome
0.09784351.9373235.html.plaintext.txt	305	num occurs cell one two mating type perhaps consequence expression mating type specific dna binding protein
0.09784351.9373235.html.plaintext.txt	306	region recombination actually occurs numnum base removed num bp instigator sequence
0.09784351.9373235.html.plaintext.txt	307	phenomenologically similar deduced mhc detailed mechanism case remain worked
0.09784351.9373235.html.plaintext.txt	308	class ii class iii region human mouse roughly colinear good correspondence presence linear order specific gene two specie
0.09784351.9373235.html.plaintext.txt	309	persuasive evidence exists chromosome numqnum num numqnum
0.09784351.9373235.html.plaintext.txt	310	num contain multigene segment dna paralogous class ii iii perhaps iv region mhc chromosome num
0.09784351.9373235.html.plaintext.txt	311	num example gene one three member rxr steroid receptor family located centromeric class ii region chromosome num chromosome num num presumably paralogous position
0.09784351.9373235.html.plaintext.txt	312	similar situation occurs respect pbx gene notch homologue gene several homologues shared least two three chromosomal region
0.09784351.9373235.html.plaintext.txt	313	chromosome num duplication particularly striking fall region class like cdnum gene lie
0.09784351.9373235.html.plaintext.txt	314	also otfnum map mhc hla e otfnum map unknown site chromosome num
0.09784351.9373235.html.plaintext.txt	315	recently new class gene called mrnum identified long arm chromosome numnum although reported location somewhat telomeric remainder mhc like gene referred
0.09784351.9373235.html.plaintext.txt	316	yet known whether mrnum polymorphic expressed protein level
0.09784351.9373235.html.plaintext.txt	317	unfortunately region chromosome num num mapped sufficient resolution see closely organization paralogous region match either present mhc plausible model precursor mhc
0.09784351.9373235.html.plaintext.txt	318	among thing observation raise interesting possibility additional immune system gene located paralogous region chromosome num num perhaps num class like zinc num glycoprotein gene located
0.09784351.9373235.html.plaintext.txt	319	discussed class ii class gene show extensive allelic variability due point mutation intra locus recombination intra locus gene conversion like event
0.09784351.9373235.html.plaintext.txt	320	addition relationship class region various mammal complex multiple cycle expansion contraction must occurred account genetic structure region inter intra specie difference
0.09784351.9373235.html.plaintext.txt	321	numnumnum human mhc overall contains least num class related gene gene fragment including num num analyzed geraghty et alnum num mic gene pseudogenesnum least num class segment near mic b respectively class related sequence class ii regionnum hemochromatosis gene
0.09784351.9373235.html.plaintext.txt	322	hfe one gene confidently ortholog specific mouse gene reflection massive change created cycle expansion contraction since divergence progenitor two mammal
0.09784351.9373235.html.plaintext.txt	323	one striking feature divergence murine human class region resulted presence functional subfamily class gene specie missing
0.09784351.9373235.html.plaintext.txt	324	thus mouse contains family tl gene largely unknown functionnum also hnum m gene interesting property binding specifically formyl methionine containing peptide occur amino terminus bacterial mitochondrial protein
0.09784351.9373235.html.plaintext.txt	325	num type class gene detected probably completely missing human
0.09784351.9373235.html.plaintext.txt	326	conversely human nonclassical class heavy chain gene including hla g genenum expressed specific location placental fetal cellsnum may serve prevent nk cell rejection fetusesnum also early stage embryogenesis
0.09784351.9373235.html.plaintext.txt	327	num recently mouse class gene found may preferentially expressed early development quite unclear whether homologues either structure evolutionary relationship even function human hla g gene
0.09784351.9373235.html.plaintext.txt	328	described human also family five gene pseudogenes termed micnum perbnum gene
0.09784351.9373235.html.plaintext.txt	329	encode least one expressed product mic protein polymorphic induced heat shock expressed preferentially intestinal mucosa precise function yet known
0.09784351.9373235.html.plaintext.txt	330	comparable product undetectable mouse
0.09784351.9373235.html.plaintext.txt	331	mic gene clearly structurally related class gene term structure protein encode position seven intron located homologous position coding sequence
0.09784351.9373235.html.plaintext.txt	332	structure mic gene differs class gene contain long num kb first intron
0.09784351.9373235.html.plaintext.txt	333	intron contains first exon transcript derived complementary strand
0.09784351.9373235.html.plaintext.txt	334	spliced form transcript one mic pseudogenes detected contains additional exon dna upstream mic transcription initiation site
0.09784351.9373235.html.plaintext.txt	335	num complex two interspersed gene pseudogenes occurs twice centromeric hla b three time hla e hla f distal mhc accounting least part observation repeated block sequence region mhc
0.09784351.9373235.html.plaintext.txt	336	mouse mhc complex apparently lack gene mic series human lack extensive series tl gene mouse
0.09784351.9373235.html.plaintext.txt	337	num mog suggests either entire region human mhc hla hla f compressed le num kb mouse contains single hnumm class genenum inversion occurred one end point lying bnum
0.09784351.9373235.html.plaintext.txt	338	evidence remarkably extensive rearrangement deletion expansion occurred vertebrate mhc class region
0.09784351.9373235.html.plaintext.txt	339	hemochromatosis gene containing region chromosome nump located num mb telomeric hla f
0.09784351.9373235.html.plaintext.txt	340	hemochromatosis region also appears originated large duplication involving histone genesnum perhaps ret finger like genenum addition class gene
0.09784351.9373235.html.plaintext.txt	341	exact duplication region defined yet apparently lack olfactory receptor gene located nearest class gene proximal histone gene cluster
0.09784351.9373235.html.plaintext.txt	342	indicated paragraph mhc exhibit several singular characteristic including clustering gene disparate structure function within immuno hematopoietic system evidence rapid evolution relative nonrepetitive sequence portion genome evidence variation rate intra mhc recombination
0.09784351.9373235.html.plaintext.txt	343	speculate phenomenon may related following way
0.09784351.9373235.html.plaintext.txt	344	class class ii gene mhc particular appear subject selective pressure diversification operate short time scale relative evolutionary event
0.09784351.9373235.html.plaintext.txt	345	environmental stress may also put selective pressure allele immune system gene
0.09784351.9373235.html.plaintext.txt	346	addition resulting rapid shift allele abundance composition class class ii gene whether due parasite driven selection effect mhc procreation may result emergence autoimmune phenomenon putting secondary selective pressure gene immune system diminish incidence consequence autoimmunity
0.09784351.9373235.html.plaintext.txt	347	also extreme divergence class region mammal compared even class ii region raise question whether evolutionary pressure class gene beyond arising presentation peptide cell receptor
0.09784351.9373235.html.plaintext.txt	348	presence immune system gene chromosomal region therefore linkage disequilibrium classical mhc gene provides opportunity simultaneous selection optimal allele gene among variety chromosome carrying newly selected class ii allele
0.09784351.9373235.html.plaintext.txt	349	diminishes rate disruption favored combination allele would result recombination reassortment chromosome meiosis
0.09784351.9373235.html.plaintext.txt	350	recombination rate mhcs would optimal low rate recombination sufficient generate favorable combination allele low enough limit genetic burden recombinant nonoptimal chromosomal segment
0.09784351.9373235.html.plaintext.txt	351	num however different mhc region exhibit heterogeneous rate recombination controlled least part sequence within mhc
0.09784351.9373235.html.plaintext.txt	352	permit recombination allele generate among others favorable combination chromosomal segment may relatively locked recombination suppression
0.09784351.9373235.html.plaintext.txt	353	chromosomal segment would advantageous thus expanded generating extended haplotype show linkage disequilibrium population
0.09784351.9373235.html.plaintext.txt	354	consideration could apply occurrence olfactory receptor gene linked mhc
0.09784351.9373235.html.plaintext.txt	355	class gene particular determinant odor reviewed might coselection receptor responsive nonresponsive class determined odor
0.09784351.9373235.html.plaintext.txt	356	mhc long known play major role determination genetic susceptibility autoimmune disorder large part due polymorphism class ii gene
0.09784351.9373235.html.plaintext.txt	357	however least case evidence strong non class ii gene mhc also play role predisposition autoimmunity
0.09784351.9373235.html.plaintext.txt	358	identification additional gene region modify propensity autoimmune disease could important diagnostic therapeutic implication
0.09784351.9373235.html.plaintext.txt	359	recent year analysis mhc encoded transcript shown within mhc num different structurally diverse family gene whose pattern expression indicate specific role immune system
0.09784351.9373235.html.plaintext.txt	360	number different mhc gene functioning immune response extensive region linkage disequilibrium seen instance mhc make particularly difficult use positional genetic approach assign disease contribution particular gene product
0.09784351.9373235.html.plaintext.txt	361	short understanding regulation function protein level effect amino acid nucleotide sequence variation could predicted perhaps best genetic approach look sense change codon variation known promoter element gene test large population see correlation disease manifestation independent disequilibrium class ii gene
0.09784351.9373235.html.plaintext.txt	362	could difficult number reason least extensive degree linkage disequilibrium consequent occurrence extended haplotype region
0.09784351.9373235.html.plaintext.txt	363	increasing amount genomic sequence data mhc emerging available directly sanger centre ftpftp
0.09784351.9373235.html.plaintext.txt	364	tapasin transmembrane glycoprotein mediates calreticulin bound mhc class molecule interaction tap recently mapped close mhc
0.09784351.9373235.html.plaintext.txt	365	submitted march num num accepted june num num
0.09784351.9373235.html.plaintext.txt	366	supported march dime birth defect research foundation clinical research grant
0.09784351.9373235.html.plaintext.txt	367	num fynum num national institute health nih grant
0.09784351.9373235.html.plaintext.txt	368	supported nih outstanding investigator award canum num
0.09784351.9373235.html.plaintext.txt	369	address reprint request jeffrey r
0.09784351.9373235.html.plaintext.txt	370	gruen md yale child health research center department pediatrics yale university school medicine num congress ave new haven ct num num
0.09784351.9373235.html.plaintext.txt	371	name given feder et al hla h
0.09784351.9373235.html.plaintext.txt	372	nomenclature confusing previously dubbed hfe year ago anticipation discovery hla h already used designate mhc class gene several year earlier mapped hla hla g
0.09784351.9373235.html.plaintext.txt	373	refer new gene simply hfe remainder review
0.09784351.9373235.html.plaintext.txt	374	author thank drs frank black chris bowlus nancy ruddle judith kidd gordon shepherd ruma raha chowdhury helpful comment correction manuscript
0.09784351.9373235.html.plaintext.txt	375	also thank colleague helpful discussion material provided drs duncan campbell peter lengyel john trowsdale
0.099135764.12639939.html.plaintext.txt	0	gonadotropin releasing hormone neuron coexpress orexin num receptor immunoreactivity receive direct contact orexin fiber rebecca e
0.099135764.12639939.html.plaintext.txt	1	oregon national primate research center beaverton oregon num department physiology pharmacology r
0.099135764.12639939.html.plaintext.txt	2	oregon health science university portland oregon num
0.099135764.12639939.html.plaintext.txt	3	address correspondence request reprint dr
0.099135764.12639939.html.plaintext.txt	4	susan smith oregon national primate research center oregon health science university beaverton oregon num
0.099135764.12639939.html.plaintext.txt	5	recent physiological neuroanatomical study suggest orexin may play important role control hypothalamo pituitary gonadal axis
0.099135764.12639939.html.plaintext.txt	6	example shown central administration orexin stimulates lh secretion num
0.099135764.12639939.html.plaintext.txt	7	however similar orexigenic peptide neuropeptide y npy orexin shown bimodal effect lh secretion orexin stimulating lh secretion steroid primed ovariectomized rat inhibiting lh secretion absence ovarian steroid num num
0.099135764.12639939.html.plaintext.txt	8	also demonstrated immunoneutralization orexin brain completely abolishes lh prl surge icv administration orexin lead dose dependent recovery fasting suppressed lh surge num
0.099135764.12639939.html.plaintext.txt	9	addition tissue explant study shown orexin stimulates gnrh release hypothalamus intact male rat female rat proestrus num
0.099135764.12639939.html.plaintext.txt	10	recently study employing low dose estrogen replacement ovariectomized rat resulting serum level similar observed diestrus demonstrated low dose estrogen potentiates suppressive effect centrally administered orexin lh secretion num suggesting orexin inhibitory diestrus low estrogen state excitatory surge condition
0.099135764.12639939.html.plaintext.txt	11	although orexin clearly implicated regulation gnrhlh secretion neuroanatomical pathway orexin may mediating effect rat remains determined
0.099135764.12639939.html.plaintext.txt	12	first aim present study investigate whether orexin fiber project come close contact gnrh neuron whether gnrh neuron express ox rnum rat
0.099135764.12639939.html.plaintext.txt	13	similar orexin npy found elicit bimodal effect lh release likely acting ynum num num num ynum num num num num ynum num num receptor subtypes
0.099135764.12639939.html.plaintext.txt	14	recently laboratory reported majority orexin cell body lha expressed ynum like immunoreactivity ynum ir orexin fiber also positive ynum ir num
0.099135764.12639939.html.plaintext.txt	15	others shown activation ynum receptor ynum agonist numunum high affinity ligand ynum receptor rat pancreatic polypeptide rpp stimulates gnrh neuron turn lh release intact male rat num important basal release lh female rat num
0.099135764.12639939.html.plaintext.txt	16	conversely infertile leptin deficient obob mouse crossed ynum knockout mouse fertility partially restored suggesting ynum receptor involved suppressing reproductive function num
0.099135764.12639939.html.plaintext.txt	17	taken together data suggest effect ynum activation lh release may mediated via orexin
0.099135764.12639939.html.plaintext.txt	18	therefore second aim present study characterize neuroanatomical relationship ynum positive orexin fiber gnrh neuron
0.099135764.12639939.html.plaintext.txt	19	immunocytochemical study animal n num num male female rat used experiment killed pentobarbital anesthesia cardiac infusion ice cold pb followed ice cold paraformaldehyde naponum buffer ph num
0.099135764.12639939.html.plaintext.txt	20	brain removed saturated num sucrose frozen cooled isopentane stored num c sectioning microtome
0.099135764.12639939.html.plaintext.txt	21	one six series tissue section num microm collected animal
0.099135764.12639939.html.plaintext.txt	22	double triple label immunofluorescence immunofluorescent labeling previously reported num num performed floating section
0.099135764.12639939.html.plaintext.txt	23	double triple label orexin gnrh one synaptophysin ox rnum ynum performed using cocktail primary antibody
0.099135764.12639939.html.plaintext.txt	24	goat polyclonal orexin antibody santa cruz biotechnology santa cruz ca used concentration numnumnum num
0.099135764.12639939.html.plaintext.txt	25	mouse monoclonal gnrh antibody kind gift h
0.099135764.12639939.html.plaintext.txt	26	urbanski oregon national primate research center beaverton used concentration numnum num
0.099135764.12639939.html.plaintext.txt	27	rabbit polyclonal synaptophysin antibody dako corp
0.099135764.12639939.html.plaintext.txt	28	carpinteria ca used concentration numnum
0.099135764.12639939.html.plaintext.txt	29	rabbit polyclonal ox rnum antibody kind gift g
0.099135764.12639939.html.plaintext.txt	30	hervieu smithkline beecham food international harlow essex uk used concentration numnum num num
0.099135764.12639939.html.plaintext.txt	31	ox rnum antibody extensively characterized shown specific evidenced agreement pattern receptor mrna protein expression num specific detection receptor cell line transfected ox rnum num loss specific staining following preabsorption antiserum immunogen peptide num
0.099135764.12639939.html.plaintext.txt	32	rabbit polyclonal ynum antibody kind gift j
0.099135764.12639939.html.plaintext.txt	33	ffrench mullen used numnumnum concentration num
0.099135764.12639939.html.plaintext.txt	34	specificity antibody confirmed showing similar expression pattern mrna protein determined western blot
0.099135764.12639939.html.plaintext.txt	35	combination double triple labeling primary antibody titrated establish maximum dilution provided robust signal minimum nonspecific staining
0.099135764.12639939.html.plaintext.txt	36	first double labeling orexin gnrh performed
0.099135764.12639939.html.plaintext.txt	37	briefly floating tissue section removed cryoprotectant washed num
0.099135764.12639939.html.plaintext.txt	38	tissue incubated blocking buffer kpbs num
0.099135764.12639939.html.plaintext.txt	39	num triton x num num normal donkey serum num min reduce background incubated cocktail orexin gnrh primary antibody num h num c
0.099135764.12639939.html.plaintext.txt	40	following wash kpbs tissue incubated num h cocktail fluorescent secondary antibody
0.099135764.12639939.html.plaintext.txt	41	orexin visualized tetramethyl rhodamine isothiocyanate tritc conjugated donkey antigoat antibody numnum jackson immunoresearch laboratory inc
0.099135764.12639939.html.plaintext.txt	42	west grove pa gnrh visualized fluorescein isothiocyanate fitc conjugated donkey antimouse antibody numnum jackson immunoresearch laboratory inc
0.099135764.12639939.html.plaintext.txt	43	subsequently double labeling gnrh ox rnum performed
0.099135764.12639939.html.plaintext.txt	44	previous experiment gnrh visualized fitc conjugated donkey antimouse antibody numnum ox rnum visualized tritc conjugated donkey antirabbit antibody numnum jackson immunoresearch laboratory inc
0.099135764.12639939.html.plaintext.txt	45	triple label experiment gnrhorexinsynaptophysin gnrhox rnumorexin gnrhorexinynum carried similar manner
0.099135764.12639939.html.plaintext.txt	46	triple label experiment gnrh visualized fitc conjugated donkey antimouse antibody numnum
0.099135764.12639939.html.plaintext.txt	47	first triple label experiment orexin visualized tritc conjugated donkey antigoat antibody numnum synaptophysin visualized cynum conjugated donkey antirabbit antibody numnum jackson immunoresearch laboratory inc
0.099135764.12639939.html.plaintext.txt	48	second triple label experiment ox rnum visualized tritc conjugated donkey antirabbit antibody numnum orexin visualized cynum conjugated donkey antigoat antibody numnum
0.099135764.12639939.html.plaintext.txt	49	final triple label experiment used cynum conjugated donkey antirabbit antibody numnum visualize ynum tritc conjugated donkey antigoat antibody numnum visualize orexin
0.099135764.12639939.html.plaintext.txt	50	enhance signal ynum ir blast technique biotinylated tyramide enhancement used reported previously num num
0.099135764.12639939.html.plaintext.txt	51	section experiment mounted onto subbed slide cover slipped glycerol sealed
0.099135764.12639939.html.plaintext.txt	52	confocal laser microscopy confocal laser microscopy previously described num num used analyze double triple label image colocalization close contact
0.099135764.12639939.html.plaintext.txt	53	tsc sp confocal system leica corp
0.099135764.12639939.html.plaintext.txt	54	germany consisting rbe inverted microscope leica corp
0.099135764.12639939.html.plaintext.txt	55	ar laser producing light num nm visualization fitc kr laser producing light num nm visualizing tritc hene laser producing light num nm visualization cynum used scan image
0.099135764.12639939.html.plaintext.txt	56	various objective xnum numerical aperture num
0.099135764.12639939.html.plaintext.txt	57	num xnum numerical aperture num
0.099135764.12639939.html.plaintext.txt	58	num used scan capture image
0.099135764.12639939.html.plaintext.txt	59	experiment fluorophore signal checked individually bleed apposing detector
0.099135764.12639939.html.plaintext.txt	60	bleed eliminated adjusting laser intensity detector window width
0.099135764.12639939.html.plaintext.txt	61	ass colocalization two signal series continuous optical section num
0.099135764.12639939.html.plaintext.txt	62	num microm interval along z axis tissue section scanned fluorescent signal
0.099135764.12639939.html.plaintext.txt	63	signal obtained fluorophore one series optical section stored separately series num x num pixel image
0.099135764.12639939.html.plaintext.txt	64	stack individual optical slice num
0.099135764.12639939.html.plaintext.txt	65	num microm resolution analyzed using metamorph imaging system universal imaging corp
0.099135764.12639939.html.plaintext.txt	66	west chester pa determine colocalization contact
0.099135764.12639939.html.plaintext.txt	67	confocal image presented projection stack optical image individual slice indicated
0.099135764.12639939.html.plaintext.txt	68	brightness contrast image adjusted photoshop match microscope visualization adobe system inc
0.099135764.12639939.html.plaintext.txt	69	data analysis double label study gnrhorexin gnrhox rnum one series tissue section num num section num microm interval section used animal n num num animal
0.099135764.12639939.html.plaintext.txt	70	gnrh neuron analyzed entire cell body including proximal dendritic process visible section
0.099135764.12639939.html.plaintext.txt	71	triple label study representative section several animal examined
0.099135764.12639939.html.plaintext.txt	72	study performed primarily proof principle
0.099135764.12639939.html.plaintext.txt	73	gnrh neuron expressing ox rnum contacted orexin fiber gnrhox rnumorexin orexin contact observed gnrh neuron represent potential synaptic contact gnrhorexinsynaptophysin
0.099135764.12639939.html.plaintext.txt	74	triple label gnrhorexinynum scattered ynum positive orexin fiber area gnrh neuron
0.099135764.12639939.html.plaintext.txt	75	view larger version numk figure num
0.099135764.12639939.html.plaintext.txt	76	orexin fiber come close contact gnrh neuron
0.099135764.12639939.html.plaintext.txt	77	low power fluorescent photomicrograph demonstrating gnrh neuron green surrounded orexin fiber red
0.099135764.12639939.html.plaintext.txt	78	higher power example individual gnrh neuron b c show orexin fiber making close contact
0.099135764.12639939.html.plaintext.txt	79	arrowhead indicate apparent close contact b c colocalization pixel result yellow color
0.099135764.12639939.html.plaintext.txt	80	d example orexin fiber red spine arrowhead colocalized synaptophysin blue make close contact gnrh cell body green
0.099135764.12639939.html.plaintext.txt	81	white pixel indicate triple label overlap yellow pixel indicate colocalization red green pixel
0.099135764.12639939.html.plaintext.txt	82	num microm resolution optical slice demonstrating triple labeling arrowhead
0.099135764.12639939.html.plaintext.txt	83	white scale bar num microm b e num microm
0.099135764.12639939.html.plaintext.txt	84	view larger version numk figure num
0.099135764.12639939.html.plaintext.txt	85	gnrh neuron express ox rnum ir receive close contact orexin fiber
0.099135764.12639939.html.plaintext.txt	86	low power example double label gnrh neuron green ox rnum expressing neuron red medial preoptic area hypothalamus
0.099135764.12639939.html.plaintext.txt	87	yellow color indicates colocalization
0.099135764.12639939.html.plaintext.txt	88	b higher power example ox rnum expressing gnrh greenyellow neuron single labeled ox rnum neuron red shown
0.099135764.12639939.html.plaintext.txt	89	c d two representative example triple label gnrh neuron green expressing ox rnum ir single label red colocalization gnrh yellow
0.099135764.12639939.html.plaintext.txt	90	orexin fiber blue make apparent close contact ox rnum expressing region gnrh neuron indicated white arrow
0.099135764.12639939.html.plaintext.txt	91	yellow arrow indicates orexin fiber contact onto single label ox rnum neuron red
0.099135764.12639939.html.plaintext.txt	92	white scale bar num microm b d num microm
0.099135764.12639939.html.plaintext.txt	93	ox rnum expression orexin innervation also investigated region gnrh terminal median eminence
0.099135764.12639939.html.plaintext.txt	94	num although ox rnum expression red region orexin fiber appear innervate dorsolateral blue coexpression ox rnum gnrh green little interaction orexin fiber gnrh nerve terminal
0.099135764.12639939.html.plaintext.txt	95	view larger version numk figure num
0.099135764.12639939.html.plaintext.txt	96	gnrh nerve terminal median eminence express ox rnum
0.099135764.12639939.html.plaintext.txt	97	b two representative image triple label gnrh fiber green ox rnum red orexin fiber blue
0.099135764.12639939.html.plaintext.txt	98	colocalization ox rnum gnrh fiber apparent orexin fiber minimal interaction gnrh nerve terminal
0.099135764.12639939.html.plaintext.txt	99	additional triple label study carried investigate whether ynum positive orexin fiber make close contact gnrh neuron
0.099135764.12639939.html.plaintext.txt	100	scattered ynum positive orexin fiber observed vicinity gnrh cell body
0.099135764.12639939.html.plaintext.txt	101	figure num depicts three gnrh cell body surrounded orexin fiber
0.099135764.12639939.html.plaintext.txt	102	white arrow indicate two fiber ynumorexin positive
0.099135764.12639939.html.plaintext.txt	103	yellow arrow indicate orexin positive fiber identified coming close contact gnrh neuron
0.099135764.12639939.html.plaintext.txt	104	although multiple close contact orexin fiber gnrh shown previously fig
0.099135764.12639939.html.plaintext.txt	105	num ynum positive orexin fiber never came close contact gnrh neuron
0.099135764.12639939.html.plaintext.txt	106	view larger version numk figure num
0.099135764.12639939.html.plaintext.txt	107	ynum positive orexin ir fiber near gnrh neuron make close contact
0.099135764.12639939.html.plaintext.txt	108	triple label demonstrates gnrh neuron green surrounded orexin fiber red ynum positive orexin double label fiber white indicated white arrow
0.099135764.12639939.html.plaintext.txt	109	noted ynum expression orexin fiber changed original color magenta white make visible photograph
0.099135764.12639939.html.plaintext.txt	110	beaded appearance ynum positive orexin neuron may exaggerated blast technique enhance ynum staining although similar appearance also observed single label orexin fiber see fig
0.099135764.12639939.html.plaintext.txt	111	orexin single label fiber coming close contact gnrh neuron indicated double label yellow pixel marked yellow arrow
0.099135764.12639939.html.plaintext.txt	112	several line evidence support contention orexin modulates neuroendocrine function
0.099135764.12639939.html.plaintext.txt	113	addition number study indicating steroid dependent effect central orexin administration lh release num num num study using vitro explants indicate stimulatory effect orexin hypothalamic level num
0.099135764.12639939.html.plaintext.txt	114	also reported orexin stimulates gnrh release hypothalamic explants collected male rat female rat proestrus
0.099135764.12639939.html.plaintext.txt	115	data suggest stimulatory effect orexin lh release via direct stimulation gnrh secretion
0.099135764.12639939.html.plaintext.txt	116	indeed present finding provide functional neuroanatomical pathway orexin may stimulate gnrh neuron subsequent lh release via direct contact ox rnum gnrh cell body nerve terminal within
0.099135764.12639939.html.plaintext.txt	117	ox rnum exclusively coupled gqnum subtype g protein num num suggesting orexin action via ox rnum gnrh neuron excitatory
0.099135764.12639939.html.plaintext.txt	118	however orexin also shown inhibit lh secretion absence gonadal steroid num although mechanism gonadal steroid modulate orexin effect lh secretion remains determined
0.099135764.12639939.html.plaintext.txt	119	possible inhibitory action orexin gnrh neuron indirect involving activation neuron within preoptic area also express ox rnum fig
0.099135764.12639939.html.plaintext.txt	120	num turn may inhibitory action gnrh neuron
0.099135764.12639939.html.plaintext.txt	121	name implies orexin activity necessary normal feeding behavior
0.099135764.12639939.html.plaintext.txt	122	central injection orexin stimulates food intake satiated rat num num whereas neutralization orexin antiorexin antibody dose dependently suppresses spontaneous feeding fasted rat num
0.099135764.12639939.html.plaintext.txt	123	furthermore orexin mrna increased fasting num
0.099135764.12639939.html.plaintext.txt	124	data suggest orexin neuron able sense nutritional state animal
0.099135764.12639939.html.plaintext.txt	125	shown repeatedly change metabolic status animal tightly linked change reproductive function
0.099135764.12639939.html.plaintext.txt	126	therefore ability orexin modulate feeding behavior reproductive function along present neuroanatomical finding suggests orexin system key position serve integrating signal energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	127	addition orexin neuron known coexpress long form leptin receptor ob rb rat num sheep num
0.099135764.12639939.html.plaintext.txt	128	leptin peripheral metabolic signal released adipocytes important denoting adiposity energy balance brain
0.099135764.12639939.html.plaintext.txt	129	also leptin shown play role regulating reproductive function
0.099135764.12639939.html.plaintext.txt	130	administration leptin restores fasting induced suppression lh secretion sheep primate num num num
0.099135764.12639939.html.plaintext.txt	131	however gnrh neuron express ob rb
0.099135764.12639939.html.plaintext.txt	132	previously suggested similar finding ovine hypothalamus num direct projection ob rb expressing orexin neuron gnrh neuron may provide one potential neuroanatomical circuit leptin regulates gnrh activity
0.099135764.12639939.html.plaintext.txt	133	npy another neuropeptide system may important integrating signal energy balancefood intake reproductive function num
0.099135764.12639939.html.plaintext.txt	134	similar effect orexin npy also elicits steroid dependent effect lh secretion num
0.099135764.12639939.html.plaintext.txt	135	orexin neuron lha receive direct synaptic contact npy neuron projecting arcuate nucleus turn send reciprocal projection arcuate nucleus npy neuron num
0.099135764.12639939.html.plaintext.txt	136	currently evidence implicating ynum num num num ynum num num num num ynum num num receptor subtypes npy modulation neuroendocrine reproductive function
0.099135764.12639939.html.plaintext.txt	137	direct relevance ynum ir mrna colocalized orexin neuron lha num
0.099135764.12639939.html.plaintext.txt	138	data coupled present finding gnrh neuron express ox rnum contacted orexin fiber demonstrate unique potential neuronal circuit whereby npy acting ynum receptor exert effect lh release via modulation orexin
0.099135764.12639939.html.plaintext.txt	139	present study also showed ynum positive orexin fiber never observed close contact gnrh neuron major action ynum receptor appear postsynaptic effect orexin cell body within lha
0.099135764.12639939.html.plaintext.txt	140	taken together data suggest orexin neuron receiving critical input via ynum leptin receptor may provide important link regulation energy balance reproductive function
0.099135764.12639939.html.plaintext.txt	141	number question remain concerning modulatory effect ynum orexin system gnrh neuron
0.099135764.12639939.html.plaintext.txt	142	first endogenous ligand brain ynum receptor clear
0.099135764.12639939.html.plaintext.txt	143	npy much lower affinity ynum receptor num pancreatic polypeptide family ligand recent study characterizing expression ynum ir orexin neuron also found administration rpp endogenous ligand ynum receptor induced robust cfo activation orexin neuron num
0.099135764.12639939.html.plaintext.txt	144	furthermore rpp stimulated modest increase food intake robust drinking response num similar response orexin
0.099135764.12639939.html.plaintext.txt	145	data suggest stimulation ynum receptor rpp excitatory orexin neuron
0.099135764.12639939.html.plaintext.txt	146	however effect ynum reproductive function shown stimulatory num num inhibitory num
0.099135764.12639939.html.plaintext.txt	147	similarly effect orexin reported stimulatory inhibitory reproductive function num num num num num
0.099135764.12639939.html.plaintext.txt	148	therefore possible action ynum receptor gnrhlh axis mediated via orexin system
0.099135764.12639939.html.plaintext.txt	149	summary data provide neuroanatomical evidence direct link orexin system gnrh neuron
0.099135764.12639939.html.plaintext.txt	150	finding suggest orexin play direct role neuroendocrine control reproduction may also uniquely positioned integrate signal associated energy balance regulation
0.099135764.12639939.html.plaintext.txt	151	additional study necessary establish relative importance novel neuronal circuitry regulation reproductive function normal cyclicity well metabolic change
0.099135764.12639939.html.plaintext.txt	152	footnote work supported nih grant hd num hd num rr num
0.099135764.12639939.html.plaintext.txt	153	abbreviation fitc fluorescein isothiocyanate immunofluorescence kpbs potassium pb lha lateral hypothalamic area median eminence npy neuropeptide y ox r orexin receptor rpp rat pancreatic polypeptide tritc tetramethyl rhodamine isothiocyanate ynum ir ynum like immunoreactivity
0.099135764.12639939.html.plaintext.txt	154	accepted publication january num num
0.100268394.15123537.html.plaintext.txt	0	differential role cholecystokinin receptor energy balance rat mouse sheng bi karen
0.100268394.15123537.html.plaintext.txt	1	department psychiatry behavioral science john hopkins university school medicine
0.100268394.15123537.html.plaintext.txt	2	baltimore maryland num molecular pharmacology research center department medicine tuft new england medical center
0.100268394.15123537.html.plaintext.txt	3	address correspondence request reprint dr
0.100268394.15123537.html.plaintext.txt	4	bi department psychiatry behavioral science john hopkins university school medicine num rutland avenue ross num baltimore maryland num
0.100268394.15123537.html.plaintext.txt	5	although satiety action peripheral cck well characterized role brain cck control food intake controversial
0.100268394.15123537.html.plaintext.txt	6	initial work reported continuous picomole infusion cck cerebral ventricle sheep suppressed feeding num result rodent model mixed
0.100268394.15123537.html.plaintext.txt	7	although study identified feeding inhibitory action central ventricular cck administration issue dosage access peripheral site raised num num
0.100268394.15123537.html.plaintext.txt	8	demonstrated infusing smaller dos cck num specific brain site resulted site specific feeding inhibitory action rat num anorexic dose cck num increase plasma cck num level sufficiently suppress feeding peripheral mechanism num
0.100268394.15123537.html.plaintext.txt	9	recent data otsuka long evans tokushima fatty oletf rat num num
0.100268394.15123537.html.plaintext.txt	10	num kb deletion cck ar gene resulting absence cck ar num suggested peripheral central role cck acting cck ar control food intake num
0.100268394.15123537.html.plaintext.txt	11	oletf rat peripheral cck satiety deficit
0.100268394.15123537.html.plaintext.txt	12	rat feeding response peripherally exogenous cck administration num
0.100268394.15123537.html.plaintext.txt	13	consistent lack intact peripheral cck satiety signaling food intake oletf rat characterized significant chronic increase meal size
0.100268394.15123537.html.plaintext.txt	14	response increase meal number decreased decrease compensatory result oletf rat hyperphagic num
0.100268394.15123537.html.plaintext.txt	15	although increase meal size oletf rat consistent absence peripheral cck signaling overall hyperphagia obesity surprising
0.100268394.15123537.html.plaintext.txt	16	pair feeding oletf rat intake long evans tokushima otsuka leto control rat completely prevents obesity demonstrating increased body weight secondary hyperphagia depend metabolic alteration
0.100268394.15123537.html.plaintext.txt	17	pair feeding prevented increased body weight also normalized elevated level leptin insulin alteration arcuate nucleus neuropeptide y npy proopiomelanocortin pomc gene expression oletf rat num
0.100268394.15123537.html.plaintext.txt	18	pair feeding also revealed seems primary deficit dorsomedial hypothalamic dmh npy mrna expression oletf rat
0.100268394.15123537.html.plaintext.txt	19	dmh npy mrna expression significantly elevated pair fed normal weight oletf rat elevation also found num wk old preobese oletf rat num
0.100268394.15123537.html.plaintext.txt	20	suggested dysregulation dmh npy gene expression may combination peripheral satiety deficit contribute hyperphagia obesity oletf rat num
0.100268394.15123537.html.plaintext.txt	21	cck ar knockout mouse demonstrate different phenotype oletf rat
0.100268394.15123537.html.plaintext.txt	22	contrast oletf rat cck ar knockout mouse normal total daily food intake maintain normal body weight well adult life num
0.100268394.15123537.html.plaintext.txt	23	although mouse insensitive feeding inhibitory action peripheral exogenous cck deficit appear affect overall food intake
0.100268394.15123537.html.plaintext.txt	24	data interpreted suggest cck essential controlling overall food intake involved long term maintenance body weight num
0.100268394.15123537.html.plaintext.txt	25	investigate basis underlying different phenotype rat mouse lacking cck ar characterized meal pattern cck ar mouse determined whether cck ar mouse demonstrated alteration dmh npy gene expression
0.100268394.15123537.html.plaintext.txt	26	finding study led u compare distribution cck ar mouse rat brain determine relationship npy cck ar rat dmh neuron
0.100268394.15123537.html.plaintext.txt	27	data demonstrate distribution cck ar differs mouse rat may account difference phenotype rat mouse lacking cck ar
0.100268394.15123537.html.plaintext.txt	28	situ hybridization mouse brain five week old male cck ar cck ar mouse decapitated brain removed rapidly frozen
0.100268394.15123537.html.plaintext.txt	29	coronal section num microm cut via cryostat mounted superfrost plus slide fisher scientific fairlawn nj fixed num paraformaldehyde
0.100268394.15123537.html.plaintext.txt	30	full length rat cck ar cdna num synthesized rt pcr subcloned pcdnanum vector linearized appropriate restriction enzyme
0.100268394.15123537.html.plaintext.txt	31	antisense sense riboprobe cck ar labeled numsutp amersham pharmacia biotech piscataway nj using vitro transcription system promega corp
0.100268394.15123537.html.plaintext.txt	32	previously described num nums labeled antisense riboprobe npy transcribed rat npy precursor cdna num
0.100268394.15123537.html.plaintext.txt	33	standard situ hybridization conducted
0.100268394.15123537.html.plaintext.txt	34	brian section paraventricular nucleus pvn dmh region num
0.100268394.15123537.html.plaintext.txt	35	num mm caudal bregma num selected examining cck ar mrna expression
0.100268394.15123537.html.plaintext.txt	36	well brain section dmh region num
0.100268394.15123537.html.plaintext.txt	37	num mm caudal bregma num selected examining npy mrna expression
0.100268394.15123537.html.plaintext.txt	38	section treated acetic anhydride incubated standard hybridization buffer containing num cpmml nums labeled probe overnight
0.100268394.15123537.html.plaintext.txt	39	incubation temperature set num c npy num c cck ar probe
0.100268394.15123537.html.plaintext.txt	40	hybridization section washed three time numx standard saline citrate ssc treated num microgml ribonuclease sigma aldrich corp
0.100268394.15123537.html.plaintext.txt	41	louis mo num c num min rinsed numx ssc twice num c npy num c cck ar finally washed twice num
0.100268394.15123537.html.plaintext.txt	42	numx ssc num c npy num c cck ar num min time
0.100268394.15123537.html.plaintext.txt	43	slide dehydrated gradient ethanol air dried exposed bmr num film eastman kodak co
0.100268394.15123537.html.plaintext.txt	44	autoradiography slide examined histologically cresyl violet staining
0.100268394.15123537.html.plaintext.txt	45	cck binding assay wild type mouse autoradiographic cck binding assay conducted previously described num
0.100268394.15123537.html.plaintext.txt	46	adult male wild type littermates cck ar mouse killed decapitation brain removed rapidly frozen isopentane num c
0.100268394.15123537.html.plaintext.txt	47	coronal section num microm pvn num
0.100268394.15123537.html.plaintext.txt	48	num mm caudal bregma dmh region num
0.100268394.15123537.html.plaintext.txt	49	num mm caudal bregma cut via cryostat mounted cold gelatin coated slide num
0.100268394.15123537.html.plaintext.txt	50	differentiate cck ar cck br compared ability cck ar antagonist devazepide cck br agonist desulfated cck num dcck displace binding site numi labeled cck num
0.100268394.15123537.html.plaintext.txt	51	binding inhibited devazepide dcck binding occurring cck ar
0.100268394.15123537.html.plaintext.txt	52	contrast binding inhibited dcck devazepide binding occurring cck br
0.100268394.15123537.html.plaintext.txt	53	thus preincubation num mm tris hcl buffer ph num
0.100268394.15123537.html.plaintext.txt	54	num bsa num min num c slide incubated standard binding buffer containing num pm numibolton hunter labeled cck num perkinelmer boston ma num h num c either alone presence num nm devazepide num nm dcck num microm sulfated cck num
0.100268394.15123537.html.plaintext.txt	55	incubation slide washed ice cold num mm tris hcl buffer ph num
0.100268394.15123537.html.plaintext.txt	56	num bsa six time num min time
0.100268394.15123537.html.plaintext.txt	57	washed slide completely air dried exposed bmr num film eastman kodak co
0.100268394.15123537.html.plaintext.txt	58	dual immunohistochemistry rat coronal section num microm brain leto oletf rat obtained otsuka pharmaceutical otsuka japan prepared described fixed num paraformaldehyde
0.100268394.15123537.html.plaintext.txt	59	dual immunohistochemistry modified procedure previously described num
0.100268394.15123537.html.plaintext.txt	60	section incubated primary antibody mixture containing numnum mouse anti npy monoclonal antibody gift dr
0.100268394.15123537.html.plaintext.txt	61	eric grouzmann centre hospitalier universitaire vaudois lausanne switzerland num numnum rabbit antirat cck ar antibody targeted amino acid sequence shmstsappp corresponding c terminal rat cck ar accurate chemical scientific corp
0.100268394.15123537.html.plaintext.txt	62	westbury ny num c overnight
0.100268394.15123537.html.plaintext.txt	63	three wash secondary antibody added slide goat antimouse conjugated fluorescein num ng microl roche indianapolis detecting npy peptide biotin labeled goat antirabbit igg numnum nen life science product inc
0.100268394.15123537.html.plaintext.txt	64	boston ma detecting cck ar
0.100268394.15123537.html.plaintext.txt	65	cck ar signal amplified tsa tyramide signal amplification biotin system nen life science product inc
0.100268394.15123537.html.plaintext.txt	66	stained streptavidin texas red conjugate numnum nen life science product inc
0.100268394.15123537.html.plaintext.txt	67	according manufacturer protocol
0.100268394.15123537.html.plaintext.txt	68	section examined lsm num confocal microscope zeiss new york ny using num nm laser excite fluorescein num nm laser excite texas red
0.100268394.15123537.html.plaintext.txt	69	dmh cannulation cck num injection rat fifteen male long evans rat charles river laboratory wilmington ma weighing num num g implanted chronic indwelling dmh cannula
0.100268394.15123537.html.plaintext.txt	70	animal individually housed hanging wire mesh cage maintained num h light num h dark cycle feeding schedule regular chow food removed cage num h light returned cage dark onset
0.100268394.15123537.html.plaintext.txt	71	time surgery rat anesthetized im mixture ketamine num mgkg xylazine num mgkg placed stereotaxic device
0.100268394.15123537.html.plaintext.txt	72	num gauge stainless steel guide cannula plastic one wallingford ct implanted dmh following coordinate num
0.100268394.15123537.html.plaintext.txt	73	num mm ventral skull surface num num
0.100268394.15123537.html.plaintext.txt	74	coordinate chosen based result pilot experiment
0.100268394.15123537.html.plaintext.txt	75	num gauge stainless steel obturator inserted cannula maintain patency
0.100268394.15123537.html.plaintext.txt	76	surgery rat given penicillin numnum u im prevent postoperative infection banamine num mgkg im pain relief
0.100268394.15123537.html.plaintext.txt	77	num d postoperative recovery num cannulated rat randomly divided two group
0.100268394.15123537.html.plaintext.txt	78	light one group eight animal injected num
0.100268394.15123537.html.plaintext.txt	79	num microl artificial cerebrospinal fluid acsf num mm na num
0.100268394.15123537.html.plaintext.txt	80	num mm cl group seven animal injected num pmol cck num bachem torrance ca num
0.100268394.15123537.html.plaintext.txt	81	dmh injection made gilmont micrometer syringe attached polyethylene tubing num gauge stainless steel injector plastic one
0.100268394.15123537.html.plaintext.txt	82	tip injector extended num
0.100268394.15123537.html.plaintext.txt	83	num mm past tip guide cannula
0.100268394.15123537.html.plaintext.txt	84	injection made num injection remained place additional num removal
0.100268394.15123537.html.plaintext.txt	85	chow food returned immediately injection
0.100268394.15123537.html.plaintext.txt	86	food intake measured num min num h num h num h num h returning food cage
0.100268394.15123537.html.plaintext.txt	87	num d period recovery rat given second dmh injection acsf cck num num pmol treatment
0.100268394.15123537.html.plaintext.txt	88	rat previously received cck num administration given acsf injection time vice versa
0.100268394.15123537.html.plaintext.txt	89	food intake measured described first injection
0.100268394.15123537.html.plaintext.txt	90	thus rat received acsf cck num administration served control comparison cck num feeding effect
0.100268394.15123537.html.plaintext.txt	91	feeding test num animal num additional dmh cannulated rat body weight matched randomly divided two group acsf control n num cck num treatment n num assessing whether cck num injection dmh affected hypothalamic npy mrna expression
0.100268394.15123537.html.plaintext.txt	92	animal maintained feeding schedule described regular chow removed cage num h light returned cage dark onset access water ad libitum
0.100268394.15123537.html.plaintext.txt	93	rat received either acsf cck num injection described without access chow food injection
0.100268394.15123537.html.plaintext.txt	94	two hour injection rat killed overdose sodium pentobarbital brain removed rapidly frozen subsequent analysis hypothalamic npy gene expression num num num
0.100268394.15123537.html.plaintext.txt	95	described series num microm coronal brain section ranging num
0.100268394.15123537.html.plaintext.txt	96	num mm caudal bregma cut num mounted slide series six section num slide num section num slide num etc
0.100268394.15123537.html.plaintext.txt	97	fixed num paraformaldehyde
0.100268394.15123537.html.plaintext.txt	98	site dmh injection rat anatomically examined via cresyl violet staining process brain section
0.100268394.15123537.html.plaintext.txt	99	data rat incorrect cannula placement excluded subsequent statistical analysis
0.100268394.15123537.html.plaintext.txt	100	situ hybridization determination hypothalamic npy mrna expression conducted described
0.100268394.15123537.html.plaintext.txt	101	quantitative analysis situ hybridization data performed nih scion image software nih bethesda md
0.100268394.15123537.html.plaintext.txt	102	autoradiographic image first scanned using epson professional scanner epson long beach ca saved via computer subsequent analysis scion image software using autoradiographic numc microscales amersham pharmacia biotech standard
0.100268394.15123537.html.plaintext.txt	103	data animal mean product hybridization area x density background density subtracted obtained four section reflecting level gene expression region num
0.100268394.15123537.html.plaintext.txt	104	num mm posterior bregma example one section num
0.100268394.15123537.html.plaintext.txt	105	num mm posterior bregma num
0.100268394.15123537.html.plaintext.txt	106	data group normalized acsf treated control num data presented mean plus minus sem
0.100268394.15123537.html.plaintext.txt	107	statistical analysis data analyzed test two group comparison
0.100268394.15123537.html.plaintext.txt	108	num taken statistically significant difference
0.100268394.15123537.html.plaintext.txt	109	meal parameter cck ar cck ar mouse
0.100268394.15123537.html.plaintext.txt	110	npy mrna expression detected dmh mouse prior work demonstrated dmh npy mrna expression elevated adult pair fed young preobese oletf rat num
0.100268394.15123537.html.plaintext.txt	111	study determined whether mouse lacking cck receptor displayed similar alteration dmh npy
0.100268394.15123537.html.plaintext.txt	112	num npy mrna expression evident arcuate nucleus cck ar cck ar mouse
0.100268394.15123537.html.plaintext.txt	113	dmh npy mrna expression detectable either cck ar cck ar mouse num wk age fig
0.100268394.15123537.html.plaintext.txt	114	num oletf rat elevated dmh npy gene expression
0.100268394.15123537.html.plaintext.txt	115	view larger version numk fig
0.100268394.15123537.html.plaintext.txt	116	situ hybridization npy mrna numsutp labeled npy riboprobe cck ar cck ar mouse
0.100268394.15123537.html.plaintext.txt	117	within hypothalamus npy mrna expression evident arcuate nucleus dmh cck ar cck ar b mouse num wk age
0.100268394.15123537.html.plaintext.txt	118	cck ar absent dmh mouse absence dmh npy mrna expression cck ar mouse raise possibility dmh npy may differentially controlled rat mouse
0.100268394.15123537.html.plaintext.txt	119	cck binding situ hybridization study demonstrated presence cck ar rat dmh num num num
0.100268394.15123537.html.plaintext.txt	120	determine whether difference distribution cck ar rat mouse brain determined distribution cck ar mouse hypothalamus using numi labeled cck num binding autoradiography situ hybridization histochemistry nums labeled cck ar riboprobe
0.100268394.15123537.html.plaintext.txt	121	autoradiograph cck binding assay mouse brain revealed within hypothalamus cck ar binding site present pvn fig
0.100268394.15123537.html.plaintext.txt	122	num c cck br binding site found ventromedial hypothalamus fig
0.100268394.15123537.html.plaintext.txt	123	num e g cck binding activity detected dmh fig
0.100268394.15123537.html.plaintext.txt	124	consistent binding data situ hybridization histochemistry revealed cck ar mrna highly expressed pvn fig
0.100268394.15123537.html.plaintext.txt	125	numa expressed dmh mouse fig
0.100268394.15123537.html.plaintext.txt	126	evidence cck ar mrna expression arcuate nucleus fig
0.100268394.15123537.html.plaintext.txt	127	numb although cck binding activity detected fig
0.100268394.15123537.html.plaintext.txt	128	thus neither cck binding assay cck ar mrna expression determination detected presence cck ar dmh mouse
0.100268394.15123537.html.plaintext.txt	129	view larger version numk fig
0.100268394.15123537.html.plaintext.txt	130	autoradiograph num pm numibolton hunter labeled cck num binding wild type mouse brain d num
0.100268394.15123537.html.plaintext.txt	131	num mm posterior bregma e h num
0.100268394.15123537.html.plaintext.txt	132	num mm posterior bregma num four condition alone e num nm devazepide b f num nm dcck c g num microm sulfated cck num scck d h
0.100268394.15123537.html.plaintext.txt	133	within hypothalamus num nm devazepide blocked numicck num binding pvn b num nm dcck blocked numicck num binding ventromedial nucleus vmh numicck num binding found dmh
0.100268394.15123537.html.plaintext.txt	134	view larger version numk fig
0.100268394.15123537.html.plaintext.txt	135	situ hybridization cck ar mrna numsutp labeled cck ar antisense riboprobe wild type mouse brain
0.100268394.15123537.html.plaintext.txt	136	within hypothalamus cck ar mrna expressed pvn slightly arcuate nucleus b dmh b
0.100268394.15123537.html.plaintext.txt	137	hybridization signal detected incubation sense probe c
0.100268394.15123537.html.plaintext.txt	138	colocalization npy cck ar dmh neuron rat previous data demonstrated npy mrna expression elevated dmh specifically compact subregion young preobese adult pair fed oletf rat lacking cck ar num presence cck ar rat dmh suggests dmh npy gene expression may normally regulated brain cck interaction cck ar
0.100268394.15123537.html.plaintext.txt	139	investigate whether npy cck ar colocalized dmh neuron performed double immunostaining anti npy anti cck ar antibody rat brain
0.100268394.15123537.html.plaintext.txt	140	num leto oletf dmh contained npy immunostaining neuron fig
0.100268394.15123537.html.plaintext.txt	141	cck ar immunostaining neuron detected dmh leto control fig
0.100268394.15123537.html.plaintext.txt	142	absence cck ar immunoreactivity oletf rat fig
0.100268394.15123537.html.plaintext.txt	143	nume consistent absence cck ar model
0.100268394.15123537.html.plaintext.txt	144	confocal microscopic analysis revealed npy cck ar colocalized dmh neuron fig
0.100268394.15123537.html.plaintext.txt	145	shown high magnification fig
0.100268394.15123537.html.plaintext.txt	146	numg cck ar staining found surface npy neuron
0.100268394.15123537.html.plaintext.txt	147	view larger version numk fig
0.100268394.15123537.html.plaintext.txt	148	dual immunohistochemistry leto control oletf rat brain anti npy anti cck ar antibody
0.100268394.15123537.html.plaintext.txt	149	leto oletf rat npy immunostaining evident dmh neuron green d
0.100268394.15123537.html.plaintext.txt	150	cck ar immunostaining neuron detected dmh leto control red b oletf rat e
0.100268394.15123537.html.plaintext.txt	151	npy cck ar colocalized dmh neuron leto control rat orange c g confocal microscopic analysis
0.100268394.15123537.html.plaintext.txt	152	brain cck act dmh npy neuron inhibit food intake finding npy cck ar colocalization dmh neuron overexpression dmh npy rat lacking cck ar suggest brain cck may normally play role controlling npy gene expression dmh npy neuron
0.100268394.15123537.html.plaintext.txt	153	test hypothesis understand basis brain cck action food intake assessed whether injection cck dmh affected hypothalamic npy gene expression
0.100268394.15123537.html.plaintext.txt	154	num npy mrna expression significantly regulated parenchymal injection cck dmh
0.100268394.15123537.html.plaintext.txt	155	exogenous cck administration resulted num reduction npy mrna expression ipsilateral compact subregion dmh fig
0.100268394.15123537.html.plaintext.txt	156	also found relative control arcuate npy mrna expression significantly reduced num cck injected rat fig
0.100268394.15123537.html.plaintext.txt	157	data confirm cck within dmh capable directly regulating npy gene expression
0.100268394.15123537.html.plaintext.txt	158	view larger version numk fig
0.100268394.15123537.html.plaintext.txt	159	effect cck injection dmh npy mrna expression
0.100268394.15123537.html.plaintext.txt	160	dmh cck injection decreased npy gene expression dmh b c arcuate nucleus b c rat compared acsf treated control
0.100268394.15123537.html.plaintext.txt	161	value mean plus minus sem n num num
0.100268394.15123537.html.plaintext.txt	162	num compared acsf treated group
0.100268394.15123537.html.plaintext.txt	163	well altering npy mrna expression found exogenous injection cck dmh resulted reduction num min food intake
0.100268394.15123537.html.plaintext.txt	164	num g vehicle control n num num
0.100268394.15123537.html.plaintext.txt	165	num g cck treated group n num p num
0.100268394.15123537.html.plaintext.txt	166	action peripheral cck control meal size well characterized
0.100268394.15123537.html.plaintext.txt	167	peripheral cck produce dose related suppression meal size result earlier appearance behavioral satiety sequence num
0.100268394.15123537.html.plaintext.txt	168	action exogenous peptide appear mimic physiological role endogenous cck administration cck antagonist result increase food intake
0.100268394.15123537.html.plaintext.txt	169	feeding inhibitory action exogenously administered endogenously released cck depend upon action cck ar
0.100268394.15123537.html.plaintext.txt	170	cck mediated inhibition food intake blocked cck ar antagonist unaffected cck br antagonist num
0.100268394.15123537.html.plaintext.txt	171	current finding increased meal size cck ar mouse demonstrates action endogenous cck control meal size mouse consistent prior data antagonist previous finding oletf rat also lack cck ar num num num
0.100268394.15123537.html.plaintext.txt	172	thus data provide additional molecular biological support physiological role endogenous cck short term control food intake
0.100268394.15123537.html.plaintext.txt	173	magnitude change meal size cck ar mouse quite bit smaller num increase found oletf rat lacking cck ar
0.100268394.15123537.html.plaintext.txt	174	difference may reflect relative difference contribution cck meal termination rat mouse
0.100268394.15123537.html.plaintext.txt	175	current data demonstrate cck ar mouse altered diurnal feeding pattern
0.100268394.15123537.html.plaintext.txt	176	oletf rat lacking cck ar increased food intake characterized increased meal size dark light period
0.100268394.15123537.html.plaintext.txt	177	response increased meal size meal number decreased dark period decrease compensatory num
0.100268394.15123537.html.plaintext.txt	178	however analysis feeding pattern cck ar mouse revealed increased food intake dark period characterized increase meal size food intake tended decreased light period characterized reduction meal frequency leading absence significant change total food intake
0.100268394.15123537.html.plaintext.txt	179	data suggest cck acting cck ar play differential role circadian activity rat mouse
0.100268394.15123537.html.plaintext.txt	180	even though rat mouse lacking cck ar peripheral cck satiety deficit resulting increased meal size total daily food intake body weight normal cck ar mouse whereas oletf rat lacking cck ar shown hyperphagic become obese
0.100268394.15123537.html.plaintext.txt	181	although may reflect differential ability compensate smaller rather larger increase meal size present data also suggest difference phenotype may outcome different distribution brain cck ar rat mouse
0.100268394.15123537.html.plaintext.txt	182	potential importance differential distribution derives finding intact rat npy cck ar colocalized dmh neuron cck play role modulating dmh npy exogenous administration cck dmh regulates dmh npy mrna expression
0.100268394.15123537.html.plaintext.txt	183	result consistent previous finding demonstrating npy gene expression regulated dmh oletf rat lack cck ar num
0.100268394.15123537.html.plaintext.txt	184	although pair feeding oletf rat prevented increased body weight normalized altered arcuate npy pomc gene expression pair feeding resulted significantly elevated npy gene expression dmh
0.100268394.15123537.html.plaintext.txt	185	elevation npy mrna expression dmh also documented young preobese oletf rat num
0.100268394.15123537.html.plaintext.txt	186	therefore cck acting cck ar dmh appears suppress dmh npy gene expression rat
0.100268394.15123537.html.plaintext.txt	187	suppression inhibits energy intake dmh cck injection reduces food intake
0.100268394.15123537.html.plaintext.txt	188	hyperphagic obese oletf rat deficit cck npy signaling pathway resulting lack cck ar production
0.100268394.15123537.html.plaintext.txt	189	cck acting cck ar appear play role controlling dmh npy mouse
0.100268394.15123537.html.plaintext.txt	190	failed detect npy mrna expression dmh either cck ar cck ar mouse situ hybridization determination
0.100268394.15123537.html.plaintext.txt	191	dmh npy mrna expression ad libitum fed rat normally low elevated experimental situation lactation num response chronic food restriction num
0.100268394.15123537.html.plaintext.txt	192	rat clear difference control dmh arcuate nucleus npy expressing neuron
0.100268394.15123537.html.plaintext.txt	193	arcuate nucleus npy containing neuron express ob rb long form leptin receptor npy expression leptin control num
0.100268394.15123537.html.plaintext.txt	194	elevated leptin level reduce npy mrna expression whereas food deprivation increase arcuate npy gene expression
0.100268394.15123537.html.plaintext.txt	195	contrast dmh npy containing neuron express leptin receptor dmh npy mrna expression increase response acute food deprivation num
0.100268394.15123537.html.plaintext.txt	196	moreover within dmh region altered npy expression response variety treatment appears differ
0.100268394.15123537.html.plaintext.txt	197	current data demonstrating reduction dmh npy expression cck localized compact subregion consistent previous finding num num
0.100268394.15123537.html.plaintext.txt	198	whereas lactating rat smith num reported although slight increase npy mrna expression compact area dmh npy mrna expression mainly induced diffuse portion dmh
0.100268394.15123537.html.plaintext.txt	199	however yet clear whether npy mrna expression different subregions dmh differentially regulated
0.100268394.15123537.html.plaintext.txt	200	control dmh npy expression mouse extensively investigated
0.100268394.15123537.html.plaintext.txt	201	evidence npy expressing neuron mouse come data demonstrating induction dmh npy expression several obesity model disrupted melanocortin signaling lethal agouti yellow ay melanocortin num receptor knockout mcnumr mouse num diet induced obese mouse num
0.100268394.15123537.html.plaintext.txt	202	data suggest interaction melanocortin signaling metabolic status control dmh npy function mouse
0.100268394.15123537.html.plaintext.txt	203	finding decreased arcuate well dmh npy mrna expression response dmh cck injection surprising
0.100268394.15123537.html.plaintext.txt	204	consistent previous study rat num num failed identify cck ar binding activity arcuate nucleus mouse
0.100268394.15123537.html.plaintext.txt	205	absence arcuate cck receptor implies dmharcuate interaction control arcuate npy
0.100268394.15123537.html.plaintext.txt	206	although main hypothalamic output dmh thought pvn projection dmh arcuate nucleus identified num
0.100268394.15123537.html.plaintext.txt	207	projection may basis arcuate npy reduction response dmh cck injection
0.100268394.15123537.html.plaintext.txt	208	role dmh feeding control long suggested
0.100268394.15123537.html.plaintext.txt	209	bellinger colleague num demonstrated small dmh electrolytic excitotoxic lesion dmhl result hypophagia hypodipsia reduced body weight reduced linear growth rat
0.100268394.15123537.html.plaintext.txt	210	pair feeding experiment one group sham operated rat pair fed computerized feeding system presented food pellet amount pattern yoked dmhl rat demonstrated altered body weight dmhl rat primarily result altered food intake num
0.100268394.15123537.html.plaintext.txt	211	despite finding particular contribution dmh interacts hypothalamic nucleus involved energy balance well understood
0.100268394.15123537.html.plaintext.txt	212	finding rat suggest basis dmhl induced hypophagia may elimination npy ergic output output normally control cck acting cck ar
0.100268394.15123537.html.plaintext.txt	213	although distribution mediation cck ar human brain unclear data primate demonstrated dmh contains cck ar binding site monkey num central injection cck ar b receptor agonist inhibits food intake baboon num
0.100268394.15123537.html.plaintext.txt	214	finding suggest dmh cck ar may play role food intake control human
0.100268394.15123537.html.plaintext.txt	215	polymorphism cck ar gene patient obesity diabetes reported various study num num num num providing support role
0.100268394.15123537.html.plaintext.txt	216	interpreted current data support view different phenotype oletf rat cck mouse derive differential role central cck ar energy balance rat mouse
0.100268394.15123537.html.plaintext.txt	217	oletf rat targeted deletion cck ar arose spontaneous mutation
0.100268394.15123537.html.plaintext.txt	218	quite possible genetic alteration oletf rat alone combination alteration cck ar signaling account hyperphagia obesity diabetes num
0.100268394.15123537.html.plaintext.txt	219	however additional genetic defect yet identified
0.100268394.15123537.html.plaintext.txt	220	summary present result suggest although rat mouse lacking cck ar demonstrate deficit meal size control differential distribution cck ar rat mouse brain may determine divergent effect cck ar gene disruption
0.100268394.15123537.html.plaintext.txt	221	rat brain cck acting cck ar appears play role regulating dmh npy gene expression
0.100268394.15123537.html.plaintext.txt	222	dmh cck inhibits npy mrna expression food intake
0.100268394.15123537.html.plaintext.txt	223	absence cck ar oletf rat deficit control dmh npy gene expression resulting increased dmh npy gene expression increased food intake eventually obesity
0.100268394.15123537.html.plaintext.txt	224	contrast found evidence presence cck ar dmh mouse
0.100268394.15123537.html.plaintext.txt	225	thus cck ar contribute control dmh npy gene expression absence central deficit mouse lacking cck ar able compensate absence cck satiety signaling become hyperphagic obese
0.100268394.15123537.html.plaintext.txt	226	acknowledgment oletf leto rat generous gift otsuka pharmaceutical tokushima japan
0.100268394.15123537.html.plaintext.txt	227	footnote work supported national institute diabetes digestive kidney disease grant dk num
0.100268394.15123537.html.plaintext.txt	228	national institute mental health grant mhnum
0.100268394.15123537.html.plaintext.txt	229	abbreviation acsf artificial cerebrospinal fluid cck cholecystokinin cck ar cholecystokinin receptor dcck desulfated cholecystokinin num dmh dorsomedial hypothalamic dmhl dmh electrolytic excitotoxic lesion leto long evans tokushima otsuka npy neuropeptide y oletf otsuka long evans tokushima fatty pomc proopiomelanocortin pvn paraventricular nucleus ssc standard saline citrate
0.100268394.15123537.html.plaintext.txt	230	accepted publication april num num
0.10528083.15870395.html.plaintext.txt	0	genome wide analysis gene transcription hypothalamus jocelyn m
0.10528083.15870395.html.plaintext.txt	1	department medical genetics university alberta edmonton alberta canada
0.10528083.15870395.html.plaintext.txt	2	hypothalamus candidate gene bioinformatics gene expression microarray
0.10528083.15870395.html.plaintext.txt	3	search obesity candidate gene used combined bioinformatic molecular biology approach identify novel gene important function hypothalamus
0.10528083.15870395.html.plaintext.txt	4	hypothalamus complex region brain involved homeostatic process including limited energy balance
0.10528083.15870395.html.plaintext.txt	5	identified set gene already known important hypothalamic function set gene previously associated hypothalamus
0.10528083.15870395.html.plaintext.txt	6	propose gene may important function hypothalamus may provide new source hypothalamus specific regulatory element may important disorder hypothalamic function obesity
0.10528083.15870395.html.plaintext.txt	7	furthermore gene identified search candidate gene obesity related trait genetically mapped chromosomal interval reside
0.10528083.15870395.html.plaintext.txt	8	rna situ hybridization performed using digoxigenin labeled antisense rna probe num microm cryosections embryonic day num
0.10528083.15870395.html.plaintext.txt	9	num mouse embryo previously described num
0.10528083.15870395.html.plaintext.txt	10	probe hcrt anum dscrnumlnum impact pnck derived pcr fragment amplified reverse transcribed adult mouse hypothalamus mrna recombinant taq dna polymerase invitrogen cloned pbluescript vector invitrogen
0.10528083.15870395.html.plaintext.txt	11	hcrt probe includes position num num hypocretin hcrt mrna nmnum
0.10528083.15870395.html.plaintext.txt	12	anum probe includes position num numnum riken cdna numlnum gene numlnumrik mrna nmnum
0.10528083.15870395.html.plaintext.txt	13	dscrnumlnum probe includes position num num syndrome critical region gene num like num dscrnumlnum mrna nmnum
0.10528083.15870395.html.plaintext.txt	14	impact probe includes position num num imprinted ancient impact mrna nmnum
0.10528083.15870395.html.plaintext.txt	15	pnck probe includes position num numnum pregnancy upregulated nonubiquitously expressed canumcalmodulin kinase pnck mrna nmnum
0.10528083.15870395.html.plaintext.txt	16	magelnum probe includes position num numnum genbank accession number nmnum previously described num
0.10528083.15870395.html.plaintext.txt	17	study involving animal performed according guideline use care laboratory animal university alberta
0.10528083.15870395.html.plaintext.txt	18	strategy identification hypothalamic transcript
0.10528083.15870395.html.plaintext.txt	19	reasoned gene important hypothalamic development function likely transcribed hypothalamic precursor tissue mature hypothalamus
0.10528083.15870395.html.plaintext.txt	20	laboratory mouse model particularly amenable study brain function similarity anatomy human hypothalamus widespread use obesity study
0.10528083.15870395.html.plaintext.txt	21	performed three search using different criterion query gnf expression database gene highly expressed postnatal murine hypothalamus
0.10528083.15870395.html.plaintext.txt	22	first search gnf database used low specificity criterion required high expression hypothalamus least num time median expression level num mouse tissue
0.10528083.15870395.html.plaintext.txt	23	search identified set gene already studied role hypothalamic function pro opiomelanocortin pomc hcrt also identified many gene broadly expressed nervous system microtubule associated protein
0.10528083.15870395.html.plaintext.txt	24	notably gene important obesity andor hypothalamic function identified condition e
0.10528083.15870395.html.plaintext.txt	25	second search gnf database used high specificity criterion first search high expression hypothalamus least eight time median expression tissue
0.10528083.15870395.html.plaintext.txt	26	addition second search required low expression num time median least num tissue
0.10528083.15870395.html.plaintext.txt	27	second search identified five gene including arginine vasopressin pomc hcrt oxytocin major role endocrine regulation hypothalamus
0.10528083.15870395.html.plaintext.txt	28	significantly high specificity search also identified magelnum developmentally regulated inactivated genetic obesity disorder prader willi syndrome
0.10528083.15870395.html.plaintext.txt	29	formulated third search intermediate specificity expression hypothalamus eight time median level tissue fewer five tissue three time median level expression
0.10528083.15870395.html.plaintext.txt	30	third search gnf database identified set num gene highly expressed hypothalamus moderately highly expressed num murine tissue table num screen num
0.10528083.15870395.html.plaintext.txt	31	repeated third search using updated database num version mouse geneatlas
0.10528083.15870395.html.plaintext.txt	32	third search gnf database search geneatlas num identified gene high expression hypothalamus low expression elsewhere brain
0.10528083.15870395.html.plaintext.txt	33	used correlation function searchable symatlas database within geneatlas
0.10528083.15870395.html.plaintext.txt	34	symatlas search refined allow either high low expression preoptic region functionally overlap hypothalamus
0.10528083.15870395.html.plaintext.txt	35	last search still using intermediate specificity criterion identified num gene num identified gnf intermediate specificity search table num screen num total num gene
0.10528083.15870395.html.plaintext.txt	36	intermediate search gnf gene expression atlas detect gene highly expressed hypothalamus expressed low level tissue
0.10528083.15870395.html.plaintext.txt	37	selection novel hypothalamic gene
0.10528083.15870395.html.plaintext.txt	38	num gene two search gnf database num gene identified search table num
0.10528083.15870395.html.plaintext.txt	39	nature search engine provided gnf changed num release num release two search criterion directly comparable
0.10528083.15870395.html.plaintext.txt	40	common two search requirement high expression hypothalamus low expression region brain
0.10528083.15870395.html.plaintext.txt	41	interested identifying gene known important hypothalamus first set aside gene whose role hypothalamic function well described
0.10528083.15870395.html.plaintext.txt	42	included gene encoding neuropeptide signaling molecule hcrtorexin pro opiomelanocortin oxytocin agouti related protein arginine vasopressin num
0.10528083.15870395.html.plaintext.txt	43	neuroendocrine role calcitonin calcitonin receptor growth hormone secretion hypothalamuspituitary previously suggested num
0.10528083.15870395.html.plaintext.txt	44	previously identified magelnum specifically expressed developing murine hypothalamus although function tissue yet known num
0.10528083.15870395.html.plaintext.txt	45	magelnum particular interest human ortholog magelnum one set gene inactivated genetic obesity disorder prader willi syndrome num num
0.10528083.15870395.html.plaintext.txt	46	finally mutation patched ptchnum result holoprosencephaly developmental delay human alternatively cause basal cell nervous syndrome homozygously inactivated somatic cell
0.10528083.15870395.html.plaintext.txt	47	ptchnum antagonist signaling molecule hedgehog function patterning neural tube known specific role hypothalamus
0.10528083.15870395.html.plaintext.txt	48	remaining num gene fell num category num novel gene function predicted sequence similarity known gene num novel gene known function limited similarity known gene table num
0.10528083.15870395.html.plaintext.txt	49	examined unigene cluster associated novel gene
0.10528083.15870395.html.plaintext.txt	50	est set made hypothalamus rna represented mouse est database expected see representation hypothalamic cdna within unigene cluster corresponding gene
0.10528083.15870395.html.plaintext.txt	51	indeed num gene corresponding est derived whole brain specifically including hypothalamus num diencephalon num table num
0.10528083.15870395.html.plaintext.txt	52	information unigene cluster point gene particularly hypothalamus specific contrast unigene cluster arginine vasopressin example num num est derived hypothalamus
0.10528083.15870395.html.plaintext.txt	53	used est profileviewer function unigene test whether expression profile derived est overlapped derived geneatlas database
0.10528083.15870395.html.plaintext.txt	54	seven eleven novel gene major contribution est brain pituitary gland hypothalamus included brain sample est profile viewer
0.10528083.15870395.html.plaintext.txt	55	one case itihnum majority unigene est derived liver small minority brain
0.10528083.15870395.html.plaintext.txt	56	consistent geneatlas distribution show highest expression itihnum liver remaining expression preoptic hypothalamus sample
0.10528083.15870395.html.plaintext.txt	57	one case dscrnumlnum unigene est distribute tissue specific pattern although examination developmental timing expression also using function unigene demonstrated vast majority est derived egg opposed preimplantation embryo postimplantation embryonic stage
0.10528083.15870395.html.plaintext.txt	58	contrast geneatlas num expression profile show little tissue specificity dscrnumlnum transcript also contrast geneatlas num expression profile showed specific expression hypothalamus
0.10528083.15870395.html.plaintext.txt	59	similarly pitpnmnum showed conflicting expression profile geneatlas num geneatlas num est profileviewer one commonality expression eye
0.10528083.15870395.html.plaintext.txt	60	est expression profile murine gene targeting study
0.10528083.15870395.html.plaintext.txt	61	first verified num selected gene indeed expressed murine hypothalamus rt pcr rna sample adult mouse hypothalamus data shown
0.10528083.15870395.html.plaintext.txt	62	localized expression specific hypothalamic nucleus rna situ hybridization using standard mouse atlas label section num
0.10528083.15870395.html.plaintext.txt	63	probe hcrt displayed strong signal lateral anterior hypothalamus consistent known abundance rna transcript region brain fig
0.10528083.15870395.html.plaintext.txt	64	consistent earlier embryonic expression magelnum suprachiasmatic nucleus num detected magelnum transcript anterior hypothalamus suprachiasmatic nucleus fig
0.10528083.15870395.html.plaintext.txt	65	selected four gene emerged bioinformatic analysis little else known
0.10528083.15870395.html.plaintext.txt	66	four gene displayed high level expression hypothalamus compared surrounding brain tissue rna situ hybridization fig
0.10528083.15870395.html.plaintext.txt	67	probe anumlnum pnck detected abundant expression anterior hypothalamus whereas probe dscrnumlnum detected strongest expression dorsal medial hypothalamus ventromedial hypothalamus arcuate nucleus probe impact detected highest expression arcuate nucleus
0.10528083.15870395.html.plaintext.txt	68	view larger version numk fig
0.10528083.15870395.html.plaintext.txt	69	expression candidate gene late embryonic hypothalamus
0.10528083.15870395.html.plaintext.txt	70	cryosections embryonic day num
0.10528083.15870395.html.plaintext.txt	71	num mouse brain hybridized digoxigenin labeled antisense rna situ hybridization probe hcrt magelnum dscrnumlnum impact anumlnum pnck
0.10528083.15870395.html.plaintext.txt	72	hybridization signal detected anterior hypothalamus ah arcuate nucleus arc dorsomedial hypothalamus dmh suprachiasmatic nucleus scn ventromedial hypothalamus vmh
0.10528083.15870395.html.plaintext.txt	73	numv third ventricle infidibular recess oc optic chiasm
0.10528083.15870395.html.plaintext.txt	74	section oriented ventral aspect bottom
0.10528083.15870395.html.plaintext.txt	75	used ncbi database map num selected gene chromosomal region mouse genome ncbi build num human genome ncbi build num table num
0.10528083.15870395.html.plaintext.txt	76	correlated map position selected gene genomic position published locus influencing obesity related trait either human mammal num table num updated published line obesity gene map database numa
0.10528083.15870395.html.plaintext.txt	77	identified eight trait body mass index fat mass percent body fat mapped chromosomal region selected gene human study weight gain obesity
0.10528083.15870395.html.plaintext.txt	78	identified case obesity trait identified mapping within mouse rat pig chromosomal region homologous human chromosome band containing selected gene
0.10528083.15870395.html.plaintext.txt	79	include trait mapped interval contained three chromosome band would contain large number candidate gene
0.10528083.15870395.html.plaintext.txt	80	way identified num obesity related trait mouse num rat num pig num correlated map position num num selected gene trait related obesity weight gain
0.10528083.15870395.html.plaintext.txt	81	except anumlnum poorly characterized predicted mouse gene chromosome num selected gene region mammalian genome genetic evidence obesity related trait exists
0.10528083.15870395.html.plaintext.txt	82	obesity trait near candidate gene
0.10528083.15870395.html.plaintext.txt	83	identified num gene whose expression enriched hypothalamus previously associated development hypothalamus function
0.10528083.15870395.html.plaintext.txt	84	candidate gene could involved number interrelated process partially mediated hypothalamus besides energy fluid balance circadian rhythm reproduction stress response temperature regulation num
0.10528083.15870395.html.plaintext.txt	85	definitive proof involvement obesity rather function hypothalamus would come demonstration gene dysregulation various model obesity including genetic diet induced obesity
0.10528083.15870395.html.plaintext.txt	86	concentrated obesity large number study providing genetically mapped obesity related trait gene identified could equally well role disorder hypothalamic function
0.10528083.15870395.html.plaintext.txt	87	region brain including cortex hindbrain important role food intake num major role neurological function
0.10528083.15870395.html.plaintext.txt	88	gut liver pancreas adipose tissue also major role appetite parallel study could reveal novel obesity susceptibility gene highly specifically expressed tissue expressed brain hypothalamus
0.10528083.15870395.html.plaintext.txt	89	susceptibility obesity part genetically determined variation gene may contribute familial obesity
0.10528083.15870395.html.plaintext.txt	90	information available cellular physiological function protein encoded gene however highly variable
0.10528083.15870395.html.plaintext.txt	91	furthermore size interval obesity trait mapped also highly variable
0.10528083.15870395.html.plaintext.txt	92	genetic molecular study would clarify possible role candidate gene obesity
0.10528083.15870395.html.plaintext.txt	93	example candidate gene located within region specific mouse strain human subject shown genetic predisposition obesity could sequenced coding regulatory sequence variant
0.10528083.15870395.html.plaintext.txt	94	variant could tested larger population association obesity related trait including trait genetically mapped chromosomal interval gene reside
0.10528083.15870395.html.plaintext.txt	95	finally investigation physiological cellular function protein identified bioinformatic screen may elucidate role specific gene gene product hypothalamic function genetic predisposition obesity
0.10528083.15870395.html.plaintext.txt	96	acknowledgment acknowledge sharee kuny megan oneill helpful discussion
0.10528083.15870395.html.plaintext.txt	97	footnote article published online print
0.10528083.15870395.html.plaintext.txt	98	see web site date publication httpphysiolgenomics
0.10528083.15870395.html.plaintext.txt	99	address reprint request correspondence r
0.10528083.15870395.html.plaintext.txt	100	medical genetics num num medical science bldg
0.10528083.15870395.html.plaintext.txt	101	alberta edmonton alberta canada tnumg numhnum e mail rachel
0.11059638.15044362.html.plaintext.txt	0	differential effect adrenalectomy melanin concentrating hormone orexin deborah l
0.11059638.15044362.html.plaintext.txt	1	genome research institute university cincinnati cincinnati ohio num department cell biology l
0.11059638.15044362.html.plaintext.txt	2	neurobiology anatomy university cincinnati cincinnati ohio num
0.11059638.15044362.html.plaintext.txt	3	address correspondence request reprint deborah l
0.11059638.15044362.html.plaintext.txt	4	drazen genome research institute university cincinnati num east galbraith road building num third floor cincinnati ohio num
0.11059638.15044362.html.plaintext.txt	5	addition important metabolic effect periphery glucocorticoid act several hypothalamic nucleus associated control energy balance
0.11059638.15044362.html.plaintext.txt	6	several study elucidated action glucocorticoid activity paraventricular arcuate nucleus arc num
0.11059638.15044362.html.plaintext.txt	7	le explored whether glucocorticoid also act upon neuropeptide system within lateral hypothalamus lh
0.11059638.15044362.html.plaintext.txt	8	long known activity lh associated increased food intake weight gain one reasonable hypothesis powerful effect glucocorticoid stimulate positive energy balance act part stimulating neuropeptide system within lh
0.11059638.15044362.html.plaintext.txt	9	first neuropeptide system lh melanin concentrating hormone mch num amino acid polypeptide originally isolated salmon pituitary num
0.11059638.15044362.html.plaintext.txt	10	neuroanatomical study rat demonstrate mch gene expression limited lh zona incerta extensive fiber projection throughout brain num
0.11059638.15044362.html.plaintext.txt	11	mch produced prepro mch along two putative peptide neuropeptides ei ge num
0.11059638.15044362.html.plaintext.txt	12	known mch receptor rat slc num g coupled protein receptor present throughout brain periphery num num
0.11059638.15044362.html.plaintext.txt	13	central mch involved many different physiological function including reproduction stress activity importantly energy balance reviewed ref
0.11059638.15044362.html.plaintext.txt	14	food restriction increase mch expression central injection mch promotes feeding num
0.11059638.15044362.html.plaintext.txt	15	addition mch deficient mouse reduced body weight lean due hypophagia increase metabolic rate num
0.11059638.15044362.html.plaintext.txt	16	central administration mch also elicits increase water intake independent food intake num
0.11059638.15044362.html.plaintext.txt	17	second peptide system contained lh orexins also known hypocretins originate prepro orexin prepro hypocretin reviewed ref
0.11059638.15044362.html.plaintext.txt	18	orexin influence variety endocrine autonomic metabolic function including control food intake wakefulness motor activity metabolic rate blood pressure num
0.11059638.15044362.html.plaintext.txt	19	orexin num amino acid peptide increase food intake body weight dose dependent manner injected brain num
0.11059638.15044362.html.plaintext.txt	20	conversely administration orexin receptor antibody reduces food intake fasted rat num
0.11059638.15044362.html.plaintext.txt	21	similar mch fasting regulates orexin mrna expression num
0.11059638.15044362.html.plaintext.txt	22	orexin containing neuron project widely central nervous system hypothalamic nucleus important control feeding orexin receptor located ventromedial hypothalamus vmn lh arc paraventricular nucleus pvn reviewed ref
0.11059638.15044362.html.plaintext.txt	23	given profound effect glucocorticoid feeding orexigenic hypothalamic peptide goal present study ass potential role glucocorticoid influence effect mch orexin food intake
0.11059638.15044362.html.plaintext.txt	24	tested hypothesis glucocorticoid promote action peptide lateral hypothalamus part complex hypothalamic system regulates energy balance
0.11059638.15044362.html.plaintext.txt	25	result present study first investigated effect third ventricular inumvt administration mch orexin food intake adx rat sham operated control
0.11059638.15044362.html.plaintext.txt	26	next examined influence glucocorticoid expression mch orexin mrna using semiquantitative pcr
0.11059638.15044362.html.plaintext.txt	27	adx cause deficiency circulating hormone addition glucocorticoid also examined whether glucocorticoid replacement could reverse effect observed adx
0.11059638.15044362.html.plaintext.txt	28	finally assessed potential colocalization mch orexin protein glucocorticoid receptor within lh determine whether glucocorticoid may act directly neuronal population
0.11059638.15044362.html.plaintext.txt	29	procedure third ventricular cannulation
0.11059638.15044362.html.plaintext.txt	30	animal surgically implanted num gauge plastic one roanoke va cannula tip third ventricle described previously num
0.11059638.15044362.html.plaintext.txt	31	rat anesthetized ketamine num mgkg ipxylazine num
0.11059638.15044362.html.plaintext.txt	32	verification cannula placement accomplished inumvt injection num ng angiotensin ii num microl num
0.11059638.15044362.html.plaintext.txt	33	animal drink num ml water within num min treatment included experiment
0.11059638.15044362.html.plaintext.txt	34	short incision made skin rostral kidney
0.11059638.15044362.html.plaintext.txt	35	perirenal fat located prominent adrenal vein located adrenal isolated surrounding fat capsule removed
0.11059638.15044362.html.plaintext.txt	36	animal allowed recover least num d experiment began
0.11059638.15044362.html.plaintext.txt	37	adx also remove mineralocorticoid necessary sodium retention adx animal access isotonic num
0.11059638.15044362.html.plaintext.txt	38	num saline addition tap water
0.11059638.15044362.html.plaintext.txt	39	maintain balanced design sham animal also access fluid
0.11059638.15044362.html.plaintext.txt	40	adx verified measuring plasma corticosterone level ria
0.11059638.15044362.html.plaintext.txt	41	tail blood sampled completion behavioral testing num h light num microl tip tail determination plasma corticosterone level
0.11059638.15044362.html.plaintext.txt	42	animal plasma level num microldl removed study
0.11059638.15044362.html.plaintext.txt	43	plasma corticosterone level determined ria using rabbit antiserum raised corticosterone num hemisuccinate bnum num endocrine science tarzana ca
0.11059638.15044362.html.plaintext.txt	44	num microldl intraassay coefficient variation num num experiment
0.11059638.15044362.html.plaintext.txt	45	experiment num effect adx feeding response mch behavioral procedure
0.11059638.15044362.html.plaintext.txt	46	rat sham n num adx n num adapted schedule food water saline removed cage num h end light cycle
0.11059638.15044362.html.plaintext.txt	47	experimental day num h food fluid removed animal received inumvt infusion num microl either mch american peptide co
0.11059638.15044362.html.plaintext.txt	48	sunnyvale ca dissolved num
0.11059638.15044362.html.plaintext.txt	49	num saline saline alone via hamilton syringe
0.11059638.15044362.html.plaintext.txt	50	food returned immediately injection food fluid weighed num min num h
0.11059638.15044362.html.plaintext.txt	51	animal received three dos mch num
0.11059638.15044362.html.plaintext.txt	52	num num num microg vehicle alone order counterbalanced across subject using latin square procedure
0.11059638.15044362.html.plaintext.txt	53	animal allowed least num d without injection experimental day
0.11059638.15044362.html.plaintext.txt	54	experiment num effect adx response mch corticosterone replaced rat adx animal saline drinking fluid replaced solution num
0.11059638.15044362.html.plaintext.txt	55	num saline num microgml corticosterone cort num
0.11059638.15044362.html.plaintext.txt	56	num alcohol keep corticosterone solution
0.11059638.15044362.html.plaintext.txt	57	providing adx rat corticosterone solution result plasma corticosterone level comparable sham operated control num
0.11059638.15044362.html.plaintext.txt	58	rat access solution num d behavioral testing
0.11059638.15044362.html.plaintext.txt	59	food intake subsequently determined num min num h group rat sham n num adx cort n num inumvt administration either num
0.11059638.15044362.html.plaintext.txt	60	num microg mch saline order treatment counterbalanced across subject
0.11059638.15044362.html.plaintext.txt	61	tail blood sampled completion behavioral testing num h light num microl tip tail determination plasma corticosterone level
0.11059638.15044362.html.plaintext.txt	62	experiment num effect adx feeding response orexin procedure
0.11059638.15044362.html.plaintext.txt	63	surgical procedure verification performed described experiment num
0.11059638.15044362.html.plaintext.txt	64	adx animal maintained plasma corticosterone level le num microldl
0.11059638.15044362.html.plaintext.txt	65	rat sham n num adx n num adapted schedule food water saline removed cage num h end light cycle
0.11059638.15044362.html.plaintext.txt	66	experimental day num h food removed animal received inumvt infusion num microl either orexin phoenix pharmaceutical inc
0.11059638.15044362.html.plaintext.txt	67	mountain view ca dissolved num
0.11059638.15044362.html.plaintext.txt	68	num saline saline alone via hamilton syringe
0.11059638.15044362.html.plaintext.txt	69	food returned immediately injection food fluid weighed num num h
0.11059638.15044362.html.plaintext.txt	70	animal received three dos orexin num
0.11059638.15044362.html.plaintext.txt	71	num nmol saline alone order counterbalanced across subject using latin square procedure
0.11059638.15044362.html.plaintext.txt	72	animal allowed least num d without injection experimental day
0.11059638.15044362.html.plaintext.txt	73	experiment num effect adx corticosterone replacement hypothalamic mch orexin expression procedure
0.11059638.15044362.html.plaintext.txt	74	half group adx animal num
0.11059638.15044362.html.plaintext.txt	75	num saline solution replaced corticosterone solution num d drinking water see three group rat semiquantitative pcr analysis sham n num adx n num adx cort n num
0.11059638.15044362.html.plaintext.txt	76	animal killed num h light brief exposure conum followed rapid decapitation removal fresh brain tissue
0.11059638.15044362.html.plaintext.txt	77	rna isolation cdna synthesis
0.11059638.15044362.html.plaintext.txt	78	brain rapidly removed decapitation placed rna later ambion austin tx stored num c num h
0.11059638.15044362.html.plaintext.txt	79	stored num c use gene measurement
0.11059638.15044362.html.plaintext.txt	80	mediobasal hypothalamus dissected total rna extracted using tri reagent molecular research center cincinnati oh
0.11059638.15044362.html.plaintext.txt	81	rna sample deoxyribonuclease treated using deoxyribonuclease free ambion austin tx
0.11059638.15044362.html.plaintext.txt	82	superscript iii first strand synthesis system invitrogen life technology carlsbad ca used synthesize cdna num microg total rna
0.11059638.15044362.html.plaintext.txt	83	semiquantitative expression mch orexin mrna real time pcr
0.11059638.15044362.html.plaintext.txt	84	primer designed amplify portion rat mch orexin gene using primernum primer design software num
0.11059638.15044362.html.plaintext.txt	85	primer sequence num num forward atatgagcctctcttac reverse gtcgtcttctacgttcctga mch forward ttccttctacaaaggttccct reverse tagcagcagcagcagcgtca orexin
0.11059638.15044362.html.plaintext.txt	86	constitutively expressed ribosomal protein lnum used obtain relative quantification gene
0.11059638.15044362.html.plaintext.txt	87	primer sequence lnum forward catcgtagaaagagcagcac reverse gcacacaagccatctattcat
0.11059638.15044362.html.plaintext.txt	88	master mix including cdna prepared num microg total rna see using superscript iii first strand synthesis kit invitrogen life technology num microm primer bio rad sybr green supermix used pcrs
0.11059638.15044362.html.plaintext.txt	89	pcrs performed using bio rad icycler richmond ca final volume num microl
0.11059638.15044362.html.plaintext.txt	90	pcr condition measurement lnum orexin consisted two step reaction annealing temperature num c extension time num sec num cycle
0.11059638.15044362.html.plaintext.txt	91	pcr condition measurement mch num c num sec num cycle
0.11059638.15044362.html.plaintext.txt	92	standard curve gene performed using dilution series spanning num order magnitude dilution factor num
0.11059638.15044362.html.plaintext.txt	93	pcr efficiency lnum mch orexin num num
0.11059638.15044362.html.plaintext.txt	94	correlation coefficient standard curve num
0.11059638.15044362.html.plaintext.txt	95	standard curve calculated slope plot threshold cycle v
0.11059638.15044362.html.plaintext.txt	96	sample run triplicate normalized constitutively expressed ribosomal protein lnum
0.11059638.15044362.html.plaintext.txt	97	data expressed mean plus minus sem mch orexin relative lnum using ct method applied biosystems foster city ca user bulletin
0.11059638.15044362.html.plaintext.txt	98	experiment num visualization glucocorticoid receptor mch orexin tissue preparation
0.11059638.15044362.html.plaintext.txt	99	adult male rat n num deeply anesthetized using pentobarbital num mgkg perfused transcardially num ml num
0.11059638.15044362.html.plaintext.txt	100	num nacl followed num ml num paraformaldehyde num
0.11059638.15044362.html.plaintext.txt	101	brain removed postfixed num h room temperature fixative placed num sucrose num
0.11059638.15044362.html.plaintext.txt	102	coronal section num microm cut freezing microtome richard allen kalamazoo mi collected four parallel series cryoprotectant solution num sucrose num ethylene glycol num
0.11059638.15044362.html.plaintext.txt	103	num m pb num stored num c processing
0.11059638.15044362.html.plaintext.txt	104	incubation performed room temperature gentle agitation
0.11059638.15044362.html.plaintext.txt	105	free floating section washed extensively num
0.11059638.15044362.html.plaintext.txt	106	section incubated num min num hnumonum blocked num h incubation solution pb containing num
0.11059638.15044362.html.plaintext.txt	107	primary antibody incubation performed incubation solution overnight room temperature
0.11059638.15044362.html.plaintext.txt	108	staining section washed thoroughly num
0.11059638.15044362.html.plaintext.txt	109	num m pb mounted onto glass slide num
0.11059638.15044362.html.plaintext.txt	110	num gelatin ddhnumo coverslipped dpx electron microscopy science fort washington pa
0.11059638.15044362.html.plaintext.txt	111	immunocytochemical control included omission primary antibody
0.11059638.15044362.html.plaintext.txt	112	section containing hypothalamus incubated overnight rabbit polyclonal antibody recognizing glucocorticoid receptor numnum panum numa affinity bioreagents golden co followed num h incubation biotinylated goat antirabbit igg numnum vector laboratory burlingame ca avidin horseradish peroxidase complex numnum abc elite kit vector laboratory burlingame ca
0.11059638.15044362.html.plaintext.txt	113	finally section incubated num min num
0.11059638.15044362.html.plaintext.txt	114	num diaminobenzidine sigma aldrich st
0.11059638.15044362.html.plaintext.txt	115	num nickel sulfate resulting blue black reaction product
0.11059638.15044362.html.plaintext.txt	116	next section incubated overnight rabbit polyclonal antibody orexin numnum phoenix pharmaceutical belmont ca rabbit anti mch numnumnum phoenix pharmaceutical biotinylated goat antirabbit igg numnum vector laboratory burlingame ca abc described
0.11059638.15044362.html.plaintext.txt	117	finally section incubated num min num
0.11059638.15044362.html.plaintext.txt	118	num hydrogen peroxide resulting reddish brown reaction product
0.11059638.15044362.html.plaintext.txt	119	data analysis food intake data experiment num num analyzed using mixed model anova
0.11059638.15044362.html.plaintext.txt	120	experiment num analyzed using one way anova experiment num analyzed using two tailed test
0.11059638.15044362.html.plaintext.txt	121	pair wise comparison mean difference conducted using tukey honestly significant difference post hoc comparison
0.11059638.15044362.html.plaintext.txt	122	difference group mean considered statistically significant p num
0.11059638.15044362.html.plaintext.txt	123	experiment num mch orexin positive cell examined coexpression glucocorticoid receptor throughout hypothalamus
0.11059638.15044362.html.plaintext.txt	124	digital image immunostained section captured using digital camera magnafire optronics goleta ca attached leica microscope leica microsystems wetzlar germany
0.11059638.15044362.html.plaintext.txt	125	image imported adobe photoshop num
0.11059638.15044362.html.plaintext.txt	126	num adobe system san jose ca compose figure
0.11059638.15044362.html.plaintext.txt	127	image adjusted altered way except occasional adjustment brightness
0.11059638.15044362.html.plaintext.txt	128	mean plus minus sem num min num h food intake g rat treated inumvt mch
0.11059638.15044362.html.plaintext.txt	129	view larger version numk fig
0.11059638.15044362.html.plaintext.txt	130	mean plus minus sem num min b num h food intake rat received either bilateral adx surgery sham surgery treated inumvt mch vehicle
0.11059638.15044362.html.plaintext.txt	131	data represented absolute change animal injected vehicle
0.11059638.15044362.html.plaintext.txt	132	significantly different paired sham p num
0.11059638.15044362.html.plaintext.txt	133	mean plus minus sem num min num h total fluid water num
0.11059638.15044362.html.plaintext.txt	134	num nacl solution intake ml rat treated inumvt mch
0.11059638.15044362.html.plaintext.txt	135	experiment num plasma corticosterone concentration significantly reduced undetectable level adx compared sham animal num
0.11059638.15044362.html.plaintext.txt	136	num microgdl assessed num h light p num
0.11059638.15044362.html.plaintext.txt	137	adx cort animal plasma corticosterone concentration similar sham animal num
0.11059638.15044362.html.plaintext.txt	138	administration num microg mch significantly increased food intake sham adx cort animal p num
0.11059638.15044362.html.plaintext.txt	139	mch increased food intake similar extent sham adx cort animal num min see fig
0.11059638.15044362.html.plaintext.txt	140	num num h data shown p num
0.11059638.15044362.html.plaintext.txt	141	view larger version numk fig
0.11059638.15044362.html.plaintext.txt	142	mean plus minus sem num min food intake rat received either sham surgery adx surgery consecutive num d corticosterone drinking water num
0.11059638.15044362.html.plaintext.txt	143	num mgml treated inumvt num microg mch vehicle
0.11059638.15044362.html.plaintext.txt	144	significantly different saline treated rat p num
0.11059638.15044362.html.plaintext.txt	145	experiment num set rat percent body weight change mean plus minus sem presurgery time experiment performed num
0.11059638.15044362.html.plaintext.txt	146	num adx weight gain significantly le adx sham p num
0.11059638.15044362.html.plaintext.txt	147	orexin num nmol significantly increased food intake p num
0.11059638.15044362.html.plaintext.txt	148	num extent p num
0.11059638.15044362.html.plaintext.txt	149	num sham adx animal num num h see table num
0.11059638.15044362.html.plaintext.txt	150	assessed absolute change food intake animal injected vehicle num h num h food intake similar sham adx animal num
0.11059638.15044362.html.plaintext.txt	151	mean plus minus sem num num h food intake g rat treated inumvt orexin
0.11059638.15044362.html.plaintext.txt	152	view larger version numk fig
0.11059638.15044362.html.plaintext.txt	153	mean plus minus sem num h b num h food intake rat received either adx sham surgery treated inumvt orexin vehicle
0.11059638.15044362.html.plaintext.txt	154	data represented absolute change animal injected vehicle
0.11059638.15044362.html.plaintext.txt	155	experiment num hypothalamic mrna expression mch relative lnum control significantly reduced adx adx cort animal compared sham animal p num
0.11059638.15044362.html.plaintext.txt	156	hypothalamic expression orexin relative lnum control also significantly reduced adx adx cort animal compared sham animal p num
0.11059638.15044362.html.plaintext.txt	157	view larger version numk fig
0.11059638.15044362.html.plaintext.txt	158	hypothalamic expression mch b orexin mrna relative lnum control data represented percentage sham expression
0.11059638.15044362.html.plaintext.txt	159	significantly different sham animal p num
0.11059638.15044362.html.plaintext.txt	160	experiment num expression glucocorticoid receptor gr mch orexin similar distribution previously described num num num
0.11059638.15044362.html.plaintext.txt	161	although gr observed neuron close vicinity neuron expressing orexin mch observed colocalization gr orexin gr mch lh see fig
0.11059638.15044362.html.plaintext.txt	162	view larger version numk fig
0.11059638.15044362.html.plaintext.txt	163	lack colocalization gr orexin b mch c d
0.11059638.15044362.html.plaintext.txt	164	gr observed neuron close vicinity neuron expressing orexin mch indicated arrow
0.11059638.15044362.html.plaintext.txt	165	addition examining effect glucocorticoid hyperphagic action mch orexin examined action glucocorticoid alter mrna expression mch orexin
0.11059638.15044362.html.plaintext.txt	166	accord previous data adx reduced hypothalamic mch mrna orexin mrna num num
0.11059638.15044362.html.plaintext.txt	167	however reduction observed mch orexin restored num d corticosterone replacement drinking water despite regimen achieving glucocorticoid level comparable sham operated animal
0.11059638.15044362.html.plaintext.txt	168	data suggest gene expression change lateral hypothalamic peptide glucocorticoid dependent depend nonglucocorticoid aspect adx
0.11059638.15044362.html.plaintext.txt	169	previous report described mch mrna increased sham control adx rat treated dexamethasone num
0.11059638.15044362.html.plaintext.txt	170	similarly dexamethasone administration restored orexin mrna adx num
0.11059638.15044362.html.plaintext.txt	171	although commonly used dexamethasone binding property glucocorticoid num make much harder ass whether physiological level glucocorticoid replacement achieved
0.11059638.15044362.html.plaintext.txt	172	work necessary address whether methodological difference underlie difference current data report group
0.11059638.15044362.html.plaintext.txt	173	nevertheless tempting speculate mineralocorticoid may significant effect lateral hypothalamus
0.11059638.15044362.html.plaintext.txt	174	particularly true case mch reported mch potent rapid effect increase water intake even absence available food num making possible osmoregulatory aspect mineralocorticoid may influence fluid ingestion via action mch
0.11059638.15044362.html.plaintext.txt	175	glucocorticoid receptor present region hypothalamus important regulation food intake body weight including arc pvn lh num suggesting glucocorticoid may directly influence activity responsiveness numerous neuropeptide system regulating feeding
0.11059638.15044362.html.plaintext.txt	176	despite fact large population glucocorticoid receptor positive cell within lh evidence located either mch orexin containing neuron
0.11059638.15044362.html.plaintext.txt	177	consistent data gene expression experiment change mch orexin expression appeared tied glucocorticoid action
0.11059638.15044362.html.plaintext.txt	178	collectively data make several interesting point
0.11059638.15044362.html.plaintext.txt	179	first data provide another dissociation mch orexin system lh
0.11059638.15044362.html.plaintext.txt	180	although system cell body almost exclusively lh act regulate food intake appear separate neural circuit
0.11059638.15044362.html.plaintext.txt	181	data indicate action mch stimulate food intake glucocorticoid dependent whereas action orexin
0.11059638.15044362.html.plaintext.txt	182	addition mch added extensive list regulatory peptide whose effect altered glucocorticoid
0.11059638.15044362.html.plaintext.txt	183	thus appears glucocorticoid broad effect number central nervous system circuit linked control food intake
0.11059638.15044362.html.plaintext.txt	184	present data also allow speculation glucocorticoid influence action mch increase food intake
0.11059638.15044362.html.plaintext.txt	185	mch projection many brain region important regulation energy balance num
0.11059638.15044362.html.plaintext.txt	186	example slc num first identified mch receptor rodent mrna immunoreactivity observed arc pvn lh vmn num
0.11059638.15044362.html.plaintext.txt	187	possible glucocorticoid exert effect mch food intake system acting target cell mch
0.11059638.15044362.html.plaintext.txt	188	example strong signal slc num gr observed pvn making potential candidate site action glucocorticoid reduce mch ability increase food intake num num
0.11059638.15044362.html.plaintext.txt	189	data indicating melanocortin system antagonizes mch system
0.11059638.15044362.html.plaintext.txt	190	consistent mch msh exert opposing antagonistic effect food intake num
0.11059638.15044362.html.plaintext.txt	191	study demonstrate administration either agouti related protein agrp shunum increase mch mrna orexin mrna num
0.11059638.15044362.html.plaintext.txt	192	adx increase melanocortin tone rodent model num num possible speculate increase melanocortin tone may antagonize orexigenic effect mch leading present effect adx mch orexin
0.11059638.15044362.html.plaintext.txt	193	another possibility mch exerts effect via action arc alter release neuropeptide y npy andor agrp
0.11059638.15044362.html.plaintext.txt	194	glucocorticoid receptor found neuron num potent orexigenic effect npy agrp blocked glucocorticoid deficiency num num
0.11059638.15044362.html.plaintext.txt	195	recent report indicate arc potent site mch increase food intake hypothalamic explants administration mch increase release npy suggesting mch may act activation npy neuron affect feeding num
0.11059638.15044362.html.plaintext.txt	196	data lead hypothesis reduced action mch glucocorticoid deficiency could due decreased action npy andor agrp
0.11059638.15044362.html.plaintext.txt	197	reverse may also true proposed npy andor agrp exert effect via recruiting mch neuron lh num
0.11059638.15044362.html.plaintext.txt	198	double label immunohistochemistry demonstrates mch neuron receive innervation npy immunoreactive fiber num data also suggest mch neuron may express npy receptor num
0.11059638.15044362.html.plaintext.txt	199	evidence encourages hypothesis effect adx reduce orexigenic action mch may responsible alteration npy action adx
0.11059638.15044362.html.plaintext.txt	200	future research identify glucocorticoid receptor population responsible ability glucocorticoid dramatically alter effect variety neuropeptides mch npy msh agrp
0.11059638.15044362.html.plaintext.txt	201	acknowledgment grateful jennifer schurdak jennifer adelman expert technical assistance
0.11059638.15044362.html.plaintext.txt	202	randall sakai measurement corticosterone
0.11059638.15044362.html.plaintext.txt	203	footnote work supported several grant national institute health dknum dknum procter gamble co
0.11059638.15044362.html.plaintext.txt	204	abbreviation adx adrenalectomy agrp agouti related protein arc arcuate nucleus cort corticosterone gr glucocorticoid receptor inumvt third ventricular lh lateral hypothalamus mch melanin concentrating hormone npy neuropeptide y pb phosphate buffer pvn paraventricular nucleus vmn ventromedial nucleus
0.11059638.15044362.html.plaintext.txt	205	accepted publication march num num
0.11429769.11978759.html.plaintext.txt	0	different rpgr exon orfnum mutation canid provide insight photoreceptor cell degeneration qi zhangnum gregory m
0.11429769.11978759.html.plaintext.txt	1	johnsonnum sue pearce kellingnum brian tullochnum raf vervoortnumnum alan f
0.11429769.11978759.html.plaintext.txt	2	numbaker institute numdepartment biomedical science cornell university ithaca new york usa nummrc human genetics unit western general hospital edinburgh uk numlaboratory glycobiology developmental genetics center human genetics university leuven leuven belgium
0.11429769.11978759.html.plaintext.txt	3	ddbjemblgenbank accession no
0.11429769.11978759.html.plaintext.txt	4	xlrp population prevalence num num num represents severe class rp early onset night blindness visual field loss eventual loss central acuity numnum
0.11429769.11978759.html.plaintext.txt	5	five xlrp locus identified causal mutation established rpnum num rpnum num
0.11429769.11978759.html.plaintext.txt	6	rpnum region span num num kb xpnum
0.11429769.11978759.html.plaintext.txt	7	num includes tctenuml srpx rpgr otc num
0.11429769.11978759.html.plaintext.txt	8	locus account approximately num num affected xlrp pedigree although previous study found rpgr mutation num family numnumnum
0.11429769.11978759.html.plaintext.txt	9	recently novel protein coding sequence identified region formerly regarded intron rpgr
0.11429769.11978759.html.plaintext.txt	10	one exon orfnum mutational hot spot mutation exon account majority rpnum case num
0.11429769.11978759.html.plaintext.txt	11	role rpgr retinal function unknown
0.11429769.11978759.html.plaintext.txt	12	first num exon encode domain highly conserved specie consisting six tandem repeat num num amino acid homologous repeat structure rccnum protein num
0.11429769.11978759.html.plaintext.txt	13	rpgr knockout mouse exon num num replaced selectable marker result lack rpgr expression develop slowly progressive post developmental photoreceptor degeneration num
0.11429769.11978759.html.plaintext.txt	14	rccnum domain used bait yeast two hybrid screen resulting identification two interacting protein delta subunit rod specific cyclic gmp phosphodiesterase num rpgr interacting protein rpgrip numnum
0.11429769.11978759.html.plaintext.txt	15	rpgrip co localizes rpgr photoreceptor outer segment num connecting cilium num may involved structural transport function respectively
0.11429769.11978759.html.plaintext.txt	16	little known function c terminal half rpgr particularly exon orfnum mutation located num
0.11429769.11978759.html.plaintext.txt	17	alternative approach address question functional role domain identify specie naturally occurring mutation region examine resultant phenotype
0.11429769.11978759.html.plaintext.txt	18	comparative genomic approach possible dog sufficient resource map positionally clone disease gene num
0.11429769.11978759.html.plaintext.txt	19	canine progressive retinal atrophy pra comprises several naturally occurring retinal disease similar phenotype rp
0.11429769.11978759.html.plaintext.txt	20	six distinct autosomal one x linked locus identified num
0.11429769.11978759.html.plaintext.txt	21	xlpra siberian husky spontaneous animal model xlrp numnum disease mapped short arm x chromosome showed recombinant rpgr
0.11429769.11978759.html.plaintext.txt	22	prior recognition novel orfnum exon human rpgr characterized rpgr splice variant found mutation num
0.11429769.11978759.html.plaintext.txt	23	original xlpra disorder renamed xlpranum distinguish second disease xlpranum mapping locus
0.11429769.11978759.html.plaintext.txt	24	recombination event located disease interval microsatellite marker associated tctenuml otc num marker define le num cm zero recombination region homologous rpnum interval containing tctenuml srpx rpgr otc orthologs
0.11429769.11978759.html.plaintext.txt	25	present study completed cloning characterization canine rpgr including num kb intron num containing exon orfnum
0.11429769.11978759.html.plaintext.txt	26	found three distinct microdeletions exon orfnum canid one benign two disease associated provide insight structure function rpgr c terminal domain human disease
0.11429769.11978759.html.plaintext.txt	27	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	28	comparative linkage physical map rpnum xlpra interval linkage distance expressed centimorgans cm orientation xp given tel cen
0.11429769.11978759.html.plaintext.txt	29	rpnum flanking region hsxpnum
0.11429769.11978759.html.plaintext.txt	30	num linkage map based genemapnum physical map meindl et al
0.11429769.11978759.html.plaintext.txt	31	sequence alnum alnum afnum taken ncbi nucleotide database
0.11429769.11978759.html.plaintext.txt	32	note contig gap srpx otc
0.11429769.11978759.html.plaintext.txt	33	linkage map taken zhang et al
0.11429769.11978759.html.plaintext.txt	34	physical map consistent human data term conserved orthologs order xp
0.11429769.11978759.html.plaintext.txt	35	cloning rpgr exon orfnum identification three microdeletions canid primer intron num exon num used amplify num kb intron num bac clone positive rpgr
0.11429769.11978759.html.plaintext.txt	36	product cloned directly sequenced using vector primer followed gene specific primer walking
0.11429769.11978759.html.plaintext.txt	37	exon orfnum genbank accession
0.11429769.11978759.html.plaintext.txt	38	afnum transcribed continuously exon num extends num
0.11429769.11978759.html.plaintext.txt	39	num kb intron num unusually rich purine num repetitive sequence
0.11429769.11978759.html.plaintext.txt	40	stop codon taa polya signal aauaaa position num num num num respectively
0.11429769.11978759.html.plaintext.txt	41	two unstable signal auuua recognition site rnase e activity num found num utr
0.11429769.11978759.html.plaintext.txt	42	human dog exon encodes set charged amino acid arg lys asp glu alternated glycine encoded protein identical number glutamic aspartic acid residue similar isoelectric point num
0.11429769.11978759.html.plaintext.txt	43	however instead repetitive eeegegege sequence human num dog sequence contains geeegeeee gegeeeeg eeegeeegee repeat
0.11429769.11978759.html.plaintext.txt	44	c terminal num amino acid highly conserved human dog
0.11429769.11978759.html.plaintext.txt	45	premature stop codon mutant exon orfnum sequence xlpranum num encode protein lacking c terminal tail
0.11429769.11978759.html.plaintext.txt	46	three microdeletions found canid num bp region nucleotide num num exon orfnum
0.11429769.11978759.html.plaintext.txt	47	red wolf three nucleotide deletion eliminates glutamic acid alter remainder protein cause disease see
0.11429769.11978759.html.plaintext.txt	48	five nucleotide deletion delgagaa num num identified xlpranum
0.11429769.11978759.html.plaintext.txt	49	xlpranum two nucleotide deletion delga num num identified num nucleotide num site xlpranum deletion fig num num
0.11429769.11978759.html.plaintext.txt	50	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	51	mutation analysis exon orfnum canid
0.11429769.11978759.html.plaintext.txt	52	wild type nucleotide sequence mutation region canine exon orfnum encompassing nucleotide num num
0.11429769.11978759.html.plaintext.txt	53	three deletion illustrated top line
0.11429769.11978759.html.plaintext.txt	54	electropherograms show deletion affected carrier dog xlpranum b xlpranum c
0.11429769.11978759.html.plaintext.txt	55	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	56	segregation deletion xlpranum xlpranum b pedigree
0.11429769.11978759.html.plaintext.txt	57	xlpranum carrier normal num mutant num allele slower migrating heteroduplex band h
0.11429769.11978759.html.plaintext.txt	58	small size difference normal mutant allele xlpranum pcr product tested sample genetically normal dog mixed denaturing num degree c num minute incubated num degree c num hour
0.11429769.11978759.html.plaintext.txt	59	dog two lane sample alone mixed test normal sample show heteroduplex h shown normal num affected num allele
0.11429769.11978759.html.plaintext.txt	60	compound heterozygous female c produce offspring xlpranum xlpranum
0.11429769.11978759.html.plaintext.txt	61	allele num num wild type allele num num xlpranum xlpranum respectively
0.11429769.11978759.html.plaintext.txt	62	xlpranum mutation cause frameshift immediate premature stop truncated protein missing num c terminal amino acid causing slight decrease isoelectric point num
0.11429769.11978759.html.plaintext.txt	63	mutation scanning also found five nucleotide deletion samoyed breed clinically similar x linked retinal degeneration data shown
0.11429769.11978759.html.plaintext.txt	64	xlpranum mutation result frameshift significantly change deduced peptide sequence causing increased isoelectric point num
0.11429769.11978759.html.plaintext.txt	65	num lead inclusion num additional basic residue prematurely terminating translation num amino acid downstream
0.11429769.11978759.html.plaintext.txt	66	produced several compound heterozygote showed severe clinical phenotype either xlpranum xlpranum hemizygotes heterozygote see
0.11429769.11978759.html.plaintext.txt	67	figure numc illustrates independent segregation two mutant allele male progeny compound heterozygote
0.11429769.11978759.html.plaintext.txt	68	exon orfnum deletion determine retinal phenotype severe abnormality retinal structure function found xlpra allele specific
0.11429769.11978759.html.plaintext.txt	69	previously reported photoreceptors xlpranum retina developed functioned normally num
0.11429769.11978759.html.plaintext.txt	70	retinal function remained normal num month age later decrease amplitude dark adapted rod cone response fig
0.11429769.11978759.html.plaintext.txt	71	morphologically xlpranum photoreceptors remained normal young adulthood thereafter rod showed distinct irregularity outer segment followed degeneration
0.11429769.11978759.html.plaintext.txt	72	cone abnormality appeared le severe proportionally larger number cone remained visual cell layer late disease fig
0.11429769.11978759.html.plaintext.txt	73	affected male showed end stage retinal disease num year age
0.11429769.11978759.html.plaintext.txt	74	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	75	erg pathology ii situ hybridization iii normal xlpra
0.11429769.11978759.html.plaintext.txt	76	panel show response scotopically balanced red blue stimulus white light num hz rod num hz cone stimulus
0.11429769.11978759.html.plaintext.txt	77	xlpranum erg develops normally anum num day remains normal early adulthood
0.11429769.11978759.html.plaintext.txt	78	amplitude decrease age anum num
0.11429769.11978759.html.plaintext.txt	79	xlpranum show rod cone response reduced amplitude abnormal waveform early bnum num day bnum num month
0.11429769.11978759.html.plaintext.txt	80	num year bnum rod response nearly absent distinct cone signal prolonged timing remain
0.11429769.11978759.html.plaintext.txt	81	num year xlpranum enum year carrier retain normal erg waveform lower amplitude especially xlpranum
0.11429769.11978759.html.plaintext.txt	82	vertical line arrow light stimulus onset calibration marker num microv num m except rod flicker num m
0.11429769.11978759.html.plaintext.txt	83	ii xlpranum retina rpe normal num
0.11429769.11978759.html.plaintext.txt	84	developing outer segment o abnormality b num month
0.11429769.11978759.html.plaintext.txt	85	degeneration occurs subsequently rate severity varies affected animal c num month d num year
0.11429769.11978759.html.plaintext.txt	86	remaining cone prominent oblique arrow
0.11429769.11978759.html.plaintext.txt	87	xlpranum retina develops abnormally outer segment disorganized disoriented early e num month photoreceptors degenerate rapidly f num month g num month h num
0.11429769.11978759.html.plaintext.txt	88	xlpranum carrier outside area patchy retinal degeneration show lower number normal surviving photoreceptors num year
0.11429769.11978759.html.plaintext.txt	89	xlpranum carrier j k num year show patchy degeneration j horizontal bracket abnormally developed photoreceptors
0.11429769.11978759.html.plaintext.txt	90	compound heterozygote l num
0.11429769.11978759.html.plaintext.txt	91	num month show advanced degeneration
0.11429769.11978759.html.plaintext.txt	92	calibration bar num microm horizontal arrowhead external limiting membrane
0.11429769.11978759.html.plaintext.txt	93	iii paired brightfield anum bnum cnum dnum combined brightfieldepipolarization anum bnum cnum dnum image normal b num month xlpranum retina num
0.11429769.11978759.html.plaintext.txt	94	num c num d month hybridized antisense c d sense b exon orfnum probe nucleotide num num
0.11429769.11978759.html.plaintext.txt	95	normal mutant show pattern intensity hybridization
0.11429769.11978759.html.plaintext.txt	96	peripheral retina older mutant d label present photoreceptor number decreased
0.11429769.11978759.html.plaintext.txt	97	wavy line panel cnumnum represent photographic apposition rpe retina
0.11429769.11978759.html.plaintext.txt	98	calibration bar dnum num microm arrow cone
0.11429769.11978759.html.plaintext.txt	99	contrast retinal development aberrant xlpranum
0.11429769.11978759.html.plaintext.txt	100	erg abnormality evident num num week age response low amplitude abnormal waveform deteriorated age fig
0.11429769.11978759.html.plaintext.txt	101	relative preservation cone flicker response rod function severely compromised cone signal abnormally small older animal increased timing
0.11429769.11978759.html.plaintext.txt	102	parallel photoreceptor morphogenesis abnormal
0.11429769.11978759.html.plaintext.txt	103	outer segment highly disorganized disoriented develop fig
0.11429769.11978759.html.plaintext.txt	104	numiie visual cell degeneration present num month progress fig
0.11429769.11978759.html.plaintext.txt	105	num year end stage degeneration present affected animal fig
0.11429769.11978759.html.plaintext.txt	106	cone abnormality le severe proportionally larger number cone remained late disease
0.11429769.11978759.html.plaintext.txt	107	heterozygote retinal functional abnormality reflected underlying photoreceptor pathology
0.11429769.11978759.html.plaintext.txt	108	low amplitude response present young adult carrier either genotype fig
0.11429769.11978759.html.plaintext.txt	109	numic e progressive loss function found xlpranum data shown
0.11429769.11978759.html.plaintext.txt	110	focus patchy retinal degeneration remaining photoreceptors xlpranum heterozygote normal fig
0.11429769.11978759.html.plaintext.txt	111	case xlpranum since carrier retina failed develop normally surviving photoreceptors showed severe structural abnormality compare fig
0.11429769.11978759.html.plaintext.txt	112	severe pathology xlpranum carrier indicates mutation kill mutant photoreceptors early development produce collateral damage surviving normal one
0.11429769.11978759.html.plaintext.txt	113	allele expressed already compromised retina compound heterozygote disease severe fig
0.11429769.11978759.html.plaintext.txt	114	expression profile rpgr splice variant protein normal mutant retina understand disease mechanism resulting exon orfnum mutation characterized rpgr alternative splicing detail examined expression normal mutant retina using probe different region rpgr cdna fig
0.11429769.11978759.html.plaintext.txt	115	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	116	schematic representation genomic organization canine rpgr drawn scale location probe used identify retinal expressed transcript b num c new transcript orfnum terminal exon
0.11429769.11978759.html.plaintext.txt	117	note bracket c identify exon orf num exon num numa orfnum exon num transcribed portion intron num num
0.11429769.11978759.html.plaintext.txt	118	asterisk identifies approximate position microdeletions associated xlpranum xlpranum
0.11429769.11978759.html.plaintext.txt	119	exon orf num transcribed rccnum like domain exon numa
0.11429769.11978759.html.plaintext.txt	120	rpgr expression examined using normal retinal rna sample loaded separate lane gel hybridized probe corresponding different exon fig
0.11429769.11978759.html.plaintext.txt	121	probe exon num num numa orfnum detected two novel common band num
0.11429769.11978759.html.plaintext.txt	122	num kb suggesting exon part transcript exon orfnum transcribed
0.11429769.11978759.html.plaintext.txt	123	also demonstrate exon numa expression retina transcription frame exon orfnum fig
0.11429769.11978759.html.plaintext.txt	124	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	125	antisense rna probe different exon rpgr hybridized total retinal rna num microglane
0.11429769.11978759.html.plaintext.txt	126	probe location follows exon num num nucleotide num num exon num num nucleotide num num exonnuma nucleotide num num exon orfnum nucleotide num num
0.11429769.11978759.html.plaintext.txt	127	b rpgr expression different tissue
0.11429769.11978759.html.plaintext.txt	128	antisense probe exon num num top exon num num middle hybridized dog tissue blot containing num microg total rnalane
0.11429769.11978759.html.plaintext.txt	129	bottom panel show blot hybridized nums cdna probe
0.11429769.11978759.html.plaintext.txt	130	c expression rpgr normal num
0.11429769.11978759.html.plaintext.txt	131	num month xlpranum num non allelic autosomal retinal disease affected sample pre degenerate stage num num week age
0.11429769.11978759.html.plaintext.txt	132	antisense rna probe hybridized total retinal rna num microglane normal pre degenerate retina xlpranum prcd xlpranum rcdnum
0.11429769.11978759.html.plaintext.txt	133	rcdnum prcd sample serve disease control animal age affected non allelic autosomal retinal disease comparable phenotype xlpranum prcd xlpranum rcdnum num
0.11429769.11978759.html.plaintext.txt	134	bottom panel show hybridization nums cdna probe blot
0.11429769.11978759.html.plaintext.txt	135	d western blot rpgr retinal tissue normal affected dog
0.11429769.11978759.html.plaintext.txt	136	protein num microg total proteinlane cytosol top membrane bottom fraction labeled dr num rpgr num antibody respectively
0.11429769.11978759.html.plaintext.txt	137	sample source age listed lane
0.11429769.11978759.html.plaintext.txt	138	tissue expression profile reveals orfnum retina predominant terminal exon
0.11429769.11978759.html.plaintext.txt	139	using probe exon num num num num found respectively num
0.11429769.11978759.html.plaintext.txt	140	num kb band northern blot fig
0.11429769.11978759.html.plaintext.txt	141	num kb band ubiquitously expressed tissue num
0.11429769.11978759.html.plaintext.txt	142	num kb band appears represent non specific binding since consistently found repeat blotting tissue
0.11429769.11978759.html.plaintext.txt	143	exon num num probe show two major high molecular size transcript num
0.11429769.11978759.html.plaintext.txt	144	num kb expression cerebellum similar retina low level brain region fig
0.11429769.11978759.html.plaintext.txt	145	num kb transcript hardly detectable liver heart
0.11429769.11978759.html.plaintext.txt	146	result obtained exon orfnum probe data shown
0.11429769.11978759.html.plaintext.txt	147	size num kb transcript expressed predominantly retina match expected sequence length num bp exon orfnum used terminal exon
0.11429769.11978759.html.plaintext.txt	148	xlpra mutant retina express rpgr transcript
0.11429769.11978759.html.plaintext.txt	149	examined expression pre degenerate num num week age xlpra retina using probe exon num num orfnum
0.11429769.11978759.html.plaintext.txt	150	age retina show cellular degeneration although abnormality outer segment structure present xlpranum
0.11429769.11978759.html.plaintext.txt	151	addition normal also used control retina animal age non allelic autosomal retinal disease comparable phenotype xlpranum prcd xlpranum rcdnum num
0.11429769.11978759.html.plaintext.txt	152	affected control probe detected band num
0.11429769.11978759.html.plaintext.txt	153	num num kb xlpranum transcript abundance normal
0.11429769.11978759.html.plaintext.txt	154	although distinct message found xlpranum probe found slightly lower level expression fig
0.11429769.11978759.html.plaintext.txt	155	result indicate rpgr exon orfnum transcribed mutant retina
0.11429769.11978759.html.plaintext.txt	156	used situ hybridization examine expression exon orfnum retina predominant transcript
0.11429769.11978759.html.plaintext.txt	157	comparable intense accumulation silver grain found normal xlpranum affected retina tissue available xlpranum animal
0.11429769.11978759.html.plaintext.txt	158	label found rpe photoreceptor inner segment nuclear layer cone inner segment showed dense cluster label
0.11429769.11978759.html.plaintext.txt	159	difference label intensity distribution found normal xlpranum affected animal compare fig
0.11429769.11978759.html.plaintext.txt	160	older affected animal label intensity reduced secondary loss visual cell remaining cell showed normal label distribution fig
0.11429769.11978759.html.plaintext.txt	161	control sense probe showed low diffuse labeling normal fig
0.11429769.11978759.html.plaintext.txt	162	numiiibnumnum mutant data shown
0.11429769.11978759.html.plaintext.txt	163	antibody dr num raised peptide human rpgr exon num num detected num kda band cytosol membrane fraction fig
0.11429769.11978759.html.plaintext.txt	164	also found num kda major band smaller num kda band membrane fraction rpgr num antibody raised c terminal num residue rpgr fig
0.11429769.11978759.html.plaintext.txt	165	numd lower panel could identify specific band cytosolic fraction using antibody
0.11429769.11978759.html.plaintext.txt	166	however difference found control mutant sample indication antibody failed detect protein containing exon orfnum
0.11429769.11978759.html.plaintext.txt	167	rpgr photoreceptor specific protein normally expressed mutant retina
0.11429769.11978759.html.plaintext.txt	168	used different rpgr antibody obtained result normal mutant retina fig
0.11429769.11978759.html.plaintext.txt	169	polyclonal rpgr num antibody intensely labeled outer segment fig
0.11429769.11978759.html.plaintext.txt	170	numanumnum result previously reported num
0.11429769.11978759.html.plaintext.txt	171	contrast antibody dr num intensely labeled inner segment inner nuclear ganglion cell fig
0.11429769.11978759.html.plaintext.txt	172	intensity distribution labeling normal mutant retina even photoreceptor degeneration started fig
0.11429769.11978759.html.plaintext.txt	173	three antibody opsin pde rod cgmp channel protein subunit produced labeling normal mutant fig
0.11429769.11978759.html.plaintext.txt	174	num column num num even eye showed disease associated pathology
0.11429769.11978759.html.plaintext.txt	175	normal labeling photoreceptor specific protein examined indicates polarized distribution mutant visual cell altered
0.11429769.11978759.html.plaintext.txt	176	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	177	expression photoreceptor protein normal xlpranum b disease stage c early disease xlpranum d dog following age num
0.11429769.11978759.html.plaintext.txt	178	num month d num week column num num num num num week column num num
0.11429769.11978759.html.plaintext.txt	179	c num microm dgd section d num microm cryosections
0.11429769.11978759.html.plaintext.txt	180	column num num num num paired nomarski numnum immunofluorescence numnum image using rpgr num dr num antibody
0.11429769.11978759.html.plaintext.txt	181	column represent single image section labeled antibody opsin pde rod cgmp channel protein subunit
0.11429769.11978759.html.plaintext.txt	182	pattern intensity labeling found normal mutant retina
0.11429769.11978759.html.plaintext.txt	183	xlpranum mutant protein aggregate er examined subcellular localization normal mutant exon orfnumgfp fusion protein using transfected cosnum cell
0.11429769.11978759.html.plaintext.txt	184	signal normal protein mainly cytoplasmic diffuse faint nuclear presence fig
0.11429769.11978759.html.plaintext.txt	185	numb similar result obtained following transfection gfp vector alone fig
0.11429769.11978759.html.plaintext.txt	186	numa exon orfnum nonsense mutation xlpranum fig
0.11429769.11978759.html.plaintext.txt	187	contrast frameshift mutation xlpranum showed intense accumulation protein aggregate distinct perinuclear subcellular compartment fig
0.11429769.11978759.html.plaintext.txt	188	faint diffuse signal rest cytoplasm minimal signal nucleus
0.11429769.11978759.html.plaintext.txt	189	staining endoplasmic reticular er specific marker confirms co localization aggregate er fig
0.11429769.11978759.html.plaintext.txt	190	view larger version numk figure num
0.11429769.11978759.html.plaintext.txt	191	transient expression different gfp exon orfnum construct cosnum cell
0.11429769.11978759.html.plaintext.txt	192	similar distribution cell expressing vector wild type b xlpranum gfp exon orfnum c construct
0.11429769.11978759.html.plaintext.txt	193	however xlpranum construct result gfp fluorescence aggregate around nucleus d
0.11429769.11978759.html.plaintext.txt	194	xlpranum gfp exon orfnum protein aggregate enum er enum co localize enum
0.11429769.11978759.html.plaintext.txt	195	hotspot rpgr mutation human occurs approximately num kb purine rich region exon orfnum frame mutation premature stop associated disease
0.11429769.11978759.html.plaintext.txt	196	num novel rpnum mutation reported recently num one two four five nucleotide deletion resulted frameshift premature termination translation num
0.11429769.11978759.html.plaintext.txt	197	proposed purine rich region may adopt unusual non b dna conformation show sequence motif similar dna polymerase arrest site found near deletion hotspot lead microdeletions following slipped strand mispairing event numnum
0.11429769.11978759.html.plaintext.txt	198	found similar microdeletions present study suggesting rpgr exon orfnum appears mutation hotspot canid
0.11429769.11978759.html.plaintext.txt	199	study demonstrate nature rpgr exon orfnum deletion determine retinal phenotype
0.11429769.11978759.html.plaintext.txt	200	disorder distinct remained even though disease present mixed breed dog genetic background
0.11429769.11978759.html.plaintext.txt	201	indicates phenotype result difference two mutant protein vivo
0.11429769.11978759.html.plaintext.txt	202	normal retinal development xlpranum argues c terminal num amino acid encoded exon orfnum vital functional structural differentiation rod cone
0.11429769.11978759.html.plaintext.txt	203	argument proposed role rccnum like domain since photoreceptor development normal rpgr knockout mouse num
0.11429769.11978759.html.plaintext.txt	204	however severe disease develops young adult animal indicates rpgr play essential role photoreceptor viability
0.11429769.11978759.html.plaintext.txt	205	contrast abnormal retinal development occurs xlpranum rapid degeneration ensues suggests mutation disrupts critical differentiation rod cone cause early degeneration
0.11429769.11978759.html.plaintext.txt	206	analysis heterozygous retina provides insight role mutant allele retinal development maintenance
0.11429769.11978759.html.plaintext.txt	207	random x inactivation num approximately num retinal cell express mutant normal rpgr expression mutant gene examined milieu half photoreceptors genetically normal
0.11429769.11978759.html.plaintext.txt	208	carrier either disease show ophthalmoscopically visible patchy retinal degeneration indication mosaicism hallmark retinal random x inactivation num
0.11429769.11978759.html.plaintext.txt	209	change variable extent severity evident carrier time young adult time advanced age
0.11429769.11978759.html.plaintext.txt	210	abnormality stationary xlpranum xlpranum carrier often show progressive disease result advanced retinal degeneration num num year age older
0.11429769.11978759.html.plaintext.txt	211	contrast lack disease aged heterozygous red wolf suggests three nucleotide deletion benign polymorphism
0.11429769.11978759.html.plaintext.txt	212	severe retinal disease phenotype canine xlpra comparable reported human patient rpgr mutation given caveat least human limited number phenotype genotype correlation study reported
0.11429769.11978759.html.plaintext.txt	213	exception two report retrospectively represent mutation exon orfnum numnum others limited primarily exon num num e
0.11429769.11978759.html.plaintext.txt	214	study show comparably severe clinical phenotype xlrp patient found two canine model
0.11429769.11978759.html.plaintext.txt	215	also majority carrier show clinical disease varying mild severe impaired night vision visual field loss numnum
0.11429769.11978759.html.plaintext.txt	216	family disease sufficiently severe female considered semidominant num
0.11429769.11978759.html.plaintext.txt	217	examination exon orfnum identified null allele four nine family j
0.11429769.11978759.html.plaintext.txt	218	rozet personal communication num july num
0.11429769.11978759.html.plaintext.txt	219	expression study rpgr shown alternative splicing complex specie specific variant may exist
0.11429769.11978759.html.plaintext.txt	220	splice variant reported rpgr mainly exon num especially brain testis numnum
0.11429769.11978759.html.plaintext.txt	221	additionally alternative exon usage intron found frequently rpgr transcript example exon numa intron num mouse num dog num exon numa numbnum numbnum orfnum intron num human mouse cow dog num present study exon numa mouse intron num num
0.11429769.11978759.html.plaintext.txt	222	alternative splicing exon usage suggests different rpgr protein isoforms produced specific function vivo
0.11429769.11978759.html.plaintext.txt	223	exon num num probe mainly detected num
0.11429769.11978759.html.plaintext.txt	224	num kb band failed detect num kb band recognized probe exon num num exon numa orfnum
0.11429769.11978759.html.plaintext.txt	225	result suggests exon orfnum used terminal exon num kb band alternatively spliced exon num num num
0.11429769.11978759.html.plaintext.txt	226	found putative consensus splice donor site conserved human dog located stop codon num coding region exon orfnum
0.11429769.11978759.html.plaintext.txt	227	may splice exon orfnum exon num num translate polypeptide frame include exon orfnum exon num num
0.11429769.11978759.html.plaintext.txt	228	case putative protein regain c terminal isoprenylation site ctil located alternative terminal exon num num
0.11429769.11978759.html.plaintext.txt	229	higher molecular weight mrna band reported previously including num
0.11429769.11978759.html.plaintext.txt	230	num num kb eye brain num present study
0.11429769.11978759.html.plaintext.txt	231	recently num kb band reported human retina orfnum exon num num probe num
0.11429769.11978759.html.plaintext.txt	232	num kb band match known size rpgr sequence
0.11429769.11978759.html.plaintext.txt	233	suggests additional undiscovered exon alternative polyadenylation site used rpgr processing
0.11429769.11978759.html.plaintext.txt	234	addition exon orfnum probe consistently detected two band similar intensity num
0.11429769.11978759.html.plaintext.txt	235	num kb another slightly smaller size fig
0.11429769.11978759.html.plaintext.txt	236	numa suggests different splice variant may exist
0.11429769.11978759.html.plaintext.txt	237	spatial relevance predominant num kb splice variant expressed retina mutation found exon orfnum may explain observed phenotype confined retina
0.11429769.11978759.html.plaintext.txt	238	transfection data emphasize difference expression profile two mutant exon orfnum protein
0.11429769.11978759.html.plaintext.txt	239	vitro xlpranum premature stop mutant behaves similarly wild type protein whereas xlpranum frameshift protein aggregate er compartment
0.11429769.11978759.html.plaintext.txt	240	examining transfection result attach significance presence absence gfp nuclear labeling since may result protein cleavage small proportion construct gfp enters nucleus weak nuclear localization vector
0.11429769.11978759.html.plaintext.txt	241	aggregation xlpranum mutant exon orfnum protein may result additional abnormal residue impair proper folding
0.11429769.11978759.html.plaintext.txt	242	vitro result consistent phenotypic difference found two disease
0.11429769.11978759.html.plaintext.txt	243	based presence retinal transcript exon orfnum normal xlpra mutant retina different phenotype two disease propose xlpranum mutation cause loss function critical visual cell development essential later sustained viability
0.11429769.11978759.html.plaintext.txt	244	contrast xlpranum mutation affect photoreceptors early development devastating consequence retina
0.11429769.11978759.html.plaintext.txt	245	result study highlight importance rpgr exon orfnum photoreceptor function viability
0.11429769.11978759.html.plaintext.txt	246	indicate different retinal phenotype result mutation novel exon situation similar human rpnum family
0.11429769.11978759.html.plaintext.txt	247	finally show value canine model tool available comparative genomic analysis aid understanding gene function disease importance human specie
0.11429769.11978759.html.plaintext.txt	248	canine bac library screening meiotic radiation hybrid rh physical mapping rpcinum canine bac library used httpwww
0.11429769.11978759.html.plaintext.txt	249	canine specific probe tctenuml srpx rpgr otc prepared pcr using degenerate primer purified bac dna digested identify microsatellite marker hybridization
0.11429769.11978759.html.plaintext.txt	250	experimental detail meiotic rh mapping described num
0.11429769.11978759.html.plaintext.txt	251	contig built bac clone positive tctenuml srpx rpgr otc extended end sequencing
0.11429769.11978759.html.plaintext.txt	252	size bac clone determined using noti digestion fingerprinting ecorv separation pulsed field gel electrophoresis
0.11429769.11978759.html.plaintext.txt	253	blast search end internal sequence exon conserved region human dog also used contig assembly
0.11429769.11978759.html.plaintext.txt	254	cloning canine rpgr intron num exon orfnum mutation identification intron num sequence amplified long range pcr forward primer rgfnum intron num num gaaagtaagcatggtctctatccacc num reverse primer rgrnum exon num num caagttcctcagccatatcctctgg num
0.11429769.11978759.html.plaintext.txt	255	num kb pcr product cloned topo xl vector invitrogen carlsbad ca
0.11429769.11978759.html.plaintext.txt	256	mutation analysis flanking primer designed normal sequence used scan mutation pcr condition num degree c num min num cycle num degree c num num degree c num num degree c num min primer pair listed pcr product separated num polyacrylamide gel
0.11429769.11978759.html.plaintext.txt	257	forward primer rgfnum num aaggggaggagaaaggggaggct num
0.11429769.11978759.html.plaintext.txt	258	reverse primer rgrnum num tccctcttcctcctccccttcata num
0.11429769.11978759.html.plaintext.txt	259	reverse primer rgrnum num tcccctacttcctcttccctctca num
0.11429769.11978759.html.plaintext.txt	260	sequencing done taq cycle sequencing using dyedeoxy terminator applied biosystems abi num automated dna sequencer
0.11429769.11978759.html.plaintext.txt	261	electroretinography erg morphology study erg recorded isofluorane anesthetized dog stimulus condition designed enable separate evaluation rod cone mediated response num preparation eyecup morphological examination utilized triple fixation protocol num
0.11429769.11978759.html.plaintext.txt	262	one micrometer section plastic embedded retina extending optic disc superior inferior periphery used analysis
0.11429769.11978759.html.plaintext.txt	263	immunocytochemistry situ hybridization immunocytochemistry done using normal affected retina collected light fixed num paraformaldehyde processed dgd control xlpranum cut num microm num oct control xlpranum cut num microm using standard method
0.11429769.11978759.html.plaintext.txt	264	different antibody rpgr retinal protein used identified target source reference
0.11429769.11978759.html.plaintext.txt	265	rpgr polyclonal rpgr num c terminal num amino acid rpgr partial exon num exon num num num b polyclonal rpgr num human rccnum like domain residue num num coded partial exon num num num c polyclonal dr num target num amino acid coded human rpgr exon num num f
0.11429769.11978759.html.plaintext.txt	266	opsin monoclonal rnum numn num
0.11429769.11978759.html.plaintext.txt	267	pde polyclonal anti mouse num
0.11429769.11978759.html.plaintext.txt	268	rod cgmp channel protein subunit monoclonal anti bovine num
0.11429769.11978759.html.plaintext.txt	269	exception polyclonal rpgr num antibody rpgr antibody required antigen retrieval step heating slide num
0.11429769.11978759.html.plaintext.txt	270	num m citric acid num min microwave num power
0.11429769.11978759.html.plaintext.txt	271	antibody directed exon orfnum polyclonal antibody synthetic peptide human no num num mouse no num num f
0.11429769.11978759.html.plaintext.txt	272	manson used lack specificity data shown
0.11429769.11978759.html.plaintext.txt	273	situ hybridization paraformaldehyde fixeddgd embedded section num microm hybridized antisense sense rna probe prepared linearized exon orfnum plasmid dna
0.11429769.11978759.html.plaintext.txt	274	slide coated kodak ntbnum emulsion exposed num num week num degree c developed stained toluidine blue
0.11429769.11978759.html.plaintext.txt	275	probe synthesized using maxiscript kit ambion austin tx labeled nums utp num cimmol nen life science
0.11429769.11978759.html.plaintext.txt	276	western northern blot western analysis rpgr cytosolic membrane fraction done using antibody rpgr num dr num
0.11429769.11978759.html.plaintext.txt	277	procedure described previously numnum
0.11429769.11978759.html.plaintext.txt	278	retinal tissue homogenized centrifuged separate cytosolic fraction crude pellet containing cell nucleus membrane sonicated centrifuged
0.11429769.11978759.html.plaintext.txt	279	protein num microglane separated num sd page band nylon membrane imobilon visualized using enhanced chemiluminescence western blotting detection kit amersham
0.11429769.11978759.html.plaintext.txt	280	northern analysis method detailed previously num
0.11429769.11978759.html.plaintext.txt	281	twenty microgram total rna separated num agarosenum
0.11429769.11978759.html.plaintext.txt	282	num m formaldehyde gel transferred nylon membrane
0.11429769.11978759.html.plaintext.txt	283	single strand rna probe prepared using maxiscript vitro transcription kit ambion
0.11429769.11978759.html.plaintext.txt	284	pcr product corresponding different part rpgr transcript ligated pcrii topo dual promoter vector invitrogen
0.11429769.11978759.html.plaintext.txt	285	linearized plasmid dna used antisense probe synthesis using numputp
0.11429769.11978759.html.plaintext.txt	286	probe northern analysis made different region rpgr using following pcr primer
0.11429769.11978759.html.plaintext.txt	287	rpgrnum forward num ggcagtaacaactggggtcagttag num
0.11429769.11978759.html.plaintext.txt	288	rpgrnum reverse num ctctccctctctcttcgccgca num
0.11429769.11978759.html.plaintext.txt	289	rgrnum reverse num atctccctgaaggatctgtgccg num
0.11429769.11978759.html.plaintext.txt	290	rpgrnum forward num gacataggtaatgactcaggccag num
0.11429769.11978759.html.plaintext.txt	291	rpgrnum reverse num aatttggacagtatgtgttcggtc num
0.11429769.11978759.html.plaintext.txt	292	rgfnum forward num aagaaccagaggatatggctgagg num
0.11429769.11978759.html.plaintext.txt	293	rgrnum reverse num gtggccttaa ctgttcagtg ttgg num
0.11429769.11978759.html.plaintext.txt	294	genbank accession number exonnuma nucleotidesnum num exon num num nucleotide num num sequence afnum afnum respectively
0.11429769.11978759.html.plaintext.txt	295	transfection expression normal mutant rpgr exon orfnum cosnum cell dmem num fcs penicillin num uml streptomycin num microgml num degree c num conum transfected using num microl fugene num roche added num
0.11429769.11978759.html.plaintext.txt	296	num microg dna green fluorescent protein gfp vector gfp vector containing one three canine orfnum sequence wild type xlpranum xlpranum
0.11429769.11978759.html.plaintext.txt	297	num h incubation cell washed pb fixed methanol num min num degree c
0.11429769.11978759.html.plaintext.txt	298	fixed cell incubated anti golgi clone numk num sigma anti er anti kdel bioquote primary antibody visualized texas red conjugated secondary jackson lab
0.11429769.11978759.html.plaintext.txt	299	slide mounted vectashield vector laboratory inc
0.11429769.11978759.html.plaintext.txt	300	burlingame ca containing dapi num
0.11429769.11978759.html.plaintext.txt	301	footnote correspondence addressed james
0.11429769.11978759.html.plaintext.txt	302	baker institute animal health college veterinary medicine cornell university ithaca ny num usa
0.11429769.11978759.html.plaintext.txt	303	telnum num num fax num num num email gdanumatcornell
0.11429769.11978759.html.plaintext.txt	304	afnum afnum afnum
0.11429769.11978759.html.plaintext.txt	305	num gene rpgr homology rccnum guanine nucleotide exchange factor mutated x linked retinitis pigmentosa rpnum
0.11429769.11978759.html.plaintext.txt	306	num x linked retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	307	num phenotype three swedish family x linked retinitis pigmentosa caused different mutation rpgr gene
0.11429769.11978759.html.plaintext.txt	308	num positional cloning gene x linked retinitis pigmentosa num
0.11429769.11978759.html.plaintext.txt	309	num spectrum mutation rpgr gene identified num family x linked retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	310	num analysis rpgr gene num pedigree retinitis pigmentosa type num genotype paucity mutation coding region splice defect two family
0.11429769.11978759.html.plaintext.txt	311	num mutational hot spot within new rpgr exon x linked retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	312	num retinitis pigmentosa gtpase regulator rpgr deficient mouse model x linked retinitis pigmentosa rpnum
0.11429769.11978759.html.plaintext.txt	313	num retinitis pigmentosa gtpase regulator rpgr interacts delta subunit rod cyclic gmp phosphodiesterase
0.11429769.11978759.html.plaintext.txt	314	num identification novel protein interacting rpgr
0.11429769.11978759.html.plaintext.txt	315	num retinitis pigmentosa gtpase regulator rpgr interacts novel transport like protein outer segment rod photoreceptors
0.11429769.11978759.html.plaintext.txt	316	num retinitis pigmentosa gtpase regulator rpgr interacting protein stably associated photoreceptor ciliary axoneme anchor rpgr connecting cilium
0.11429769.11978759.html.plaintext.txt	317	num sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.11429769.11978759.html.plaintext.txt	318	num disease retinal pigment epithelium photoreceptor complex non rodent animal model
0.11429769.11978759.html.plaintext.txt	319	ed retinal pigment epithelium current aspect function disease
0.11429769.11978759.html.plaintext.txt	320	oxford university press new york pp
0.11429769.11978759.html.plaintext.txt	321	num xlpra canine retinal degeneration inherited x linked trait
0.11429769.11978759.html.plaintext.txt	322	num retinal pathology canine x linked progressive retinal atrophy locus homolog rpnum
0.11429769.11978759.html.plaintext.txt	323	num mapping x linked progressive retinal atrophy xlpra canine homolog retinitis pigmentosa num rpnum
0.11429769.11978759.html.plaintext.txt	324	num fine mapping canine xlpra establishes homology human canine rpnum interval
0.11429769.11978759.html.plaintext.txt	325	num human rnase e like activity cleaves rna sequence involved mrna stability control
0.11429769.11978759.html.plaintext.txt	326	num specific sequence native dna arrest synthesis dna polymerase alpha
0.11429769.11978759.html.plaintext.txt	327	num mutagenesis mammalian cell induced triple helix formation transcription coupled repair
0.11429769.11978759.html.plaintext.txt	328	num william allan memorial award address x chromosome inactivation location expression x linked gene
0.11429769.11978759.html.plaintext.txt	329	num longitudinal study visual function carrier x linked recessive retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	330	ophthalmology num num num
0.11429769.11978759.html.plaintext.txt	331	num rpgr transcription study mouse human tissue reveal retina specific isoform disrupted patient x linked retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	332	num remapping rpnum locus x linked cone rod degeneration xpnum
0.11429769.11978759.html.plaintext.txt	333	num identification de novo insertion rpgr exon orfnum
0.11429769.11978759.html.plaintext.txt	334	num x linked retinitis pigmentosa mutation spectrum rpgr rpnum gene correlation visual function
0.11429769.11978759.html.plaintext.txt	335	num severe manifestation carrier female x linked retinitis pigmentosa
0.11429769.11978759.html.plaintext.txt	336	num dna sequence comparison human mouse retinitis pigmentosa gtpase regulator rpgr identifies tissue specific exon putative regulatory element
0.11429769.11978759.html.plaintext.txt	337	num retinal degeneration dog iv
0.11429769.11978759.html.plaintext.txt	338	early retinal degeneration erd norwegian elkhound
0.11429769.11978759.html.plaintext.txt	339	num differential expression photoreceptor specific protein disease degeneration progressive rod cone degeneration prcd retina
0.11429769.11978759.html.plaintext.txt	340	num anti rhodopsin monoclonal antibody defined specificity characterization application
0.11429769.11978759.html.plaintext.txt	341	num canine rod photoreceptor cgmp gated channel protein alpha subunit study expression gene characterization cdna
0.11429769.11978759.html.plaintext.txt	342	num expression cytosolic phospholipase anum prostaglandin endoperoxide synthase ovine maternal uterine fetal tissue late gestation labor
0.11429769.11978759.html.plaintext.txt	343	endocrinology num num num
0.11429769.11978759.html.plaintext.txt	344	num suppression subtractive hybridization identified marked increase thrombospondin num associated parturition pregnant sheep myometrium
0.11429769.11978759.html.plaintext.txt	345	endocrinology num num num
0.1154272.14871886.html.plaintext.txt	0	reduction circulating anabolic hormone induced sustained sleep deprivation rat carol
0.1154272.14871886.html.plaintext.txt	1	numdepartment neurology medical college wisconsin milwaukee wisconsin num numdepartment pharmacology toxicology university utah health science center salt lake city utah num
0.1154272.14871886.html.plaintext.txt	2	submitted num december num accepted final form num february num
0.1154272.14871886.html.plaintext.txt	3	growth hormone thyroxine prolactin insulin like growth factor leptin corticosterone
0.1154272.14871886.html.plaintext.txt	4	sleep considered critical maintenance health num num numb numa support life num num num
0.1154272.14871886.html.plaintext.txt	5	clinical state associated abnormal sleep include pulmonary cardiovascular disorder cerebrovascular disease thrombotic disease epilepsy arthritis mood disorder chronic pain shortened life span reviewed ref
0.1154272.14871886.html.plaintext.txt	6	physical consequence sleep deprivation localized
0.1154272.14871886.html.plaintext.txt	7	evidence study laboratory animal suggest multitropic factor immune hormonal system contribute absence localization
0.1154272.14871886.html.plaintext.txt	8	three principal consequence prolonged sleep deprivation rat progressively deepening negative energy balance num num num reduced thyroid hormone concentration num num num abnormal control microorganism num
0.1154272.14871886.html.plaintext.txt	9	sleep deprived rat become strikingly progressively hyperphagic gain weight
0.1154272.14871886.html.plaintext.txt	10	negative energy balance due malabsorption calorie num diabetes num may metabolic response infectious process
0.1154272.14871886.html.plaintext.txt	11	abnormal control microorganism discovered detection live pathogenic bacteria normally sterile body tissue num num
0.1154272.14871886.html.plaintext.txt	12	deficiency host defense system earliest clinically biologically significant sign far discovered occurring within five experimental day outward appearance animal healthy metabolic change marked later become
0.1154272.14871886.html.plaintext.txt	13	third principal feature hypothyroxinemia manifested progressive decline thyroxine tnum triiodothyronine tnum tnum eventually reaching level assay detection case num
0.1154272.14871886.html.plaintext.txt	14	average num wk sign result advanced morbidity scrawny feeble appearance decreased food intake peak consumption hypothermia num num primary bacteremia poor absent inflammatory response num subsequent lethality num
0.1154272.14871886.html.plaintext.txt	15	recent finding alteration thyroid hormone sleep deprived rat point brain essential site sleep deprivation effect
0.1154272.14871886.html.plaintext.txt	16	progressive decline plasma tnum sleep deprived rat accompanied increase plasma thyroid stimulating hormone tsh whereas low plasma tnum normally potent stimulant pituitary tsh secretion num
0.1154272.14871886.html.plaintext.txt	17	challenge test tsh release pituitary exogenous administration hypothalamic peptide thyrotropin releasing hormone trh revealed normal stimulated release tsh appropriate increase circulating tnum tnum num
0.1154272.14871886.html.plaintext.txt	18	examination paraventricular nucleus pvn hypothalamus revealed eventual tripling trh transcript level experimental animal suggesting compensatory response low tnum presumably increased negative feedback hypothalamus
0.1154272.14871886.html.plaintext.txt	19	even tsh failed respond increased trh biosynthesis num
0.1154272.14871886.html.plaintext.txt	20	data suggest trh stimulation tsh inhibited one locus sleep deprivation effect trh translation release hypothalamus
0.1154272.14871886.html.plaintext.txt	21	relatively little known regarding neuroendocrine consequence sustained sleep deprivation whether broad pituitary hypothalamic involvement
0.1154272.14871886.html.plaintext.txt	22	one objective present series experiment determine whether chronic sleep deprivation also affect secretion growth hormone gh prolactin prl
0.1154272.14871886.html.plaintext.txt	23	alteration pleiotropic function could provide future avenue discovery sleep deprivation specifically result health consequence
0.1154272.14871886.html.plaintext.txt	24	linkage gh prl secretion non rapid eye movement nrem sleep repeatedly demonstrated human
0.1154272.14871886.html.plaintext.txt	25	plasma peak gh concentration generally coincides sleep onset delayed sleep delayed
0.1154272.14871886.html.plaintext.txt	26	smaller gh peak generally coincide subsequent slow wave sleep phase num num num num
0.1154272.14871886.html.plaintext.txt	27	prl concentration elevated sleep even sleep delayed num
0.1154272.14871886.html.plaintext.txt	28	short term sleep deprivation num num h blunts amplitude major gh secretory period time num num whereas sleep sleep deprivation associated return normal amplitude num num num
0.1154272.14871886.html.plaintext.txt	29	similarly gh pulse rat abolished short term sleep deprivation num h num
0.1154272.14871886.html.plaintext.txt	30	whether abolishment would persist beyond num h whether acute reaction unknown
0.1154272.14871886.html.plaintext.txt	31	proximal hypothalamic mechanism regulating gh secretion pituitary growth hormone releasing hormone ghrh somatostatin somatotropin release inhibiting factor srif operate reciprocal manner
0.1154272.14871886.html.plaintext.txt	32	previous study shown short term sleep deprivation num num h reduce content ghrh hypothalamus num result increased ghrh mrna pvn increased srif mrna arcuate nucleus hypothalamus num
0.1154272.14871886.html.plaintext.txt	33	whether change important hypophysioportal stimulation gh secretion unknown whereas hypothesis exist role regulation sleep behavior num
0.1154272.14871886.html.plaintext.txt	34	furthermore ghrh binding receptor mrna level decreased num hypothalamus rat sleep deprived num h whereas pituitary level remain unchanged
0.1154272.14871886.html.plaintext.txt	35	latter finding interpreted indicating downregulation receptor response ghrh release num
0.1154272.14871886.html.plaintext.txt	36	addition role lactation prl major anabolic hormone cytokine num
0.1154272.14871886.html.plaintext.txt	37	short term sleep deprivation sleep fragmentation human associated lower nocturnal prl level sleep occurs num num
0.1154272.14871886.html.plaintext.txt	38	prl considered sleep promoting laboratory animal num num reduced num num h num h sleep deprivation combined
0.1154272.14871886.html.plaintext.txt	39	confounded constant forced locomotion num
0.1154272.14871886.html.plaintext.txt	40	deficiency prl result grossly reduced immunocompetency laboratory animal num sleep deprived rat share resemblance
0.1154272.14871886.html.plaintext.txt	41	also unknown present whether sustained sleep deprivation affect secretion adipocyte derived hormone leptin act hypothalamus
0.1154272.14871886.html.plaintext.txt	42	leptin endocrine action pleiotropic effect include major role regulation energy balance reviewed ref
0.1154272.14871886.html.plaintext.txt	43	several line evidence suggest link hormone different pathophysiological change resulting sleep deprivation
0.1154272.14871886.html.plaintext.txt	44	example decreased leptin concentration occur decreased fat reserve impairment immunity reviewed ref
0.1154272.14871886.html.plaintext.txt	45	num consequence sleep deprivation
0.1154272.14871886.html.plaintext.txt	46	hand increase leptin secretion associated increased sympathetic activation num elevated metabolic rate num decreased body weight num also produced prolonged sleep deprivation reviewed ref
0.1154272.14871886.html.plaintext.txt	47	leptin also increase response exposure bacterial cell component reviewed ref
0.1154272.14871886.html.plaintext.txt	48	num would expected event resulting bacterial translocation effort control posttranslocation survival sleep deprived animal num
0.1154272.14871886.html.plaintext.txt	49	human substantially reduced leptin concentration found narcoleptic patient abnormal sleep architecture num num mildly reduced leptin concentration found normal subject condition acute sleep reduction num
0.1154272.14871886.html.plaintext.txt	50	objective present study determine whether chronic sleep deprivation change regulation gh prl leptin nature alteration
0.1154272.14871886.html.plaintext.txt	51	effect sleep deprivation determined concentration insulin like growth factor igf principal physiological mediator many gh action concentration corticosterone high level associated endocrine abnormality disease state reviewed ref
0.1154272.14871886.html.plaintext.txt	52	end employed well established procedure producing sleep deprivation num examined effect hormonal secretory pattern interval first two third typical survival period rat time advanced morbidity
0.1154272.14871886.html.plaintext.txt	53	present result indicate abnormally low concentration gh igf prl leptin appropriately increased prl release stimulated
0.1154272.14871886.html.plaintext.txt	54	result provide evidence altered hormonal regulation level hypothalamus implicate suppression anabolic hormone among important health consequence sleep deprivation
0.1154272.14871886.html.plaintext.txt	55	rat anesthetized ketamine hydrochloride num mgkg ip xylazine hydrochloride num
0.1154272.14871886.html.plaintext.txt	56	num mgkg im atropine sulfate num
0.1154272.14871886.html.plaintext.txt	57	supplementary dos ketamine hydrochloride num mgkg ip provided needed
0.1154272.14871886.html.plaintext.txt	58	surgery included implantation cortical eeg muscle electrode electrophysiographic determination sleep stage wakefulness described previously num
0.1154272.14871886.html.plaintext.txt	59	enable repeated sampling blood freely moving animal venous catheter inserted external jugular advanced right atrium described previously num num num
0.1154272.14871886.html.plaintext.txt	60	catheter sutured neck muscle threaded subcutaneously exit scalp back head anchored electrode head plug assembly
0.1154272.14871886.html.plaintext.txt	61	catheter tubing extended along num cm eeg recording cable attached swivel commutator counterbalanced boom assembly permitted daily blood sampling without handling animal
0.1154272.14871886.html.plaintext.txt	62	catheter flushed daily heparinized saline containing small amount ampicillin num
0.1154272.14871886.html.plaintext.txt	63	beginning num day surgery num unit streptokinase num microl heparinized saline infused num mlmin fill catheter lumen procedure reduce occurrence fibrin clot blockage
0.1154272.14871886.html.plaintext.txt	64	rat permitted least num day recovery surgery study
0.1154272.14871886.html.plaintext.txt	65	rat sleep deprived serve yoked comparison housed apparatus described
0.1154272.14871886.html.plaintext.txt	66	week allotted recovery rat fed ad libitum balanced purified diet isocaloric normal augmented protein num
0.1154272.14871886.html.plaintext.txt	67	num mineral fiber vitamin num
0.1154272.14871886.html.plaintext.txt	68	num calg metabolizable energy used previous study comparison num num num
0.1154272.14871886.html.plaintext.txt	69	food water intake body weight recorded daily
0.1154272.14871886.html.plaintext.txt	70	special food tube waste receptacle afforded accurate measurement food consumption num
0.1154272.14871886.html.plaintext.txt	71	ambient light constant diminish influence circadian rhythm factor study num
0.1154272.14871886.html.plaintext.txt	72	ambient temperature kept constant num degree c within thermoneutral zone rat num mean thermostatically controlled heat lamp
0.1154272.14871886.html.plaintext.txt	73	procedure producing sleep deprivation yoked control
0.1154272.14871886.html.plaintext.txt	74	experimental apparatus procedure used present experiment bergmann rechtschaffen method num subsequent minor modification
0.1154272.14871886.html.plaintext.txt	75	method validated selectivity sleep deprivation num num num num num feature benign arousal stimulus freedom movement comparison condition partial full sleep opportunity described detail illustrated elsewhere num num
0.1154272.14871886.html.plaintext.txt	76	briefly two animal housed identical experimental condition either side large round platform num cm diameter divided plexiglas wall
0.1154272.14871886.html.plaintext.txt	77	one rat designated sleep deprivation rat designated yoked animal subjected experimental variable yet allowed opportunity sleep
0.1154272.14871886.html.plaintext.txt	78	beneath around platform shallow water serf soft boundary
0.1154272.14871886.html.plaintext.txt	79	rat almost always avoid water stay platform eat sleep explore normally
0.1154272.14871886.html.plaintext.txt	80	recording eeg variable rat freely moving condition accomplished connecting long recording cable attached head electrode assembly num degree commutator counterbalanced boom assembly
0.1154272.14871886.html.plaintext.txt	81	num day period basal measurement platform rotated one time per hour num acquaint rat platform movement
0.1154272.14871886.html.plaintext.txt	82	method produce consistent amount sleep reduction study num num num num
0.1154272.14871886.html.plaintext.txt	83	baseline condition sleep occurs average num time
0.1154272.14871886.html.plaintext.txt	84	sleep comprises num nrem sleep comparable human stage num num num paradoxical sleep p also known rapid eye movement sleep
0.1154272.14871886.html.plaintext.txt	85	baseline period experimental period begin
0.1154272.14871886.html.plaintext.txt	86	detection sleep onset sleep deprived rat programmed microprocessing amplitude change cortical eeg cortical theta electromyographic variable result num forced locomotion rat sufficient produce arousal
0.1154272.14871886.html.plaintext.txt	87	repeated upon subsequent sleep onset sleep deprived rat resulting wakefulness sustained num total time
0.1154272.14871886.html.plaintext.txt	88	num time consists mostly transitional sleep fragmented high amplitude nrem sleep
0.1154272.14871886.html.plaintext.txt	89	p comprises num total time
0.1154272.14871886.html.plaintext.txt	90	yoked rat may sleep platform stationery sleep deprived rat engaged behavior trying sleep
0.1154272.14871886.html.plaintext.txt	91	yoked animal awake num time obtain nrem p sleep num num total time respectively
0.1154272.14871886.html.plaintext.txt	92	yoked animal frequently awakened asleep sleep normally occupies num time yoked rat paired sleep deprived rat may fall asleep thus triggering platform rotation
0.1154272.14871886.html.plaintext.txt	93	yoked rat therefore partially sleep deprived usually exhibit several sign direction sleep deprived rat degree e
0.1154272.14871886.html.plaintext.txt	94	yoked animal considered important showing severe morbidity death sleep deprived rat due experimental condition extraneous sleep loss matched group num
0.1154272.14871886.html.plaintext.txt	95	addition yoked rat viewed comprising part dose response curve wherein partial sleep deprivation intermediate sleep loss total sleep loss
0.1154272.14871886.html.plaintext.txt	96	eight set experiment one pair sleep deprived yoked rat carried determination plasma igf leptin corticosterone change food intake body weight
0.1154272.14871886.html.plaintext.txt	97	subset four experiment serial blood sampling protocol followed determination basal stimulated prl secretion characteristic pulsatile gh secretion
0.1154272.14871886.html.plaintext.txt	98	duration experiment num num wk period included least num day recovery surgery num day baseline condition num experimental day
0.1154272.14871886.html.plaintext.txt	99	addition operated animal intended serve back animal apparatus postsurgery recovery period catheter become nonpatent one first two rat
0.1154272.14871886.html.plaintext.txt	100	five animal used purpose continued study home cage animal determination plasma igf leptin corticosteroid change food intake body weight
0.1154272.14871886.html.plaintext.txt	101	home cage control animal subjected daily procedure rat housed apparatus except housed cylindrical cage num cm od num cm high permitted uninterrupted sleep
0.1154272.14871886.html.plaintext.txt	102	general procedure sampling blood measurement blood hormone concentration
0.1154272.14871886.html.plaintext.txt	103	blood specimen collected starting time day according rotating schedule permitted determination factor study interval across baseline experimental period
0.1154272.14871886.html.plaintext.txt	104	igf leptin corticosterone determined one time consecutive num day interval experimental period whereas pulsatile gh basal stimulated prl release determined weekly
0.1154272.14871886.html.plaintext.txt	105	briefly small amount blood aspirated clear catheter clot initial num unit heparin num
0.1154272.14871886.html.plaintext.txt	106	num ml heparin whole blood withdrawn discarded
0.1154272.14871886.html.plaintext.txt	107	blood sample drawn placed microcentrifuge tube ice
0.1154272.14871886.html.plaintext.txt	108	volume drawn replaced equivalent volume heparinized saline injected catheter minimize hypovolemia
0.1154272.14871886.html.plaintext.txt	109	specimen centrifuged cold numnum g num min plasma pipetted chilled microcentrifuge tube subsequent storage num degree c
0.1154272.14871886.html.plaintext.txt	110	help prevent anemia red blood cell rbc resuspended heparinized saline injected catheter flushed heparinized saline
0.1154272.14871886.html.plaintext.txt	111	general protocol applied plasma sample stored determination igf leptin corticosterone elaborated protocol described
0.1154272.14871886.html.plaintext.txt	112	determination major gh secretory period
0.1154272.14871886.html.plaintext.txt	113	basal pulsatile gh assessed subset four sleep deprived yoked pair mean blood collection animal every num min across num h period num num
0.1154272.14871886.html.plaintext.txt	114	previous study determined gh secretory pattern affected constant illumination num
0.1154272.14871886.html.plaintext.txt	115	protocol determination gh secretory pulse sleep deprived yoked rat conducted one time num day baseline period num num day interval experimental period
0.1154272.14871886.html.plaintext.txt	116	total amount blood drawn rat num
0.1154272.14871886.html.plaintext.txt	117	num mlh volume rbc replacement given throughout num h period
0.1154272.14871886.html.plaintext.txt	118	blood collected day sampling gh secretory episode
0.1154272.14871886.html.plaintext.txt	119	determination basal prl secretory period stimulated prl release
0.1154272.14871886.html.plaintext.txt	120	prl secretion exhibit low amplitude pulsatility num num therefore measurement integrated time better reflect basal prl secretion singular determination
0.1154272.14871886.html.plaintext.txt	121	blood sampled six time num min interval num min period based data lopez et al
0.1154272.14871886.html.plaintext.txt	122	num prl pulse last num num min would expected occur every num min
0.1154272.14871886.html.plaintext.txt	123	protocol conducted subset experiment major gh secretory period determined different day baseline period one time per week experimental period
0.1154272.14871886.html.plaintext.txt	124	total volume blood drawn protocol num
0.1154272.14871886.html.plaintext.txt	125	num ml volume rbc replacement
0.1154272.14871886.html.plaintext.txt	126	prl challenge test intravenous trh bolus injection completed one time baseline period one time per week experimental period experimental subgroup
0.1154272.14871886.html.plaintext.txt	127	blood sampled immediately num num num min intravenous administration trh num microgkg based previous study num num
0.1154272.14871886.html.plaintext.txt	128	total volume blood drawn num
0.1154272.14871886.html.plaintext.txt	129	num ml volume rbc replacement
0.1154272.14871886.html.plaintext.txt	130	gh prl antiserum reference hormone provided dr
0.1154272.14871886.html.plaintext.txt	131	parlow national hormone pituitary program national institute diabetes digestive kidney disease
0.1154272.14871886.html.plaintext.txt	132	low detection limit gh assay num
0.1154272.14871886.html.plaintext.txt	133	num pgml high detection limit num num pgml
0.1154272.14871886.html.plaintext.txt	134	low high sensitivity prl num
0.1154272.14871886.html.plaintext.txt	135	intra assay coefficient variation cv gh prl num
0.1154272.14871886.html.plaintext.txt	136	determination basal plasma igf leptin corticosteroid performed using commercial ria enzyme immunoassay kit
0.1154272.14871886.html.plaintext.txt	137	sensitivity range igf num num ngml diagnostic system laboratory webster tx
0.1154272.14871886.html.plaintext.txt	138	intra interassay cv num
0.1154272.14871886.html.plaintext.txt	139	low high detection limit leptin num
0.1154272.14871886.html.plaintext.txt	140	num num ngml linco research st
0.1154272.14871886.html.plaintext.txt	141	charles mo intra interassay cv num num respectively
0.1154272.14871886.html.plaintext.txt	142	low high detection limit corticosterone num numnum ngml diagnostic system laboratory intra interassay cv num num respectively
0.1154272.14871886.html.plaintext.txt	143	determination made duplicate
0.1154272.14871886.html.plaintext.txt	144	value fell range assay detection set equal lower upper limit sensitivity respectively
0.1154272.14871886.html.plaintext.txt	145	apart baseline period data rat experimental period truncated num day experimental condition continued longer
0.1154272.14871886.html.plaintext.txt	146	permitted value igf leptin corticosterone food intake change body weight partitioned four consecutive num day interval
0.1154272.14871886.html.plaintext.txt	147	data averaged across num day interval rat averaged within interval experimental group
0.1154272.14871886.html.plaintext.txt	148	data compared mean unbalanced two way repeated measure anova
0.1154272.14871886.html.plaintext.txt	149	one yoked subject eliminated study electrode assembly became detached skull resulting imbalance number subject per group
0.1154272.14871886.html.plaintext.txt	150	occasionally missing value within subject across time typically result indwelling catheter nonpatency day blood collection particular factor insufficient specimen volume analysis
0.1154272.14871886.html.plaintext.txt	151	missing value given num day bin replaced interpolation extrapolation isolated instance
0.1154272.14871886.html.plaintext.txt	152	interpolation extrapolation limited two num yoked num home cage data point leptin igf one data point corticosterone
0.1154272.14871886.html.plaintext.txt	153	subject value excluded toto given analysis two num day value missing
0.1154272.14871886.html.plaintext.txt	154	exclusion included one yoked rat determination leptin igf one sleep deprived rat determination food intake one animal sleep deprived yoked home cage group analysis corticosterone
0.1154272.14871886.html.plaintext.txt	155	analysis statistical significance considered p num
0.1154272.14871886.html.plaintext.txt	156	post hoc comparison performed mean student test
0.1154272.14871886.html.plaintext.txt	157	comparison included analysis change group particular time point baseline specific num day interval group particular time point
0.1154272.14871886.html.plaintext.txt	158	paired test used possible comparison unpaired mean performed occasion data could paired exclusion subject
0.1154272.14871886.html.plaintext.txt	159	nonsignificant statistical difference designated significant
0.1154272.14871886.html.plaintext.txt	160	variance given mean plus minus se unless specifically noted mean plus minus sd
0.1154272.14871886.html.plaintext.txt	161	characteristic gh pulsatile secretion analyzed ultra statistical algorithm separate small peak background variation according guideline described van cauter num
0.1154272.14871886.html.plaintext.txt	162	ultra cv assay used determine whether increment decrement chronological data point within range expected variation
0.1154272.14871886.html.plaintext.txt	163	number cv used determines threshold significant change typically two three cv applied num
0.1154272.14871886.html.plaintext.txt	164	way increment decrement hormonal concentration may considered part pulse value criterion threshold assay variability thus limiting false positive pulse
0.1154272.14871886.html.plaintext.txt	165	analysis used three time cv radioactive count per minute ranged num
0.1154272.14871886.html.plaintext.txt	166	num constant algorithm signifying significant change previous subsequent value across value within particular assay
0.1154272.14871886.html.plaintext.txt	167	characterization gh prl secretion based following parameter given lafuente et al
0.1154272.14871886.html.plaintext.txt	168	num num minimum maximum value observed num integrative value average value sample collected period observation num absolute amplitude difference concentration peak minimum value num relative amplitude ratio absolute amplitude minimum value
0.1154272.14871886.html.plaintext.txt	169	pulse gh detected ultra additionally assessed frequency instance two peak captured num h sampling period
0.1154272.14871886.html.plaintext.txt	170	parameter characterizing prl gh concentration compared priori student test p num
0.1154272.14871886.html.plaintext.txt	171	num considered statistically significant
0.1154272.14871886.html.plaintext.txt	172	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	173	mean percentage change mean plus minus se individual baseline value food intake body weight b sleep deprived food intake n num body weight n num yoked n num operated home cage control n num rat num day interval experimental period
0.1154272.14871886.html.plaintext.txt	174	basal gh igf concentration
0.1154272.14871886.html.plaintext.txt	175	basal gh secretion determined analysis blood specimen collected every num min num h period four sleep deprived four yoked animal baseline four sleep deprived three yoked animal day num num four sleep deprived two yoked animal day num num experimental period
0.1154272.14871886.html.plaintext.txt	176	different group number reflect varying success maintaining catheter patency num day surgery
0.1154272.14871886.html.plaintext.txt	177	num num data point comprising secretory gh profile analyzed missing value replaced interpolation
0.1154272.14871886.html.plaintext.txt	178	analysis gh secretory period revealed near abolishment major gh peak sleep deprived rat
0.1154272.14871886.html.plaintext.txt	179	representative profile gh secretory period baseline experimental period shown yoked rat sleep deprived rat fig
0.1154272.14871886.html.plaintext.txt	180	baseline period high amplitude gh peak
0.1154272.14871886.html.plaintext.txt	181	num ngml num maximal value measured detected eight animal occasional intermediate peak
0.1154272.14871886.html.plaintext.txt	182	num num ngml additionally detected animal
0.1154272.14871886.html.plaintext.txt	183	pulse detected baseline num considered large pulse num ngml num considered intermediate num considered small num ngml
0.1154272.14871886.html.plaintext.txt	184	experimental period sleep deprived rat high amplitude pulse one intermediate amplitude pulse single individual observed
0.1154272.14871886.html.plaintext.txt	185	remaining num pulse considered small
0.1154272.14871886.html.plaintext.txt	186	contrast large pulse continued observed yoked subject time point comprised num pulse
0.1154272.14871886.html.plaintext.txt	187	overall frequency pulse determined using ultra regardless amplitude appreciably different among condition
0.1154272.14871886.html.plaintext.txt	188	per num h period study num
0.1154272.14871886.html.plaintext.txt	189	num sd pulse baseline condition compared num
0.1154272.14871886.html.plaintext.txt	190	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	191	pulsatile growth hormone gh concentration representative case yoked animal sleep deprived animal paired together experimental condition baseline period week num num experimental period
0.1154272.14871886.html.plaintext.txt	192	data truncated num num h purpose illustration show peak concentration
0.1154272.14871886.html.plaintext.txt	193	major gh secretory period abolished rat totally sleep deprived
0.1154272.14871886.html.plaintext.txt	194	four eight animal displayed one high amplitude gh pulse num h time frame blood sampling baseline condition sleep deprivation thus allowed calculation frequency major gh secretory episode animal
0.1154272.14871886.html.plaintext.txt	195	baseline peak peak interpulse interval high amplitude gh episode five animal num
0.1154272.14871886.html.plaintext.txt	196	num sd h n num experimental period yoked animal num
0.1154272.14871886.html.plaintext.txt	197	num sd h n num considered equivalent previous investigation animal model num num
0.1154272.14871886.html.plaintext.txt	198	comparison could made sleep deprived animal high amplitude pulse uniformly abolished experimental period
0.1154272.14871886.html.plaintext.txt	199	average gh value determination num h sampling period integrative measurement gh secretion fig
0.1154272.14871886.html.plaintext.txt	200	sleep deprived animal displayed significant decrease gh concentration experimental period compared baseline period week num paired tnum num
0.1154272.14871886.html.plaintext.txt	201	num compared yoked animal week num unpaired tnum num
0.1154272.14871886.html.plaintext.txt	202	decrease baseline gh concentration week num num sleep deprived animal num yoked animal yoked animal statistically different baseline
0.1154272.14871886.html.plaintext.txt	203	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	204	integrative gh concentration expressed average value gh determined num consecutive blood sample collected num h sampling period mean plus minus se baseline experimental condition sleep deprived rat n num bar yoked rat n num baseline n num week num n num week num
0.1154272.14871886.html.plaintext.txt	205	comparison statistically significant baseline week num num sleep deprived rat sleep deprived rat yoked rat week num num
0.1154272.14871886.html.plaintext.txt	206	significant decrease plasma igf concentration sleep deprived rat shown fig
0.1154272.14871886.html.plaintext.txt	207	num consistent absence high amplitude pulse overall suppression gh concentration
0.1154272.14871886.html.plaintext.txt	208	concentration plasma igf significantly lower sleep deprived rat compared yoked rat fnumnum num
0.1154272.14871886.html.plaintext.txt	209	num home cage rat fnumnum num
0.1154272.14871886.html.plaintext.txt	210	yoked animal group show suppression igf time except insofar igf concentration elevated home cage animal percent change baseline yoked v
0.1154272.14871886.html.plaintext.txt	211	num sleep permitted ad libitum positive correlation igf concentration body weight r num
0.1154272.14871886.html.plaintext.txt	212	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	213	change plasma igf expressed percent change individual value grouped baseline mean plus minus se sleep deprived n num yoked n num operated home cage n num rat baseline consecutive num day interval experimental period
0.1154272.14871886.html.plaintext.txt	214	group difference sleep deprived yoked sleep deprived home cage yoked home cage statistically significant num way repeated measure anova
0.1154272.14871886.html.plaintext.txt	215	basal stimulated prl concentration
0.1154272.14871886.html.plaintext.txt	216	basal prl secretion determined animal subset baseline week num
0.1154272.14871886.html.plaintext.txt	217	day num num week num day num num experimental period sampling blood six time num min period
0.1154272.14871886.html.plaintext.txt	218	four animal comprised result group except last time period three animal comprised yoked group due nonpatency one catheter
0.1154272.14871886.html.plaintext.txt	219	resulting baseline value plus minus sd num animal comparable previous report male rat num num minimum num
0.1154272.14871886.html.plaintext.txt	220	week num num experimental period sleep deprived rat showed significant decrease baseline average prl concentration compared yoked rat week num num num tailed paired test num
0.1154272.14871886.html.plaintext.txt	221	week num sleep deprived animal also displayed significant decrease maximum prl value expressed percentage change baseline num
0.1154272.14871886.html.plaintext.txt	222	num mean plus minus sd compared num
0.1154272.14871886.html.plaintext.txt	223	num mean plus minus sd yoked animal paired tnum num
0.1154272.14871886.html.plaintext.txt	224	also week num sleep deprived animal showed significant percentage decrease baseline absolute prl amplitude num
0.1154272.14871886.html.plaintext.txt	225	num mean plus minus sd compared num
0.1154272.14871886.html.plaintext.txt	226	num mean plus minus sd yoked animal paired tnum num
0.1154272.14871886.html.plaintext.txt	227	decrease prl parameter suggest diminished secretion lower amplitude sleep deprivation
0.1154272.14871886.html.plaintext.txt	228	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	229	mean percentage change plus minus se individual baseline value prolactin average value across num min observation period sleep deprived n num yoked n num baseline week num n num week num rat week num num experimental period
0.1154272.14871886.html.plaintext.txt	230	statistical significance group
0.1154272.14871886.html.plaintext.txt	231	stimulated release prl trh administration assessed measurement prl plasma collected num num num min trh administration
0.1154272.14871886.html.plaintext.txt	232	four animal comprised result group except last time period two animal comprised yoked group nonpatency two catheter
0.1154272.14871886.html.plaintext.txt	233	data yoked subject week num insufficient statistical test shown comparison
0.1154272.14871886.html.plaintext.txt	234	absolute relative amplitude time num peak concentration differ sleep deprived rat compared baseline yoked animal
0.1154272.14871886.html.plaintext.txt	235	relative amplitude shown fig
0.1154272.14871886.html.plaintext.txt	236	average value prl num min trh stimulation significantly changed baseline num plus minus num mean plus minus sd week num paired tnum num
0.1154272.14871886.html.plaintext.txt	237	num num plus minus num mean plus minus sd week num paired tnum num
0.1154272.14871886.html.plaintext.txt	238	average value prl yoked rat trh stimulation showed strong tendency toward decreased amount compared baseline value
0.1154272.14871886.html.plaintext.txt	239	two yoked animal showed higher post trh average prl value week num compared individual baseline value occur sleep deprived animal studied
0.1154272.14871886.html.plaintext.txt	240	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	241	change plasma prolactin prl concentration bolus dose thyrotropin releasing hormone trh
0.1154272.14871886.html.plaintext.txt	242	change expressed ratio change amplitude relative pre trh concentration mean plus minus se b average value prl num min poststimulation period mean plus minus se
0.1154272.14871886.html.plaintext.txt	243	group mean shown sleep deprived n num yoked n num baseline week num n num week num experimental period rat
0.1154272.14871886.html.plaintext.txt	244	statistical significance group
0.1154272.14871886.html.plaintext.txt	245	plasma leptin corticosterone concentration
0.1154272.14871886.html.plaintext.txt	246	leptin concentration suppressed early continuously sleep deprived yoked animal compared operated home cage control percent change group x time interaction sleep deprived v
0.1154272.14871886.html.plaintext.txt	247	num sleep deprived yoked animal differ
0.1154272.14871886.html.plaintext.txt	248	average leptin value across num day interval sleep deprived yoked animal num
0.1154272.14871886.html.plaintext.txt	249	operated comparison animal showed evidence increased leptin concentration correspond postsurgery weight gain increasing adiposity r num
0.1154272.14871886.html.plaintext.txt	250	significant difference plasma corticosterone concentration found group interaction group time
0.1154272.14871886.html.plaintext.txt	251	absolute concentration corticosterone baseline consecutive num day interval experimental period shown fig
0.1154272.14871886.html.plaintext.txt	252	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	253	change plasma leptin expressed percent change individual value grouped baseline mean plus minus se sleep deprived n num yoked n num operated home cage n num rat baseline consecutive num day interval experimental period
0.1154272.14871886.html.plaintext.txt	254	group comparison sleep deprived yoked group home cage group statistically significant num way repeated measure anova
0.1154272.14871886.html.plaintext.txt	255	view larger version numk fig
0.1154272.14871886.html.plaintext.txt	256	mean basal plasma corticosteroid concentration mean plus minus se sleep deprived n num yoked n num operated home cage n num rat baseline consecutive num day interval experimental period
0.1154272.14871886.html.plaintext.txt	257	group difference group x time interaction statistically significant
0.1154272.14871886.html.plaintext.txt	258	gh secretion assessed measurement major gh secretory period subgroup sleep deprived yoked comparison studied intensive blood sampling protocol freely moving condition
0.1154272.14871886.html.plaintext.txt	259	sleep deprived animal showed diminished circulating gh prevailing absence major secretory gh burst observed baseline period
0.1154272.14871886.html.plaintext.txt	260	igf considered main effector molecule gh secretion many tissue also consistently suppressed sleep deprived rat num num throughout num day interval observation concomitant robust food intake
0.1154272.14871886.html.plaintext.txt	261	measurement circulating igf level well nourished subject believed reflect num h secretion gh pituitary gland reviewed ref
0.1154272.14871886.html.plaintext.txt	262	yoked animal partial sleep deprivation condition showed strong tendency overall decrease baseline gh concentration showed evidence relatively well preserved major gh secretory period high amplitude pulse relatively unchanged duration frequency
0.1154272.14871886.html.plaintext.txt	263	taken together result provide evidence diminished gh availability effector activity periphery totally sleep deprived rat
0.1154272.14871886.html.plaintext.txt	264	prl gh share num homology gh substitute prl deficiency extent reviewed ref
0.1154272.14871886.html.plaintext.txt	265	sleep deprived animal also showed large reduction num basal circulating prl first day sleep deprivation maintenance suppressed concentration experimental period
0.1154272.14871886.html.plaintext.txt	266	comparison yoked animal partial sleep deprivation variously affected individual instance sometimes increased prl concentration
0.1154272.14871886.html.plaintext.txt	267	challenge test pituitary secretion prl trh administration yielded initial prl response proportional normal sleep deprived yoked rat
0.1154272.14871886.html.plaintext.txt	268	however total amount poststimulation prl secreted num min significantly le sleep deprived rat baseline period reflecting diminished basal concentration
0.1154272.14871886.html.plaintext.txt	269	yoked animal condition partial sleep deprivation tended show direction change post trh prl concentration totally sleep deprived rat
0.1154272.14871886.html.plaintext.txt	270	experimental group sleep deprived rat partially sleep deprived yoked rat showed significant reduction circulating leptin concentration
0.1154272.14871886.html.plaintext.txt	271	finding effectively ruled hyperleptinemia plausible mediator sleep deprivation sign activation sympathetic nervous system increased energy expenditure loss weight suppression igf
0.1154272.14871886.html.plaintext.txt	272	rather plasma level leptin appeared reflect energy store became inadequate eventually manifested animal increased food consumption failure gain weight
0.1154272.14871886.html.plaintext.txt	273	leptin considered critical peripheral hormonal signal status body energy store brain function within long term homeostatic system balancing food intake energy expenditure requiring time gear adaptive response negative energy balance reviewed ref
0.1154272.14871886.html.plaintext.txt	274	low leptin increased corticosterone concentration reciprocal response negative energy balance starvation reviewed ref
0.1154272.14871886.html.plaintext.txt	275	num experimentally induced insulin deficient diabetes num
0.1154272.14871886.html.plaintext.txt	276	state increased glucocorticoid known alter function carried hypothalamic pituitary axis suppress immunity reviewed ref
0.1154272.14871886.html.plaintext.txt	277	present result suggest reciprocal relationship associated circumstance extend de facto sleep deprived state
0.1154272.14871886.html.plaintext.txt	278	rat rendered diabetic num rat fasted num num h num num num increase corticosterone typically three fivefold
0.1154272.14871886.html.plaintext.txt	279	rat study behavioral stress increase corticosterone ninefold num num prl increased num
0.1154272.14871886.html.plaintext.txt	280	comparison present study sleep deprived rat showed mild tendency increased corticosteroid concentration num recorded various time two group
0.1154272.14871886.html.plaintext.txt	281	result replicates previous finding num num corroborates mild unchanged value found result human study selective sleep deprivation num num num
0.1154272.14871886.html.plaintext.txt	282	although change corticosteroid receptor sensitivity catabolism yet ruled corticosterone concentration sleep deprived rat appears consistent may expected mobilize fuel support metabolic cellular requirement
0.1154272.14871886.html.plaintext.txt	283	hypothalamic pituitary adrenal axis thus appear overactivated implying corticosterone modulatory role either suppression anabolic hormone suppression immunity sleep deprived rat
0.1154272.14871886.html.plaintext.txt	284	study necessary characterize mechanism underlying suppression gh prl igf leptin elucidated present study inappropriately low tsh shown previously num num
0.1154272.14871886.html.plaintext.txt	285	however several line evidence suggest hypothalamus primary locus affected sleep deprivation possible secondary pituitary involvement
0.1154272.14871886.html.plaintext.txt	286	example normal condition decrease igf associated increase gh release via long negative feedback loop brain reviewed ref
0.1154272.14871886.html.plaintext.txt	287	specific feedback mechanism igf gh mechanism hypothalamus well elucidated believed involve increased inhibitory tone srif reduced ghrh reviewed ref
0.1154272.14871886.html.plaintext.txt	288	num normally operate reciprocal manner regulate gh secretion
0.1154272.14871886.html.plaintext.txt	289	reduced igf negative feedback hypothalamus fail increase gh would suggest increased srif tone andor decreased ghrh
0.1154272.14871886.html.plaintext.txt	290	evidence consistent framework finding gardi et al
0.1154272.14871886.html.plaintext.txt	291	num short term sleep deprivation rat reduces amount ghrh tends increase amount srif hypothalamus finding toppila et al
0.1154272.14871886.html.plaintext.txt	292	num show increase srif mrna arcuate nucleus short term sleep deprivation
0.1154272.14871886.html.plaintext.txt	293	prl different pituitary hormone target organ supply feedback hormone
0.1154272.14871886.html.plaintext.txt	294	primary influence prl secretion inhibition hypothalamus
0.1154272.14871886.html.plaintext.txt	295	present study absolute concentration prl diminished sleep deprived rat yet exogenous stimulation hypothalamic peptide trh led prl response comparable relative amplitude baseline comparison condition suggesting prl synthesis storage primary reason low circulating prl
0.1154272.14871886.html.plaintext.txt	296	finding consistent previous study showed appropriate pituitary response tsh release trh administration num point insufficient stimulation pituitary sleep deprivation manner would resulted maintenance normal peripheral prl concentration
0.1154272.14871886.html.plaintext.txt	297	possible decrease circulating leptin consequent sleep deprivation induced negative energy balance contributes reduction gh prl secretion inappropriately low tsh concentration associated hypothyroxinemia
0.1154272.14871886.html.plaintext.txt	298	leptin exerts negative feedback directly hypothalamus reviewed ref
0.1154272.14871886.html.plaintext.txt	299	low circulating leptin condition negative energy balance induced experimental mean potent signal increased mrna expression secretion neuropeptide y agouti related peptide hypothalamus reduced signaling melanocyte stimulating hormone precursor proopiomelanocortin reviewed ref
0.1154272.14871886.html.plaintext.txt	300	change relevant determining mediation increased food intake causal direction altered regulation neuroendocrine peptide development negative energy balance
0.1154272.14871886.html.plaintext.txt	301	diminished leptin associated abolition gh secretory peak administration leptin associated restoration peak num affecting ghrh srif num
0.1154272.14871886.html.plaintext.txt	302	similarly decreased leptin resulting food deprivation associated decreased circulating thyroid hormone prl administration leptin condition revers hormonal change num num num num
0.1154272.14871886.html.plaintext.txt	303	however present result suggest leptin may necessary sufficient factor reduction hormone since partially sleep deprived rat showed equivalent reduction leptin secretion le interference pituitary hormone secretion
0.1154272.14871886.html.plaintext.txt	304	growing body evidence indicates central integration leptin signaling central control leptin concentration
0.1154272.14871886.html.plaintext.txt	305	hormonal change sleep deprived rat may viewed either dysfunctional adaptive response
0.1154272.14871886.html.plaintext.txt	306	one hand abundant evidence disease central locus hypothalamic dysfunction produce peripheral effect change neuroendocrine regulation reviewed ref
0.1154272.14871886.html.plaintext.txt	307	hand low leptin suppression anabolic hormone may viewed adaptive response negative energy balance evidenced progressive food intake body weight change sleep deprived rat
0.1154272.14871886.html.plaintext.txt	308	suggestion central effect sleep deprivation considered dysfunctional rather adaptive come example contrast sleep deprived starved rat
0.1154272.14871886.html.plaintext.txt	309	quite opposite starved rat decline tnum tnum sleep deprived rat consistent metabolic activation downregulation
0.1154272.14871886.html.plaintext.txt	310	ratio tnum tnum dramatically increased num indicating strong preference metabolically active form thyroid hormone without increase reverse tnum metabolically inactive pathway
0.1154272.14871886.html.plaintext.txt	311	also contrast starvation sleep deprivation associated num fold increase tnum tnum conversion enzyme num deiodinase type ii brown adipose tissue num consistent experimental hypothyroidism num num suggesting central change regulation anabolic hormone produce state peripheral mechanism show activity consistent compensation
0.1154272.14871886.html.plaintext.txt	312	clinical implication suppression hormone based many pleiotropic action
0.1154272.14871886.html.plaintext.txt	313	deficiency prl induced hypophysectomy reduces circulating prl num control value associated normocytic anemia grossly reduced immunocompetence decreased body weight several abnormality num shared sleep deprived animal
0.1154272.14871886.html.plaintext.txt	314	gh widespread effect growth metabolism tissue including increasing dna rna protein synthesis mitosis reviewed ref
0.1154272.14871886.html.plaintext.txt	315	suppression leptin would expected extend beyond effect energy balance include numerous effect
0.1154272.14871886.html.plaintext.txt	316	example leptin deficient obob mouse show many endocrine metabolic abnormality including decreased body temperature immune defect reviewed ref
0.1154272.14871886.html.plaintext.txt	317	decrease igf would expected diminish many effector function include autocrine paracrine growth factor mediation mitosis differentiation chemotaxis apoptosis many tissue reviewed ref
0.1154272.14871886.html.plaintext.txt	318	administration igf burn injury improves body weight gut mucosal weight stimulates mucosal dna protein content reduces incidence bacterial translocation num
0.1154272.14871886.html.plaintext.txt	319	endocrine immune system intricately linked hormonal change may contributing decreased resistance infectious disease animal model
0.1154272.14871886.html.plaintext.txt	320	deficiency gh igf prl thyroid hormone leptin induced sleep deprivation affect health provide one explanation absence localization specific sleep deprivation effect
0.1154272.14871886.html.plaintext.txt	321	low basal prl lack reciprocal relationship igf gh leptin corticosterone point hypothalamus locus sleep deprivation effect key factor interact presentation integrated signal pituitary
0.1154272.14871886.html.plaintext.txt	322	acknowledgment express appreciation christa d
0.1154272.14871886.html.plaintext.txt	323	laatsch jason scott technical assistance
0.1154272.14871886.html.plaintext.txt	324	footnote address reprint request correspondence c
0.1154272.14871886.html.plaintext.txt	325	everson medical college wisconsin neurology research num va medical center bldg
0.1154272.14871886.html.plaintext.txt	326	num d num num west national ave
0.1154272.14871886.html.plaintext.txt	327	milwaukee wi num e mail ceversonatmcw
0.1154272.14871886.html.plaintext.txt	328	cost publication article defrayed part payment page charge
0.1154272.14871886.html.plaintext.txt	329	article must therefore hereby marked advertisement accordance num u
0.1154272.14871886.html.plaintext.txt	330	section num solely indicate fact
0.119480975.15905320.html.plaintext.txt	0	sex difference response melanin concentrating hormone neuron lateral hypothalamic area glucose revealed expression phosphorylated cyclic adenosine numnum monophosphate response element binding protein kazutaka mogi toshiya funabashi dai mitsushima hiroko hagiwara fukuko kimura
0.119480975.15905320.html.plaintext.txt	1	department neuroendocrinology k
0.119480975.15905320.html.plaintext.txt	2	yokohama city university graduate school medicine kanazawa ku yokohama num num international university health welfare f
0.119480975.15905320.html.plaintext.txt	3	amity nogizaka minamiaoyama minato ku tokyo num num japan
0.119480975.15905320.html.plaintext.txt	4	address correspondence request reprint dr
0.119480975.15905320.html.plaintext.txt	5	toshiya funabashi department neuroendocrinology yokohama city university graduate school medicine num num fukuura kanazawa ku yokohama num num japan
0.119480975.15905320.html.plaintext.txt	6	recent study identified distinct neuron lateral hypothalamic area lha containing melanin concentrating hormone mch neuron num generate hunger num num
0.119480975.15905320.html.plaintext.txt	7	neuropeptide y npy produced neuron arcuate nucleus hypothalamus num another neuropeptide prominently induces feeding num num
0.119480975.15905320.html.plaintext.txt	8	hypothalamic circuit lha arcuate nucleus thus important component central system controlling feeding behavior num
0.119480975.15905320.html.plaintext.txt	9	circuit judging study genetically disrupted orexigenic neuropeptides mch neuron lha play key role
0.119480975.15905320.html.plaintext.txt	10	mouse lacking gene encoding mch lean num whereas mouse overexpressing mch gene susceptible obesity num
0.119480975.15905320.html.plaintext.txt	11	also suggested mch neuron involved glucosensing system hypothalamic mch mrna level increased hypoglycemic condition fasting insulin injection num deoxy d glucose treatment num num num
0.119480975.15905320.html.plaintext.txt	12	contrast mch mouse lacking gene encoding prepro orexin npy display normal growth num num num
0.119480975.15905320.html.plaintext.txt	13	probable sex difference feeding behavior least part attributable sex difference neuron involved feeding behavior
0.119480975.15905320.html.plaintext.txt	14	mch neuron lha play important role regulation feeding behavior hypothesized might sex difference activity mch neuron lha fasting andor glucose injection
0.119480975.15905320.html.plaintext.txt	15	support view hypothalamic mch neuron suggested involved estrogen induced weight loss male rat num
0.119480975.15905320.html.plaintext.txt	16	therefore examined response mch neuron iv injection glucose num h fasting adult male female rat using expression phosphorylated camp response element binding protein pcreb immunoreactivity marker neural activity
0.119480975.15905320.html.plaintext.txt	17	assumption sex difference mch neuron existed also examined whether could affected gonadal steroid hormone testosterone andor estrogen
0.119480975.15905320.html.plaintext.txt	18	present study used pcreb marker neural activity increased generally used c fo increase expression c fo need transcription andor translation occur num take long time see change would difficult examine acute change response glucose
0.119480975.15905320.html.plaintext.txt	19	contrast creb constitutively expressed transcription factor immediately activated phosphorylation via camp calcium dependent cascade num num
0.119480975.15905320.html.plaintext.txt	20	thus thought pcreb suitable marker examine neural activity change within short period response dynamic change blood glucose concentration
0.119480975.15905320.html.plaintext.txt	21	determination blood glucose insulin concentration determine change blood glucose insulin concentration glucose injection num mgkg intact male orchidectomized orx male female proestrus diestrus num ovariectomized ovx female implanted silicone cannula right atrium ether anesthesia
0.119480975.15905320.html.plaintext.txt	22	male female rat castrated num wk experiment
0.119480975.15905320.html.plaintext.txt	23	cannula implantation fasted num h injected num mgkg glucose dissolved num microl saline first blood sampling num microl
0.119480975.15905320.html.plaintext.txt	24	control rat injected volume saline
0.119480975.15905320.html.plaintext.txt	25	thereafter blood sampled num num num num num num min injection though cannula
0.119480975.15905320.html.plaintext.txt	26	equal volume heparinized saline num iuml injected sampling
0.119480975.15905320.html.plaintext.txt	27	another control blood sample obtained intact male orx male female proestrus ovx female fasted
0.119480975.15905320.html.plaintext.txt	28	blood glucose concentration determined instant blood glucose assay apparatus accu chek comfort roche tokyo japan
0.119480975.15905320.html.plaintext.txt	29	serum insulin concentration measured elisa kit morinaga institute biological science yokohama japan
0.119480975.15905320.html.plaintext.txt	30	experiment num sex difference activity mch neuron determine whether sex difference activity mch neuron male female rat fed normally injected iv num microl saline fedsaline group male female rat fasted num h given iv injection num microl saline fastsaline group glucose fastglucose group num mgkg dissolved num microl saline num num h
0.119480975.15905320.html.plaintext.txt	31	injection made silicon cannula right atrium described
0.119480975.15905320.html.plaintext.txt	32	dose glucose used present study based previous study showed treatment could reverse inhibition pulsatile lh secretion caused insulin induced hypoglycemia num
0.119480975.15905320.html.plaintext.txt	33	female three group composed rat diestrus num dnum group proestrus p group estrus e group prepared check effect stage estrous cycle
0.119480975.15905320.html.plaintext.txt	34	rat dnum group fasted day estrus p group fasted day last diestrus num e group fasted day last diestrus num
0.119480975.15905320.html.plaintext.txt	35	thus num group rat four group containing three treatment group prepared processed blindly immunohistochemistry
0.119480975.15905320.html.plaintext.txt	36	group rat killed num min saline glucose injection iv injection overdose pentobarbital num mgkg
0.119480975.15905320.html.plaintext.txt	37	perfusion cardiac ventricle quickly started num paraformaldehyde num acrolein phosphate buffer pb ph num
0.119480975.15905320.html.plaintext.txt	38	perfusion brain removed cranium fixed overnight num c pb containing num paraformaldehyde incubated overnight num c num sucrose pb
0.119480975.15905320.html.plaintext.txt	39	brain frozen powdered dry ice stored num c immunohistochemical processing
0.119480975.15905320.html.plaintext.txt	40	experiment num time dependent change activity mch neuron glucose injection examine time dependent change activity mch neuron iv glucose injection male rat fasted num h injected iv glucose num mgkg dissolved num microl saline num num h
0.119480975.15905320.html.plaintext.txt	41	rat killed num num num min glucose injection fastglucose num min group fastglucose num min group fastglucose num min group iv injection overdose pentobarbital
0.119480975.15905320.html.plaintext.txt	42	female rat diestrus num fasted num h day estrus similarly killed
0.119480975.15905320.html.plaintext.txt	43	subsequent procedure obtain brain described experiment num
0.119480975.15905320.html.plaintext.txt	44	experiment num effect testosterone estrogen response mch neuron glucose determine whether gonadal steroid hormone affected response mch neuron glucose male female rat castrated ether anesthesia used experiment num wk later
0.119480975.15905320.html.plaintext.txt	45	orx ovx rat implanted sc silicone tube inside diameter num
0.119480975.15905320.html.plaintext.txt	46	num mm length num mm containing num testosterone crystal orxt group ovxt group silicone tube inside diameter num
0.119480975.15905320.html.plaintext.txt	47	num mm length num mm containing num numss estradiol crystal orxenum group ovxenum group silicone tube inside diameter num
0.119480975.15905320.html.plaintext.txt	48	num mm length num mm containing cholesterol alone orx group ovx group control
0.119480975.15905320.html.plaintext.txt	49	silicone tube previously soaked saline num h facilitate rapid hormone release
0.119480975.15905320.html.plaintext.txt	50	shown previously tube containing dose numss estradiol produced serum numss estradiol concentration equivalent observed proestrus intact female rat num tube containing testosterone produced serum testosterone concentration equivalent observed intact male rat num
0.119480975.15905320.html.plaintext.txt	51	implantation tube rat fed normally rat fasted num h
0.119480975.15905320.html.plaintext.txt	52	normally fed rat injected iv num microl saline fedsaline group fasted rat injected iv num microl saline fastsaline group glucose fastglucose group num mgkg dissolved num microl saline num num h
0.119480975.15905320.html.plaintext.txt	53	rat killed num min iv injection
0.119480975.15905320.html.plaintext.txt	54	thus total num group rat six group containing three treatment group orx orxt orxenum ovx ovxt ovxenum group x fedsaline fastsaline fastglucose group prepared
0.119480975.15905320.html.plaintext.txt	55	subsequent procedure obtain brain described experiment num
0.119480975.15905320.html.plaintext.txt	56	immunohistochemistry thirty micrometer frozen coronal section cut bright cryostat jencons ltd
0.119480975.15905320.html.plaintext.txt	57	leighton buzzard uk every fourth section used study
0.119480975.15905320.html.plaintext.txt	58	section incubated num sodium borohydride pb num
0.119480975.15905320.html.plaintext.txt	59	incubated overnight rabbit polyclonal antibody pcreb diluted numnum cell signaling technology beverly ma pb containing num
0.119480975.15905320.html.plaintext.txt	60	next day incubated biotinylated antirabbit igg diluted numnum pb containing num
0.119480975.15905320.html.plaintext.txt	61	num triton x num thereafter incubated streptavidin biotin peroxidase complex vectastain elite abc kit vector laboratory inc
0.119480975.15905320.html.plaintext.txt	62	bound peroxidase visualized incubating section num min num
0.119480975.15905320.html.plaintext.txt	63	num numnum diaminobenzidine hnumonum
0.119480975.15905320.html.plaintext.txt	64	double staining section incubated overnight rabbit polyclonal antibody mch diluted numnum phoenix pharmaceutical belmont ca pb containing num
0.119480975.15905320.html.plaintext.txt	65	additionally incubated biotinylated antirabbit igg diluted numnum pb containing num
0.119480975.15905320.html.plaintext.txt	66	num triton x num cynum labeled streptavidin amersham bioscience little chalfont uk
0.119480975.15905320.html.plaintext.txt	67	finally mounted glass slide dehydrated graded alcohol cleared xylene coverslipped permount fisher scientific fairlawn nj
0.119480975.15905320.html.plaintext.txt	68	total eight series immunohistochemical procedure performed incubation time numnum diaminobenzidine staining experimental condition checked carefully reproducibility
0.119480975.15905320.html.plaintext.txt	69	histological analysis counting performed investigator blind experimental condition expectation
0.119480975.15905320.html.plaintext.txt	70	initially used every fourth section lha thus approximately num sectionsrat stained mch pcreb antibody
0.119480975.15905320.html.plaintext.txt	71	using fluorescence microscope five section per rat finally selected counting mch immunoreactive cell mch neuron pcreb immunoreactive cell pcreb cell dorsolateral hypothalamic group lha distribution mch neuron varies anterior posterior diencepalon group lha comprises numerically predominant grouping mch expressing cell diencephalon num
0.119480975.15905320.html.plaintext.txt	72	section carefully matched across animal experimental group
0.119480975.15905320.html.plaintext.txt	73	number mch neuron lha square region num
0.119480975.15905320.html.plaintext.txt	74	num mm counted bilaterally fluorescence microscope num x num magnification
0.119480975.15905320.html.plaintext.txt	75	mch cell nucleus clearly visible surrounded fluorescent cytoplasmic staining counted
0.119480975.15905320.html.plaintext.txt	76	section pcreb cell also observed number mch neuron expressing pcreb immunoreactive nucleus double stained neuron fig
0.119480975.15905320.html.plaintext.txt	77	cell defined double stained mch pcreb blue black nucleus surrounded fluorescent cytoplasm num x num magnification
0.119480975.15905320.html.plaintext.txt	78	average ratio percentage number double stained neuron number mch neuron rat calculated
0.119480975.15905320.html.plaintext.txt	79	average number mch neuron per section rat average percentage double stained neuron per section rat used statistical analysis
0.119480975.15905320.html.plaintext.txt	80	male rat female rat p group experiment num counted number pcreb cell lha
0.119480975.15905320.html.plaintext.txt	81	view larger version numk fig
0.119480975.15905320.html.plaintext.txt	82	representative photograph double stained neuron lha
0.119480975.15905320.html.plaintext.txt	83	fluorescent mch immunoreactive neuron top arrowhead pcreb immunoreactive nucleus bottom arrowhead tissue section magnification xnum fastsaline group left panel fastglucose group right panel male female p rat experiment num shown
0.119480975.15905320.html.plaintext.txt	84	data analyzed one way anova followed fisher protected least significant difference post hoc test comparison treatment group animal group
0.119480975.15905320.html.plaintext.txt	85	difference considered significant p num
0.119480975.15905320.html.plaintext.txt	86	change blood glucose concentration milligram per deciliter saline injection
0.119480975.15905320.html.plaintext.txt	87	change blood glucose insulin concentration num mgkg glucose injection
0.119480975.15905320.html.plaintext.txt	88	rat overall distribution mch neuron red fluorescent cytoplasm good accord previous report num experiment
0.119480975.15905320.html.plaintext.txt	89	average number mch neuron per section approximately num group number vary experiment data shown
0.119480975.15905320.html.plaintext.txt	90	intact male p group number pcreb expressing cell slightly larger mch neuron expressing pcreb table num change number pcreb cell similar mch neuron expressing pcreb indicated
0.119480975.15905320.html.plaintext.txt	91	result suggest mch neuron population cell expressing pcreb lha
0.119480975.15905320.html.plaintext.txt	92	change number pcreb expressing cell lateral hypothalamic area male rat female rat proestrus
0.119480975.15905320.html.plaintext.txt	93	experiment num female rat e dnum group exhibited regular num d estrous cycle monitored vaginal smear experiment
0.119480975.15905320.html.plaintext.txt	94	almost num female rat fasted num h p group however diestrus like vaginal smear day supposed proestrus
0.119480975.15905320.html.plaintext.txt	95	data rat showing perturbed cycle discarded rat showing proestrous vaginal smear included p group
0.119480975.15905320.html.plaintext.txt	96	fedsaline group pcreb cell blue black nucleus scattered lha arcuate nucleus hypothalamus data shown ratio double stained neuron approximately num fig
0.119480975.15905320.html.plaintext.txt	97	view larger version numk fig
0.119480975.15905320.html.plaintext.txt	98	effect num h fasting glucose injection num h fasting ratio percentage mch immunoreactive neuron expressing pcreb immunoreactive nucleus experiment num
0.119480975.15905320.html.plaintext.txt	99	group rat examined num min saline glucose injection
0.119480975.15905320.html.plaintext.txt	100	column vertical line indicate mean sem respectively
0.119480975.15905320.html.plaintext.txt	101	number parenthesis refer number rat
0.119480975.15905320.html.plaintext.txt	102	number column body weight mean plus minus sem time testing
0.119480975.15905320.html.plaintext.txt	103	see text detail statistic
0.119480975.15905320.html.plaintext.txt	104	dnum diestrus num p proestrus e estrus
0.119480975.15905320.html.plaintext.txt	105	fastsaline group large number pcreb cell observed lha arcuate nucleus hypothalamus data shown ratio double stained neuron approximately num fig
0.119480975.15905320.html.plaintext.txt	106	one way anova showed significant effect treatment ratio double stained neuron animal group intact male group fnumnum num
0.119480975.15905320.html.plaintext.txt	107	num dnum group fnumnum num
0.119480975.15905320.html.plaintext.txt	108	group post hoc comparison showed significantly greater ratio double stained neuron fastsaline group fedsaline group fig
0.119480975.15905320.html.plaintext.txt	109	result indicated num h fasting significantly increased ratio double stained neuron animal group
0.119480975.15905320.html.plaintext.txt	110	fastglucose group number pcreb cell lha varied among animal group data shown
0.119480975.15905320.html.plaintext.txt	111	post hoc comparison male group showed significantly greater ratio double stained neuron fastglucose group fedsaline group p num
0.119480975.15905320.html.plaintext.txt	112	num significant difference fastglucose group fastsaline group indicating glucose injection affect increase ratio double stained neuron caused fasting intact male rat fig
0.119480975.15905320.html.plaintext.txt	113	contrast pcreb cell relatively lha female group glucose injection data shown
0.119480975.15905320.html.plaintext.txt	114	post hoc comparison female group showed significantly smaller ratio double stained neuron fastglucose group fastsaline group fig
0.119480975.15905320.html.plaintext.txt	115	p e group ratio double stained neuron differ fastglucose group fedsaline group indicating glucose injection completely blocked fasting induced increase ratio double stained neuron fig
0.119480975.15905320.html.plaintext.txt	116	dnum group contrast ratio double stained neuron significantly greater fastglucose group fedsaline group fig
0.119480975.15905320.html.plaintext.txt	117	num indicating num h fasting glucose injection le effective dnum group p e group
0.119480975.15905320.html.plaintext.txt	118	experiment num data experiment num analyzed data experiment num fastsaline fastglucose group intact male rat dnum group female rat fig
0.119480975.15905320.html.plaintext.txt	119	view larger version numk fig
0.119480975.15905320.html.plaintext.txt	120	time dependent change ratio percentage mch immunoreactive cell expressing pcreb immunoreactive nucleus fastsaline fastglucose group male female dnum rat experiment num
0.119480975.15905320.html.plaintext.txt	121	group rat fasted num h examined num min saline injection num num num min glucose injection
0.119480975.15905320.html.plaintext.txt	122	column vertical line indicate mean sem respectively
0.119480975.15905320.html.plaintext.txt	123	number parenthesis refer number rat
0.119480975.15905320.html.plaintext.txt	124	number column body weight mean plus minus sem time testing
0.119480975.15905320.html.plaintext.txt	125	intact male rat pcreb cell lha fastglucose num min group fastglucose num min group ratio double stained neuron le num fig
0.119480975.15905320.html.plaintext.txt	126	number pcreb cell relatively large fastglucose num min group
0.119480975.15905320.html.plaintext.txt	127	one way anova showed significant effect treatment ratio double stained neuron intact male rat fnumnum num
0.119480975.15905320.html.plaintext.txt	128	post hoc comparison intact male rat showed significantly smaller ratio double stained neuron fastglucose num min group fastglucose num min group fastsaline group p num
0.119480975.15905320.html.plaintext.txt	129	result indicated glucose injection significantly decreased ratio double stained neuron num num min injection intact male rat effect disappeared num min injection
0.119480975.15905320.html.plaintext.txt	130	dnum group female rat pcreb cell lha fastglucose num min group ratio double stained neuron approximately num fig
0.119480975.15905320.html.plaintext.txt	131	number pcreb cell relatively large fastglucose num min group fastglucose num min group
0.119480975.15905320.html.plaintext.txt	132	one way anova showed significant effect treatment ratio double stained neuron dnum group fnumnum num
0.119480975.15905320.html.plaintext.txt	133	post hoc comparison dnum group showed significantly smaller ratio double stained neuron fastglucose num min group fastglucose num min group fastsaline group p num
0.119480975.15905320.html.plaintext.txt	134	result indicated glucose injection significantly decreased ratio double stained neuron num num min injection female rat effect disappeared num min injection
0.119480975.15905320.html.plaintext.txt	135	experiment num fedsaline group fastsaline group ratio double stained neuron approximately num num respectively fig
0.119480975.15905320.html.plaintext.txt	136	one way anova showed significant effect treatment ratio double stained neuron animal group orx group fnumnum num
0.119480975.15905320.html.plaintext.txt	137	num orxt group fnumnum num
0.119480975.15905320.html.plaintext.txt	138	num orxenum group fnumnum num
0.119480975.15905320.html.plaintext.txt	139	num ovxt group fnumnum num
0.119480975.15905320.html.plaintext.txt	140	num ovxenum group fnumnum num
0.119480975.15905320.html.plaintext.txt	141	animal group post hoc comparison showed significantly greater ratio double stained neuron fastsaline group fedsaline group fig
0.119480975.15905320.html.plaintext.txt	142	ratio double stained neuron fedsaline group fastsaline group experiment num comparable experiment num result indicated num h fasting significantly increased ratio double stained neuron regardless presence absence gonadal steroid hormone
0.119480975.15905320.html.plaintext.txt	143	view larger version numk fig
0.119480975.15905320.html.plaintext.txt	144	effect testosterone estrogen ratio percentage mch immunoreactive neuron expressing pcreb immunoreactive nucleus fedsaline fastsaline fastglucose group experiment num
0.119480975.15905320.html.plaintext.txt	145	group rat examined num min saline glucose injection
0.119480975.15905320.html.plaintext.txt	146	column vertical line indicate mean sem respectively
0.119480975.15905320.html.plaintext.txt	147	number parenthesis refer number rat
0.119480975.15905320.html.plaintext.txt	148	number column body weight mean plus minus sem time testing
0.119480975.15905320.html.plaintext.txt	149	see text detail statistic
0.119480975.15905320.html.plaintext.txt	150	enum implantation numss estradiol crystal implantation testosterone crystal
0.119480975.15905320.html.plaintext.txt	151	effect glucose injection varied among group
0.119480975.15905320.html.plaintext.txt	152	orx orxenum group post hoc comparison showed ratio double stained neuron fastglucose group significantly smaller fastsaline group p num
0.119480975.15905320.html.plaintext.txt	153	num ratio double stained neuron fastglucose group different fedsaline group p num
0.119480975.15905320.html.plaintext.txt	154	orxt group post hoc comparison showed ratio double stained neuron fastglucose group different fastsaline group fedsaline group p num
0.119480975.15905320.html.plaintext.txt	155	result indicated orchidectomy estrogen replacement decreased ratio double stained neuron num min glucose injection testosterone replacement blocked orchidectomy induced decrease ratio double stained neuron male rat
0.119480975.15905320.html.plaintext.txt	156	ovxt ovxenum group post hoc comparison showed ratio double stained neuron fastglucose group significantly smaller fastsaline group p num
0.119480975.15905320.html.plaintext.txt	157	num ratio double stained neuron fastglucose group different fedsaline group p num
0.119480975.15905320.html.plaintext.txt	158	ovx group post hoc comparison showed ratio double stained neuron fastglucose group different fastsaline group p num
0.119480975.15905320.html.plaintext.txt	159	num ratio double stained neuron fastglucose group significantly larger fedsaline group p num
0.119480975.15905320.html.plaintext.txt	160	result indicated ovariectomy increased ratio double stained neuron num min glucose injection testosterone estrogen replacement blocked ovariectomy induced increase ratio double stained neuron female rat
0.119480975.15905320.html.plaintext.txt	161	although hypoglycemia caused treatment fasting insulin injection num deoxy d glucose injection increase expression hypothalamic mch mrna num num num little information second messenger system would stimulated hypoglycemic condition
0.119480975.15905320.html.plaintext.txt	162	example fo expression increased lha insulin induced hypoglycemia mch neuron expressed fo protein num num
0.119480975.15905320.html.plaintext.txt	163	thus unclear whether fo protein involved control expression mch mrna lha hypoglycemia
0.119480975.15905320.html.plaintext.txt	164	experiment num showed normal feeding condition male female rat stage estrous cycle examined approximately num mch neuron expressed pcreb immunoreactive nucleus lha indicating small population mch neuron active lha
0.119480975.15905320.html.plaintext.txt	165	however found fasting num h increased ratio double stained neuron approximately num sex
0.119480975.15905320.html.plaintext.txt	166	furthermore showed fasting induced increase independent presence testosterone estrogen
0.119480975.15905320.html.plaintext.txt	167	first demonstration mch neuron express pcreb nucleus response fasting good accord result previous study showing fasting num h increased pcreb level nuclear extract rat hypothalamus although neuron expressed pcreb shown num
0.119480975.15905320.html.plaintext.txt	168	analog camp agent increase level endogenous camp promote phosphorylation creb num reported elicit vigorous feeding response microinjected lha num
0.119480975.15905320.html.plaintext.txt	169	thus pcreb reliable marker activation mch neuron num h fasting phosphorylation creb probably promoted increase camp may contribute least part orexigenic activity mch neuron
0.119480975.15905320.html.plaintext.txt	170	thus suggest sex difference fasting induced activation mch neuron
0.119480975.15905320.html.plaintext.txt	171	also examined change activity mch neuron glucose injection num h fasted rat experiment num found significant decrease ratio double stained neuron induced num min female rat stage estrous cycle examined
0.119480975.15905320.html.plaintext.txt	172	contrast female rat mch neuron male rat failed respond glucose within num min
0.119480975.15905320.html.plaintext.txt	173	additional time course study experiment num demonstrated mch neuron male rat responded glucose num num min glucose injection whereas female rat stage insensitive glucose mch neuron responded num num min
0.119480975.15905320.html.plaintext.txt	174	study found clear sex difference response mch neuron glucose response mch neuron glucose delayed male rat compared female rat
0.119480975.15905320.html.plaintext.txt	175	due difference blood glucose concentration sex difference blood glucose concentration glucose injection intact male female rat
0.119480975.15905320.html.plaintext.txt	176	furthermore due sex difference insulin secretion response glucose sex difference effect castration insulin secretion thus could explain result experiment num
0.119480975.15905320.html.plaintext.txt	177	one possible reason delay decrease pcreb may sensitivity mch neuron glucose male rat le female rat thus mch neuron respond increase glucose concentration blood resulting delay decrease pcreb
0.119480975.15905320.html.plaintext.txt	178	according glucostatic theory increase glucose blood signal meal termination num dietary glucose may inactivate orexigenic activity mch neuron induce meal termination rapidly female rat male rat
0.119480975.15905320.html.plaintext.txt	179	may account sex difference meal size smaller female male num num
0.119480975.15905320.html.plaintext.txt	180	although glucose sensing neuron may respond physiological change blood glucose regulate integrative metabolic function counterregulatory response food intake metabolic rate num glucostatic theory sufficient explain complex regulation feeding behavior num
0.119480975.15905320.html.plaintext.txt	181	glucose obviously one several peripheral metabolic signal involved regulation feeding behavior physiological condition num
0.119480975.15905320.html.plaintext.txt	182	hence speculate inactivation mch neuron metabolic signal feeding faster female male
0.119480975.15905320.html.plaintext.txt	183	currently know glucose act mch neuron
0.119480975.15905320.html.plaintext.txt	184	however judging electrophysiological study showing neuron lha respond change glucose concentration vitro num direct effect glucose mch neuron likely
0.119480975.15905320.html.plaintext.txt	185	effect afferent signal glucose sensor localized different central peripheral structure also likely num num
0.119480975.15905320.html.plaintext.txt	186	hypothalamus npy neuron arcuate nucleus shown glucose sensitive neuron vitro electrophysiological study num
0.119480975.15905320.html.plaintext.txt	187	considering hypothalamic circuit involving lha arcuate nucleus num probable glucose affect mch neuron indirectly via npy neuron arcuate nucleus
0.119480975.15905320.html.plaintext.txt	188	also found present study response mch neuron glucose varied depending stage estrous cycle
0.119480975.15905320.html.plaintext.txt	189	magnitude decrease number double stained neuron glucose injection greater proestrus estrus diestrus num
0.119480975.15905320.html.plaintext.txt	190	additional time course study confirmed ratio double stained neuron diestrus num decreased num min glucose injection approximately num similar level proestrus estrus num min glucose injection indicating response mch neuron glucose diestrus num delayed
0.119480975.15905320.html.plaintext.txt	191	discussed decrease activity mch neuron related meal termination follows meal termination occurs rapidly proestrus estrus diestrus num
0.119480975.15905320.html.plaintext.txt	192	support meal size smaller proestrus estrus diestrus num num
0.119480975.15905320.html.plaintext.txt	193	therefore mch neuron may also participate fluctuation feeding behavior estrous cycle
0.119480975.15905320.html.plaintext.txt	194	finding experiment num indicate sex difference mch neuron least part attributable presence gonadal steroid hormone adult
0.119480975.15905320.html.plaintext.txt	195	presence testosterone male estrogen female critical male female type response mch neuron glucose
0.119480975.15905320.html.plaintext.txt	196	male rat found orchidectomy significantly enhanced response mch neuron glucose testosterone replacement attenuated effect
0.119480975.15905320.html.plaintext.txt	197	orchidectomy decreased food intake num effect reversed testosterone replacement orx rat num num num speculate testosterone attenuates response mch neuron metabolic signal increase food intake male
0.119480975.15905320.html.plaintext.txt	198	contrast estrogen replacement cause significant effect orchidectomy induced enhancement response glucose male rat
0.119480975.15905320.html.plaintext.txt	199	result good accord report food intake orx rat relatively insensitive influence estrogen compared ovx rat num
0.119480975.15905320.html.plaintext.txt	200	result present study male rat therefore suggest estrogen could longer enhance response mch neuron glucose orchidectomy caused response reach maximum
0.119480975.15905320.html.plaintext.txt	201	female rat ovariectomy attenuated response mch neuron glucose estrogen replacement prevented ovariectomy induced attenuation response
0.119480975.15905320.html.plaintext.txt	202	result good accord previous study ovariectomy adult female rat increased food intake num num effect reversed estrogen replacement num
0.119480975.15905320.html.plaintext.txt	203	thus easily hypothesized estrogen enhances response mch neuron metabolic signal female cause decrease food intake body weight
0.119480975.15905320.html.plaintext.txt	204	support estrogen inhibited expression mch mrna lha female num male num rat
0.119480975.15905320.html.plaintext.txt	205	contrast effect testosterone orx rat testosterone enhanced response mch neuron ovx rat estrogen
0.119480975.15905320.html.plaintext.txt	206	effect testosterone ovx rat could explained postulating testosterone enhances response mch neuron converted estrogen
0.119480975.15905320.html.plaintext.txt	207	support speculation suggested male rat reduced food intake weight gain seen high dose testosterone treatment due aromatization testosterone estrogen num
0.119480975.15905320.html.plaintext.txt	208	light previous report female sensitive effect estrogen food intake male num num male sensitive effect testosterone food intake num num present study indicates dominant effect testosterone response mch neuron female testosterone induced attenuation estrogen induced enhancement
0.119480975.15905320.html.plaintext.txt	209	male contrast dominant effect testosterone response mch neuron estrogen induced enhancement testosterone induced attenuation
0.119480975.15905320.html.plaintext.txt	210	hence present study may provide neural basis sex difference feeding behavior although mechanism action estrogen testosterone need determined future study
0.119480975.15905320.html.plaintext.txt	211	recent report demonstrating estrogen attenuates neuroendocrine response hypoglycemia woman num female rat num suggest estrogen enhances effect glucose brain
0.119480975.15905320.html.plaintext.txt	212	light result present study estrogen may enhance glucose transport metabolism brain num num num
0.119480975.15905320.html.plaintext.txt	213	suggests one mechanism estrogen exerts widely reported protective effect brain num enhancing glucose transport metabolism
0.119480975.15905320.html.plaintext.txt	214	footnote work supported part grant yokohama foundation advancement medical science k
0.119480975.15905320.html.plaintext.txt	215	first published online may num num
0.119480975.15905320.html.plaintext.txt	216	abbreviation auc area curve lha lateral hypothalamic area mch melanin concentrating hormone npy neuropeptide y orx orchidectomized ovx ovariectomized pb phosphate buffer pcreb phosphorylated camp response element binding protein
0.119480975.15905320.html.plaintext.txt	217	accepted publication may num num
0.119480975.15905320.html.plaintext.txt	218	home help feedback subscription archive search table content endocrinology endocrine review j
0.119480975.15905320.html.plaintext.txt	219	molecular endocrinology recent prog
0.11980948.12663466.html.plaintext.txt	0	ghrelin directly interacts neuropeptide y containing neuron rat arcuate nucleus canum signaling via protein kinase n type channel dependent mechanism cross talk leptin orexin daisuke kohnonumnum hong zhi gaonumnum shinji muroyanumnum sakae kikuyamanum toshihiko yadanum
0.11980948.12663466.html.plaintext.txt	1	num department physiology jichi medical school school medicine minamikawachi tochigi japan num department biology school education waseda university nishi waseda shinjuku ku tokyo japan num department anatomy school medicine kagoshima university kagoshima japan num department psychiatry kagoshima university school medicine kagoshima japan
0.11980948.12663466.html.plaintext.txt	2	ghrelin endogenous ligand growth hormone secretagogue ghs receptor ghsr synthesized abundantly stomach much lesser extent hypothalamic arcuate nucleus arc num
0.11980948.12663466.html.plaintext.txt	3	peripheral intracerebroventricular icv injection ghrelin release growth hormone stimulates food intake increase body weight mouse rat human num num
0.11980948.12663466.html.plaintext.txt	4	icv injection antighrelin igg suppresses starvation induced feeding num
0.11980948.12663466.html.plaintext.txt	5	daily pattern plasma ghrelin level normal human characterized preprandial rise postprandial fall num
0.11980948.12663466.html.plaintext.txt	6	finding suggested ghrelin play physiological role meal initiation
0.11980948.12663466.html.plaintext.txt	7	neuropeptide y npy containing neuron localized arc implicated stimulation food intake injection npy hypothalamus rat potently stimulates food intake num npy secretion hypothalamus increased fasting num
0.11980948.12663466.html.plaintext.txt	8	regarding possible link ghrelin npy neuron arc shown ghsr mrna expressed num npy neuron arc double labeling situ hybridization histochemistry num
0.11980948.12663466.html.plaintext.txt	9	systemic icv administration ghrelin cause arc neuron express fo egr num numnum num num fo positive neuron express npy mrna num
0.11980948.12663466.html.plaintext.txt	10	moreover ghrelin increase expression npy mrna num num icv administration npy ynum antagonist suppresses ghrelin stimulated food intake num numnum
0.11980948.12663466.html.plaintext.txt	11	finding suggest npy neuron arc could important effector orexigenic action ghrelin
0.11980948.12663466.html.plaintext.txt	12	second messenger system ghsr fully elucidated
0.11980948.12663466.html.plaintext.txt	13	signaling pathway artificial ghs act ghsr pituitary cell investigated
0.11980948.12663466.html.plaintext.txt	14	ghrp num ghs increase intracellular camp level ovine rat pituitary somatotropes numnum
0.11980948.12663466.html.plaintext.txt	15	ghrp num stimulates gh release rat pituitary cell activating protein kinase c pkc numnum
0.11980948.12663466.html.plaintext.txt	16	thus post ghsr pathway could involve g andor gq protein
0.11980948.12663466.html.plaintext.txt	17	however intracellular signaling ghrelin orexigenic action effector neuron well understood
0.11980948.12663466.html.plaintext.txt	18	therefore first aim present study examine whether ghrelin directly interacts npy neuron arc explore signal transduction mechanism special attention toward canum signaling
0.11980948.12663466.html.plaintext.txt	19	leptin adipocyte derived potent anorexic peptide
0.11980948.12663466.html.plaintext.txt	20	leptin receptor present npy neuron arc leptin exerts anorexic effect partly suppression npy neuron num
0.11980948.12663466.html.plaintext.txt	21	coinjection leptin decrease stimulatory effect ghrelin feeding free fed rat num
0.11980948.12663466.html.plaintext.txt	22	orexin b orexigenic peptide produced cell body located lateral hypothalamus num
0.11980948.12663466.html.plaintext.txt	23	orexin num receptor localized npy containing neuron arc num orexin induced feeding inhibited npy ynum andor ynum receptor antagonist num num suggesting orexin could elicit feeding via npy neuron
0.11980948.12663466.html.plaintext.txt	24	therefore second aim present study examine whether subset npy neuron arc could serve common target ghrelin leptin orexins
0.11980948.12663466.html.plaintext.txt	25	found ghrelin increase canumi num npy neuron via mechanism involving protein kinase pka n type canum channel majority ghrelin activated npy neuron also regulated orexin leptin
0.11980948.12663466.html.plaintext.txt	26	measurement canumi single arc neuron
0.11980948.12663466.html.plaintext.txt	27	num num h cell preparation canumi measured radiometric fura num microfluorometry combination digital imaging previously reported numnum
0.11980948.12663466.html.plaintext.txt	28	briefly following incubation num micromoll fura numam dojin chemical kumamoto japan num h num degree c cell mounted chamber superfused hkrb num mlmin num degree c
0.11980948.12663466.html.plaintext.txt	29	fluorescence image due excitation num num nm detected every num
0.11980948.12663466.html.plaintext.txt	30	num intensified charge coupled device iccd camera ratio image produced argus num system hamamatsu photonics hamamatsu japan
0.11980948.12663466.html.plaintext.txt	31	ratio value converted canumi according calibration curve num
0.11980948.12663466.html.plaintext.txt	32	agent dissolved dmso distilled water stock diluted superfusate hkrb lenumnumnum
0.11980948.12663466.html.plaintext.txt	33	num dmso administered alone effect canumi arc neuron
0.11980948.12663466.html.plaintext.txt	34	data taken cell identified neuron procedure reported previously numnum
0.11980948.12663466.html.plaintext.txt	35	briefly single cell immunoreactive microtubule associated protein num neuron specific marker showed relatively large diameter num microm clear round nucleus phase contrast microscope
0.11980948.12663466.html.plaintext.txt	36	data taken cell fulfilled criterion neuron
0.11980948.12663466.html.plaintext.txt	37	immunocytochemistry identification npy neuron
0.11980948.12663466.html.plaintext.txt	38	canumi measurement cell fixed num paraformaldehyde overnight
0.11980948.12663466.html.plaintext.txt	39	incubated first rabbit antiserum npy diasorin stillwater mn dilution numnumnum num h num degree c followed biotinylated antibody raised rabbit igg vector laboratory burlingame ca diluted num fold num h avidin peroxidase complex vector num h
0.11980948.12663466.html.plaintext.txt	40	section developed numnum diaminobenzidine
0.11980948.12663466.html.plaintext.txt	41	control experiment carried omitting primary antiserum
0.11980948.12663466.html.plaintext.txt	42	correlation canumi immunocytochemical data performed procedure reported previously num num
0.11980948.12663466.html.plaintext.txt	43	brief end canumi imaging took phase contrast photograph cell microscopic field subjected canumi measurement
0.11980948.12663466.html.plaintext.txt	44	based photograph cell canumi recorded correlated corresponding immunocytochemical result
0.11980948.12663466.html.plaintext.txt	45	criterion canumi response inhibition determination response amplitude
0.11980948.12663466.html.plaintext.txt	46	ghrelin forskolin num num tetradecanoylphorbol num acetate tpa orexin administered num num min num min superfusion solution
0.11980948.12663466.html.plaintext.txt	47	amplitude canumi increase response agent calculated subtracting prestimulatory basal canumi level peak canumi level
0.11980948.12663466.html.plaintext.txt	48	increase canumi took place within num min addition agent amplitude num nmoll larger considered response
0.11980948.12663466.html.plaintext.txt	49	repetitive addition ghrelin twice induced repeated canumi increase
0.11980948.12663466.html.plaintext.txt	50	therefore test effect drug second challenge ghrelin performed presence drug
0.11980948.12663466.html.plaintext.txt	51	alternatively pretreatment neuron drug performed second challenge ghrelin
0.11980948.12663466.html.plaintext.txt	52	amplitude canumi response second addition ghrelin reduced lenum compared control canumi response first addition ghrelin without drug considered inhibition
0.11980948.12663466.html.plaintext.txt	53	measurement carried hkrb solution composed num mmoll nacl num
0.11980948.12663466.html.plaintext.txt	54	num mmoll mgsonum num mmoll hepes ph num
0.11980948.12663466.html.plaintext.txt	55	kangawa later obtained peptide institute osaka japan
0.11980948.12663466.html.plaintext.txt	56	conotoxin gvia orexin obtained peptide institute
0.11980948.12663466.html.plaintext.txt	57	fura num acetoxymethylester dojin chemical kumamoto japan nitrendipine yoshitomi pharmaceutical industry osaka japan hnum hnum seikagaku tokyo japan calphostin c bisindolylmaleimide calbiochem la jolla ca
0.11980948.12663466.html.plaintext.txt	58	chemical sigma
0.11980948.12663466.html.plaintext.txt	59	data presentation statistical analysis
0.11980948.12663466.html.plaintext.txt	60	data presented mean plus minus se n number neuron
0.11980948.12663466.html.plaintext.txt	61	study based least seven neuron prepared least three rat
0.11980948.12663466.html.plaintext.txt	62	total num neuron examined
0.11980948.12663466.html.plaintext.txt	63	student paired unpaired test used evaluate difference value p num
0.11980948.12663466.html.plaintext.txt	64	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	65	ghrelin increase canumi npy neuron arc
0.11980948.12663466.html.plaintext.txt	66	b ghrelin num num moll increased canumi single arc neuron proved npy containing subsequent immunocytochemical staining anti npy antibody arrow b
0.11980948.12663466.html.plaintext.txt	67	bar tracing specifies period exposure ghrelin
0.11980948.12663466.html.plaintext.txt	68	glucose concentration num mmoll throughout measurement
0.11980948.12663466.html.plaintext.txt	69	c among num neuron exhibited canumi increase response ghrelin num neuron num npy containing neuron
0.11980948.12663466.html.plaintext.txt	70	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	71	ghrelin increase canumi glucose sensitive neuron arc
0.11980948.12663466.html.plaintext.txt	72	ghrelin responsive neuron exhibited canumi increase response lowering glucose concentration num num
0.11980948.12663466.html.plaintext.txt	73	num mmoll showing glucose sensitive neuron
0.11980948.12663466.html.plaintext.txt	74	result shown representative eight neuron arc n num
0.11980948.12663466.html.plaintext.txt	75	bar tracing specify period exposure agent indicated
0.11980948.12663466.html.plaintext.txt	76	unless otherwise specified glucose concentration num mmoll
0.11980948.12663466.html.plaintext.txt	77	b among num neuron responded ghrelin num neuron num glucose sensitive neuron
0.11980948.12663466.html.plaintext.txt	78	concentration dependent effect ghrelin increase canumi
0.11980948.12663466.html.plaintext.txt	79	ghrelin concentration range num num num num moll administered single arc neuron
0.11980948.12663466.html.plaintext.txt	80	ghrelin num num moll increased canumi none num neuron num num num moll num num neuron num num num moll num num neuron num num num moll num num neuron num showing concentration dependent effect fig
0.11980948.12663466.html.plaintext.txt	81	neuron exemplified fig
0.11980948.12663466.html.plaintext.txt	82	numa num num moll ghrelin induced oscillatory canumi increase num num moll ghrelin sustained canumi increase larger amplitude
0.11980948.12663466.html.plaintext.txt	83	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	84	concentration dependent effect ghrelin increase canumi arc neuron
0.11980948.12663466.html.plaintext.txt	85	sequential addition ghrelin num num moll num num moll increased canumi arc neuron
0.11980948.12663466.html.plaintext.txt	86	b concentration response relationship
0.11980948.12663466.html.plaintext.txt	87	response expressed percentage cell exhibited canumi increase response ghrelin
0.11980948.12663466.html.plaintext.txt	88	number point indicate number neuron responded number neuron examined
0.11980948.12663466.html.plaintext.txt	89	inhibition ghrelin induced canumi increase canum free condition n type canum channel blocker
0.11980948.12663466.html.plaintext.txt	90	second addition ghrelin neuron carried absence canum presence drug
0.11980948.12663466.html.plaintext.txt	91	canum free condition added canum num
0.11980948.12663466.html.plaintext.txt	92	num mmoll egta canumi increase response ghrelin abolished seven neuron fig
0.11980948.12663466.html.plaintext.txt	93	numa e f bringing canum back hkrb canumi response ghrelin restored showing inhibition reversible
0.11980948.12663466.html.plaintext.txt	94	ghrelin induced canumi increase also inhibited n type canum channel blocker conotoxin giva num nmoll reversible manner num num neuron fig
0.11980948.12663466.html.plaintext.txt	95	numb e mean amplitude canumi increase canumi amp significantly reduced compared response second addition ghrelin without blocker control num
0.11980948.12663466.html.plaintext.txt	96	num nmoll num control p num
0.11980948.12663466.html.plaintext.txt	97	contrast l type canum channel blocker nitrendipine num micromoll failed affect ghrelin induced canumi increase majority neuron n num suppressed response minor fraction neuron n num canumi amp num
0.11980948.12663466.html.plaintext.txt	98	blocker endoplasmic reticulum er canum pump thapsigargin num micromoll effect ghrelin induced canumi increase canumi amp num
0.11980948.12663466.html.plaintext.txt	99	num nmoll num moderately elevated basal canumi fig
0.11980948.12663466.html.plaintext.txt	100	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	101	ghrelin induced canumi increase inhibited canum free condition blocker n type canum channel
0.11980948.12663466.html.plaintext.txt	102	d ghrelin induced canumi increase abolished canum free condition n num
0.11980948.12663466.html.plaintext.txt	103	markedly inhibited conotoxin gvia b blocker n type canum channel n num including num npy containig neuron slightly suppressed unaltered nitrendipine c blocker l type canum channel
0.11980948.12663466.html.plaintext.txt	104	thapsigargin d inhibitor canum pump er failed significantly affect ghrelin induced canumi increase
0.11980948.12663466.html.plaintext.txt	105	e incidence response control test condition expressed percentage cell exhibited canumi response second addition ghrelin cell
0.11980948.12663466.html.plaintext.txt	106	number bar indicate number neuron responded number neuron examined
0.11980948.12663466.html.plaintext.txt	107	f amplitude ghrelin induced canumi increase control condition canum free condition conotoxin
0.11980948.12663466.html.plaintext.txt	108	number bar indicates number neuron examined
0.11980948.12663466.html.plaintext.txt	109	num control canum free group p num
0.11980948.12663466.html.plaintext.txt	110	num control conotoxin group
0.11980948.12663466.html.plaintext.txt	111	ghrelin induced canumi increase inhibited inhibitor pka pkc
0.11980948.12663466.html.plaintext.txt	112	pretreatment neuron pka inhibitor hnum num micromoll canumi response ghrelin markedly significantly inhibited canumi amp num
0.11980948.12663466.html.plaintext.txt	113	contrast hnum num micromoll related compound hnum without inhibitory action pka significant effect ghrelin induced canumi increase canumi amp num
0.11980948.12663466.html.plaintext.txt	114	neither calphostin c num nmoll bisindolylmaleimide num micromoll specific pkc inhibitor affected ghrelin induced canumi increase canumi amp num
0.11980948.12663466.html.plaintext.txt	115	num nmoll num calphostin c num
0.11980948.12663466.html.plaintext.txt	116	num num bisindolylmaleimide fig
0.11980948.12663466.html.plaintext.txt	117	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	118	ghrelin induced canumi increase inhibited pka inhibitor
0.11980948.12663466.html.plaintext.txt	119	pretreatment num micromoll hnum pka inhibitor inhibited ghrelin induced canumi increase arc neuron n num including num npy containing neuron whereas pretreatment num micromoll hnum analog hnum without inhibitory action pka little effect b
0.11980948.12663466.html.plaintext.txt	120	neither num nmoll calphostin c c num micromoll bisindolylmaleimide d specific pkc inhibitor affected ghrelin induced canumi increase
0.11980948.12663466.html.plaintext.txt	121	e incidence response control condition inhibitor expressed percentage cell exhibited canumi response second addition ghrelin cell
0.11980948.12663466.html.plaintext.txt	122	f amplitude ghrelin induced canumi increase control condition pretreated hnum hnum
0.11980948.12663466.html.plaintext.txt	123	num control hnum group hnum hnum group
0.11980948.12663466.html.plaintext.txt	124	significant difference control hnum group
0.11980948.12663466.html.plaintext.txt	125	forskolin tpa increase canumi ghrelin responsive neuron
0.11980948.12663466.html.plaintext.txt	126	adenylate cyclase activator forskolin num micromoll increased canumi num num num ghrelin responsive neuron canumi amp num
0.11980948.12663466.html.plaintext.txt	127	pkc activator tpa num nmoll also increased canumi num num num ghrelin responsive neuron canumi amp num
0.11980948.12663466.html.plaintext.txt	128	thus ghrelin responsive neuron highly overlapped neuron responding forskolin lesser extent responding tpa
0.11980948.12663466.html.plaintext.txt	129	furthermore forskolin tpa increased canumi similar pattern ghrelin
0.11980948.12663466.html.plaintext.txt	130	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	131	forskolin tpa increase canumi ghrelin responsive neuron num micromoll forskolin adenylate cyclase activator num nmoll tpa pkc activator b increased canumi ghrelin responsive neuron
0.11980948.12663466.html.plaintext.txt	132	c incidence canumi response forskolin tpa ghrelin responsive neuron expressed percentage
0.11980948.12663466.html.plaintext.txt	133	ghrelin orexin increase canumi neuron
0.11980948.12663466.html.plaintext.txt	134	ghrelin orexin num num moll sequentially administered increased canumi neuron arc similar pattern comparable amplitude fig
0.11980948.12663466.html.plaintext.txt	135	among num neuron examined num neuron including num npy containing neuron responded ghrelin orexin num neuron responded ghrelin num neuron responded orexin fig
0.11980948.12663466.html.plaintext.txt	136	thus ghrelin responsive neuron extensively overlapped orexin responsive neuron num fig
0.11980948.12663466.html.plaintext.txt	137	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	138	ghrelin orexin increase canumi npy neuron
0.11980948.12663466.html.plaintext.txt	139	ghrelin responsive neuron also exhibited canumi response num num moll orexin
0.11980948.12663466.html.plaintext.txt	140	b twelve neuron responded ghrelin orexin num neuron ghrelin num neuron orexin among num neuron responded either two peptide
0.11980948.12663466.html.plaintext.txt	141	ghrelin orexin responsive neuron included eight npy containing neuron
0.11980948.12663466.html.plaintext.txt	142	ghrelin induced canumi increase counteracted leptin
0.11980948.12663466.html.plaintext.txt	143	num num moll ghrelin administered num min canumi increased continuous manner eight responsive neuron arc examined fig
0.11980948.12663466.html.plaintext.txt	144	continuous canumi increase markedly reduced subsequent administration num num moll leptin num num num ghrelin responsive neuron fig
0.11980948.12663466.html.plaintext.txt	145	ghrelin leptin responsive neuron included seven npy containing neuron
0.11980948.12663466.html.plaintext.txt	146	num num moll leptin administered first ghrelin added ghrelin induced canumi increase also reduced three nine responding neuron leptin little effect basal canumi num mmoll glucose fig
0.11980948.12663466.html.plaintext.txt	147	view larger version numk fig
0.11980948.12663466.html.plaintext.txt	148	ghrelin increase canumi leptin suppresses npy neuron
0.11980948.12663466.html.plaintext.txt	149	ghrelin administered alone num min increased canumi continuously arc neuron n num
0.11980948.12663466.html.plaintext.txt	150	b c leptin num num moll suppressed ghrelin induced canumi increase num num ghrelin responsive neuron
0.11980948.12663466.html.plaintext.txt	151	ghrelin leptin responsive neuron included seven npy containing neuron
0.11980948.12663466.html.plaintext.txt	152	d leptin num num moll added advance suppressed canumi response subsequent administration ghrelin n num
0.11980948.12663466.html.plaintext.txt	153	reported concentration leptin cerebrospinal fluid measured radioimmunoassay num
0.11980948.12663466.html.plaintext.txt	154	num x num num moll orexin num x num num moll num
0.11980948.12663466.html.plaintext.txt	155	although concentration ghrelin cerebrospinal fluid available ghrelin transported blood brain barrier rate similar peptide including leptin num estimated ghrelin concentration brain num num moll
0.11980948.12663466.html.plaintext.txt	156	value may reflect physiological concentration peptide brain
0.11980948.12663466.html.plaintext.txt	157	concentration ghrelin leptin orexin used present study num num moll close value therefore effect observed could physiological
0.11980948.12663466.html.plaintext.txt	158	previously shown ghsr ghrelin receptor abundant npy neuron arc num ghrelin induced food intake inhibited antagonist npy ynum receptor num numnum
0.11980948.12663466.html.plaintext.txt	159	report suggested involvement npy neuron ghrelin signaling pathway orexigenic effect
0.11980948.12663466.html.plaintext.txt	160	present study clearly demonstrated ghrelin directly activates substantial population num arc neuron high num ghrelin responsive neuron npy containing neuron
0.11980948.12663466.html.plaintext.txt	161	pharmacological experiment study signaling mechanism ghrelin immunocytochemical identification npy neuron following canumi measurement carried experiment hnum conotoxin
0.11980948.12663466.html.plaintext.txt	162	however examined num num ghrelin responsive neuron pharmacological experiment major population num ghrelin responsive neuron proved npy containing fig
0.11980948.12663466.html.plaintext.txt	163	num result obtained may largely solely reflect npy neuron
0.11980948.12663466.html.plaintext.txt	164	ghrelin induced canumi increase inhibited canum free condition blocker n type canum channel slightly suppressed blocker l type canum channel
0.11980948.12663466.html.plaintext.txt	165	thapsigargin inhibitor canum pump er consequently canum release er effect ghrelin induced canumi increase
0.11980948.12663466.html.plaintext.txt	166	result n type canum channel blocker obtained mainly immunocytochemically identified npy neuron
0.11980948.12663466.html.plaintext.txt	167	data indicate ghrelin increase canumi mainly via canum influx n type canum channel
0.11980948.12663466.html.plaintext.txt	168	shown n type canum channel involved release npy stimulated high potassium num
0.11980948.12663466.html.plaintext.txt	169	reported npy ynum receptor npy neuron linked decrease canum current due inhibition n type canum channel num
0.11980948.12663466.html.plaintext.txt	170	thus n type canum channel could play pivotal role regulation canum influx canumi npy neuron
0.11980948.12663466.html.plaintext.txt	171	second messenger system ghrelin npy neuron adequately elucidated
0.11980948.12663466.html.plaintext.txt	172	present study adenylate cyclase activator forskolin pkc activator tpa increased canumi indicating camp pka pkc pathway capable activating canum signaling
0.11980948.12663466.html.plaintext.txt	173	furthermore specific pka inhibitor hnum nonspecific inhibitor hnum pkc inhibitor significantly suppressed ghrelin induced canumi increase
0.11980948.12663466.html.plaintext.txt	174	result pka inhibitor obtained mainly immunocytochemically identified npy neuron
0.11980948.12663466.html.plaintext.txt	175	result reveal pka required ghrelin activate canum signaling npy neuron arc
0.11980948.12663466.html.plaintext.txt	176	two possible explanation role pka
0.11980948.12663466.html.plaintext.txt	177	first basal activity pka may required ghrelin produce canum signaling
0.11980948.12663466.html.plaintext.txt	178	second ghrelin ghsr system may activate g adenylate cyclase camp pka cascade turn lead canum influx canumi increase
0.11980948.12663466.html.plaintext.txt	179	pka mediated facilitation canum influx canumi increase indicated cardiac muscle pancreatic s cell numnum
0.11980948.12663466.html.plaintext.txt	180	shown pka indispensable creb phosphorylation camp response element mediated gene expression npy neuron fasted state num
0.11980948.12663466.html.plaintext.txt	181	ghrelin could couple fasting activation pka release peptide greatly stimulated fasting num
0.11980948.12663466.html.plaintext.txt	182	finding present study others indicate pka important ghrelin induced activation npy neuron
0.11980948.12663466.html.plaintext.txt	183	whether ghrelin induced canum signaling npy neuron depends basal pka activity requires activation pka peptide remains clarified
0.11980948.12663466.html.plaintext.txt	184	present study ghrelin orexin increased canumi neuron arc
0.11980948.12663466.html.plaintext.txt	185	majority ghrelin responsive neuron num also responded orexin vise versa num showing two population responder highly overlapped
0.11980948.12663466.html.plaintext.txt	186	ghrelin orexin responsive neuron included eight npy containing neuron
0.11980948.12663466.html.plaintext.txt	187	orexin num receptor reportedly expressed num npy neuron num
0.11980948.12663466.html.plaintext.txt	188	result clearly demonstrate presence subset npy neuron serf common target ghrelin orexin
0.11980948.12663466.html.plaintext.txt	189	shown fasting lowering glucose concentration increase level ghrelin num activate orexin neuron numnum suggesting release two peptide regulated parallel
0.11980948.12663466.html.plaintext.txt	190	finding indicates ghrelin orexin may also cooperate common effector site npy neuron arc could result efficient stimulation npy mediated neural signaling feeding
0.11980948.12663466.html.plaintext.txt	191	found leptin suppresses ghrelin induced canumi increase majority ghrelin responsive neuron num
0.11980948.12663466.html.plaintext.txt	192	ghrelin leptin responsive neuron included seven npy containing neuron
0.11980948.12663466.html.plaintext.txt	193	thus npy neuron arc regulated reciprocally ghrelin leptin
0.11980948.12663466.html.plaintext.txt	194	accord report num fo positive cell ventromedial arc due intraperitoneal injection ghrelin also immunoreactive leptin receptor num
0.11980948.12663466.html.plaintext.txt	195	recently reported action leptin antagonize camp elevation num num possible mechanism leptin counteracts effect ghrelin dependent camp pka demonstrated present study
0.11980948.12663466.html.plaintext.txt	196	action leptin could also involve phosphoinositide num kinase num num
0.11980948.12663466.html.plaintext.txt	197	furthermore found orexin induced canumi increase npy neuron arc inhibited leptin
0.11980948.12663466.html.plaintext.txt	198	thus npy neuron regulated directly cooperatively ghrelin orexin leptin important regulator feeding
0.11980948.12663466.html.plaintext.txt	199	conclusion data demonstrate ghrelin directly interacts npy neuron arc elicit canum signaling via pka n type canum channel dependent mechanism
0.11980948.12663466.html.plaintext.txt	200	could serve major neuronal signaling mechanism ghrelin stimulates npy release thereby feeding
0.11980948.12663466.html.plaintext.txt	201	ghrelin responsive neuron highly overlapped orexin leptin responsive neuron
0.11980948.12663466.html.plaintext.txt	202	integration stimulatory effect ghrelin orexin inhibitory effect leptin may play important role regulation activity npy neuron thereby feeding
0.11980948.12663466.html.plaintext.txt	203	acknowledgment work supported grant aid scientific research japan society promotion science num grant japan diabetes foundation national cardiovascular research institute asahi life foundation adult disease institute
0.11980948.12663466.html.plaintext.txt	204	nakazato providing ghrelin helpful discussion
0.11980948.12663466.html.plaintext.txt	205	footnote address correspondence reprint request dr
0.11980948.12663466.html.plaintext.txt	206	toshihiko yada department physiology division integrative physiology jichi medical school school medicine minamikawachi kawachi tochigi num num japan
0.11980948.12663466.html.plaintext.txt	207	received publication num september num accepted revised form num january num
0.11980948.12663466.html.plaintext.txt	208	arc arcuate nucleus er endoplasmic reticulum ghs growth hormone secretagogue ghsr ghs receptor hkrb hepes buffered krebs ringer bicarbonate buffer icv intracerebroventricular npy neuropeptide y pka protein kinase pkc protein kinase c tpa num num tetradecanoylphorbol num acetate
0.12693419.14871884.html.plaintext.txt	0	sleep enhances nocturnal plasma ghrelin level healthy subject andrea dzaja mira
0.12693419.14871884.html.plaintext.txt	1	dalal hubertus himmerich manfred uhr thomas pollmacher andreas schuld
0.12693419.14871884.html.plaintext.txt	2	max planck institute psychiatry num munich germany
0.12693419.14871884.html.plaintext.txt	3	submitted num november num accepted final form num february num
0.12693419.14871884.html.plaintext.txt	4	growth hormone cortisol circadian rhythm slow wave sleep sleep deprivation
0.12693419.14871884.html.plaintext.txt	5	ghrelin num amino acid polypeptide discovered endogenous ligand growth hormone secretagogue receptor num
0.12693419.14871884.html.plaintext.txt	6	ghrelin synthesized mainly stomach endocrine cell also identified tissue including hypothalamus num num num
0.12693419.14871884.html.plaintext.txt	7	ghrelin stimulates growth hormone secretion increase food intake appetite promotes body weight gain num num num
0.12693419.14871884.html.plaintext.txt	8	recent finding suggest ghrelin might involved regulation sleep human promoting slow wave sleep sw num
0.12693419.14871884.html.plaintext.txt	9	plasma ghrelin level increase fasting decline within num h food intake num
0.12693419.14871884.html.plaintext.txt	10	furthermore ghrelin level observed increase night sleeping subject decrease morning hour awakening thus breakfast num
0.12693419.14871884.html.plaintext.txt	11	time course sleeping subject suggests existence mechanism regulating ghrelin production dependent food intake
0.12693419.14871884.html.plaintext.txt	12	possible candidate circadian rhythm regulating numerous endocrine network example secretion cortisol leptin num num turn related insulin blood glucose level num
0.12693419.14871884.html.plaintext.txt	13	alternatively sleep might directly influence ghrelin production demonstrated example secretion growth hormone pituitary num
0.12693419.14871884.html.plaintext.txt	14	dissect diurnal variation sleep related influence ghrelin production performed study num h pattern ghrelin secretion healthy male
0.12693419.14871884.html.plaintext.txt	15	two experimental session num num following morning subject allowed sleep sleep deprived balanced order
0.12693419.14871884.html.plaintext.txt	16	nocturnal ghrelin secretion compared two condition using within subject design
0.12693419.14871884.html.plaintext.txt	17	study performed using balanced randomized within subject design
0.12693419.14871884.html.plaintext.txt	18	every subject participated two num h experiment
0.12693419.14871884.html.plaintext.txt	19	subject totally sleep deprived time allowed sleep num num
0.12693419.14871884.html.plaintext.txt	20	time interval two session bordernumnum wk
0.12693419.14871884.html.plaintext.txt	21	adjust experimental setting subject spent night session num num sleep laboratory
0.12693419.14871884.html.plaintext.txt	22	num electrode eeg electromyogram electrooculogram recording placed according standardized criterion num
0.12693419.14871884.html.plaintext.txt	23	subject remained semirecumbent position received standardized meal four different time point
0.12693419.14871884.html.plaintext.txt	24	subject received standardized diet hospital kitchen numnum kcalnum h containing num fat num carbohydrate num protein
0.12693419.14871884.html.plaintext.txt	25	subject allowed eat additional food
0.12693419.14871884.html.plaintext.txt	26	measurement started num
0.12693419.14871884.html.plaintext.txt	27	subject stayed bed num h num next morning
0.12693419.14871884.html.plaintext.txt	28	artificial light intensity always num lux
0.12693419.14871884.html.plaintext.txt	29	light turned subject allowed sleep num num sleep condition
0.12693419.14871884.html.plaintext.txt	30	sleep deprivation another person stayed continuously room subject prevent lapse sleep
0.12693419.14871884.html.plaintext.txt	31	standardized meal served num num num num next morning
0.12693419.14871884.html.plaintext.txt	32	water freely available whole experimental session
0.12693419.14871884.html.plaintext.txt	33	blood sample taken hourly via intravenous catheter placed antecubital vein kept patent continuous num
0.12693419.14871884.html.plaintext.txt	34	num saline infusion containing num iu na heparinl rate num mlh
0.12693419.14871884.html.plaintext.txt	35	minimize disturbance sleep continuity blood sampling done wall via long line room adjacent sleep laboratory
0.12693419.14871884.html.plaintext.txt	36	blood collected tube stored ice contained na edta num mgml blood aprotinin num kallikrein inhibitor unitsml blood
0.12693419.14871884.html.plaintext.txt	37	immediately withdrawal blood centrifuged numnum g num min num degree c plasma aliquoted frozen num degree c various assay performed
0.12693419.14871884.html.plaintext.txt	38	ensure sleep deprivation successful polygraphic recording obtained throughout num h
0.12693419.14871884.html.plaintext.txt	39	record visually scored num epoch standardized criterion num experienced person blind experimental condition
0.12693419.14871884.html.plaintext.txt	40	sleep deprivation none subject displayed rapid eye movement rem sleep non rem sleep stage num num
0.12693419.14871884.html.plaintext.txt	41	sleep parameter sleep phase sleep condition shown table num
0.12693419.14871884.html.plaintext.txt	42	sleep quality distribution different sleep stage comparable data study healthy male volunteer underwent sleep recording intermittent blood sampling num num num table num
0.12693419.14871884.html.plaintext.txt	43	sleep parameter sleep condition
0.12693419.14871884.html.plaintext.txt	44	determination ghrelin human growth hormone cortisol plasma level
0.12693419.14871884.html.plaintext.txt	45	total plasma ghrelin level determined radioimmunoassay phoenix pharmaceutical mountain view ca
0.12693419.14871884.html.plaintext.txt	46	limit detection num pgml
0.12693419.14871884.html.plaintext.txt	47	intra interassay coefficient variation num
0.12693419.14871884.html.plaintext.txt	48	human growth hormone hgh plasma level determined using radioimmunoassay purchased nichols institute diagnostics san juan capistrano ca
0.12693419.14871884.html.plaintext.txt	49	num ngml intra interassay coefficient variation num
0.12693419.14871884.html.plaintext.txt	50	plasma cortisol level determined mean radioimmunoassay icn biomedicals carson ca
0.12693419.14871884.html.plaintext.txt	51	num ngml intra interassay coefficient variation num
0.12693419.14871884.html.plaintext.txt	52	compare nocturnal hormone plasma level sleep condition sleep deprivation condition anova repeated measure performed time condition sleep v
0.12693419.14871884.html.plaintext.txt	53	sleep deprivation within subject factor
0.12693419.14871884.html.plaintext.txt	54	avoid many posteriori test would imply strong reduction level significance five time point num num included num num num num num anova
0.12693419.14871884.html.plaintext.txt	55	hormone average measured plasma concentration sleep period considered baseline value condition tested significance separate anova
0.12693419.14871884.html.plaintext.txt	56	hormone baseline plasma concentration differed significantly two condition corresponding value sleep period normed baseline value anova application
0.12693419.14871884.html.plaintext.txt	57	additionally ghrelin level compared condition recently developed methodology comparison stability hormone concentration curve num
0.12693419.14871884.html.plaintext.txt	58	finally peak level hgh num num determined associated ghrelin concentration num num area curve interval well using pearsons correlation coefficient
0.12693419.14871884.html.plaintext.txt	59	level statistical significance set num
0.12693419.14871884.html.plaintext.txt	60	one subject excluded statistical analysis blood sample available num num sleep condition due technical reason
0.12693419.14871884.html.plaintext.txt	61	figure data depicted mean plus minus se table data given mean plus minus sd
0.12693419.14871884.html.plaintext.txt	62	view larger version numk fig
0.12693419.14871884.html.plaintext.txt	63	plasma level ghrelin human growth hormone hgh cortisol num healthy subject sleep sleep deprivation
0.12693419.14871884.html.plaintext.txt	64	arrow indicate food intake black bar indicates time subject allowed sleep kept awake respectively
0.12693419.14871884.html.plaintext.txt	65	anova also revealed significant difference nocturnal hgh secretion condition fnumnum num
0.12693419.14871884.html.plaintext.txt	66	num confirming well established hgh peak around sleep onset strong attenuation sleep deprivation fig
0.12693419.14871884.html.plaintext.txt	67	peak hgh level night sleep positively correlated ghrelin secretion first num h sleep r num
0.12693419.14871884.html.plaintext.txt	68	similar nonsignificant n relationship r num
0.12693419.14871884.html.plaintext.txt	69	num n obvious hgh ghrelin level suppressed sleep deprivation
0.12693419.14871884.html.plaintext.txt	70	day ghrelin hgh plasma level increased meal declined thereafter fig
0.12693419.14871884.html.plaintext.txt	71	view larger version numk fig
0.12693419.14871884.html.plaintext.txt	72	area curve auc ghrelin secretion num num sleep num healthy subject
0.12693419.14871884.html.plaintext.txt	73	pearsons correlation coefficient revealed significant positive correlation r num
0.12693419.14871884.html.plaintext.txt	74	cortisol level across num h experimental period showed well known circadian variability maximum morning nadir night
0.12693419.14871884.html.plaintext.txt	75	anova repeated measure revealed significant difference two condition fnumnum num
0.12693419.14871884.html.plaintext.txt	76	sleep related growth hormone secretion probably caused increased production hypothalamic growth hormone releasing hormone ghrh acting pituitary num
0.12693419.14871884.html.plaintext.txt	77	ghrelin contrast produced mainly stomach splanchnic organ num num
0.12693419.14871884.html.plaintext.txt	78	small quantity might also produced hypothalamus review see ref
0.12693419.14871884.html.plaintext.txt	79	num unlikely contribute systemic level num
0.12693419.14871884.html.plaintext.txt	80	hence almost certain increased ghrelin level found sleeping subject due peripheral production
0.12693419.14871884.html.plaintext.txt	81	yet unclear present brain might act ghrelin producing cell
0.12693419.14871884.html.plaintext.txt	82	despite positive correlation ghrelin hgh secretion causative role hgh unlikely number study demonstrated hgh administration affect ghrelin level num num num num
0.12693419.14871884.html.plaintext.txt	83	study investigating interaction ghrelin production feeding suggest influence vagal cholinergic efferent ghrelin production transmission ghrelin signal brain vagal afferent num num
0.12693419.14871884.html.plaintext.txt	84	study indicate negative influence vagus ghrelin secretion
0.12693419.14871884.html.plaintext.txt	85	therefore increased parasympathetic tone occurring sleep num unlikely explain increased ghrelin secretion opposite would rather expected
0.12693419.14871884.html.plaintext.txt	86	hence although present result clearly demonstrate increased ghrelin level sleep question remains solved sleeping brain stimulates ghrelin secretion
0.12693419.14871884.html.plaintext.txt	87	first glance easy understand production appetite stimulating hormone increased sleep
0.12693419.14871884.html.plaintext.txt	88	however interaction among metabolic endocrine sleep regulating network complex ghrelin numerous function
0.12693419.14871884.html.plaintext.txt	89	ghrelin recently shown increase sw effect probably dependent ghrh receptor num num
0.12693419.14871884.html.plaintext.txt	90	therefore ghrelin might represent peripheral feed forward signal support sw initiation andor maintenance first hour night sleep concert central sw promoting action ghrh num
0.12693419.14871884.html.plaintext.txt	91	similarly ghrelin potent growth hormone secretagogue num might reinforce central ghrh signal enhanced hgh production
0.12693419.14871884.html.plaintext.txt	92	idea supported correlation hgh ghrelin production shown fig
0.12693419.14871884.html.plaintext.txt	93	study interaction sleep neuroendocrine factor date back late nums e
0.12693419.14871884.html.plaintext.txt	94	num recently particularly intriguing link sleep regulation appetite became evident
0.12693419.14871884.html.plaintext.txt	95	orexins hypothalamic peptide initially thought mainly regulate food intake also potent arousing property num play crucial role pathophysiology narcolepsy
0.12693419.14871884.html.plaintext.txt	96	narcolepsy characterized excessive daytime sleepiness cataplexy sudden short lasting loss muscle tone triggered emotion acquired complete loss hypothalamic orexin production hypothalamus patient num
0.12693419.14871884.html.plaintext.txt	97	addition sleep related symptom patient display various endocrine metabolic abnormality obesity hypoleptinemia num num
0.12693419.14871884.html.plaintext.txt	98	like ghrelin plasma level orexin cerebrospinal fluid level increased night num ghrelin induced food intake mediated orexinergic pathway num
0.12693419.14871884.html.plaintext.txt	99	therefore might great interest investigate ghrelin baseline condition association sleep sleep deprivation association meal narcoleptic patient
0.12693419.14871884.html.plaintext.txt	100	conclude ghrelin production enhanced night sleep healthy human correlate increased release hgh occurring parallel
0.12693419.14871884.html.plaintext.txt	101	although underlying mechanism remain elucidated present study support idea ghrelin novel important player within sleep neuroendocrine interplay
0.12693419.14871884.html.plaintext.txt	102	acknowledgment gratefully acknowledge statistical advice dr
0.12693419.14871884.html.plaintext.txt	103	alexander yassouridis helpful comment dr
0.12693419.14871884.html.plaintext.txt	104	furthermore thank gabriele kohl expert technical assistance dorothea skottke assistance preparing manuscript
0.12693419.14871884.html.plaintext.txt	105	footnote address reprint request correspondence
0.12693419.14871884.html.plaintext.txt	106	schuld max planck institute psychiatry kraepelinstrasse num num munich germany e mail schuldatmpipsykl
0.12693419.14871884.html.plaintext.txt	107	cost publication article defrayed part payment page charge
0.12693419.14871884.html.plaintext.txt	108	article must therefore hereby marked advertisement accordance num u
0.12693419.14871884.html.plaintext.txt	109	section num solely indicate fact
0.14533791.15976062.html.plaintext.txt	0	orexin modulates mitral cell activity rat olfactory bulb patch clamp study slice immunocytochemical localization orexin receptor alexandre b
0.14533791.15976062.html.plaintext.txt	1	hardy josiane aioun christine baly karyn
0.14533791.15976062.html.plaintext.txt	2	julliard monique caillol roland salesse patricia duchamp viret
0.14533791.15976062.html.plaintext.txt	3	laboratoire de neuroscience et systemes sensoriels
0.14533791.15976062.html.plaintext.txt	4	centre national de la recherche scientifique unite mixte de recherche num universite claude bernard num lyon cedex num laboratoire neurobiologie de l olfaction et prise alimentaire j
0.14533791.15976062.html.plaintext.txt	5	equipe recepteurs et communication chimique institut national de la recherche agronomique num jouy en josas france
0.14533791.15976062.html.plaintext.txt	6	address correspondence request reprint patricia duchamp viret laboratoire de neuroscience et systemes sensoriels centre national de la recherche scientifique unite mixte de recherche num universite claude bernard num avenue tony garnier num lyon cedex num france
0.14533791.15976062.html.plaintext.txt	7	conversely shown odor regulate food intake behavior
0.14533791.15976062.html.plaintext.txt	8	indeed le magnen num showed rat increased food intake satiated presented differently odorized food
0.14533791.15976062.html.plaintext.txt	9	moreover everyday experience human animal food odor attractive feeding whereas stimulus may become neutral even aversive feeding
0.14533791.15976062.html.plaintext.txt	10	sensory olfactory input thus crucial nutrition behavior human animal
0.14533791.15976062.html.plaintext.txt	11	olfactory system involvement begin food search step olfactory sensitivity level provide signal detection allows animal follow concentration gradient toward food source
0.14533791.15976062.html.plaintext.txt	12	olfactory system contributes palatability analysis food appetence animal food defined internal physiological status
0.14533791.15976062.html.plaintext.txt	13	hypothalamic feeding center num analyze metabolic cue turn regulate appetite
0.14533791.15976062.html.plaintext.txt	14	center send direct specific projection olfactory structure especially olfactory bulb ob first integrative relay system num num num num num
0.14533791.15976062.html.plaintext.txt	15	discovery orexin oxa b oxb hypocretin ii num num two peptide derived prepropeptide contained neuron localized lateral hypothalamus perifornical area provided new insight regulation mechanism feeding
0.14533791.15976062.html.plaintext.txt	16	orexin ox neuron lateral hypothalamus perifornical area controlled change circulating nutriment activated natural hypoglycemic condition num insulin induced one num whereas inhibited glucose signal related ingestion food num num num num num
0.14533791.15976062.html.plaintext.txt	17	data led classification ox neuron lateral hypothalamus perifornical area glucose sensitive neuron num
0.14533791.15976062.html.plaintext.txt	18	furthermore ox neuron stimulated increase circulating lipid
0.14533791.15976062.html.plaintext.txt	19	thus ox neuron negatively related glucose level inversely related circulating fat num latter relation suggesting role peptide increased activity associated high fat diet num num
0.14533791.15976062.html.plaintext.txt	20	majority physiological study review see ref
0.14533791.15976062.html.plaintext.txt	21	num num indicate orexins potent stimulators food intake num num oxa effective oxb
0.14533791.15976062.html.plaintext.txt	22	moreover peptide interact various neuronal pathway potentiate apparently divergent function review see ref
0.14533791.15976062.html.plaintext.txt	23	currently two closely related g protein coupled receptor type termed type num orexin receptor orxnum type num orexin receptor orxnum identified
0.14533791.15976062.html.plaintext.txt	24	although oxa affinity orxnum orxnum oxb num fold greater affinity orxnum num num num
0.14533791.15976062.html.plaintext.txt	25	num demonstrated ob immunoreactive oxa varicose fiber mainly around glomerulus mitral cell granule cell layer
0.14533791.15976062.html.plaintext.txt	26	glomerulus spherical neuropile lying ob periphery primary axon synapse mitral cell delimited gabaergic interneurons called periglomerular cell
0.14533791.15976062.html.plaintext.txt	27	granule cell deep gabaergic inhibitory interneurons
0.14533791.15976062.html.plaintext.txt	28	localization oxb labeling paralleled oxa
0.14533791.15976062.html.plaintext.txt	29	however immunoreactivity orxnum orxnum detected mitraltufted cell body orxnum labeling faint num
0.14533791.15976062.html.plaintext.txt	30	localization may support least partly data reporting ob mitral cell reactivity odor modulated according hunger satiation state rat num
0.14533791.15976062.html.plaintext.txt	31	exploration ox action ob network provide better understanding cross talk olfactory metabolic cue brain basis nutritional behavior
0.14533791.15976062.html.plaintext.txt	32	study analyzed specifically ox action mitral cell putative cell target ob num vitro patch clamp study
0.14533791.15976062.html.plaintext.txt	33	action oxa sb num orxnum antagonist glaxosmithkline harlow essex uk tested spontaneous activity excitability mitral cell
0.14533791.15976062.html.plaintext.txt	34	furthermore immunocytochemical study done clarify cellular subcellular localization orxnum expressed orexin receptor ob
0.14533791.15976062.html.plaintext.txt	35	addition data available early ontogenetic development orexin innervation orexin receptor ob electrophysiological study slice performed num num d old rat presence orxnum evaluated rt pcr experiment rat adult num num postnatal day p old
0.14533791.15976062.html.plaintext.txt	36	altogether data expected provide enlightenment neurochemical modulatory effect oxa ob activity reveal cell type bulbar network target orexin innervation
0.14533791.15976062.html.plaintext.txt	37	furthermore first functional study expected give rise preliminary hypothesis dealing role olfactory system regulation food intake process
0.14533791.15976062.html.plaintext.txt	38	rt pcr analysis orexin receptor expression hypothalamus hypo ob animal tissue preparation
0.14533791.15976062.html.plaintext.txt	39	experimental procedure carried minimize animal suffering number rat used
0.14533791.15976062.html.plaintext.txt	40	male wistar rat breeding stock housed num h light num h dark cycle free access food water
0.14533791.15976062.html.plaintext.txt	41	total three animal killed decapitation num d num d pnum pnum num month adult
0.14533791.15976062.html.plaintext.txt	42	weaning pnum young kept dam
0.14533791.15976062.html.plaintext.txt	43	brain quickly removed hypo ob dissected ice
0.14533791.15976062.html.plaintext.txt	44	total rna isolation rt pcr analysis
0.14533791.15976062.html.plaintext.txt	45	total rna isolated hypo ob using guanidium thiocyanate phenol chloroform extraction method num dnase treated roche molecular biochemicals meylan france cdna reverse transcribed num microg total rna num u superscript ii reverse transcriptase according manufacturer procedure life technology inc
0.14533791.15976062.html.plaintext.txt	46	control reaction omitting enzyme systematically included confirm absence genomic contamination
0.14533791.15976062.html.plaintext.txt	47	internal standard using glyceraldehyde num phophate dehydrogenase gapdh referent housekeeping gene systematically included
0.14533791.15976062.html.plaintext.txt	48	pcr amplification num microl reverse transcription aliquot added num microl reaction mixture containing pair primer gapdh primer num aaacccatcaccatcttcca num num nmnum low num aggggccatccacagtcttct num num orxnum primer num cctgcctccagactatgagga num num nmnum low num atcttagggtagagttcatct num num orxnum primer num gattccctccctcgtcgcaa num num nmnum
0.14533791.15976062.html.plaintext.txt	49	num low num cagcgttcatcgcagactgta num num
0.14533791.15976062.html.plaintext.txt	50	pcrs done according standard procedure using num
0.14533791.15976062.html.plaintext.txt	51	numu taq dna polymerase promega charbonnieres france
0.14533791.15976062.html.plaintext.txt	52	thermal cycler apparatus used following condition num sec num c num sec num c num sec num c num gapdh num cycle orxnum orxnum
0.14533791.15976062.html.plaintext.txt	53	pcr product num microl aliquot resolved num
0.14533791.15976062.html.plaintext.txt	54	num agarose gel numx tae tris acetate edta buffer containing num microgml ethidium bromide
0.14533791.15976062.html.plaintext.txt	55	molecular weight marker systematically included num kb dna ladder life technology inc
0.14533791.15976062.html.plaintext.txt	56	invitrogen cergy pontoise france
0.14533791.15976062.html.plaintext.txt	57	gel photographed uv light
0.14533791.15976062.html.plaintext.txt	58	ob pcr product num d old rat sequenced genome express paris france analyzed using blast program
0.14533791.15976062.html.plaintext.txt	59	structural ultrastructural immunocytochemical study seven male wistar rat used light microscopy three adult rat num month old body weight num g two pnum two pnum
0.14533791.15976062.html.plaintext.txt	60	animal deeply anesthetized pentobarbital num mgkg body weight ip sanofi paris france perfused transcardially num ml saline num ml freshly prepared fixative solution num paraformaldehyde num
0.14533791.15976062.html.plaintext.txt	61	olfactory bulb carefully dissected postfixed fixative num h room temperature cryoprotected saccharose num cut cryostat serial coronal section num microm thick
0.14533791.15976062.html.plaintext.txt	62	section first treated num min num c num
0.14533791.15976062.html.plaintext.txt	63	num hnumonum pb eliminate endogenous peroxidase carefully washed
0.14533791.15976062.html.plaintext.txt	64	num h immersion solution num normal goat serum pb room temperature rt used block nonspecific site
0.14533791.15976062.html.plaintext.txt	65	section incubated num c num d primary antibody diluted numnum pb containing num normal goat serum num
0.14533791.15976062.html.plaintext.txt	66	num bsa rabbit antiserum directed rathuman orxnum alpha diagnostic international cortec france
0.14533791.15976062.html.plaintext.txt	67	control section incubated without primary antibody
0.14533791.15976062.html.plaintext.txt	68	several washing pb containing num nonfat freeze dried milk section incubated biotinylated goat antirabbit igg vectastain elite kit vector laboratory burlingame ca buffer num num h rt
0.14533791.15976062.html.plaintext.txt	69	section rinsed pb incubated num h rt either avidin biotin peroxidase complex vectastain elite kit labeling visualized using num num diaminobenzidine tetrahydrochloride solution intensified nickel peroxidase substrate kit vector laboratory streptavidin fluorescein numnum vector laboratory numnum diamino num phenylindole dapi added num min numnumnum pb achieve nuclear counterstaining
0.14533791.15976062.html.plaintext.txt	70	electron microscopy done three adult male wistar rat deeply anesthetized described
0.14533791.15976062.html.plaintext.txt	71	transcardially perfused num ml saline followed num ml freshly prepared fixative solution paraformaldehyde num picric acid num
0.14533791.15976062.html.plaintext.txt	72	brain dissected postfixed overnight num c fixative
0.14533791.15976062.html.plaintext.txt	73	serial coronal section num microm obtained vibratome vtnums leica nussloch germany collected phosphate buffer
0.14533791.15976062.html.plaintext.txt	74	immunocytochemical study performed free floating section pb using preembedding protocol previously described except triton x num omitted section immersed num sodium borohydride nabhnum sigma aldrich saint quentin fallavier france pb quench free aldehydic site blocking nonspecific site
0.14533791.15976062.html.plaintext.txt	75	orxnum visualized using diaminobenzidine dab method adapted electron microscopy
0.14533791.15976062.html.plaintext.txt	76	num m sucrosed tris buffer ph num
0.14533791.15976062.html.plaintext.txt	77	num dab substrate presence hnumonum
0.14533791.15976062.html.plaintext.txt	78	reaction conducted stereomicroscope stopped immersion section tris buffer
0.14533791.15976062.html.plaintext.txt	79	immunostained section selected osmicated num osonum solution stained en bloc num uranyl acetate dehydrated graded series ethanol embedded epoxy resin lxnum ladd research industry inland europe conflanslanterne france
0.14533791.15976062.html.plaintext.txt	80	semithin section num num microm obtained resin embedded material stained toluidine blue
0.14533791.15976062.html.plaintext.txt	81	ultrathin section num num nm collected copper grid contrasted lead citrate observed philip suresne france cmnum electron microscope num kv accelerating voltage
0.14533791.15976062.html.plaintext.txt	82	patch clamp recording experiment slice preparation
0.14533791.15976062.html.plaintext.txt	83	experiment performed num num d old rat wistar
0.14533791.15976062.html.plaintext.txt	84	animal killed decapitation head quickly immersed ice cold artificial cerebrospinal fluid acsf num num c containing millimoles num nacl num kcl num nahconum num caclnum num
0.14533791.15976062.html.plaintext.txt	85	num bubbled mixture num onum num conum osmolarity adjusted num mosm glucose
0.14533791.15976062.html.plaintext.txt	86	ob removed previously detailed num cut sagittal horizontal slice num num microm thick using vibratome
0.14533791.15976062.html.plaintext.txt	87	slice incubated gibb chamber num c num h stored rt
0.14533791.15976062.html.plaintext.txt	88	electrophysiological recording slice transferred experimental chamber num ml mounted upright microscope axioscope f zeiss gottingen germany
0.14533791.15976062.html.plaintext.txt	89	recording slice continuously perfused oxygenated num c acsf num
0.14533791.15976062.html.plaintext.txt	90	neuron visualized using water immersion xnum objective differential interference contrast optic nomarski edgewater nj infrared illumination hamamatsu camera hamamatsu photonics france massy france
0.14533791.15976062.html.plaintext.txt	91	electrophysiological recording
0.14533791.15976062.html.plaintext.txt	92	whole cell recording technique used
0.14533791.15976062.html.plaintext.txt	93	patch pipette pulled borosilicate glass outer diameter num
0.14533791.15976062.html.plaintext.txt	94	num mm clark electromedical instrument phymep paris france without internal filament fired polished
0.14533791.15976062.html.plaintext.txt	95	recording pipette tip resistance num num m
0.14533791.15976062.html.plaintext.txt	96	seal resistance always greater num g
0.14533791.15976062.html.plaintext.txt	97	recording pipette solution contained millimoles num
0.14533791.15976062.html.plaintext.txt	98	num gtpna num hepes num mgclnum ph set num
0.14533791.15976062.html.plaintext.txt	99	num naoh osmolarity num mosmol glucose
0.14533791.15976062.html.plaintext.txt	100	experiment reported value membrane potential value correction junction potential
0.14533791.15976062.html.plaintext.txt	101	bipolar concentric electrode placed olfactory nerve layer near recorded mitraltufted cell stimulate olfactory nerve
0.14533791.15976062.html.plaintext.txt	102	monophasic square pulse delivered stimulus isolation unit
0.14533791.15976062.html.plaintext.txt	103	voltage current measurement neuron activity performed axoclamp numb amplifier axon instrument foster city ca
0.14533791.15976062.html.plaintext.txt	104	experiment controlled pc pentium iii computer using num bit ad da converter digidata numb axon instrument sampling frequency num khz clampex software version num
0.14533791.15976062.html.plaintext.txt	105	data presented mean plus minus sd
0.14533791.15976062.html.plaintext.txt	106	oxa bachem voisins le brettoneux france aliquoted stored num c
0.14533791.15976062.html.plaintext.txt	107	oxa action mitral cell tested switching acsf solution num min one containing oxa num num nm see ref
0.14533791.15976062.html.plaintext.txt	108	solution perfused tissue num
0.14533791.15976062.html.plaintext.txt	109	experiment performed presence tetrodotoxin ttx num microm tocris fisher bioblock scientific illkirch france block voltage gated sodium channel
0.14533791.15976062.html.plaintext.txt	110	picrotoxin num microm sigma bicuculline num microm sigma also used block chloride conductance gabaa receptor respectively
0.14533791.15976062.html.plaintext.txt	111	orxnum blocked sb num num microm glaxosmithkline see ref
0.14533791.15976062.html.plaintext.txt	112	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	113	detection different orexin receptor mrna rt pcr analysis hypo ob tissue
0.14533791.15976062.html.plaintext.txt	114	pcr product gapdh orxnum orxnum obtained hypo ob sample num num d old num num adult rat ad run ethidium bromide stained num
0.14533791.15976062.html.plaintext.txt	115	product expected size controlled sequencing pcr product derived obnum sample
0.14533791.15976062.html.plaintext.txt	116	o control without dna matrix mwm molecular weight marker num kb dna ladder numnum bp band specified
0.14533791.15976062.html.plaintext.txt	117	one representative rat experimental point shown n num
0.14533791.15976062.html.plaintext.txt	118	structural ultrastructural immunocytochemical study light microscopic localization orxnum immunoreactivity ob
0.14533791.15976062.html.plaintext.txt	119	num showed orxnum seems expressed higher level orxnum protein level present study focused orxnum
0.14533791.15976062.html.plaintext.txt	120	observation confirmed refined previous description orxnum localization ob num
0.14533791.15976062.html.plaintext.txt	121	light microscopic level orxnum immunoreactive cell identified dark staining due presence dab nickel reaction product green fluorescence cytoplasm fig
0.14533791.15976062.html.plaintext.txt	122	pnum pnum adult rat orxnum distributed laminar pattern
0.14533791.15976062.html.plaintext.txt	123	orxnum immunoreactivity obvious cell body glomerular fig
0.14533791.15976062.html.plaintext.txt	124	num b e mitral cell granule cell layer fig
0.14533791.15976062.html.plaintext.txt	125	immunolabeling homogeneous along mitral cell layer immunoreactive mitral cell clustered patch
0.14533791.15976062.html.plaintext.txt	126	way glomerulus orxnum immunoreactive whereas others devoid immunolabeling
0.14533791.15976062.html.plaintext.txt	127	often orxnum immunoreactive glomerulus located immunoreactive zone mitral cell layer
0.14533791.15976062.html.plaintext.txt	128	glomerular layer immunoreactive cell body found base glomerulus external plexiform layer
0.14533791.15976062.html.plaintext.txt	129	neuron rather elongated shape whereas others slightly smaller round
0.14533791.15976062.html.plaintext.txt	130	round neuron also observed around glomerulus
0.14533791.15976062.html.plaintext.txt	131	according location neuron could correspond external tufted cell periglomerular cell pgs respectively
0.14533791.15976062.html.plaintext.txt	132	semifine section brown dot probably corresponding mitral cell dendrite appeared dispersed external plexiform layer epl inside glomerulus
0.14533791.15976062.html.plaintext.txt	133	section primary antiserum omitted immunolabeling observed
0.14533791.15976062.html.plaintext.txt	134	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	135	light microscopic localization orxnum immunoreactivity ob
0.14533791.15976062.html.plaintext.txt	136	presence orxnum ob checked semithin section obtained num microm section embedded epoxy resin adult d thin section num microm pnum rat e pnum rat f
0.14533791.15976062.html.plaintext.txt	137	semithin section observed either stained toluidine blue num microm thick c without counterstaining num microm thick b d
0.14533791.15976062.html.plaintext.txt	138	presence orxnum visualized dark dab d dab nickel staining spread cytoplasm immunoreactive ir cell e green fluorescence f blue staining numnum diamino num phenylindole nuclear coloration
0.14533791.15976062.html.plaintext.txt	139	orxnum ir cell body identified layer except olfactory nerve layer
0.14533791.15976062.html.plaintext.txt	140	glomerular layer b xnum immersion ir cell body observed around glomerulus
0.14533791.15976062.html.plaintext.txt	141	large elongated cell body mostly located basis glomerulus could external tufted cell large arrow whereas small round cell body border could identified pg cell thin arrow
0.14533791.15976062.html.plaintext.txt	142	inside glomerulus brown dot likely mitral cell dendrite arrowhead
0.14533791.15976062.html.plaintext.txt	143	mitral cell layer cytoplasm mitral cell highly ir large arrow c d xnum immersion
0.14533791.15976062.html.plaintext.txt	144	mitral cell express orxnum arrowhead c d
0.14533791.15976062.html.plaintext.txt	145	section mitral cell nucleus apparent devoid immunolabeling c d
0.14533791.15976062.html.plaintext.txt	146	granule cell orxnum ir e f
0.14533791.15976062.html.plaintext.txt	147	epl punctiform dab labeling thin arrow numd corresponded presumably mitral cell dendrite
0.14533791.15976062.html.plaintext.txt	148	bc blood capillary gcl granular cell layer gl glomerulus mcl mitral cell layer n nucleus
0.14533791.15976062.html.plaintext.txt	149	ultrastructural localization orxnum immunoreactivity ob
0.14533791.15976062.html.plaintext.txt	150	electron microscopy observation confirmed light microscopy observation
0.14533791.15976062.html.plaintext.txt	151	ultrastrutural level presence orxnum visualized electron dense dab deposit
0.14533791.15976062.html.plaintext.txt	152	identification immunoreactive element based description pinching powell num num price powell num
0.14533791.15976062.html.plaintext.txt	153	deep ob orxnum expressed granule cell body localized cytoplasm neighborhood plasma membrane fig
0.14533791.15976062.html.plaintext.txt	154	mitral cell layer rather mitral cell body characterized typical abundant stack rough endoplasmic reticulum orxnum labeled
0.14533791.15976062.html.plaintext.txt	155	however orxnum immunoreactive mitral cell labeling obvious consisted numerous patch localized cisterna endoplasmic reticulum neighborhood plasma membrane indicating orxnum locally synthesized folded membrane fig
0.14533791.15976062.html.plaintext.txt	156	epl immunolabeling shown mitral cell granule cell dendrite fig numc reciprocal synapsis orxnum immunoreactive mitral cell granule cell dendrite could observed fig
0.14533791.15976062.html.plaintext.txt	157	numd accumulation labeling near synapse noted
0.14533791.15976062.html.plaintext.txt	158	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	159	ultrastructural localization orxnum granule cell layer mitral cell layer epl ob
0.14533791.15976062.html.plaintext.txt	160	ultrastructural level presence orxnum visualized electron dense dab deposit arrow
0.14533791.15976062.html.plaintext.txt	161	granule cell layer xnumnum orxnum immunoreactivity identified numerous granule cell body
0.14533791.15976062.html.plaintext.txt	162	labeling either cytoplasmic close plasma membrane
0.14533791.15976062.html.plaintext.txt	163	mitral cell layer b xnumnum mitral cell exhibited punctuated labeling also cytoplasmic close plasma membrane
0.14533791.15976062.html.plaintext.txt	164	epl c xnum orxnum immunoreactivity found mitral cell granule cell dendrite
0.14533791.15976062.html.plaintext.txt	165	case d xnumnum orxnum immunoreactive gemmule granule cell observed establishing synaptic contact mitral cell dendrite reciprocal synapsis arrowhead
0.14533791.15976062.html.plaintext.txt	166	rer rough endoplasmic reticulum gcg gemmule granule cell gc granule cell m mitochondrion mcd mitral cell dendrite mc mitral cell gcd granule cell dendrite v synaptic vesicle
0.14533791.15976062.html.plaintext.txt	167	glomerular layer immunolabeling found cell body process
0.14533791.15976062.html.plaintext.txt	168	orxnum immunoreactive neuron observed periphery glomerulus small round cell almost completely filled nucleus surrounded thin rim cytoplasm fig
0.14533791.15976062.html.plaintext.txt	169	ultrastructural feature corresponded pgs
0.14533791.15976062.html.plaintext.txt	170	base glomerulus infraglomerular area immunoreactive neuron identified
0.14533791.15976062.html.plaintext.txt	171	slightly larger pgs cytoplasm abundant showed well developed granular endoplasmic reticulum fig
0.14533791.15976062.html.plaintext.txt	172	basis description pinching powell num neuron identified external tufted cell
0.14533791.15976062.html.plaintext.txt	173	glomerular neuropil showed numerous orxnum immunoreactive process
0.14533791.15976062.html.plaintext.txt	174	strongly immunoreactive dendritic shaft observed
0.14533791.15976062.html.plaintext.txt	175	given regular arrangement neurotubules identified main dendritic shaft tufted cell shown
0.14533791.15976062.html.plaintext.txt	176	numerous dendrite mitraltufted cell surrounded olfactory neuron terminal orxnum immunoreactive fig
0.14533791.15976062.html.plaintext.txt	177	gemmule pg also orxnum immunoreactive fig
0.14533791.15976062.html.plaintext.txt	178	glomerular neuropil terminal olfactory axon never orxnum immunoreactive
0.14533791.15976062.html.plaintext.txt	179	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	180	ultrastructural localization orxnum glomerular layer ob
0.14533791.15976062.html.plaintext.txt	181	ultrastructural level presence orxnum visualized electron dense dab deposit arrow
0.14533791.15976062.html.plaintext.txt	182	glomerular layer xnumnum dab electron dense deposit arrow found small cell exhibiting large nucleus surrounded thin rim cytoplasm
0.14533791.15976062.html.plaintext.txt	183	cell located around glomerulus identified pgs
0.14533791.15976062.html.plaintext.txt	184	basis glomerulus infraglomerular layer area b xnumnum larger cell characterized stack rer also orxnum immunoreactive
0.14533791.15976062.html.plaintext.txt	185	ultrastructural characteristic correspond external tuft cell
0.14533791.15976062.html.plaintext.txt	186	glomerular neuropile c xnumnum d xnumnum orxnum immunoreactive dendrite mitraltufted cell numerous surrounded orn terminal showing synaptic contact c curved arrow
0.14533791.15976062.html.plaintext.txt	187	gemmule kind typical varicosity termed ob anatomist see ref
0.14533791.15976062.html.plaintext.txt	188	num pgs also orxnum immunoreactive e xnumnum
0.14533791.15976062.html.plaintext.txt	189	etc external tufted cell g glomerulus m mitochondrion mtcd mitraltufted cell dendrite orn olfactory receptor neuron rer rough endoplasmic reticulum v synaptic vesicle pgg gemmule periglomerular cell
0.14533791.15976062.html.plaintext.txt	190	patch clamp recording experiment whole cell recording obtained num mitral cell strictly located mitral cell layer
0.14533791.15976062.html.plaintext.txt	191	cell identification based location electrophysiological property morphology size
0.14533791.15976062.html.plaintext.txt	192	mitral cell showed average resting potential num plus minus num mv mean input resistance num plus minus num m
0.14533791.15976062.html.plaintext.txt	193	among num mitral cell num num responsive oxa
0.14533791.15976062.html.plaintext.txt	194	current clamp mode bath application oxa induced hyperpolarization n num num depolarization n num num mitral cell two type response observed two distinct subset
0.14533791.15976062.html.plaintext.txt	195	oxa induced hyperpolarizations long lasting small amplitude
0.14533791.15976062.html.plaintext.txt	196	num nm hyperpolarizations num plus minus num mv mean amplitude occurred num plus minus num
0.14533791.15976062.html.plaintext.txt	197	num sec delay lasted num plus minus num sec
0.14533791.15976062.html.plaintext.txt	198	spontaneously active cell n num hyperpolarizations caused complete cessation spontaneous spike excitatory postsynaptic potential epsp fig
0.14533791.15976062.html.plaintext.txt	199	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	200	inhibitory action oxa mitral cell
0.14533791.15976062.html.plaintext.txt	201	num nm oxa horizontal bar totally abolished mitral cell spontaneous activity control activity recovered rinsing period num sec
0.14533791.15976062.html.plaintext.txt	202	b mitral cell showing spontaneous activity composed spike epsps abolished oxa num nm
0.14533791.15976062.html.plaintext.txt	203	bnum bnum enlargement num sec period focusing epsps
0.14533791.15976062.html.plaintext.txt	204	bnum spontaneous epsps control
0.14533791.15976062.html.plaintext.txt	205	bnum disappearance epsps oxa
0.14533791.15976062.html.plaintext.txt	206	bnum recovery spontaneous epsps rinsing
0.14533791.15976062.html.plaintext.txt	207	mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	208	oxa induced hyperpolarizations reproducible cell tested successive application n num data shown abolished ttx fast na channel blocker added acsf n num fig
0.14533791.15976062.html.plaintext.txt	209	num c d seen oxa caused cessation spontaneous firing control whereas presence bicuculline slowed spontaneous firing
0.14533791.15976062.html.plaintext.txt	210	bicuculline decreased amplitude oxa hyperpolarizing response num num n num
0.14533791.15976062.html.plaintext.txt	211	picrotoxin n num similar effect bicuculline data shown
0.14533791.15976062.html.plaintext.txt	212	acsf perfusion contained sb num orxnum antagonist hyperpolarizing response completely blocked n num fig
0.14533791.15976062.html.plaintext.txt	213	altogether result indicate hyperpolarizing effect oxa indirect effect
0.14533791.15976062.html.plaintext.txt	214	oxa may act orxnum gabaergic neuron would act turn mitral cell gabaa receptor
0.14533791.15976062.html.plaintext.txt	215	consistent hypothesis bicuculline decreased oxa hyperpolarizing effect mitral cell
0.14533791.15976062.html.plaintext.txt	216	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	217	inhibitory action oxa may indirect
0.14533791.15976062.html.plaintext.txt	218	oxa num nm hyperpolarized silent mitral cell
0.14533791.15976062.html.plaintext.txt	219	b hyperpolarizing effect oxa abolished ttx num microm
0.14533791.15976062.html.plaintext.txt	220	c oxa num nm hyperpolarized spontaneously active mitral cell num
0.14533791.15976062.html.plaintext.txt	221	num mv horizontal scale bar num sec vertical scale bar num mv
0.14533791.15976062.html.plaintext.txt	222	d hyperpolarizing effect oxa maintained bicuculline num microm reduced num
0.14533791.15976062.html.plaintext.txt	223	mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	224	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	225	characterization orexin receptor type involved mitral cell hyperpolarizing response
0.14533791.15976062.html.plaintext.txt	226	oxa num nm hyperpolarized mitral cell control condition
0.14533791.15976062.html.plaintext.txt	227	b sb num orxnum antagonist num microm blocked completely oxa induced hyperpolarization
0.14533791.15976062.html.plaintext.txt	228	mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	229	distinct set num mitral cell bath application oxa induced long lasting small amplitude depolarization fig
0.14533791.15976062.html.plaintext.txt	230	num nm oxa depolarization num plus minus num
0.14533791.15976062.html.plaintext.txt	231	num mv mean amplitude occurred num plus minus num sec delay lasted num plus minus num sec
0.14533791.15976062.html.plaintext.txt	232	orexin depolarization insensitive ttx n num fig
0.14533791.15976062.html.plaintext.txt	233	examine depolarizing effect detail subsequent experiment conducted voltage clamp condition
0.14533791.15976062.html.plaintext.txt	234	membrane potential voltage clamped near resting level oxa produced inward current whose delay duration matched oxa induced depolarization fig
0.14533791.15976062.html.plaintext.txt	235	inward current blocked sb num n num fig
0.14533791.15976062.html.plaintext.txt	236	experiment indicate oxa depolarizing action mitral cell direct mediated orxnum
0.14533791.15976062.html.plaintext.txt	237	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	238	oxa num nm depolarized mitral cell num mv
0.14533791.15976062.html.plaintext.txt	239	b depolarization prevented ttx
0.14533791.15976062.html.plaintext.txt	240	mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	241	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	242	orxnum involved oxa induced inward current
0.14533791.15976062.html.plaintext.txt	243	oxa induced slow inward current
0.14533791.15976062.html.plaintext.txt	244	b sb num num microm abolished current
0.14533791.15976062.html.plaintext.txt	245	vh holding potential mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	246	among num mitral cell hyperpolarized oxa num submitted electrical stimulation applied olfactory nerve complete protocol described ref
0.14533791.15976062.html.plaintext.txt	247	num num mitral cell responsive stimulation
0.14533791.15976062.html.plaintext.txt	248	recorded cell excitation threshold determined control condition stimulation intensity adjusted elicit one spike per shock stable latency
0.14533791.15976062.html.plaintext.txt	249	oxa perfused recording chamber effect mitral cell response parameter threshold latency number spike analyzed function time
0.14533791.15976062.html.plaintext.txt	250	four mitral cell olfactory nerve stimulation excitability decreased oxa fig
0.14533791.15976062.html.plaintext.txt	251	num although affected num
0.14533791.15976062.html.plaintext.txt	252	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	253	effect oxa mitral cell response evoked olfactory nerve stimulation
0.14533791.15976062.html.plaintext.txt	254	three superimposed control response olfactory nerve stimulation one spike per stimulation
0.14533791.15976062.html.plaintext.txt	255	b five minute perfusion num nm oxa solution hyperpolarized cell num mv stimulation failed induce action potential
0.14533791.15976062.html.plaintext.txt	256	c partial recovery control excitability two spike three stimulation obtained rinsing period num min
0.14533791.15976062.html.plaintext.txt	257	mp resting membrane potential beginning recording
0.14533791.15976062.html.plaintext.txt	258	furthermore anatomical result appears cellular localization orxnum similar preweaning adult rat
0.14533791.15976062.html.plaintext.txt	259	light microscopic level immunocytochemical study confirms localization orxnum mitraltufted cell body reported caillol et al
0.14533791.15976062.html.plaintext.txt	260	ultrastructural level localization orexin receptor widely studied one recent publication arcuate nucleus num
0.14533791.15976062.html.plaintext.txt	261	result agreement study showing orxnum localized cell body well pre postsynaptic level
0.14533791.15976062.html.plaintext.txt	262	study part labeling localized rough endoplasmic reticulum suggesting local synthesis orxnum
0.14533791.15976062.html.plaintext.txt	263	orxnum immunoreactivity also shown mitraltufted cell dendrite running epl body process external tuft cell periglomerular granule cell
0.14533791.15976062.html.plaintext.txt	264	thus orxnum seems expressed ob cell category systematic homogeneous way
0.14533791.15976062.html.plaintext.txt	265	indeed orxnum labeling homogeneously distributed neither along mitral cell layer glomerular layer
0.14533791.15976062.html.plaintext.txt	266	interestingly orxnum immunoreactive mitral cell body found case adjacent orxnum immunoreactive glomerulus
0.14533791.15976062.html.plaintext.txt	267	although observation need documented may suggest columnar organization orexin receptive cell ob
0.14533791.15976062.html.plaintext.txt	268	optimize vitro neuron survival electrophysiological recording performed num num d old rat period surrounding weaning
0.14533791.15976062.html.plaintext.txt	269	period ingestive behavior evolves type food change liquid diet full fat solid diet le fat
0.14533791.15976062.html.plaintext.txt	270	however experimental condition observed weaning progressive developing rat suck mother nipple eat solid food available ad libitum dam
0.14533791.15976062.html.plaintext.txt	271	furthermore recording num made num num d old rat obvious variability due different age rat observed mitral cell reactivity oxa
0.14533791.15976062.html.plaintext.txt	272	result show oxa modulates mitral cell activity
0.14533791.15976062.html.plaintext.txt	273	num mitral cell num shown modulated oxa num num depolarized hyperpolarized respectively
0.14533791.15976062.html.plaintext.txt	274	result agreement immunocytochemical observation indicate rather mitral cell orxnum immunoreactive
0.14533791.15976062.html.plaintext.txt	275	oxa shown exert two opposite effect two distinct set mitral cell either direct depolarizing effect inducing ttx insensitive inward current indirect hyperpolarizing effect
0.14533791.15976062.html.plaintext.txt	276	however oxa effect blocked sb num demonstrated involvement orxnum fig
0.14533791.15976062.html.plaintext.txt	277	view larger version numk fig
0.14533791.15976062.html.plaintext.txt	278	oxa action mitral cell rat ob network
0.14533791.15976062.html.plaintext.txt	279	olfactory mucosa olfactory receptor neuron orn send axon ob terminating glomerulus glo spherical neuropile lying ob periphery
0.14533791.15976062.html.plaintext.txt	280	within glomerulus axon synapse primary dendrite pd mitral cell mc
0.14533791.15976062.html.plaintext.txt	281	mitral cell make reciprocal dendrodendritic synapsis two category gabaergic inhibitory interneurons pd pgs secondary dendrite sd granule cell gc
0.14533791.15976062.html.plaintext.txt	282	mitral cell activity modulated double gabaergic control sending axon olfactory cortex
0.14533791.15976062.html.plaintext.txt	283	orxnum found expressed subset mc pg gc cell dark gray tufted cell tc light gray receptor localized soma process neuron
0.14533791.15976062.html.plaintext.txt	284	left diagram schematizes indirect hyperpolarizing action oxa mc oxa acting orxnum hypothesized depolarize gabaergic inhibitory interneurons pgs gc dark gray turn would inhibit mc white via gaba release acting gabaa receptor localized mc
0.14533791.15976062.html.plaintext.txt	285	within glomerulus part oxa indirect hyperpolarizing action also ascribed action gaba released pgs gabab receptor localized orn axon mc pd
0.14533791.15976062.html.plaintext.txt	286	right diagram schematizes direct depolarizing action oxa mc oxa acting orxnum expressed subset mitral cell hypothesized depolarize mc dark gray
0.14533791.15976062.html.plaintext.txt	287	hyperpolarizing action oxa sufficient completely shut mitral cell spontaneous activity antagonized voltage gated na channel blocker ttx
0.14533791.15976062.html.plaintext.txt	288	latter observation support oxa action indirect
0.14533791.15976062.html.plaintext.txt	289	oxa indirect effect reported brain area like substantia nigra num laterodorsal tegmental nucleus num hypo num raphe nucleus num
0.14533791.15976062.html.plaintext.txt	290	oxa effect either excitatory inhibitory
0.14533791.15976062.html.plaintext.txt	291	show oxa hyperpolarizing response partly antagonized gabaa receptor antagonist bicuculline
0.14533791.15976062.html.plaintext.txt	292	result indicates gabaergic interneurons involved oxa induced hyperpolarization mitral cell
0.14533791.15976062.html.plaintext.txt	293	immunocytochemical observation pg granule cell body express orxnum support gabaergic interneurons could contacted orexin fiber localized mainly glomerular layer feebly granule cell layer num
0.14533791.15976062.html.plaintext.txt	294	indeed pg granule cell main interneurons two layer mainly gabaergic num num shown inhibit mitral cell activation gabaa receptor num num
0.14533791.15976062.html.plaintext.txt	295	along line gabaergic interneurons excited oxa may act metabotropic gabab receptor
0.14533791.15976062.html.plaintext.txt	296	indeed gabab receptor activation reported elsewhere abolish completely spontaneous activity mitral cell decrease mitral cell excitability electrical shock applied olfactory nerve layer num num num
0.14533791.15976062.html.plaintext.txt	297	present study oxa also observed decrease mitral cell excitability electrical shock
0.14533791.15976062.html.plaintext.txt	298	effect oxa induced gaba release may act extrasynaptic presynaptic gabab receptor located primary afferent axon num num strongly suspected act depressing neurotransmitter release num num num num num
0.14533791.15976062.html.plaintext.txt	299	hand decreasing mitral cell spontaneous activity oxa induced gaba release may act gabab receptor located either soma dendritic intraglomerular tuft rat mitral cell num num
0.14533791.15976062.html.plaintext.txt	300	one mechanism gabab would silence spontaneous activity may gabab would slightly hyperpolarize mitral cell rest shifting cell polarization state state latter signaling steady silent state num
0.14533791.15976062.html.plaintext.txt	301	dopamine gaba colocalized pg interneurons num num num dopamine also would good candidate support oxa indirect inhibition mitral cell
0.14533791.15976062.html.plaintext.txt	302	consistent hypothesis frog ob dopamine found inhibit mitral cell spontaneous activity num
0.14533791.15976062.html.plaintext.txt	303	coaction gaba dopamine ruled
0.14533791.15976062.html.plaintext.txt	304	especially interesting fact electrophysiological result fully consistent vivo study num
0.14533791.15976062.html.plaintext.txt	305	author recorded unit extracellular activity mitral cell anesthetized rat whereas applied oxa directly ob surface lateral ventricle
0.14533791.15976062.html.plaintext.txt	306	type application shown induce decrease spontaneous rate cell increase others distinct cell
0.14533791.15976062.html.plaintext.txt	307	noteworthy vivo vitro study oxa induces two type opposite action mitral cell spontaneous activity
0.14533791.15976062.html.plaintext.txt	308	conclusion study brings information ontogenetic expression orexin receptor rat ob clarifies orxnum structural ultrastructural localization within network
0.14533791.15976062.html.plaintext.txt	309	addition vitro recording demonstrate oxa act mitral cell directly indirectly inducing apparently opposite effect
0.14533791.15976062.html.plaintext.txt	310	direct depolarizing effect could mediated orxnum located mitral cell body dendrite
0.14533791.15976062.html.plaintext.txt	311	orxnum located pg granular cell could responsible indirect hyperpolarizing action oxa via gaba induced release
0.14533791.15976062.html.plaintext.txt	312	altogether data provide new insight apprehending mechanism olfactory system involved regulation food intake behavior
0.14533791.15976062.html.plaintext.txt	313	hungry animal hypothalamic ox neuron stimulated hypoglycemia num probably increase release centrifugal pathway
0.14533791.15976062.html.plaintext.txt	314	electrophysiological data detail ox action ob
0.14533791.15976062.html.plaintext.txt	315	indeed acting directly increasing output neuron background activity indirectly inhibitory interneuron network ox depress excite mitral cell
0.14533791.15976062.html.plaintext.txt	316	two opposite action shown occur two distinct mitral cell set
0.14533791.15976062.html.plaintext.txt	317	ox may provide selective dual action olfactory information processing favoring mitral cell involved food odor processing silencing others involved
0.14533791.15976062.html.plaintext.txt	318	duality action could result increasing signal noise ratio may increase olfactory detection power
0.14533791.15976062.html.plaintext.txt	319	hypothesis fully agrees behavioral experiment progress research team
0.14533791.15976062.html.plaintext.txt	320	indeed preliminary result indicate olfactory detection threshold rat enhanced oxa intracerebral injection
0.14533791.15976062.html.plaintext.txt	321	acknowledgment thank glaxosmithkline harlow essex uk generous gift sb num professor edwin griff university cincinnati cincinnati oh careful reading english
0.14533791.15976062.html.plaintext.txt	322	footnote first published online june num num
0.14533791.15976062.html.plaintext.txt	323	abbreviation acsf artificial cerebrospinal fluid dab diaminobenzidine epl external plexiform layer epsp excitatory postsynaptic potential gaba aminobutyric acid gabaergic neuron use gaba neurotransmitter gapdh glyceraldehyde num phophate dehydrogenase hypo hypothalamus ob olfactory bulb orxnum orexin receptor num orxnum orexin receptor num ox orexin oxa orexin oxb orexin b p postnatal day pg periglomerular cell rt room temperature ttx tetrodotoxin
0.14533791.15976062.html.plaintext.txt	324	accepted publication june num num
0.14533791.15976062.html.plaintext.txt	325	home help feedback subscription archive search table content endocrinology endocrine review j
0.14533791.15976062.html.plaintext.txt	326	molecular endocrinology recent prog
0.14565748.12351581.html.plaintext.txt	0	allelic structure common disease desmond j
0.14565748.12351581.html.plaintext.txt	1	numdepartment molecular medical pharmacology numcrump institute molecular imaging numdepartment microbiology immunology molecular genetics numdepartment medicine numdepartment human genetics university california los angeles ca num usa
0.14565748.12351581.html.plaintext.txt	2	received june num num accepted july num num
0.14565748.12351581.html.plaintext.txt	3	one early dream human genome project goal personalized medicine
0.14565748.12351581.html.plaintext.txt	4	vision individual would compact disk containing unique dna sequence guiding myriad decision lifestyle disease prevention treatment conceivably even career choice
0.14565748.12351581.html.plaintext.txt	5	present dna sequencing technology nowhere near cheap enough fast enough allow dream
0.14565748.12351581.html.plaintext.txt	6	nevertheless genotyping technology made dramatic stride last decade technology may fast enough allow interrogation relevant disease allele given individual
0.14565748.12351581.html.plaintext.txt	7	feasibility approach depends critically allelic structure human disease gene
0.14565748.12351581.html.plaintext.txt	8	num num gene make important contribution disease susceptibility num allele gene total numxnum genotypings reliably performed daunting prospect
0.14565748.12351581.html.plaintext.txt	9	however num gene make appreciable contribution human disease gene num relevant allele number genotypings performed num highly feasible
0.14565748.12351581.html.plaintext.txt	10	review look present knowledge allelic complexity human disease gene well providing brief glance future
0.14565748.12351581.html.plaintext.txt	11	view larger version numk figure num
0.14565748.12351581.html.plaintext.txt	12	three dimensional space provides aid visualizing possible structure polymorphism human disease gene
0.14565748.12351581.html.plaintext.txt	13	monogenic disorder rare disease green bar complex allelic spectrum high number allele per locus common disease yellow bar simple spectrum low number allele per locus
0.14565748.12351581.html.plaintext.txt	14	special case gray bar exist situation heterozygous advantage population bottleneck
0.14565748.12351581.html.plaintext.txt	15	common complex disease trait situation le clear
0.14565748.12351581.html.plaintext.txt	16	two extreme model interaction model cdcv hypothesis dark blue bar genetic heterogeneity model red bar
0.14565748.12351581.html.plaintext.txt	17	however two extreme model also formally possible small number locus large number allele cyan bar large number locus large number allele magenta bar
0.14565748.12351581.html.plaintext.txt	18	consideration human population genetics num suggest one four extreme model small number locus large number allele cyan bar unlikely
0.14565748.12351581.html.plaintext.txt	19	however present data insufficient confidently place complex disease trait remaining three extreme indicated two dimensional gray surface
0.14565748.12351581.html.plaintext.txt	20	figure following example employed num num monogenic rare retinoblastoma monogenic common glucose num phosphate dehydrogenase deficiency south china monogenic special case s thalassemia sardinia complex interaction model alzheimers disease speculative complex genetic heterogeneity model colon cancer speculative
0.14565748.12351581.html.plaintext.txt	21	known example yet exist two hypothetical case common complex disease caused small number locus large number allele large number locus large number allele
0.14565748.12351581.html.plaintext.txt	22	clarity disease frequency monogenic common complex disorder rounded num num within one order magnitude known frequency
0.14565748.12351581.html.plaintext.txt	23	case complex disease alzheimers disease colon cancer assigned value number locus number allele per locus highly speculative
0.14565748.12351581.html.plaintext.txt	24	purpose figure assumed alzheimers disease example interaction model whereas colon cancer example genetic heterogeneity model
0.14565748.12351581.html.plaintext.txt	25	although assumption conjectural evidence favor genetic heterogeneity model cancer num
0.14565748.12351581.html.plaintext.txt	26	two extreme model usually envisaged complex disease trait fig
0.14565748.12351581.html.plaintext.txt	27	one idea common allele handful locus interact cause disease
0.14565748.12351581.html.plaintext.txt	28	referred interaction model common diseasecommon variant cdcv hypothesis
0.14565748.12351581.html.plaintext.txt	29	competing notion rare allele numerous locus single handedly cause disease
0.14565748.12351581.html.plaintext.txt	30	referred genetic heterogeneity model
0.14565748.12351581.html.plaintext.txt	31	two extreme model also formally possible complex disease trait caused small number locus large number allele caused large number locus large number allele fig
0.14565748.12351581.html.plaintext.txt	32	one last two alternative small number locus large number allele rendered unlikely consideration human population structure see
0.14565748.12351581.html.plaintext.txt	33	however remaining three extreme complex disease trait could occupy middle ground
0.14565748.12351581.html.plaintext.txt	34	large amount evidence suggesting dramatic expansion human population num num num num year num num generation ago
0.14565748.12351581.html.plaintext.txt	35	resulted increased effective population size num individual present size numxnum
0.14565748.12351581.html.plaintext.txt	36	assume expansion one allele rare disease gene one allele common gene fig
0.14565748.12351581.html.plaintext.txt	37	notable exception available evidence suggests fairly similar mutation rate gene num num num num per gene per generation num num
0.14565748.12351581.html.plaintext.txt	38	rare disease number individual expanded population still small hence relative term quickly swamped newly mutated allele
0.14565748.12351581.html.plaintext.txt	39	contrast population reservoir common disease gene large take long time allele taken new mutation
0.14565748.12351581.html.plaintext.txt	40	addition face similar mutation rate lower prevalence rare disease implies higher allele disappearance rate negative selection disease common disease
0.14565748.12351581.html.plaintext.txt	41	effect reservoir effect selection pressure imply population expansion allelic spectrum became diverse much quickly rare disease common
0.14565748.12351581.html.plaintext.txt	42	long run however expected spectrum rare common disease become equally diverse fig
0.14565748.12351581.html.plaintext.txt	43	reich lander estimate intermediate stage presently exists population rare disease diverse allelic structure common disorder simple structure
0.14565748.12351581.html.plaintext.txt	44	prediction theory rare disorder largely consist recent allele whereas common disorder consist old ancestral allele
0.14565748.12351581.html.plaintext.txt	45	view larger version numk figure num
0.14565748.12351581.html.plaintext.txt	46	dramatic population expansion lead increased number individual single allele rare num square common num circle disease gene
0.14565748.12351581.html.plaintext.txt	47	rare disease gene strong negative selection three allele disappear population replaced three new allele
0.14565748.12351581.html.plaintext.txt	48	thus numnum num allele represent ancestral allele
0.14565748.12351581.html.plaintext.txt	49	contrast common disease gene much le strong negative selection one allele lost replaced three new allele
0.14565748.12351581.html.plaintext.txt	50	proportion ancestral allele hence numnum num
0.14565748.12351581.html.plaintext.txt	51	consequently common disease gene much simpler allelic structure present population rare gene
0.14565748.12351581.html.plaintext.txt	52	b graphical depiction
0.14565748.12351581.html.plaintext.txt	53	population expansion lead proportionate increase single allele common disease gene red rare disease gene blue
0.14565748.12351581.html.plaintext.txt	54	present human population rapid loss allele smaller population reservoir rare disease gene lead allelic spectrum gene becoming relatively much diverse common gene
0.14565748.12351581.html.plaintext.txt	55	however far distant future equilibrium common disease gene expected catch rare gene allelic spectrum gene equally diverse
0.14565748.12351581.html.plaintext.txt	56	three line evidence supporting common diseasecommon variant hypothesis another valid test cdcv hypothesis examine genetic complexity quantitative trait related common disease blood pressure body mass index plasma lipid
0.14565748.12351581.html.plaintext.txt	57	one well studied group phenotype comprises level composition plasma lipoprotein strongly associated coronary heart disease
0.14565748.12351581.html.plaintext.txt	58	exception mutation ldl receptor underlie familial hypercholesterolemia relatively common monogenic disorder known variation associated trait due small number common allele table num
0.14565748.12351581.html.plaintext.txt	59	corollary cdcv hypothesis individual carry susceptibility gene numerous disorder
0.14565748.12351581.html.plaintext.txt	60	point difficult examine systematically human although clearly older individual frequently suffer host common malady
0.14565748.12351581.html.plaintext.txt	61	convincing example provided surveying inbred mouse strain difference disease related trait
0.14565748.12351581.html.plaintext.txt	62	table num list common disease related trait differing two inbred strain dbanumj cnumblnumj
0.14565748.12351581.html.plaintext.txt	63	many trait analyzed genetic cross two strain known due multiple quantitative trait locus qtl
0.14565748.12351581.html.plaintext.txt	64	one might argue since mouse maintained continuous brother sister mating many generation numerous mutation fixed responsible trait difference
0.14565748.12351581.html.plaintext.txt	65	counter argument however fact number locus observed dbanumjxcnumblnumj cross also observed cross strain case locus syntenic human locus corresponding trait num
0.14565748.12351581.html.plaintext.txt	66	apart example rapid fall disease rate relative affected observed common disease argues interaction model heterogeneity model
0.14565748.12351581.html.plaintext.txt	67	addition many common disease exhibit high ratio relative risk monozygotic twin dizygotic twin also consistent genetics multifactorial threshold model numnum
0.14565748.12351581.html.plaintext.txt	68	example common disease familial combined hyperlipidemia prevalence num num exhibit apparent dominant mode inheritance many generation yet clearly complex num
0.14565748.12351581.html.plaintext.txt	69	furthermore inheritance cancer way consistent heterogeneity model see
0.14565748.12351581.html.plaintext.txt	70	challenge cdcv hypothesis also area cancer presented breast cancer gene brcanum brcanum num
0.14565748.12351581.html.plaintext.txt	71	locus contribute relatively common genetic disorder many different rare mutation even ashkenazi population see
0.14565748.12351581.html.plaintext.txt	72	addition even cdcv hypothesis true disease gene may dominated allele large number minor allele
0.14565748.12351581.html.plaintext.txt	73	case cystic fibrosis num disease allele caucasian population accounted single mutation
0.14565748.12351581.html.plaintext.txt	74	nevertheless total number known disease allele exceeds num num
0.14565748.12351581.html.plaintext.txt	75	pertinent note whereas understanding kind variation occur mendelian disease extensive knowledge variation explain common disease limited
0.14565748.12351581.html.plaintext.txt	76	relevant transcriptional regulation one approach identification common disease gene candidate survey case control using expression array analysis
0.14565748.12351581.html.plaintext.txt	77	regard noteworthy one third known common disease gene table num affect expression level num
0.14565748.12351581.html.plaintext.txt	78	interesting evidence inheritance cancer distinct common disease provided risch num
0.14565748.12351581.html.plaintext.txt	79	exception different cancer roughly familial relative risk frr although frr increase early age onset
0.14565748.12351581.html.plaintext.txt	80	traditionally study attribute large environmental component cancer
0.14565748.12351581.html.plaintext.txt	81	relevant evidence includes observation dramatic shift cancer incidence due population migration
0.14565748.12351581.html.plaintext.txt	82	however careful evaluation twin family study suggest genetics also play large part cancer risk num
0.14565748.12351581.html.plaintext.txt	83	key quantity rmd frr ratio monozygotic mz dizygotic dz twin
0.14565748.12351581.html.plaintext.txt	84	idea mz dz twin comparable sharing environmental factor difference concordance rate mz dz twin must reflect genetic factor
0.14565748.12351581.html.plaintext.txt	85	disease due single rare dominant gene rmdnum recessive rare gene rmdnum diminishes toward num allele common
0.14565748.12351581.html.plaintext.txt	86	multiple locus rmd become large
0.14565748.12351581.html.plaintext.txt	87	cancer rmdnum compared much higher ratio many complex disease schizophrenia multiple sclerosis autism
0.14565748.12351581.html.plaintext.txt	88	data consistent either rare dominant allele additive gene effect cancer rather interactive multigenic model
0.14565748.12351581.html.plaintext.txt	89	estimate extent ld obtained sampling various restricted genomic region num well num autosomal region spanning total num megabases num
0.14565748.12351581.html.plaintext.txt	90	addition somatic cell genetics used analyze ld entire chromosome num num
0.14565748.12351581.html.plaintext.txt	91	ld sampling average distance useful ld preserved num num kb
0.14565748.12351581.html.plaintext.txt	92	however considerable variability locus ld found far away num kb region useful disequilibrium found
0.14565748.12351581.html.plaintext.txt	93	chromosome num study found considerable linkage disequilibrium long block conserved haplotype
0.14565748.12351581.html.plaintext.txt	94	interestingly greater num haplotype structure could defined le num snp
0.14565748.12351581.html.plaintext.txt	95	based study appears extent linkage disequilibrium genome region population specific
0.14565748.12351581.html.plaintext.txt	96	dark side linkage disequilibrium revealed recent study identify gene chromosome num involved crohn disease num
0.14565748.12351581.html.plaintext.txt	97	although region linkage disequilibrium associated disease identified lack recombination event within relevant haplotype block precluded identification responsible gene
0.14565748.12351581.html.plaintext.txt	98	thus although existence large haplotype block good news point view cheap diagnostics may hinder definitive identification responsible gene associated biological insight
0.14565748.12351581.html.plaintext.txt	99	situation use alternate population may come rescue allowing subdivision large region linkage disequilibrium
0.14565748.12351581.html.plaintext.txt	100	narcolepsy possible identify recombination event japanese family broke haplotype block hla region allowing finer mapping responsible gene num
0.14565748.12351581.html.plaintext.txt	101	alternatively scientist may rely animal model mouse ultimately identify causative gene
0.14565748.12351581.html.plaintext.txt	102	although particular allele haplotype may numerically rare population whole nevertheless likely individual harbor significant number variant
0.14565748.12351581.html.plaintext.txt	103	addition estimate gene mutation rate imply individual three de novo gene mutation within genome
0.14565748.12351581.html.plaintext.txt	104	thus even interaction model prof true locus personalized medicine still benefit individually tailored genotyping
0.14565748.12351581.html.plaintext.txt	105	distinction interaction genetic heterogeneity model restated using following question human population would rather know rare severe genetic mutation e
0.14565748.12351581.html.plaintext.txt	106	nonsense frameshift non synonymous would rather know common variation present limitation speed genotyping lack knowledge genetic causation common human disease best choice two alternative unclear
0.14565748.12351581.html.plaintext.txt	107	course optimal situation would know answer question
0.14565748.12351581.html.plaintext.txt	108	thus need ever rapid genotyping sequencing technology likely continue foreseeable future
0.14565748.12351581.html.plaintext.txt	109	footnote correspondence addressed pharmacology ucla school medicine num num chs box num los angeles ca num num usa
0.14565748.12351581.html.plaintext.txt	110	tel num num fax num num
0.14565748.12351581.html.plaintext.txt	111	edu u d correspondence may also addressed
0.14565748.12351581.html.plaintext.txt	112	lusis microbiology immunology molecular genetics ucla num mrl box num los angeles ca num num usa
0.14565748.12351581.html.plaintext.txt	113	tel num num fax num num
0.14565748.12351581.html.plaintext.txt	114	num allelic spectrum human disease
0.14565748.12351581.html.plaintext.txt	115	num achondroplasia defined recurrent gnumr mutation fgfrnum
0.14565748.12351581.html.plaintext.txt	116	num origin pattern implication human spontaneous mutation
0.14565748.12351581.html.plaintext.txt	117	num high genomic deleterious mutation rate hominid
0.14565748.12351581.html.plaintext.txt	118	num deficient dna mismatch repair common etiologic risk factor colon cancer
0.14565748.12351581.html.plaintext.txt	119	num ionizing radiation genetic risk ix
0.14565748.12351581.html.plaintext.txt	120	estimate frequency mendelian disease spontaneous mutation rate human population num perspective
0.14565748.12351581.html.plaintext.txt	121	num online mendelian inheritance man
0.14565748.12351581.html.plaintext.txt	122	num genetic epidemiology cancer interpreting family twin study implication molecular genetic approach
0.14565748.12351581.html.plaintext.txt	123	num genome scan familial combined hyperlipidemia reveals evidence locus chromosome num
0.14565748.12351581.html.plaintext.txt	124	num ashkenazi jewish population frequency common mutation brcanum brcanum
0.14565748.12351581.html.plaintext.txt	125	num partitioning genetic variation regulatory coding gene segment predominance software variation gene encoding introvert protein
0.14565748.12351581.html.plaintext.txt	126	num functionally gene linked polymorphic region genetically controlled neurotransmitter metabolism
0.14565748.12351581.html.plaintext.txt	127	num num lipoxygenase promoter regulated dna methylation
0.14565748.12351581.html.plaintext.txt	128	num mutation human num lipoxygenase gene
0.14565748.12351581.html.plaintext.txt	129	num hypertension genetics single nucleotide polymorphism common disease common variant hypothesis
0.14565748.12351581.html.plaintext.txt	130	num structure haplotype block human genome
0.14565748.12351581.html.plaintext.txt	131	num block limited haplotype diversity revealed high resolution scanning human chromosome num
0.14565748.12351581.html.plaintext.txt	132	num genetic variation numqnum cytokine gene cluster confers susceptibility crohn disease
0.14565748.12351581.html.plaintext.txt	133	num identification telomeric boundary hla region potential predisposition human narcolepsy
0.14565748.12351581.html.plaintext.txt	134	num frameshift mutation nodnum associated susceptibility crohn disease
0.14565748.12351581.html.plaintext.txt	135	num association nodnum leucine rich repeat variant susceptibility crohn disease
0.14565748.12351581.html.plaintext.txt	136	num low serum paraoxonase risk factor atherosclerotic disease chem
0.14565748.12351581.html.plaintext.txt	137	num genome aetiology multifactorial disease type num diabetes
0.14565748.12351581.html.plaintext.txt	138	num challenge identifying genetic variation affecting susceptibility type num diabetes example study calpain num gene
0.14565748.12351581.html.plaintext.txt	139	num calpains play role insulin secretion action
0.14565748.12351581.html.plaintext.txt	140	num lipoprotein lipid metabolism
0.14565748.12351581.html.plaintext.txt	141	edsemery rimoins principle practice medical genetics numth edn
0.14565748.12351581.html.plaintext.txt	142	churchill livingstone london pp
0.14565748.12351581.html.plaintext.txt	143	num apolipoprotein influencing triglyceride human mouse revealed comparative sequencing
0.14565748.12351581.html.plaintext.txt	144	num human serum paraoxonase
0.16537316.15829503.html.plaintext.txt	0	sine exonic insertion ptpla gene lead multiple splicing defect segregate autosomal recessive centronuclear myopathy dog manuel pelenum laurent tiretnum jean louis kesslernum stephane blotnumnum jean jacques panthiernum
0.16537316.15829503.html.plaintext.txt	1	numumr num inra enva de genetique moleculaire et cellulaire numlaboratoire de neurobiologie ecole nationale veterinaire dalfort num avenue du general de gaulle num maisons alfort cedex france numinserm emi enum num num creteil france
0.16537316.15829503.html.plaintext.txt	2	correspondence addressed
0.16537316.15829503.html.plaintext.txt	3	tel num num fax num num email ltiretatvet alfort
0.16537316.15829503.html.plaintext.txt	4	received february num num revised march num num accepted april num num
0.16537316.15829503.html.plaintext.txt	5	spontaneous case labrador retriever suffering congenital form hereditary myopathy hereditary myopathy labrador retriever hmlr first described usa num num later group across world num num
0.16537316.15829503.html.plaintext.txt	6	myopathy transmitted autosomal recessive disease num num
0.16537316.15829503.html.plaintext.txt	7	clinical feature male female pup include hypotonia generalized muscle weakness abnormal posture stiff hopping gait exercise intolerance increased collapse exposed cold see movie published supplementary material hmg online
0.16537316.15829503.html.plaintext.txt	8	examination evidence skeletal muscle atrophy particularly involving muscle head tendinous areflexia
0.16537316.15829503.html.plaintext.txt	9	metabolic shape remodeling muscle observed type num fiber deficiency predominance atrophic hypertrophic type num fiber numnumnumnum
0.16537316.15829503.html.plaintext.txt	10	reported case histopathological evaluation muscle biopsy demonstrated characteristic centralization myonuclei often located area devoid myofibril mitochondrial aggregation
0.16537316.15829503.html.plaintext.txt	11	centronuclear myopathy cnm therefore proposed alternative name hmlr num knowledge spontaneous animal model human autosomal centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	12	previously described experimental pedigree labrador retriever segregating centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	13	cnm locus mapped highly significant lod score num
0.16537316.15829503.html.plaintext.txt	14	num cm segment centromeric region canine chromosome num cfanum num region form shuffled block synteny human chromosome segment numpnum numpnum
0.16537316.15829503.html.plaintext.txt	15	interestingly gene mtmnum family map human chromosome nump num
0.16537316.15829503.html.plaintext.txt	16	purpose study identify plausible candidate gene within cnm interval characterize disease causing mutation one gene
0.16537316.15829503.html.plaintext.txt	17	report mutation gene encoding protein tyrosine phosphatase like member ptpla perfectly segregate cnm labrador retriever experimental pedigree
0.16537316.15829503.html.plaintext.txt	18	indeed trna like short interspersed repeat element sine insertion identified exon num ptpla lead multiple transcriptional alteration sine containing ptpla allele
0.16537316.15829503.html.plaintext.txt	19	moreover disclose original complex disease associated mutation multiple transcriptional defect arising trna like sine insertion
0.16537316.15829503.html.plaintext.txt	20	mutation identification segregation experimental pedigree detailed structure canine ptpla gene phylogenetic analysis ptpla family member described elsewhere pele et al
0.16537316.15829503.html.plaintext.txt	21	following data taken consideration designing experiment detailed subsequently
0.16537316.15829503.html.plaintext.txt	22	canine ptpla span num kb contains seven exon fig
0.16537316.15829503.html.plaintext.txt	23	numa structure shared human num murine orthologs see ensembl gene id ensmusgnum
0.16537316.15829503.html.plaintext.txt	24	dog skeletal muscle ptpla transcript exist two isoforms fig
0.16537316.15829503.html.plaintext.txt	25	numb differing retention ptplafl full length embl accession
0.16537316.15829503.html.plaintext.txt	26	ajnum exclusion exon num ptpladnum deleted exon num embl accession
0.16537316.15829503.html.plaintext.txt	27	ptplafl transcript encodes putative protein num amino acid contains four transmembrane domain putative tyrosine phosphatase like hcxnumgxnump catalytic site fig
0.16537316.15829503.html.plaintext.txt	28	exon num skipping ptpladnum transcript lead frame disruption premature translation termination
0.16537316.15829503.html.plaintext.txt	29	resulting predicted ptpladnum protein contains two transmembrane domain putative tyrosine phosphatase like hcxnumgxnump catalytic site
0.16537316.15829503.html.plaintext.txt	30	ptplafl ptpladnum protein share common num amino acid n terminus domain differ c terminus region num amino acid num amino acid length respectively fig
0.16537316.15829503.html.plaintext.txt	31	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	32	structure gene drawn follows seven exon indicated vertical bar
0.16537316.15829503.html.plaintext.txt	33	size individual exon intron indicated horizontal bar respectively
0.16537316.15829503.html.plaintext.txt	34	b skeletal muscle ptpla transcript exist two isoforms differing retention ptplafl full length exclusion ptpladnum exon num deleted isoform exon num
0.16537316.15829503.html.plaintext.txt	35	box represents exon number indicated
0.16537316.15829503.html.plaintext.txt	36	probe used southern span seven exon gene cover num full length cdna
0.16537316.15829503.html.plaintext.txt	37	c sequence ptplafl ptpladnum protein inferred corresponding mrna
0.16537316.15829503.html.plaintext.txt	38	predicted transmembrane domain indicated drawing
0.16537316.15829503.html.plaintext.txt	39	prosite bar indicates putative protein tyrosine phosphatase like site
0.16537316.15829503.html.plaintext.txt	40	gene searched specific polymorphism would segregate disease experimental pedigree
0.16537316.15829503.html.plaintext.txt	41	genomic dna wild type wt cnm healthy carrier cnm affected cnm labrador digested hybridized probe encompassing ptpla cdna shown fig
0.16537316.15829503.html.plaintext.txt	42	bamhi restriction fragment length polymorphism rflp detected dna sample cnm cnm dog seen dna sample cnm dog
0.16537316.15829503.html.plaintext.txt	43	furthermore rflp perfectly segregated disease data shown
0.16537316.15829503.html.plaintext.txt	44	using pcr rt pcr amplified individual exon ptpla genomic dna rna skeletal muscle
0.16537316.15829503.html.plaintext.txt	45	pcr rt pcr amplification carried sample healthy carrier cnm affected cnm dog
0.16537316.15829503.html.plaintext.txt	46	figure num illustrates result obtained exon num num
0.16537316.15829503.html.plaintext.txt	47	pcr rt pcr amplification exon num using exnumfnum exnumrnum primer fig
0.16537316.15829503.html.plaintext.txt	48	numa led single num bp fragment corresponding exon num fig
0.16537316.15829503.html.plaintext.txt	49	num bp signal weaker rna cnm muscle used template rt pcr reaction compared rna cnm muscle fig
0.16537316.15829503.html.plaintext.txt	50	pcr amplification exon num using genomic dna cnm dog template exnumfnum exnumrnum primer yielded two product num num bp respectively fig
0.16537316.15829503.html.plaintext.txt	51	num bp product normal size exon num fragment expected primer
0.16537316.15829503.html.plaintext.txt	52	num bp fragment also obtained rna cnm muscle used template rt pcr reaction detected rna cnm muscle used fig
0.16537316.15829503.html.plaintext.txt	53	numb lane num num respectively
0.16537316.15829503.html.plaintext.txt	54	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	55	mutation analysis ptpla segregation cnm pedigree
0.16537316.15829503.html.plaintext.txt	56	location pcr primer indicated black arrow
0.16537316.15829503.html.plaintext.txt	57	b size marker lane num num bp ladder
0.16537316.15829503.html.plaintext.txt	58	pcr genomic dna lane num num rt pcr muscular mrna lane num num num num healthy carrier cnm affected dog cnm using exnumfnumexnumrnum lane num num exnumfnumexnumrnum lane num num primer pair
0.16537316.15829503.html.plaintext.txt	59	insertion within exon num ptpla seen cnm dog genomic sample
0.16537316.15829503.html.plaintext.txt	60	c pcr amplification genomic dna representative panel healthy unrelated labrador cnm lane num num healthy carrier cnm lane num num affected labrador cnm lane num num cnm pedigree using exnumfnum exnumrnum primer
0.16537316.15829503.html.plaintext.txt	61	size marker lane num num num bp ladder
0.16537316.15829503.html.plaintext.txt	62	characterize num bp fragment pcr amplification exon num intron num using exnumfnum exnumrnum primer performed genomic dna num individual six generation experimental pedigree num three unrelated healthy cnm labrador
0.16537316.15829503.html.plaintext.txt	63	representative panel resulting pcr product presented fig
0.16537316.15829503.html.plaintext.txt	64	numc complete amplification num animal among num affected dog provided supplementary material fig
0.16537316.15829503.html.plaintext.txt	65	pcr using dna wt cnm dog template yielded single num bp product lane num num
0.16537316.15829503.html.plaintext.txt	66	pcr performed affected cnm dog dna contained single num bp product lane num num
0.16537316.15829503.html.plaintext.txt	67	finally pcr using cnm dog dna yielded num num bp product lane num num
0.16537316.15829503.html.plaintext.txt	68	explain size shift seen genomic dna cnm cnm dog used template cloned sequenced num bp product
0.16537316.15829503.html.plaintext.txt	69	contained num bp antisense canine trna like sine embl accession
0.16537316.15829503.html.plaintext.txt	70	ajnum flanked side num bp direct duplication insertion site fig
0.16537316.15829503.html.plaintext.txt	71	comparison repeatmasker library known vertebrate carnivore specific repeat element sine sequence found within ptpla best aligned sineccf repeat sinelys subfamily first described minnick et al
0.16537316.15829503.html.plaintext.txt	72	using trnascan identified glutamine anticodon within trna like sequence sine
0.16537316.15829503.html.plaintext.txt	73	finally sequence analysis revealed bamhi restriction site within insertion explained rflp previously described
0.16537316.15829503.html.plaintext.txt	74	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	75	structure inserted sine
0.16537316.15829503.html.plaintext.txt	76	nucleotide sequence trna like sine depicted large black letter
0.16537316.15829503.html.plaintext.txt	77	small grey letter correspond ptpla exon num sequence
0.16537316.15829503.html.plaintext.txt	78	num bp direct duplication insertion site underlined
0.16537316.15829503.html.plaintext.txt	79	bamhi restriction site ggatcc detected southern blot shown bold character
0.16537316.15829503.html.plaintext.txt	80	grey box indicate repeated splicing donor acceptor allow proper splicing sine
0.16537316.15829503.html.plaintext.txt	81	circle highlight cryptic splicing site leading variant vnum synthesis fig
0.16537316.15829503.html.plaintext.txt	82	strengthen causative link insertion centronuclear myopathy num dog num breed num mongrel six additional unrelated healthy french labrador screened presence sine
0.16537316.15829503.html.plaintext.txt	83	num tested dog lacked insertion data shown
0.16537316.15829503.html.plaintext.txt	84	finally blast analysis conducted boxer genome assembly httpwww
0.16537316.15829503.html.plaintext.txt	85	sine inserted within ptpla exon num genome
0.16537316.15829503.html.plaintext.txt	86	hence sine insertion seemed highly specific labrador retriever pedigree segregating centronuclear myopathy developed alfort school veterinary medicine
0.16537316.15829503.html.plaintext.txt	87	using standard nomenclature system human mutation num ptpla corresponding genomic sequence boxer genome assembly mutation called ptpla gnum numinsnum
0.16537316.15829503.html.plaintext.txt	88	hereafter referred ptplaalf
0.16537316.15829503.html.plaintext.txt	89	sine insertion lead aberrant splicing pattern skeletal muscle alu insertion frequently associated human disease
0.16537316.15829503.html.plaintext.txt	90	insertion occurred within intron causing either close hand exon skipping e
0.16537316.15829503.html.plaintext.txt	91	num num incorporation alu sequence mature mrna splicing mediated process called exonization num
0.16537316.15829503.html.plaintext.txt	92	sine insertion within coding sequence reported
0.16537316.15829503.html.plaintext.txt	93	may lead specific skipping mutated exon e
0.16537316.15829503.html.plaintext.txt	94	numnum frame disruption premature translation termination signal e
0.16537316.15829503.html.plaintext.txt	95	test putative transcriptional defect resulting sine insertion within ptpla exon num ptpla transcript amplified rt pcr using sequence exon num exon num primer rna skeletal muscle cnm cnm cnm dog template
0.16537316.15829503.html.plaintext.txt	96	ptplafl ptpladnum transcript amplified cnm cnm sample fig
0.16537316.15829503.html.plaintext.txt	97	contrast ladder like profile seven rt pcr product obtained cnm sample fig
0.16537316.15829503.html.plaintext.txt	98	seven amplicons cloned sequenced precisely determine acceptor donor splicing site used synthesis corresponding transcript cnm muscle fig
0.16537316.15829503.html.plaintext.txt	99	figure numc proposes classification ptpla transcript based splicing profile predicted protein
0.16537316.15829503.html.plaintext.txt	100	far cnm dog concerned rt pcr product corresponding ptplafl ptpladnum wt isoforms observed indicates sine occasionally spliced
0.16537316.15829503.html.plaintext.txt	101	furthermore point mutation could detected transcript indicating wt cnm associated ptpla allele differ sine insertion
0.16537316.15829503.html.plaintext.txt	102	rt pcr product vnum corresponds splicing variant carried partial num bp deletion ptpla exon num well num bp exonization num region inserted sine
0.16537316.15829503.html.plaintext.txt	103	analysis sine sequence confirmed presence cryptic splicing donor acceptor site could lead either proper splicing insertion transcript ptplafl ptpladnum variant vnum fig
0.16537316.15829503.html.plaintext.txt	104	remaining variant vnum vnum lacked internal exon
0.16537316.15829503.html.plaintext.txt	105	variant arose exon skipping involving respectively exon num vnum exon num num vnum exon num num num vnum exon num num num num vnum fig
0.16537316.15829503.html.plaintext.txt	106	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	107	splicing alteration ptplaalf mutated allele
0.16537316.15829503.html.plaintext.txt	108	rt pcr amplification ptpla using mrna skeletal muscle cnm lane num cnm lane num cnm lane num dog primer depicted b
0.16537316.15829503.html.plaintext.txt	109	b schematic representation transcript sine containing ptplaalf allele skeletal muscle affected dog lane num
0.16537316.15829503.html.plaintext.txt	110	dashed line represent inferred splicing profile transcript
0.16537316.15829503.html.plaintext.txt	111	c classification seven splicing variant fl dnum vnum vnum vnum vnum vnum according splicing profile predicted protein
0.16537316.15829503.html.plaintext.txt	112	dart indicate position premature stop condons
0.16537316.15829503.html.plaintext.txt	113	ass biological impact sine induced splicing defect amino acid sequence inferred transcript
0.16537316.15829503.html.plaintext.txt	114	ptplafl ptpladnum protein deduced transcript ptplafl ptpladnum respectively
0.16537316.15829503.html.plaintext.txt	115	frameshift mutation found variant vnum vnum vnum vnum hence leading truncated form ptpla
0.16537316.15829503.html.plaintext.txt	116	finally exon num num frame variant vnum sequence encodes small truncated protein lacking ptpl site fig
0.16537316.15829503.html.plaintext.txt	117	sine insertion within ptpla ptplaalf allele strongly affected splicing mechanism
0.16537316.15829503.html.plaintext.txt	118	however quite surprisingly aggt sequence contained within num bp repeat flanking insertion fig
0.16537316.15829503.html.plaintext.txt	119	num allowed proper splicing sine thus leading wt transcript
0.16537316.15829503.html.plaintext.txt	120	trna like sine sufficient alter splicing test whether sine responsible characterized splicing defect performed ex vivo analysis using exon trapping experiment
0.16537316.15829503.html.plaintext.txt	121	two ptpla genomic fragment spanning intron num intron num differed absence presence sine insertion cloned psplnum exon trapping vector fig
0.16537316.15829503.html.plaintext.txt	122	plasmid termed pcos cnm pcos wt respectively transfected co num cell resulting transcript analyzed rt pcr
0.16537316.15829503.html.plaintext.txt	123	pcos wt plasmid used rt pcr nested pcr product corresponded properly spliced transcript containing ptpla exon num num num flanked two num num s globin exon vector fig
0.16537316.15829503.html.plaintext.txt	124	saci digestion confirmed presence ptpla exon num fig
0.16537316.15829503.html.plaintext.txt	125	contrast smaller product observed rt pcr nested pcr total rna co num cell transfected sine containing plasmid pcos cnm used template
0.16537316.15829503.html.plaintext.txt	126	saci digestion suggested ptpla exon num present product fig
0.16537316.15829503.html.plaintext.txt	127	hypothesis confirmed sequence analysis
0.16537316.15829503.html.plaintext.txt	128	indeed smaller size transcript resulted absence ptpla exon num
0.16537316.15829503.html.plaintext.txt	129	additional rt pcr experiment revealed low level wt transcript containing ptpla exon num num num data shown
0.16537316.15829503.html.plaintext.txt	130	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	131	sine induced splicing defect transfected co num cell
0.16537316.15829503.html.plaintext.txt	132	psplnum vector sequence genomic structure wt pcos wt insert sine containing pcos cnm insert sequence depicted
0.16537316.15829503.html.plaintext.txt	133	full line correspond intronic plasmidic sequence
0.16537316.15829503.html.plaintext.txt	134	white black vertical arrow head indicate location splicing donor acceptor site respectively
0.16537316.15829503.html.plaintext.txt	135	b rt pcr amplification total rna pcos wt pcos cnm transfected cell using sdnumsanum primer pair followed nested pcr using sdnumsanum primer pair
0.16537316.15829503.html.plaintext.txt	136	sdnum sanum sdnum sanum primer depicted
0.16537316.15829503.html.plaintext.txt	137	pcr product digested saci loaded onto agarose gel
0.16537316.15829503.html.plaintext.txt	138	thus precise splicing sine inserted sequence skipping mutated exon num induced ex vivo using num
0.16537316.15829503.html.plaintext.txt	139	num kb mini ptplaalf allele recapitulating splicing defect seen complete ptplaalf allele transcribed muscle cell vivo
0.16537316.15829503.html.plaintext.txt	140	quantification ptpla transcript affected dog muscle seven splicing variant resulting transcription ptplaalf allele detected cnm muscle two wt isoforms ptplafl ptpladnum
0.16537316.15829503.html.plaintext.txt	141	determine total amount ptpla transcript proportion wt ptpla transcript cnm muscle performed quantitative analysis using real time rt pcr
0.16537316.15829503.html.plaintext.txt	142	ptpla transcript identified cnm cnm muscle contained exon num num fig
0.16537316.15829503.html.plaintext.txt	143	hence specific primer pair encompassing sequence exon num num designed quantify total amount ptpla transcript fig
0.16537316.15829503.html.plaintext.txt	144	contrast exon num either deleted partially skipped aberrant ptpla transcript cnm fig
0.16537316.15829503.html.plaintext.txt	145	hence specific forward primer designed num bp exon num fragment specific wt transcript used combination reverse primer located within exon num quantify amount wt transcript fig
0.16537316.15829503.html.plaintext.txt	146	view larger version numk figure num
0.16537316.15829503.html.plaintext.txt	147	quantitative analysis ptpla expression skeletal muscle affected labrador
0.16537316.15829503.html.plaintext.txt	148	genomic structure sine containing ptplaalf allele reminded
0.16537316.15829503.html.plaintext.txt	149	black arrow indicate location primer used rt pcr amplification wt ptplafl ptpladnum isoforms wt
0.16537316.15829503.html.plaintext.txt	150	empty arrow indicate primer pair used rt pcr amplification ptpla transcript
0.16537316.15829503.html.plaintext.txt	151	histogram show normalized proportion ptpla wt isoforms b ptpla transcript c calculated quantitative real time rt pcr experiment using mrna skeletal muscle cnm cnm labrador
0.16537316.15829503.html.plaintext.txt	152	five healthy cnm control five affected cnm dog included analysis
0.16537316.15829503.html.plaintext.txt	153	amount ptpla transcript normalized tata box binding protein tbp muscular phosphofructo kinase mpfk housekeeping gene transcript
0.16537316.15829503.html.plaintext.txt	154	amount ptpla transcript cnm cnm muscle compared histogram summarizing result presented fig
0.16537316.15829503.html.plaintext.txt	155	ptpla transcript detected muscle cnm dog represented num num
0.16537316.15829503.html.plaintext.txt	156	num amount ptpla transcript found muscle cnm dog
0.16537316.15829503.html.plaintext.txt	157	furthermore ptplafl ptpladnum transcript cnm muscle represented num num
0.16537316.15829503.html.plaintext.txt	158	num ptplafl ptpladnum transcript expressed cnm muscle
0.16537316.15829503.html.plaintext.txt	159	statistical analysis based pair wise fixed reallocation randomization test num confirmed observed difference highly significant pnum
0.16537316.15829503.html.plaintext.txt	160	conclusion ptplaalf allele transcribed cnm affected muscle rather low efficiency num total transcript compared healthy cnm muscle
0.16537316.15829503.html.plaintext.txt	161	furthermore transcription mainly led abnormal transcript either premature stop codon codon encoding truncated protein
0.16537316.15829503.html.plaintext.txt	162	finally transcription ptplaalf allele also led normal wt transcript although low level num
0.16537316.15829503.html.plaintext.txt	163	experiment ptpla expressed canine skeletal muscle tested stage birth adulthood data shown
0.16537316.15829503.html.plaintext.txt	164	temporal expression pattern compatible clinical histological evolution disease affected dog
0.16537316.15829503.html.plaintext.txt	165	furthermore observed homozygous trna like sine insertion within ptpla exon num affected dog
0.16537316.15829503.html.plaintext.txt	166	human genome alu element abundant sine numerous alu insertion gene associated hereditary disorder num
0.16537316.15829503.html.plaintext.txt	167	case demonstrated directly causative disease lack detectable mutation rarity alu insertion strongly suggest likely candidate
0.16537316.15829503.html.plaintext.txt	168	case labrador retriever centronuclear myopathy two line reasoning suggest sine exonic insertion responsible disease
0.16537316.15829503.html.plaintext.txt	169	first sine insertion identified pedigree labrador retriever perfectly segregate disease
0.16537316.15829503.html.plaintext.txt	170	sampled num healthy dog num pure mixed breed failed detect insertion
0.16537316.15829503.html.plaintext.txt	171	particular sine insertion found nine healthy french labrador retriever unrelated experimental pedigree
0.16537316.15829503.html.plaintext.txt	172	presence retroposed sine within ptpla therefore highly correlated segregation centronuclear myopathy french labrador retriever
0.16537316.15829503.html.plaintext.txt	173	second compellingly show repeat element insertion severely affect splicing corresponding sine containing ptplaalf allele
0.16537316.15829503.html.plaintext.txt	174	provide strong evidence trna like sine responsible cumulative transcriptional abnormality based four following feature sine properly spliced although low level num ii partial exonization sine iii exon skipping involving several exon iv total amount ptpla transcript markedly reduced
0.16537316.15829503.html.plaintext.txt	175	taken together observation show exonic sine insertion within ptpla gene cnm dog act hypomorphic mutation
0.16537316.15829503.html.plaintext.txt	176	existing data ongoing experiment help u confirm sine insertion within ptpla causative event leading canine centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	177	first experimental pedigree established two affected labrador unrelated num generation num
0.16537316.15829503.html.plaintext.txt	178	found dog homozygote insertion within ptpla exon num
0.16537316.15829503.html.plaintext.txt	179	genotyping additional affected labrador coming alfort clinic allow u reinforce association sine insertion cnm
0.16537316.15829503.html.plaintext.txt	180	also believe close clinical histopathological relationship exist centronuclear myopathy found french labrador retriever hmlr identified dog country num
0.16537316.15829503.html.plaintext.txt	181	although precisely determined yet number generation common ancestor affected labrador usa france higher affected french dog
0.16537316.15829503.html.plaintext.txt	182	amplifying sine insertion affected labrador retriever usa country reinforce sine insertion causative disease mutation founder effect
0.16537316.15829503.html.plaintext.txt	183	finally characterization mutation ptpla similar phenotype either transgenic mouse human patient affected autosomal recessive cnm would provide strong evidence ptpla play central role etiology centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	184	human related x linked myotubular myopathy attributed truncating missense mutation mtmnum gene encoding myotubularin numnumnum
0.16537316.15829503.html.plaintext.txt	185	classical tissue specific gene targeting inactivation mtmnum mouse confirmed absence muscular expression mtmnum affect myogenesis induces lethal degeneration skeletal muscle num week age num
0.16537316.15829503.html.plaintext.txt	186	myotubularin phosphatase dual activity specifically dephosphorylates subpools phosphatidylinositols pi numnumnumnum
0.16537316.15829503.html.plaintext.txt	187	pi implicated number physiological process including cell proliferation death motility cytoskeletal regulation intracellular vesicle trafficking num
0.16537316.15829503.html.plaintext.txt	188	ptpla first annotated mouse human basis putative protein tyrosine phosphatase like catalytic site proline replacing arginine consensus hcxnumxnumr sequence numnum
0.16537316.15829503.html.plaintext.txt	189	ptpla protein share sequence homology mtmnum protein family data shown quite surprisingly canine cnm associated histopathological feature closely resemble observed human murine xlmtm
0.16537316.15829503.html.plaintext.txt	190	hence ptpla protein may involved pi dependent functional signaling pathway mtmnum least skeletal muscle
0.16537316.15829503.html.plaintext.txt	191	hypothesis addressed testing putative ptpla phosphatase activity andor investigating functional interaction ptpla mtmnum protein analyzing example subcellular localization mtmnum muscle affected labrador subcellular localization ptpla muscle mtmnum mouse
0.16537316.15829503.html.plaintext.txt	192	work presented show sine insertion detected within ptpla exon num associated various transcriptional feature
0.16537316.15829503.html.plaintext.txt	193	first sine insertion flanked direct duplication insertion site characteristic retroposition mechanism sine
0.16537316.15829503.html.plaintext.txt	194	duplicated sequence contains aggt tetranucleotide sine acquired uncommon intron like status num splicing donor site gt num splicing acceptor site ag allowing proper excision
0.16537316.15829503.html.plaintext.txt	195	although generates complete normal mature ptpla transcript mechanism seems poorly efficient num wt ptpla transcript detected muscle affected cnm labrador compared healthy cnm dog
0.16537316.15829503.html.plaintext.txt	196	precise elimination sine observed vivo reproduced ex vivo
0.16537316.15829503.html.plaintext.txt	197	addition exceptionally fine removal parasitic sequence repeat element insertion deleterious consequence transcription sine containing ptplaalf allele
0.16537316.15829503.html.plaintext.txt	198	indeed provide evidence splicing machinery recognizes cryptic splice site within sine exon num sequence yield mature elongated transcript containing partially exonized sine sequence
0.16537316.15829503.html.plaintext.txt	199	concomitantly exon skipping involving either exon num alone combination exon result several ptpla truncated transcript
0.16537316.15829503.html.plaintext.txt	200	ptplaalf associated aberrant exon skipping could undoubtedly attributed sine sequence reproduced ex vivo splicing experiment
0.16537316.15829503.html.plaintext.txt	201	alu insertion associated disease num numnumnum
0.16537316.15829503.html.plaintext.txt	202	insertion either associated exonization repeat element sequence specific exon skipping
0.16537316.15829503.html.plaintext.txt	203	strikingly work presented highlight two mutational mechanism previously reported independent defect necessarily mutually exclusive
0.16537316.15829503.html.plaintext.txt	204	systematic dichotomy observed exonization exon skipping mechanism may depend splicing regulatory element either contained inserted alu sequence located genomic vicinity
0.16537316.15829503.html.plaintext.txt	205	alternatively technical limitation might prevented identification concomittant subtle transcriptional aberration previously reported study
0.16537316.15829503.html.plaintext.txt	206	owing transcriptional defect associated sine insertion ptpla tempting speculate repeat element contains splicing regulatory motif strong enough drive exonization exon skipping
0.16537316.15829503.html.plaintext.txt	207	furthermore sine associated exon skipping previously reported refer skipping single exon
0.16537316.15829503.html.plaintext.txt	208	example alu insertion exon num human bcranum gene induces alternative skipping exon may play role development breast cancer num
0.16537316.15829503.html.plaintext.txt	209	surprisingly labrador affected centronuclear myopathy sine targeted exon num also exon num num num abnormally skipped muscular transcript
0.16537316.15829503.html.plaintext.txt	210	intron num num canine ptpla num num bp length respectively
0.16537316.15829503.html.plaintext.txt	211	may thus assume sine hamper spliceosome machinery recognize normal consensus splicing site modifying spatial conformation transcript andor specific interaction rna regulatory protein
0.16537316.15829503.html.plaintext.txt	212	abnormal skipping exon num num would thus result closeness sine
0.16537316.15829503.html.plaintext.txt	213	finally one ptpla abnormal transcript bear disruption reading frame
0.16537316.15829503.html.plaintext.txt	214	princeps study yeast human paved way nonsense mediated mrna decay nmd surveillance mechanism eliminates transcript containing premature termination codon numnum
0.16537316.15829503.html.plaintext.txt	215	reduced total amount num ptpla transcript detected muscle cnm dog using real time rt pcr analysis could therefore result nmd leading degradation ptpla abnormal transcript
0.16537316.15829503.html.plaintext.txt	216	deleterious effect repeat element already reported dog
0.16537316.15829503.html.plaintext.txt	217	example intronic sine insertion within hypocretin receptor num doberman pinscher induces exon skipping leading narcolepsy num
0.16537316.15829503.html.plaintext.txt	218	date relatively canine disease characterized genomic level
0.16537316.15829503.html.plaintext.txt	219	example narcolepsy hemophilia centronuclear myopathy disease associated insertion repeat element seem well represented
0.16537316.15829503.html.plaintext.txt	220	low average divergence sineccf repeat dog high percentage bimorphic locus respect presence absence sine insertion num
0.16537316.15829503.html.plaintext.txt	221	num dog different breed indicate expansion sine recent still active process num ewen kirkness personal communication
0.16537316.15829503.html.plaintext.txt	222	high incidence disease associated insertion dog may explained recent expansion repeat sequence represent num canine genome num
0.16537316.15829503.html.plaintext.txt	223	comparison finding num gross insertion duplication mutation human genetic mutation database contains num num characterized human mutation suggests alu insertion occur lower rate hardly contribute num
0.16537316.15829503.html.plaintext.txt	224	besides deleterious consequence gene expression insertion sine dog observed bimorphism may contribute interbreed intrabreed modulation gene expression accompanying physiological phenotypic diversity num
0.16537316.15829503.html.plaintext.txt	225	functional effect ptpla mutation reported present paper disclose rare example single sine insertion several modification rna processing provides molecular basis dynamic evolutionary mechanism gene control mobile element reviewed num
0.16537316.15829503.html.plaintext.txt	226	conclusion work presented show exonic sine insertion within ptpla gene cnm dog act hypomorphic mutation recapitulates sine dependent mutational molecular mechanism
0.16537316.15829503.html.plaintext.txt	227	result also illustrate relevance canine model genetic study
0.16537316.15829503.html.plaintext.txt	228	indeed major advance development canine genomic genetic resource reported recently soon available integrated num marker fishrh map num ii publication num
0.16537316.15829503.html.plaintext.txt	229	numx poodle genome num iii partial annotation num
0.16537316.15829503.html.plaintext.txt	230	numx canine genome assembly identification num num snp kerstin lindblad toh personal communication iv num num gene map canine genome help assembly sequence useful comparative mapping christophe hitte personal communication
0.16537316.15829503.html.plaintext.txt	231	resource provide long awaited mean mapping gene underlying striking diversity among breed morphology behavior well canine disease gene
0.16537316.15829503.html.plaintext.txt	232	mutation screening ptpla locus segregation analysis centronuclear myopathic canine primer designed num num end ptpla exon num num used amplify exon healthy carrier cnm affected dog cnm sample
0.16537316.15829503.html.plaintext.txt	233	pcr rt pcr performed genomic dna polya mrna respectively using following primer pair exonnum exnumfnum num gacgaggacggcaccaac numexnumrnum num ggtcatggcatgttgtaga num exon num exnumfnum num gctattgccatggtacgtttt numexnumrnum num aagcaaggcaaatgtttgga num
0.16537316.15829503.html.plaintext.txt	234	cycling condition num degree c num min num cycle num degree c num num degree c exon num num degree c exon num num num degree c num min num degree c num min
0.16537316.15829503.html.plaintext.txt	235	initial detection sine insertion new primer specific exon num exnumfnum num ggaaaaaggaacacacaaagg num exon num exnumrnum num accaattaaacagtggactat num designed detect sine insertion following pcr amplification genomic dna
0.16537316.15829503.html.plaintext.txt	236	pcr condition num degree c num min two cycle num degree c num num degree c num num degree c num min two cycle num degree c num num degree c num num degree c num min two cycle num degree c num num degree c num num degree c num min num cycle num degree c num num degree c num num degree c num min num degree c num min
0.16537316.15829503.html.plaintext.txt	237	cloning sequencing sine insertion pcr product extracted num seakem gtg agarose tebu gel using nucleospin extract ii macherey nagel ligated pcrnum topo plasmid invitrogen following manufacturer recommendation
0.16537316.15829503.html.plaintext.txt	238	insert sequenced using tnum tnum primer
0.16537316.15829503.html.plaintext.txt	239	splicing pattern analysis ptplaalf allele ptpla transcript amplified rt pcr using muscular polya mrna sample cnm cnm cnm dog template exnumfnum num ctacaacatcgccatgacc num exnumr num cacctctccatgaagcacct num primer
0.16537316.15829503.html.plaintext.txt	240	pcr condition num degree c num min two cycle num degree c num num degree c num num degree c num min three cycle num degree c num num degree c num num degree c num min num cycle num degree c num num degree c num num degree c num min num degree c num min
0.16537316.15829503.html.plaintext.txt	241	rt pcr product either visualized using standard electrophoresis technique distinct fragment purified cloned sequenced described earlier
0.16537316.15829503.html.plaintext.txt	242	ex vivo splicing experiment primer containing ecori noti restriction site designed num end ptpla intron num intnumf num cggaattccgcagatgctcaaccacccag num num end ptpla intron num intnumr num ttgcggccgcaacccttccaacttttcatttagtctt num
0.16537316.15829503.html.plaintext.txt	243	used amplify wt sine containing cnm genomic insert
0.16537316.15829503.html.plaintext.txt	244	amplified fragment checked size ligated psplnum vector using standard ecorinoti double digestion ligation protocol
0.16537316.15829503.html.plaintext.txt	245	resulting pcos wt pcos cnm plasmid transfected co num cell follows cell grown num degree c num conum dmem medium gibco supplemented num fetal calf serum d
0.16537316.15829503.html.plaintext.txt	246	deutscher penicilin num uml invitrogen streptomycin num microgml invitrogen
0.16537316.15829503.html.plaintext.txt	247	num confluence cell trypsinated centrifuged resuspended final concentration numxnum cellsml
0.16537316.15829503.html.plaintext.txt	248	cell incubated ice num min num microg plasmid electroporation num num microf num
0.16537316.15829503.html.plaintext.txt	249	num mm cuvettes using biorad genepulser
0.16537316.15829503.html.plaintext.txt	250	electroporated cell grown using standard cell culture condition num h num degree c num conum
0.16537316.15829503.html.plaintext.txt	251	total rna extraction transfected co num cell done using trizol reagent invitrogen according manufacturer recommendation first strand cdna synthesis performed described earlier
0.16537316.15829503.html.plaintext.txt	252	amplification performed using sanum num atctcagtggtatttgtgagc num sdnum num tctgagtcacctggacaacc num primer
0.16537316.15829503.html.plaintext.txt	253	num fold dilution first pcr used template nested pcr using sanum num cacctgaggagtgaattggtcg num sdnum num gtgacctgcactgtgacaagc num primer pair
0.16537316.15829503.html.plaintext.txt	254	pcr condition num degree c num min num cycle num degree c num min num degree c first pcr num degree c nested pcr num min num degree c num min num degree c num min
0.16537316.15829503.html.plaintext.txt	255	real time rt pcr analysis prior first strand cdna synthesis genomic dna removed num ng mrna sample using dna free kit ambion
0.16537316.15829503.html.plaintext.txt	256	three independent cdna sample skeletal muscle healthy golden retriever cnm used internal calibrator normalize data independent reaction
0.16537316.15829503.html.plaintext.txt	257	primer pair sequence mgclnum final concentration used presented supplementary material table snum
0.16537316.15829503.html.plaintext.txt	258	annealing temperature num degree c sample
0.16537316.15829503.html.plaintext.txt	259	real time pcr reaction performed lightcycler roche using cdna dilution specific primer num
0.16537316.15829503.html.plaintext.txt	260	num microm lc faststart dna master sybr green kit according manufacturer recommendation
0.16537316.15829503.html.plaintext.txt	261	sample evaluated crossing point cp automatically calculated using second derivative maximum method lightcycler software
0.16537316.15829503.html.plaintext.txt	262	standard curve primer pair generated using duplicated num fold dilution series calibrator sample
0.16537316.15829503.html.plaintext.txt	263	corresponding pcr efficiency indicated supplementary material table snum
0.16537316.15829503.html.plaintext.txt	264	bioinformatics primer designed using primernum software httpfrodo
0.16537316.15829503.html.plaintext.txt	265	educgi binprimernumprimernumwww
0.16537316.15829503.html.plaintext.txt	266	blast search human genome canine genome assembly performed nbci blast page httpwww
0.16537316.15829503.html.plaintext.txt	267	sequence alignment performed using cap dialignnum software freely available infobiogen service home page httpwww
0.16537316.15829503.html.plaintext.txt	268	canine tbp mpfk sequence retrieved sr database httpsrs
0.16537316.15829503.html.plaintext.txt	269	quantitative expression analysis rest software downloaded gene quantification academic industrial information platform qpcr httpwww
0.16537316.15829503.html.plaintext.txt	270	num myotubular myopathy differential diagnosis x linked recessive autosomal dominant autosomal recessive form present state dna study
0.16537316.15829503.html.plaintext.txt	271	num clinical histologic finding autosomal centronuclear myopathy
0.16537316.15829503.html.plaintext.txt	272	num familial neuromuscular disease myotubes
0.16537316.15829503.html.plaintext.txt	273	num medical complication long term survivor x linked myotubular myopathy
0.16537316.15829503.html.plaintext.txt	274	num myotubular myopathy differential diagnosis x linked recessive autosomal dominant autosomal recessive form present state dna study
0.16537316.15829503.html.plaintext.txt	275	num myotubular myopathy morphological immunohistochemical clinical variation
0.16537316.15829503.html.plaintext.txt	276	num x linked myotubular myopathy refinement gene num kb region new highly informative microsatellite marker
0.16537316.15829503.html.plaintext.txt	277	num gene mutated x linked myotubular myopathy defines new putative tyrosine phosphatase family conserved yeast
0.16537316.15829503.html.plaintext.txt	278	num characterisation mutation num patient x linked myotubular myopathy including family mild phenotype
0.16537316.15829503.html.plaintext.txt	279	num myotubularin phosphatase deficient myotubular myopathy act phosphatidylinositol num kinase phosphatidylinositol num phosphate pathway
0.16537316.15829503.html.plaintext.txt	280	num inaugural article myotubularin protein tyrosine phosphatase mutated myotubular myopathy dephosphorylates lipid second messenger phosphatidylinositol num phosphate
0.16537316.15829503.html.plaintext.txt	281	num myotubularin family genetic disease phosphoinositide metabolism
0.16537316.15829503.html.plaintext.txt	282	num phosphatidylinositol num phosphate activation conserved substrate specificity myotubularin phosphatidylinositol num phosphatase
0.16537316.15829503.html.plaintext.txt	283	num production phosphatidylinositol num phosphate phosphoinositide num phosphatase myotubularin mammalian cell
0.16537316.15829503.html.plaintext.txt	284	num charcot marie tooth type numb caused mutation gene encoding myotubularin related protein num
0.16537316.15829503.html.plaintext.txt	285	num mutation mtmrnum new pseudophosphatase homologue mtmrnum sbfnum two family autosomal recessive demyelinating form charcot marie tooth disease associated early onset glaucoma
0.16537316.15829503.html.plaintext.txt	286	num mutation sbfnum gene encoding novel member myotubularin family charcot marie tooth neuropathy type numbnumnumpnum
0.16537316.15829503.html.plaintext.txt	287	num myotubularins large disease associated family cooperating catalytically active inactive phosphoinositides phosphatase
0.16537316.15829503.html.plaintext.txt	288	num characterization adapter subunit phosphatidylinositol nump num phosphatase identification myotubularin related protein lacking catalytic activity
0.16537316.15829503.html.plaintext.txt	289	num myotubularin family novel phosphoinositide regulator
0.16537316.15829503.html.plaintext.txt	290	num regulation myotubularin related mtmrnum phosphatidylinositol phosphatase mtmrnum catalytically inactive phosphatase
0.16537316.15829503.html.plaintext.txt	291	num characterization myotubularin related protein num binding partner myotubularin related protein num
0.16537316.15829503.html.plaintext.txt	292	num identification myotubularin lipid phosphatase catalytic subunit associated num phosphatase adapter protein num pap
0.16537316.15829503.html.plaintext.txt	293	num muscle disorder labrador retriever characterized deficiency type ii muscle fiber
0.16537316.15829503.html.plaintext.txt	294	num hereditary myopathy labrador retriever morphologic study
0.16537316.15829503.html.plaintext.txt	295	num myopathy labrador retriever
0.16537316.15829503.html.plaintext.txt	296	num inherited myopathy litter labrador retriever
0.16537316.15829503.html.plaintext.txt	297	num genetic aspect labrador retriever myopathy
0.16537316.15829503.html.plaintext.txt	298	num cnm locus canine homologue human autosomal form centronuclear myopathy map chromosome num
0.16537316.15829503.html.plaintext.txt	299	num inheritance neuromuscular disorder labrador retriever dog
0.16537316.15829503.html.plaintext.txt	300	num integrated num marker fishrh map canine genome
0.16537316.15829503.html.plaintext.txt	301	num molecular cloning chromosomal mapping developmental expression novel protein tyrosine phosphatase like gene
0.16537316.15829503.html.plaintext.txt	302	num human protein tyrosine phosphatase like gene expression profile genomic structure mutation analysis family arvd
0.16537316.15829503.html.plaintext.txt	303	num highly repetitive dna sequence possibly unique canid
0.16537316.15829503.html.plaintext.txt	304	num recommendation nomenclature system human gene mutation
0.16537316.15829503.html.plaintext.txt	305	conum olinktypedoi crossrefisimedline
0.16537316.15829503.html.plaintext.txt	306	num alu repeat human disease
0.16537316.15829503.html.plaintext.txt	307	num inactivation fa gene alu insertion retrotransposition intron causing splicing variation autoimmune lymphoproliferative syndrome
0.16537316.15829503.html.plaintext.txt	308	num exon skipping caused intronic insertion young alu ybnum element lead severe hemophilia
0.16537316.15829503.html.plaintext.txt	309	num alu mediated rearrangement cause exon skipping hunter disease
0.16537316.15829503.html.plaintext.txt	310	num alu containing exon alternatively spliced
0.16537316.15829503.html.plaintext.txt	311	num insertion alu element responsible acute intermittent porphyria
0.16537316.15829503.html.plaintext.txt	312	conum plinktypedoi crossrefisimedline
0.16537316.15829503.html.plaintext.txt	313	num de novo insertion alu sequence coding region clcnnum gene result dent disease
0.16537316.15829503.html.plaintext.txt	314	num relative expression software tool rest group wise comparison statistical analysis relative expression result real time pcr
0.16537316.15829503.html.plaintext.txt	315	num mtmnum mutation x linked myotubular myopathy
0.16537316.15829503.html.plaintext.txt	316	conum rlinktypedoi crossrefisimedline
0.16537316.15829503.html.plaintext.txt	317	num lipid phosphatase myotubularin essential skeletal muscle maintenance myogenesis mouse
0.16537316.15829503.html.plaintext.txt	318	num phosphoinositides signal transduction
0.16537316.15829503.html.plaintext.txt	319	num de novo alu element insertion fgfrnum identify distinct pathological basis apert syndrome
0.16537316.15829503.html.plaintext.txt	320	num mutation analysis brcanum gene primary breast cancer
0.16537316.15829503.html.plaintext.txt	321	num perfect message rna surveillance nonsense mediated decay
0.16537316.15829503.html.plaintext.txt	322	num listening silence understanding nonsense exonic mutation affect splicing
0.16537316.15829503.html.plaintext.txt	323	num sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.16537316.15829503.html.plaintext.txt	324	num dog genome survey sequencing comparative analysis
0.16537316.15829503.html.plaintext.txt	325	num dna sequence insertion evolutionary variation gene regulation
0.16720255.15271651.html.plaintext.txt	0	orexin stimulate food intake old rat saeko takanonumnum setsuko kanainum hiroko hosoyanum minoru ohtanum hiroshi uematsunum kyoko miyasakanum
0.16720255.15271651.html.plaintext.txt	1	numdepartment clinical physiology tokyo metropolitan institute gerontology tokyo num num numgerodontology department gerodontology division gerontology gerodontology graduate school tokyo medical dental university tokyo num num japan
0.16720255.15271651.html.plaintext.txt	2	submitted num may num accepted final form num july num
0.16720255.15271651.html.plaintext.txt	3	age anorexia aging brain hypothalamus orexin receptor
0.16720255.15271651.html.plaintext.txt	4	aging associated progressive decrease appetite food intake num num
0.16720255.15271651.html.plaintext.txt	5	decline food intake often happens healthy elderly person predisposes pathological weight loss protein energy malnutrition thereby raising morbidity mortality
0.16720255.15271651.html.plaintext.txt	6	reason decline food intake multifactorial
0.16720255.15271651.html.plaintext.txt	7	although sensitivity cck classic neuropeptide show satiety effect enhanced old animal num mechanism underlying effect elucidated num
0.16720255.15271651.html.plaintext.txt	8	orexins appetite stimulating peptide discovered num num
0.16720255.15271651.html.plaintext.txt	9	classified orexin orexin b neuropeptides endogenous ligand orphan g protein coupled receptor
0.16720255.15271651.html.plaintext.txt	10	orexin num amino acid orexin b num amino acid peptide produced single precursor polypeptide preproorexin
0.16720255.15271651.html.plaintext.txt	11	two orexin receptor subtypes identified orexin num receptor oxnumr selective orexin whereas orexin num receptor oxnumr nonselective receptor orexin b neuropeptide agonist
0.16720255.15271651.html.plaintext.txt	12	orexins expressed almost exclusively lateral hypothalamic area num region classically implicated control mammalian feeding behavior num
0.16720255.15271651.html.plaintext.txt	13	administered centrally rat peptide stimulate food consumption dose dependently num
0.16720255.15271651.html.plaintext.txt	14	addition preproorexin mrna level upregulated fasting num
0.16720255.15271651.html.plaintext.txt	15	finding suggested orexin neuropeptide system play significant role feeding behavior orexins therefore categorized orexigenic appetite stimulating factor
0.16720255.15271651.html.plaintext.txt	16	moreover reported num orexin stimulates pancreatic exocrine secretion via vagal efferent nerve orexin may important candidate mediator cephalic phase secretory response feeding
0.16720255.15271651.html.plaintext.txt	17	present study determine mechanism age associated decrease appetite food intake compared food intake young old male rat indication stimulatory effect intracerebroventricular administration orexins
0.16720255.15271651.html.plaintext.txt	18	also examined protein expression orexin receptor hypothalamus important region brain regulation food intake
0.16720255.15271651.html.plaintext.txt	19	synthetic orexin num amino acid peptide orexin b num amino acid peptide purchased peptide institute osaka japan
0.16720255.15271651.html.plaintext.txt	20	stainless steel cannula num gauge guide cannula num gauge insert plastic one roanoke va used study
0.16720255.15271651.html.plaintext.txt	21	western blot analysis used primary antibody oxnumr oxnumrnum oxnumr oxnumrnum alpha diagnostic international san antonio tx secondary anti rabbit igg horseradish peroxidase linked whole antibody amersham life science piscataway nj
0.16720255.15271651.html.plaintext.txt	22	young num mo old num num g body wt old num num mo old num num g body wt wistar rat purchased shizuoka jikken dobutsu shizuoka japan num wk age maintained specific pathogen free aging farm institute
0.16720255.15271651.html.plaintext.txt	23	given commercial rat chow crf num oriental yeast tokyo japan kept room controlled temperature num plus minus num degree c numnum h light dark cycle starting num
0.16720255.15271651.html.plaintext.txt	24	rat anesthetized intraperitoneal injection pentobarbital sodium num num mgnum g body wt
0.16720255.15271651.html.plaintext.txt	25	intracerebroventricular injection orexins stainless steel cannula implanted stereotactically left lateral ventricle using following coordinate bregma anteroposterior num
0.16720255.15271651.html.plaintext.txt	26	operation rat maintained individual cage num ratcage condition controlled temperature num degree c illumination numnum h light dark cycle num day
0.16720255.15271651.html.plaintext.txt	27	rat provided food water ad libitum
0.16720255.15271651.html.plaintext.txt	28	mock injected handled num min daily minimize injection induced stress throughout num day recovery period
0.16720255.15271651.html.plaintext.txt	29	effect orexins food water intake
0.16720255.15271651.html.plaintext.txt	30	measured food water consumption young old rat nighttime num num total num h without treatment comparison
0.16720255.15271651.html.plaintext.txt	31	orexins dissolved num bsasaline
0.16720255.15271651.html.plaintext.txt	32	num day recovery period experiment conducted without overnight fasting
0.16720255.15271651.html.plaintext.txt	33	num num num g rat chow crf num water supplied orexins injected intracerebroventriculaly
0.16720255.15271651.html.plaintext.txt	34	different dos orexin num
0.16720255.15271651.html.plaintext.txt	35	num nmolnum microl injected subsequently respective num day recovery period one rat
0.16720255.15271651.html.plaintext.txt	36	num nmolnum microl administered old rat confirm biological effect
0.16720255.15271651.html.plaintext.txt	37	num nmolnum microl also determined another animal
0.16720255.15271651.html.plaintext.txt	38	physiological saline administered vehicle
0.16720255.15271651.html.plaintext.txt	39	injection given num using num microl hamilton microsyringe injector left place num injection ensure complete dispersal peptide
0.16720255.15271651.html.plaintext.txt	40	remaining chow water weighed num num num h injection estimate food intake water consumption time point
0.16720255.15271651.html.plaintext.txt	41	end experiment rat killed black ink injected lateral ventricle
0.16720255.15271651.html.plaintext.txt	42	success cannulation verified visualization
0.16720255.15271651.html.plaintext.txt	43	determination orexin receptor western blot analysis
0.16720255.15271651.html.plaintext.txt	44	young n num old n num rat killed guillotine num num without treatment whole brain immediately removed
0.16720255.15271651.html.plaintext.txt	45	hypothalamus quickly dissected stored num degree c later experiment
0.16720255.15271651.html.plaintext.txt	46	dissection hypothalamus carried according method gispen et al
0.16720255.15271651.html.plaintext.txt	47	tissue sample separately homogenized lysis buffer
0.16720255.15271651.html.plaintext.txt	48	respective hypothalamus homogenate num microg protein oxnumr num microg protein oxnumr separated sd num polyacrylamide gel
0.16720255.15271651.html.plaintext.txt	49	protein electrophoretically transferred polyvinylidene difluoride membrane bio rad hercules ca blocked num skim milk num h room temperature
0.16720255.15271651.html.plaintext.txt	50	membrane incubated polyclonal rabbit antibody numnum oxnumrnum numnum oxnumrnum alpha diagnostics international san antonio tx overnight num degree c
0.16720255.15271651.html.plaintext.txt	51	three wash membrane incubated secondary anti rabbit igg numnumnum oxnumr numnumnum oxnumr num h room temperature
0.16720255.15271651.html.plaintext.txt	52	three additional wash immunoreactive band detected using enhanced chemiluminescence assay system plus amersham bioscience little chalfont uk num
0.16720255.15271651.html.plaintext.txt	53	autoradiograms underwent semiquantitative densitometric analysis
0.16720255.15271651.html.plaintext.txt	54	data expressed mean plus minus se
0.16720255.15271651.html.plaintext.txt	55	optical density immunoreactive band calculated using nih image software package
0.16720255.15271651.html.plaintext.txt	56	result expressed mean plus minus se
0.16720255.15271651.html.plaintext.txt	57	result analyzed one way anova repeated measure multiple anova manova followed fisher protected least significant difference test
0.16720255.15271651.html.plaintext.txt	58	body weight old rat significantly higher young rat indicated value food water intake relative body weight gnum g body wt
0.16720255.15271651.html.plaintext.txt	59	food consumption nighttime significantly le old rat young rat p num
0.16720255.15271651.html.plaintext.txt	60	similarly water consumption old rat significantly le young rat p num
0.16720255.15271651.html.plaintext.txt	61	view larger version numk fig
0.16720255.15271651.html.plaintext.txt	62	food water consumption nighttime
0.16720255.15271651.html.plaintext.txt	63	food intake water intake b young old rat num night
0.16720255.15271651.html.plaintext.txt	64	food water intake shown relative body weight
0.16720255.15271651.html.plaintext.txt	65	value mean plus minus se
0.16720255.15271651.html.plaintext.txt	66	number rat group indicated parenthesis p num
0.16720255.15271651.html.plaintext.txt	67	num significant difference young rat anova followed fisher protected least significant difference test
0.16720255.15271651.html.plaintext.txt	68	effect orexin food water intake
0.16720255.15271651.html.plaintext.txt	69	analysis multiple comparison test repeated measure manova revealed intracerebroventricular injection orexin stimulated food intake dose dependent manner num num num h young rat although effect num
0.16720255.15271651.html.plaintext.txt	70	num nmol orexin significant fig
0.16720255.15271651.html.plaintext.txt	71	integrated food intake num h period shown fig
0.16720255.15271651.html.plaintext.txt	72	num num nmol orexin significantly increased food intake
0.16720255.15271651.html.plaintext.txt	73	view larger version numk fig
0.16720255.15271651.html.plaintext.txt	74	effect intracerebroventricular injection orexin food intake
0.16720255.15271651.html.plaintext.txt	75	time course effect injection num
0.16720255.15271651.html.plaintext.txt	76	food intake measured num num num h injection
0.16720255.15271651.html.plaintext.txt	77	b effect integrated food intake num h young rat
0.16720255.15271651.html.plaintext.txt	78	c time course effect injection num
0.16720255.15271651.html.plaintext.txt	79	num num nmol food intake old rat
0.16720255.15271651.html.plaintext.txt	80	significant effect observed
0.16720255.15271651.html.plaintext.txt	81	d effect integrated food intake num h old rat
0.16720255.15271651.html.plaintext.txt	82	significant effect observed
0.16720255.15271651.html.plaintext.txt	83	food intake shown relative body weight
0.16720255.15271651.html.plaintext.txt	84	value mean plus minus se
0.16720255.15271651.html.plaintext.txt	85	number rat group indicated parenthesis p num
0.16720255.15271651.html.plaintext.txt	86	num significant difference saline control
0.16720255.15271651.html.plaintext.txt	87	contrast significant increase observed old rat even higher dos num num num nmol applied fig
0.16720255.15271651.html.plaintext.txt	88	two higher dos orexin tended increase water intake young rat difference significant f num
0.16720255.15271651.html.plaintext.txt	89	num num h water intake fig
0.16720255.15271651.html.plaintext.txt	90	effect dose observed old rat fig
0.16720255.15271651.html.plaintext.txt	91	view larger version numk fig
0.16720255.15271651.html.plaintext.txt	92	effect intracerebroventricular injection orexin water intake
0.16720255.15271651.html.plaintext.txt	93	significant effect observed result
0.16720255.15271651.html.plaintext.txt	94	time course effect injection num
0.16720255.15271651.html.plaintext.txt	95	num nmol water intake young rat
0.16720255.15271651.html.plaintext.txt	96	water intake measured num num num h injection
0.16720255.15271651.html.plaintext.txt	97	b effect integrated water intake num h young rat
0.16720255.15271651.html.plaintext.txt	98	c time course effect injection num
0.16720255.15271651.html.plaintext.txt	99	num num nmol water intake old rat
0.16720255.15271651.html.plaintext.txt	100	d effect integrated water intake num h old rat
0.16720255.15271651.html.plaintext.txt	101	water intake shown relative body weight
0.16720255.15271651.html.plaintext.txt	102	value mean plus minus se
0.16720255.15271651.html.plaintext.txt	103	number rat group indicated parenthesis
0.16720255.15271651.html.plaintext.txt	104	effect orexin b food water intake
0.16720255.15271651.html.plaintext.txt	105	intracerebroventricular injection orexin b slightly increased food intake young old rat effect significant
0.16720255.15271651.html.plaintext.txt	106	integrated food intake num h shown fig
0.16720255.15271651.html.plaintext.txt	107	orexin b stimulate water intake dose either young old rat fig
0.16720255.15271651.html.plaintext.txt	108	view larger version numk fig
0.16720255.15271651.html.plaintext.txt	109	effect intracerebroventricular injection orexin b food water intake
0.16720255.15271651.html.plaintext.txt	110	significant effect observed result
0.16720255.15271651.html.plaintext.txt	111	num nmol integrated food intake num h young rat
0.16720255.15271651.html.plaintext.txt	112	b effect integrated food intake num h old rat
0.16720255.15271651.html.plaintext.txt	113	num nmol integrated water intake num h young rat
0.16720255.15271651.html.plaintext.txt	114	d effect integrated water intake num h old rat
0.16720255.15271651.html.plaintext.txt	115	food water intake shown relative body weight
0.16720255.15271651.html.plaintext.txt	116	value mean plus minus se
0.16720255.15271651.html.plaintext.txt	117	number rat group indicated parenthesis
0.16720255.15271651.html.plaintext.txt	118	determination orexin receptor
0.16720255.15271651.html.plaintext.txt	119	western blot analysis using anti oxnumr antibody oxnumrnum detected specific band corresponding num kda fig
0.16720255.15271651.html.plaintext.txt	120	intensity band hypothalamus old rat significantly lower young rat anova p num
0.16720255.15271651.html.plaintext.txt	121	view larger version numk fig
0.16720255.15271651.html.plaintext.txt	122	western blot analysis showing optical density
0.16720255.15271651.html.plaintext.txt	123	western blot analysis orexin num receptor oxnumr selective orexin orexin num receptor oxnumr selective orexin b b hypothalamus young old rat
0.16720255.15271651.html.plaintext.txt	124	band intensity expressed optical density
0.16720255.15271651.html.plaintext.txt	125	value mean plus minus se
0.16720255.15271651.html.plaintext.txt	126	number rat group indicated parenthesis
0.16720255.15271651.html.plaintext.txt	127	example western blot analysis presented top b
0.16720255.15271651.html.plaintext.txt	128	num significant difference young rat anova followed fisher protected least significant difference test
0.16720255.15271651.html.plaintext.txt	129	western blot analysis using anti oxnumr antibody oxnumrnum detected three band hypothalamus young old rat num num num kda
0.16720255.15271651.html.plaintext.txt	130	oxnumr pure protein num
0.16720255.15271651.html.plaintext.txt	131	num kda num compared intensity num kda immunosignal young old rat fig
0.16720255.15271651.html.plaintext.txt	132	intensity num kda band higher old rat compared young one difference significant
0.16720255.15271651.html.plaintext.txt	133	examine mechanism underlying effect orexin measured protein level receptor hypothalamus compared level young old rat
0.16720255.15271651.html.plaintext.txt	134	protein level oxnumr significantly lower old rat young
0.16720255.15271651.html.plaintext.txt	135	band intensity old rat num le young rat
0.16720255.15271651.html.plaintext.txt	136	result indicates decrease oxnumr protein level hypothalamus could responsible lack orexin stimulatory effect food intake old rat
0.16720255.15271651.html.plaintext.txt	137	however answer question num reduction protein level oxnumr would yield num reduction behavioral response
0.16720255.15271651.html.plaintext.txt	138	several neural pathway involved orexigenic action orexins num aging change pathway might implicated
0.16720255.15271651.html.plaintext.txt	139	another hypothesis age related decrease food intake orexin secondary phenomenon due decline ability orexin increase arousal
0.16720255.15271651.html.plaintext.txt	140	problem discussed previous report num num num although record awakening time present study
0.16720255.15271651.html.plaintext.txt	141	num reported change food intake independent change sleepwake cycle
0.16720255.15271651.html.plaintext.txt	142	moreover selective oxnumr antagonist sb num reduced orexin induced food intake num
0.16720255.15271651.html.plaintext.txt	143	previously abnormality oxnumr shown cause canine narcolepsy num
0.16720255.15271651.html.plaintext.txt	144	oxnumr expression decrease age study decrease food intake old rat seem depend level arousal
0.16720255.15271651.html.plaintext.txt	145	previous study num reported central administration orexins stimulated water intake significantly
0.16720255.15271651.html.plaintext.txt	146	however observed two higher dos orexin significantly increase water intake even young rat
0.16720255.15271651.html.plaintext.txt	147	difference study kunii et al
0.16720255.15271651.html.plaintext.txt	148	num present study different dos orexin applied experimental condition
0.16720255.15271651.html.plaintext.txt	149	num determined effect num num nmol orexins whereas used num
0.16720255.15271651.html.plaintext.txt	150	num num nmol also measured water intake without feeding whereas measured water food consumption simultaneously
0.16720255.15271651.html.plaintext.txt	151	recent study num reported preproorexin gene expression content orexins rat brain decreased course aging
0.16720255.15271651.html.plaintext.txt	152	also report num site specific decrease immunostaining orexin observed locus coeruleus old cat
0.16720255.15271651.html.plaintext.txt	153	report indicate deterioration orexin system old animal
0.16720255.15271651.html.plaintext.txt	154	measure orexin content brain whether content decreased age remains unknown
0.16720255.15271651.html.plaintext.txt	155	however orexin bind oxnumr oxnumr specificity oxnumr orexin high num age associated change oxnumr could biologically important orexin
0.16720255.15271651.html.plaintext.txt	156	observation lead u propose age associated decline oxnumr may related age associated decline appetite food intake
0.16720255.15271651.html.plaintext.txt	157	hand orexin b showed significant effect either young old rat
0.16720255.15271651.html.plaintext.txt	158	present observation compatible previous study num num central orexin b le effective stimulant food intake orexin
0.16720255.15271651.html.plaintext.txt	159	protein level oxnumr significantly different young old rat
0.16720255.15271651.html.plaintext.txt	160	num measured mrna level oxnumr oxnumr eight brain region num num num num mo old cnumblnum mouse
0.16720255.15271651.html.plaintext.txt	161	observed declining trend oxnumr mrna level hypothalamus although age related change oxnumr mrna expression
0.16720255.15271651.html.plaintext.txt	162	difference might due specie difference although precise mechanism unknown
0.16720255.15271651.html.plaintext.txt	163	conclusion function orexin system stimulating feeding behavior reduced old rat compared young one
0.16720255.15271651.html.plaintext.txt	164	decrease oxnumr protein level hypothalamus could responsible orexin lack stimulatory effect food intake old rat
0.16720255.15271651.html.plaintext.txt	165	footnote address reprint request correspondence k
0.16720255.15271651.html.plaintext.txt	166	clinical physiology tokyo metropolitan institute gerontology num num sakaecho itabashiku tokyo num num japan e mail miyasakaattmig
0.16720255.15271651.html.plaintext.txt	167	cost publication article defrayed part payment page charge
0.16720255.15271651.html.plaintext.txt	168	article must therefore hereby marked advertisement accordance num u
0.16720255.15271651.html.plaintext.txt	169	section num solely indicate fact
0.17200397.15961555.html.plaintext.txt	0	orexin expression function glucocorticoid manipulation stress feeding study gemma k
0.17200397.15961555.html.plaintext.txt	1	al barazanji shelagh wilson declan n
0.17200397.15961555.html.plaintext.txt	2	henry wellcome laboratory integrative neuroscience endocrinology g
0.17200397.15961555.html.plaintext.txt	3	university bristol bristol bsnum numny united kingdom department biology d
0.17200397.15961555.html.plaintext.txt	4	psychiatry centre excellence drug discovery cedd discovery research
0.17200397.15961555.html.plaintext.txt	5	glaxosmithkline harlow essex cmnum numaw united kingdom metabolic disease k
0.17200397.15961555.html.plaintext.txt	6	metabolic viral disease cedd glaxosmithkline research triangle park north carolina num
0.17200397.15961555.html.plaintext.txt	7	address correspondence request reprint dr
0.17200397.15961555.html.plaintext.txt	8	harbuz henry wellcome laboratory integrative neuroscience endocrinology dorothy hodgkin building whitson street bristol bsnum numny united kingdom
0.17200397.15961555.html.plaintext.txt	9	lha long implicated feeding behavior initial observation highlighted role orexins stimulating appetite num
0.17200397.15961555.html.plaintext.txt	10	however clear orexins also involved regulation sleep arousal locomotor activity neuroendocrine response num num therefore orexigenic activity may secondary behavioral trait influence feeding
0.17200397.15961555.html.plaintext.txt	11	behavioral study orexins modulate stress related behavior grooming chewing inedible material num num num
0.17200397.15961555.html.plaintext.txt	12	orexin containing neurones project lha many cns area involved mediating stress including paraventricular nucleus pvn hypothalamus arcuate nucleus arc locus coeruleus num num num
0.17200397.15961555.html.plaintext.txt	13	ox num ox num receptor widely differentially distributed throughout cns including pvn suprachiasmatic nucleus supraoptic nucleus arc hypothalamus also locus coeruleus hippocampus num num num num
0.17200397.15961555.html.plaintext.txt	14	area individual synergistic involvement regulating circadian rhythm behavioral neuroendocrine response stressor
0.17200397.15961555.html.plaintext.txt	15	hypothalamo pituitary adrenal hpa axis one principal pathway mediating neuroendocrine response stress
0.17200397.15961555.html.plaintext.txt	16	hypothalamic neuropeptides corticotropin releasing factor crf arginine vasopressin avp stimulate release proopiomelanocortin derived peptide acth anterior pituitary consequent release glucocorticoid adrenal cortex
0.17200397.15961555.html.plaintext.txt	17	corticosterone cort principal glucocorticoid rodent act glucocorticoid receptor hippocampus hypothalamus mineralocorticoid receptor within hippocampus negatively regulate hpa axis activity num
0.17200397.15961555.html.plaintext.txt	18	many study demonstrated orexins influence hpa axis activity
0.17200397.15961555.html.plaintext.txt	19	plasma acth cort concentration elevated rat intracerebroventricular icv ox administration num num num num num num num num num
0.17200397.15961555.html.plaintext.txt	20	accompanied induction c fo mrna num avp crf mrna num parvocellular subdivision pvn
0.17200397.15961555.html.plaintext.txt	21	addition vitro study revealed release crf peptide avp hypothalamic explants num
0.17200397.15961555.html.plaintext.txt	22	ox b also reported stimulate hpa axis activity num
0.17200397.15961555.html.plaintext.txt	23	orexin expression rat lha increased stressor immobilization num cold stress num hypoglycemia num
0.17200397.15961555.html.plaintext.txt	24	reduced secretion plasma acth cortisol reported patient narcolepsy num condition associated orexin deficiency
0.17200397.15961555.html.plaintext.txt	25	therefore considerable evidence orexins modulate hpa axis activity orexin expression responsive alteration hpa axis activity
0.17200397.15961555.html.plaintext.txt	26	well documented glucocorticoid administration stimulates feeding conversely glucocorticoid deficiency result loss appetite weight loss adrenalectomized adx rat exhibit decreased feeding reversed cort administration num num
0.17200397.15961555.html.plaintext.txt	27	therefore orexins may exert direct effect appetite regulation within hypothalamus may act indirectly stimulate feeding increased cort secretion
0.17200397.15961555.html.plaintext.txt	28	test hypothesis designed experiment investigate effect adx without cort replacement ox induced feeding determine whether endogenous cort involved ox induced feeding behavior
0.17200397.15961555.html.plaintext.txt	29	also investigated effect glucocorticoid manipulation orexin expression morning evening determine whether orexin expression exhibit diurnal rhythm expression num num may correlated diurnal rhythm hpa axis activity
0.17200397.15961555.html.plaintext.txt	30	finally investigated effect orexin expression lipopolysaccharide lp immunological stressor elicits robust prolonged activation hpa axis num num
0.17200397.15961555.html.plaintext.txt	31	surgical procedure intracerebroventricular cannulation
0.17200397.15961555.html.plaintext.txt	32	rat anesthetized im injection domitor medetomidine hcl num
0.17200397.15961555.html.plaintext.txt	33	num ml per num g pfizer sandwich kent uk ip injection sublimaze fentanyl num
0.17200397.15961555.html.plaintext.txt	34	num ml per num g janssen cilag high wycombe buckinghamshire uk
0.17200397.15961555.html.plaintext.txt	35	rat positioned stereotaxic frame implanted num gauge stainless steel guide cannula left lateral ventricle brain sterile condition
0.17200397.15961555.html.plaintext.txt	36	cannula secured surface skull jeweler screw dental cement
0.17200397.15961555.html.plaintext.txt	37	stereotaxic coordinate left brain ventricle follows num
0.17200397.15961555.html.plaintext.txt	38	num mm lateral midline num
0.17200397.15961555.html.plaintext.txt	39	num mm vertical skull surface incisor bar num
0.17200397.15961555.html.plaintext.txt	40	completion surgery anesthesia reversed ip numnum mixture antisedan atipamezole hcl num
0.17200397.15961555.html.plaintext.txt	41	num ml per num g pfizer nubain nalbuphine hcl num
0.17200397.15961555.html.plaintext.txt	42	num ml per num g dupont pharmaceutical stevenage hertfordshire uk
0.17200397.15961555.html.plaintext.txt	43	implantation guide cannula correct placement checked using gravitational flow sterile saline filled cannula
0.17200397.15961555.html.plaintext.txt	44	rat bilaterally adx via dorsal approach
0.17200397.15961555.html.plaintext.txt	45	small incision made along midline back rib cage connective tissue fat displaced small hole made muscle either side back using blunt cut scissors
0.17200397.15961555.html.plaintext.txt	46	adrenal excised curved forceps
0.17200397.15961555.html.plaintext.txt	47	adrenal checked remained intact excision
0.17200397.15961555.html.plaintext.txt	48	animal complete removal adrenal considered adx
0.17200397.15961555.html.plaintext.txt	49	surgery adx animal immediately given num
0.17200397.15961555.html.plaintext.txt	50	num saline drink maintain salt balance
0.17200397.15961555.html.plaintext.txt	51	surgery sham animal identical adrenal removed
0.17200397.15961555.html.plaintext.txt	52	animal allowed num d postoperative recovery handled daily
0.17200397.15961555.html.plaintext.txt	53	effect glucocorticoid ox induced feeding thirty two rat bilaterally adx whereas num rat subjected sham adx
0.17200397.15961555.html.plaintext.txt	54	animal returned home cage adx animal immediately given num
0.17200397.15961555.html.plaintext.txt	55	num saline whereas two group adx rat given num
0.17200397.15961555.html.plaintext.txt	56	num saline supplemented cort sigma poole dorset uk either num mgliter low cort num mgliter high cort
0.17200397.15961555.html.plaintext.txt	57	concentration cort selected within basal physiological range endogenous cort num
0.17200397.15961555.html.plaintext.txt	58	morning experimentation sham adx animal divided two group n num equal mean body weight receive icv injection either ox num micrograt num microl num
0.17200397.15961555.html.plaintext.txt	59	dose equivalent num nmol fall within accepted range num num nmol num used extensively
0.17200397.15961555.html.plaintext.txt	60	low cort high cort replacement group also received icv injection either ox num micrograt saline
0.17200397.15961555.html.plaintext.txt	61	icv injection cannula extension tubing preloaded drug vehicle inserted guide cannula
0.17200397.15961555.html.plaintext.txt	62	injection given period num min
0.17200397.15961555.html.plaintext.txt	63	needle left position minute ensure complete dispersal peptide
0.17200397.15961555.html.plaintext.txt	64	injection given num num h
0.17200397.15961555.html.plaintext.txt	65	preweighed food pellet water bottle supplied icv injection
0.17200397.15961555.html.plaintext.txt	66	food intake determined num num num num h time point icv injection
0.17200397.15961555.html.plaintext.txt	67	num h rat killed decapitation trunk blood collected chilled edta tube ice centrifugation collect plasma
0.17200397.15961555.html.plaintext.txt	68	acth measured ria prior extraction plasma seppak column num
0.17200397.15961555.html.plaintext.txt	69	assay sensitivity num pgml
0.17200397.15961555.html.plaintext.txt	70	total cort measured unextracted plasma house ria num
0.17200397.15961555.html.plaintext.txt	71	radioactive tracer inum cort icn biomedicals basingstoke hampshire uk specific activity num
0.17200397.15961555.html.plaintext.txt	72	sensitivity assay num ngml
0.17200397.15961555.html.plaintext.txt	73	acth cort primary antiserum kindly supplied g
0.17200397.15961555.html.plaintext.txt	74	makara hungarian academy science budapest hungary
0.17200397.15961555.html.plaintext.txt	75	sample either acth cort processed assay intraassay variation le num
0.17200397.15961555.html.plaintext.txt	76	distribution prepro ox expression lateral hypothalamus two male sprague dawley rat killed decapitation brain removed stored num c sectioning
0.17200397.15961555.html.plaintext.txt	77	coronal brain section num microm collected lha pvn cryostat immediately stored num c
0.17200397.15961555.html.plaintext.txt	78	two section collected every four section num num section collected animal
0.17200397.15961555.html.plaintext.txt	79	prepro ox expression investigated using situ hybridization performed described previously num num
0.17200397.15961555.html.plaintext.txt	80	section warmed room temperature num min fixed num formaldehyde num min washed twice pb incubated num
0.17200397.15961555.html.plaintext.txt	81	section dehydrated graded ethanol wash num num min num num min num num min num num min delipidated chloroform num num min rehydrated num num min num num min ethanol drying air
0.17200397.15961555.html.plaintext.txt	82	probe used num mer oligonucleotide complementary nucleotide num num exonic sequence rat prepro ox mrna num tgcccgcggcgtggttgccagctccgtgcaaca num genbank accession
0.17200397.15961555.html.plaintext.txt	83	probe labeled num end nums atp column purified nuctrap probe purification column stratagene uk
0.17200397.15961555.html.plaintext.txt	84	probe labeled specific activity num
0.17200397.15961555.html.plaintext.txt	85	forty five microliters hybridization buffer num formamide numx saline sodium citrate ssc num
0.17200397.15961555.html.plaintext.txt	86	num mgml sheared single stranded salmon sperm dna num
0.17200397.15961555.html.plaintext.txt	87	num x denhardt solution num dextran sulfate containing labeled probe numnum cpm applied slide
0.17200397.15961555.html.plaintext.txt	88	hybridization performed overnight num c
0.17200397.15961555.html.plaintext.txt	89	section experiment processed time
0.17200397.15961555.html.plaintext.txt	90	section washed four time num c numx ssc numx ssc num
0.17200397.15961555.html.plaintext.txt	91	num followed two num min wash room temperature numx ssc remove nonspecific binding two brief rinse distilled water
0.17200397.15961555.html.plaintext.txt	92	section air dried exposed amersham hyperfilmmp amersham international aylesbury buckinghamshire uk together numc labeled standard num d
0.17200397.15961555.html.plaintext.txt	93	autoradiographic image probe bound brain section analyzed using densitometry method described previously num using image software
0.17200397.15961555.html.plaintext.txt	94	result presented arbitrary value prepro ox expression lha
0.17200397.15961555.html.plaintext.txt	95	effect adrenalectomy glucocorticoid manipulation prepro ox expression lateral hypothalamus fifteen rat bilaterally adx described whereas num rat subjected sham adx
0.17200397.15961555.html.plaintext.txt	96	num saline whereas seven adx rat eight sham adx rat given num
0.17200397.15961555.html.plaintext.txt	97	num saline supplemented cort high cort num mgliter described
0.17200397.15961555.html.plaintext.txt	98	remaining sham adx animal given tap water drink
0.17200397.15961555.html.plaintext.txt	99	animal placed regimen num d handled daily
0.17200397.15961555.html.plaintext.txt	100	morning experiment rat killed decapitation brain removed trunk blood collected chilled edta tube ice acth cort rias described
0.17200397.15961555.html.plaintext.txt	101	section cut cryostat two lha area determined distribution study lhanum bregma num
0.17200397.15961555.html.plaintext.txt	102	num mm atlas paxinos watson num
0.17200397.15961555.html.plaintext.txt	103	nine consecutive coronal lateral hypothalamic brain section collected spanning num microm slide three section encompassing num microm lha allow apparent variation prepro ox expression demonstrated present lha result distribution study
0.17200397.15961555.html.plaintext.txt	104	prepro ox mrna measurement situ hybridization performed described
0.17200397.15961555.html.plaintext.txt	105	adx adx cort hybridized section dipped autoradiographic emulsion exposed num c num wk
0.17200397.15961555.html.plaintext.txt	106	section processed time
0.17200397.15961555.html.plaintext.txt	107	slide developed fixed counterstained methyl green
0.17200397.15961555.html.plaintext.txt	108	seven emulsion dipped slide per treatment analyzed cellular level counting number labeled cell silver grain per cell
0.17200397.15961555.html.plaintext.txt	109	least two five cell per section minimum eight cell per slide three section per slide randomly selected xnum magnification microscope leica heidelberg germany saved image
0.17200397.15961555.html.plaintext.txt	110	silver grain counted hand microscope image enlarged num photo editor microsoft redmond ca
0.17200397.15961555.html.plaintext.txt	111	silver grain dotted onto plastic sheet attached monitor screen counted
0.17200397.15961555.html.plaintext.txt	112	silver grain individual cell counted three time manner
0.17200397.15961555.html.plaintext.txt	113	sixty one num cell counted treatment
0.17200397.15961555.html.plaintext.txt	114	effect diurnal variation prepro ox expression adx rat given glucocorticoid replacement thirty three rat bilaterally adx whereas num rat subjected sham adx described previously
0.17200397.15961555.html.plaintext.txt	115	seventeen adx rat given num
0.17200397.15961555.html.plaintext.txt	116	num saline whereas num given num
0.17200397.15961555.html.plaintext.txt	117	num saline supplemented cort num mgliter
0.17200397.15961555.html.plaintext.txt	118	sham animal supplied tap water drink
0.17200397.15961555.html.plaintext.txt	119	animal left regimen num d handled daily
0.17200397.15961555.html.plaintext.txt	120	morning experimentation five sham eight adx seven adx cort rat killed decapitation morning num num h remaining animal killed evening num h
0.17200397.15961555.html.plaintext.txt	121	brain trunk blood collected described previously prepro ox measurement sectioning performed described
0.17200397.15961555.html.plaintext.txt	122	effect lp injection prepro ox mrna animal received ip injection num num h either lp num micrograt num
0.17200397.15961555.html.plaintext.txt	123	num saline escherichia coli serotype numbnum sigma saline
0.17200397.15961555.html.plaintext.txt	124	animal killed decapitation num h injection
0.17200397.15961555.html.plaintext.txt	125	brain trunk blood collected prepro ox mrna measured described
0.17200397.15961555.html.plaintext.txt	126	plasma acth cort measured rias
0.17200397.15961555.html.plaintext.txt	127	statistic statistical comparison multiple group made using fisher protected least significant difference test one way anova
0.17200397.15961555.html.plaintext.txt	128	lp study student test used
0.17200397.15961555.html.plaintext.txt	129	value expressed mean plus minus sem
0.17200397.15961555.html.plaintext.txt	130	analysis generated using statview
0.17200397.15961555.html.plaintext.txt	131	plasma acth concentration pgml num h intracerebroventricular administration orexin saline
0.17200397.15961555.html.plaintext.txt	132	num h food intake significantly greater sham ox num
0.17200397.15961555.html.plaintext.txt	133	num g group compared sham vehicle group num
0.17200397.15961555.html.plaintext.txt	134	adx significantly reduced ox induced food intake num
0.17200397.15961555.html.plaintext.txt	135	num g num reduction reversed high cort num
0.17200397.15961555.html.plaintext.txt	136	num g low cort replacement
0.17200397.15961555.html.plaintext.txt	137	food intake significantly greater adx ox rat num
0.17200397.15961555.html.plaintext.txt	138	num g compared sham vehicle num
0.17200397.15961555.html.plaintext.txt	139	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	140	effect adx corticosterone replacement cumulative food intake num h single icv injection ox num micrograt vehicle num microlrat conscious rat
0.17200397.15961555.html.plaintext.txt	141	value mean plus minus sem n num numgroup
0.17200397.15961555.html.plaintext.txt	142	num compared adx vehicle sham vehicle group p num
0.17200397.15961555.html.plaintext.txt	143	num compared adx orexin group p num
0.17200397.15961555.html.plaintext.txt	144	num compared adx vehicle group
0.17200397.15961555.html.plaintext.txt	145	distribution prepro ox expression lateral hypothalamus considerable variation prepro ox mrna expression level throughout lha fig
0.17200397.15961555.html.plaintext.txt	146	however section collected caudal pvn area num
0.17200397.15961555.html.plaintext.txt	147	num mm end anterior commissure profile expression tended peak trough around similar area case prepro ox level overlapped two animal
0.17200397.15961555.html.plaintext.txt	148	area lhnum lhnum area overlap prepro ox mrna two brain clearly defined anatomically therefore permitted greater reproducibility
0.17200397.15961555.html.plaintext.txt	149	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	150	comparison prepro ox mrna distribution lha two control rat
0.17200397.15961555.html.plaintext.txt	151	lhanum lhanum represent area sectioned prepro ox mrna measurement
0.17200397.15961555.html.plaintext.txt	152	effect adrenalectomy glucocorticoid manipulation prepro ox expression lateral hypothalamus concentration plasma cort measured confirm success adx
0.17200397.15961555.html.plaintext.txt	153	adx rat concentration plasma cort limit assay detection num ngml compared sham group num plus minus num ngml
0.17200397.15961555.html.plaintext.txt	154	adx animal cort replacement cort concentration num plus minus num ngml compared sham cort group num plus minus num ngml
0.17200397.15961555.html.plaintext.txt	155	effect adx prepro ox mrna level lhanum fig
0.17200397.15961555.html.plaintext.txt	156	numb area compared sham animal
0.17200397.15961555.html.plaintext.txt	157	sham adx group cort replacement significantly elevated level prepro ox mrna lhanum lhanum compared sham adx group without cort replacement
0.17200397.15961555.html.plaintext.txt	158	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	159	morning level prepro ox mrna lhanum lhanum b rat num d adx sham surgery without corticosterone replacement
0.17200397.15961555.html.plaintext.txt	160	mrna level expressed percentage control group mean plus minus sem n num numgroup
0.17200397.15961555.html.plaintext.txt	161	num compared sham group p num
0.17200397.15961555.html.plaintext.txt	162	representative autoradiographic image prepro ox mrna expression distribution lhanum area shown fig
0.17200397.15961555.html.plaintext.txt	163	num treatment group
0.17200397.15961555.html.plaintext.txt	164	photomicrograph emulsion dipped slide showing prepro ox mrna expression individual cell shown fig
0.17200397.15961555.html.plaintext.txt	165	image demonstrate prepro ox mrna expressed cell different size
0.17200397.15961555.html.plaintext.txt	166	number silver grain per cell individual prepro ox gene expressing cell emulsion dipped slide significantly p num
0.17200397.15961555.html.plaintext.txt	167	num increased lha adx rat receiving cort replacement compared adx rat fig
0.17200397.15961555.html.plaintext.txt	168	amount orexin expression remarkably consistent given treatment num plus minus num grainscell adx group compared num plus minus num grainscell adx cort group
0.17200397.15961555.html.plaintext.txt	169	significant difference number cell expressing prepro ox mrna adx num cell adxcort num cell counted selected field view
0.17200397.15961555.html.plaintext.txt	170	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	171	representative autoradiographic image prepro ox mrna distribution lhanum adx cort replaced adx adx cort rat num microm brain coronal section
0.17200397.15961555.html.plaintext.txt	172	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	173	photomicrograph emulsion dipped slide hybridized nums labeled oligonucleotide probe complementary mrna prepro ox lhanum adx cort replaced adx adx cort rat
0.17200397.15961555.html.plaintext.txt	174	lateral hypothalamic cell counterstained num
0.17200397.15961555.html.plaintext.txt	175	num methyl green num microm brain coronal section
0.17200397.15961555.html.plaintext.txt	176	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	177	number prepro ox emulsion grain per cell lha rat num d adx surgery without cort replacement
0.17200397.15961555.html.plaintext.txt	178	value mean plus minus sem n numgroup eight nine cell counted per animal
0.17200397.15961555.html.plaintext.txt	179	effect diurnal variation orexin expression adrenalectomized rat glucocorticoid replacement plasma cort concentration sham animal significantly higher p num
0.17200397.15961555.html.plaintext.txt	180	num evening num plus minus num ngml compared morning num plus minus num ngml
0.17200397.15961555.html.plaintext.txt	181	plasma cort morning evening adx group limit detection num ngml
0.17200397.15961555.html.plaintext.txt	182	cort replacement adx animal resulted similar morning num plus minus num ngml evening concentration num plus minus num ngml significantly different morning concentration sham group
0.17200397.15961555.html.plaintext.txt	183	adx effect morning level prepro ox mrna lhanum whereas cort replacement regulated orexin mrna sham adx group fig
0.17200397.15961555.html.plaintext.txt	184	consistent observation significant effect adx prepro ox mrna expression lhanum area morning evening fig
0.17200397.15961555.html.plaintext.txt	185	cort replacement significantly elevated prepro ox mrna level morning compared sham adx group increase observed evening fig
0.17200397.15961555.html.plaintext.txt	186	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	187	morning num h evening num h level prepro ox mrna lhanum adx rat num d surgery without cort replacement
0.17200397.15961555.html.plaintext.txt	188	value mean plus minus sem n num numgroup
0.17200397.15961555.html.plaintext.txt	189	num compared group
0.17200397.15961555.html.plaintext.txt	190	effect lp stress prepro ox expression lp evoked num fold increase plasma cort concentration num plus minus num ngml compared saline control num plus minus num ngml
0.17200397.15961555.html.plaintext.txt	191	significant num increase prepro ox mrna expression lhanum num h lp injection compared saline injected rat fig
0.17200397.15961555.html.plaintext.txt	192	view larger version numk fig
0.17200397.15961555.html.plaintext.txt	193	level prepro ox mrna lhanum num h ip injection lp num microg
0.17200397.15961555.html.plaintext.txt	194	mrna expressed percentage control group mean plus minus sem n numgroup
0.17200397.15961555.html.plaintext.txt	195	num compared saline treated animal
0.17200397.15961555.html.plaintext.txt	196	one recent study investigated effect adx ox induced feeding num
0.17200397.15961555.html.plaintext.txt	197	contrast finding investigator observed effect adx ox induced food intake num h period num
0.17200397.15961555.html.plaintext.txt	198	may due suboptimal dos ox employed dose range num
0.17200397.15961555.html.plaintext.txt	199	num num nmol compared num nmol present study latter dose considered optimal ox induced feeding behavior num
0.17200397.15961555.html.plaintext.txt	200	finding may also result shorter period food intake studied maximum num h compared maximum num h study
0.17200397.15961555.html.plaintext.txt	201	num seems evident adx associated decreased food intake higher dos ox num h time point small increase food intake response ox sham rat permit adx effect reach significance
0.17200397.15961555.html.plaintext.txt	202	larger dose orexin used elicited greater food intake sham rat compared observed drazen et al
0.17200397.15961555.html.plaintext.txt	203	num consequently able observe significant reproducible decrease orexin induced food intake adx rat
0.17200397.15961555.html.plaintext.txt	204	initially experiment performed adx sham group given orexin saline
0.17200397.15961555.html.plaintext.txt	205	consequent observation significant decrease orexin induced food intake adx group repeated experiment expanded include low cort high cort replacement group
0.17200397.15961555.html.plaintext.txt	206	observation reproducible time point full study repeated num
0.17200397.15961555.html.plaintext.txt	207	together ability physiological concentration cort reverse effect adx orexin induced food intake increase confidence endogenous glucocorticoid exert physiologically relevant control orexin induced feeding behavior
0.17200397.15961555.html.plaintext.txt	208	observation orexin induced food intake decreased num adx rat evidence significant component eating behavior dependent endogenous cort
0.17200397.15961555.html.plaintext.txt	209	known cort directly stimulate appetite num indirect effect appetite cort mediated hypothalamic neuropeptides well understood
0.17200397.15961555.html.plaintext.txt	210	number mechanism may invoked explain relationship among cort ox food intake
0.17200397.15961555.html.plaintext.txt	211	cort may stimulate endogenous orexin expression action glucocorticoid receptor within lha intermediary nucleus may act via orexin peptide release within pvnarc area hypothalamus cort may stimulate food intake consequent orexin activation hpa axis activity
0.17200397.15961555.html.plaintext.txt	212	also possibility cort may exert effect food intake via peptide modulate appetite rather directly orexins
0.17200397.15961555.html.plaintext.txt	213	well defined pathway glucocorticoid feedback crf expression pvn release median eminence num
0.17200397.15961555.html.plaintext.txt	214	crf inhibits food intake therefore increased cort could increase food intake inhibitory action crf
0.17200397.15961555.html.plaintext.txt	215	orexin induced feeding enhanced crf receptor antagonist suggesting crf involvement num
0.17200397.15961555.html.plaintext.txt	216	neuropeptide y npy also possible mediator orexin induced feeding
0.17200397.15961555.html.plaintext.txt	217	glucocorticoid manipulation result marked similarity orexin npy effect feeding
0.17200397.15961555.html.plaintext.txt	218	adx reduced npy induced food intake num similar effect adx orexin induced feeding reversed cort replacement num
0.17200397.15961555.html.plaintext.txt	219	npy potent known inducer food intake num orexin induced feeding blocked ynum receptor antagonist num
0.17200397.15961555.html.plaintext.txt	220	therefore conceivable orexin exerts principal glucocorticoid dependent action food intake npy direct effect cort npy orexin expression explains observation
0.17200397.15961555.html.plaintext.txt	221	however observed num increase food intake response ox adx rat complete absence cort strong evidence glucocorticoid independent central pathway direct orexin induced food intake may mediated npy
0.17200397.15961555.html.plaintext.txt	222	situ hybridization histochemistry confirmed prepro orexin expression restricted lha extension perifornical nucleus posterior hypothalamic area agreement previously reported study num
0.17200397.15961555.html.plaintext.txt	223	novel finding distribution study prepro ox mrna expression measured coronal sequential section running num microm throughout lha show considerable difference section emphasizing importance consistent choice section hybridization measuring prepro ox mrna lha treatment group
0.17200397.15961555.html.plaintext.txt	224	observation confirms need use anatomical marker ensure consistency sectioning sample
0.17200397.15961555.html.plaintext.txt	225	observed regulation morning evening prepro ox mrna lha cort administration
0.17200397.15961555.html.plaintext.txt	226	increased blood cort may regulate orexin expression large population glucocorticoid receptor positive cell within lha num num
0.17200397.15961555.html.plaintext.txt	227	emulsion staining established significant difference number cell expressing prepro ox treatment group
0.17200397.15961555.html.plaintext.txt	228	therefore increase prepro ox mrna observed response cort represent increased expression prepro ox within cell lha
0.17200397.15961555.html.plaintext.txt	229	slight increase prepro ox mrna expression sham group evening compared morning although statistically significant
0.17200397.15961555.html.plaintext.txt	230	plasma cort level significantly increased evening compared morning sham animal agreement previous study demonstrating diurnal variation hpa axis activity num
0.17200397.15961555.html.plaintext.txt	231	however important note cort level similar morning evening replacement group significantly different morning level sham animal
0.17200397.15961555.html.plaintext.txt	232	possible increase evening prepro ox expression although statistically significant may consequence circadian increase endogenous circulating cort
0.17200397.15961555.html.plaintext.txt	233	increase may sufficient mask stimulatory effect orexin expression exogenous cort
0.17200397.15961555.html.plaintext.txt	234	investigation interrelationship circadian cycle hpa axis activity orexin expression undoubtedly shed light regulatory mechanism controlling highly integrated modality sleep wake pattern feeding behavior
0.17200397.15961555.html.plaintext.txt	235	found effect adx alone orexin expression lha suggests basal orexin expression rat tonic regulation endogenous glucocorticoid
0.17200397.15961555.html.plaintext.txt	236	contrast decrease prepro ox mrna expression num d adx reported num
0.17200397.15961555.html.plaintext.txt	237	however data hpa axis activity presented study difficult determine effectiveness adx surgery
0.17200397.15961555.html.plaintext.txt	238	addition information section sliced within lha
0.17200397.15961555.html.plaintext.txt	239	given variability prepro ox expression observed throughout lha important choice section justified well defined
0.17200397.15961555.html.plaintext.txt	240	decrease orexin expression adx reversed dexamethasone replacement num observation consistent data demonstrating cort regulation orexin expression sham animal
0.17200397.15961555.html.plaintext.txt	241	decrease prepro ox mrna level lha num d adx also reported phenomenon could reversed cort num
0.17200397.15961555.html.plaintext.txt	242	discrepancy data published report effect adx prepro ox mrna expression lha num num lack agreement effect exogenous glucocorticoid may due methodological difference
0.17200397.15961555.html.plaintext.txt	243	experiment used num d adx cort replacement compared previous study using num d adx dexamethasone num num d adx cort num
0.17200397.15961555.html.plaintext.txt	244	instructive compare discrepancy literature npy expression adx
0.17200397.15961555.html.plaintext.txt	245	although general consensus npy regulated glucocorticoid report differ effect npy expression eliminating endogenous cortisosterone adx
0.17200397.15961555.html.plaintext.txt	246	short term adx num d alter npy peptide level arc pvn num whereas group observed long term adx num d deceased npy peptide level area num
0.17200397.15961555.html.plaintext.txt	247	adx num d effect npy immunoreactivity hypothalamic area one notable exception pvn num
0.17200397.15961555.html.plaintext.txt	248	longer term adx num d effect prepro npy mrna arc num peptide level measured study
0.17200397.15961555.html.plaintext.txt	249	either dexamethasone cort replacement regulated npy mrna dexamethasone much potent num
0.17200397.15961555.html.plaintext.txt	250	therefore effect glucocorticoid manipulation orexin expression npy may dependent period adx concentration type glucocorticoid whether orexin peptide mrna measured specifically defined hypothalamic site selected analysis
0.17200397.15961555.html.plaintext.txt	251	finally demonstrated single injection lp immunological stressor regulate prepro ox mrna expression lha
0.17200397.15961555.html.plaintext.txt	252	increase prepro ox mrna reported response stressor robustly stimulate hpa axis immobilization cold stress num hypoglycemia num
0.17200397.15961555.html.plaintext.txt	253	present study expands repertoire stressor include immune mediated stress
0.17200397.15961555.html.plaintext.txt	254	lp potent stimulator hpa axis activity subsequently cort release possible increase prepro ox mrna may result increasing blood cort concentration
0.17200397.15961555.html.plaintext.txt	255	work necessary elucidate whether increased orexin response lp direct result lp induced cort release indirectly response increased cytokine
0.17200397.15961555.html.plaintext.txt	256	may briefly speculate physiological importance increased orexin expression response immunological stimulus
0.17200397.15961555.html.plaintext.txt	257	orexins demonstrated analgesic property inflammatory induced hyperalgesia ox num receptor antagonist sb num reduces ox mediated analgesia num
0.17200397.15961555.html.plaintext.txt	258	suggests may hypothalamic mechanism involving orexin analgesic agent neurogenic pain
0.17200397.15961555.html.plaintext.txt	259	also possible onset inflammation acute phase response lp play crucial role important maintain homeostatic control peripheral release inflammatory cytokine increased secretion cort immunological stimulus activate hypothalamic component drive hpa axis activity including orexins
0.17200397.15961555.html.plaintext.txt	260	conclusion data establish ox induced feeding prepro ox mrna expression sensitive glucocorticoid manipulation
0.17200397.15961555.html.plaintext.txt	261	regulation prepro ox expression response cort may circadian related level increased morning evening
0.17200397.15961555.html.plaintext.txt	262	however study required determine mechanism underlying data
0.17200397.15961555.html.plaintext.txt	263	observation highlight interdependence orexins hpa axis activity provide insight role glucocorticoid regulating centrally mediated orexin induced feeding orexin expression within brain
0.17200397.15961555.html.plaintext.txt	264	footnote work supported needham cooper trust uk glaxosmithkline neuroendocrine charitable trust uk ph
0.17200397.15961555.html.plaintext.txt	265	result work presented part numth annual meeting endocrine society philadelphia pennsylvania june num abstract pnum num
0.17200397.15961555.html.plaintext.txt	266	first published online june num num
0.17200397.15961555.html.plaintext.txt	267	abbreviation adx adrenalectomized arc arcuate nucleus avp arginine vasopressin cns central nervous system cort corticosterone crf corticotropin releasing factor hpa hypothalamo pituitary adrenal icv intracerebroventricular lha lateral hypothalamic area lp lipopolysaccharide npy neuropeptide y ox orexin pvn paraventricular nucleus ssc saline sodium citrate
0.17200397.15961555.html.plaintext.txt	268	accepted publication june num num
0.17200397.15961555.html.plaintext.txt	269	home help feedback subscription archive search table content endocrinology endocrine review j
0.17200397.15961555.html.plaintext.txt	270	molecular endocrinology recent prog
0.18602495.16160021.html.plaintext.txt	0	shared genetic risk factor obstructive sleep apnea obesity sanjay r
0.18602495.16160021.html.plaintext.txt	1	division sleep medicine brigham woman hospital boston massachusetts
0.18602495.16160021.html.plaintext.txt	2	susceptibility gene pleiotropy gene x environment effect
0.18602495.16160021.html.plaintext.txt	3	obstructive sleep apnea osa disorder characterized repetitive collapse upper airway sleep one common respiratory disorder estimated prevalence num num among middle aged american men woman respectively num
0.18602495.16160021.html.plaintext.txt	4	obesity modern western society also extremely common
0.18602495.16160021.html.plaintext.txt	5	num nearly one third u adult met clinical criterion obesity prevalence appears increasing num
0.18602495.16160021.html.plaintext.txt	6	obesity osa often colocalize surprise
0.18602495.16160021.html.plaintext.txt	7	perhaps male gender obesity strongest risk factor development osa
0.18602495.16160021.html.plaintext.txt	8	relative stable weight num increase weight num yr associated sixfold increase risk developing moderate severe osa num
0.18602495.16160021.html.plaintext.txt	9	weight loss trial found significant reduction apnea severity moderate weight loss num num
0.18602495.16160021.html.plaintext.txt	10	however mechanism obesity cause osa completely defined many potential pathway hypothesized num
0.18602495.16160021.html.plaintext.txt	11	perhaps obvious fat deposition neck airway lumen may lead increased collapsibility upper airway
0.18602495.16160021.html.plaintext.txt	12	addition adiposity chest abdomen may result reduction lung volume
0.18602495.16160021.html.plaintext.txt	13	recent study suggest reduced lung volume may independently predispose upper airway collapse num
0.18602495.16160021.html.plaintext.txt	14	another possible mechanism relating obesity sleep apnea via hormonal effect adipose tissue
0.18602495.16160021.html.plaintext.txt	15	leptin hormone produced adipose tissue important effect weight regulation stimulating hypothalamic satiety center num num num
0.18602495.16160021.html.plaintext.txt	16	human obesity typically associated elevated leptin level suggesting state leptin resistance num
0.18602495.16160021.html.plaintext.txt	17	besides regulating weight leptin may important effect ventilatory drive
0.18602495.16160021.html.plaintext.txt	18	leptin deficient mouse hypoventilate blunted response hypercapnia num num
0.18602495.16160021.html.plaintext.txt	19	administration leptin corrects abnormality independent change weight num
0.18602495.16160021.html.plaintext.txt	20	effect ventilatory control elevated leptin level underlying leptin resistant state may play pathogenic role development osa
0.18602495.16160021.html.plaintext.txt	21	also possible osa may play causal role development obesity
0.18602495.16160021.html.plaintext.txt	22	osa patient elevated leptin level compared weight matched control osa treatment lower level num num num
0.18602495.16160021.html.plaintext.txt	23	finding suggest osa may cause leptin resistance thus propensity weight gain
0.18602495.16160021.html.plaintext.txt	24	sleep disruption common result osa reduce serum leptin level also increase level appetite stimulating hormone ghrelin num num
0.18602495.16160021.html.plaintext.txt	25	finding associated increase hunger appetite score num
0.18602495.16160021.html.plaintext.txt	26	epidemiological study consistently implicate reduced sleep risk factor development obesity num num num num num num
0.18602495.16160021.html.plaintext.txt	27	although overall weight appear fall treatment osa one study find amount fat inside abdominal cavity visceral fat diminishes num
0.18602495.16160021.html.plaintext.txt	28	fat compartment appears unique hormonal effect amount visceral adipose tissue strongly associated metabolic complication obesity insulin resistance dyslipidemia measure subcutaneous fat overall obesity num num
0.18602495.16160021.html.plaintext.txt	29	similarly familial factor known influence osa risk nearly num year num
0.18602495.16160021.html.plaintext.txt	30	since several group quantified familial risk osa studying widely different population
0.18602495.16160021.html.plaintext.txt	31	study identified strong heritable component osa num num num num num
0.18602495.16160021.html.plaintext.txt	32	family based study suggest risk osa approximately twice great among relative apneic person num num
0.18602495.16160021.html.plaintext.txt	33	addition dose response relationship exists risk osa increase increasing number apneic relative num
0.18602495.16160021.html.plaintext.txt	34	quantitative apnea related phenotype also demonstrate substantial heritability
0.18602495.16160021.html.plaintext.txt	35	study elderly twin found heritability respiratory disturbance index oxygen desaturation index nearly num num
0.18602495.16160021.html.plaintext.txt	36	clearly given strong effect obesity osa pathogenesis genetic variant predisposes obesity secondarily also lead development osa
0.18602495.16160021.html.plaintext.txt	37	thus obesity gene might also considered apnea gene
0.18602495.16160021.html.plaintext.txt	38	however obesity monolithic process
0.18602495.16160021.html.plaintext.txt	39	clearly form obesity important role pathogenesis sleep apnea
0.18602495.16160021.html.plaintext.txt	40	example fat deposition neck much important fat deposition limb num
0.18602495.16160021.html.plaintext.txt	41	android fat deposition pattern excess subcutaneous truncal abdominal fat visceral adiposity also found closely predict osa overall obesity num num
0.18602495.16160021.html.plaintext.txt	42	therefore genetic polymorphism influence fat deposition site important osa gene
0.18602495.16160021.html.plaintext.txt	43	wealth evidence fat distribution pattern phenotype genetically driven
0.18602495.16160021.html.plaintext.txt	44	large difference pattern fat deposition exist across inbred strain cattle suggesting important role genetics num
0.18602495.16160021.html.plaintext.txt	45	among human even correction overall obesity measure fat deposition pattern aggregate within family
0.18602495.16160021.html.plaintext.txt	46	ratio subscapular skinfold thickness subscapular plus suprailiac thickness measure android fat pattern reported heritability num num
0.18602495.16160021.html.plaintext.txt	47	measure central obesity bmi adjusted waist circumference ratio trunk extremity skinfold ratio heritabilities num num num
0.18602495.16160021.html.plaintext.txt	48	finding strongly support hypothesis genetic polymorphism specifically promote fat deposition subcutaneous region torso around abdominal viscera
0.18602495.16160021.html.plaintext.txt	49	mechanism variant would promote development obesity osa
0.18602495.16160021.html.plaintext.txt	50	another type potential genetic interaction obesity osa one particular polymorphism lead obesity osa independent mechanism fig
0.18602495.16160021.html.plaintext.txt	51	example impacting leptin function genetic polymorphism may reduce satiety also increase ventilatory instability
0.18602495.16160021.html.plaintext.txt	52	referred genetic pleiotropy
0.18602495.16160021.html.plaintext.txt	53	pleiotropic genetic effect clearly described situation
0.18602495.16160021.html.plaintext.txt	54	well known example apoe locus code apolipoprotein e
0.18602495.16160021.html.plaintext.txt	55	num allele apoe important risk factor atherosclerotic heart disease well alzheimer dementia num num
0.18602495.16160021.html.plaintext.txt	56	circadian regulatory gene clock also appears influence multiple biological system
0.18602495.16160021.html.plaintext.txt	57	clock knockout mouse profound disruption circadian rhythmicity surprising animal would abnormal timing feeding activity num
0.18602495.16160021.html.plaintext.txt	58	addition however mutant animal demonstrate overall increase caloric intake associated phenotype obesity metabolic syndrome num
0.18602495.16160021.html.plaintext.txt	59	similarly given large number neurological metabolic mechanical overlap obesity osa likely polymorphism affecting one biochemical system may affect risk disorder via multiple path
0.18602495.16160021.html.plaintext.txt	60	example disruption orexin system could potentially result common link obesity osa
0.18602495.16160021.html.plaintext.txt	61	orexinergic neuron lateral hypothalamus play important role sustaining wakefulness projection wake promoting area brain num
0.18602495.16160021.html.plaintext.txt	62	loss neuron associated narcolepsy phenotype num
0.18602495.16160021.html.plaintext.txt	63	neuron name orexin implies also play important role stimulating appetite projecting arcuate nucleus hypothalamus num
0.18602495.16160021.html.plaintext.txt	64	thus mutation affecting orexin orexin receptor protein involved downstream signaling orexin binding might simultaneously affect metabolic sleep related function
0.18602495.16160021.html.plaintext.txt	65	several potential candidate gene listed table num
0.18602495.16160021.html.plaintext.txt	66	view larger version numk fig
0.18602495.16160021.html.plaintext.txt	67	obesity sleep apnea heavily influenced underlying genotype
0.18602495.16160021.html.plaintext.txt	68	susceptibility gene act directly one phenotype causal relationship obesity sleep apnea indirect effect
0.18602495.16160021.html.plaintext.txt	69	locus pleiotropic effect impacting susceptibility obesity sleep apnea via independent mechanism
0.18602495.16160021.html.plaintext.txt	70	candidate gene might link genetic mechanism obesity sleep apnea either pleiotropy gene x environment interaction
0.18602495.16160021.html.plaintext.txt	71	recently reported linkage scan cleveland family study represent first genomewide linkage study osa phenotype num num
0.18602495.16160021.html.plaintext.txt	72	result provide insight possible genetic overlap obesity osa
0.18602495.16160021.html.plaintext.txt	73	linkage apnea hypopnea index ahi measure osa bmi measure obesity tested across autosomal chromosome caucasian african american cohort
0.18602495.16160021.html.plaintext.txt	74	heritability ahi group num whereas heritability bmi num
0.18602495.16160021.html.plaintext.txt	75	controlling bmi significant heritability ahi remained supporting notion genetic susceptibility osa completely defined weight
0.18602495.16160021.html.plaintext.txt	76	multivariate modeling larger subset cleveland family study obesity measure bmi serum leptin explained num num genetic variance ahi num
0.18602495.16160021.html.plaintext.txt	77	suggests half genetic determinant ahi obesity related half obesity independent
0.18602495.16160021.html.plaintext.txt	78	linkage finding described logarithmic odds lod score measure odds ratio linkage linkage
0.18602495.16160021.html.plaintext.txt	79	although none linkage finding either racial group achieved genomewide significance lod num
0.18602495.16160021.html.plaintext.txt	80	num num several region intermediate lod score indicative possible linkage setting complex multifactorial disease obesity osa num
0.18602495.16160021.html.plaintext.txt	81	furthermore change linkage evidence ahi adjustment bmi provides insight mechanism action susceptibility locus present
0.18602495.16160021.html.plaintext.txt	82	among caucasian lod score num
0.18602495.16160021.html.plaintext.txt	83	num bmi chromosome nump num
0.18602495.16160021.html.plaintext.txt	84	adjustment bmi maximal lod ahi region dropped num
0.18602495.16160021.html.plaintext.txt	85	num whereas lod bmi adjusted ahi fell num
0.18602495.16160021.html.plaintext.txt	86	data suggest susceptibility gene ahi exists region likely mediates effect apnea via obesity
0.18602495.16160021.html.plaintext.txt	87	hand maximal lod ahi num
0.18602495.16160021.html.plaintext.txt	88	num found numq linkage evidence bmi region num
0.18602495.16160021.html.plaintext.txt	89	adjustment bmi effect ahi lod suggesting susceptibility gene region exerts effect ahi obesity independent mechanism
0.18602495.16160021.html.plaintext.txt	90	different pattern linkage finding found short arm chromosome num
0.18602495.16160021.html.plaintext.txt	91	among caucasian maximal lod ahi num
0.18602495.16160021.html.plaintext.txt	92	num region suggesting susceptibility locus phenotype might exist region num
0.18602495.16160021.html.plaintext.txt	93	however adjustment bmi dropped lod ahi num
0.18602495.16160021.html.plaintext.txt	94	num suggesting obesity effect locus fully explain apnea effect
0.18602495.16160021.html.plaintext.txt	95	may represent two independent locus one influencing ahi one bmi
0.18602495.16160021.html.plaintext.txt	96	another possibility one locus nump regulating ahi bmi via independent mechanism
0.18602495.16160021.html.plaintext.txt	97	strong candidate gene phenotype region proopiomelanocortin pomc
0.18602495.16160021.html.plaintext.txt	98	num encodes number hormone including melanocyte stimulating hormone msh
0.18602495.16160021.html.plaintext.txt	99	pomc neuron arcuate nucleus hypothalamus important energy homeostasis via msh
0.18602495.16160021.html.plaintext.txt	100	leptin anorexic activity mediated via depolarization neuron use msh agonist decrease body fat leptin level human num num
0.18602495.16160021.html.plaintext.txt	101	obesity phenotype consistently linked pomc locus num num num num haplotype gene associated leptin level num num severe mutation gene produce severe childhood obesity phenotype num
0.18602495.16160021.html.plaintext.txt	102	leptin effect ventilatory drive mouse model also mediated via msh suggesting pathway may independently predispose apnea well num
0.18602495.16160021.html.plaintext.txt	103	evidence pleiotropy also exists chromosome numq
0.18602495.16160021.html.plaintext.txt	104	among african american cleveland family study peak lod score num
0.18602495.16160021.html.plaintext.txt	105	num ahi bmi respectively num
0.18602495.16160021.html.plaintext.txt	106	controlling bmi ahi lod dropped num
0.18602495.16160021.html.plaintext.txt	107	num suggesting obesity apnea promoting effect region independent
0.18602495.16160021.html.plaintext.txt	108	potential candidate locus region cohnum gene numqnum num
0.18602495.16160021.html.plaintext.txt	109	gene encodes transmembrane protein presumed role vesicle mediated sorting intracellular protein transport basis structure num
0.18602495.16160021.html.plaintext.txt	110	severe mutation gene associated cohen syndrome autosomal recessive condition characterized truncal obesity num
0.18602495.16160021.html.plaintext.txt	111	finding include facial dysmorphism mental retardation ocular anomaly
0.18602495.16160021.html.plaintext.txt	112	craniofacial abnormality include microcephaly facial hypotonia laryngomalacia could predispose osa
0.18602495.16160021.html.plaintext.txt	113	thus mutation gene milder common may play role via separate pathway contributing nonsyndromic form obesity osa
0.18602495.16160021.html.plaintext.txt	114	serotoninergic system another common pathway could link obesity osa
0.18602495.16160021.html.plaintext.txt	115	serotonin important effect stimulation satiety center arcuate nucleus num
0.18602495.16160021.html.plaintext.txt	116	addition serotonin potentiates hypoglossal neural output increase upper airway dilator muscle activity num num
0.18602495.16160021.html.plaintext.txt	117	thus reduction serotoninergic activity increasing appetite could promote obesity lowering muscle tone upper airway could promote osa
0.18602495.16160021.html.plaintext.txt	118	linkage haplotype association study finnish population suggest serotonin related gene xqnum associated obesity num num
0.18602495.16160021.html.plaintext.txt	119	slcnumanum gene encodes sodium chloride dependent transporter neutral cationic amino acid appears play important role transport tryptophan precursor serotonin central nervous system num
0.18602495.16160021.html.plaintext.txt	120	french study confirmed association polymorphism obesity association hunger satiety score also found num
0.18602495.16160021.html.plaintext.txt	121	whether polymorphism associated osa via independent obesity effect yet studied osa linkage scan reported thus far included sex chromosome
0.18602495.16160021.html.plaintext.txt	122	view larger version numk fig
0.18602495.16160021.html.plaintext.txt	123	sleep apnea susceptibility gene may interact obesity numerous mechanism influence sleep apnea predisposition
0.18602495.16160021.html.plaintext.txt	124	genetic polymorphism may modulate degree obesity alters ventilatory drive reduces lung volume narrow upper airway
0.18602495.16160021.html.plaintext.txt	125	polymorphism may affect degree stress result development sleep apnea
0.18602495.16160021.html.plaintext.txt	126	similarly obesity susceptibility gene may interact sleep apnea potential effect obesity
0.18602495.16160021.html.plaintext.txt	127	peroxisome proliferator activated receptor pparg gene located chromosome numpnum encodes protein key component nuclear transcription factor important adipocyte differentiation num
0.18602495.16160021.html.plaintext.txt	128	variant gene implicated risk factor development obesity num num num num num
0.18602495.16160021.html.plaintext.txt	129	hypoxia known suppress pparg gene transcription num num importance mild defect pparg function may become magnified setting recurrent exposure hypoxia osa
0.18602495.16160021.html.plaintext.txt	130	thus pparg allelic variant may play much important role determining obesity phenotype individual osa osa may play much important role promoting weight gain among mutation pparg
0.18602495.16160021.html.plaintext.txt	131	similarly effect uncoupling protein num ucpnum ucpnum two obesity candidate gene may influenced osa
0.18602495.16160021.html.plaintext.txt	132	gene encode uncoupling protein mitochondrial proton channel divert energy atp synthesis thermogenesis num
0.18602495.16160021.html.plaintext.txt	133	activation increase energy consumption
0.18602495.16160021.html.plaintext.txt	134	polymorphism gene associated obesity phenotype num num num num num
0.18602495.16160021.html.plaintext.txt	135	interestingly sleep deprivation rodent model shown increase expression ucpnum ucpnum num num suggesting sleep disruption osa may influence expression gene thus relative importance variant locus determining obesity risk
0.18602495.16160021.html.plaintext.txt	136	use dense single nucleotide polymorphism map allow better resolution linkage finding narrow candidate locus
0.18602495.16160021.html.plaintext.txt	137	better understanding neurobiology molecular pathway underlying obesity sleep apnea also allow rational selection candidate gene test association disorder
0.18602495.16160021.html.plaintext.txt	138	ultimately use gene knockout animal model important establish causality identified association
0.18602495.16160021.html.plaintext.txt	139	performing genetic study important simultaneously consider disorder given close relationship
0.18602495.16160021.html.plaintext.txt	140	methodology conducting bivariate linkage scan already developed evidence suggest strategy powerful traditional univariate approach num
0.18602495.16160021.html.plaintext.txt	141	many genetic variant influence development osa causing obesity vice versa likely also variant pleiotropic effect predisposing obesity osa via independent mechanism
0.18602495.16160021.html.plaintext.txt	142	identifying gene understanding function provide novel insight shared pathogenesis disease
0.18602495.16160021.html.plaintext.txt	143	finally possibility genetic polymorphism may affect susceptibility disease confers toward ignored
0.18602495.16160021.html.plaintext.txt	144	incorporating model gene x environment interaction future study design along understanding effect obesity osa allow better delineation osa susceptibility gene vice versa
0.18602495.16160021.html.plaintext.txt	145	similarly use model along information genetics obesity would allow complete understanding osa may impact obesity
0.18602495.16160021.html.plaintext.txt	146	footnote address reprint request correspondence
0.18602495.16160021.html.plaintext.txt	147	patel bwh sleep disorder program bidmc brigham woman hospital num francis st
0.18602495.16160021.html.plaintext.txt	148	boston ma num e mail spatelatpartners
0.18766233.15687100.html.plaintext.txt	0	food deprivation differentially modulates orexin receptor expression signaling rat hypothalamus adrenal cortex emmanouil karterisnum rachel j
0.18766233.15687100.html.plaintext.txt	1	machadonum jing chennum sevasti zervounum edward w
0.18766233.15687100.html.plaintext.txt	2	numbiomedical research institute department biological science numwarwick medical school university warwick coventry numthe dean office medical school university leeds leeds united kingdom
0.18766233.15687100.html.plaintext.txt	3	submitted num august num accepted final form num january num
0.18766233.15687100.html.plaintext.txt	4	starvation induced biochemical metabolic change perceived hypothalamus turn coordinate behavioral autonomic neuroendocrine response stimulus num
0.18766233.15687100.html.plaintext.txt	5	study rodent shown food deprivation induces marked acth corticosterone response implicating feeding major synchronizer rhythm hypothalamic pituitary adrenal hpa axis num num
0.18766233.15687100.html.plaintext.txt	6	besides nutritional state neuropeptides corticotropin releasing hormone neuropeptide y npy known regulate hpa system feeding behavior several signal known regulate hpa system
0.18766233.15687100.html.plaintext.txt	7	hypoglycemia potent activator hpa axis reflecting strong functional relationship hypothalamic feeding center hpa axis num leptin whose concentration governed nutritional status inhibitory effect plasma corticosterone rat num
0.18766233.15687100.html.plaintext.txt	8	recently orexin orexin b b produced neuron localized lateral dorsal hypothalamic area perifornical hypothalamus num implicated central regulation feeding energy homeostasis num
0.18766233.15687100.html.plaintext.txt	9	num residue peptide b num residue peptide proteolytically cleaved common precursor prepro orexin share num amino acid sequence homology
0.18766233.15687100.html.plaintext.txt	10	besides playing role regulation feeding energy homeostasis orexins reported exert divergent physiological action num num
0.18766233.15687100.html.plaintext.txt	11	orexins orchestrate action binding activating two type g protein coupled receptor orexin num receptor oxnumr orexin num receptor oxnumr display num homology amino acid sequence num
0.18766233.15687100.html.plaintext.txt	12	oxnumr preferentially bind whereas oxnumr bind b apparently similar affinity num
0.18766233.15687100.html.plaintext.txt	13	hypothalamus level prepro orexin messenger rna regulated several nutritional state signal
0.18766233.15687100.html.plaintext.txt	14	fasting num insulin induced hypoglycemia num num increase prepro orexin mrna rat lateral hypothalamic area whereas leptin converse effect num
0.18766233.15687100.html.plaintext.txt	15	interestingly fasting leptin also regulate hypothalamic expression orexin receptor num num
0.18766233.15687100.html.plaintext.txt	16	finding observation intracerebroventricular administration b stimulates food consumption rat num suggests physiological role neuropeptides mediator regulation feeding particularly response energy deprivation
0.18766233.15687100.html.plaintext.txt	17	although hypothalamus considered cornerstone maintenance energy homeostasis adrenal gland play role integration metabolic activity energy balance
0.18766233.15687100.html.plaintext.txt	18	example study food deprived rat suggested hpa axis integral larger hypothalamic system mediates energy flow num animal catabolic activity quickly predominates reinforced elevated corticosterone driven hypothalamic control acth implicating adrenal activity metabolic regulator num
0.18766233.15687100.html.plaintext.txt	19	addition hypothalamic effect nutritional signal leptin npy direct action adrenal level via receptor including modulation corticosteroid secretion num num
0.18766233.15687100.html.plaintext.txt	20	interest rat adrenal express orexin receptor num orexins stimulate corticosterone secretion rat adrenocortical cell activation adenylyl cyclase dependent signaling cascade num
0.18766233.15687100.html.plaintext.txt	21	expression orexin receptor rat human adrenal well documented
0.18766233.15687100.html.plaintext.txt	22	rat receptor expressed adrenal cortex
0.18766233.15687100.html.plaintext.txt	23	interestingly highest amount oxnumr mrna found adrenal gland male rat four time higher brain oxnumr mrna level num
0.18766233.15687100.html.plaintext.txt	24	situ hybridization revealed oxnumr mrna localized primarily zona glomerulosa zona reticularis whereas expression adrenal medulla num
0.18766233.15687100.html.plaintext.txt	25	view finding observation change orexin level closely related nutritional status rather state hunger satiety num hypothesizsed activation orexin receptor adrenal level may explain acth independent rise corticosterone seen starved rat
0.18766233.15687100.html.plaintext.txt	26	sought investigate hypothalamus adrenal gland num whether level orexins receptor oxnumr oxnumr differ fed food deprived rat assessing expression mrna protein level num elucidate whether nutritional status elicits functional change oxnumr oxnumr studying g protein coupling subsequent activation second messenger pathway
0.18766233.15687100.html.plaintext.txt	27	university warwick uk ethic committee use care animal approved procedure described
0.18766233.15687100.html.plaintext.txt	28	adult male initially num g wistar rat housed group two n num group environmentally controlled condition num plus minus num degree c humidity num num numnum h light dark schedule light num
0.18766233.15687100.html.plaintext.txt	29	rat allowed unrestricted access standard laboratory pellet rodent diet num
0.18766233.15687100.html.plaintext.txt	30	num kcalg crm biosure cambridge uk access tap water subjected study
0.18766233.15687100.html.plaintext.txt	31	week habituation condition rat randomly distributed two group
0.18766233.15687100.html.plaintext.txt	32	first group allowed eat freelyad libitum
0.18766233.15687100.html.plaintext.txt	33	second group food deprived num h beginning onset dark cycle light num group animal killed conum inhalation cervical dislocation following day num
0.18766233.15687100.html.plaintext.txt	34	hypothalamic adrenal dissection
0.18766233.15687100.html.plaintext.txt	35	isolate hypothalamus animal decapitated brain removed rapidly
0.18766233.15687100.html.plaintext.txt	36	hypothalamus defined posterior margin optic chiasm anterior margin mamillary body depth num num mm dissected
0.18766233.15687100.html.plaintext.txt	37	adrenal cortex fraction freed adipose tissue separated inner adrenomedullary tissue pressure glass plate
0.18766233.15687100.html.plaintext.txt	38	upon removal tissue immediately snap frozen liquid nitrogen
0.18766233.15687100.html.plaintext.txt	39	sample stored num degree c use
0.18766233.15687100.html.plaintext.txt	40	assay plasma corticosterone concentration
0.18766233.15687100.html.plaintext.txt	41	plasma corticosterone level fed n num group
0.18766233.15687100.html.plaintext.txt	42	conumcervical dislocation food deprived rat n num group measured radioimmunoassay amersham life science buckinghamshire uk
0.18766233.15687100.html.plaintext.txt	43	range radioimmunoassay specific corticosterone num
0.18766233.15687100.html.plaintext.txt	44	total rna extraction cdna synthesis
0.18766233.15687100.html.plaintext.txt	45	total rna prepared individual sample using rneasy total rna kit qiagen crawley uk according manufacturer guideline
0.18766233.15687100.html.plaintext.txt	46	first strand cdna synthesis performed using rnase reverse transcriptase gibco brl paisley uk according manufacturer recommendation
0.18766233.15687100.html.plaintext.txt	47	quantitative pcr performed roche light cycler system roche molecular biochemicals manheim germany
0.18766233.15687100.html.plaintext.txt	48	pcr reaction carried reaction mixture consisting num
0.18766233.15687100.html.plaintext.txt	49	num microl reaction buffer num
0.18766233.15687100.html.plaintext.txt	50	num mm mgclnum biogene kimbolton uk num
0.18766233.15687100.html.plaintext.txt	51	num microl primer num ng microl num
0.18766233.15687100.html.plaintext.txt	52	num microl light cycler sybr gold biogene
0.18766233.15687100.html.plaintext.txt	53	protocol condition consisted denaturation num degree c num followed num cycle num degree c num num degree c num num degree c num followed melting curve analysis
0.18766233.15687100.html.plaintext.txt	54	analysis quantitative amount gene interest standardized housekeeping gene actin
0.18766233.15687100.html.plaintext.txt	55	negative control reaction preparation lacking rna reverse transcriptase used place cdna
0.18766233.15687100.html.plaintext.txt	56	quantitative analysis cdna six fed six food deprived rat used
0.18766233.15687100.html.plaintext.txt	57	serial dilution hypothalamic adrenal cdna provided template line best fit plotted used standard curve demonstrate accuracy reproducibility analysis
0.18766233.15687100.html.plaintext.txt	58	quantification data analyzed using light cycler analysis software
0.18766233.15687100.html.plaintext.txt	59	rna level expressed ratio using delta delta method comparing relative expression result treatment real time pcr num
0.18766233.15687100.html.plaintext.txt	60	resultant pcr product sequenced automated dna sequencer sequence data analyzed using blast nucleic acid database search national center biotechnology information
0.18766233.15687100.html.plaintext.txt	61	preparation hypothalamic adrenocortical membrane
0.18766233.15687100.html.plaintext.txt	62	rat hypothalamus adrenal cortex obtained food deprived control male wistar rat described
0.18766233.15687100.html.plaintext.txt	63	tissue homogenized dulbeccos phosphate buffered saline containing num mm mgclnum num mm egta num
0.18766233.15687100.html.plaintext.txt	64	num gl bovine serum albumin bsa wtvol num
0.18766233.15687100.html.plaintext.txt	65	num mm bacitracin num mm phenylmethylsulfonyl fluoride pmsf ph num
0.18766233.15687100.html.plaintext.txt	66	num extraction buffer num degree c
0.18766233.15687100.html.plaintext.txt	67	homogenate centrifuged num g num min num degree c
0.18766233.15687100.html.plaintext.txt	68	pellet discarded supernatant spun numnum g num min num degree c
0.18766233.15687100.html.plaintext.txt	69	resultant pellet washed resuspended extraction buffer spun numnum g num min num degree c
0.18766233.15687100.html.plaintext.txt	70	final pellet resuspended num ml extraction buffer use homogenizer
0.18766233.15687100.html.plaintext.txt	71	protein concentration membrane suspension determined using bicinchoninic acid method bsa standard num
0.18766233.15687100.html.plaintext.txt	72	hypothalamic n num group
0.18766233.15687100.html.plaintext.txt	73	fed food deprived num microg adrenocortical membrane n num group num microg centrifuged numnum g num min num degree c
0.18766233.15687100.html.plaintext.txt	74	supernatant discarded resultant pellet solubilized laemmli buffer num m urea num
0.18766233.15687100.html.plaintext.txt	75	num m sodium dodecyl sulfate sd num
0.18766233.15687100.html.plaintext.txt	76	num m dithiothreitol dtt num mm tris hcl ph num
0.18766233.15687100.html.plaintext.txt	77	num mixed placed boiling water bath num min allowed cool room temperature
0.18766233.15687100.html.plaintext.txt	78	sample separated num sd polyacrylamide gel protein electrophoretically transferred nitrocellulose membrane num ma num h transfer buffer containing num mm tris num mm glycine num methanol
0.18766233.15687100.html.plaintext.txt	79	filter blocked pb containing num
0.18766233.15687100.html.plaintext.txt	80	num tween num num milk powder wtvol num h room temperature
0.18766233.15687100.html.plaintext.txt	81	num tween nitrocellulose membrane incubated primary antibody oxnumr oxnumr santa cruz biotechnology santa cruz ca
0.18766233.15687100.html.plaintext.txt	82	primary antiserum used numnumnum dilution pb num
0.18766233.15687100.html.plaintext.txt	83	num tween num h room temperature
0.18766233.15687100.html.plaintext.txt	84	filter washed thoroughly num min pb num
0.18766233.15687100.html.plaintext.txt	85	num tween incubation secondary anti rabbit horseradish peroxidase conjugated immunoglobulin numnumnum num h room temperature washing num min pb num
0.18766233.15687100.html.plaintext.txt	86	antibody complex visualized previously described num
0.18766233.15687100.html.plaintext.txt	87	ensure specificity also performed preabsorption oxnumr oxnumr blocking peptide santa cruz biotechnology prior western blotting
0.18766233.15687100.html.plaintext.txt	88	detection b similar procedure followed using specific non cross reactive antibody phoenix peptide belmont ma total hypothalamic adrenal lysate
0.18766233.15687100.html.plaintext.txt	89	ensure protein amount loaded sample used western blotting used antibody housekeeping gene actin santa cruz biotechnology
0.18766233.15687100.html.plaintext.txt	90	treatment membrane pertussis cholera toxin
0.18766233.15687100.html.plaintext.txt	91	pertussis num microgml cholera num microgml toxin preactivated num
0.18766233.15687100.html.plaintext.txt	92	num containing num mm dtt num mm glycine num min num degree c final volume num microl cooled ice num min
0.18766233.15687100.html.plaintext.txt	93	hypothalamic adrenal membrane n num group num microg incubated num mm tris ph num
0.18766233.15687100.html.plaintext.txt	94	num containing num mm edta num mm dtt num mm atp num mm gtp num mm mgclnum num mm thymidine num microm nad num microci numpnad together preactivated toxin
0.18766233.15687100.html.plaintext.txt	95	reaction carried num degree c num min incubation terminated num
0.18766233.15687100.html.plaintext.txt	96	num ml ice cold num mm tris buffer ph num
0.18766233.15687100.html.plaintext.txt	97	control sample prepared incubating membrane medium absence toxin
0.18766233.15687100.html.plaintext.txt	98	termination sample centrifuged numnum rpm num min pellet washed respun three time
0.18766233.15687100.html.plaintext.txt	99	resultant pellet resuspended num microl num sd num microl buffer containing num volvol triton x num num deoxycholate num
0.18766233.15687100.html.plaintext.txt	100	num wtvol sd num mm nacl num mm tris hcl ph num
0.18766233.15687100.html.plaintext.txt	101	num mm pmsf num microgml aprotinin
0.18766233.15687100.html.plaintext.txt	102	resuspended sample centrifuged numnum rpm num min room temperature resulting supernatant equally aliquoted num microl
0.18766233.15687100.html.plaintext.txt	103	aliquot num microl gi g antiserum new england nuclear dupont boston ma added left continuous agitation num h followed addition num microl protein sepharose per tube agitation overnight num degree c
0.18766233.15687100.html.plaintext.txt	104	sample centrifuged numnum rpm num min pellet solubilized laemmli buffer mixed placed boiling water bath num min cooling room temperature
0.18766233.15687100.html.plaintext.txt	105	sample loaded onto sd num polyacrylamide gel electrophoresis gel dried autoradiographed using kodak x ray film ass extent adp ribosylation
0.18766233.15687100.html.plaintext.txt	106	synthesis numpgtp azidoanilide photoaffinity labeling g subunit
0.18766233.15687100.html.plaintext.txt	107	gtp azidoanilide gtp aa synthesized using method previously described num
0.18766233.15687100.html.plaintext.txt	108	hypothalamic adrenocortical membrane n num group num microg incubated num min num degree c num nm buffer num mm hepes num mm kcl num mm mgclnum num mm benzamidine num
0.18766233.15687100.html.plaintext.txt	109	num mm edta followed addition num microm gdp num microci gtp aa
0.18766233.15687100.html.plaintext.txt	110	incubation num min num degree c darkened room membrane placed ice collected centrifugation numnum g num min num degree c
0.18766233.15687100.html.plaintext.txt	111	supernatant carefully removed membrane pellet resuspended num microll modified buffer num
0.18766233.15687100.html.plaintext.txt	112	sample vortexed irradiated num min num degree c ultraviolet light num nm distance num cm cross link gtp aa g protein
0.18766233.15687100.html.plaintext.txt	113	immunoprecipitation using num microl undiluted g protein antiserum new england nuclear dupont subunit carried previously described num
0.18766233.15687100.html.plaintext.txt	114	sample subjected gel electrophoresis using discontinuous sd page slab gel num running num stacking
0.18766233.15687100.html.plaintext.txt	115	gel stained coomassie blue dried using slab gel dryer exposed fuji x ray film num degree c num num day intensifying screen
0.18766233.15687100.html.plaintext.txt	116	camp inositol triphosphate second messenger study
0.18766233.15687100.html.plaintext.txt	117	camp study using commercially available kit new england nuclear dupont hypothalamic adrenocortical membrane suspension n num group num microg incubated increasing concentration amount camp incubate determined radioimmunoassay previously described num
0.18766233.15687100.html.plaintext.txt	118	standard camp concentration covering range num
0.18766233.15687100.html.plaintext.txt	119	num num pmolml used determination standard curve radioimmunoassay
0.18766233.15687100.html.plaintext.txt	120	interassay coefficient variation num
0.18766233.15687100.html.plaintext.txt	121	camp assay buffer without membrane preparation used negative control
0.18766233.15687100.html.plaintext.txt	122	inositol triphosphate ipnum assay amersham pharmacia biotech little chalfont uk hypothalamic adrenocortical membrane incubated increasing concentration followed addition num microl ipnum generation buffer previously described num
0.18766233.15687100.html.plaintext.txt	123	membrane incubated num min num degree c reaction terminated addition num m ice cold trichloroacetic acid followed extraction inositol phosphate neutralization
0.18766233.15687100.html.plaintext.txt	124	ipnum level estimated radioimmunoassay basis displacement numhipnum specific bovine adrenocortical ipnum binding protein
0.18766233.15687100.html.plaintext.txt	125	interassay coefficient variation num
0.18766233.15687100.html.plaintext.txt	126	data shown mean plus minus sd measurement
0.18766233.15687100.html.plaintext.txt	127	real time pcr measurement photoaffinity labeling western immunoblotting result evaluated group using two tailed student test significance determined level p num
0.18766233.15687100.html.plaintext.txt	128	western immunoblotting photoaffinity labeling experiment density measured using scanning densitometer coupled scanning software imagequant molecular dynamic amersham pharmacia little chalfont uk
0.18766233.15687100.html.plaintext.txt	129	second messenger measurement one way analysis variance used followed dunnetts test compare treatment dose
0.18766233.15687100.html.plaintext.txt	130	plasma corticosterone level almost twofold higher p num
0.18766233.15687100.html.plaintext.txt	131	num food deprived rat num plus minus num
0.18766233.15687100.html.plaintext.txt	132	num ngml compared fed one num plus minus num
0.18766233.15687100.html.plaintext.txt	133	num ngml measured radioimmunoassay fig
0.18766233.15687100.html.plaintext.txt	134	given rat killed conum inhalation corticosterone level rat killed cervical dislocation also measured
0.18766233.15687100.html.plaintext.txt	135	two subgroup compared appeared apparent difference two different method killing animal thus suggesting model conum inhalation constitute additional stress factor fig
0.18766233.15687100.html.plaintext.txt	136	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	137	significant upregulation p num
0.18766233.15687100.html.plaintext.txt	138	num corticosterone production food deprived rat n num compared fed one n num
0.18766233.15687100.html.plaintext.txt	139	method sacrificing exert effect corticosterone level num group
0.18766233.15687100.html.plaintext.txt	140	b significant increase prepro orexin mrna level food deprived hypothalamus rat n num
0.18766233.15687100.html.plaintext.txt	141	difference mrna expression seen large difference amplification efficiency demonstrated delay amplification intercept cycle fed rat sample
0.18766233.15687100.html.plaintext.txt	142	c western blot analysis b rat hypothalamic lysates
0.18766233.15687100.html.plaintext.txt	143	lane num corresponds positive control b lane num corresponds fed hypothalamus lane num corresponds food deprived hypothalamic lysates
0.18766233.15687100.html.plaintext.txt	144	quantification immunocomplexes revealed significant increase protein expression b food deprivation condition n num
0.18766233.15687100.html.plaintext.txt	145	effect food deprivation peptide receptor expression hypothalamus
0.18766233.15687100.html.plaintext.txt	146	serial dilution hypothalamic cdna provided template line best fit plotted used standard curve demonstrate accuracy reproducibility analysis
0.18766233.15687100.html.plaintext.txt	147	melting curve analysis pcr product presented fluorescence time dfdt temperature degree c
0.18766233.15687100.html.plaintext.txt	148	melting curve analysis showed single melting maximum num
0.18766233.15687100.html.plaintext.txt	149	num degree c prepro orexin gene single melting maximum num
0.18766233.15687100.html.plaintext.txt	150	num degree c actin gene thus confirming product specificity data shown
0.18766233.15687100.html.plaintext.txt	151	fivefold increase prepro orexin message p num
0.18766233.15687100.html.plaintext.txt	152	num hypothalamus food deprived animal fig
0.18766233.15687100.html.plaintext.txt	153	mrna change prepro orexin peptide also confirmed immunoblotting analysis protein expression b significantly p num
0.18766233.15687100.html.plaintext.txt	154	num respectively increased food deprivation fig
0.18766233.15687100.html.plaintext.txt	155	compared control oxrnum oxrnum mrna significantly p num
0.18766233.15687100.html.plaintext.txt	156	num increased hypothalamus food deprived rat fig
0.18766233.15687100.html.plaintext.txt	157	increase similar form orexin receptor num
0.18766233.15687100.html.plaintext.txt	158	num fold increase oxnumr num fold increase oxnumr
0.18766233.15687100.html.plaintext.txt	159	protein expression oxrnum oxrnum confirmed immunoblotting using specific goat polyclonal antibody fig
0.18766233.15687100.html.plaintext.txt	160	oxrnum antibody raised peptide mapping carboxy terminus oxrnum rat origin whereas oxrnum antibody raised peptide mapping amino terminus oxnumr human origin rat cross reactive
0.18766233.15687100.html.plaintext.txt	161	detected protein oxnumr apparent molecular mass num kda whereas oxnumr detected num kda peptide
0.18766233.15687100.html.plaintext.txt	162	specificity response confirmed preincubation oxnumr oxnumr antibody blocking peptide fig
0.18766233.15687100.html.plaintext.txt	163	protein expression reflected mrna data fig
0.18766233.15687100.html.plaintext.txt	164	numa significant increase p num
0.18766233.15687100.html.plaintext.txt	165	num receptor food deprived animal fig
0.18766233.15687100.html.plaintext.txt	166	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	167	significant upregulation oxnumr oxnumr mrna level food deprived hypothalamus n num rat compared fed one n num assessed real time pcr
0.18766233.15687100.html.plaintext.txt	168	b western blot analysis membrane protein extract rat adrenal lane num hypothalamus lane num demonstrate antibody orexin num receptor oxnumr recognized band apparent molecular mass num kda
0.18766233.15687100.html.plaintext.txt	169	similarly specific oxnumr antibody used recognized single band apparent molecular mass num kda
0.18766233.15687100.html.plaintext.txt	170	band appeared specific orexin receptor antibody preabsorbed respective blocking peptide lane num num rat adrenal hypothalamus respectively apparent immunodetection
0.18766233.15687100.html.plaintext.txt	171	c western blot analysis oxnumr oxnumr hypothalamic membrane fed n num food deprived rat n num
0.18766233.15687100.html.plaintext.txt	172	quantification immunocomplexes revealed significant increase protein expression orexin receptor food deprivation condition whereas protein level housekeeping gene actin appeared unaltered
0.18766233.15687100.html.plaintext.txt	173	effect food deprivation orexin receptor expression adrenal cortex
0.18766233.15687100.html.plaintext.txt	174	interestingly finding adrenal cortex marked contrast observed hypothalamus
0.18766233.15687100.html.plaintext.txt	175	quantitative analysis pcr product rat adrenal cortex showed oxnumr oxnumr level significantly p num
0.18766233.15687100.html.plaintext.txt	176	num respectively reduced food deprived animal compared control fig
0.18766233.15687100.html.plaintext.txt	177	decrease profound oxnumr num fold whereas oxnumr demonstrated twofold decrease fig
0.18766233.15687100.html.plaintext.txt	178	similarly oxnumr oxnumr protein level significantly decreased p num
0.18766233.15687100.html.plaintext.txt	179	num respectively adrenal cortex food deprived animal compared control
0.18766233.15687100.html.plaintext.txt	180	decrease pronounced oxrnum
0.18766233.15687100.html.plaintext.txt	181	group studied protein level actin remained unaltered fig
0.18766233.15687100.html.plaintext.txt	182	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	183	significant updownregulation oxnumr oxnumr mrna level food deprived rat adrenal cortex n num compared fed adrenal assessed real time pcr
0.18766233.15687100.html.plaintext.txt	184	change mrna expression shown difference amplification efficiency demonstrated delay amplification intercept cycle food deprived cdna
0.18766233.15687100.html.plaintext.txt	185	b western blot analysis oxnumr oxnumr adrenal membrane fed n num food deprived n num rat
0.18766233.15687100.html.plaintext.txt	186	quantification immunocomplexes revealed significant decrease protein expression orexin receptor food deprivation condition whereas protein level house keeping gene actin appeared unaltered
0.18766233.15687100.html.plaintext.txt	187	change agreement mrna data
0.18766233.15687100.html.plaintext.txt	188	incubating membrane cholera toxin resulted incorporation numpadp ribose two band num num kda hypothalamic adrenal membrane
0.18766233.15687100.html.plaintext.txt	189	apparent difference incorporation probe fed food deprived preparation tissue fig
0.18766233.15687100.html.plaintext.txt	190	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	191	adp ribosylation cholera toxin ctx hypothalamic h n num adrenal n num membrane g subunit
0.18766233.15687100.html.plaintext.txt	192	membrane incubated num microgml ctx
0.18766233.15687100.html.plaintext.txt	193	protein precipitation sample denatured applied num sd polyacrylamide gel
0.18766233.15687100.html.plaintext.txt	194	incorporation label resulted detection num band num num kda hypothalamic adrenal membrane respectively
0.18766233.15687100.html.plaintext.txt	195	apparent difference fed food deprived sample
0.18766233.15687100.html.plaintext.txt	196	b adp ribosylation pertussis toxin ptx hypothalamic n num adrenal n num membrane gi subunit
0.18766233.15687100.html.plaintext.txt	197	protein precipitation sample denatured applied num sd polyacrylamide gel
0.18766233.15687100.html.plaintext.txt	198	incorporation label resulted detection single band num kda hypothalamic adrenal membrane
0.18766233.15687100.html.plaintext.txt	199	apparent difference fed food deprived sample
0.18766233.15687100.html.plaintext.txt	200	c autoradiograph induced photolabeling numpgtp azidoanilide numpgtp aa g subunit rat hypothalamic adrenal membrane
0.18766233.15687100.html.plaintext.txt	201	membrane incubated numpgtp aa different concentration num num num numm followed uv cross linking immunoprecipitation g specific antibody
0.18766233.15687100.html.plaintext.txt	202	protein resolved sd page gel followed autoradiography
0.18766233.15687100.html.plaintext.txt	203	immunodetected band quantified scanning densitometric analysis
0.18766233.15687100.html.plaintext.txt	204	identical result obtained num independent experiment mean plus minus sd
0.18766233.15687100.html.plaintext.txt	205	treatment hypothalamic adrenal membrane pertussis toxin resulted incorporation numpadp ribose single band apparent molecular mass num kda fig
0.18766233.15687100.html.plaintext.txt	206	incorporation label seen either hypothalamic adrenal tissue absence pertussis toxin
0.18766233.15687100.html.plaintext.txt	207	similarly detectable difference fed food deprived gi subunit
0.18766233.15687100.html.plaintext.txt	208	data confirm functional integrity g protein subunit also reveal nutritional status interfere expression signaling protein
0.18766233.15687100.html.plaintext.txt	209	functional analysis g protein activation effect food deprivation
0.18766233.15687100.html.plaintext.txt	210	determine g protein coupled orexin receptor food deprived fed state hypothalamic adrenocortical membrane labeled gtp aa presence absence followed immunoprecipitation specific g subunit antibody g gi gq go
0.18766233.15687100.html.plaintext.txt	211	optimal labeling g subunit gtp aa requires receptor activation heterotrimeric g protein release bound gdp
0.18766233.15687100.html.plaintext.txt	212	binding gtp aa dependent gdp concentration gtp affinity g subunit agonist incubation time num
0.18766233.15687100.html.plaintext.txt	213	therefore condition labeling g subunit established empirically
0.18766233.15687100.html.plaintext.txt	214	demonstrated optimum labeling obtained presence num microm gdp data shown
0.18766233.15687100.html.plaintext.txt	215	induced labeling gtp aa time dependent optimal incubation time num min data shown
0.18766233.15687100.html.plaintext.txt	216	using g subunit paradigm able demonstrate coupling orexin receptor upon challenge dose dependent maximal activation concentration num nm fig
0.18766233.15687100.html.plaintext.txt	217	specificity immunoprecipitating property g antibody assessed comparing migration position orexin induced gtp aa photoaffinity labeled g protein adp ribosylated using numpnad cholera toxin demonstrate protein band radiolabeled immunoprecipitated specific antibody
0.18766233.15687100.html.plaintext.txt	218	surprisingly photoaffinity numpgtp aa experiment indicated orexin receptor hypothalamus adrenal cortex preferentially activate num kda form g protein
0.18766233.15687100.html.plaintext.txt	219	observation requires investigation
0.18766233.15687100.html.plaintext.txt	220	treatment hypothalamic membrane num nm revealed orexin receptor coupled multiple g protein including go gi g lesser extent gq control group fig
0.18766233.15687100.html.plaintext.txt	221	food deprived rat however change profile g protein activation
0.18766233.15687100.html.plaintext.txt	222	compared control significant increase coupling orexin receptor gq g go whereas le coupling orexin receptor gi fig
0.18766233.15687100.html.plaintext.txt	223	quantification immunocomplexes shown fig
0.18766233.15687100.html.plaintext.txt	224	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	225	autoradiograph agonist induced photolabeling g protein subunit gtp aa
0.18766233.15687100.html.plaintext.txt	226	hypothalamic adrenal cortex membrane fed rat n num group incubated gtp aa num nm
0.18766233.15687100.html.plaintext.txt	227	experiment repeated food deprived rat n num group
0.18766233.15687100.html.plaintext.txt	228	uv cross linking g protein subunit immunoprecipitated specific antiserum g gq gi go resolved num sd polyacrylamide gel
0.18766233.15687100.html.plaintext.txt	229	immunodetected band quantified scanning densitometric analysis
0.18766233.15687100.html.plaintext.txt	230	data expressed mean plus minus sd
0.18766233.15687100.html.plaintext.txt	231	optical density od unit expressed ratio treated untreated membrane rat hypothalamus b rat adrenal cortex c
0.18766233.15687100.html.plaintext.txt	232	treatment adrenocortical membrane num nm revealed similar promiscuity g protein profile adrenal orexin receptor
0.18766233.15687100.html.plaintext.txt	233	control group fed rat increased labeling g gq go gi fig
0.18766233.15687100.html.plaintext.txt	234	hypothalamus food deprivation modulated g protein activation profile
0.18766233.15687100.html.plaintext.txt	235	interestingly food deprived animal decreased coupling orexin receptor g go increased gi whereas coupling toward gq fig
0.18766233.15687100.html.plaintext.txt	236	quantification immunocomplexes shown fig
0.18766233.15687100.html.plaintext.txt	237	functional analysis intracellular second messenger generation effect food deprivation
0.18766233.15687100.html.plaintext.txt	238	addition g protein data dissected signaling characteristic orexin receptor hypothalamus adrenal cortex measuring second messenger camp ipnum control food deprived animal upon stimulation different concentration
0.18766233.15687100.html.plaintext.txt	239	test ability activate hypothalamic adenylyl cyclase determined effect camp production
0.18766233.15687100.html.plaintext.txt	240	hypothalamic membrane fed rat incubated num pm num nm num min num degree c significant increase camp production
0.18766233.15687100.html.plaintext.txt	241	increase found dose dependent whereas maximal response num plus minus num basal observed concentration num nm fig
0.18766233.15687100.html.plaintext.txt	242	response amplified food deprived rat num nm treatment induced camp response num plus minus num basal fig
0.18766233.15687100.html.plaintext.txt	243	view larger version numk fig
0.18766233.15687100.html.plaintext.txt	244	camp inositol triphosphate ipnum b accumulation rat hypothalamic membrane num microg protein presence different concentration
0.18766233.15687100.html.plaintext.txt	245	result expressed mean plus minus sd num independent experiment
0.18766233.15687100.html.plaintext.txt	246	camp c ipnum d accumulation rat adrenal cortex membrane num microg protein presence different concentration orexin
0.18766233.15687100.html.plaintext.txt	247	result expressed mean plus minus sd num independent experiment
0.18766233.15687100.html.plaintext.txt	248	control treatment hypothalamus adrenal cortex
0.18766233.15687100.html.plaintext.txt	249	similarly found treatment hypothalamic membrane induced rapid ipnum turnover dose dependent manner
0.18766233.15687100.html.plaintext.txt	250	effect threshold num nm maximum response num nm num plus minus num basal fig
0.18766233.15687100.html.plaintext.txt	251	consistent g protein labeling study significant p num
0.18766233.15687100.html.plaintext.txt	252	num increase ipnum production hypothalamus food deprived rat compared control num plus minus num basal fig
0.18766233.15687100.html.plaintext.txt	253	similarly rat adrenocortical membrane fed rat incubated num
0.18766233.15687100.html.plaintext.txt	254	num nm num nm significant increase camp ipnum production fig
0.18766233.15687100.html.plaintext.txt	255	increase appeared dose dependent maximum response num nm camp num plus minus num basal num nm ipnum num plus minus num basal
0.18766233.15687100.html.plaintext.txt	256	however food deprived animal compared control treatment adrenocortical membrane induced modest response toward camp production significant num nm apparent effect toward ipnum turnover fig
0.18766233.15687100.html.plaintext.txt	257	finding keeping photoaffinity labeling experiment
0.18766233.15687100.html.plaintext.txt	258	hypothalamus play major role regulation food intake energy balance integrating multiple anorexigenic orexigenic signal including elicited orexins num num
0.18766233.15687100.html.plaintext.txt	259	similar role adrenal gland possible given express receptor leptin npy num orexin num num regulator energy homeostasis
0.18766233.15687100.html.plaintext.txt	260	agreement previous study num num able show level prepro orexin mrna influenced nutritional status upregulated upon fasting hypothalamus
0.18766233.15687100.html.plaintext.txt	261	detailed analysis protein level confirmed cleaved bioactive peptide b upregulated food deprivation
0.18766233.15687100.html.plaintext.txt	262	previous study fasted lactating rat demonstrated hypothalamic b level raised num fold control nonfasted whereas showed change num
0.18766233.15687100.html.plaintext.txt	263	difference due rodent strain used sex metabolic status duration food deprivation
0.18766233.15687100.html.plaintext.txt	264	food deprivation lead change activity hpa axis within num h increase corticosterone num
0.18766233.15687100.html.plaintext.txt	265	finding interest given orexins stimulate hpa axis administered centrally num
0.18766233.15687100.html.plaintext.txt	266	furthermore orexin neuron sensitive nutritional signal insulin glucose alter food deprivation num hypothalamic orexin neuron express leptin receptor
0.18766233.15687100.html.plaintext.txt	267	prepro orexin expression fasting leptin also regulate hypothalamic expression orexin receptor num num num
0.18766233.15687100.html.plaintext.txt	268	numerous study mapped detail expression orexin orexin receptor hypothalamic level
0.18766233.15687100.html.plaintext.txt	269	num demonstrated within hypothalamus oxnumr mrna abundant ventromedial hypothalamic nucleus whereas oxnumr predominantly expressed paraventricular nucleus
0.18766233.15687100.html.plaintext.txt	270	another study shown num h fasting level rat oxnumr mrna significantly increased ventromedial hypothalamic nucleus medial division amygdala whereas level oxnumr mrna augmented arcuate nucleus remained unchanged dorsomedial hypothalamic nucleus paraventricular hypothalamic nucleus amygdala following fasting num
0.18766233.15687100.html.plaintext.txt	271	three different study num num num indicated prepro orexin upregulated hypothalamus upon food deprivation lateral hypothalamic area rat
0.18766233.15687100.html.plaintext.txt	272	agreement study noted fasting hypothalamic oxnumr oxnumr gene expression induced
0.18766233.15687100.html.plaintext.txt	273	given detailed analysis study provided shifted interest expression protein level
0.18766233.15687100.html.plaintext.txt	274	provide new evidence change also mirrored protein level assessed semiquantitative western blotting analysis
0.18766233.15687100.html.plaintext.txt	275	previous study num num shown food deprivation switch feeding response adrenocortical response time food presentation appears potent synchronizer phase plasma corticosteroid level light dark cycle num
0.18766233.15687100.html.plaintext.txt	276	observation interest given orexins circadian dependent action orexins known increase corticosterone production rat num cortisol human adrenocortical cell num
0.18766233.15687100.html.plaintext.txt	277	however view data conclude adrenal orexin receptor influence mediate rise corticosterone level seen food deprivation condition
0.18766233.15687100.html.plaintext.txt	278	well documented food deprivation induces multiple metabolic change may directly influence orexin receptor expression adrenal gland
0.18766233.15687100.html.plaintext.txt	279	example negative correlation testosterone level fasting num
0.18766233.15687100.html.plaintext.txt	280	study laboratory shown testosterone level also decrease following num h food deprivation unpublished observation
0.18766233.15687100.html.plaintext.txt	281	interestingly gonadectomized rat significant downregulation adrenal oxnumr effect reversed upon testosterone replacement num
0.18766233.15687100.html.plaintext.txt	282	although regulation adrenal orexin receptor gonadal steroid directly relevant finding suggests change orexin receptor expression may secondary phenomenon following initial food deprivation induced alteration
0.18766233.15687100.html.plaintext.txt	283	future study concentrate elucidating central peripheral action orexins
0.18766233.15687100.html.plaintext.txt	284	done systematically deleting oxnumr andor oxnumr tissue specific fashion using cre loxp system
0.18766233.15687100.html.plaintext.txt	285	use approach model generated bearing neuronal adrenal specific deletion orexin receptor
0.18766233.15687100.html.plaintext.txt	286	data indicate orexin signaling may enhanced response energy deficit sensed hypothalamus possibly predominantly via oxnumr time decreased adrenal cortex
0.18766233.15687100.html.plaintext.txt	287	orexins act two distinct g protein coupled receptor transduce intracellular signal activating heterotrimeric g protein
0.18766233.15687100.html.plaintext.txt	288	likely multiple second messenger system involved orexins shown increase intracellular calcium influx num num num num
0.18766233.15687100.html.plaintext.txt	289	also suggestion oxnumr coupled inhibitory gi protein num
0.18766233.15687100.html.plaintext.txt	290	shown first time native orexin receptor hypothalamus activate four type g protein namely g gq go gi response
0.18766233.15687100.html.plaintext.txt	291	although gi go two major inhibitory signaling pathway rat brain previously shown multiple subtypes g protein couple g protein coupled receptor system num
0.18766233.15687100.html.plaintext.txt	292	food deprivation altered g protein coupling profile
0.18766233.15687100.html.plaintext.txt	293	finding supported functional assay camp ipnum assay reflecting g protein coupling status
0.18766233.15687100.html.plaintext.txt	294	research needed investigate whether subunit implicated activating second messenger also ass effect b g protein signaling
0.18766233.15687100.html.plaintext.txt	295	although demonstrated functional orexin receptor human fetal adult adrenal gland num num first report g protein coupling orexin receptor rat adrenal cortex
0.18766233.15687100.html.plaintext.txt	296	interestingly note downregulation g protein apart gi response upon food deprivation
0.18766233.15687100.html.plaintext.txt	297	second messenger study confirmed finding minimal response toward camp production none ipnum adrenal cortex food deprived rat
0.18766233.15687100.html.plaintext.txt	298	finding support observation rat adrenocortical cell stimulates corticosterone release via camp pathway num
0.18766233.15687100.html.plaintext.txt	299	despite demonstrating first time rat orexin receptor couple differentially several g protein subunit activate multiple second messenger caution exercised interpret change
0.18766233.15687100.html.plaintext.txt	300	given plethora different cell type reside within hypothalamus adrenal gland distinction made specific subpopulation brain region adrenal zone data
0.18766233.15687100.html.plaintext.txt	301	provide evidence signaling characteristic orexin receptor food deprivation total hypothalamic adrenal preparation
0.18766233.15687100.html.plaintext.txt	302	conclusion study indicates nutritional change like food deprivation exert differential effect orexin receptor expression signaling characteristic hypothalamic adrenocortical level
0.18766233.15687100.html.plaintext.txt	303	however significance novel finding particular differential expression g protein activation upon food deprivation hypothalamus adrenal cortex need elucidation
0.18766233.15687100.html.plaintext.txt	304	footnote address reprint request correspondence e
0.18766233.15687100.html.plaintext.txt	305	karteris biomedical research institute univ
0.18766233.15687100.html.plaintext.txt	306	coventry cvnum numal uk e mail e
0.18766233.15687100.html.plaintext.txt	307	cost publication article defrayed part payment page charge
0.18766233.15687100.html.plaintext.txt	308	article must therefore hereby marked advertisement accordance num u
0.18766233.15687100.html.plaintext.txt	309	section num solely indicate fact
0.18766233.15687100.html.plaintext.txt	310	machado contributed equally study
0.18766233.15687100.html.plaintext.txt	311	home help feedback subscription archive search table content visit aps journal online copyright num american physiological society
0.18986537.11878678.html.plaintext.txt	0	editorial central noradrenergic neurones mechanism general anaesthesia k
0.18986537.11878678.html.plaintext.txt	1	modern anaesthetic main safe predictable use highly efficient
0.18986537.11878678.html.plaintext.txt	2	moreover could argued without property major advance surgical practice often highlighted medium could taken place
0.18986537.11878678.html.plaintext.txt	3	however example pharmacology production anaesthetic state remains somewhat mystery
0.18986537.11878678.html.plaintext.txt	4	mystery result controversy related existence unitary anaesthetic target site
0.18986537.11878678.html.plaintext.txt	5	direct observation clinical anaesthesia seems unlikely different anaesthetic agent produce different type anaesthesia
0.18986537.11878678.html.plaintext.txt	6	gabaa receptor long held unifying cellular target exception others also suggested
0.18986537.11878678.html.plaintext.txt	7	editorial consider evidence support role noradrenergic transmission wiring target anaesthetic action
0.18986537.11878678.html.plaintext.txt	8	clear role system analgesia considered
0.18986537.11878678.html.plaintext.txt	9	norepinephrine major central nervous system neurotransmitter brainstem
0.18986537.11878678.html.plaintext.txt	10	noradrenergic neurones great importance regulation range behaviour including sleep wake cycle feeding thermoregulation attention motor activity growth development
0.18986537.11878678.html.plaintext.txt	11	num addition many study suggesting noradrenergic system may involved production anaesthetic state
0.18986537.11878678.html.plaintext.txt	12	brain anum anum anum anum noradrenergic cluster constituting lateral tegmental area project thalamus hypothalamus
0.18986537.11878678.html.plaintext.txt	13	num locus coeruleus anum cluster distinct lateral tegmental area innervates cerebral cortex hippocampus cerebellum spinal cord
0.18986537.11878678.html.plaintext.txt	14	activity locus coeruleus neurones slow regular wakefulness
0.18986537.11878678.html.plaintext.txt	15	num contrast animal becomes drowsy entering slow wave rem sleep decrease discharge rate rem sleep neurones silent
0.18986537.11878678.html.plaintext.txt	16	num interestingly noradrenergic projection cerebrocortex originate locus coeruleus
0.18986537.11878678.html.plaintext.txt	17	preoptic area receives input locus coeruleus anum lateral tegmental group anum anum anum anum noradrenergic neurones
0.18986537.11878678.html.plaintext.txt	18	num addition neurones preoptic area project back locus coeruleus
0.18986537.11878678.html.plaintext.txt	19	num area play important role sleep hypnosis
0.18986537.11878678.html.plaintext.txt	20	role noradrenergic neurones area previous studiesnum suggest norepinephrine neurones preoptic area may contribute wakefulness direct activation injection norepinephrine area inhibits sleep
0.18986537.11878678.html.plaintext.txt	21	however several study also suggest norepinephrine neurones may involved induction sleep
0.18986537.11878678.html.plaintext.txt	22	num num mohan kumar colleaguesnum reported microinjection norepinephrine medial preoptic area destruction ventral noradrenergic bundle induced sleep
0.18986537.11878678.html.plaintext.txt	23	group also reported mild reduction sleep increase wakefulness destruction catecholaminergic terminal medial preoptic area bilateral intracerebral injection num hydroxydopamine
0.18986537.11878678.html.plaintext.txt	24	num thus appears noradrenergic fibre medial preoptic area may hypnogenic
0.18986537.11878678.html.plaintext.txt	25	central noradrenergic neurones regulated s adrenergic receptor
0.18986537.11878678.html.plaintext.txt	26	reported num adrenoceptor antagonist prazosin given orally increased active waking slow wave sleep decreased paradoxical sleep rat
0.18986537.11878678.html.plaintext.txt	27	num contrast num adrenoceptor stimulation systemic methoxamine increased aroused wakefulness decreased slow wave sleep paradoxical sleep cat
0.18986537.11878678.html.plaintext.txt	28	num addition prazosin increased num agonist st num decreased duration thiopental anaesthesia rat
0.18986537.11878678.html.plaintext.txt	29	num matsumoto colleague also reported direct intracerebroventricular administration methoxamine dose dependently reduced pentobarbital anaesthesia time mouse
0.18986537.11878678.html.plaintext.txt	30	num central physiological effect num agonist attributed num adrenoceptors present locus coeruleus
0.18986537.11878678.html.plaintext.txt	31	num rat microinjection num agonist dexmedetomedine locus coeruleus per se produce anaesthesia defined loss righting reflex
0.18986537.11878678.html.plaintext.txt	32	num num agonist also reduce anaesthetic requirement human many specie
0.18986537.11878678.html.plaintext.txt	33	num contrast data num antagonist yohimbine decrease sleepnum anaesthesia timenum variety non human specie
0.18986537.11878678.html.plaintext.txt	34	angel group showed propranolol non selective s antagonist dose dependently increased sleep timenum thiopental anaesthesia timenum rat
0.18986537.11878678.html.plaintext.txt	35	however failed show effect selective ssnum antagonist metoprolol atenolol
0.18986537.11878678.html.plaintext.txt	36	num num also studied role ssnum adrenoceptors sleep general anaesthesianum num num found selective ssnum antagonist ici num increased sleep timenum duration thiopental anaesthesia
0.18986537.11878678.html.plaintext.txt	37	num collectively data indicate effect non selective antagonist propranolol may mediated via ssnum adrenoceptors
0.18986537.11878678.html.plaintext.txt	38	recently identified rat hypothalamus neuropeptides orexin bnum endogenous agonist g protein coupled orexin num oxnum oxnum receptor
0.18986537.11878678.html.plaintext.txt	39	num orexin equal affinity oxnum oxnum orexin b higher affinity oxnum
0.18986537.11878678.html.plaintext.txt	40	orexins receptor widely distributed brain
0.18986537.11878678.html.plaintext.txt	41	num orexins activate locus coeruleus noradrenergic system activation may increase arousal locomotor activity
0.18986537.11878678.html.plaintext.txt	42	num addition several reportsnum suggest link orexin receptor narcolepsy
0.18986537.11878678.html.plaintext.txt	43	therefore modulation noradrenergic neurones orexins receptor may contribute control sleep wake cycle
0.18986537.11878678.html.plaintext.txt	44	moreover suggest neuropeptides receptor may also involved general anaesthesia although remains examined
0.18986537.11878678.html.plaintext.txt	45	based consideration others began systematic evaluation range anaesthetic agent central norepinephrine release using vivo microdialysis technique
0.18986537.11878678.html.plaintext.txt	46	mizuno colleague reported intraperitoneal pentobarbital inhibited norepinephrine release medial preoptic area rat
0.18986537.11878678.html.plaintext.txt	47	num addition shown systemic administration midazolam propofol significantly reduced norepinephrine release medial prefrontal cortexnum pentobarbital ineffective
0.18986537.11878678.html.plaintext.txt	48	num noradrenergic neurones prefrontal cortex receive innervation locus coeruleusnum activity noradrenergic neurones prefrontal cortex indirectly reflects locus coeruleus activity
0.18986537.11878678.html.plaintext.txt	49	thus anaesthetic activate enhance gabaa receptor may reduce noradrenergic neuronal activity
0.18986537.11878678.html.plaintext.txt	50	contrast ketaminenum num nitrous oxide xenonnum nmda receptor antagonistic action markedly increased norepinephrine release prefrontal cortex preoptic area rat
0.18986537.11878678.html.plaintext.txt	51	clearly anaesthetic modulation norepinephrine release depends type anaesthetic
0.18986537.11878678.html.plaintext.txt	52	might argue noradrenergic transmission anaesthetic target
0.18986537.11878678.html.plaintext.txt	53	however already mentioned unitary site highly unlikely
0.18986537.11878678.html.plaintext.txt	54	loss consciousness result reduction cerebral activity also result cerebral excitation occurs convulsion
0.18986537.11878678.html.plaintext.txt	55	addition sleepiness induced hypothermia also increased body temperature activates heat sensitive neurones preoptic area
0.18986537.11878678.html.plaintext.txt	56	num feel wakefulness may occur set range range exceeded unconsciousness may occur
0.18986537.11878678.html.plaintext.txt	57	support hypothesis found physostigmine reported antagonize ketamine anaesthesia reduced duration ketamine anaesthesia ketamine increased norepinephrine release rat prefrontal cortex
0.18986537.11878678.html.plaintext.txt	58	collectively data presented editorial provide compelling evidence favour role noradrenergic transmission control wakefulness production mysterious anaesthetic state
0.18986537.11878678.html.plaintext.txt	59	university hirosaki school medicine
0.18986537.11878678.html.plaintext.txt	60	neurotransmitter modulated ionic current brainstem neuron target
0.18986537.11878678.html.plaintext.txt	61	steriade m mccarley rw ed
0.18986537.11878678.html.plaintext.txt	62	brainstem control wakefulness sleep
0.18986537.11878678.html.plaintext.txt	63	new york plenum press num num num
0.18986537.11878678.html.plaintext.txt	64	survey chemically defined cell group pathway
0.18986537.11878678.html.plaintext.txt	65	chemoarchitecture brain
0.18986537.11878678.html.plaintext.txt	66	berlin springer verlag num num num
0.18986537.11878678.html.plaintext.txt	67	relationship locus coeruleus discharge rate rate norepinephrine release within neocortex assessed vivo microdialysis
0.18986537.11878678.html.plaintext.txt	68	neurosciencenum num num numisimedline
0.18986537.11878678.html.plaintext.txt	69	pentobarbital sodium inhibits release noradrenaline medial preoptic area
0.18986537.11878678.html.plaintext.txt	70	neurosci lettnum num num numisimedline
0.18986537.11878678.html.plaintext.txt	71	noradrenergic input sleep related neuron preoptic area locus coeruleus ventrolateral medulla rat
0.18986537.11878678.html.plaintext.txt	72	neurosci re num num num numisimedline
0.18986537.11878678.html.plaintext.txt	73	noradrenaline inhibits preoptic sleep active neuron num receptor rat
0.18986537.11878678.html.plaintext.txt	74	neurosci resnum num num numisimedline
0.18986537.11878678.html.plaintext.txt	75	num mohan kumar v sharma r wadhwa manchanda sk
0.18986537.11878678.html.plaintext.txt	76	sleep inducing function noradrenergic fiber medial preoptic area
0.18986537.11878678.html.plaintext.txt	77	brain re bull num num num numisimedline
0.18986537.11878678.html.plaintext.txt	78	change sleep wakefulness num hydroxydopamine lesion preoptic area
0.18986537.11878678.html.plaintext.txt	79	neuroscience num num num numisimedline
0.18986537.11878678.html.plaintext.txt	80	effect selective alpha num adrenoceptor blocker prazocin eeg sleep waking stage rat
0.18986537.11878678.html.plaintext.txt	81	neuropsychobiologynum num num numisimedline
0.18986537.11878678.html.plaintext.txt	82	effect methoxamine alpha num adrenoceptor agonist prazosin alpha num antagonist stage sleep waking cycle cat
0.18986537.11878678.html.plaintext.txt	83	acta physiol scand num num num numisimedline
0.18986537.11878678.html.plaintext.txt	84	anaesthesia role adrenergic mechanism
0.18986537.11878678.html.plaintext.txt	85	eur j pharmacol num num num numisimedline
0.18986537.11878678.html.plaintext.txt	86	num matsumoto k kohno si ojima k watanabe h
0.18986537.11878678.html.plaintext.txt	87	flumazenil fgnum revers decrease pentobarbital sleep caused activation central noradrenergic system mouse
0.18986537.11878678.html.plaintext.txt	88	brain re num num num numisimedline
0.18986537.11878678.html.plaintext.txt	89	spatiotemporal interaction num autoreceptors noradrenaline transporter rat locus coeruleus implication volume transmission
0.18986537.11878678.html.plaintext.txt	90	j neurochem num num num numisimedline
0.18986537.11878678.html.plaintext.txt	91	num nacif coelhoc correa sale c chang ll maze m
0.18986537.11878678.html.plaintext.txt	92	perturbation ion channel conductance alters hypnotic response num adrenergic agonist dexmedetomidine locus coeruleus rat
0.18986537.11878678.html.plaintext.txt	93	anesthesiology num num num numisimedline
0.18986537.11878678.html.plaintext.txt	94	alpha num adrenergic agonist defining role clinical anesthesia
0.18986537.11878678.html.plaintext.txt	95	anesthesiology num num num numisimedline
0.18986537.11878678.html.plaintext.txt	96	alteration sleeping time rat induced drug modulate central monoaminergic system
0.18986537.11878678.html.plaintext.txt	97	br j anaesth num num num numabstract
0.18986537.11878678.html.plaintext.txt	98	brain noradrenaline anaesthesia characterization beta receptor
0.18986537.11878678.html.plaintext.txt	99	neuropharmacology num num num numisimedline
0.18986537.11878678.html.plaintext.txt	100	orexins new family neuropeptides
0.18986537.11878678.html.plaintext.txt	101	br j anaesthnum num num numfree full text
0.18986537.11878678.html.plaintext.txt	102	num hagan jj leslie ra patel et al
0.18986537.11878678.html.plaintext.txt	103	orexin activates locus coeruleus cell firing increase arousal rat
0.18986537.11878678.html.plaintext.txt	104	proc natl acad sci usa num num num numabstractfree full text
0.18986537.11878678.html.plaintext.txt	105	num lin l faraco j li r et al
0.18986537.11878678.html.plaintext.txt	106	sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.18986537.11878678.html.plaintext.txt	107	cell num num num numisimedline
0.18986537.11878678.html.plaintext.txt	108	num kubota k hirota k yoshida h et al
0.18986537.11878678.html.plaintext.txt	109	effect sedative noradrenaline release medial prefrontal cortex rat
0.18986537.11878678.html.plaintext.txt	110	gabaa receptor activator v nmda receptor inhibitor
0.18986537.11878678.html.plaintext.txt	111	psychopharmacology num num num numisimedline
0.18986537.11878678.html.plaintext.txt	112	num kubota anzawa n hirota k yoshida h matsuki
0.18986537.11878678.html.plaintext.txt	113	effect ketamine pentobarbital norepinephrine release median frontal cortex rat
0.18986537.11878678.html.plaintext.txt	114	j anaesth num num num numabstract
0.18986537.11878678.html.plaintext.txt	115	num yoshida h kushikata kubota hirota k ishihara h matsuki
0.18986537.11878678.html.plaintext.txt	116	increased norepinephrine release anterior posterior hypothalamus following xenon inhalation
0.18986537.11878678.html.plaintext.txt	117	j anesth num num num numabstractfree full text
0.18986537.11878678.html.plaintext.txt	118	num alam mn mcginity d szymusiak r
0.18986537.11878678.html.plaintext.txt	119	neuronal discharge preopticanterior hypothalamus thermosensitive neuron relation nrem sleep
0.18986537.11878678.html.plaintext.txt	120	j physiol num num rnum numabstractfree full text
0.18986537.11878678.html.plaintext.txt	121	num kubota k hirota k anzawa n yoshida h takahashi matsuki
0.18986537.11878678.html.plaintext.txt	122	physostigmine antagonizes ketamine induced noradrenaline release medial prefrontal cortex rat
0.18986537.11878678.html.plaintext.txt	123	brain re num num num numisimedline
0.20187694.15557013.html.plaintext.txt	0	orexin stimulates breathing via medullary spinal pathway john k
0.20187694.15557013.html.plaintext.txt	1	youngnum mingfei wunum kebreten f
0.20187694.15557013.html.plaintext.txt	2	numhoward university specialized neuroscience research program department physiology anatomy washington district columbia numdepartments pediatrics anatomy case western university cleveland ohio
0.20187694.15557013.html.plaintext.txt	3	submitted num august num accepted final form num november num
0.20187694.15557013.html.plaintext.txt	4	hypothalamus pre botzinger region phrenic motor neuron orexin num receptor sleep apnea
0.20187694.15557013.html.plaintext.txt	5	breathing active neurally controlled process regulated neural mechanism adjust respiratory related drive behavioral state metabolic demand organism
0.20187694.15557013.html.plaintext.txt	6	hypothalamic neuron part controlling system play important role regulation breathing rate depth num num
0.20187694.15557013.html.plaintext.txt	7	neuron lateral hypothalamus synthesize orexin orexin b also called hypocretin num hcrt num hypocretin num hcrt num
0.20187694.15557013.html.plaintext.txt	8	peptide neurotransmitter processed common precursor prepro orexin encoded gene localized human chromosome numqnum
0.20187694.15557013.html.plaintext.txt	9	orexin containing neuron affect autonomic neuroendocrine sleep wakefulness neuroregulatory system turn could potentially influence breathing num num num num
0.20187694.15557013.html.plaintext.txt	10	orexins stimulate target cell via two orexin g protein coupled receptor orexin rnum orexin rnum num
0.20187694.15557013.html.plaintext.txt	11	proposed orexin containing neuron promote wakefulness excitation cholinergic neuron basal forebrain release acetylcholine thereby contribute cortical activation wakefulness
0.20187694.15557013.html.plaintext.txt	12	however causality association remains determined wakefulness often accompanied behavioral activation
0.20187694.15557013.html.plaintext.txt	13	suppression rapid eye movement sleep occurs inhibition cholinergic neuron laterodorsal tegmental pedunculopontine nucleus num
0.20187694.15557013.html.plaintext.txt	14	central nervous system orexin containing neuron innervate multiple site including cell group brain stem spinal cord involved regulation cardiovascular function num num num num num
0.20187694.15557013.html.plaintext.txt	15	however information projection orexin containing neuron respiratory related brain stem region spinal cord motoneuron innervate respiratory muscle diaphragm
0.20187694.15557013.html.plaintext.txt	16	furthermore known whether brain stem region involved generation inspiratory rhythmic activity pre botzinger complex ventrolateral medulla andor inspiratory motoneuron phrenic motor neuron express orexin receptor num
0.20187694.15557013.html.plaintext.txt	17	hypothesized orexin containing neuron involved arousal also participate respiratory control via direct projection pre botzinger complex phrenic motor neuron
0.20187694.15557013.html.plaintext.txt	18	experimental protocol approved howard university institutional animal care use committee
0.20187694.15557013.html.plaintext.txt	19	experiment performed male sprague dawley rat harlan indianapolis num num g according national institute health guide care use laboratory animal
0.20187694.15557013.html.plaintext.txt	20	male rat chosen reduce potential effect hormonal cycling female
0.20187694.15557013.html.plaintext.txt	21	present study distribution neuron express orexin num receptor within rostral ventrolateral medulla cervical spinal cord determined
0.20187694.15557013.html.plaintext.txt	22	define whether phrenic motor neuron express orexin receptor animal n num rat anesthetized pentobarbital sodium num mgkg retrograde tracer cholera toxin b subunit num
0.20187694.15557013.html.plaintext.txt	23	num ctb list biological laboratory campbell ca injected costal region diaphragm num site num nlsite
0.20187694.15557013.html.plaintext.txt	24	procedure specifically identifies phrenic motoneuron project diaphragm
0.20187694.15557013.html.plaintext.txt	25	seven day ctb injection animal deeply anesthetized num mgkg ip pentobarbital rapidly perfused transcardially num
0.20187694.15557013.html.plaintext.txt	26	num buffered saline followed num paraformaldehyde num
0.20187694.15557013.html.plaintext.txt	27	perfused brain removed animal postfixed num paraformaldehyde num
0.20187694.15557013.html.plaintext.txt	28	cryoprotection immersion num sucrose num
0.20187694.15557013.html.plaintext.txt	29	num m pb num degree c num h num microm thick frozen section brain prepared using leitz microtome
0.20187694.15557013.html.plaintext.txt	30	experiment immunostaining procedure orexin receptor performed sequentially rather simultaneously previous study laboratory demonstrated approach provides better specificity lower background staining num
0.20187694.15557013.html.plaintext.txt	31	briefly enhance immunoreactivity free floating section brain stem cervical spinal cord cnum cnum region washed pb incubated num mm citric acid num degree c num h followed three wash pb incubation num min pb triton solution containing num normal serum block nonspecific binding site
0.20187694.15557013.html.plaintext.txt	32	wash section incubated num h num degree c pb triton solution containing rabbit anti orexin num receptor antibody chemicon international numnum dilution
0.20187694.15557013.html.plaintext.txt	33	section rinsed incubated num h numnum dilution goat anti rabbit igg conjugated alexa fluro num fluorescein isothiocyanate fitc molecular probe eugene
0.20187694.15557013.html.plaintext.txt	34	briefly second step section rinsed pb stained ctb
0.20187694.15557013.html.plaintext.txt	35	section placed primary polyclonal antibody solution numnum num dilution goat anti ctb pb triton list biological laboratory num h num degree c
0.20187694.15557013.html.plaintext.txt	36	section washed twice pb incubated num h numnum solution donkey anti goat igg conjugated alexa fluro num texas red molecular probe
0.20187694.15557013.html.plaintext.txt	37	section washed mounted gelatinalum coated glass slide
0.20187694.15557013.html.plaintext.txt	38	drop vecta shield vector laboratory burlingame ca applied air dried section slide coverslipped
0.20187694.15557013.html.plaintext.txt	39	selected section medulla oblongata also stained orexin num receptor peroxidase labeled antibody diaminobenzidine chromogen abc technique described
0.20187694.15557013.html.plaintext.txt	40	control experiment experiment done determine whether primary secondary antibody produced false positive result
0.20187694.15557013.html.plaintext.txt	41	experiment section stained possible combination primary secondary antibody single immunoprobe omitted
0.20187694.15557013.html.plaintext.txt	42	omission primary secondary antibody resulted absence labeling demonstrating false positive result obtained reagent
0.20187694.15557013.html.plaintext.txt	43	slide viewed bright field fluorescence microscope olympus axnum olympus america equipped adequate filter system observe texas red green fitc fluorescence
0.20187694.15557013.html.plaintext.txt	44	colocalization ctb orexin num receptor identified alternating filter view texas red fitc fluorescence analyzing merged image exact site
0.20187694.15557013.html.plaintext.txt	45	qualitative approach problem attempt quantitatively estimate total number identifiable phrenic motor neuron cnum cnum percentage phrenic motor neuron stained positively orexin receptor
0.20187694.15557013.html.plaintext.txt	46	second set experiment orexin containing lateral hypothalamic cell project phrenic nucleus identified neuroanatomic tracing
0.20187694.15557013.html.plaintext.txt	47	anesthetized animal n num rat ctb unilaterally injected ventral horn cervical spinal cord extending cnum cnum total num nl num
0.20187694.15557013.html.plaintext.txt	48	num solution previously described num
0.20187694.15557013.html.plaintext.txt	49	injection made glass micropipette num num microm diameter num
0.20187694.15557013.html.plaintext.txt	50	num mm dorsal surface spinal cord
0.20187694.15557013.html.plaintext.txt	51	seven day ctb injection animal perfused brain prepared outlined
0.20187694.15557013.html.plaintext.txt	52	third set experiment three experimental subject projection orexin containing neuron pre botzinger complex determined unilateral microinjection ctb num
0.20187694.15557013.html.plaintext.txt	53	num mm dorsal ventral surface ventrolateral medulla oblongata right site num nl num
0.20187694.15557013.html.plaintext.txt	54	coordinate used previous study laboratory examine respiration regulating neuron possessing neurokinin num receptor within called pre botzinger complex region num num
0.20187694.15557013.html.plaintext.txt	55	coordinate later utilized microinjection either orexin toluidine blue marker dye see
0.20187694.15557013.html.plaintext.txt	56	histological inspection section confirmed injection site caudal facial nucleus rostral level hypoglossal nucleus within anatomic border pre botzinger complex see also fig
0.20187694.15557013.html.plaintext.txt	57	seven day injection animal deeply anesthetized perfused described brain removed processed immunohistochemically ctb orexin labeling
0.20187694.15557013.html.plaintext.txt	58	transverse section whole brain animal cut num microm
0.20187694.15557013.html.plaintext.txt	59	immunohistochemical procedure used previously described num staining tissue section hypothalamus
0.20187694.15557013.html.plaintext.txt	60	briefly free floating section washed pb containing num
0.20187694.15557013.html.plaintext.txt	61	num triton x num num num series tissue section exposed num min pb triton solution containing num bsa block nonspecific binding site
0.20187694.15557013.html.plaintext.txt	62	wash tissue placed overnight num degree c primary polyclonal antibody solution numnumnum dilution rabbit anti orexin num normal goat serum pb triton oncogene research product num h num degree c
0.20187694.15557013.html.plaintext.txt	63	section washed twice pb incubated num h solution biotinylated goat anti rabbit secondary antibody vector laboratory
0.20187694.15557013.html.plaintext.txt	64	section washed pb incubated num min avidin biotin peroxidase complex recommended supplier
0.20187694.15557013.html.plaintext.txt	65	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	66	schematic diagram area medulla investigated num
0.20187694.15557013.html.plaintext.txt	67	num mm posterior bregma num paired section showing distribution toluidine blue dye microperfused using coordinate volume used infuse orexin
0.20187694.15557013.html.plaintext.txt	68	boxed region show area examined higher magnification b c d
0.20187694.15557013.html.plaintext.txt	69	amb ambiguus prbo pre botzinger complex sol solitary tract ml medial lemniscus py pyramid spnum spinal tract num
0.20187694.15557013.html.plaintext.txt	70	b orexin immunoreactive beaded axon present within region pre botzinger complex
0.20187694.15557013.html.plaintext.txt	71	c low magnification view medulla showing orexin receptor immunoreactivity brown nucleus ambiguus subjacent neuron pre botzinger complex section counterstained thionin
0.20187694.15557013.html.plaintext.txt	72	d higher magnification view neuron nucleus ambiguus immunoreactive orexin receptor
0.20187694.15557013.html.plaintext.txt	73	identify retrogradely labeled neuron within lateral hypothalamus produce orexin labeled orexin section washed pb placed primary polyclonal antibody solution numnumnum dilution goat anti ctb pb triton num h num degree c
0.20187694.15557013.html.plaintext.txt	74	section washed twice pb incubated num h numnum solution donkey anti goat igg conjugated alexa fluro num texas red molecular probe
0.20187694.15557013.html.plaintext.txt	75	section washed mounted gelatinalum coated glass slide
0.20187694.15557013.html.plaintext.txt	76	drop vecta shield vector laboratory applied air dried section slide coverslipped
0.20187694.15557013.html.plaintext.txt	77	section viewed either bright field microscopy orexin immunoreactivity brown diaminobenzidine precipitate fluorescence microscopy ctb immunoreactivity red fluorescence
0.20187694.15557013.html.plaintext.txt	78	digitized bright field image merged fluorescence image using imaging software detect double labeled cell sigma scan pro spss chicago il
0.20187694.15557013.html.plaintext.txt	79	rat anesthetized urethane num
0.20187694.15557013.html.plaintext.txt	80	num gkg carotid artery external jugular vein catheterized recording blood pressure heart rate administering fluid anesthetic one tenth initial concentration per hour
0.20187694.15557013.html.plaintext.txt	81	bilateral vagotomy tracheotomy rat placed stereotaxic apparatus prone position
0.20187694.15557013.html.plaintext.txt	82	diaphragm electromyographic activity demg recorded via bipolar electrode placed costal diaphragm
0.20187694.15557013.html.plaintext.txt	83	animal ventilated onum pump rate provided num total ventilatory activity obtained num conum onum previously described num num
0.20187694.15557013.html.plaintext.txt	84	investigate effect orexin phrenic motoneuron cervical spinal cord segment cnum cnum exposed laminectomy dura opened retracted n num rat
0.20187694.15557013.html.plaintext.txt	85	control value recorded spinal cord segment microperfused num microl saline orexin dissolved saline applied surface cord respiratory variable recorded num min solution
0.20187694.15557013.html.plaintext.txt	86	respiratory cardiovascular response three dos orexin num num num microgml sterile saline studied
0.20187694.15557013.html.plaintext.txt	87	dos corresponded dos proven effective stimulating neuronal firing andor arousal study e
0.20187694.15557013.html.plaintext.txt	88	examine medullary effect orexin num nl either saline three dos orexin microinjected pre botzinger complex additional five rat via hamilton syringe coordinate described
0.20187694.15557013.html.plaintext.txt	89	respiratory variable recorded described
0.20187694.15557013.html.plaintext.txt	90	finally end physiological experiment three five rat microinjected medullary stereotaxic coordinate num nl num toluidine blue mark anatomic location perfusion site
0.20187694.15557013.html.plaintext.txt	91	rat perfused brain sectioned medullary section dried onto slide counterstained num
0.20187694.15557013.html.plaintext.txt	92	num basic fuchsin mounted vecta shield without exposure slide alcohol
0.20187694.15557013.html.plaintext.txt	93	procedure avoided elution marker dye toluidine blue section alcohol
0.20187694.15557013.html.plaintext.txt	94	moving average demg used determine amplitude well frequency inspiratory burst
0.20187694.15557013.html.plaintext.txt	95	respiratory response quantified averaging parameter control period num consecutive breath num breath peak response microperfusion saline increasing concentration orexin
0.20187694.15557013.html.plaintext.txt	96	blood pressure heart rate measured control period peak change occurred orexin administration
0.20187694.15557013.html.plaintext.txt	97	average value mean plus minus sd analyzed variable compared analysis variance repeated measure tukeys protected test
0.20187694.15557013.html.plaintext.txt	98	statistical significance considered achieved p num
0.20187694.15557013.html.plaintext.txt	99	connectivity orexin ir neuron phrenic motor nucleus spinal cord
0.20187694.15557013.html.plaintext.txt	100	ctb injection spinal phrenic nucleus retrogradely labeled cell abundant lateral hypothalamus dorsal fornix
0.20187694.15557013.html.plaintext.txt	101	distribution showed considerable overlap distribution orexin immunoreactive ir neuron lateral hypothalamus
0.20187694.15557013.html.plaintext.txt	102	rat num orexin ir cell num ctb labeled cell examined total num double labeled cell mainly concentrated portion orexin ir neuron dorsolateral fornix found fig
0.20187694.15557013.html.plaintext.txt	103	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	104	schematic diagram area hypothalamus investigated num
0.20187694.15557013.html.plaintext.txt	105	boxed region show location orexin immunoreactive neuron
0.20187694.15557013.html.plaintext.txt	106	b bright field microscopy lateral hypothalamus showing orexin immunoreactive neuron brown labeled diaminobenzidine
0.20187694.15557013.html.plaintext.txt	107	c field b viewed fluorescence microscopy show neuron retrogradely labeled ctb rhodamine labeled antibody infused phrenic motor nucleus
0.20187694.15557013.html.plaintext.txt	108	neuron labeled ctb appear white whereas orexin immunoreactive neuron also labeled ctb appears red arrow
0.20187694.15557013.html.plaintext.txt	109	calibration bar num microm f fornix
0.20187694.15557013.html.plaintext.txt	110	connectivity orexin ir neuron pre botzinger complex
0.20187694.15557013.html.plaintext.txt	111	ctb injection pre botzinger complex labeled cell tended located somewhat closer third ventricle cell projecting phrenic motor nucleus
0.20187694.15557013.html.plaintext.txt	112	hypothalamic area num orexin ir cell num ctb labeled cell examined one cell double labeled
0.20187694.15557013.html.plaintext.txt	113	however orexin containing fiber observed pre botzinger complex region rostral ventrolateral medulla fig
0.20187694.15557013.html.plaintext.txt	114	detection orexin num receptor
0.20187694.15557013.html.plaintext.txt	115	immunoreactivity present neuron nucleus ambiguus nearby area ventrolateral medulla roughly corresponding pre botzinger complex fig
0.20187694.15557013.html.plaintext.txt	116	area precisely corresponds region recently reported contain unusually dense accumulation orexin ir fiber num
0.20187694.15557013.html.plaintext.txt	117	immunocytochemistry orexin receptor protein showed positive staining neuron phrenic motor nucleus identified retrograde transport ctb diaphragm fig
0.20187694.15557013.html.plaintext.txt	118	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	119	diagram location phrenic motor neuron boxed region segment cnum spinal cord num
0.20187694.15557013.html.plaintext.txt	120	b phrenic motor neuron ventral horn spinal cord retrogradely labeled ctb infused diaphragm green fitc labeled secondary antibody
0.20187694.15557013.html.plaintext.txt	121	c view b displaying section showing red fluorescence rhodamine labeled secondary antibody site orexin receptor immunoreactivity
0.20187694.15557013.html.plaintext.txt	122	double labeled cell demonstrate phrenic motor neuron posse orexin receptor
0.20187694.15557013.html.plaintext.txt	123	physiological effect orexin receptor activation respiratory drive
0.20187694.15557013.html.plaintext.txt	124	analyze effect microinjection orexin pre botzinger complex change induced orexin expressed percentage baseline discharge compared fig
0.20187694.15557013.html.plaintext.txt	125	analysis showed two higher dos orexin elicited statistically significant change peak demg compared response saline p num
0.20187694.15557013.html.plaintext.txt	126	num num microgml num microgml tukeys protected test analysis variance
0.20187694.15557013.html.plaintext.txt	127	toluidine blue dye infusion confirmed anatomic position infusion site within pre botzinger complex fig
0.20187694.15557013.html.plaintext.txt	128	close inspection infusion site microscope showed intense color dye confined area diameter num microm dye could detected farther num microm away center infusion site
0.20187694.15557013.html.plaintext.txt	129	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	130	mean peak integrated respiratory diaphragmatic voltage expressed percent deviation electromyographic value observed baseline recording diaphragm
0.20187694.15557013.html.plaintext.txt	131	respiratory response microperfusion num num microg orexin ventrolateral medulla significantly different response saline num microgml orexin p num
0.20187694.15557013.html.plaintext.txt	132	b breathing rate num treatment condition
0.20187694.15557013.html.plaintext.txt	133	heart rate blood pressure value rat study num higher previous experience slightly elevated typical value reported others e
0.20187694.15557013.html.plaintext.txt	134	exact explanation although value may related specific experimental condition employed
0.20187694.15557013.html.plaintext.txt	135	multiple vascular cannulae vagotomy tracheal cannula etc
0.20187694.15557013.html.plaintext.txt	136	statistically significant effect orexin heart rate blood pressure detected table num
0.20187694.15557013.html.plaintext.txt	137	recording single rat representative group difference treatment condition shown fig
0.20187694.15557013.html.plaintext.txt	138	cardiovascular variable following microperfusion test solution pre botzinger complex rostral ventrolateral medulla
0.20187694.15557013.html.plaintext.txt	139	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	140	respiratory activity rat num microperfusion saline ventrolateral medulla application num microgml orexin medulla b
0.20187694.15557013.html.plaintext.txt	141	demg integrated electromyographic activity diaphragm
0.20187694.15557013.html.plaintext.txt	142	similarly microperfusion two higher dos orexin onto spinal cord elicited statistically significant change peak demg compared response saline p num
0.20187694.15557013.html.plaintext.txt	143	num num microgml p num
0.20187694.15557013.html.plaintext.txt	144	statistically significant change p num
0.20187694.15557013.html.plaintext.txt	145	num breathing rate treatment condition detected fig
0.20187694.15557013.html.plaintext.txt	146	orexin produced slight statistically significant increase heart rate p num
0.20187694.15557013.html.plaintext.txt	147	num num num microgml p num
0.20187694.15557013.html.plaintext.txt	148	num num microgml orexin table num
0.20187694.15557013.html.plaintext.txt	149	recording single rat representative mean result shown fig
0.20187694.15557013.html.plaintext.txt	150	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	151	mean peak integrated respiratory diaphragmatic voltage expressed percent change electromyographic value observed baseline recording diaphragm
0.20187694.15557013.html.plaintext.txt	152	respiratory response application num num microgml orexin onto spinal cord significantly different response saline num microgml orexin p num
0.20187694.15557013.html.plaintext.txt	153	b breathing rate num treatment condition
0.20187694.15557013.html.plaintext.txt	154	cardiovascular variable following microperfusion test solution phrenic motor nucleus spinal cord
0.20187694.15557013.html.plaintext.txt	155	view larger version numk fig
0.20187694.15557013.html.plaintext.txt	156	respiratory activity rat num application saline spinal cord application num microgml orexin spinal cord b
0.20187694.15557013.html.plaintext.txt	157	result study showed first time discrete population orexin ir neuron lateral hypothalamus project ventrolateral medulla phrenic nucleus
0.20187694.15557013.html.plaintext.txt	158	finding extend previous report demonstrating long descending orexin containing axonal projection innervate spinal cord num num
0.20187694.15557013.html.plaintext.txt	159	however result suggest direct synaptic contact pre botzinger neuron orexin ir neuron infrequent despite presence numerous orexin containing fiber region
0.20187694.15557013.html.plaintext.txt	160	conceivably apparent projection subset lateral hypothalamic orexin containing neuron pre botzinger neuron phrenic nucleus could partly due nonspecific labeling produced diffusion retrograde tracer region contain nonrespiratory related cell andor uptake tracer descending fiber orexin neuron innervate intermediate cell column thoracolumbar portion spinal cord num
0.20187694.15557013.html.plaintext.txt	161	addition ctb may also taken fiber passage
0.20187694.15557013.html.plaintext.txt	162	however ctb continues regarded useful retrograde tracer even recent neuroanatomic study num
0.20187694.15557013.html.plaintext.txt	163	furthermore result accord report transsynaptic transport pseudorabies virus diaphragm lateral hypothalamus num num num
0.20187694.15557013.html.plaintext.txt	164	considerable number orexin containing fiber present within rostral ventrolateral medulla rat
0.20187694.15557013.html.plaintext.txt	165	finding accordance recent data orexin containing neuron innervate vagal preganglionic cell within nucleus ambiguus num
0.20187694.15557013.html.plaintext.txt	166	however found little retrograde transport ctb infused area hypothalamic orexin ir neuron ctb labeled cell mostly located medial orexin ir neuron
0.20187694.15557013.html.plaintext.txt	167	ctb taken synaptic vesicle possibility exists synapsis pre botzinger complex neuron orexinergic fiber passage may sparse
0.20187694.15557013.html.plaintext.txt	168	may orexin released passing fiber nonsynaptically activates receptor orexin circulating within cerebrospinal fluid may activate neuron contain orexin receptor volume transmission analogy effect endogenously released catecholamine region num num
0.20187694.15557013.html.plaintext.txt	169	medullary neuron ventral compact portion nucleus ambiguus study also immunoreactive orexin receptor may belong external loose portion nucleus ambiguus
0.20187694.15557013.html.plaintext.txt	170	vagal preganglionic neuron may contribute control respiration pre botzinger complex else may directly involved control respiratory timing
0.20187694.15557013.html.plaintext.txt	171	diversity function orexin sensitive neuron medulla may explain stimulatory effect orexin respiratory amplitude apparent lack effect respiratory timing
0.20187694.15557013.html.plaintext.txt	172	orexin receptor expression brain stem spinal cord respiratory related neuron
0.20187694.15557013.html.plaintext.txt	173	result present study showed neuron within rostral ventrolateral medullary region corresponding pre botzinger complex stain positively orexin receptor
0.20187694.15557013.html.plaintext.txt	174	finding accord numerous study orexin receptor found throughout brain stem rostral brain region num num num num num num
0.20187694.15557013.html.plaintext.txt	175	furthermore finding first time indicate identified phrenic motor neuron express orexin receptor
0.20187694.15557013.html.plaintext.txt	176	respiratory effect orexin activation
0.20187694.15557013.html.plaintext.txt	177	orexin microinjected pre botzinger region administered topically cervical spinal cord increased demg without affecting discharge frequency bilaterally vagotomized rat
0.20187694.15557013.html.plaintext.txt	178	increase peak integrated moving average activity diaphragm without change respiratory timing indicates neuron involved regulation tidal volume activity inspiratory pumping muscle independent frequency discharge
0.20187694.15557013.html.plaintext.txt	179	however result exclude critical role inspiratory rhythm generating cell pre botzinger complex control respiratory timing num
0.20187694.15557013.html.plaintext.txt	180	orexin may also affect respiration via projection site e
0.20187694.15557013.html.plaintext.txt	181	may cause increase respiratory drive via activation hypothalamic neuron project pre botzinger complex phrenic nucleus num num num num num
0.20187694.15557013.html.plaintext.txt	182	furthermore activity upper airway dilating muscle genioglossus muscle could affected via direct projection orexin containing neuron hypoglossal motoneuron activation orexin num receptor expressed hypoglossal motor cell innervate muscle num
0.20187694.15557013.html.plaintext.txt	183	addition dense orexinergic projection innervate intermediolateral cell column spinal cord majority sympathetic preganglionic neuronal cell body reside num num
0.20187694.15557013.html.plaintext.txt	184	indicates lateral hypothalamic orexinergic neuron may act directly different brain stem spinal cord cell group providing parallel control cardiovascular respiratory related output neuron behavioral state control defensive response energy homeostasis num num
0.20187694.15557013.html.plaintext.txt	185	orexin topically applied spinal cord slight significant effect heart rate
0.20187694.15557013.html.plaintext.txt	186	finding accord data showing intracisternal intrathecal injection orexin b provoke dose related increase heart rate sympathetic neuronal activity urethane anesthetized rat
0.20187694.15557013.html.plaintext.txt	187	orexin given route could activate multiple central nervous system spinal orexin sensitive site including excitatory brain stem neuron spinal cord sympathetic preganglionic neuron num num
0.20187694.15557013.html.plaintext.txt	188	observed effect medullary infusion orexin heart rate possibly rat vagotomized num
0.20187694.15557013.html.plaintext.txt	189	physiological effect observed study showed reliable dose response curve obtained using relatively high concentration orexin
0.20187694.15557013.html.plaintext.txt	190	possibly response could part pharmacological
0.20187694.15557013.html.plaintext.txt	191	blockade result pretreatment orexin antagonist e
0.20187694.15557013.html.plaintext.txt	192	sb num would required completely eliminate possibility could partly non orexin receptor mediated num
0.20187694.15557013.html.plaintext.txt	193	physiological relevance finding
0.20187694.15557013.html.plaintext.txt	194	orexin neuron provide link central nervous system mechanism coordinate sleep wakefulness state central nervous system control autonomic function via multiple projection num
0.20187694.15557013.html.plaintext.txt	195	neuron also shown present study involved regulation breathing activity via projection brain stem spinal cord respiratory related network presumably orexin rnum signaling pathway
0.20187694.15557013.html.plaintext.txt	196	accord recent report stimulation perifornical lateral hypothalamus elicits increase respiratory activity response diminished mouse genetically engineered lack orexin num
0.20187694.15557013.html.plaintext.txt	197	human orexin prof stimulate respiration deficit orexin action may contribute decrease respiratory drive sleeping review see ref
0.20187694.15557013.html.plaintext.txt	198	assumption consistent recent finding indicating orexin play important role maintenance wakefulness review see ref
0.20187694.15557013.html.plaintext.txt	199	decreased influence orexin brain region regulate sleep breathing could cause simultaneous decrease arousal respiratory drive
0.20187694.15557013.html.plaintext.txt	200	recently reported patient sleep apnea decreased blood level orexin relative control num
0.20187694.15557013.html.plaintext.txt	201	mechanism could produce decreased production orexin unknown may related apparent link obesity sleep apnea
0.20187694.15557013.html.plaintext.txt	202	well known obesity prominent risk factor sleep apnea num num
0.20187694.15557013.html.plaintext.txt	203	diabetes mellitus hyperglycemia also appear provoke sleep apnea num
0.20187694.15557013.html.plaintext.txt	204	seems likely metabolic alteration provoked obesity possibly elevation circulating nutrient molecule could partly explain association obesity sleep apnea
0.20187694.15557013.html.plaintext.txt	205	genetic diet induced obesity rodent blood concentration number circulating molecule elevated
0.20187694.15557013.html.plaintext.txt	206	increased effect glucose free fatty acid leptin hypothalamic function could provoke altered activity orexin containing neuron num num num num num num num num num num num
0.20187694.15557013.html.plaintext.txt	207	thus orexin containing neuron may key component connection obesity sleep apnea
0.20187694.15557013.html.plaintext.txt	208	study required investigate hypothesis
0.20187694.15557013.html.plaintext.txt	209	summary hypothalamic orexin containing neuron part brain stem spinal cord respiratory related network
0.20187694.15557013.html.plaintext.txt	210	orexin acting via orexin rnum expressed pre botzinger neuron phrenic nucleus increase respiratory drive
0.20187694.15557013.html.plaintext.txt	211	indicates orexin orexin rnum pathway may play important role linking central nervous system nucleus involved regulation sleep wakefulness state central nervous system control respiration
0.20187694.15557013.html.plaintext.txt	212	alteration regulatory system could lead autonomic dysfunction sleep related respiratory disorder
0.20187694.15557013.html.plaintext.txt	213	footnote address reprint request correspondence j
0.20187694.15557013.html.plaintext.txt	214	nw washington dc num e mail jyoungathoward
0.20187694.15557013.html.plaintext.txt	215	cost publication article defrayed part payment page charge
0.20187694.15557013.html.plaintext.txt	216	article must therefore hereby marked advertisement accordance num u
0.20187694.15557013.html.plaintext.txt	217	section num solely indicate fact
0.20854747.15870393.html.plaintext.txt	0	genetic modifier interact cpefat affect body weight adiposity hyperglycemia gayle b
0.20854747.15870393.html.plaintext.txt	1	maddatunum aunak sennumnum jurgen k
0.20854747.15870393.html.plaintext.txt	2	num jackson laboratory bar harbor maine num department epidemiology biostatistics university california san francisco california
0.20854747.15870393.html.plaintext.txt	3	quantitative trait locus type ii diabetes
0.20854747.15870393.html.plaintext.txt	4	five single gene mutation result obese phenotype identified mouse one fat mutation
0.20854747.15870393.html.plaintext.txt	5	fat mutation single nucleotide change carboxypeptidase e cpe gene resulting numser pro change cpe protein fat mouse num
0.20854747.15870393.html.plaintext.txt	6	cpe gene cpe encodes enzyme responsible processing hormone insulin proopiomelanocortin
0.20854747.15870393.html.plaintext.txt	7	cpe present high concentration secretory granule pancreatic islet required excision residual dibasic residue remaining carboxy terminal end propeptides processing endolytic prohormone convertases pcsknum pcsknum num
0.20854747.15870393.html.plaintext.txt	8	mutation cpefat render enzyme unstable ultimately degraded endoplasmic reticulum
0.20854747.15870393.html.plaintext.txt	9	reduction cpe activity turn lead decrease biologically active hormone insulin
0.20854747.15870393.html.plaintext.txt	10	cpe defect also observed tissue including hypothalamus suggests number additional prohormones may implicated obesity phenotype neuropeptides melanin stimulating hormone num melanin concentrating hormone num
0.20854747.15870393.html.plaintext.txt	11	fat mutation initially arose inbred hrsj hr strain num
0.20854747.15870393.html.plaintext.txt	12	hr fatfat mouse exhibit early chronic hyperinsulinemia followed mature onset obesity without hyperglycemia
0.20854747.15870393.html.plaintext.txt	13	fat mutation transferred cnumblksj bk background male mouse harboring mutation homozygous state became hyperglycemic sixth backcross generation nnum
0.20854747.15870393.html.plaintext.txt	14	addition bk fatfat mouse exhibit elevated plasma triglyceride high density lipoprotein hdl total cholesterol level
0.20854747.15870393.html.plaintext.txt	15	background strain difference respect diabetes development demonstrates cpefat necessary sufficient development diabesity obesitydiabetes cpefat model
0.20854747.15870393.html.plaintext.txt	16	susceptibility locus must interact fat produce hyperglycemia metabolic phenotype observed bk fatfat mouse
0.20854747.15870393.html.plaintext.txt	17	dissect susceptibility locus interacting cpefat performed genetic analysis male mouse homozygous cpefat mutation large bk x hrshr fnum cpefat intercross inbred hr strain also carry mutation hairless gene hr
0.20854747.15870393.html.plaintext.txt	18	temporal phenotype body weight plasma glucose constructed set derived phenotype capture key aspect longitudinal measurement rate flux severity phenotype
0.20854747.15870393.html.plaintext.txt	19	present outcome genome wide screen susceptibility locus interact cpefat development obesity diabetes related disorder
0.20854747.15870393.html.plaintext.txt	20	phenotypic measurement body weight
0.20854747.15870393.html.plaintext.txt	21	mouse weighed monthly termination num cohort ii iii num wk cohort age
0.20854747.15870393.html.plaintext.txt	22	see table num schedule phenotypic measurement
0.20854747.15870393.html.plaintext.txt	23	schedule phenotypic measurement fnum intercross progeny
0.20854747.15870393.html.plaintext.txt	24	whole blood collected via orbital sinus biweekly num num using edta coated capillary tube
0.20854747.15870393.html.plaintext.txt	25	sample centrifuged plasma used biochemical assay
0.20854747.15870393.html.plaintext.txt	26	plasma glucose cholesterol triglyceride level measured using commercial colorimetric assay sigma st
0.20854747.15870393.html.plaintext.txt	27	louis mo roche indianapolis
0.20854747.15870393.html.plaintext.txt	28	determine hdl cholesterol level low density low density lipoprotein particle precipitated polyethylene glycol num
0.20854747.15870393.html.plaintext.txt	29	determine plasma triglyceride level free glycerol subtracted total glycerol content
0.20854747.15870393.html.plaintext.txt	30	plasma insulin level measured using radioimmunoassay kit linco st
0.20854747.15870393.html.plaintext.txt	31	plasma glucose level monitored biweekly whereas lipid insulin level determined num wk age termination
0.20854747.15870393.html.plaintext.txt	32	subcutaneous rostral caudal retroperitoneal epididymal fat pad isolated weighed termination
0.20854747.15870393.html.plaintext.txt	33	total fat pad weight defined sum fat pad described
0.20854747.15870393.html.plaintext.txt	34	adiposity index calculated dividing total fat pad weight carcass weight multiplying num
0.20854747.15870393.html.plaintext.txt	35	addition fat pad weight body length nose tail girth animal measured
0.20854747.15870393.html.plaintext.txt	36	dna isolated tail tissue using proteinase k digestion salt precipitation num
0.20854747.15870393.html.plaintext.txt	37	cpefat hr segregating fnum intercross progeny dna pcr amplified allele specific primer determine genotype locus
0.20854747.15870393.html.plaintext.txt	38	pcr condition cpe primer previously described num
0.20854747.15870393.html.plaintext.txt	39	cycling condition pcr amplification hr follows num degree c num min followed num cycle num degree c num num degree c num num degree c num
0.20854747.15870393.html.plaintext.txt	40	final extension done num degree c num min
0.20854747.15870393.html.plaintext.txt	41	pcrs done num microl volume containing numx pcr buffer roche num ng genomic dna num
0.20854747.15870393.html.plaintext.txt	42	num microm primer fnum num agggaggtcagagcctctg num num
0.20854747.15870393.html.plaintext.txt	43	num microm primer rnumnum ggtcctcctgtttgcttgg num num
0.20854747.15870393.html.plaintext.txt	44	num microm primer fnum num gccactccttgaacctgtg num
0.20854747.15870393.html.plaintext.txt	45	dna separated num metaphor num agarose gel bma rockland stained ethidium bromide examined ultraviolet light
0.20854747.15870393.html.plaintext.txt	46	dna heterozygous hr animal yielded two fragment num num bps respectively
0.20854747.15870393.html.plaintext.txt	47	identify polymorphic region bk hr strain across genome dna parental bk fatfat nnum bk fatfat nnum hr mouse typed single stranded length polymorphism sslp marker research genetics using pcr assay previously described num
0.20854747.15870393.html.plaintext.txt	48	initially total num sslp marker average spacing num cm tested genome scan largest gap num cm marker dnummitnum dnummitnum marker information available upon request
0.20854747.15870393.html.plaintext.txt	49	additional marker tested chromosomal region showing significant linkage
0.20854747.15870393.html.plaintext.txt	50	resolution detected numnum marker tested scan region chromosome num differed bk fatfat nnum nnum animal
0.20854747.15870393.html.plaintext.txt	51	nnum animal hr genotype dnummitnum whereas nnum animal segregating hr bk allele
0.20854747.15870393.html.plaintext.txt	52	area hr contaminated region may exist num genome num bk modifying qtl may missed
0.20854747.15870393.html.plaintext.txt	53	numnum fnum mouse generated intercross dna num fatfat fnum male progeny pcr amplified
0.20854747.15870393.html.plaintext.txt	54	num fatfat male mouse instead expected num
0.20854747.15870393.html.plaintext.txt	55	num available mouse died early lost completion study
0.20854747.15870393.html.plaintext.txt	56	approximately num possible genotype complete
0.20854747.15870393.html.plaintext.txt	57	determine whether qtl modified trait absence cpe defect genome scan performed dna num fnum fat num fnum mouse
0.20854747.15870393.html.plaintext.txt	58	statistical analysis data analysis data thoroughly examined mouse exhibiting spontaneous extraneous ailment malocclusion
0.20854747.15870393.html.plaintext.txt	59	animal removed data set analysis
0.20854747.15870393.html.plaintext.txt	60	phenotypic profile fnum progeny obtained using one way anova
0.20854747.15870393.html.plaintext.txt	61	examining longitudinal data male fnum fatfat mouse noted different pattern disease progression
0.20854747.15870393.html.plaintext.txt	62	example mouse became hyperglycemic early sustained hyperglycemia others transiently hyperglycemic others showed slow moderate rise plasma glucose level
0.20854747.15870393.html.plaintext.txt	63	address longitudinal nature phenotype created derived phenotype body weight plasma glucose
0.20854747.15870393.html.plaintext.txt	64	allowed u obtain result clear biological interpretation
0.20854747.15870393.html.plaintext.txt	65	detect modifier act early late disease process change affect rate disease progression curvature affect disease severity final remain constitutively expressed throughout time course average
0.20854747.15870393.html.plaintext.txt	66	also make result comparable future study may measure body weight progression different time point even irregular time interval
0.20854747.15870393.html.plaintext.txt	67	constructed following set derived phenotype
0.20854747.15870393.html.plaintext.txt	68	let bi log body weight week
0.20854747.15870393.html.plaintext.txt	69	let gi log plasma glucose level mouse week
0.20854747.15870393.html.plaintext.txt	70	termination age time necropsy performed differed cohort num num wk age
0.20854747.15870393.html.plaintext.txt	71	statistically examined whether difference mean value necropsy done num versus num wk
0.20854747.15870393.html.plaintext.txt	72	adiposity index measured num num wk age significantly different p num
0.20854747.15870393.html.plaintext.txt	73	therefore genome scan analysis combined adiposity data cohort increase power detect linkage
0.20854747.15870393.html.plaintext.txt	74	adjust included additive effect cohort analysis adiposity
0.20854747.15870393.html.plaintext.txt	75	view larger version numk fig
0.20854747.15870393.html.plaintext.txt	76	schematic showing derived phenotype body weight bw plasma glucose pg b
0.20854747.15870393.html.plaintext.txt	77	multiple imputation method sen churchill num used perform one dimensional two dimensional genome scan derived phenotype adiposity
0.20854747.15870393.html.plaintext.txt	78	one dimensional genome scan also commonly referred genome scan survey single locus model explaining phenotype
0.20854747.15870393.html.plaintext.txt	79	amount performing anova every locus complete genotype information available
0.20854747.15870393.html.plaintext.txt	80	examine much phenotypic variation explained genetic variation every locus summarize statistical evidence locus affect phenotype lod score
0.20854747.15870393.html.plaintext.txt	81	two dimensional genome scan survey two locus model explaining phenotype
0.20854747.15870393.html.plaintext.txt	82	examined much phenotypic variation explained genetic variation every pair locus genome
0.20854747.15870393.html.plaintext.txt	83	one dimensional two dimensional scan included additive cohort effect three cohort mouse
0.20854747.15870393.html.plaintext.txt	84	method analysis able combine overall evidence favor locus three cohort respecting difference
0.20854747.15870393.html.plaintext.txt	85	rationale combining cross previously reported used study num num num num
0.20854747.15870393.html.plaintext.txt	86	genotype chromosome num linked fat mutation distal chromosome num cohort ii animal hr genotype hence excluded genome analysis
0.20854747.15870393.html.plaintext.txt	87	genome scan two stage model selection procedure followed
0.20854747.15870393.html.plaintext.txt	88	locus locus pair selection previously described num
0.20854747.15870393.html.plaintext.txt	89	locus cleared num permutation test threshold one dimensional scan selected
0.20854747.15870393.html.plaintext.txt	90	selected locus pair follows
0.20854747.15870393.html.plaintext.txt	91	pair cleared num permutation test threshold two dimensional scan full two locus model subjected secondary test
0.20854747.15870393.html.plaintext.txt	92	determine whether locus pair acting additively compared two locus additive model single locus model dropping locus turn
0.20854747.15870393.html.plaintext.txt	93	comparison used nominal p value num
0.20854747.15870393.html.plaintext.txt	94	corresponds approximately num permutation test threshold one dimensional genome scan
0.20854747.15870393.html.plaintext.txt	95	tested interaction component two locus model using nominal p value num
0.20854747.15870393.html.plaintext.txt	96	corresponds num permutation test threshold interaction test
0.20854747.15870393.html.plaintext.txt	97	backward elimination previously described num
0.20854747.15870393.html.plaintext.txt	98	locus locus pair selected previous stage put together multiple qtl model
0.20854747.15870393.html.plaintext.txt	99	additive cohort effect always included multiple qtl model
0.20854747.15870393.html.plaintext.txt	100	multiple qtl model formed selecting marker closest locus
0.20854747.15870393.html.plaintext.txt	101	genotype missing marker multiple imputation method num used account missing genotype
0.20854747.15870393.html.plaintext.txt	102	basic idea missing genotype probabilistically inferred genotype nearby marker
0.20854747.15870393.html.plaintext.txt	103	done simulating missing genotype marker conditional flanking typed marker
0.20854747.15870393.html.plaintext.txt	104	account uncertainty knowledge true genotype number imputation num used
0.20854747.15870393.html.plaintext.txt	105	term model including cohort effect dropped change lod score noted
0.20854747.15870393.html.plaintext.txt	106	corresponds type iii anova
0.20854747.15870393.html.plaintext.txt	107	nominal p value change lod score num
0.20854747.15870393.html.plaintext.txt	108	num main effect num
0.20854747.15870393.html.plaintext.txt	109	num interaction term dropped
0.20854747.15870393.html.plaintext.txt	110	procedure continued term could dropped
0.20854747.15870393.html.plaintext.txt	111	test whether major qtls specific fatfat animal performed anova test fatfat non fatfat male progeny
0.20854747.15870393.html.plaintext.txt	112	selected nearest typed marker fatfat non fatfat progeny
0.20854747.15870393.html.plaintext.txt	113	num cm initial plasma glucose fat induced diabetes num findnum dnummitnum num
0.20854747.15870393.html.plaintext.txt	114	num cm average plasma glucose findnum dnummitnum num
0.20854747.15870393.html.plaintext.txt	115	num cm adiposity index fat induced adiposity num finanum dnummitnum num
0.20854747.15870393.html.plaintext.txt	116	num cm final body weight body weight num bwtnum
0.20854747.15870393.html.plaintext.txt	117	plasma glucose measured num wk non fatfat mouse redefined average glucose measurement animal average plasma glucose level num num num num num wk test
0.20854747.15870393.html.plaintext.txt	118	phenotype definition three phenotype left unchanged
0.20854747.15870393.html.plaintext.txt	119	individual missing phenotype genotype discarded
0.20854747.15870393.html.plaintext.txt	120	anova performed qtl marker genotype separately fatfat non fatfat animal
0.20854747.15870393.html.plaintext.txt	121	mutation analysis total rna prepared whole brain cnumblksj hrsj mouse
0.20854747.15870393.html.plaintext.txt	122	tissue homogenized rna isolated treatment trizol life technology according manufacturer protocol
0.20854747.15870393.html.plaintext.txt	123	cdna generated using superscript one step rt pcr kit life technology gaithersburg md
0.20854747.15870393.html.plaintext.txt	124	pcr primer mutation analysis orexinhypocretin hcrt carboxypeptidase d gene cpd designed sequence public database national center biotechnology information
0.20854747.15870393.html.plaintext.txt	125	pcr amplification cdna performed using expand template system roche
0.20854747.15870393.html.plaintext.txt	126	amplified product separated num num
0.20854747.15870393.html.plaintext.txt	127	num gel excised purified using nucleospin column clontech palo alto ca sequenced abi prism num using forward reverse primer
0.20854747.15870393.html.plaintext.txt	128	phenotypic profile parental bk fatfat nnum nnum hr fatfat fnum fatfat fat mouse cohort
0.20854747.15870393.html.plaintext.txt	129	general fatfat mouse significantly higher body weight fat mouse
0.20854747.15870393.html.plaintext.txt	130	heterozygous effect body weight fat mouse evident time period examined
0.20854747.15870393.html.plaintext.txt	131	expected adiposity index fatfat mutant mouse much higher nonobese control
0.20854747.15870393.html.plaintext.txt	132	whereas fat mouse tended toward higher adiposity level significantly different normal littermates
0.20854747.15870393.html.plaintext.txt	133	interestingly significant difference body length girth also observed three subgroup
0.20854747.15870393.html.plaintext.txt	134	fnum fat mouse normoglycemic
0.20854747.15870393.html.plaintext.txt	135	total num fnum fatfat male cohort iii monitored plasma glucose level num abnormal level plasma glucose num mgdl
0.20854747.15870393.html.plaintext.txt	136	fifty eight percent defined diabetic chronically diabetic plasma glucose num mgdl num timepoints termination
0.20854747.15870393.html.plaintext.txt	137	plasma glucose level ranged num numnum mgdl mean num
0.20854747.15870393.html.plaintext.txt	138	different form diabetes onset observed fnum generation mouse transiently diabetic early whereas others became diabetic later life
0.20854747.15870393.html.plaintext.txt	139	hyperlipidemia hyperinsulinemia
0.20854747.15870393.html.plaintext.txt	140	fnum fatfat mouse developed chronic hyperinsulinemia plasma insulin num ngml mild moderate hyperlipidemia
0.20854747.15870393.html.plaintext.txt	141	num wk age plasma insulin level elevated num fold total cholesterol level nearly doubled fnum fatfat mouse compared nonobese littermates
0.20854747.15870393.html.plaintext.txt	142	qtl mapping locus interacting cpefat genome scan analysis qtl analysis data logarithmically transformed stabilize variance
0.20854747.15870393.html.plaintext.txt	143	resulting phenotypic distribution much symmetric shown fig
0.20854747.15870393.html.plaintext.txt	144	frequency distribution body weight varies age whereas frequency distribution plasma glucose remains homogenous num num wk age
0.20854747.15870393.html.plaintext.txt	145	disease progression examined animal individually different pattern observed body weight plasma glucose
0.20854747.15870393.html.plaintext.txt	146	make observation biologically meaningful derived data phenotype different category detect modifier affecting rate flux severity disease progression see material method
0.20854747.15870393.html.plaintext.txt	147	view larger version numk fig
0.20854747.15870393.html.plaintext.txt	148	frequency distribution bw pg level b fnum fatfat male mouse biweekly time interval
0.20854747.15870393.html.plaintext.txt	149	length horizontal line corresponds number observation
0.20854747.15870393.html.plaintext.txt	150	total num sslp marker used genotype total num fatfat male progeny
0.20854747.15870393.html.plaintext.txt	151	result one two dimensional scan shown fig
0.20854747.15870393.html.plaintext.txt	152	table num summary major qtls position presented whereas table num type iii anova table corresponding multiple qtl model selected trait shown
0.20854747.15870393.html.plaintext.txt	153	view larger version numk fig
0.20854747.15870393.html.plaintext.txt	154	genome scan plot one dimensional trait
0.20854747.15870393.html.plaintext.txt	155	chromosome containing significant marker shown bold
0.20854747.15870393.html.plaintext.txt	156	b allelic plot significant quanitative trait locus qtl adiposity bw pg plasma insulin total cholesterol derived phenotype
0.20854747.15870393.html.plaintext.txt	157	c allelic plot significant interactive qtl bw two dimensional scan
0.20854747.15870393.html.plaintext.txt	158	summary major qtl adiposity body weight pg plasma insulin blood cholesterol detected fnum bk x hr fatfat mouse
0.20854747.15870393.html.plaintext.txt	159	multiple qtl model type iii anova trait
0.20854747.15870393.html.plaintext.txt	160	major qtl cpefat induced adiposity finanum identified chromosome num fnum fatfat male progeny peak lod score dnummitnum
0.20854747.15870393.html.plaintext.txt	161	qtl analysis individual fat pad weight detected qtls rostral caudal epididymal fat pad region chromosome num
0.20854747.15870393.html.plaintext.txt	162	mouse homozygous bk derived allele dnummitnum significantly higher fat depot weight fig
0.20854747.15870393.html.plaintext.txt	163	fnum male progeny major locus body weight bwtnum identified chromosome num tightly linked hr
0.20854747.15870393.html.plaintext.txt	164	determine effect hr various trait fnum intercross progeny fatfat fat mouse genotyped allele specific primer hr mutation mean value trait compared table num
0.20854747.15870393.html.plaintext.txt	165	three genetic subgroup mouse homozygous hr mutation significantly reduced body weight measurement suggests bwtnum acting independently fat body weight
0.20854747.15870393.html.plaintext.txt	166	addition fatfat fat hr mouse lowered total cholesterol plasma insulin level shown
0.20854747.15870393.html.plaintext.txt	167	body weight bk x hr fnum fatfat fat mouse segregated hr
0.20854747.15870393.html.plaintext.txt	168	identified locus chromosome num interacts bwtnum lower body weight intra allelic interaction heterosis
0.20854747.15870393.html.plaintext.txt	169	heterozygosity chromosome num strongest epistatic effect body weight mouse homozygous hr derived allele bwtnum fig
0.20854747.15870393.html.plaintext.txt	170	chromosome num locus showed significant effect body weight interacting bwtnum independent effect body weight measurement
0.20854747.15870393.html.plaintext.txt	171	major locus weight gain maximum lod score num
0.20854747.15870393.html.plaintext.txt	172	num dnummitnum overlapped adiposity locus finanum also detected
0.20854747.15870393.html.plaintext.txt	173	mouse homozygous bk derived allele bb largest weight gain compared heterozygous bh homozygous hh hr littermates fig
0.20854747.15870393.html.plaintext.txt	174	hyperglycemia hyperinsulinemia hypercholesterolemia
0.20854747.15870393.html.plaintext.txt	175	two locus cpefat induced diabetes findnum findnum detected chromosome num num respectively fig
0.20854747.15870393.html.plaintext.txt	176	findnum mouse homozygous bk derived allele bb exhibited higher plasma glucose level bh homozygous hh littermates whereas findnum presence hr allele resulted elevated plasma glucose level
0.20854747.15870393.html.plaintext.txt	177	findnum locus found affect metabolic feature besides plasma glucose insulin total cholesterol level
0.20854747.15870393.html.plaintext.txt	178	use backward elimination multiple qtl model locus including findnum identified interaction findnum
0.20854747.15870393.html.plaintext.txt	179	fact significant interaction detected findnum surprising hr fatfat mouse become diabetic
0.20854747.15870393.html.plaintext.txt	180	hr segregated cross hypothesized findnum effect plasma glucose may dependent hr genotype chromosome num
0.20854747.15870393.html.plaintext.txt	181	compared plasma glucose mean mouse homozygous hr derived allele findnum two genotypic cohort bb hh dnummitnum marker tightly linked hr locus table num
0.20854747.15870393.html.plaintext.txt	182	suspected mouse homozygous hr derived allele findnum homozygous bk derived allele dnummitnum significantly higher plasma glucose level mouse homozygous hr derived allele findnum dnummitnum
0.20854747.15870393.html.plaintext.txt	183	comparison pg level bb hh genotype dnummitnum
0.20854747.15870393.html.plaintext.txt	184	significant locus plasma insulin num wk total cholesterol num wk detected chromosome num findnum fig
0.20854747.15870393.html.plaintext.txt	185	fnum mouse homozygous bk derived allele dnummitnum significantly higher total cholesterol level lower plasma insulin level
0.20854747.15870393.html.plaintext.txt	186	evaluation major qtl fat progeny determine whether major qtl identified acted modifier cpefat mutation performed anova qtl marker genotype separately fatfat non fatfat male intercross progeny table num
0.20854747.15870393.html.plaintext.txt	187	fatfat mouse significant effect also observed bwtnum fat mouse dnummitnum marker linked hr locus
0.20854747.15870393.html.plaintext.txt	188	however none qtls findnum findnum finanum showed strong effect non fatfat male progeny consistent modifier hypothesis
0.20854747.15870393.html.plaintext.txt	189	anova result major qtl effect cpefatcpefat cpefat cpe mouse
0.20854747.15870393.html.plaintext.txt	190	evaluation candidate gene region spanning finanum includes attractive biological candidate hcrt cpd
0.20854747.15870393.html.plaintext.txt	191	orexin positive neuron localized lateral hypothalamus project throughout brain
0.20854747.15870393.html.plaintext.txt	192	orexin knockout mouse exhibit narcoleptic phenotype suggests orexin may function regulation arousal sleep wake cycle num
0.20854747.15870393.html.plaintext.txt	193	however intraventricular injection orexin peptide increase feeding cnumblnumj mouse num
0.20854747.15870393.html.plaintext.txt	194	carboxypeptidase d similar enzymatic activity cpe might functionally complement cpe deficit cell type
0.20854747.15870393.html.plaintext.txt	195	mutation analysis coding region hcrt cpd mrna hr bk mouse detected sequence difference
0.20854747.15870393.html.plaintext.txt	196	although promotor region examined mrna abundance differ judged amount ethidium bromide stained rt pcr product obtained two strain
0.20854747.15870393.html.plaintext.txt	197	bk x hr fnum fatfat mouse homozygous hr allele findnum elevated plasma glucose level
0.20854747.15870393.html.plaintext.txt	198	hr fatfat mouse become hyperglycemic implies findnum interacting additional locus bk background
0.20854747.15870393.html.plaintext.txt	199	multiple qtl model detect locus interacting findnum however observe association plasma glucose level mouse homozygous hh findnum genotype near hr locus chromosome num
0.20854747.15870393.html.plaintext.txt	200	suggests hr gene closely linked gene may effect findnum expression
0.20854747.15870393.html.plaintext.txt	201	addition locus closely linked cpe locus chromosome num ruled mouse analyzed homozygous cpefat
0.20854747.15870393.html.plaintext.txt	202	diabetes susceptibility locus found interval findnum distal mouse chromosome num several rodent experiment num num num num
0.20854747.15870393.html.plaintext.txt	203	whether locus due mutation gene remains determined
0.20854747.15870393.html.plaintext.txt	204	major qtl body weight bwtnum identified chromosome num
0.20854747.15870393.html.plaintext.txt	205	lod peak bwtnum close vicinity hr making hr plausible candidate
0.20854747.15870393.html.plaintext.txt	206	allele typing hr allele fnum progeny showed hrhr mutant mouse significantly lower mean body weight value haired mouse
0.20854747.15870393.html.plaintext.txt	207	hairless hr mouse hr hrhr mouse also lower mean adipose depot body weight normally haired albino hr littermates num
0.20854747.15870393.html.plaintext.txt	208	previously shown hairless mouse higher metabolic rate normally haired albino mouse num
0.20854747.15870393.html.plaintext.txt	209	attributed greater energy requirement thermoregulation mouse lacking body hair
0.20854747.15870393.html.plaintext.txt	210	however recently discovered hr gene product act corepressor thyroid hormone receptor num hr mutation might therefore mimic effect thyroid hormone energy metabolism
0.20854747.15870393.html.plaintext.txt	211	altogether data suggest hr responsible lowered body weight hr hrhr mouse hr gene explains variance observed fnum fatfat male act independently fat locus
0.20854747.15870393.html.plaintext.txt	212	currently published report adiposity human patient congenital alopecia artrichia carrying mutation hr gene unclear whether hr mutation effect metabolism human mouse
0.20854747.15870393.html.plaintext.txt	213	major locus finanum chromosome num strongly associated adiposity genome scan fnum fatfat mouse
0.20854747.15870393.html.plaintext.txt	214	fact finanum observed lean control implies finanum locus epistatically interacting fat thereby masking effect hr adipose depot distribution fnum fatfat mutant mouse
0.20854747.15870393.html.plaintext.txt	215	interval finanum still fairly large includes intriguing candidate hcrt cpd
0.20854747.15870393.html.plaintext.txt	216	although sequence variation observed coding region gene possibility promoter defect need exploration
0.20854747.15870393.html.plaintext.txt	217	study carried genetic analysis complex phenotype caused prohormone processing defect fat mutant mouse
0.20854747.15870393.html.plaintext.txt	218	use novel method analyzing modifier gene involved different pattern disease progression rate fluctuation severity
0.20854747.15870393.html.plaintext.txt	219	also show many phenotype observed fat mouse ameliorated action major modifier gene
0.20854747.15870393.html.plaintext.txt	220	obesity often associated alteration neuropeptide level identification diabesity associated modifier qtl also lead better understanding biological pathway neuropeptides may involved common form obesity
0.20854747.15870393.html.plaintext.txt	221	acknowledgment gratefully acknowledge technical assistance theolyn gilley jay young
0.20854747.15870393.html.plaintext.txt	222	footnote article published online print
0.20854747.15870393.html.plaintext.txt	223	see web site date publication httpphysiolgenomics
0.20854747.15870393.html.plaintext.txt	224	address reprint request correspondence j
0.20854747.15870393.html.plaintext.txt	225	naggert jackson laboratory num main st
0.20854747.15870393.html.plaintext.txt	226	bar harbor num e mail jknatjax
0.20854747.15870393.html.plaintext.txt	227	maddatu contributed equally work
0.21321544.12639935.html.plaintext.txt	0	ghrelin induced food intake mediated via orexin pathway koji toshinai yukari date noboru murakami mitsushi shimada muhtashan
0.21321544.12639935.html.plaintext.txt	1	mondal takuya shimbara jian lian guan qing ping wang hisayuki funahashi takeshi sakurai seiji shioda shigeru matsukura kenji kangawa masamitsu nakazato
0.21321544.12639935.html.plaintext.txt	2	department internal medicine k
0.21321544.12639935.html.plaintext.txt	3	miyazaki medical college miyazaki num num japan department veterinary physiology n
0.21321544.12639935.html.plaintext.txt	4	university miyazaki miyazaki num num japan first department internal medicine m
0.21321544.12639935.html.plaintext.txt	5	oita medical university oita num num japan department anatomy j
0.21321544.12639935.html.plaintext.txt	6	showa university school medicine tokyo num num japan department pharmacology university tsukuba
0.21321544.12639935.html.plaintext.txt	7	ibaraki num num japan national cardiovascular center research institute y
0.21321544.12639935.html.plaintext.txt	8	address correspondence request reprint masamitsu nakazato m
0.21321544.12639935.html.plaintext.txt	9	third department internal medicine miyazaki medical college kiyotake miyazaki num num japan
0.21321544.12639935.html.plaintext.txt	10	although ghrelin predominantly produced endocrine cell stomach num num also synthesized hypothalamic arcuate nucleus num num critical region feeding
0.21321544.12639935.html.plaintext.txt	11	ghrelin receptor however extensively distributed throughout brain area lateral hypothalamus lh arcuate nucleus num num
0.21321544.12639935.html.plaintext.txt	12	area contain several subset neuron produce neuropeptides implicated feeding regulation including neuropeptide y npy agouti related protein agrp cocaine amphetamine regulated transcript proopiomelanocortin melanin concentrating hormone mch orexins orexin orexin b also termed hypocretins num num
0.21321544.12639935.html.plaintext.txt	13	centrally administered ghrelin may interact peptide regulate food intake energy homeostasis
0.21321544.12639935.html.plaintext.txt	14	although mechanism ghrelin orexigenic activity related npy agrp pathway num num num interaction ghrelin energy regulating system unclear
0.21321544.12639935.html.plaintext.txt	15	orexin b produced num amino acid prepro orexin precursor lh num amino acid sequence identity stimulate food intake num
0.21321544.12639935.html.plaintext.txt	16	mch num amino acid neuropeptide whose neuron coextensive colocalized orexin neuron lh num also stimulates feeding centrally administered num
0.21321544.12639935.html.plaintext.txt	17	using electron microscope immunohistochemistry immunofluorescence microscopy investigated anatomical distribution ghrelin orexin mch
0.21321544.12639935.html.plaintext.txt	18	also examined ghrelin induced expression c fo marker neuronal activation num orexin mch expressing neuron
0.21321544.12639935.html.plaintext.txt	19	investigate functional relationship ghrelin orexins mch examined effect pretreatment anti orexin b igg anti mch igg ghrelin inducing feeding
0.21321544.12639935.html.plaintext.txt	20	also studied ghrelin induced food intake orexin knockout mouse
0.21321544.12639935.html.plaintext.txt	21	demonstrate ghrelin interacts orexin system induce feeding
0.21321544.12639935.html.plaintext.txt	22	electron microscope immunohistochemistry forty eight hour perfusion three wistar rat injected colchicine num microg per rat lateral ventricle increase immunostaining ghrelin orexin expressing neuron
0.21321544.12639935.html.plaintext.txt	23	following anesthesia ip injection sodium pentobarbital rat perfused ascending aorta num min num ml num
0.21321544.12639935.html.plaintext.txt	24	num saline num min num ml fixative num paraformaldehyde num
0.21321544.12639935.html.plaintext.txt	25	brain removed immediately postfixed fixative num num h num c
0.21321544.12639935.html.plaintext.txt	26	brain cut num num microm thick section using oxford vibratome oxford instrument abingdon uk
0.21321544.12639935.html.plaintext.txt	27	section incubated num h rabbit anti ghrelin antiserum
0.21321544.12639935.html.plaintext.txt	28	gnum final dilution numnumnum ref
0.21321544.12639935.html.plaintext.txt	29	num num c visualized avidin biotin complex abc method vectastain elite abc kit vector laboratory inc
0.21321544.12639935.html.plaintext.txt	30	num numnum diaminobenzidine tetrahydrochloride dab sigma st louis mo num
0.21321544.12639935.html.plaintext.txt	31	num hydrogen peroxide num mm tris hcl ph num
0.21321544.12639935.html.plaintext.txt	32	section subjected either direct observation light microscope silver gold intensification sgi ref
0.21321544.12639935.html.plaintext.txt	33	section treated sgi incubated goat anti orexin antiserum santa cruz biotechnology inc
0.21321544.12639935.html.plaintext.txt	34	santa cruz ca dilution numnumnum num h num c visualized abc
0.21321544.12639935.html.plaintext.txt	35	orexin labeling performed using dab without sgi
0.21321544.12639935.html.plaintext.txt	36	examination electron microscopy section postfixed num osonum num
0.21321544.12639935.html.plaintext.txt	37	num num h num c dehydrated graded series ethanol concentration embedded epon araldite structure probe inc
0.21321544.12639935.html.plaintext.txt	38	ultrathin section cut examined h num electron microscope hitachi tokyo japan
0.21321544.12639935.html.plaintext.txt	39	control anti ghrelin antiserum either omitted replaced normal rabbit goat serum
0.21321544.12639935.html.plaintext.txt	40	immunofluorescence double staining following perfusion num paraformaldehyde brain three wistar rat removed immersed num h fixative num c
0.21321544.12639935.html.plaintext.txt	41	sample transferred num solution sucrose
0.21321544.12639935.html.plaintext.txt	42	brain quickly frozen tissue tek o
0.21321544.12639935.html.plaintext.txt	43	compound sakura finetechnical co
0.21321544.12639935.html.plaintext.txt	44	tokyo japan cut num microm thick coronal section cryostat microm hm num microm heidelberg germany
0.21321544.12639935.html.plaintext.txt	45	section incubated num d goat anti orexin antiserum dilution numnumnum num c alexa num conjugated donkey antigoat igg antibody molecular probe inc
0.21321544.12639935.html.plaintext.txt	46	eugene dilution numnum num h
0.21321544.12639935.html.plaintext.txt	47	washing phosphate buffer saline ph num
0.21321544.12639935.html.plaintext.txt	48	num sample incubated num d rabbit anti ghrelin antibody num c
0.21321544.12639935.html.plaintext.txt	49	slide incubated alexa num labeled goat antirabbit igg antibody molecular probe inc dilution numnum
0.21321544.12639935.html.plaintext.txt	50	sample observed olympus ax num fluorescence microscope olympus co
0.21321544.12639935.html.plaintext.txt	51	fo expression ghrelin peptide institute inc
0.21321544.12639935.html.plaintext.txt	52	osaka japan num pmolnum microl saline saline injected icv rat n num per group num min transcardial perfusion num paraformaldehyde fixative
0.21321544.12639935.html.plaintext.txt	53	also rat n num per group administered anti npy igg peptide institute inc
0.21321544.12639935.html.plaintext.txt	54	num micrognum microl saline control serum igg num
0.21321544.12639935.html.plaintext.txt	55	num micrognum microl saline icv num h icv ghrelin num pmolnum microl saline administration
0.21321544.12639935.html.plaintext.txt	56	num microg sufficient suppress ghrelin induced feeding num
0.21321544.12639935.html.plaintext.txt	57	following transcardial perfusion num min later tuberal hypothalamus cut num microm thick section
0.21321544.12639935.html.plaintext.txt	58	section incubated num d goat anti fo antiserum santa cruz biotechnology inc
0.21321544.12639935.html.plaintext.txt	59	dilution numnum stained abc
0.21321544.12639935.html.plaintext.txt	60	proportion hypothalamic section additionally stained either rabbit anti orexin antiserum num rabbit anti mch antiserum phoenix pharmaceutical inc
0.21321544.12639935.html.plaintext.txt	61	quantitated number neuron orexin mch fo colocalization light microscope counting two randomly selected visual field two section rat
0.21321544.12639935.html.plaintext.txt	62	food intake rabbit anti orexin anti orexin b antiserum produced described elsewhere num
0.21321544.12639935.html.plaintext.txt	63	purified anti orexin igg anti orexin b igg affi gel protein affinity bio rad laboratory inc
0.21321544.12639935.html.plaintext.txt	64	hercules ca either cnbr sepharose coupled bio rad laboratory inc
0.21321544.12639935.html.plaintext.txt	65	orexin orexin b affinity chromatography
0.21321544.12639935.html.plaintext.txt	66	determined quantity purified igg using dc protein assay kit bio rad laboratory inc
0.21321544.12639935.html.plaintext.txt	67	anti orexin igg cross react orexin b anti orexin b cross react orexin two igg given concurrently icv administration
0.21321544.12639935.html.plaintext.txt	68	rat n num num per group given icv administration anti orexin igg num
0.21321544.12639935.html.plaintext.txt	69	num microg anti orexin b igg num
0.21321544.12639935.html.plaintext.txt	70	num microg control serum igg num
0.21321544.12639935.html.plaintext.txt	71	measured dark phase food intake num h
0.21321544.12639935.html.plaintext.txt	72	ghrelin num pmol injected icv num h rat n num num per group num h icv administration anti orexin b igg num
0.21321544.12639935.html.plaintext.txt	73	num microg anti mch igg num
0.21321544.12639935.html.plaintext.txt	74	num microg control serum igg num
0.21321544.12639935.html.plaintext.txt	75	num microg num h food intake measured
0.21321544.12639935.html.plaintext.txt	76	ghrelin num pmol also administrated rat n num num per group icv concurrently either npy receptor antagonist numunum num microg ynum npy receptor antagonist num kind gift banyu pharmaceutical tokyo japan control serum igg num h icv administration either anti orexin b igg num
0.21321544.12639935.html.plaintext.txt	77	num microg control serum igg num
0.21321544.12639935.html.plaintext.txt	78	ghrelin num pmolnum microl saline also administered icv orexin knockout mouse n num wild type lettermates n num
0.21321544.12639935.html.plaintext.txt	79	following injection rat mouse returned cage food intake measured num h treatment
0.21321544.12639935.html.plaintext.txt	80	statistical analysis mean plus minus sem determined one way anova followed unpaired test
0.21321544.12639935.html.plaintext.txt	81	difference considered significant p num
0.21321544.12639935.html.plaintext.txt	82	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	83	innervation ghrelin immunoreactive axon orexin producing neuron
0.21321544.12639935.html.plaintext.txt	84	b electron micrographs whereas c d immunofluorescent micrographs
0.21321544.12639935.html.plaintext.txt	85	ghrelin immunoreactive axon terminal g make synapse arrow orexin immunoreactive perikaryon o
0.21321544.12639935.html.plaintext.txt	86	perikaryon contains many dense cored vesicle closed arrowhead immunopositive orexin
0.21321544.12639935.html.plaintext.txt	87	b ghrelin immunoreactive axon terminal g make symmetrical synapse arrow orexin immunoreactive dendrite od
0.21321544.12639935.html.plaintext.txt	88	ghrelin immunoreactive axon terminal contains immunopositive dense cored vesicle open arrowhead
0.21321544.12639935.html.plaintext.txt	89	c ghrelin producing neuron red fluorescence orexin producing neuron green fluorescence localized arcuate nucleus lh respectively
0.21321544.12639935.html.plaintext.txt	90	d higher magnification area outlined c
0.21321544.12639935.html.plaintext.txt	91	ghrelin immunoreactive fiber red found close proximity orexin producing neuron green
0.21321544.12639935.html.plaintext.txt	92	arrow indicate apposition ghrelin fiber orexin neuron
0.21321544.12639935.html.plaintext.txt	93	arc arcuate nucleus f fornix vmh ventromedial hypothalamus iii third ventricle
0.21321544.12639935.html.plaintext.txt	94	num microm c num microm d num microm
0.21321544.12639935.html.plaintext.txt	95	ghrelin expressing neuron predominantly found hypothalamic arcuate nucleus whereas orexin producing neuron restricted lh fig
0.21321544.12639935.html.plaintext.txt	96	dense population ghrelin containing fiber small number orexin containing fiber identified arcuate nucleus fig
0.21321544.12639935.html.plaintext.txt	97	ghrelin fiber also found lh fig
0.21321544.12639935.html.plaintext.txt	98	subpopulation ghrelin immunoreactive terminal directly contacted orexin containing neuron lh fig
0.21321544.12639935.html.plaintext.txt	99	fo expression following icv administration ghrelin fo immunoreactive neuron observed lh
0.21321544.12639935.html.plaintext.txt	100	ghrelin found induce fo expression num plus minus num orexin immunoreactive neuron double immunohistochemistry fig
0.21321544.12639935.html.plaintext.txt	101	ghrelin however induce fo expression mch immunoreactive neuron fig
0.21321544.12639935.html.plaintext.txt	102	despite pretreatment anti npy control serum igg ghrelin remained capable inducing fo expression orexin immunoreactive neuron fig
0.21321544.12639935.html.plaintext.txt	103	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	104	fo expression determined immunohistochemistry lh following icv administration ghrelin
0.21321544.12639935.html.plaintext.txt	105	costaining arrow fo dark blue black orexin brown neuron rat given ghrelin
0.21321544.12639935.html.plaintext.txt	106	b fo dark blue black expressed mch containing neuron arrow brown following ghrelin administration
0.21321544.12639935.html.plaintext.txt	107	c costaining arrow fo dark blue black orexin brown ghrelin treated rat following anti npy igg num
0.21321544.12639935.html.plaintext.txt	108	d costaining arrow fo dark blue black orexin brown ghrelin treated rat following control igg num
0.21321544.12639935.html.plaintext.txt	109	rat received num pmol ghrelin
0.21321544.12639935.html.plaintext.txt	110	effect orexins mch ghrelin induced feeding coadministered anti orexin igg anti orexin b igg block activity orexins
0.21321544.12639935.html.plaintext.txt	111	first examined effect anti orexin b igg anti mch igg suppression feeding
0.21321544.12639935.html.plaintext.txt	112	significantly reduced dark phase food intake comparison control igg treatment fig
0.21321544.12639935.html.plaintext.txt	113	next investigated effect endogenous orexin mch blockade ghrelin induced feeding
0.21321544.12639935.html.plaintext.txt	114	ghrelin increased num h food intake rat following icv administration control igg fig
0.21321544.12639935.html.plaintext.txt	115	pretreatment anti orexin b igg however reduced ghrelin induced food intake one half level seen rat given control igg ghrelin fig
0.21321544.12639935.html.plaintext.txt	116	pretreatment anti mch igg affect ghrelin induced feeding fig
0.21321544.12639935.html.plaintext.txt	117	ghrelin induced food intake orexin deficient mouse significantly reduced comparison wild type littermates fig
0.21321544.12639935.html.plaintext.txt	118	ynum npy receptor antagonist affect num h food intake
0.21321544.12639935.html.plaintext.txt	119	coadministration ghrelin ynum npy receptor antagonist also reduced ghrelin induced feeding num fig
0.21321544.12639935.html.plaintext.txt	120	combination ghrelin ynum npy receptor antagonist coadministration icv administration anti orexin b igg additively reduced ghrelin induced feeding num fig
0.21321544.12639935.html.plaintext.txt	121	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	122	effect icv administration anti orexin num
0.21321544.12639935.html.plaintext.txt	123	num microg igg anti mch igg num
0.21321544.12639935.html.plaintext.txt	124	num microg num h dark phase food intake num num h
0.21321544.12639935.html.plaintext.txt	125	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	126	effect administration anti orexin num
0.21321544.12639935.html.plaintext.txt	127	num microg igg anti mch igg num
0.21321544.12639935.html.plaintext.txt	128	num microg ghrelin induced feeding
0.21321544.12639935.html.plaintext.txt	129	two hour food intake measured ghrelin treated num pmol rat following either anti orexin b igg control igg
0.21321544.12639935.html.plaintext.txt	130	b two hour food intake ghrelin treated num pmol rat following anti mch igg control igg
0.21321544.12639935.html.plaintext.txt	131	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	132	effect icv ghrelin num pmol vehicle injection feeding orexin knockout mouse wild type littermates
0.21321544.12639935.html.plaintext.txt	133	view larger version numk figure num
0.21321544.12639935.html.plaintext.txt	134	suppressive effect ynum antagonist ynum npy receptor antagonist anti orexin num
0.21321544.12639935.html.plaintext.txt	135	num microg igg ghrelin induced feeding
0.21321544.12639935.html.plaintext.txt	136	control vehicle control igg
0.21321544.12639935.html.plaintext.txt	137	ghrelin ynum antagonist control igg
0.21321544.12639935.html.plaintext.txt	138	ghrelin receptor mrna also present lh rat num region implicated regulation feeding behavior energy homeostasis
0.21321544.12639935.html.plaintext.txt	139	animal lh lesion exhibit decreased food intake num num whereas electrical stimulation lh satiated state promotes feeding num num
0.21321544.12639935.html.plaintext.txt	140	orexin mch orexigenic neuropeptides synthesized specifically lh num num num num num num num
0.21321544.12639935.html.plaintext.txt	141	ghrelin fiber project lh synapse orexin immunoreactive neuron
0.21321544.12639935.html.plaintext.txt	142	icv administration ghrelin induced fo expression orexin expressing neuron mch expressing neuron result consistent recent finding icv administration ghrp num synthetic gh releasing hexapeptide bind ghrelin receptor num induced fo similar neuronal pattern num
0.21321544.12639935.html.plaintext.txt	143	finding indicate ghrelin may stimulate feeding orexin system npy agrp system
0.21321544.12639935.html.plaintext.txt	144	several peptidergic monoaminergic system participate regulation feeding energy homeostasis hypothalamus link neuronal circuit
0.21321544.12639935.html.plaintext.txt	145	npy fiber directly project orexin neuron num num icv injection anti orexin antiserum npy injection significantly attenuated npy induced feeding num indicating npy interacts orexin anatomically functionally
0.21321544.12639935.html.plaintext.txt	146	ghrelin induces feeding activation npy system sought investigate activation orexin producing neuron ghrelin via npy system
0.21321544.12639935.html.plaintext.txt	147	therefore examined ghrelin induced fo expression orexin producing neuron following pretreatment anti npy igg
0.21321544.12639935.html.plaintext.txt	148	ghrelin remained competent induce fo expression orexin producing neuron following pretreatment anti npy igg suggesting ghrelin activates orexin producing neuron manner independent npy
0.21321544.12639935.html.plaintext.txt	149	orexin regulates feeding energy homeostasis also sleep wakefulness neuroendocrine homeostasis autonomic function num num num num num
0.21321544.12639935.html.plaintext.txt	150	ghrelin induced fo expression approximately num orexin immunoreactive neuron
0.21321544.12639935.html.plaintext.txt	151	num orexin immunoreactive neuron glucosensitive num subset neuron express receptor leptin num satiation signal produced adipocytes part orexin expressing neuron may play crucial role regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	152	investigate functional relationship ghrelin either orexins mch examined effect anti orexin b igg anti mch igg pretreatment ghrelin induced feeding
0.21321544.12639935.html.plaintext.txt	153	food intake induced ghrelin attenuated anti orexin b igg anti mch igg pretreatment
0.21321544.12639935.html.plaintext.txt	154	addition ghrelin induced food intake mouse deficient orexin significantly lower seen wild type littermates
0.21321544.12639935.html.plaintext.txt	155	data suggest centrally administered ghrelin increase food intake action orexin system
0.21321544.12639935.html.plaintext.txt	156	date six functional npy receptor ynum ynum identified num num
0.21321544.12639935.html.plaintext.txt	157	npy stimulates feeding predominantly ynum npy receptor num num
0.21321544.12639935.html.plaintext.txt	158	icv injection ynum npy receptor antagonist significantly reduced ghrelin induced food intake
0.21321544.12639935.html.plaintext.txt	159	moreover coadministration ghrelin ynum npy receptor antagonist following anti orexin b igg pretreatment abolished ghrelin induced feeding
0.21321544.12639935.html.plaintext.txt	160	therefore ghrelin likely interacts npy orexin system induce feeding
0.21321544.12639935.html.plaintext.txt	161	feeding behavior involves complicated integration large number learning memory cognitive emotional somatosensorimotor autonomic event
0.21321544.12639935.html.plaintext.txt	162	icv administration ghrelin strongly induces fo hypothalamus brain stem hippocampus dentate gyrus piriform cortex num
0.21321544.12639935.html.plaintext.txt	163	centrally administered ghrelin may regulate feeding energy homeostasis direct activation orexin npy pathway also influence learning memory state mood formation emotion
0.21321544.12639935.html.plaintext.txt	164	investigation ghrelin interaction neuronal system provide novel insight regulation feeding energy homeostasis
0.21321544.12639935.html.plaintext.txt	165	footnote study supported part numst century coe program grant aid ministry education culture sport science technology japan ministry health labor welfare japan uehara memorial foundation ono medical research foundation mitsui life social welfare foundation yamanouchi foundation research metabolic disorder m
0.21321544.12639935.html.plaintext.txt	166	foundation growth science japan narishige research foundation y
0.21321544.12639935.html.plaintext.txt	167	abbreviation abc avidin biotin complex agrp agouti related protein dab numnum diaminobenzidine tetrahydrochloride ghs r gh secretagogue receptor icv intracerebroventricular lh lateral hypothalamus mch melanin concentrating hormone npy neuropeptide y sgi silver gold intensification
0.21321544.12639935.html.plaintext.txt	168	accepted publication december num num
0.2210986.14656716.html.plaintext.txt	0	orexin hypocretin num injected hypothalamic paraventricular nucleus spontaneous physical activity rat kohji kiwakinum catherine m
0.2210986.14656716.html.plaintext.txt	1	kotznumnumnum chuanfeng wangnum lorraine lanningham fosternum james
0.2210986.14656716.html.plaintext.txt	2	numendocrine research unit mayo clinic mayo foundation rochester num numveterans affair medical center numminnesota obesity center minneapolis num numdepartments food science nutrition university minnesota saint paul minnesota num
0.2210986.14656716.html.plaintext.txt	3	submitted num march num accepted final form num november num
0.2210986.14656716.html.plaintext.txt	4	energy expenditure hypothalamus obesity nonexercise activity thermogenesis
0.2210986.14656716.html.plaintext.txt	5	obesity affect one third american population second leading cause death united state smoking num
0.2210986.14656716.html.plaintext.txt	6	treatment obesity proven difficult intractability may due fact energy balance regulated multiple complex mechanism fully understood num
0.2210986.14656716.html.plaintext.txt	7	maintenance body weight achieved intricate balance energy intake expenditure
0.2210986.14656716.html.plaintext.txt	8	found change nonexercise activity thermogenesis neat mediate resistance weight gain overfeeding sedentary adult num
0.2210986.14656716.html.plaintext.txt	9	evidence spontaneous physical activity spa familial num show marked interindividual difference contribution daily energy expenditure num however mediator interaction overfeeding physical activity unknown
0.2210986.14656716.html.plaintext.txt	10	orexins b also known hypocretin num num recently identified neuropeptides synthesized exclusively lateral hypothalamus area classically believed crucial feeding center num
0.2210986.14656716.html.plaintext.txt	11	initial interest neuropeptides concentrated orexigenic action since central injection orexins increased food intake prepro orexin mrna shown upregulated fasting num
0.2210986.14656716.html.plaintext.txt	12	apart appetite regulation orexins implicated central nervous system cns regulation arousal sleep cardiovascular function temperature metabolic rate locomotor activity pituitary secretion glucose homeostasis gastric acid secretion num num num num num num
0.2210986.14656716.html.plaintext.txt	13	num reported following intracerebroventricular administration orexin hypothalamic c fo marker neuronal activation highly expressed hypothalamic paraventricular nucleus pvn orexin injected directly pvn stimulated food intake although effect powerful
0.2210986.14656716.html.plaintext.txt	14	author suggested pvn might primary site action orexins orexigenic role rather orexins might perform role via pvn
0.2210986.14656716.html.plaintext.txt	15	pvn demonstrated one site innervated orexin containing neuron num num express orexin receptor num num num
0.2210986.14656716.html.plaintext.txt	16	observation intrigued u wondered whether spontaneous physical activity spa random rather intricately regulated cns
0.2210986.14656716.html.plaintext.txt	17	furthermore would propose interaction overfeeding physical activity undergoes processing within hypothalamus due role energy homeostasis
0.2210986.14656716.html.plaintext.txt	18	study address hypothesis orexin act pvn increase spa independently feeding behavior
0.2210986.14656716.html.plaintext.txt	19	approach inject orexin pvn measure spa thermogenesis feeding behavior use array infrared activity sensor indirect calorimetry infrared num h videotaping
0.2210986.14656716.html.plaintext.txt	20	additionally observed effect orexin receptor antagonist selective orexin num receptor oxnumr sb num injected pvn
0.2210986.14656716.html.plaintext.txt	21	male sprague dawley rat charles river wilmington ma num num g time surgery housed individually cage numnum h light dark photocycle light numnum room num plus minus num degree c
0.2210986.14656716.html.plaintext.txt	22	food laboratory rodent diet num pmi nutrition international st
0.2210986.14656716.html.plaintext.txt	23	louis mo water allowed ad libitum
0.2210986.14656716.html.plaintext.txt	24	protocol approved mayo foundation institutional animal care use committee
0.2210986.14656716.html.plaintext.txt	25	cannulation verification placement
0.2210986.14656716.html.plaintext.txt	26	rat anesthetized ketamine xylazine mixture numnum mgkg body wt ip fitted num gauge stainless steel cannula placed right pvn
0.2210986.14656716.html.plaintext.txt	27	stereotaxic coordinate determined rat brain atlas paxinos watson num follows num
0.2210986.14656716.html.plaintext.txt	28	injector extended num mm beyond end guide cannula
0.2210986.14656716.html.plaintext.txt	29	cannulation incisor bar set num
0.2210986.14656716.html.plaintext.txt	30	least num day elapsed following surgery experimental trial
0.2210986.14656716.html.plaintext.txt	31	experiment brain dissected stored num formaldehyde solution placement verification histology
0.2210986.14656716.html.plaintext.txt	32	verification performed blinded fashion whereby physical activity data unknown histologist
0.2210986.14656716.html.plaintext.txt	33	cannula deemed incorrect actual injection site farther num
0.2210986.14656716.html.plaintext.txt	34	num mm away targeted site
0.2210986.14656716.html.plaintext.txt	35	rationale based diffusion coefficient injection volume delivered num previous data num num
0.2210986.14656716.html.plaintext.txt	36	rat misplaced cannula excluded data analysis study num num
0.2210986.14656716.html.plaintext.txt	37	number rat listed experimental design represents number rat final analysis cannula correctly placed
0.2210986.14656716.html.plaintext.txt	38	orexin phoenix pharmaceutical mountain view ca dissolved artificial cerebrospinal fluid acsf
0.2210986.14656716.html.plaintext.txt	39	dose orexin num nmol used study based previous study observed feeding pvn injection orexin num num num
0.2210986.14656716.html.plaintext.txt	40	sb num num num methylbenzoxazol num yl num numnumnaphthyridin num yl urea hydrochloride synthesized glaxosmithkline num num dissolved num dmso acsf
0.2210986.14656716.html.plaintext.txt	41	sb num num fold higher affinity oxnumr orexin num receptor oxnumr num
0.2210986.14656716.html.plaintext.txt	42	injection cannula num gauge purchased plastic one roanoke va
0.2210986.14656716.html.plaintext.txt	43	fabricated inserted maximum depth protrude num
0.2210986.14656716.html.plaintext.txt	44	num mm beyond tip guide cannula
0.2210986.14656716.html.plaintext.txt	45	num microl either orexin dissolved acsf acsf alone study num num either orexin dissolved num dmso acsf sb num num dmso acsf num dmso acsf alone study num injected slowly num injector left place additional num ensure extrusion tip minimize distribution drug upward cannula tract
0.2210986.14656716.html.plaintext.txt	46	injection cannula withdrawn stylet replaced
0.2210986.14656716.html.plaintext.txt	47	injection unilateral right pvn
0.2210986.14656716.html.plaintext.txt	48	total number injection animal one three study num seven eight study num num
0.2210986.14656716.html.plaintext.txt	49	previous study demonstrated lack demonstrable tissue damage num repeated injection measured gliosis around injection site num
0.2210986.14656716.html.plaintext.txt	50	injection site examined light microscopy tissue damage present study none found
0.2210986.14656716.html.plaintext.txt	51	compared spa first second third injection pvn num nmol orexin vehicle study num significant difference data shown
0.2210986.14656716.html.plaintext.txt	52	measurement onum consumption conum production spa duration feeding behavior
0.2210986.14656716.html.plaintext.txt	53	onum consumption conum production measured using customized high precision single chamber indirect calorimeter columbus instrument columbus oh reported previously num num
0.2210986.14656716.html.plaintext.txt	54	thermogenesis calculated onum consumption conum production
0.2210986.14656716.html.plaintext.txt	55	calibration calorimeter performed measurement
0.2210986.14656716.html.plaintext.txt	56	animal placed inside cylindrical calorimeter chamber acrylic diameter num cm height num cm volume num liter along food water bowl study num without food water study num num
0.2210986.14656716.html.plaintext.txt	57	chamber lid attached sealed room air pumped atmospheric pressure chamber num
0.2210986.14656716.html.plaintext.txt	58	data onum consumption conum production collected every minute num h stored personal computer
0.2210986.14656716.html.plaintext.txt	59	data point identified time stamp
0.2210986.14656716.html.plaintext.txt	60	spa measured simultaneously onum consumption conum production measurement
0.2210986.14656716.html.plaintext.txt	61	measurement performed using customized high precision rack collimated infrared activity sensor columbus instrument placed around acrylic chamber
0.2210986.14656716.html.plaintext.txt	62	num collimated beam infrared light crossing num cm diameter cage allowing detection num cm movement three orthogonal ax
0.2210986.14656716.html.plaintext.txt	63	photosensors registered activity unit time beam interrupted
0.2210986.14656716.html.plaintext.txt	64	fashion activity detected simultaneously three ax forward backward side side
0.2210986.14656716.html.plaintext.txt	65	data spa summed every minute stored pc use time stamp identification
0.2210986.14656716.html.plaintext.txt	66	data thereby derived simultaneously onum consumption spa animal minute minute num h measurement period
0.2210986.14656716.html.plaintext.txt	67	duration spa defined duration activity sensor read greater zero
0.2210986.14656716.html.plaintext.txt	68	num mm charge coupled device video camera infrared digital time recording capability used measuring feeding behavior
0.2210986.14656716.html.plaintext.txt	69	experiment videotaped overhead duration feeding behavior measured investigator blinded whether animal received orexin acsf
0.2210986.14656716.html.plaintext.txt	70	test day rat first acclimated experimental num liter cylindrical cage num h
0.2210986.14656716.html.plaintext.txt	71	food water pot placed floor cylindrical cage access ad libitum acclimation period
0.2210986.14656716.html.plaintext.txt	72	pot prevented tipping using purposely built acrylic plate designed
0.2210986.14656716.html.plaintext.txt	73	unmanned animal room sound plus light proof locked throughout experiment
0.2210986.14656716.html.plaintext.txt	74	study num effect orexin injected different time point spa onum consumption feeding behavior
0.2210986.14656716.html.plaintext.txt	75	three separate experiment rat injected num nmol orexin n num volume num
0.2210986.14656716.html.plaintext.txt	76	num microl acsf n num different time day experiment num injection numnum numnum pm n num orexin numnum acsf experiment num injection numnum pm n num orexin acsf experiment num injection numnum pm numnum pm n num orexin acsf
0.2210986.14656716.html.plaintext.txt	77	onum consumption measured experiment num
0.2210986.14656716.html.plaintext.txt	78	food water pot placed floor cage access ad libitum observation
0.2210986.14656716.html.plaintext.txt	79	twenty four hour food consumption measured weighing food numnum experiment num numnum pm experiment num numnum noon experiment num
0.2210986.14656716.html.plaintext.txt	80	study num relationship dose orexin effect spa thermogenesis
0.2210986.14656716.html.plaintext.txt	81	rat n num injected interval num h different dos orexin num
0.2210986.14656716.html.plaintext.txt	82	num num num nmol vehicle light cycle
0.2210986.14656716.html.plaintext.txt	83	order injection different dos orexin vehicle randomized
0.2210986.14656716.html.plaintext.txt	84	injection spa thermogenesis measured num h
0.2210986.14656716.html.plaintext.txt	85	food water provided num h num h observation
0.2210986.14656716.html.plaintext.txt	86	study num effect sb num spa thermogenesis
0.2210986.14656716.html.plaintext.txt	87	two injection spaced num min apart num vehicle plus vehicle num num microg sb num plus vehicle num vehicle plus num nmol orexin num num microg sb num plus num nmol orexin given rat n num interval num h light cycle
0.2210986.14656716.html.plaintext.txt	88	order injection num num randomized
0.2210986.14656716.html.plaintext.txt	89	injection spa thermogenesis measured num h
0.2210986.14656716.html.plaintext.txt	90	food water provided num h num h observation
0.2210986.14656716.html.plaintext.txt	91	result expressed mean plus minus se fig
0.2210986.14656716.html.plaintext.txt	92	spa onum consumption thermogenesis feeding behavior analyzed using mann whitney u test
0.2210986.14656716.html.plaintext.txt	93	comparison spa induced orexin different time point made kruskal wallis rank test
0.2210986.14656716.html.plaintext.txt	94	correlation orexin induced spa feeding behavior analyzed spearmans rank correlation test
0.2210986.14656716.html.plaintext.txt	95	correlation spa thermogenesis dose response experiment analyzed pearsons correlation test
0.2210986.14656716.html.plaintext.txt	96	num considered statistically significant
0.2210986.14656716.html.plaintext.txt	97	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	98	twenty four hour time course effect orexin spontaneous physical activity spa onum consumption b
0.2210986.14656716.html.plaintext.txt	99	rat received paraventricular nucleus pvn injection artificial cerebrospinal fluid acsf num nmol orexin numnum numnum pm
0.2210986.14656716.html.plaintext.txt	100	spa shown mean total beam break plus minus se num h group left difference mean spa orexin group acsf group right
0.2210986.14656716.html.plaintext.txt	101	onum consumption shown mean mlkg body wt plus minus se num h group b left difference mean onum consumption orexin group acsf group b right
0.2210986.14656716.html.plaintext.txt	102	significant difference respective acsf control group orexin group acsf group orexin group acsf group
0.2210986.14656716.html.plaintext.txt	103	open horizontal bar light period filled horizontal bar light period
0.2210986.14656716.html.plaintext.txt	104	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	105	effect orexin injection different time point spa b feeding behavior c
0.2210986.14656716.html.plaintext.txt	106	rat received pvn injection acsf num nmol orexin different time numnum numnum pm experiment num numnum pm experiment num numnum noon numnum pm experiment num
0.2210986.14656716.html.plaintext.txt	107	data mean plus minus se shown total beam break num h injection duration spa num h injection b total duration feeding behavior num h injection c
0.2210986.14656716.html.plaintext.txt	108	significant difference respective acsf control group
0.2210986.14656716.html.plaintext.txt	109	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	110	effect orexin spa duration feeding behavior
0.2210986.14656716.html.plaintext.txt	111	spa duration feeding num h pvn injection orexin animal across num experiment plotted
0.2210986.14656716.html.plaintext.txt	112	spa represented beam break count duration min b
0.2210986.14656716.html.plaintext.txt	113	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	114	relationship dose orexin effect spa thermogenesis b
0.2210986.14656716.html.plaintext.txt	115	rat received pvn injection acsf different dose orexin light cycle
0.2210986.14656716.html.plaintext.txt	116	data mean plus minus se shown total beam break num h injection thermogenesis num h injection b
0.2210986.14656716.html.plaintext.txt	117	significant difference respective acsf vehicle control group
0.2210986.14656716.html.plaintext.txt	118	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	119	effect orexin receptor antagonist sb num spa thermogenesis b
0.2210986.14656716.html.plaintext.txt	120	rat received pvn injection vehicle vehicle num microg sb num vehicle vehicle num nmol orexin num microg sb num num nmol orexin light cycle
0.2210986.14656716.html.plaintext.txt	121	data mean plus minus se shown total beam break num h injection thermogenesis num h injection b
0.2210986.14656716.html.plaintext.txt	122	significant difference num group
0.2210986.14656716.html.plaintext.txt	123	view larger version numk fig
0.2210986.14656716.html.plaintext.txt	124	photomicrograph histological verification correct placement injection hypothalamic pvn diagram coronal section depicting actual injection site b
0.2210986.14656716.html.plaintext.txt	125	vnum numrd ventricle opt optic tract
0.2210986.14656716.html.plaintext.txt	126	site deemed correctly located site deemed incorrectly located b
0.2210986.14656716.html.plaintext.txt	127	section b number top left show anteroposterior distance bregma
0.2210986.14656716.html.plaintext.txt	128	adult male sprague dawley rat microinjected right lateral pvn num nmol orexin vehicle acsf different time day experiment num injection numnum numnum pm experiment num numnum pm experiment num numnum noon numnum pm light numnum light numnum pm
0.2210986.14656716.html.plaintext.txt	129	figure num represents mean num h time course spa fig
0.2210986.14656716.html.plaintext.txt	130	numa oxygen consumption fig
0.2210986.14656716.html.plaintext.txt	131	orexin associated increase spa num num h injection followed decrease spa num num h afterward
0.2210986.14656716.html.plaintext.txt	132	pattern spa observed orexin injection experiment num num data shown
0.2210986.14656716.html.plaintext.txt	133	transition onum consumption response orexin similar spa orexin associated increase onum consumption num num h injection
0.2210986.14656716.html.plaintext.txt	134	regardless time point injection orexin associated dramatic increase spa num h injection fig
0.2210986.14656716.html.plaintext.txt	135	experiment combined mean plus minus sd spa num h injection follows orexin num
0.2210986.14656716.html.plaintext.txt	136	num x num beam break count vehicle num
0.2210986.14656716.html.plaintext.txt	137	injection num orexin treated animal num acsf treated animal
0.2210986.14656716.html.plaintext.txt	138	interestingly difference total spa num h orexin vehicle three experiment orexin num
0.2210986.14656716.html.plaintext.txt	139	num x num beam break count n num vehicle num
0.2210986.14656716.html.plaintext.txt	140	num x num beam break count n num
0.2210986.14656716.html.plaintext.txt	141	type orexin induced physical activity primarily intense grooming face washing behavior secondarily rearing searching behavior
0.2210986.14656716.html.plaintext.txt	142	behavior appeared immediately num min injection
0.2210986.14656716.html.plaintext.txt	143	review videotaped recording apparent intensity orexin induced behavior greater similar type spontaneous activity grooming rearing observed absence experimental manipulation
0.2210986.14656716.html.plaintext.txt	144	effect orexin feeding behavior
0.2210986.14656716.html.plaintext.txt	145	known orexin associated increased feeding behavior
0.2210986.14656716.html.plaintext.txt	146	duration feeding behavior num h injection measured blinded fashion using videotaped recording
0.2210986.14656716.html.plaintext.txt	147	five time point throughout day one time point numnum duration feeding behavior longer orexin injected animal acsf fig
0.2210986.14656716.html.plaintext.txt	148	effect orexin feeding behavior accounted num
0.2210986.14656716.html.plaintext.txt	149	num n num increase spa time point
0.2210986.14656716.html.plaintext.txt	150	figure num represents relationship spa duration feeding behavior num h injection experiment
0.2210986.14656716.html.plaintext.txt	151	correlation spa duration feeding behavior induced orexin
0.2210986.14656716.html.plaintext.txt	152	three experiment difference num h food consumption acsf orexin orexin num
0.2210986.14656716.html.plaintext.txt	153	relationship dose orexin effect spa thermogenesis
0.2210986.14656716.html.plaintext.txt	154	establish dose response relationship different dos orexin num
0.2210986.14656716.html.plaintext.txt	155	num num nmol injected pvn
0.2210986.14656716.html.plaintext.txt	156	num h injection spa thermogenesis measured without food water
0.2210986.14656716.html.plaintext.txt	157	numb well correlated dose orexin examined range
0.2210986.14656716.html.plaintext.txt	158	num nmol associated significant increase spa lower dose num
0.2210986.14656716.html.plaintext.txt	159	num nmol associated significant increase thermogenesis
0.2210986.14656716.html.plaintext.txt	160	strong correlation spa difference spa orexin vehicle thermogenesis difference thermogenesis orexin vehicle r num
0.2210986.14656716.html.plaintext.txt	161	effect sb num spa thermogenesis
0.2210986.14656716.html.plaintext.txt	162	establish specificity effect orexin pvn orexin receptor antagonist sb num injected pvn
0.2210986.14656716.html.plaintext.txt	163	sb num num microg associated decrease spa partially attenuated effect orexin spa fig
0.2210986.14656716.html.plaintext.txt	164	verification injection site
0.2210986.14656716.html.plaintext.txt	165	figure numa illustrates example histological verification correct location injection pvn
0.2210986.14656716.html.plaintext.txt	166	figure numb illustrates map actual injection site demonstrates injection deemed correctly incorrectly located
0.2210986.14656716.html.plaintext.txt	167	animal underwent histological confirmation cannula placement
0.2210986.14656716.html.plaintext.txt	168	investigator blinded orexin response
0.2210986.14656716.html.plaintext.txt	169	nine incorrectly cannulated rat mean plus minus sd spa num h injection follows num nmol orexin num
0.2210986.14656716.html.plaintext.txt	170	num x num beam break count vehicle num
0.2210986.14656716.html.plaintext.txt	171	injection num orexin num vehicle
0.2210986.14656716.html.plaintext.txt	172	significant difference spa orexin vehicle animal
0.2210986.14656716.html.plaintext.txt	173	establish specificity effect orexin pvn observed effect orexin receptor antagonist sb num injected pvn
0.2210986.14656716.html.plaintext.txt	174	decrease spa followed antagonist injection partially blocked effect orexin spa thermogenesis
0.2210986.14656716.html.plaintext.txt	175	sb num num fold higher affinity oxnumr oxnumr num
0.2210986.14656716.html.plaintext.txt	176	rat brain differential expression oxnumr oxnumr reported oxnumr predominantly expressed pvn num num
0.2210986.14656716.html.plaintext.txt	177	oxnumr considered selective receptor orexin oxnumr considered nonselective receptor orexin orexin b
0.2210986.14656716.html.plaintext.txt	178	despite lower affinity oxnumr high concentration sb num site pvn might attenuate effect orexin via block oxnumr however also reported intraperitoneal injection compound attenuated orexin evoked grooming num selective oxnumr antagonist needed verify role receptor subtype effect orexin pvn
0.2210986.14656716.html.plaintext.txt	179	data consistent observation regarding neurohumoral role orexin
0.2210986.14656716.html.plaintext.txt	180	central orexin system may critical regulator sleepwake state based neuroanatomic genetic data num num num num num num
0.2210986.14656716.html.plaintext.txt	181	specifically orexin may activate arousal center num
0.2210986.14656716.html.plaintext.txt	182	observation pvn injected orexin induces spa compatible fact orexin act maintain waking state num
0.2210986.14656716.html.plaintext.txt	183	behavior observed response orexin injection consistent wakefulness namely intense grooming face washing behavior rearing searching activity
0.2210986.14656716.html.plaintext.txt	184	several report also describe immediate increase grooming face washing activity locomotor activity intracerebroventricular injection orexin num num num num num
0.2210986.14656716.html.plaintext.txt	185	additionally report showing relationship endogenous orexin locomotor activity
0.2210986.14656716.html.plaintext.txt	186	num showed orexin release cerebrospinal fluid higher active waking quiet waking cat
0.2210986.14656716.html.plaintext.txt	187	num reported fo expression orexin neuron correlated locomotor activity rat
0.2210986.14656716.html.plaintext.txt	188	num showed genetic ablation orexin neuron mouse resulted decrease spontaneous motor activity transgenic mouse became obese despite hypophagia
0.2210986.14656716.html.plaintext.txt	189	report also strongly suggest orexin play role regulation spa
0.2210986.14656716.html.plaintext.txt	190	corticotropin releasing factor crf suggested involved orexin induced behavior num known grooming behavior closely associated environmental stress num intracerebroventricular administration orexin increase plasma corticosterone num num adreno corticotropin level num num
0.2210986.14656716.html.plaintext.txt	191	intracerebroventricular administration crf increased grooming behavior num intracerebroventricular administration helical crf crf antagonist blocked orexin induced behavior specifically grooming face washing num
0.2210986.14656716.html.plaintext.txt	192	term brain concentration crf synthesized mainly pvn num peptide also thought integral energy balance
0.2210986.14656716.html.plaintext.txt	193	pvn one site densely innervated orexin containing neuron express oxnumr num num num
0.2210986.14656716.html.plaintext.txt	194	thus result consistent thesis orexin stimulates specific behavior via crf
0.2210986.14656716.html.plaintext.txt	195	dopaminergic system also suggested mediate orexin induced activity grooming behavior
0.2210986.14656716.html.plaintext.txt	196	involvement ventral tegmental area dopaminergic system intraventricularly administered orexin induced hyperactivity rat demonstrated num
0.2210986.14656716.html.plaintext.txt	197	study needed determine downstream pathway orexin induced hyperactivity
0.2210986.14656716.html.plaintext.txt	198	known orexin injected pvn induces feeding
0.2210986.14656716.html.plaintext.txt	199	however data demonstrate pvn injected orexin induced feeding behavior injected early light cycle feeding behavior minimal control animal
0.2210986.14656716.html.plaintext.txt	200	relation magnitude orexin induced spa duration feeding behavior
0.2210986.14656716.html.plaintext.txt	201	word pvn injected orexin increase spa without induction feeding behavior
0.2210986.14656716.html.plaintext.txt	202	elevation activity without concomitant feeding behavior consistent previous study examining effect orexin injected lateral hypothalamus another brain site integral energy homeostasis num
0.2210986.14656716.html.plaintext.txt	203	early light cycle feeding induced pvn injected orexin study agreement data others indicating orexin injected ventricle lateral hypothalamus stimulates feeding light cycle num num
0.2210986.14656716.html.plaintext.txt	204	reason stimulation feeding orexin injection occurs light cycle remains unclear
0.2210986.14656716.html.plaintext.txt	205	demonstrated orexin injected lateral hypothalamus twofold greater feeding response orexin food restricted rat high level rate feeding num
0.2210986.14656716.html.plaintext.txt	206	thus level andor rate feeding unlikely related lack feeding orexin dark cycle
0.2210986.14656716.html.plaintext.txt	207	num reported orexin induced icv administration feeding largely circadian dependent orexin induced increase grooming moderately circadian dependent
0.2210986.14656716.html.plaintext.txt	208	author suggested possibility increase feeding appeared largely reflect wake increase action
0.2210986.14656716.html.plaintext.txt	209	report regarding orexin injection pvn shown variable result num num num
0.2210986.14656716.html.plaintext.txt	210	num reported pvn injected orexin num
0.2210986.14656716.html.plaintext.txt	211	num nmol stimulated food intake although effect powerful
0.2210986.14656716.html.plaintext.txt	212	num showed num nmol orexin injected pvn stimulated food intake reported behavioral effect feeding drinking
0.2210986.14656716.html.plaintext.txt	213	difference dose orexin num
0.2210986.14656716.html.plaintext.txt	214	num num nmol injected light cycle report generally moderate effect orexin feeding may explain discrepant result feeding response three report
0.2210986.14656716.html.plaintext.txt	215	present study injected num nmol orexin observed increased feeding injected early light cycle also observed remarkably increased physical activity
0.2210986.14656716.html.plaintext.txt	216	observation contrast somewhat dube et al
0.2210986.14656716.html.plaintext.txt	217	however examine spa
0.2210986.14656716.html.plaintext.txt	218	recorded animal behavior using videotaped recording quantified activity using array infrared activity sensor
0.2210986.14656716.html.plaintext.txt	219	result suggest orexin pvn act predominantly increase nonfeeding physical activity
0.2210986.14656716.html.plaintext.txt	220	level spa human cluster family num mouse within strain num
0.2210986.14656716.html.plaintext.txt	221	observation suggest identifiable genetic component may exist account variance neat
0.2210986.14656716.html.plaintext.txt	222	additionally observed neat increase positive energy balance num
0.2210986.14656716.html.plaintext.txt	223	recently decreased plasma orexin level obese individual demonstrated num
0.2210986.14656716.html.plaintext.txt	224	orexin pas blood brain barrier num peripheral orexin level might reflect cns level
0.2210986.14656716.html.plaintext.txt	225	mouse hypothalamus age related decline oxnumr messenger rna level shown num known old rat decreased activity num
0.2210986.14656716.html.plaintext.txt	226	decline orexin obesity aging may support hypothesis orexin pvn mediator neat
0.2210986.14656716.html.plaintext.txt	227	lubkin stricker krongrad num reported intracerebroventricular injection orexin resulted increase metabolic rate dependent increase activity mouse
0.2210986.14656716.html.plaintext.txt	228	measured onum consumption conum production indirect calorimetry
0.2210986.14656716.html.plaintext.txt	229	increased onum consumption accompanied increased activity thermogenic response orexin clearly track orexin effect spa
0.2210986.14656716.html.plaintext.txt	230	thus consider increase onum consumption thermogenesis result increase spa associated orexin
0.2210986.14656716.html.plaintext.txt	231	reason contrast may due difference injection site study site specific injection reach much limited receptor population ventricular injection
0.2210986.14656716.html.plaintext.txt	232	ventricular injection unknown injectate ultimately predominantly reach thus effect observed could result stimulation receptor multiple location
0.2210986.14656716.html.plaintext.txt	233	unlike neuropeptide y potent orexigenic hypothermic signal clearly defined pattern energy balance state orexin activity energy balance state appears complicated
0.2210986.14656716.html.plaintext.txt	234	study show difference orexin activity fasting num num num whereas others show elevated orexin expression activity fasting num num num
0.2210986.14656716.html.plaintext.txt	235	orexin activity state positive energy balance thoroughly tested
0.2210986.14656716.html.plaintext.txt	236	one study showed high fat feeding increased gene expression orexin num consistent hypothesis increased orexin activity positive energy balance
0.2210986.14656716.html.plaintext.txt	237	however study obese animal model show either decrease orexin expression activity num num num change num num
0.2210986.14656716.html.plaintext.txt	238	conflicting data likely represent complicated role orexin energy balance although orexin administration stimulates feeding also elevates activity perhaps predominantly enhances thermogenesis
0.2210986.14656716.html.plaintext.txt	239	therefore one simply place orexin class obesity promoting neuropeptides basis feeding stimulatory property
0.2210986.14656716.html.plaintext.txt	240	clearly illustrated data hara et al
0.2210986.14656716.html.plaintext.txt	241	num demonstrated loss orexin activity resulted obese animal model
0.2210986.14656716.html.plaintext.txt	242	although animal ate le also much le active
0.2210986.14656716.html.plaintext.txt	243	obese state animal study indicates decreased energy expenditure brought loss orexin function clearly potent hypophagia affecting energy balance
0.2210986.14656716.html.plaintext.txt	244	thus although present data others num num indicate positive energy balance may stimulate orexin study examining endogenous orexin activity lean obese animal model overfeeding paradigm help determine role orexin play modulating neat
0.2210986.14656716.html.plaintext.txt	245	summary injection orexin pvn dramatically increase spa
0.2210986.14656716.html.plaintext.txt	246	increase spa num h occurs regardless time injection
0.2210986.14656716.html.plaintext.txt	247	effect orexin spa appears predominantly increase general activity
0.2210986.14656716.html.plaintext.txt	248	however concur others orexin via pvn also stimulates feeding behavior
0.2210986.14656716.html.plaintext.txt	249	orexin therefore appears neurohumoral mediator spa neat feeding
0.2210986.14656716.html.plaintext.txt	250	role physiology energy balance requires investigation
0.2210986.14656716.html.plaintext.txt	251	acknowledgment thank mary mullet expert technical assistance stereotaxic surgery shelly k
0.2210986.14656716.html.plaintext.txt	252	mccrady lana nysse technical help
0.2210986.14656716.html.plaintext.txt	253	footnote address reprint request correspondence j
0.2210986.14656716.html.plaintext.txt	254	levine endocrine research unit joseph num num mayo clinic rochester num first st
0.2210986.14656716.html.plaintext.txt	255	sw rochester mn num e mail levine
0.2210986.14656716.html.plaintext.txt	256	cost publication article defrayed part payment page charge
0.2210986.14656716.html.plaintext.txt	257	article must therefore hereby marked advertisement accordance num u
0.2210986.14656716.html.plaintext.txt	258	section num solely indicate fact
0.22697699.15746258.html.plaintext.txt	0	dual regulatory effect orexins sympathetic nerve activity innervating brown adipose tissue rat tohru yasuda takayuki masaki tetsuya kakuma masahide hara tomoko nawata isao katsuragi hironobu yoshimatsu
0.22697699.15746258.html.plaintext.txt	1	department internal medicine faculty medicine oita university hasama oita num num japan
0.22697699.15746258.html.plaintext.txt	2	address correspondence request reprint professor hironobu yoshimatsu m
0.22697699.15746258.html.plaintext.txt	3	department internal medicine faculty medicine oita university num num idaigaoka hasama oita num num japan
0.22697699.15746258.html.plaintext.txt	4	brown adipose tissue bat play major role energy expenditure thermogenesis via function uncoupling protein num
0.22697699.15746258.html.plaintext.txt	5	regulation energy expenditure bat control sympathetic nervous system higher brain structure
0.22697699.15746258.html.plaintext.txt	6	discrete hypothalamic nucleus various orexigenic anorexigenic neuropeptides regulate bat metabolism affecting efferent sympathetic nerve activity num num num num
0.22697699.15746258.html.plaintext.txt	7	hypothalamic neuronal histamine anorexigenic substance increase bat sympathetic nerve activity num
0.22697699.15746258.html.plaintext.txt	8	orexins affect energy balance thermoregulation
0.22697699.15746258.html.plaintext.txt	9	orexin shown induce hypothermia food intake orexins increase renal sympathetic nerve activity num num num num
0.22697699.15746258.html.plaintext.txt	10	therefore highly probable orexins regulate bat energy expenditure thermogenesis influencing sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	11	thus hypothesized hypothalamic neuronal histamine may mediate orexin signal sympathetic nerve innervate bat close relationship two system recognized anatomically functionally num num
0.22697699.15746258.html.plaintext.txt	12	study therefore examined effect central administration orexins electrophysiological sympathetic nerve activity bat modulation response neuronal histamine
0.22697699.15746258.html.plaintext.txt	13	reagent orexin orexin b fluoromethylhistidine fmh purchased sigma chemical co
0.22697699.15746258.html.plaintext.txt	14	louis mo dissolved pb final concentration num microm num microm num mm respectively
0.22697699.15746258.html.plaintext.txt	15	solution freshly prepared day use
0.22697699.15746258.html.plaintext.txt	16	ph solution adjusted num
0.22697699.15746258.html.plaintext.txt	17	cerebroventricular cannula implantation rat fixed stereotaxic apparatus narishige tokyo japan sodium pentobarbital anesthesia num mgkg ip stainless steel guide cannula num gauge surgically implanted third cerebral ventricle inumvt
0.22697699.15746258.html.plaintext.txt	18	stainless steel wire stylet num gauge left place guide cannula maintain patency prevent leakage cerebrospinal fluid
0.22697699.15746258.html.plaintext.txt	19	surgery carried least num wk infusion test solution detail surgical procedure described elsewhere num
0.22697699.15746258.html.plaintext.txt	20	measurement sympathetic nerve activity electrophysiological recording made anesthesia urethane num
0.22697699.15746258.html.plaintext.txt	21	num gkg chloralose num mgkg using num cannulated rat
0.22697699.15746258.html.plaintext.txt	22	dissection fine branch sympathetic nerve innervate interscapular bat nerve transected entered bat
0.22697699.15746258.html.plaintext.txt	23	nerve activity measured using pair silver wire electrode immersed mixture liquid paraffin white petroleum jelly prevent dehydration nerve tissue
0.22697699.15746258.html.plaintext.txt	24	action potential amplified filtered low high frequency cutoff
0.22697699.15746258.html.plaintext.txt	25	nerve signal distinguished background noise using window discriminator
0.22697699.15746258.html.plaintext.txt	26	nerve activity analyzed based value obtained conversion raw data standard pulse using analog digital converter
0.22697699.15746258.html.plaintext.txt	27	impulse integrated rate meter reset time num sec recorded using chart recorder
0.22697699.15746258.html.plaintext.txt	28	detail nerve recording technique described elsewhere num num
0.22697699.15746258.html.plaintext.txt	29	determination background firing rate sympathetic nerve change nerve activity measured num min bolus inumvt infusion orexin num num nmolrat num
0.22697699.15746258.html.plaintext.txt	30	num microlmin num min orexin b num num nmolrat num
0.22697699.15746258.html.plaintext.txt	31	num microlmin num min fmh num num micromolkg num
0.22697699.15746258.html.plaintext.txt	32	num microlmin num min pb n num treatment
0.22697699.15746258.html.plaintext.txt	33	dos orexins fmh determined previous study num num preliminary study
0.22697699.15746258.html.plaintext.txt	34	infusion orexins performed num h pretreatment fmh num h
0.22697699.15746258.html.plaintext.txt	35	nerve activity measured num min interval beginning num min continuing num min administration test solution
0.22697699.15746258.html.plaintext.txt	36	nerve activity value recorded administration test solution expressed percentage difference baseline value num min
0.22697699.15746258.html.plaintext.txt	37	baseline num figure signifies num min average score bat sympathetic nerve activity orexin treatment
0.22697699.15746258.html.plaintext.txt	38	analysis dose dependence orexins intracerebroventricular icv pb icv infusion performed sympathetic nerve activity bat recorded num num min infusion
0.22697699.15746258.html.plaintext.txt	39	statistical analysis difference among group assessed using two way anova post hoc fisher protected least significant difference test
0.22697699.15746258.html.plaintext.txt	40	two sided p value le num
0.22697699.15746258.html.plaintext.txt	41	num considered statistically significant
0.22697699.15746258.html.plaintext.txt	42	statistical analysis dose dependence assessed spearman correlation coefficient rank
0.22697699.15746258.html.plaintext.txt	43	dose dependent effect orexin orexin b bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	44	effect inumvt infusion orexin bat sympathetic nerve activity figure numa show typical response bat sympathetic nerve activity infusion orexin inumvt
0.22697699.15746258.html.plaintext.txt	45	sympathetic nerve activity rapidly decreased central administration orexin
0.22697699.15746258.html.plaintext.txt	46	change sympathetic nerve activity response orexin treatment differed significantly induced pb p num
0.22697699.15746258.html.plaintext.txt	47	view larger version numk fig
0.22697699.15746258.html.plaintext.txt	48	rate meter plot bat sympathetic nerve activity infusion orexin num
0.22697699.15746258.html.plaintext.txt	49	vertical axis show nerve impulse per num sec
0.22697699.15746258.html.plaintext.txt	50	horizontal bar num min time scale bold horizontal bar orexin infusion
0.22697699.15746258.html.plaintext.txt	51	b percentage difference sympathetic nerve activity baseline num inumvt infusion orexin num
0.22697699.15746258.html.plaintext.txt	52	baseline num signifies num min average score bat sympathetic nerve activity orexin treatment
0.22697699.15746258.html.plaintext.txt	53	data mean plus minus sem n num per group
0.22697699.15746258.html.plaintext.txt	54	orexin treated animal control
0.22697699.15746258.html.plaintext.txt	55	effect pretreatment fmh change bat sympathetic nerve activity induced orexin figure numa show typical response bat sympathetic nerve activity infusion orexin rat pretreated infusion fmh inumvt
0.22697699.15746258.html.plaintext.txt	56	mean change sympathetic nerve activity induced orexin pretreatment fmh shown fig
0.22697699.15746258.html.plaintext.txt	57	sympathetic nerve activity decreased rapidly central administration orexin pretreated rat change differed significantly induced pb p num
0.22697699.15746258.html.plaintext.txt	58	num differ significantly induced orexin rat pretreated pb p num
0.22697699.15746258.html.plaintext.txt	59	view larger version numk fig
0.22697699.15746258.html.plaintext.txt	60	rate meter plot bat sympathetic nerve activity inumvt injection orexin num
0.22697699.15746258.html.plaintext.txt	61	num nmol num h pretreatment fmh num
0.22697699.15746258.html.plaintext.txt	62	vertical axis show nerve impulse per num sec
0.22697699.15746258.html.plaintext.txt	63	horizontal bar num min time scale bold bar orexin infusion
0.22697699.15746258.html.plaintext.txt	64	b percentage difference sympathetic nerve activity baseline inumvt injection orexin num
0.22697699.15746258.html.plaintext.txt	65	num micromol pretreatment pb control
0.22697699.15746258.html.plaintext.txt	66	baseline num signifies num min average score bat sympathetic nerve activity orexin treatment
0.22697699.15746258.html.plaintext.txt	67	data mean plus minus sem n num per group
0.22697699.15746258.html.plaintext.txt	68	orexin treated animal orexin treated animal fmh pretreatment control
0.22697699.15746258.html.plaintext.txt	69	effect inumvt infusion orexin b bat sympathetic nerve activity typical response bat sympathetic nerve activity inumvt infusion orexin b shown fig
0.22697699.15746258.html.plaintext.txt	70	sympathetic nerve activity gradually increased central administration orexin b
0.22697699.15746258.html.plaintext.txt	71	mean change sympathetic nerve activity response orexin b treatment statistically significant compared induced pb p num
0.22697699.15746258.html.plaintext.txt	72	view larger version numk fig
0.22697699.15746258.html.plaintext.txt	73	rate meter plot bat sympathetic nerve activity infusion orexin b num
0.22697699.15746258.html.plaintext.txt	74	vertical axis show nerve impulse per num sec
0.22697699.15746258.html.plaintext.txt	75	horizontal bar num min time scale bold horizontal bar orexin b infusion
0.22697699.15746258.html.plaintext.txt	76	b percentage difference sympathetic nerve activity baseline inumvt infusion orexin b num
0.22697699.15746258.html.plaintext.txt	77	baseline num signifies num min average score bat sympathetic nerve activity orexin treatment
0.22697699.15746258.html.plaintext.txt	78	data mean plus minus sem n num per group
0.22697699.15746258.html.plaintext.txt	79	orexin b treated animal control
0.22697699.15746258.html.plaintext.txt	80	effect pretreatment fmh change bat sympathetic nerve activity induced orexin b figure numa show typical response bat sympathetic nerve activity infusion orexin b rat pretreated infusion fmh inumvt
0.22697699.15746258.html.plaintext.txt	81	sympathetic nerve activity gradually increased central administration orexin b rat pretreated fmh
0.22697699.15746258.html.plaintext.txt	82	change sympathetic nerve activity response orexin b significantly attenuated pretreated rat compared induced orexin b rat pretreated pb p num
0.22697699.15746258.html.plaintext.txt	83	view larger version numk fig
0.22697699.15746258.html.plaintext.txt	84	rate meter plot bat sympathetic nerve activity inumvt injection orexin b num
0.22697699.15746258.html.plaintext.txt	85	num nmol num h pretreatment fmh num
0.22697699.15746258.html.plaintext.txt	86	vertical axis show nerve impulse per num sec
0.22697699.15746258.html.plaintext.txt	87	horizontal bar num min time scale bold bar orexin b infusion
0.22697699.15746258.html.plaintext.txt	88	b percentage difference sympathetic nerve activity baseline num inumvt injection orexin b num
0.22697699.15746258.html.plaintext.txt	89	num micromol pretreatment pb control
0.22697699.15746258.html.plaintext.txt	90	data mean plus minus sem n num per group
0.22697699.15746258.html.plaintext.txt	91	orexin b treated animal orexin b treated animal fmh pretreatment control
0.22697699.15746258.html.plaintext.txt	92	action orexins mediated via two g protein coupled receptor oxnumr oxnumr num num
0.22697699.15746258.html.plaintext.txt	93	receptor binding affinity orexin num num time greater orexin b oxnumr whereas orexins equipotent oxnumr num num num num
0.22697699.15746258.html.plaintext.txt	94	distinct expression pattern two receptor subtypes identified throughout brain num
0.22697699.15746258.html.plaintext.txt	95	considering inumvt infusion site used study target site binding orexin receptor may either hypothalamus brain stem
0.22697699.15746258.html.plaintext.txt	96	standpoint ventromedial hypothalamic nucleus anum cell group lc express high level oxnumr mrna may candidate target orexin nucleus identified central origin efferent pathway bat num
0.22697699.15746258.html.plaintext.txt	97	hand high density expression oxnumr observed arcuate nucleus arc lha paraventricular nucleus pvn ventral premammillary nucleus tmn moderate expression level found medial preoptic area dorsal motor nucleus vagus num
0.22697699.15746258.html.plaintext.txt	98	pvn medial preoptic area identified major hypothalamic origin efferent pathway bat neuroanatomical study num
0.22697699.15746258.html.plaintext.txt	99	fact chemical stimulation nucleus increased bat sympathetic nerve activity num
0.22697699.15746258.html.plaintext.txt	100	arc lha especially orexin neuron pvn direct neuronal projection intermediolateral cell column spinal cord location sympathetic preganglionic neuron identified num num
0.22697699.15746258.html.plaintext.txt	101	among nucleus cumulative evidence indicates importance lha arc orexin oxnumr signaling suppress bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	102	electrophysiological study demonstrated excitatory effect orexin lha neuronal activity inhibitory influence area bat sympathetic nerve activity num indicating lha target site orexin regulation sympathetic innervation bat
0.22697699.15746258.html.plaintext.txt	103	contrast suppressive effect orexin central administration orexin b present study increased bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	104	addition orexin b induced response attenuated histamine depletion caused pretreatment fmh
0.22697699.15746258.html.plaintext.txt	105	described presence orexin neuron well orexin receptor oxrnum identified tmn site origin histamine neuron num
0.22697699.15746258.html.plaintext.txt	106	demonstrated neuronal histamine mediates orexin signaling regulation sleep wakefulness cycle num
0.22697699.15746258.html.plaintext.txt	107	finally central administration histamine shown increase bat sympathetic nerve activity num
0.22697699.15746258.html.plaintext.txt	108	taken together evidence suggests highly probable orexin b regulates bat sympathetic nerve activity excitatory manner oxnumr tmn
0.22697699.15746258.html.plaintext.txt	109	unpublished observation demonstrated fmh treatment neuropeptide y antagonist influenced orexin b induced feeding andor sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	110	result suggested neuronal histamine neuropeptide y might closely involved orexin b induced feeding behavior sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	111	study necessary clarify detail mechanism
0.22697699.15746258.html.plaintext.txt	112	considering present previous study result suggest oxr hypothalamus brain stem may mediate orexin induced effect bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	113	addition modulation oxr outside hypothalamus cerebral cortex spinal cord cisterna magna also possible
0.22697699.15746258.html.plaintext.txt	114	previous study demonstrated orexin could direct effect level sympathetic preganglionic neuron num
0.22697699.15746258.html.plaintext.txt	115	beyond bat sympathetic nerve activity study examine sympathetic nerve activity renal lumber nerve may merited
0.22697699.15746258.html.plaintext.txt	116	functional study recently demonstrated central administration orexin orexin b induces hypothermia hyperthermia respectively num num
0.22697699.15746258.html.plaintext.txt	117	result consistent present study time course bat thermogenesis assessed local bat temperature similar observed bat sympathetic nerve activity num
0.22697699.15746258.html.plaintext.txt	118	hand previous study demonstrated orexin induced hyperthermic response unanesthetized animal num num
0.22697699.15746258.html.plaintext.txt	119	well known arousal state muscle movement affect body temperature unanesthetized condition administration orexin induced increase arousal level consequent arbitrary movement may elevate body temperature
0.22697699.15746258.html.plaintext.txt	120	possibility anesthesia might modulate bat sympathetic nerve activity thermogenesis anesthesia factor sole mechanism regulating arousal state body temperature
0.22697699.15746258.html.plaintext.txt	121	present study limited acute phase orexins effect anesthetized rat possible difference state arousal may determine effect orexins body temperature
0.22697699.15746258.html.plaintext.txt	122	addition timing infusion might influence orexin induced sympathetic nerve activity effect orexins clearly dependent sleep wake cycle num
0.22697699.15746258.html.plaintext.txt	123	summary demonstrated central administration orexins induces dual effect bat sympathetic nerve activity inhibition orexin stimulation orexin b
0.22697699.15746258.html.plaintext.txt	124	hypothalamic neuronal histamine involved latter response bat sympathetic nerve activity
0.22697699.15746258.html.plaintext.txt	125	footnote work supported grant aid num japanese ministry education science culture research grant intractable disease japanese ministry health welfare num num
0.22697699.15746258.html.plaintext.txt	126	work also supported part grant smoking research foundation venture business laboratory oita university grant num japan society promotion science
0.22697699.15746258.html.plaintext.txt	127	first published online march num num
0.22697699.15746258.html.plaintext.txt	128	abbreviation arc arcuate nucleus bat brown adipose tissue fmh fluoromethylhistidine inumvt third cerebral ventricle icv intracerebroventricular lc locus coeruleus lha lateral hypothalamic area oxnum orexin num oxnum orexin num oxnumr oxnum receptor oxnumr oxnum receptor pvn paraventricular nucleus tmn tuberomammillary nucleus
0.22697699.15746258.html.plaintext.txt	129	accepted publication february num num
0.23939125.12519822.html.plaintext.txt	0	time wake individual variation sleep need scott
0.23939125.12519822.html.plaintext.txt	1	yale child health research center yale university new haven connecticut num
0.23939125.12519822.html.plaintext.txt	2	address correspondence request reprint scott
0.23939125.12519822.html.plaintext.txt	3	yale child health research center yale university new haven connecticut num
0.23939125.12519822.html.plaintext.txt	4	novel important set clinical study reported issue jcem aeschbach et al
0.23939125.12519822.html.plaintext.txt	5	num examined long short sleeper sleep greater num h le num h per night respectively
0.23939125.12519822.html.plaintext.txt	6	assessing melatonin cortisol level monitoring body temperature found longer biological night long sleeper short sleeper characterized greater duration nocturnal melatonin secretion later early morning temperature nadir cortisol peak num
0.23939125.12519822.html.plaintext.txt	7	thus physiological process mark output circadian timing system parallel sleep duration
0.23939125.12519822.html.plaintext.txt	8	finding aeschbach et al
0.23939125.12519822.html.plaintext.txt	9	num give credence everyday observation sleep need vary individually suggest amount sleep need reflects intrinsic factor
0.23939125.12519822.html.plaintext.txt	10	observation also underlie difficult change sleep pattern fighting inherent physiology
0.23939125.12519822.html.plaintext.txt	11	notion one sleep duration intrinsically determined widespread implication many discipline including industry healthcare education
0.23939125.12519822.html.plaintext.txt	12	sleep debt caused sleep deprivation recognized cause industrial accident impaired worker productivity num
0.23939125.12519822.html.plaintext.txt	13	example roadway accident common sleep deprived truck driver num
0.23939125.12519822.html.plaintext.txt	14	productivity air traffic controller adversely affected shift work well num
0.23939125.12519822.html.plaintext.txt	15	excessive work hour medical house officer work night call raised concern patient safety
0.23939125.12519822.html.plaintext.txt	16	understandably issue caught scrutiny legislator regulatory agency num
0.23939125.12519822.html.plaintext.txt	17	effort resulted new policy limit work hour medical staff
0.23939125.12519822.html.plaintext.txt	18	curtailing sleep adult name productivity educational system cutting sleep child adolescent
0.23939125.12519822.html.plaintext.txt	19	many educational district school day begin early morning hour num
0.23939125.12519822.html.plaintext.txt	20	uncommon see child standing street corner awaiting school bus early morning darkness
0.23939125.12519822.html.plaintext.txt	21	reflecting fact difficult advance hand one biological clock irrespective age adverse effect reduced sleep early morning awakening academic performance increasingly recognized child adolescent num
0.23939125.12519822.html.plaintext.txt	22	live society control photic environment simple flip switch convenient clap hand
0.23939125.12519822.html.plaintext.txt	23	using alarm clock planned schedule believe override natural sleep need
0.23939125.12519822.html.plaintext.txt	24	believe comfortably live life synchrony num h light dark cycle reverse day night without penalty
0.23939125.12519822.html.plaintext.txt	25	however reflected ever increasing number business devoted optimizing schedule shift worker difficult willfully change sleep habit hand circadian clock
0.23939125.12519822.html.plaintext.txt	26	thought exposing shift worker bright light night circadian clock could reset
0.23939125.12519822.html.plaintext.txt	27	yet unless stringent effort made limit daytime lighting exposure resetting biological clock occur melatonin cortisol rhythm may remain phase period sleep wakefulness num
0.23939125.12519822.html.plaintext.txt	28	individual working night may thus phase optimal period alertness task performance
0.23939125.12519822.html.plaintext.txt	29	effort develop agent reset circadian clock
0.23939125.12519822.html.plaintext.txt	30	jet lag drug also largely unrealized num
0.23939125.12519822.html.plaintext.txt	31	despite popular hype melatonin conveniently shift circadian phase data support notion striking show modest effect best num num
0.23939125.12519822.html.plaintext.txt	32	difficult change one circadian phase observation aeschbach et al
0.23939125.12519822.html.plaintext.txt	33	num provide basis difficult change sleep habit
0.23939125.12519822.html.plaintext.txt	34	duration biological night varies individually may difficult individual adapt condensed sleep schedule others
0.23939125.12519822.html.plaintext.txt	35	strategy guideline aimed improving health productivity shift worker may therefore effective individual ineffective others
0.23939125.12519822.html.plaintext.txt	36	biological basis variability sleep duration unknown present remains intriguing issue
0.23939125.12519822.html.plaintext.txt	37	evolving body evidence suggests sleep cycle circadian rhythmicity integrally related circadian system influencing timing duration sleep
0.23939125.12519822.html.plaintext.txt	38	expressed circadian rhythm like sleep wake cycle rhythm hormone production generated regulated biological clock located suprachiasmatic nucleus scn anterior hypothalamus num
0.23939125.12519822.html.plaintext.txt	39	damage nucleus result episode sleep wakefulness occurring throughout num h day rather consolidated night
0.23939125.12519822.html.plaintext.txt	40	scn damage also result increase total duration sleep primate num
0.23939125.12519822.html.plaintext.txt	41	past decade dissection molecular hand circadian clock lead fascinating new insight
0.23939125.12519822.html.plaintext.txt	42	generation circadian rhythm seems related complex interaction handful transcriptional regulator kinase resulting num h cycle protein expression action scn num
0.23939125.12519822.html.plaintext.txt	43	mammal factor include protein period clock cry bmal casein kinase num num
0.23939125.12519822.html.plaintext.txt	44	mutation factor discovered recently
0.23939125.12519822.html.plaintext.txt	45	human mutation period num associated advanced circadian phase syndrome num
0.23939125.12519822.html.plaintext.txt	46	individual condition wake early morning retire bed early evening hour
0.23939125.12519822.html.plaintext.txt	47	animal mutation clock result abnormal disorganized sleep problem num
0.23939125.12519822.html.plaintext.txt	48	mutation casein kinase num result short circadian day period num
0.23939125.12519822.html.plaintext.txt	49	whereas possible localize circadian clock mammal discrete region brain brain region involved sleep organization far diffuse involving complex subcortical network num
0.23939125.12519822.html.plaintext.txt	50	similar clock gene mutation providing insight biological basis circadian rhythmicity discovery novel protein also provided insight pathogenesis sleep disorder num num num
0.23939125.12519822.html.plaintext.txt	51	inability produce respond orexinhypocretin found cause narcolepsy num likely seminal discovery lead new diagnostic test treatment disorder num
0.23939125.12519822.html.plaintext.txt	52	coupling knowledge basic clock sleep mechanism powerful genetic approach permit identification specific gene small cohort likely identification elucidation factor regulate duration timing sleep num
0.23939125.12519822.html.plaintext.txt	53	continued characterization individual variation sleep identification family cohort unusual sleep circadian property also greatly enhance genetic approach regard
0.23939125.12519822.html.plaintext.txt	54	thus may someday learn individual ability stay watch david letterman num o clock news whereas others retire news num o clock
0.23939125.12519822.html.plaintext.txt	55	society industry medicine becoming increasingly aware importance sleep proper timing sleep cycle reflected sleep work hour related law
0.23939125.12519822.html.plaintext.txt	56	however compared advance understanding basic sleep circadian physiology molecular biology public attention arena lagged considerably
0.23939125.12519822.html.plaintext.txt	57	readily manipulate photic environment yet stubbornly recognize difficult overcome mother nature change timing amount sleep need
0.23939125.12519822.html.plaintext.txt	58	increasingly seem value alarm clock internal clock
0.23939125.12519822.html.plaintext.txt	59	thus important challenge modern fluid society able accommodate normal circadian cycle individual sleep requirement name progress productivity
0.23939125.12519822.html.plaintext.txt	60	abbreviation scn suprachiasmatic nucleus
0.23939125.12519822.html.plaintext.txt	61	aeschbach d sher l postolache tt matthew jr jackson ma wehr ta num longer biological night long sleeper short sleeper
0.23939125.12519822.html.plaintext.txt	62	j clin endocrinol metab numnum numabstractfree full text bonnet mh arand dl num chronically sleep deprived
0.23939125.12519822.html.plaintext.txt	63	sleep numnum nummedline braver er pantula jf num sleep long haul truck driver
0.23939125.12519822.html.plaintext.txt	64	n engl j med numnum discussion numfree full text luna td num air traffic controller shiftwork implication aviation safety review
0.23939125.12519822.html.plaintext.txt	65	aviat space environ med numnum nummedline gaba dm howard sk num fatigue among clinician safety patient
0.23939125.12519822.html.plaintext.txt	66	n engl j med numnum numfree full text carskadon ma wolfson ar acebo c tzischinsky o seifer r num adolescent sleep pattern circadian timing sleepiness transition early school day
0.23939125.12519822.html.plaintext.txt	67	sleep numnum nummedline czeisler ca johnson mp duffy jf brown en ronda jm kronauer re num exposure bright light darkness treat physiologic maladaptation night work
0.23939125.12519822.html.plaintext.txt	68	n engl j med numnum numabstract dawson d armstrong sm num chronobiotics drug shift rhythm
0.23939125.12519822.html.plaintext.txt	69	pharmacol ther numnum numcrossrefmedline hao h rivkees num melatonin shift circadian phase baboon
0.23939125.12519822.html.plaintext.txt	70	j clin endocrinol metab numnum numabstractfree full text sharkey km eastman ci num melatonin phase shift human circadian rhythm placebo controlled simulated night work study
0.23939125.12519822.html.plaintext.txt	71	j physiol regul integr comp physiol numrnum rnum reppert sm weaver dr num coordination circadian timing mammal
0.23939125.12519822.html.plaintext.txt	72	nature numnum numcrossrefmedline edgar dm dement wc fuller ca num effect scn lesion sleep squirrel monkey evidence opponent process sleep wake regulation
0.23939125.12519822.html.plaintext.txt	73	j neurosci numnum numabstract toh kl jones cr y eide ej hinz wa virshup dm ptacek lj fu yh num hpernum phosphorylation site mutation familial advanced sleep phase syndrome
0.23939125.12519822.html.plaintext.txt	74	science numnum numabstractfree full text naylor e bergmann bm krauski k zee pc takahashi j vitaterna mh turek fw num circadian clock mutation alters sleep homeostasis mouse
0.23939125.12519822.html.plaintext.txt	75	j neurosci numnum numabstractfree full text eide ej virshup dm num casein kinase another cog circadian clockwork
0.23939125.12519822.html.plaintext.txt	76	chronobiol int numnum numcrossrefmedline pace schott ef hobson ja num neurobiology sleep genetics cellular physiology subcortical network
0.23939125.12519822.html.plaintext.txt	77	nat rev neurosci numnum nummedline taheri zeitzer jm mignot e num role hypocretins orexins sleep regulation narcolepsy
0.23939125.12519822.html.plaintext.txt	78	annu rev neurosci numnum numcrossrefmedline tafti m franken p num invited review genetic dissection sleep
0.23939125.12519822.html.plaintext.txt	79	j appl physiol numnum numabstractfree full text franken p chollet d tafti m num homeostatic regulation sleep need genetic control
0.23939125.12519822.html.plaintext.txt	80	j neurosci numnum numabstractfree full text article full text pdf submit related letter editor purchase article view shopping cart alert article cited alert eletters posted alert correction posted citation map service email article friend similar article journal similar article pubmed alert new issue journal download citation manager request copyright permission google scholar article rivkees
0.23939125.12519822.html.plaintext.txt	81	article citing article pubmed pubmed citation article rivkees
0.23939125.12519822.html.plaintext.txt	82	home help feedback subscription archive search table content endocrinology endocrine review j
0.23939125.12519822.html.plaintext.txt	83	molecular endocrinology recent prog
0.27402496.12639903.html.plaintext.txt	0	gonadal steroid differentially regulate messenger ribonucleic acid expression pituitary orexin type num receptor adrenal orexin type num receptor olaf johren norbert bruggemann andreas dendorfer peter dominiak
0.27402496.12639903.html.plaintext.txt	1	institute experimental clinical pharmacology toxicology university clinic lubeck d num lubeck germany
0.27402496.12639903.html.plaintext.txt	2	address correspondence request reprint olaf johren ph
0.27402496.12639903.html.plaintext.txt	3	institute experimental clinical pharmacology toxicology university clinic lubeck ratzeburger allee num d num lubeck germany
0.27402496.12639903.html.plaintext.txt	4	female rat pituitary oxnum receptor mrna level increased num fold ovariectomy compared sham operated rat
0.27402496.12639903.html.plaintext.txt	5	increase pituitary oxnum receptor mrna inhibited treatment numss estradiol
0.27402496.12639903.html.plaintext.txt	6	adrenal mrna level oxnum receptor ovariectomized rat increased num fold compared sham operated rat also reduced treatment numss estradiol
0.27402496.12639903.html.plaintext.txt	7	male rat orchidectomy increased mrna level pituitary oxnum receptor compared sham operated rat
0.27402496.12639903.html.plaintext.txt	8	contrast adrenal oxnum receptor mrna reduced orchidectomy
0.27402496.12639903.html.plaintext.txt	9	testosterone treatment reversed effect orchidectomy pituitary oxnum adrenal oxnum receptor
0.27402496.12639903.html.plaintext.txt	10	hypothalamus difference found mrna level prepro orexin oxnum oxnum receptor sham operated placebo treated steroid treated female male rat
0.27402496.12639903.html.plaintext.txt	11	result indicate gonadal steroid differentially regulate pituitary oxnum receptor adrenal oxnum receptor male female rat may contribute specific sex dependent neuroendocrine endocrine action orexins
0.27402496.12639903.html.plaintext.txt	12	two subtypes orexin receptor namely oxnum oxnum receptor cloned num
0.27402496.12639903.html.plaintext.txt	13	expression pattern rat brain good agreement widespread projection orexin immunoreactive neuron num num
0.27402496.12639903.html.plaintext.txt	14	within hypothalamus oxnum receptor mrna detected area like medial preoptic nucleus anterior hypothalamic nucleus ventromedial nucleus whereas oxnum receptor mrna found region paraventricular arcuate nucleus num
0.27402496.12639903.html.plaintext.txt	15	therefore effect intracerebroventricularly icv injected orexins plasma hormone acth prolactin lh gh num num num num may mediated affecting synthesis andor liberation releasing hormone
0.27402496.12639903.html.plaintext.txt	16	addition orexins may directly influence pituitary hormone orexinergic nerve fiber present median eminence pituitary gland orexin receptor detected pituitary gland num num num
0.27402496.12639903.html.plaintext.txt	17	indeed orexins shown stimulate crh gnrh release hypothalamus num also inhibit releasing hormone stimulated acth lh release pituitary num num
0.27402496.12639903.html.plaintext.txt	18	inhibitory action orexin gnrh stimulated pituitary lh release observed proestrous female rat male rat num
0.27402496.12639903.html.plaintext.txt	19	moreover female rat effect icv injected orexins dependent status ovarian steroid num
0.27402496.12639903.html.plaintext.txt	20	furthermore whereas ovariectomized ovx rat treated numss estradiol enum progesterone icv orexin increased plasma lh level untreated ovx rat orexin decreased plasma lh level num
0.27402496.12639903.html.plaintext.txt	21	one explanation bimodal action orexins lh release possible regulation orexin receptor estrogen
0.27402496.12639903.html.plaintext.txt	22	interestingly recently detected sexually dimorphic expression peripheral orexin receptor higher mrna level oxnum receptor pituitary oxnum receptor adrenal gland male rat compared female rat num
0.27402496.12639903.html.plaintext.txt	23	clarify effect gonadal steroid orexin system analyzed mrna expression prepro orexin well oxnum oxnum receptor hypothalamus pituitary adrenal gland sham operated gonadectomized male female rat influence subsequent enum treatment using quantitative real time pcr
0.27402496.12639903.html.plaintext.txt	24	rna isolation cdna synthesis total rna isolated tissue homogenate guanidinium isothiocyanate method purified using silica gel based spin column rneasy kit qiagen gmbh hilden germany digestion genomic dna treatment deoxyribonuclease qiagen
0.27402496.12639903.html.plaintext.txt	25	first strand cdna synthesized num microg total rna presence num mm mgclnum num mm tris hcl ph num
0.27402496.12639903.html.plaintext.txt	26	num triton x num num mm deoxy ntps num u microl rnasin num
0.27402496.12639903.html.plaintext.txt	27	num microg oligo deoxythymidinenum primer num u avian myeloblastosis virus reverse transcriptase promega gmbh mannheim germany
0.27402496.12639903.html.plaintext.txt	28	validate successful deoxyribonuclease treatment reverse transcriptase omitted control reaction
0.27402496.12639903.html.plaintext.txt	29	absence pcr amplified dna fragment sample indicated isolation rna free genomic dna
0.27402496.12639903.html.plaintext.txt	30	quantitative real time pcr amplify prepro orexin oxnum oxnum receptor glyceraldehyde num phosphate dehydrogenase gapdh cdna sense antisense oligonucleotide primer designed based published cdna sequence num num using primernum software
0.27402496.12639903.html.plaintext.txt	31	skaletsky code available httpwww genome
0.27402496.12639903.html.plaintext.txt	32	edugenome softwareotherprimernum
0.27402496.12639903.html.plaintext.txt	33	oligonucleotides obtained invitrogen gmbh karlsruhe germany
0.27402496.12639903.html.plaintext.txt	34	sequence primer follows num gcc gtc tct acg aac tgt tg num prepro orexin sense num cga gga gag ggg aaa gtt ag num prepro orexin antisense num ccc tca act cca gtc cta gc num oxnum sense num cag gga ggg cct ata att ga num oxnum antisense num caa tgt tgt tgg ggt gct ta num oxnum sense num tcc ccc tct cat aaa ctt gg num oxnum antisense num ctc cct caa gat tgt cag ca num gapdh sense num gtt cag ctc tgg gat gac ct num gapdh antisense
0.27402496.12639903.html.plaintext.txt	35	quantitative measurement prepro orexin oxnum oxnum receptor gapdh cdna performed kinetic pcr using sybr green fluorescent dye eurogentec sa seraing belgium described previously num
0.27402496.12639903.html.plaintext.txt	36	sample analyzed triplicate geneamp num sequence detection system pe applied biosystems weiterstadt germany along specific standard template control monitor contaminating dna
0.27402496.12639903.html.plaintext.txt	37	reaction consisted num ng cdna num
0.27402496.12639903.html.plaintext.txt	38	num microm primer num mm tris hcl num mm kcl num mm mgclnum num
0.27402496.12639903.html.plaintext.txt	39	num u hot goldstar dna polymerase eurogentec final volume num microl
0.27402496.12639903.html.plaintext.txt	40	denaturation num c num min cdna product amplified num cycle cycle consisting denaturation num c num sec annealing extension num c num sec
0.27402496.12639903.html.plaintext.txt	41	accumulating dna product monitored geneamp num sequence detection system data stored continuously reaction
0.27402496.12639903.html.plaintext.txt	42	product purity confirmed dissociation curve analysis agarose gel electrophoresis presence ethidium bromide
0.27402496.12639903.html.plaintext.txt	43	identity amplified cdna fragment confirmed restriction analysis
0.27402496.12639903.html.plaintext.txt	44	furthermore amplified prepro orexin oxnum oxnum receptor gapdh cdna fragment cloned using ta cloning kit invitrogen identity nucleotide sequence confirmed
0.27402496.12639903.html.plaintext.txt	45	calculation initial mrna copy number sample made according cycle threshold ct method num
0.27402496.12639903.html.plaintext.txt	46	dilution known amount cloned prepro orexin oxnum oxnum receptor cdna fragment used generate standard curve num
0.27402496.12639903.html.plaintext.txt	47	ct sample calculated fluorescence threshold rn num
0.27402496.12639903.html.plaintext.txt	48	num using geneamp num sequence detection system software automatic baseline setting
0.27402496.12639903.html.plaintext.txt	49	detection limit gene interest num copy per num ng cdna
0.27402496.12639903.html.plaintext.txt	50	copy number prepro orexin oxnum oxnum receptor mrna normalized using gapdh mrna level
0.27402496.12639903.html.plaintext.txt	51	difference observed treatment group gapdh mrna level
0.27402496.12639903.html.plaintext.txt	52	rias concentration plasma enum measured using numi ria kit icn biomedicals inc
0.27402496.12639903.html.plaintext.txt	53	two extraction num microl serum num ml ether evaporation sample reconstituted num microl ria buffer num microl sample assayed duplicate according manufacturer instruction
0.27402496.12639903.html.plaintext.txt	54	intraassay interassay variation le num num respectively
0.27402496.12639903.html.plaintext.txt	55	plasma orexin extracted adsorption phenyl silica isolute spe international sorbent technology mid glamorgan uk
0.27402496.12639903.html.plaintext.txt	56	elution num acetonitrile num trifluoroacetic acid sample concentrated lyophilization
0.27402496.12639903.html.plaintext.txt	57	orexin concentration determined specific ria according manufacturer instruction peninsula laboratory inc
0.27402496.12639903.html.plaintext.txt	58	detection limit assay num pgtube based amount orexin produced least num tracer displacement
0.27402496.12639903.html.plaintext.txt	59	sample analyzed within assay
0.27402496.12639903.html.plaintext.txt	60	intraassay variability le num
0.27402496.12639903.html.plaintext.txt	61	statistic data presented mean plus minus sem
0.27402496.12639903.html.plaintext.txt	62	difference treatment group estimated one way variance analysis anova followed bonferroni posttest using graphpad software inc
0.27402496.12639903.html.plaintext.txt	63	san diego ca prism software
0.27402496.12639903.html.plaintext.txt	64	num indicated statistically significant difference
0.27402496.12639903.html.plaintext.txt	65	view larger version numk figure num
0.27402496.12639903.html.plaintext.txt	66	amplification restriction analysis cdna fragment expected size num bp prepro orexin num bp oxnum receptor b num bp oxnum receptor c
0.27402496.12639903.html.plaintext.txt	67	pvuii cut prepro orexin cdna fragment num num bp fragment
0.27402496.12639903.html.plaintext.txt	68	alu cut oxnum receptor cdna fragment four fragment num bp visible gel num bp num bp num bp b oxnum receptor cdna fragment two fragment size num bp num bp c
0.27402496.12639903.html.plaintext.txt	69	treatment restriction enzyme
0.27402496.12639903.html.plaintext.txt	70	m dna size marker indicated base pair left
0.27402496.12639903.html.plaintext.txt	71	view larger version numk figure num
0.27402496.12639903.html.plaintext.txt	72	amplification plot prepro orexin oxnum receptor mrna b oxnum receptor mrna c hypothalamus pituitary adrenal gland male rat n num
0.27402496.12639903.html.plaintext.txt	73	fluorescence measured pcr every cycle using geneamp num sequence detection system
0.27402496.12639903.html.plaintext.txt	74	sample ct determined automatically rn num
0.27402496.12639903.html.plaintext.txt	75	template control hnumo used estimate background amplification
0.27402496.12639903.html.plaintext.txt	76	pituitary adrenal significant amount prepro orexin mrna previously detected num real time pcr prepro orexin performed organ
0.27402496.12639903.html.plaintext.txt	77	expression prepro orexin mrna hypothalamus male female rat effect gonadectomy hormone treatment high mrna level prepro orexin found hypothalamus female fig
0.27402496.12639903.html.plaintext.txt	78	numb rat quantitative real time pcr using ct method
0.27402496.12639903.html.plaintext.txt	79	difference detected mrna level hypothalamic prepro orexin sham operated control rat gonadectomized rat treated plac steroid treated female male rat fig
0.27402496.12639903.html.plaintext.txt	80	view larger version numk figure num
0.27402496.12639903.html.plaintext.txt	81	effect ovx enum treatment orx treatment b hypothalamic prepro orexin mrna level
0.27402496.12639903.html.plaintext.txt	82	shown mean plus minus sem n num
0.27402496.12639903.html.plaintext.txt	83	expression oxnum oxnum receptor mrna female rat effect ovariectomy enum treatment high mrna level oxnum oxnum receptor found hypothalamus female rat fig
0.27402496.12639903.html.plaintext.txt	84	pituitary gland sham operated female rat significant amount oxnum receptor mrna present fig
0.27402496.12639903.html.plaintext.txt	85	numa whereas low mrna level oxnum receptor detected fig
0.27402496.12639903.html.plaintext.txt	86	adrenal gland female rat found low mrna level oxnum receptor high mrna level oxnum receptor fig
0.27402496.12639903.html.plaintext.txt	87	view larger version numk figure num
0.27402496.12639903.html.plaintext.txt	88	effect ovx enum treatment hypothalamic pituitary adrenal oxnum oxnum receptor mrna level female rat
0.27402496.12639903.html.plaintext.txt	89	shown mean plus minus sem n num
0.27402496.12639903.html.plaintext.txt	90	hypothalamus female rat difference detected mrna level oxnum oxnum receptor sham operated control rat ovx rat ovx rat treated enum num d fig
0.27402496.12639903.html.plaintext.txt	91	pituitary gland plac treated ovx rat oxnum receptor mrna level significantly higher compared plac treated sham operated rat fig
0.27402496.12639903.html.plaintext.txt	92	treatment ovx rat enum completely reversed ovx induced increase mrna level pituitary oxnum receptor fig
0.27402496.12639903.html.plaintext.txt	93	control rat low amount oxnum receptor mrna found pituitary gland plac enum treated ovx rat fig
0.27402496.12639903.html.plaintext.txt	94	adrenal gland substantial difference mrna level oxnum receptor treatment group fig
0.27402496.12639903.html.plaintext.txt	95	however oxnum receptor mrna level significantly higher plac treated ovx rat compared plac treated sham operated rat significantly reduced enum treatment ovx rat fig
0.27402496.12639903.html.plaintext.txt	96	expression oxnum oxnum receptor mrna male rat effect orx treatment oxnum oxnum receptor mrna detected high level hypothalamus male rat fig
0.27402496.12639903.html.plaintext.txt	97	pituitary gland high mrna level oxnum receptor low mrna level oxnum receptor present male rat fig
0.27402496.12639903.html.plaintext.txt	98	contrast low level adrenal oxnum receptor mrna fig
0.27402496.12639903.html.plaintext.txt	99	numa high mrna level oxnum receptor detected adrenal gland male rat fig
0.27402496.12639903.html.plaintext.txt	100	view larger version numk figure num
0.27402496.12639903.html.plaintext.txt	101	effect orx treatment hypothalamic pituitary adrenal oxnum oxnum receptor mrna level male rat
0.27402496.12639903.html.plaintext.txt	102	shown mean plus minus sem n num
0.27402496.12639903.html.plaintext.txt	103	difference detected amount oxnum oxnum receptor mrna hypothalamus male sham operated control rat orx rat orx rat treated num d fig
0.27402496.12639903.html.plaintext.txt	104	pituitary mrna level oxnum receptor significantly regulated mrna level adrenal oxnum receptor significantly regulated plac treated orx rat compared sham operated rat fig
0.27402496.12639903.html.plaintext.txt	105	effect orchidectomy pituitary adrenal gland reversed treatment orx rat fig
0.27402496.12639903.html.plaintext.txt	106	difference observed low amount pituitary oxnum adrenal oxnum receptor mrna treatment group male rat fig
0.27402496.12639903.html.plaintext.txt	107	effect gonadectomy hormone treatment plasma hormone body weight ovariectomy reduced subsequent treatment ovx rat enum significantly increased plasma enum level table num
0.27402496.12639903.html.plaintext.txt	108	plasma level undetectable orchidectomy restored treatment table num
0.27402496.12639903.html.plaintext.txt	109	difference plasma orexin level observed sham operated ovx enum treated female rat table num
0.27402496.12639903.html.plaintext.txt	110	male rat showed slight significant reduction plasma orexin level orx compared sham operated rat
0.27402496.12639903.html.plaintext.txt	111	treatment orx rat restored plasma orexin level table num
0.27402496.12639903.html.plaintext.txt	112	plasma enum concentration plasma orexin concentration body weight sham operated ovx female rat treated placebo enum
0.27402496.12639903.html.plaintext.txt	113	plasma concentration plasma orexin concentration body weight sham operated orx male rat treated placebo
0.27402496.12639903.html.plaintext.txt	114	body weight significantly increased female rat ovariectomy whereas treatment enum num d suppressed weight gain table num
0.27402496.12639903.html.plaintext.txt	115	difference body weight observed male sham operated control rat orx rat orx rat treated num d table num
0.27402496.12639903.html.plaintext.txt	116	addition effect energy homeostasis considerable evidence orexins regulate activity hypothalamo pituitary gonadal axis num num num num num
0.27402496.12639903.html.plaintext.txt	117	icv injected orexins increased plasma lh concentration ovarian steroid treated female rat whereas untreated ovx rat plasma lh reduced initially shown pu et al
0.27402496.12639903.html.plaintext.txt	118	bimodal response appears part mediated gnrh orexin stimulates gnrh release hypothalamic explants male proestrous female rat num num
0.27402496.12639903.html.plaintext.txt	119	addition orexin containing neuron project several hypothalamic nucleus including area involved regulation gnrh orexin receptor present num num num num
0.27402496.12639903.html.plaintext.txt	120	however orexin receptor also present pituitary gland direct effect orexins assumed
0.27402496.12639903.html.plaintext.txt	121	ovarian steroid treated rat stimulatory effect icv orexins pituitary lh release observed already low dos whereas high dose orexin necessary suppress release lh absence ovarian steroid num num
0.27402496.12639903.html.plaintext.txt	122	could possible orexins injected icv high dos reach pituitary gland diffusion portal circulation stimulate pituitary oxnum receptor regulated absence ovarian steroid shown result
0.27402496.12639903.html.plaintext.txt	123	although significant effect orexin basal lh release dispersed pituitary cell orexin inhibited gnrh induced release lh isolated pituitary cell proestrous female rat num
0.27402496.12639903.html.plaintext.txt	124	thus orexins may differentially regulate activity hypothalamo pituitary gonadal axis exerting contrary effect hypothalamus pituitary gland
0.27402496.12639903.html.plaintext.txt	125	estrogen dependent bimodal action orexins lh release female rat may caused regulation oxnum receptor low enum level
0.27402496.12639903.html.plaintext.txt	126	receptor dependent regulation hormone release well established peptide angiotensin ii num num
0.27402496.12639903.html.plaintext.txt	127	addition effect gnrh induced lh release direct action orexin pituitary gland possible
0.27402496.12639903.html.plaintext.txt	128	although effect orexins basal acth observed male female rat samson taylor num reported inhibitory effect orexins crh stimulated acth release vitro
0.27402496.12639903.html.plaintext.txt	129	finding supported localization orexin receptor human corticotrope pituitary cell num
0.27402496.12639903.html.plaintext.txt	130	interestingly acth response stress depends gonadal steroid male female rat num num
0.27402496.12639903.html.plaintext.txt	131	role orexins response remains unclear
0.27402496.12639903.html.plaintext.txt	132	however finding strong regulation pituitary oxnum receptor enum lesser degree imply far undefined hormonal regulation orexin action pituitary gland male female rat
0.27402496.12639903.html.plaintext.txt	133	adrenal gland found high mrna level oxnum receptor accordance previous finding also showed much higher amount oxnum receptor mrna male rat compared female rat num
0.27402496.12639903.html.plaintext.txt	134	interestingly gonadal hormone differentially affected mrna level adrenal oxnum receptor
0.27402496.12639903.html.plaintext.txt	135	enum reduced mrna level oxnum receptor whereas increased mrna level oxnum receptor
0.27402496.12639903.html.plaintext.txt	136	therefore enum female rat male rat may contribute observed sex difference adrenal oxnum receptor mrna expression
0.27402496.12639903.html.plaintext.txt	137	inconsistent data exist regarding localization adrenal orexin receptor
0.27402496.12639903.html.plaintext.txt	138	rat oxnum oxnum receptor like immunoreactivity found adrenal medulla cortex num
0.27402496.12639903.html.plaintext.txt	139	contrast quantitative pcr showed much higher level oxnum receptor mrna selectively localized adrenal cortex rat situ hybridization num
0.27402496.12639903.html.plaintext.txt	140	result supported finding randeva et al
0.27402496.12639903.html.plaintext.txt	141	num found oxnum receptor oxnum receptor selectively cortex human adrenal using rt pcr situ hybridization immunostaining
0.27402496.12639903.html.plaintext.txt	142	others however described oxnum receptor cortex oxnum receptor medulla human adrenal num
0.27402496.12639903.html.plaintext.txt	143	orexins stimulate adrenal glucocorticoid release rat human num num glucocorticoid play unique role energy homeostasis intriguing speculate male rat orexins may regulate glucose metabolism via regulation glucocorticoid
0.27402496.12639903.html.plaintext.txt	144	interestingly found increased level plasma orexin male rat contrast female rat plasma orexin level unchanged enum
0.27402496.12639903.html.plaintext.txt	145	experiment needed clarify possible dependent function adrenal orexin system
0.27402496.12639903.html.plaintext.txt	146	thus far unclear whether rat adrenal oxnum receptor stimulated circulating orexins whether orexins locally produced adrenal gland described randeva et al
0.27402496.12639903.html.plaintext.txt	147	presence orexin plasma described rat human circulating orexins may activate adrenal orexin receptor num num
0.27402496.12639903.html.plaintext.txt	148	although source plasma orexins currently uncertain orexin producing neuron project median eminence may therefore contribute plasma orexins num
0.27402496.12639903.html.plaintext.txt	149	contrast lower mrna level orexin receptor pituitary adrenal gland female rat compared male rat prepro orexin oxnum receptor mrna level elevated hypothalamus female rat num num
0.27402496.12639903.html.plaintext.txt	150	present study could reveal change hypothalamic prepro orexin orexin receptor mrna gonadectomy hormonal treatment male female rat
0.27402496.12639903.html.plaintext.txt	151	result female rat accordance finding russell et al
0.27402496.12639903.html.plaintext.txt	152	num showing effect estrogen hypothalamic prepro orexin mrna female rat
0.27402496.12639903.html.plaintext.txt	153	addition male sheep enum affect prepro orexin mrna level num
0.27402496.12639903.html.plaintext.txt	154	thus factor may responsible observed difference male female rat may concluded central hypothalamic expression prepro orexin orexin receptor control ovarian steroid
0.27402496.12639903.html.plaintext.txt	155	however orexin receptor subtypes distinctively expressed hypothalamic nucleus num discrete change orexin receptor mrna level specific hypothalamic nucleus might detectable analyzing whole hypothalamic extract using rt pcr completely ruled result
0.27402496.12639903.html.plaintext.txt	156	estrogen divergent effect food intake energy expenditure body weight plasma level estrogen correlate positively whereas plasma level correlate negatively body fat mass num
0.27402496.12639903.html.plaintext.txt	157	finding weight gain ovariectomy accordance previous observation num
0.27402496.12639903.html.plaintext.txt	158	reduced weight female rat enum replacement may attributed somewhat higher plasma enum level enum treated female rat comparison sham operated female rat num
0.27402496.12639903.html.plaintext.txt	159	num showed ovx could influence body weight independently food intake separately central mechanism
0.27402496.12639903.html.plaintext.txt	160	study regulation orexin receptor gonadal steroid appears limited peripheral organ
0.27402496.12639903.html.plaintext.txt	161	thus peripheral orexin system particularly adrenal oxnum receptor may contribute sex specific regulation energy homeostasis
0.27402496.12639903.html.plaintext.txt	162	summary result show enum differentially regulate mrna expression pituitary oxnum adrenal oxnum receptor female male rat
0.27402496.12639903.html.plaintext.txt	163	thus addition ability orexins regulate reproductive system sex steroid may affect action orexins
0.27402496.12639903.html.plaintext.txt	164	like peptide regulating energy homeostasis reproductive function num orexins may play important role coordinating system may also sex dependently influence orexin related function like autonomic system sleeping behavior
0.27402496.12639903.html.plaintext.txt	165	acknowledgment author wish thank c
0.27402496.12639903.html.plaintext.txt	166	eichholz real time pcr assistance g
0.27402496.12639903.html.plaintext.txt	167	footnote abbreviation ct cycle threshold enum numss estradiol gapdh glyceraldehyde num phosphate dehydrogenase icv intracerebroventricular orx orchidectomized ovx ovariectomized oxnum orexin type num oxnum orexin type num plac placebo rn fluorescence threshold testosterone
0.27402496.12639903.html.plaintext.txt	168	accepted publication december num num
0.30595517.15525658.html.plaintext.txt	0	orexin loss huntington disease asa petersennum joana gilnum marion l
0.30595517.15525658.html.plaintext.txt	1	maat schiemannum maria bjorkqvistnum heikki tanilanum ines m
0.30595517.15525658.html.plaintext.txt	2	arauacutejonum ruben smithnum natalija popovicnum nil wierupnum per norlennum jia yi linum raymund
0.30595517.15525658.html.plaintext.txt	3	roosnum frank sundlernum hindrik muldernum patrik brundinnum
0.30595517.15525658.html.plaintext.txt	4	numdepartment physiological science section neuronal survival bmc anum num lund sweden numdepartment neurology lumc leiden netherlands numdepartment cell molecular biology lund sweden numdepartment neuroscience neurology university kuopiodepartment neurology kuopio university hospital finland numcenter neuroscience cell biology department zoology coimbra portugal numdepartment physiological science section neuroendocrine cell biology lund sweden numdepartment experimental clinical pharmacology institute laboratory medicine lund university hospital lund sweden
0.30595517.15525658.html.plaintext.txt	5	correspondence addressed
0.30595517.15525658.html.plaintext.txt	6	tel num num fax num num email asa
0.30595517.15525658.html.plaintext.txt	7	received september num num accepted october num num
0.30595517.15525658.html.plaintext.txt	8	studied animal model hd rnumnum mouse express exon num human mutant hd gene num cag repeat num
0.30595517.15525658.html.plaintext.txt	9	advanced stage mouse display several clinical feature reminiscent hd
0.30595517.15525658.html.plaintext.txt	10	include impaired motor coordination tremor change open field behavior progressive weight loss increased incidence epileptic seizure num
0.30595517.15525658.html.plaintext.txt	11	unclear reason die prematurely age num num week
0.30595517.15525658.html.plaintext.txt	12	brain exhibit high frequency intraneuronal nuclear inclusion polyglutamine containing protein
0.30595517.15525658.html.plaintext.txt	13	far relatively little cell death scattered neuron undergoing dark degeneration described numnum
0.30595517.15525658.html.plaintext.txt	14	neuropathological study end stage hd patient demonstrated num neuronal loss tuber nucleus lateral hypothalamus numnum
0.30595517.15525658.html.plaintext.txt	15	human region particularly enriched nmda receptor num
0.30595517.15525658.html.plaintext.txt	16	implicates involvement excitotoxic cell death repeatedly suggested play role pathogenesis hd brain region numnum
0.30595517.15525658.html.plaintext.txt	17	interestingly recent study showed slice culture rat lateral hypothalamus neuron containing peptide orexin also known hypocretin particularly susceptible excitotoxic damage num
0.30595517.15525658.html.plaintext.txt	18	orexin b synthesized precursor gene expressed neuron cell body concentrated lateral hypothalamus numnum
0.30595517.15525658.html.plaintext.txt	19	neuron project widely throughout central nervous system particular dense projection monoaminergic center
0.30595517.15525658.html.plaintext.txt	20	thought interact autonomic neuroendocrine arousal system excitatory effect orexin reviewed num
0.30595517.15525658.html.plaintext.txt	21	importantly study mouse null mutation gene orexin num one receptor num well transgenic mouse targeted ablation orexin neuron num revealed severe disturbance sleep wakefulness similar narcoleptic symptom human num
0.30595517.15525658.html.plaintext.txt	22	subsequent study shown human narcolepsy patient reduced level orexin cerebrospinal fluid csf num case number orexin neuron lateral hypothalamus reduced num
0.30595517.15525658.html.plaintext.txt	23	taken together finding strongly implicate orexin system sleep regulation
0.30595517.15525658.html.plaintext.txt	24	describe first time progressive loss orexin neuron ultrastructural sign neurodegeneration lateral hypothalamus rnumnum mouse
0.30595517.15525658.html.plaintext.txt	25	importantly also observed significant reduction number orexin positive neuron well significant atrophy remaining orexin neuron lateral hypothalamus hd patient
0.30595517.15525658.html.plaintext.txt	26	also report significant reduction orexin level rnumnum mouse csf suggests measuring csf level orexin hd patient could novel mean ass disease progression potential effect novel therapy
0.30595517.15525658.html.plaintext.txt	27	view larger version numk figure num
0.30595517.15525658.html.plaintext.txt	28	progressive loss atrophy orexin neuron rnumnum mouse
0.30595517.15525658.html.plaintext.txt	29	section lateral hypothalamus processed orexin immunohistochemistry wild type c rnumnum b d mouse num
0.30595517.15525658.html.plaintext.txt	30	scale bar num microm num microm c
0.30595517.15525658.html.plaintext.txt	31	progressive reduction density orexin immunopositive neuron e nnum num per genotype per age two factor anova genotype p num
0.30595517.15525658.html.plaintext.txt	32	num cross sectional surface area soma orexin positive neuron f nnum per genotype rnumnum mouse compared wild type littermates f two factor anova genotype p num
0.30595517.15525658.html.plaintext.txt	33	value represent mean plus minus sem
0.30595517.15525658.html.plaintext.txt	34	view larger version numk figure num
0.30595517.15525658.html.plaintext.txt	35	dark neuron degeneration rnumnum lateral hypothalamus
0.30595517.15525658.html.plaintext.txt	36	transmission electron micrographs lateral hypothalamus num week old wild type mouse rnumnum mouse b showing example dark degenerating nerve cell body rnumnum mouse
0.30595517.15525658.html.plaintext.txt	37	also studied frequency huntingtin inclusion orexin immunopositive neuron rnumnum mouse
0.30595517.15525658.html.plaintext.txt	38	num week old rnumnum mouse none orexin neuron lateral hypothalamus contained emnum immunopositive inclusion whereas num
0.30595517.15525658.html.plaintext.txt	39	num week num plus minus num orexin positive neuron emnum positive
0.30595517.15525658.html.plaintext.txt	40	num plus minus num neun immunopositive neuron num
0.30595517.15525658.html.plaintext.txt	41	num week old rnumnum lateral hypothalamus displayed emnum immunoreactive inclusion whereas num plus minus num remaining orexin positive neuron contained inclusion student test p num
0.30595517.15525658.html.plaintext.txt	42	using radioimmunoassay ria found significant reduction orexin b level rnumnum compared wild type mouse num
0.30595517.15525658.html.plaintext.txt	43	num week age hypothalamus remaining brain tissue student test p num
0.30595517.15525658.html.plaintext.txt	44	latter result indicates projection orexin neuron throughout cns affected
0.30595517.15525658.html.plaintext.txt	45	importantly found severe loss orexin immunoreactive fiber around third ventricle subcommisural organ region comprising pineal gland num num
0.30595517.15525658.html.plaintext.txt	46	also examined whether orexin level measured mouse csf could used biomarker disease compartment readily monitored living patient
0.30595517.15525658.html.plaintext.txt	47	indeed found marked reduction orexin csf num week old rnumnum mouse num plus minus num pgml nnum compared wild type littermates num plus minus num pgml nnum student test pnum
0.30595517.15525658.html.plaintext.txt	48	loss orexin fiber rnumnum pineal region
0.30595517.15525658.html.plaintext.txt	49	photomicrograph pineal region around third ventricle num week old wild type mouse rnumnum b mouse showing loss orexin fiber rnumnum mouse
0.30595517.15525658.html.plaintext.txt	50	pc posterior commisure sco subcommisural organ numv third ventricle
0.30595517.15525658.html.plaintext.txt	51	narcoleptic episode rnumnum mouse performed infrared video recording mouse different age first num h dark cycle analyze whether orexin loss rnumnum mouse would result appearance narcoleptic episode num
0.30595517.15525658.html.plaintext.txt	52	num week age rnumnum mouse indistinguishable wild type control period hyperactivity intense exploratory behavior intercalated prolonged period rest normal sleeping fig
0.30595517.15525658.html.plaintext.txt	53	num week age observed several period brief behavioral arrest rnumnum mouse num num episode per mouse group mediannum nnum fig
0.30595517.15525658.html.plaintext.txt	54	episode characterized sudden interruption purposeful motor activity associated change posture maintained throughout episode
0.30595517.15525658.html.plaintext.txt	55	closely resembled narcoleptic episode described orexin knockout mouse num
0.30595517.15525658.html.plaintext.txt	56	num week episode became even frequent num h observed num num group mediannum nnum num num episode behavioral arrest per mouse group mediannum nnum respectively fig
0.30595517.15525658.html.plaintext.txt	57	num week age episode occurred first third hour dark phase duration varied num num group averagenum nnum example distribution episode one rnumnum mouse illustrated fig
0.30595517.15525658.html.plaintext.txt	58	view larger version numk figure num
0.30595517.15525658.html.plaintext.txt	59	characterization narcoleptic episode rnumnum mouse
0.30595517.15525658.html.plaintext.txt	60	analysis narcoleptic episode performed first num h dark phase active period mouse
0.30595517.15525658.html.plaintext.txt	61	total number narcoleptic episode increase age rnumnum mouse
0.30595517.15525658.html.plaintext.txt	62	different mouse used time point
0.30595517.15525658.html.plaintext.txt	63	b duration narcoleptic episode one num
0.30595517.15525658.html.plaintext.txt	64	num week old rnumnum mouse time occurred illustrated vertical line
0.30595517.15525658.html.plaintext.txt	65	c total number narcoleptic episode per mouse divided three different category num
0.30595517.15525658.html.plaintext.txt	66	insert table show mean duration different category narcoleptic episode
0.30595517.15525658.html.plaintext.txt	67	d typical eegemg recording narcoleptic episode num
0.30595517.15525658.html.plaintext.txt	68	num week old rnumnum mouse showing reduced emg activity epileptic activity eeg
0.30595517.15525658.html.plaintext.txt	69	arrow indicate beginning end narcoleptic episode
0.30595517.15525658.html.plaintext.txt	70	contrast eegemg recording resting wild type mouse display continued low level emg activity even mouse ambulatory
0.30595517.15525658.html.plaintext.txt	71	arrow indicates beginning period
0.30595517.15525658.html.plaintext.txt	72	analyze behavior end stage mouse num
0.30595517.15525658.html.plaintext.txt	73	num week divided episode behavioral arrest three different category according severity num period movement num period movement abruptsudden change posture beginning episode num episode involving loss muscular tone andor sudden collapse head neck occasionally causing mouse fall completely onto side
0.30595517.15525658.html.plaintext.txt	74	rnumnum mouse studied nnum showed episode movement num num episode per mouse group mediannum
0.30595517.15525658.html.plaintext.txt	75	two animal also exhibited abrupt sudden change posture interestingly three mouse displayed interpreted narcoleptic episode complete fall onto side num num fall per mouse group mediannum fig
0.30595517.15525658.html.plaintext.txt	76	episode followed sudden bout locomotion typically hyperactive compared wild type control mouse
0.30595517.15525658.html.plaintext.txt	77	num week old rnumnum mouse displaying severe narcoleptic episode viewed online supplementary material
0.30595517.15525658.html.plaintext.txt	78	also evaluated behavior num week old rnumnum mouse daytime mouse normally largely spend sleeping
0.30595517.15525658.html.plaintext.txt	79	interestingly light phase diurnal cycle rnumnum mouse generally spent le time sleeping wild type mouse exhibited repeated sudden episode behavioral arrest sometimes associated abrupt change posture
0.30595517.15525658.html.plaintext.txt	80	episode never seen wild type littermate control data shown
0.30595517.15525658.html.plaintext.txt	81	rnumnum mouse known seizure prone num subjected different group num
0.30595517.15525658.html.plaintext.txt	82	num week old rnumnum nnum wild type nnum mouse eegemg recording order confirm observed episode behavioral arrest interpreted narcolepsy caused epileptiform brain activity
0.30595517.15525658.html.plaintext.txt	83	mouse videorecorded eegemg activity assessed episode behavioral arrest scored
0.30595517.15525658.html.plaintext.txt	84	video eeg recording revealed epileptiform electrographic activity type episode motor arrest
0.30595517.15525658.html.plaintext.txt	85	rather eeg characterized small amplitude theta activity reduced emg signal neck muscle fig
0.30595517.15525658.html.plaintext.txt	86	contrast wild type mouse occasionally paused movement emg activity decreased fig
0.30595517.15525658.html.plaintext.txt	87	orexin loss human hd brain ensure loss orexin containing neuron also relevant human hd examined lateral hypothalamus hd affected individual
0.30595517.15525658.html.plaintext.txt	88	average number orexin positive neuron per square millimeter section showing highest density orexin positive neuron subject given table num
0.30595517.15525658.html.plaintext.txt	89	control brain healthy individual average number orexin positive neuron per square millimeter estimated num plus minus num neuron
0.30595517.15525658.html.plaintext.txt	90	corresponding area brain hd affected individual grade ii iv average number orexin positive neuron num plus minus nummmnum student test p num
0.30595517.15525658.html.plaintext.txt	91	also significant neuronal atrophy detected reduction average cross sectional surface area orexin cell body hd patient num plus minus num micromnum compared control num plus minus num micromnum student test p num
0.30595517.15525658.html.plaintext.txt	92	reduction orexin neuron hd patient
0.30595517.15525658.html.plaintext.txt	93	representative photograph orexin immunopositive neuron lateral hypothalamus control individual hd patient b
0.30595517.15525658.html.plaintext.txt	94	illustration show atrophy individual neuron reduction orexin immunopositive neuron hd patient brain compared control brain
0.30595517.15525658.html.plaintext.txt	95	connection narcoleptic like episode loss orexin neuron lateral hypothalamus rnumnum mouse deficit orexin neurotransmission known result behavior reminiscent narcolepsy mouse dog num numnum
0.30595517.15525658.html.plaintext.txt	96	interestingly frequency duration general appearance narcoleptic episode seen rnumnum mouse similar observed genetically modified mouse lacking orexin carrying mutant orexin receptor num num
0.30595517.15525658.html.plaintext.txt	97	furthermore correlation progressive loss orexin neuron gradual onset narcoleptic phenotype rnumnum mouse
0.30595517.15525658.html.plaintext.txt	98	taken together striking motor arrest rnumnum mouse likely direct consequence observed loss orexin neuron
0.30595517.15525658.html.plaintext.txt	99	loss hypothalamic orexin containing neuron hd rnumnum mouse model clearly sensitive expression expanded polyglutamine protein mouse rat model expressing ataxin num construct increased number cag repeat control orexin promoter exhibited adult onset degeneration hypothalamic orexin neuron numnum
0.30595517.15525658.html.plaintext.txt	100	possibly expanded polyglutamine stretch disturb function crucial interacting protein
0.30595517.15525658.html.plaintext.txt	101	thus huntingtin associated protein num hap num partner huntingtin unknown function enriched hypothalamus null mutant mouse hap num die early owing impaired feeding exhibit hypothalamic degeneration num
0.30595517.15525658.html.plaintext.txt	102	study transgenic mouse model expressing first num amino acid huntingtin num glutamine nnum numq mouse also showed hap num depletion degeneration neuron hypothalamus
0.30595517.15525658.html.plaintext.txt	103	although transmitter identity dying neuron model established degenerative phenomenon included lateral hypothalamus
0.30595517.15525658.html.plaintext.txt	104	another explanation selective vulnerability hypothalamic orexin containing neuron may related expression nmda receptor
0.30595517.15525658.html.plaintext.txt	105	recently shown exposure rat hypothalamic culture excitotoxicity resulted specific loss orexin neuron num
0.30595517.15525658.html.plaintext.txt	106	excitotoxicity widely regarded likely contributor cell death hd numnum
0.30595517.15525658.html.plaintext.txt	107	evidence functional change glutamatergic pathway rnumnum mouse several level release transmitter inactivation receptor composition intracellular signaling neuron receiving glutamatergic input num num
0.30595517.15525658.html.plaintext.txt	108	despite little cell death striatum rnumnum mouse
0.30595517.15525658.html.plaintext.txt	109	possibly striatal neuron gradually develop resistance damage due protracted low grade excitotoxic stress num
0.30595517.15525658.html.plaintext.txt	110	resistance acute excitotoxic damage correlated number neuron exhibiting intranuclear inclusion rnumnum striatum num proportion generally lower lateral hypothalamus num study compared striatum num num
0.30595517.15525658.html.plaintext.txt	111	implication finding characterization death orexin neuron may shed light cellular event leading neuronal death hd
0.30595517.15525658.html.plaintext.txt	112	addition monitoring loss orexin containing neuron lateral hypothalamus may also important index measure therapeutic efficacy novel drug rnumnum mouse
0.30595517.15525658.html.plaintext.txt	113	change sleep behavior occurrence narcoleptic episode constitute functional outcome parameter follow
0.30595517.15525658.html.plaintext.txt	114	although study showing hd patient actually suffer symptom similar narcolepsy reported far sleep pattern disturbed num
0.30595517.15525658.html.plaintext.txt	115	indeed hd patient abnormal sleepwake cycle rnumnum mouse exhibit progressive disruption circadian rhythm caused dysregulation circadian rhythm gene suprachiasmatic nucleus hypothalamus j
0.30595517.15525658.html.plaintext.txt	116	morton personal communication
0.30595517.15525658.html.plaintext.txt	117	importantly found orexin fiber lost rnumnum pineal region involved regulating circadian rhythm via connection suprachiasmatic nucleus
0.30595517.15525658.html.plaintext.txt	118	hd state biomarkers available
0.30595517.15525658.html.plaintext.txt	119	plasma csf measurement substance secreted site neuropathology hypothalamus feasible identification affected neuronal subpopulation open new possibility identify marker
0.30595517.15525658.html.plaintext.txt	120	end stage rnumnum mouse number orexin neuron lateral hypothalamus level orexin csf reduced num compared wild type littermates
0.30595517.15525658.html.plaintext.txt	121	suggests orexin could used biomarker reflecting hypothalamic neurodegeneration
0.30595517.15525658.html.plaintext.txt	122	considering substantial loss atrophy orexin also human condition hypothesize symptomatic hd patient reduced csf orexin level level considered diagnostic narcolepsy
0.30595517.15525658.html.plaintext.txt	123	healthy individual normal orexin value csf num pgml
0.30595517.15525658.html.plaintext.txt	124	orexin level num pgml diagnostic narcolepsy num
0.30595517.15525658.html.plaintext.txt	125	one predict similar decrease hd patient study show hd patient vonsattel grade ii iii around num cag repeat
0.30595517.15525658.html.plaintext.txt	126	mild moderate case completely lost num orexin neuron
0.30595517.15525658.html.plaintext.txt	127	remaining num neuron undergone atrophy neuronal cross sectional area num representing even greater percentage loss volume cell taken together suggest reduction total cell volume atrophy cell death considered would lead reduction csf level orexin diagnostic level narcolepsy
0.30595517.15525658.html.plaintext.txt	128	considering scenario csf orexin level could constitute novel biomarker ass disease progression effectiveness therapeutic intervention hd
0.30595517.15525658.html.plaintext.txt	129	currently biomarker lacking hd
0.30595517.15525658.html.plaintext.txt	130	human hd brain evaluated formalin fixed brain five hd patient age num plus minus num year four control age num plus minus num year leiden university hospital brain bank table num
0.30595517.15525658.html.plaintext.txt	131	immunohistochemistry rnumnum mouse wild type littermates num
0.30595517.15525658.html.plaintext.txt	132	num week age perfused num paraformaldehyde
0.30595517.15525658.html.plaintext.txt	133	coronal section num microm cut six series throughout brain using microtome
0.30595517.15525658.html.plaintext.txt	134	tissue wild typecontrols rnumnumhd subject processed parallel immunohistochemistry control staining intensity time
0.30595517.15525658.html.plaintext.txt	135	processed free floating mouse section primary antibody following marker orexin diluted num num mouse tissue phoenix pharm
0.30595517.15525658.html.plaintext.txt	136	belmont ca usa neun diluted num num chemicon temecula ca usa gfap num num dako nissl stain cresyl violet icn biomedicals inc
0.30595517.15525658.html.plaintext.txt	137	double labeling employed mouse anti emnum antibody num num chemicon shown specific also mouse tissue num anti orexin antibody
0.30595517.15525658.html.plaintext.txt	138	paraffin embedded human brain section num microm immunohistochemically processed orexin num num human tissue phoenix pharm
0.30595517.15525658.html.plaintext.txt	139	cell measurement morphological analysis performed blind coded slide using olympus cast grid system olympus danmark albertslund denmark composed olympus bhnum microscope x y step motor run ibm personal computer
0.30595517.15525658.html.plaintext.txt	140	density orexin neuron lateral hypothalamus assessed three section largest number orexin immunopositive neuron per mouse age nnum num per genotype per age
0.30595517.15525658.html.plaintext.txt	141	outer border area orexin immunopositive neuron first delineated area assessed olympus cast grid system
0.30595517.15525658.html.plaintext.txt	142	using systematic random sampling technique number profile assessed num area
0.30595517.15525658.html.plaintext.txt	143	technique used mouse
0.30595517.15525658.html.plaintext.txt	144	profile characterized intense dark staining throughout cell body counted included independently size shape soma cell atrophied see result
0.30595517.15525658.html.plaintext.txt	145	average density orexin positive neuron three section mouse used statistical analysis
0.30595517.15525658.html.plaintext.txt	146	cross sectional soma area orexin neuron assessed num randomly selected orexin immunopositive neuron three section four mouse per genotype age using olympus cast grid system
0.30595517.15525658.html.plaintext.txt	147	area total number cell neuron emnum positive neuron analyzed num
0.30595517.15525658.html.plaintext.txt	148	presence emnum immunopositive inclusion orexin neuron analyzed num randomly selected orexin neuron three mentioned section four mouse per genotype age num
0.30595517.15525658.html.plaintext.txt	149	human brain compared section containing orexin positive cell individual selected section estimated show highest density orexin positive cell
0.30595517.15525658.html.plaintext.txt	150	section orexin positive cell counted four different field delineated num mmnum ocular grid
0.30595517.15525658.html.plaintext.txt	151	measured cross sectional soma area orexin cell body num orexin positive neuronsindividual using olympus cast grid system
0.30595517.15525658.html.plaintext.txt	152	radioimmunoassay hypothalamus dissected num
0.30595517.15525658.html.plaintext.txt	153	num week old mouse nnum per genotype csf withdrawn cisterna magna num week old mouse nnum per genotype used peptide extraction
0.30595517.15525658.html.plaintext.txt	154	using commercially available numi ria kit phoenix pharm
0.30595517.15525658.html.plaintext.txt	155	orexin csf brain tissue orexin b brain tissue measured
0.30595517.15525658.html.plaintext.txt	156	duplicate sample assayed level determined known standard
0.30595517.15525658.html.plaintext.txt	157	electron microscopy mouse num week age nnum per genotype perfused num
0.30595517.15525658.html.plaintext.txt	158	num m sorensen buffer containing num parafomaldehyde num glutaraldehyde
0.30595517.15525658.html.plaintext.txt	159	hypothalamus dissected fixed overnight fixative rinsed sorensen buffer post fixed num h num osonum buffer dehydrated acetone embedded polybed num
0.30595517.15525658.html.plaintext.txt	160	ultrathin section cut placed copper grid contrasted num
0.30595517.15525658.html.plaintext.txt	161	num lead citrate num uranyl acetate
0.30595517.15525658.html.plaintext.txt	162	specimen examined philip cmnum transmission electron microscope
0.30595517.15525658.html.plaintext.txt	163	scoring narcoleptic episode videorecorded scored narcoleptic episode num rnumnum wild type mouse following age num
0.30595517.15525658.html.plaintext.txt	164	different mouse used age
0.30595517.15525658.html.plaintext.txt	165	briefly mouse habituated num h individual glass cylinder covered bedding material recorded first num h dark cycle sony ccd infrared videocamera
0.30595517.15525658.html.plaintext.txt	166	behavioral experiment one rnumnum mouse one wild type mouse videorecorded simultaneously
0.30595517.15525658.html.plaintext.txt	167	scoring episode carried two investigator blinded mouse genotype
0.30595517.15525658.html.plaintext.txt	168	protocol used evaluate behavior num week old rnumnum mouse nnum light phase diurnal cycle
0.30595517.15525658.html.plaintext.txt	169	eegemg recording num week age mouse nnum rnumnum nnum wild type implanted recording electrode
0.30595517.15525658.html.plaintext.txt	170	one cortical screw electrode attached right parietal bone record eeg wire electrode insulated copper num microm diameter tip exposed num
0.30595517.15525658.html.plaintext.txt	171	num mm belden st louis mi usa attached occipital bone neck muscle record emg
0.30595517.15525658.html.plaintext.txt	172	electrode referred ground frontal screw electrode
0.30595517.15525658.html.plaintext.txt	173	two additional anchor screw attached onto left parietal frontal bone three way connector plastic one roanoke va usa fixed screw dental acrylic cement
0.30595517.15525658.html.plaintext.txt	174	num num day following electrode implantation pair mouse wild type rnumnum videotaped eegemg recorded continuously chart num
0.30595517.15525658.html.plaintext.txt	175	num powerlabmaclab adinstruments arhus denmark first num h dark cycle
0.30595517.15525658.html.plaintext.txt	176	videotape scored narcoleptic episode eeg parameter analyzed chart num
0.30595517.15525658.html.plaintext.txt	177	statistic data analyzed one two factor anova appropriate un paired student test using statview num
0.30595517.15525658.html.plaintext.txt	178	num package abacus concept berkeley ca usa
0.30595517.15525658.html.plaintext.txt	179	data presented mean median plus minus sem
0.30595517.15525658.html.plaintext.txt	180	footnote author wish known opinion first two author regarded joint first author
0.30595517.15525658.html.plaintext.txt	181	huntington disease collaborative research group
0.30595517.15525658.html.plaintext.txt	182	num novel gene containing trinucleotide repeat expanded unstable huntington disease chromosome
0.30595517.15525658.html.plaintext.txt	183	num wild type huntingtin play role brain development neuronal survival
0.30595517.15525658.html.plaintext.txt	184	num loss normal huntingtin function new development huntington disease research
0.30595517.15525658.html.plaintext.txt	185	num aggregation huntingtin neuronal intranuclear inclusion dystrophic neurites brain
0.30595517.15525658.html.plaintext.txt	186	num distribution inclusion neuronal nucleus dystrophic neurites huntington disease brain
0.30595517.15525658.html.plaintext.txt	187	num atrophy hypothalamic lateral tuberal nucleus huntington disease
0.30595517.15525658.html.plaintext.txt	188	num hypothalamic lateral tuberal nucleus characteristic neuronal loss huntington disease
0.30595517.15525658.html.plaintext.txt	189	num exon num hd gene expanded cag repeat sufficient cause progressive neurological phenotype transgenic mouse
0.30595517.15525658.html.plaintext.txt	190	num mouse model huntington disease
0.30595517.15525658.html.plaintext.txt	191	num nonapoptotic neurodegeneration transgenic mouse model huntington disease
0.30595517.15525658.html.plaintext.txt	192	num early alteration gene expression cell morphology mouse model huntington disease
0.30595517.15525658.html.plaintext.txt	193	num ampa nmda binding site hypothalamic lateral tuberal nucleus implication huntington disease
0.30595517.15525658.html.plaintext.txt	194	num energetics pathogenesis neurodegenerative disease
0.30595517.15525658.html.plaintext.txt	195	num excitotoxic degeneration hypothalamic orexin neuron slice culture
0.30595517.15525658.html.plaintext.txt	196	num hypocretins hypothalamus specific peptide neuroexcitatory activity
0.30595517.15525658.html.plaintext.txt	197	num orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.30595517.15525658.html.plaintext.txt	198	num hypocretin orexin role normal behavior neuropathology
0.30595517.15525658.html.plaintext.txt	199	num narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.30595517.15525658.html.plaintext.txt	200	num distinct narcolepsy syndrome orexin receptor num orexin null mouse molecular genetic dissection non rem rem sleep regulatory process
0.30595517.15525658.html.plaintext.txt	201	num genetic ablation orexin neuron mouse result narcolepsy hypophagia obesity
0.30595517.15525658.html.plaintext.txt	202	num narcolepsy key role hypocretins orexins
0.30595517.15525658.html.plaintext.txt	203	num csf hypocretinorexin level narcolepsy neurological condition
0.30595517.15525658.html.plaintext.txt	204	num mutation case early onset narcolepsy generalized absence hypocretin peptide human narcoleptic brain
0.30595517.15525658.html.plaintext.txt	205	num hypocretin orexin rat pineal gland central transmitter effect noradrenaline induced release melatonin
0.30595517.15525658.html.plaintext.txt	206	num progressive retinal degeneration dysfunction rnum huntington disease mouse
0.30595517.15525658.html.plaintext.txt	207	num experimental therapeutic transgenic mouse model huntington disease
0.30595517.15525658.html.plaintext.txt	208	jr num neuropathological classification huntington disease
0.30595517.15525658.html.plaintext.txt	209	num sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.30595517.15525658.html.plaintext.txt	210	num expression poly glutamine ataxin num transgene orexin neuron induces narcolepsy cataplexy rat
0.30595517.15525658.html.plaintext.txt	211	num lack huntingtin associated protein num cause neuronal death resembling hypothalamic degeneration huntington disease
0.30595517.15525658.html.plaintext.txt	212	num transient progressive electrophysiological alteration corticostriatal pathway mouse model huntington disease
0.30595517.15525658.html.plaintext.txt	213	num impaired glutamate uptake rnum huntington disease transgenic mouse
0.30595517.15525658.html.plaintext.txt	214	num altered striatal amino acid neurotransmitter release monitored using microdialysis rnumnum huntington transgenic mouse
0.30595517.15525658.html.plaintext.txt	215	num resistance nmda toxicity correlate appearance nuclear inclusion behavioural deficit change calcium homeostasis mouse transgenic exon num huntington gene
0.30595517.15525658.html.plaintext.txt	216	num abnormal association mutant huntingtin synaptic vesicle inhibits glutamate release
0.30595517.15525658.html.plaintext.txt	217	num impaired glutamate transport glutamate glutamine cycling downstream effect huntington mutation
0.30595517.15525658.html.plaintext.txt	218	num transgenic mouse expressing huntington disease mutation resistant quinolinic acid induced striatal excitotoxicity
0.30595517.15525658.html.plaintext.txt	219	num progressive formation inclusion striatum hippocampus mouse transgenic human huntington disease mutation
0.30595517.15525658.html.plaintext.txt	220	num sleep quantitative eeg neurodegenerative disorder
0.30595517.15525658.html.plaintext.txt	221	num role cerebrospinal fluid hypocretin measurement diagnosis narcolepsy hypersomnia
0.30595517.15525658.html.plaintext.txt	222	num huntingtin inclusion deplete polyglutamine containing transcription factor hd mouse
0.32579625.12933647.html.plaintext.txt	0	fasting activates nonhuman primate hypocretin orexin system postsynaptic target sabrina diano balazs horvath henryk f
0.32579625.12933647.html.plaintext.txt	1	urbanski peter sotonyi tamas l
0.32579625.12933647.html.plaintext.txt	2	department obstetrics gynecology
0.32579625.12933647.html.plaintext.txt	3	yale university school medicine new haven connecticut num division neuroscience h
0.32579625.12933647.html.plaintext.txt	4	oregon regional primate research center beaverton oregon num department anatomy histology p
0.32579625.12933647.html.plaintext.txt	5	szent istvan university school veterinary medicine budapest hungary num
0.32579625.12933647.html.plaintext.txt	6	address correspondence request reprint tamas l
0.32579625.12933647.html.plaintext.txt	7	horvath department obstetrics gynecology yale medical school num cedar street fmb num new haven connecticut num
0.32579625.12933647.html.plaintext.txt	8	rodent hypocretin hcrt also called orexin influence variety endocrine autonomic metabolic function
0.32579625.12933647.html.plaintext.txt	9	present study undertaken determine whether hcrt producing circuit involved hypothalamic regulation homeostasis primate well
0.32579625.12933647.html.plaintext.txt	10	studied female monkey cercopithecus aethiops either fed fasted num h
0.32579625.12933647.html.plaintext.txt	11	immunocytochemistry revealed hcrt producing perikarya exclusively lateral hypothalamus perifornical region dorsomedial hypothalamus monkey brain
0.32579625.12933647.html.plaintext.txt	12	hcrt axon axon terminal present different part hypothalamus adjacent forebrain thalamic nucleus
0.32579625.12933647.html.plaintext.txt	13	num h fast resulted approximately num decline circulating leptin level significantly elevated c fo expression perifornical region dorsomedial ventromedial arcuate nucleus medial preoptic area
0.32579625.12933647.html.plaintext.txt	14	dorsomedial nucleus perifornical region fasted monkey three time hcrt neuron expressed nuclear c fo normally fed control
0.32579625.12933647.html.plaintext.txt	15	neuron different part hypothalamus basal forebrain expressed c fo contain hcrt target hcrt immunopositive boutons establishing asymmetric synapsis
0.32579625.12933647.html.plaintext.txt	16	arcuate nucleus subset hcrt targeted c fo expressing cell contained neuropeptide y
0.32579625.12933647.html.plaintext.txt	17	present study provides first experimental evidence implicate hcrt hypothalamic regulation homeostasis primate
0.32579625.12933647.html.plaintext.txt	18	fact lateral hypothalamic cell leptin receptor activated metabolic challenge innervate diverse brain region indicates hcrt system may key integrator environmental cue regulation diverse brain activity
0.32579625.12933647.html.plaintext.txt	19	energy homeostasis regulated discrete central nervous system circuit predominantly hypothalamic area sensitive peripheral metabolic signal num
0.32579625.12933647.html.plaintext.txt	20	great part current understanding human physiology disorder hypothalamus inferred rodent model whereas little known primate hypothalamic circuit control homeostasis
0.32579625.12933647.html.plaintext.txt	21	particular clear whether peptidergic circuit known involved hypothalamic regulation rodent homeostasis similar function primate brain
0.32579625.12933647.html.plaintext.txt	22	hypocretin hcrt also called orexin peptide produced exclusively hypothalamus num num num emerged important regulator autonomic endocrine metabolic function rodent num num num
0.32579625.12933647.html.plaintext.txt	23	hcrt cell rat monkey found express leptin receptor immunoreactivity provide synaptic input distinct hypothalamic brainstem circuit known participate central regulation endocrine metabolic autonomic system num num
0.32579625.12933647.html.plaintext.txt	24	although determination synaptic interaction hcrt hypothalamic system provided map via signal may travel within hypothalamus demonstrate whether signaling modality involved homeostatic regulation
0.32579625.12933647.html.plaintext.txt	25	determination cytochemical identification c fo indicator cell activity different metabolic condition may used
0.32579625.12933647.html.plaintext.txt	26	metabolic challenge distinct population hypothalamic neuron begin express c fo rat num well monkey num
0.32579625.12933647.html.plaintext.txt	27	using paradigm current study aimed determine whether monkey hypothalamus hcrt cell postsynaptic target activated metabolic challenge fasting
0.32579625.12933647.html.plaintext.txt	28	num kg female african green monkey cercopithecus aethiops n num used
0.32579625.12933647.html.plaintext.txt	29	monkey previously ovariectomized use unrelated experiment three monkey killed fasting food withdrawal num h whereas three killed without fasting
0.32579625.12933647.html.plaintext.txt	30	primate tissue collected protocol approved yale animal care use committee
0.32579625.12933647.html.plaintext.txt	31	receiving lethal dose anesthetic monkey killed transcardial perfusion num ml heparinized saline num
0.32579625.12933647.html.plaintext.txt	32	num followed num ml fixative consisting num paraformaldehyde num saturated picric acid num
0.32579625.12933647.html.plaintext.txt	33	num m phosphate buffer pb ph num
0.32579625.12933647.html.plaintext.txt	34	mediobasal hypothalamus dissected postfixed additional num
0.32579625.12933647.html.plaintext.txt	35	num h glutaraldehyde free fixative
0.32579625.12933647.html.plaintext.txt	36	tissue block washed stored num
0.32579625.12933647.html.plaintext.txt	37	light electron microscopic double immunostaining light microscopic double immunostaining hcrt c fo carried according previously published protocol
0.32579625.12933647.html.plaintext.txt	38	section incubated one primary antiserum rabbit anti hcrt numnum processed avidin biotin peroxidase technique
0.32579625.12933647.html.plaintext.txt	39	immunoreaction visualized modified version nickel diaminobenzidine dab reaction num mg dab num
0.32579625.12933647.html.plaintext.txt	40	num mg glucose oxidase num mg ammonium chloride num microl num
0.32579625.12933647.html.plaintext.txt	41	num m nickel ammonium sulfate num microl num s d glucose num ml pb resulting dark blue reaction product
0.32579625.12933647.html.plaintext.txt	42	several rinse pb section incubated sheep anti c fo numnum cambridge research biochemicals inc
0.32579625.12933647.html.plaintext.txt	43	wilmington de num h num c processed peroxidase anti peroxidase technique
0.32579625.12933647.html.plaintext.txt	44	tissue bound peroxidase visualized dab reaction num mg dab num microl num
0.32579625.12933647.html.plaintext.txt	45	num hnumonum num ml pb resulting light brown reaction product
0.32579625.12933647.html.plaintext.txt	46	visualization tissue antigen section processed electron microscopy num osonum pb num min
0.32579625.12933647.html.plaintext.txt	47	dehydrated increasing ethanol concentration using num uranyl acetate num ethanol num min flat embedded araldite liquid release coated slide electron microscopy science fort washington pa
0.32579625.12933647.html.plaintext.txt	48	specificity hcrt antiserum thoroughly tested u others previous study num num
0.32579625.12933647.html.plaintext.txt	49	analysis c fo expressing cell single double labeled c fo hcrt material estimate induction c fo expression primate hypothalamus num h fasting matching section hypothalamus control fasted monkey coincubated vial either single immunostaining c fo double immunostaining c fo hcrt see
0.32579625.12933647.html.plaintext.txt	50	ensure matching section coprocessed section selected using comparative assessment location following anatomical landmark optic chiasm tract shape third ventricle anterior commissure fornix mammilo thalamic tract median eminence
0.32579625.12933647.html.plaintext.txt	51	one group section either control experimental marked placing notch one side tissue block vibratome sectioning
0.32579625.12933647.html.plaintext.txt	52	analyzer blind code revealed collection count
0.32579625.12933647.html.plaintext.txt	53	immunostaining completed three set coincubations six monkey three control three experimental matching section placed slide coverslipped analyzed using light microscopy
0.32579625.12933647.html.plaintext.txt	54	number c fo immunolabeled cell labeled hcrt labeled antigen noted several nucleus hypothalamus see
0.32579625.12933647.html.plaintext.txt	55	cell surface section counted
0.32579625.12933647.html.plaintext.txt	56	guided stereotaxic atlas african green monkey num following hypothalamic area analyzed medial preoptic area mpoa parvicellular magnocellular paraventricular nucleus arcuate infundibular nucleus arc dorsomedial hypothalamic nucleus ventromedial nucleus lateral hypothalamus perifornical region
0.32579625.12933647.html.plaintext.txt	57	determining mean value student test used comparison
0.32579625.12933647.html.plaintext.txt	58	significance concluded p num
0.32579625.12933647.html.plaintext.txt	59	light microscopic triple immunostaining hcrt present neuronal perikarya arc c fo expressed cell nucleus neuropeptide y npy expressed cytoplasm neuron triple labeled hypothalamic section using triple labeling protocol num
0.32579625.12933647.html.plaintext.txt	60	section first incubated num h room temperature mixture hcrt c fo antiserum processed avidin biotin peroxidase tissue bound peroxidase visualized nickel diaminobenzidine reaction resulting dark blue black color
0.32579625.12933647.html.plaintext.txt	61	subsequently section immunostained npy using sheep anti npy auspep pty ltd
0.32579625.12933647.html.plaintext.txt	62	perkwille australia peroxidase antiperoxidase method tissue bound peroxidase visualized dab reaction give light brown reaction product
0.32579625.12933647.html.plaintext.txt	63	leptin measurement blood sample collected morning serum stored frozen
0.32579625.12933647.html.plaintext.txt	64	sample collected animal fasted
0.32579625.12933647.html.plaintext.txt	65	leptin measured using primate leptin ria kit linco research inc
0.32579625.12933647.html.plaintext.txt	66	minimum detectable concentration num binding num
0.32579625.12933647.html.plaintext.txt	67	num ng ml interassay coefficient variation num serum sample assayed together single ria
0.32579625.12933647.html.plaintext.txt	68	student test two tail probability used statistical comparison leptin value two group
0.32579625.12933647.html.plaintext.txt	69	significance concluded p num
0.32579625.12933647.html.plaintext.txt	70	circulating leptin level fasted normally fed control african green monkey circulating leptin level value differ fasted control group num h num
0.32579625.12933647.html.plaintext.txt	71	num significantly lower fasted animal num h fast num
0.32579625.12933647.html.plaintext.txt	72	overall pattern hcrt immunolabeling monkey corresponded earlier description num num
0.32579625.12933647.html.plaintext.txt	73	hcrt immunoreactive perikarya present exclusively lateral hypothalamus perifornical region lesser extent dorsomedial hypothalamus whereas projection abundant different hypothalamic nucleus
0.32579625.12933647.html.plaintext.txt	74	detected obvious difference hcrt immunoreactivity hypothalamus control v
0.32579625.12933647.html.plaintext.txt	75	accordance recent report num c fo immunoreactivity detected different part hypothalamus fasted normally fed control monkey
0.32579625.12933647.html.plaintext.txt	76	control animal moderate number c fo labeled nucleus homogenously distributed mpoa periventricular region paraventricular nucleus parvo magnocellular region anterior hypothalamus suprachiasmatic arcuate dorsomedial ventromedial nucleus lateral hypothalamus perifornical region
0.32579625.12933647.html.plaintext.txt	77	number c fo expressing cell individual hypothalamic subnuclei fasted monkey distinctly different control value fig
0.32579625.12933647.html.plaintext.txt	78	fasted animal significantly higher number c fo expressing cell detected mpoa num plus minus num v
0.32579625.12933647.html.plaintext.txt	79	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	80	num lateral hypothalamus perifornical lh pf region num plus minus num v
0.32579625.12933647.html.plaintext.txt	81	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	82	num b arcuate num plus minus num v
0.32579625.12933647.html.plaintext.txt	83	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	84	num dorsomedial nucleus num plus minus num v
0.32579625.12933647.html.plaintext.txt	85	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	86	view larger version numk fig
0.32579625.12933647.html.plaintext.txt	87	light micrographs monkey perifornical region pf immunostaining c fo taken control fasted animal b
0.32579625.12933647.html.plaintext.txt	88	c bar graph showing number c fo immunoreactive nucleus different part hypothalamus control white bar fasted black bar animal
0.32579625.12933647.html.plaintext.txt	89	addition difference albeit nonsignificant detected ventromedial num plus minus num v
0.32579625.12933647.html.plaintext.txt	90	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	91	num parvicellular paraventricular num plus minus num v
0.32579625.12933647.html.plaintext.txt	92	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	93	num magnocellular paraventricular hypothalamic nucleus num plus minus num v
0.32579625.12933647.html.plaintext.txt	94	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	95	however noted low sample value n num may mask significant difference might detected higher number animal studied
0.32579625.12933647.html.plaintext.txt	96	c fo expression hcrt cell c fo immunoreactivity detected cell nucleus hcrt immunoreactive cell control num h fasted animal fig
0.32579625.12933647.html.plaintext.txt	97	difference mean number hcrt labeled cell control fasted animal num plus minus num v
0.32579625.12933647.html.plaintext.txt	98	num plus minus num p num
0.32579625.12933647.html.plaintext.txt	99	however percentage hcrt cell expressing nuclear c fo robustly significantly elevated fasted animal compared control value p num
0.32579625.12933647.html.plaintext.txt	100	control lh pf num plus minus num hcrt cell exhibited nuclear c fo labeling represented num
0.32579625.12933647.html.plaintext.txt	101	num total hcrt cell counted
0.32579625.12933647.html.plaintext.txt	102	contrast fasted animal num plus minus num hcrt cell exhibited c fo immunoreactivity represented num
0.32579625.12933647.html.plaintext.txt	103	num total hcrt cell counted fig
0.32579625.12933647.html.plaintext.txt	104	number c fo expressing neuron contained hcrt control monkey num plus minus num represented approximately num cell c fo immunopositive num plus minus num lh pf region
0.32579625.12933647.html.plaintext.txt	105	ratio remains similar fasted animal num num total c fo immunolabaled nucleus num plus minus num hcrt immunoreactive perikarya fig
0.32579625.12933647.html.plaintext.txt	106	view larger version numk fig
0.32579625.12933647.html.plaintext.txt	107	fasting induced c fo expression associated exclusively cell nucleus c
0.32579625.12933647.html.plaintext.txt	108	perifornical region many nuclear c fo labeled cell red nucleus b d also immunopositive hcrt
0.32579625.12933647.html.plaintext.txt	109	bar scale c num microm b num microm c d
0.32579625.12933647.html.plaintext.txt	110	e bar graph showing c fo immunoreactive hcrt neuron white bar total hcrt neuron black bar counted control fasted animal
0.32579625.12933647.html.plaintext.txt	111	f bar graph showing c fo immunoreactive hcrt neuron white bar total c fo immunolabeled neuron black bar counted control fasted animal
0.32579625.12933647.html.plaintext.txt	112	hypocretin axon synapse c fo containing cell analyzed light microscopy apparent control fasted animal c fo immunolabeled cell surrounded numerous hcrt immunopositive boutons fig
0.32579625.12933647.html.plaintext.txt	113	region significant elevation c fo labeling fasting mpoa arc lh pf dorsomedial nucleus found c fo immunolabeled cell either control experimental group contacted numerous hcrt labeled axon terminal
0.32579625.12933647.html.plaintext.txt	114	synaptic membrane specialization hcrt boutons c fo expressing cell asymmetrical contact fig
0.32579625.12933647.html.plaintext.txt	115	arc increased c fo expression detected fasting hypothalamic npy producing cell located hcrt axon close proximity perikarya contained npy c fo fig
0.32579625.12933647.html.plaintext.txt	116	view larger version numk fig
0.32579625.12933647.html.plaintext.txt	117	region monkey hypothalamus c fo induction observed fasting cell nucleus hcrt boutons observed close apposition activated cell electron microscopy showed b c contact synapsis arrow c point membrane specialization
0.32579625.12933647.html.plaintext.txt	118	bar scale num microm num microm b c
0.32579625.12933647.html.plaintext.txt	119	view larger version numk fig
0.32579625.12933647.html.plaintext.txt	120	subset fasting activated hcrt targeted cell npy cell arc
0.32579625.12933647.html.plaintext.txt	121	present study provides first suggestive evidence hcrt system nonhuman primate involved hypothalamic signal transduction associated metabolic alteration
0.32579625.12933647.html.plaintext.txt	122	fact short term food withdrawal underlies robust activation transcriptional mechanism primate lateral hypothalamic hcrt system together widespread distribution hcrt projection homeostatic center beyond argues coordinating role hcrt autonomic endocrine metabolic process
0.32579625.12933647.html.plaintext.txt	123	assertion line evidence available role hcrt modulation food intake blood pressure arousal num num num num num
0.32579625.12933647.html.plaintext.txt	124	previous study num monkey arc found receive robust hcrt innervation hcrt axon heavily innervating npy cell num
0.32579625.12933647.html.plaintext.txt	125	whether arc npy system may participate modulation hcrt food intake primate suggested rat num num remains tested
0.32579625.12933647.html.plaintext.txt	126	present observation hcrt input fasting activated npy cell african green monkey lends support possibility
0.32579625.12933647.html.plaintext.txt	127	nevertheless also conceivable activation hcrt neuron fasting occurs secondary activation arc
0.32579625.12933647.html.plaintext.txt	128	however arc npy cell likely protected blood brain barrier direct projection arc lateral hypothalamus robust nonhuman primate num
0.32579625.12933647.html.plaintext.txt	129	may also plausible hcrt system heavily involved regulation sleepwake cycle disturbance sleep fasting affect hcrt neuronal function
0.32579625.12933647.html.plaintext.txt	130	alternatively metabolic signal affect hcrt cell fasting sleep disturbance may consequence hcrt neuronal activation
0.32579625.12933647.html.plaintext.txt	131	leptin receptor immunoreactivity detected primate lateral hypothalamic hcrt cell num leptin suggested cross blood brain barrier num
0.32579625.12933647.html.plaintext.txt	132	thus observed induction c fo gene expression hcrt cell may direct consequence diminishing leptin level observed short term fasting
0.32579625.12933647.html.plaintext.txt	133	however fasting paradigm particularly used primate allow distinction effect particular hormone underlie complex response variety endocrine mechanism
0.32579625.12933647.html.plaintext.txt	134	example rodent evidence available indicate circulating insulin andor glucose level regulatory influence hypothalamic hcrt expression num
0.32579625.12933647.html.plaintext.txt	135	future study determine extent contribution involved humoral metabolic signal activation primate hcrt system
0.32579625.12933647.html.plaintext.txt	136	interestingly hypothalamic nucleus including arc lh pf dorsomedial nucleus mpoa short term fasting induced c fo expression robustly activated cell received multiple hcrt input
0.32579625.12933647.html.plaintext.txt	137	rodent hcrt exerts excitatory postsynaptic current num intracerebroventricular administration hcrt induces c fo expression manner dissimilar describe nonhuman primate num num
0.32579625.12933647.html.plaintext.txt	138	synaptic membrane specialization hcrt axon c fo expressing perikarya primate hypothalamus asymmetrical stimulatory synapsis activation hypothalamic circuitry metabolic challenge may mediated part hcrt system
0.32579625.12933647.html.plaintext.txt	139	thank anthony van den pol providing hcrt antiserum
0.32579625.12933647.html.plaintext.txt	140	work supported nih grant rr num
0.32579625.12933647.html.plaintext.txt	141	albert szent gyorgyi fellow
0.32579625.12933647.html.plaintext.txt	142	abbreviation arc arcuate nucleus dab diaminobenzidine hcrt hypocretin lh pf lateral hypothalamus perifornical mpoa medial preoptic area npy neuropeptide y pb phosphate buffer
0.32579625.12933647.html.plaintext.txt	143	accepted publication june num num
0.32579625.12933647.html.plaintext.txt	144	kalra sp xu b dube mg pu horvath tl kalra p num interacting appetite regulating pathway hypothalamic regulation body weight
0.32579625.12933647.html.plaintext.txt	145	endocr rev numnum num de lecea l kilduff t peyron c gao xb foye pe danielson pe fukuhara c battenberg elf gautvik vt bartlett ii f frankel wn van den pol bloom fe gautvik km sutcliffe jg num hypocretins two hypothalamic peptide neuroexcitatory activity
0.32579625.12933647.html.plaintext.txt	146	proc natl acad sci usa numnum numabstractfree full text sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan r mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m num orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.32579625.12933647.html.plaintext.txt	147	cell numnum nummedline horvath tl diano van den pol num synaptic interaction hypocretin orexin neuropeptide y cell rodent primate hypothalamus novel circuit implicated metabolic endocrine regulation
0.32579625.12933647.html.plaintext.txt	148	j neurosci numnum numabstractfree full text chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m num narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.32579625.12933647.html.plaintext.txt	149	cell numnum nummedline lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e num sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.32579625.12933647.html.plaintext.txt	150	cell numnum nummedline horvath tl peyron c diano ivanov aston jones g kilduff t van den pol num hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system
0.32579625.12933647.html.plaintext.txt	151	conum u numcrossrefmedline caston balderrama al cameron jl hoffman ge num immunocytochemical localization fo perfused nonhuman primate brain tissue fixation antiserum selection
0.32579625.12933647.html.plaintext.txt	152	j histochem cytochem numnum numabstractfree full text contreras cm mexicano g guzman flores c num stereotaxic brain atlas green monkey cecopithecus aethiops aethiops
0.32579625.12933647.html.plaintext.txt	153	bol estud med biol numnum nummedline samson wk gosnell b chang jk resch zt murphy tc num cardiovascular regulatory action hypocretins brain
0.32579625.12933647.html.plaintext.txt	154	brain re numnum num kukkonen jp holmqvist ammoun akerman ke num function orexinergichypocretinergic system
0.32579625.12933647.html.plaintext.txt	155	j physiol cell physiol numcnum cnum jain mr horvath tl kalra p kalra sp num evidence npy ynum receptor involved stimulation feeding orexins hypocretins sated rat
0.32579625.12933647.html.plaintext.txt	156	regul pept numnum num lopez m seoane lm garcia mdel c dieguez c senaris r num neuropeptide y agouti related peptide melanin concentrating hormone target peptide orexin feeding action rat hypothalamus
0.32579625.12933647.html.plaintext.txt	157	neuroendocrinology numnum numcrossrefmedline bjorbaek c elmquist jk michl p ahima r vanbueren mccall al flier j num expression leptin receptor isoform rat brain microvessels
0.32579625.12933647.html.plaintext.txt	158	endocrinology numnum numabstractfree full text cai xj widdowson p harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g num hypothalamic orexin expression modulation blood glucose feeding
0.32579625.12933647.html.plaintext.txt	159	diabetes numnum num van den pol gao xb obrietan k kilduff belousov num pre postsynaptic action modulation neuroendocrine neuron new hypothalamic peptide hypocretinorexin
0.32579625.12933647.html.plaintext.txt	160	j neurosci numnum numabstractfree full text date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m num orexins orexigenic hypothalamic peptide interact autonomic neuroendocrine neuroregulatory system
0.32579625.12933647.html.plaintext.txt	161	proc natl acad sci usa numnum numabstractfree full text mullett ma billington cj levine kotz cm num hypocretin lateral hypothalamus activates key feeding regulatory brain site
0.32579625.12933647.html.plaintext.txt	162	neuroreport numnum nummedline
0.35575834.12419707.html.plaintext.txt	0	invited review function orexinergichypocretinergic system jyrki p
0.35575834.12419707.html.plaintext.txt	1	kukkonennum tomas holmqvistnum sylwia ammounnum karl e
0.35575834.12419707.html.plaintext.txt	2	num laboratory cell physiology department neuroscience division physiology uppsala university biomedical center se num uppsala sweden num department neurobiology
0.35575834.12419707.html.plaintext.txt	3	virtanen institute molecular science university kuopio bioteknia fin num kuopio finland
0.35575834.12419707.html.plaintext.txt	4	orexin orexin b hypothalamic peptide act target via two g protein coupled receptor oxnum oxnum receptor
0.35575834.12419707.html.plaintext.txt	5	central nervous system cell body producing orexins localized narrow region within lateral hypothalamus project mainly region involved feeding sleep autonomic function
0.35575834.12419707.html.plaintext.txt	6	via putative pre postsynaptic effect orexins increase synaptic activity region
0.35575834.12419707.html.plaintext.txt	7	isolated neuron cell expressing recombinant receptor orexins cause canum elevation mainly dependent influx
0.35575834.12419707.html.plaintext.txt	8	activity orexinergic cell appears controlled feeding sleep related signal via variety neurotransmittershormones brain tissue
0.35575834.12419707.html.plaintext.txt	9	orexins orexin receptor also found outside central nervous system particularly organ involved feeding energy metabolism e
0.35575834.12419707.html.plaintext.txt	10	gastrointestinal tract pancreas adrenal gland
0.35575834.12419707.html.plaintext.txt	11	present review focus physiological property cell secrete respond orexins
0.35575834.12419707.html.plaintext.txt	12	sleep feeding calcium neuron neuroendocrine regulation
0.35575834.12419707.html.plaintext.txt	13	knowledge orexinergic system initiated num two independent group approach reviewed ref
0.35575834.12419707.html.plaintext.txt	14	january num group sutcliffe published study num predicted particular rat hypothalamic mrna specie clone num ref
0.35575834.12419707.html.plaintext.txt	15	num would code precursor peptide num amino acid aa length molecule would generate two separate peptide num num aa length
0.35575834.12419707.html.plaintext.txt	16	peptide named hypocretins basis hypothalamic localization proposed sequence similarity secretin family peptide however orexin b bear significant resemblance secretin
0.35575834.12419707.html.plaintext.txt	17	precursor peptide would thus preprohypocretin two final peptide hypocretin hcrt num hcrt num
0.35575834.12419707.html.plaintext.txt	18	simultaneously work group sutcliffe group yanagisawa num isolated hypothalamic num aa peptide activated orphan receptor hfgannum
0.35575834.12419707.html.plaintext.txt	19	receptor found also respond another peptide num aa length
0.35575834.12419707.html.plaintext.txt	20	second receptor cloned basis sequence similarity hfgannum receptor also responded isolated peptide canum elevation
0.35575834.12419707.html.plaintext.txt	21	basis peptide sequence sakurai coworkers num cloned cdna precursor peptide num aa rat
0.35575834.12419707.html.plaintext.txt	22	peptide named orexins increased food intake nonfasted rat injected lateral ventricle
0.35575834.12419707.html.plaintext.txt	23	precursor peptide thus became preproorexin num num aa final peptide orexin orexin b respectively receptor oxnum oxnum receptor
0.35575834.12419707.html.plaintext.txt	24	preprohypocretin preproorexin found preferentially rat brain specifically hypothalamus num num
0.35575834.12419707.html.plaintext.txt	25	cellular systemic response peptide observed rat
0.35575834.12419707.html.plaintext.txt	26	application hcrt num increased postsynaptic current frequency rat hypothalamic neuron culture num orexin b increased food intake nonfasted rat num
0.35575834.12419707.html.plaintext.txt	27	soon became clear peptide isolated two group principle identical
0.35575834.12419707.html.plaintext.txt	28	however error peptide sequence deduced de lecea coworkers num author refer accepted sequence sakurai et al
0.35575834.12419707.html.plaintext.txt	29	num de lecea et al
0.35575834.12419707.html.plaintext.txt	30	num even using hypocretin nomenclature
0.35575834.12419707.html.plaintext.txt	31	therefore current praxis make preproorexin preprohypocretin orexin hcrt num orexin b hcrt num oxnum receptor hcrtr num oxnum receptor hcrtr num
0.35575834.12419707.html.plaintext.txt	32	ongoing argument concerning nomenclature used
0.35575834.12419707.html.plaintext.txt	33	avoid confusion sequence use orexin nomenclature throughout review
0.35575834.12419707.html.plaintext.txt	34	today wealth information concerning anatomic architecture orexinergic system well systemic effect orexins
0.35575834.12419707.html.plaintext.txt	35	prominent well demonstrated effect orexins undoubtedly regulation sleepwakefulness reviewed ref
0.35575834.12419707.html.plaintext.txt	36	although many response shown physiological significance le clear
0.35575834.12419707.html.plaintext.txt	37	effect feeding behavior demonstrated multitude study result somewhat contradictory
0.35575834.12419707.html.plaintext.txt	38	current view orexins may rather regulate short term appetite energy metabolism feeding associated process e
0.35575834.12419707.html.plaintext.txt	39	gastrointestinal function mastication
0.35575834.12419707.html.plaintext.txt	40	orexins also affect hormonal secretion well demonstrated effect hormone involved stress response energy metabolism glucocorticoid norepinephrine
0.35575834.12419707.html.plaintext.txt	41	time information concerning regulatory mechanism orexinergic system target cellular level lagging behind
0.35575834.12419707.html.plaintext.txt	42	review try create comprehensive picture orexins proven putative physiological role
0.35575834.12419707.html.plaintext.txt	43	main emphasis placed functional property interaction orexin producing orexin responding cell
0.35575834.12419707.html.plaintext.txt	44	genetics chemistry orexins
0.35575834.12419707.html.plaintext.txt	45	mammalian human pig dog rat mouse preproorexin composed num num aa num num num num num
0.35575834.12419707.html.plaintext.txt	46	human preproorexin gene chromosome num thoroughly characterized num
0.35575834.12419707.html.plaintext.txt	47	composed two exon latter includes whole coding region final peptide
0.35575834.12419707.html.plaintext.txt	48	num kb promoter region preproorexin gene seems enough direct expression downstream gene lateral hypothalamus mouse num
0.35575834.12419707.html.plaintext.txt	49	utilized cause selective depletion orexinergic neuron transgenic mouse expressing preproorexin ataxin num fusion protein num
0.35575834.12419707.html.plaintext.txt	50	mouse orexinergic neuron progressively lost postnatally
0.35575834.12419707.html.plaintext.txt	51	transcription essential part suggested num bp proximal gene num
0.35575834.12419707.html.plaintext.txt	52	cleavage one molecule preproorexin modification lead production one molecule orexin orexin b however hplc detection orexins human brain suggests two fivefold higher level orexin b orexin several area central nervous system cns num num num num
0.35575834.12419707.html.plaintext.txt	53	mammalian orexin rat num aa peptide two intrachain disulfide bridge orexin b num aa linear peptide fig
0.35575834.12419707.html.plaintext.txt	54	substantial sequence identity cooh terminus peptide
0.35575834.12419707.html.plaintext.txt	55	addition orexin b secretin contain identical stretch seven amino acid
0.35575834.12419707.html.plaintext.txt	56	orexin b likely cooh terminally amidated nhnum terminal glutamine residue orexin may modified pyroglutamoyl residue num however posttranslational modification experimentally verified rat
0.35575834.12419707.html.plaintext.txt	57	orexin human pig dog rat mouse identical fig
0.35575834.12419707.html.plaintext.txt	58	numb whereas orexin b pig dog differs one amino acid orexin b rat mouse two amino acid human orexin b fig
0.35575834.12419707.html.plaintext.txt	59	three dimensional structure orexin known orexin b determined consist two helix num num degree angle num
0.35575834.12419707.html.plaintext.txt	60	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	61	alignment orexin orexin b peptide sequence different specie c
0.35575834.12419707.html.plaintext.txt	62	gray box indicate dissimilar amino acid compared human orexin variant
0.35575834.12419707.html.plaintext.txt	63	cystine bridge orexin shown black line
0.35575834.12419707.html.plaintext.txt	64	d oxnum receptor antagonist sb num
0.35575834.12419707.html.plaintext.txt	65	orexin seems much higher stability orexin b physiological milieu num may explain orexin readily detected cerebrospinal fluid csf orexin b num
0.35575834.12419707.html.plaintext.txt	66	orexin also display much higher lipid solubility orexin b probably making orexin ain contrast orexin bblood brain barrier permeant num
0.35575834.12419707.html.plaintext.txt	67	orexin immunoreactivity found putative endocrine release site hypothalamus neurohypophysis pancreas see offering interesting possibility orexins could also act hormone cns periphery
0.35575834.12419707.html.plaintext.txt	68	yet indirect evidence suggests orexin plasma originates peripheral source num brain penetration intravenous orexin seen rat num
0.35575834.12419707.html.plaintext.txt	69	orexins xenopus laevis also described num
0.35575834.12419707.html.plaintext.txt	70	specie preproorexin rather similar human overall identity num
0.35575834.12419707.html.plaintext.txt	71	xenopus orexin num aa long lacking two nhnum terminal amino acid seen human orexin contains num aa substitution compared human orexin fig
0.35575834.12419707.html.plaintext.txt	72	xenopus orexin b num aa long contains num aa substitution compared human orexin b fig
0.35575834.12419707.html.plaintext.txt	73	xenopus orexins supposed posttranslationally modified way rat orexins disulfide bridge cooh terminal amidation except xenopus orexin contain nhnum terminal pyroglutamoyl residue
0.35575834.12419707.html.plaintext.txt	74	orexin preproorexin mrna concentration show circadian variation rat numnum h light dark cycle num num num
0.35575834.12419707.html.plaintext.txt	75	preproorexin mrna orexin concentration hypothalamus reach maximum around light onset somewhat later minimum light offset somewhat later
0.35575834.12419707.html.plaintext.txt	76	measurement orexin pons intracisternal space also show diurnal variation time point shifted compared hypothalamus num num
0.35575834.12419707.html.plaintext.txt	77	num find circadian variation hypothalamic orexin b concentration time point num h dark num h light onset may unfortunately chosen light result ref
0.35575834.12419707.html.plaintext.txt	78	appear bilateral connection suprachiasmatic nucleus orexinergic neuron rat posterior hypothalamus num num num num num may indicate reciprocal regulation circadian rhythm
0.35575834.12419707.html.plaintext.txt	79	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	80	human orexin receptor sequence putative num transmembrane plot
0.35575834.12419707.html.plaintext.txt	81	sequence swissprot ref
0.35575834.12419707.html.plaintext.txt	82	putative transmembrane domain represented gpcrdb database ref
0.35575834.12419707.html.plaintext.txt	83	putative n glycosylation site calculated netnglyc r
0.35575834.12419707.html.plaintext.txt	84	brunak unpublished httpwww
0.35575834.12419707.html.plaintext.txt	85	dkservicesnetnglyc putative phosphorylation site protein kinase pka c pkc canumcalmodulin kinase ii camkii phosphobase ref
0.35575834.12419707.html.plaintext.txt	86	possible palmitoylated cysteine also shown
0.35575834.12419707.html.plaintext.txt	87	amino acid may represent polymorphism marked see orexin receptor narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	88	original study orexin receptor two cellular response identified recombinantly expressed orexin receptor strongly elevated canum chinese hamster ovary cho knum cell num whereas hypothalamic neuron increased action potential frequency observed num
0.35575834.12419707.html.plaintext.txt	89	many systemic response described thereafter molecular mechanism case investigated detail
0.35575834.12419707.html.plaintext.txt	90	oxnum oxnum receptor elevate canum recombinantly expressed cho cell num num num num num
0.35575834.12419707.html.plaintext.txt	91	orexin receptor caused canum elevation high magnitude cell line devoid voltage gated canum channel thought couple phospholipase c inositol numnumnum trisphosphate ipnum canum release cascade via gq family g protein
0.35575834.12419707.html.plaintext.txt	92	orexins subsequently shown elevate intracellular canum neuronal cell culture hypothalamus cortex num num
0.35575834.12419707.html.plaintext.txt	93	canum elevation neuron found independent intracellular release require extracellular canum fig
0.35575834.12419707.html.plaintext.txt	94	requirement extracellular canum typical property gq mediated response consists canum release intracellular store followed capacitative canum entry refill store
0.35575834.12419707.html.plaintext.txt	95	observed canum elevation neuron blocked bisindoylmaleimide protein kinase c inhibitor
0.35575834.12419707.html.plaintext.txt	96	therefore suggested orexin receptor would activate protein kinase c would phosphorylate thereby activate voltage gated canum channel num
0.35575834.12419707.html.plaintext.txt	97	similar finding described uramura et al
0.35575834.12419707.html.plaintext.txt	98	num isolated rat ventral tegmental neuron
0.35575834.12419707.html.plaintext.txt	99	orexin determined elevate intracellular canum via activation nitrendipine conotoxin sensitive canum channel
0.35575834.12419707.html.plaintext.txt	100	response also sensitive calphostin c inhibitor protein kinase c dnum inhibitor phosphatidylcholine specific phospholipase c suggested following activation sequence orexin receptor phosphatidylcholine specific phospholipase c protein kinase c n l type voltage gated canum channel influx canum
0.35575834.12419707.html.plaintext.txt	101	canum elevation also measured cultured rat embryonic spinal cord neuron although source canum investigated num
0.35575834.12419707.html.plaintext.txt	102	indirect evidence rat locus ceruleus tuberomamillary nucleus also suggests activation canum influx num num
0.35575834.12419707.html.plaintext.txt	103	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	104	extracellular canum dependence orexin stimulated canum response rat medial hypothalamic neuron culture
0.35575834.12419707.html.plaintext.txt	105	data demonstrate extracellular canum dependence orexin stimulated canum response
0.35575834.12419707.html.plaintext.txt	106	cell stimulated num microm rat hcrt num h presence num mm num mm num canumegta extracellular canum concentration canumo intracellular canum level monitored fura num methodology
0.35575834.12419707.html.plaintext.txt	107	shown response hypocretin num completely blocked removal extracellular canum
0.35575834.12419707.html.plaintext.txt	108	experiment performed continuous presence num microm tetrodotoxin ttx
0.35575834.12419707.html.plaintext.txt	109	rat hcrt num identical rat orexin bnum num
0.35575834.12419707.html.plaintext.txt	110	num permission copyright num society neuroscience
0.35575834.12419707.html.plaintext.txt	111	general role canum influx orexin receptor mediated cellular response neuronal cell canum influx observed fura num measurement num num num also suggested electrophysiological measurement num num
0.35575834.12419707.html.plaintext.txt	112	orexins may depolarize neuron via block k channel see depolarizing action canum influx may even result indirect activation voltage gated canum channel
0.35575834.12419707.html.plaintext.txt	113	situation may complex site discussed
0.35575834.12419707.html.plaintext.txt	114	num discovered removal extracellular canum caused significant num num fold drop potency orexin oxnum receptor fig
0.35575834.12419707.html.plaintext.txt	115	respect result smart et al
0.35575834.12419707.html.plaintext.txt	116	num suggest quality expected gq dependent signaling sensitivity phospholipase c inhibitor u num rapid transient spike extracellular canum dependent secondary phase capacitative canum entry
0.35575834.12419707.html.plaintext.txt	117	contrast detailed analysis canum signaling cho cell indicated dependence canum response extracellular canum due activation canum influx pathway num
0.35575834.12419707.html.plaintext.txt	118	canum response abolished membrane potential held close reversal potential canum fig
0.35575834.12419707.html.plaintext.txt	119	numb canum elevation could observed returning negative holding potential num
0.35575834.12419707.html.plaintext.txt	120	addition orexin activated influx mnnum ion condition intracellular release occurred
0.35575834.12419707.html.plaintext.txt	121	primary response oxnum receptor stimulation cho cell thus receptor operated canum influx num
0.35575834.12419707.html.plaintext.txt	122	canum influx amplifies phosphatidylinositol specific phospholipase c absence canum influx ipnum production canum release occur potency num time lower presence canum influx
0.35575834.12419707.html.plaintext.txt	123	canum elevation alone sufficient activate phospholipase c cell suggesting canum influx act concert g protein mediated mechanism
0.35575834.12419707.html.plaintext.txt	124	identity canum influx pathway activation mechanism orexin receptor remains unresolved however potency pharmacological blocker suggests different molecular entity store operated canum channel cho cell num
0.35575834.12419707.html.plaintext.txt	125	thus seems neuronal nonneuronal cell orexin receptor activate canum influx phosphatidylinositol specific phospholipase c pathway view supported study orexin receptor heterologously expressed variety different cell type holmqvist akerman kukkonen unpublished observation
0.35575834.12419707.html.plaintext.txt	126	recent study orexin b equipotently increased norepinephrine release rat cerebrocortical slice
0.35575834.12419707.html.plaintext.txt	127	extracellular canum removed maximum response peptide lowered num ecnum value shifted num fold higher concentration num
0.35575834.12419707.html.plaintext.txt	128	although response mechanism clarified direct canum measurement overall pattern similar seen recombinant cho cell num
0.35575834.12419707.html.plaintext.txt	129	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	130	extracellular canum dependence orexin stimulated canum response cho cell expressing human oxnum receptor cho hoxnum
0.35575834.12419707.html.plaintext.txt	131	reduction canumo num nm shift orexin concentration response curve num order magnitude right
0.35575834.12419707.html.plaintext.txt	132	b orexin mediated canum response blocked reducing driving force canum entry
0.35575834.12419707.html.plaintext.txt	133	cho hoxnum cell patch clamped whole cell configuration regulate membrane potential therefore driving force canum entry canum transient measured fura num
0.35575834.12419707.html.plaintext.txt	134	gray box black bar indicate presence num nm orexin bath
0.35575834.12419707.html.plaintext.txt	135	light gray box cell exposed orexin holding potential num mv dark gray box cell exposed orexin holding potential num num mv
0.35575834.12419707.html.plaintext.txt	136	inset voltage application profile
0.35575834.12419707.html.plaintext.txt	137	canum response orexin seen negative holding potential indicates canum influx required response
0.35575834.12419707.html.plaintext.txt	138	functional experiment indicate addition canum release activation store operated canum channel several type canum influx pathway activated g protein coupled receptor reviewed ref
0.35575834.12419707.html.plaintext.txt	139	although case mechanism clarified pathway may activated directly g protein subunit second messenger
0.35575834.12419707.html.plaintext.txt	140	pathway may identical related transient receptor potential trp ion channel family reviewed ref
0.35575834.12419707.html.plaintext.txt	141	trp gene encode family num protein
0.35575834.12419707.html.plaintext.txt	142	many trp gene product form canum permeable nonselective cation channel member trp superfamily even inherent protein kinase adp ribose pyrophosphatase domain
0.35575834.12419707.html.plaintext.txt	143	trp channel widely expressed mammalian cell activated gq coupled receptor stimulation activation mechanism many case unknown
0.35575834.12419707.html.plaintext.txt	144	interesting see whether trp channel held responsible orexin receptor mediated canum influx
0.35575834.12419707.html.plaintext.txt	145	characterization receptor mediated electrical response neuronal preparation performed common electrophysiological technique
0.35575834.12419707.html.plaintext.txt	146	many situation intracellular recording difficult extracellular electrode practical use likely induce much le cellular damage
0.35575834.12419707.html.plaintext.txt	147	hand response measurement usually limited registration action potential frequency
0.35575834.12419707.html.plaintext.txt	148	measurement intracellular electrode normal microelectrodes performed feedback amplification allowing voltage current clamp free running mode case voltage change monitored
0.35575834.12419707.html.plaintext.txt	149	latter method importantly offer better possibility investigation mechanism underlying electrical activity extracellular electrode
0.35575834.12419707.html.plaintext.txt	150	recording neuron usually performed slice similar preparation cell synaptically coupled
0.35575834.12419707.html.plaintext.txt	151	cell measured thus target upstream signal rather responding directly orexins
0.35575834.12419707.html.plaintext.txt	152	usual way eliminating secondary effect far upstream measured cell use tetrodotoxin ttx
0.35575834.12419707.html.plaintext.txt	153	blocking voltage gated na channel hinders action potential propagation neuron
0.35575834.12419707.html.plaintext.txt	154	however ttx instance block direct effect orexins presynaptic terminal immediately upstream cell investigated
0.35575834.12419707.html.plaintext.txt	155	therefore ttx exclusively separate pre postsynaptic effect
0.35575834.12419707.html.plaintext.txt	156	presynaptic voltage gated canum channelsand therefore transmitter releasecan blocked example conum cdnum ninum specific drug toxin
0.35575834.12419707.html.plaintext.txt	157	however orexin receptor may activate canum channel sensitive inhibitor see canum elevation
0.35575834.12419707.html.plaintext.txt	158	hand blocker may also affect instance orexin activated canum channel voltage gated channel
0.35575834.12419707.html.plaintext.txt	159	may lead block pre postsynaptic response orexin
0.35575834.12419707.html.plaintext.txt	160	example ninum block voltage gated canum channel orexin activated non voltage gated canum channel num even nacanum exchanger num
0.35575834.12419707.html.plaintext.txt	161	synaptic isolation performed using medium low extracellular canum num
0.35575834.12419707.html.plaintext.txt	162	num mm high extracellular mgnum num mm
0.35575834.12419707.html.plaintext.txt	163	widely used method appears block electrically evoked synaptic transmission mechanistic basis unclear
0.35575834.12419707.html.plaintext.txt	164	similarly unknown whether method would affect orexin mediated presynaptic response mediated voltage gated canum channel canum release
0.35575834.12419707.html.plaintext.txt	165	also difficult preclude possible postsynaptic effect
0.35575834.12419707.html.plaintext.txt	166	method give clearer separation pre postsynaptic response
0.35575834.12419707.html.plaintext.txt	167	dissociation cell remove presynaptic contact
0.35575834.12419707.html.plaintext.txt	168	however even case possible although unlikely response mediated indirect messenger released neighboring cell
0.35575834.12419707.html.plaintext.txt	169	measurement synaptic activity method often used study receptor coupled mechanism
0.35575834.12419707.html.plaintext.txt	170	increaseddecreased frequency excitatory inhibitory postsynaptic current epsc ipsc respectively orexins suggests stimulatory effect transmitter release
0.35575834.12419707.html.plaintext.txt	171	amplitude synaptic current increased difficult conclude whether response pre postsynaptic
0.35575834.12419707.html.plaintext.txt	172	common electrophysiological response orexins appears increase spontaneous evoked action potential frequency observed extracellular intracellular electrode
0.35575834.12419707.html.plaintext.txt	173	increased action potential frequency measured hypothalamus rat tuberomamillary nucleus magnocellular preoptic nucleus lateral hypothalamic glucose sensitive responsive indifferent neuron definition see response orexinergic cell feeding stimulus arcuate nucleus paraventricular nucleus ref
0.35575834.12419707.html.plaintext.txt	174	num num num num num num num num num brain stem rat locus ceruleus substantia nigra par reticulata dorsal motor nucleus vagus mouse laterodorsal tegmental nucleus ref
0.35575834.12419707.html.plaintext.txt	175	num num num num num num num spinal cord rat preganglionic sympathetic neuron intermediolateral cell column thoracic lumbar cord ref
0.35575834.12419707.html.plaintext.txt	176	num peripheral neuron guinea pig ileal type submucosal neuron ref
0.35575834.12419707.html.plaintext.txt	177	contrast orexin suppresses firing rate glucose responsive neuron rat ventromedial hypothalamic nucleus antagonizing effect glucose num
0.35575834.12419707.html.plaintext.txt	178	action potential enhancement orexins blocked ttx num num num num num num num num usually synaptic isolation low canum high mgnum num num num num voltage gated canum channel block cdnum num
0.35575834.12419707.html.plaintext.txt	179	latter data therefore suggest orexins would directly affect postsynaptic neuron site reservation methodological shortcoming see
0.35575834.12419707.html.plaintext.txt	180	also noted putative presynaptic block applied minority study
0.35575834.12419707.html.plaintext.txt	181	interestingly ttx insensitive response observed rat locus ceruleus
0.35575834.12419707.html.plaintext.txt	182	hypocretin num orexin b depolarizes increase spontaneous firing frequency locus ceruleus slice num
0.35575834.12419707.html.plaintext.txt	183	presence ttx spontaneous spike vanish orexin b still cause small depolarization num
0.35575834.12419707.html.plaintext.txt	184	num mv electrical discharge although spike slower spontaneous spike
0.35575834.12419707.html.plaintext.txt	185	spike may caused canum channel ttx insensitive na channel
0.35575834.12419707.html.plaintext.txt	186	detailed analysis individual synaptic current show enhancement synaptic activity orexins increase spontaneous evoked epsc rat hypothalamus rat superficial dorsal horn mouse laterodorsal tegmental nucleus ref
0.35575834.12419707.html.plaintext.txt	187	num num num num num num ipsc rat hypothalamic superficial dorsal horn neuron ref
0.35575834.12419707.html.plaintext.txt	188	epscs ipscs blocked ttx rat superficial dorsal horn mouse laterodorsal tegmental nucleus num num rat hypothalamus num num
0.35575834.12419707.html.plaintext.txt	189	therefore orexin receptor mediating putative presynaptic response may lie farther upstream rat superficial dorsal horn mouse laterodorsal tegmental nucleus
0.35575834.12419707.html.plaintext.txt	190	site depolarization mediated orexins persists presence ttx suggesting orexin receptor expressed cell investigated upstream neuron
0.35575834.12419707.html.plaintext.txt	191	case released transmitter causing postsynaptic current investigated receptor blocker
0.35575834.12419707.html.plaintext.txt	192	mouse laterodorsal tegmental neuron orexin mediated elevation epsc frequency attenuated ionotropic glutamate receptor block whereas postsynaptic depolarization response affected num
0.35575834.12419707.html.plaintext.txt	193	rat embryonic hypothalamic neuron culture hypocretin num orexin b increase ipsc epsc frequency ttx insensitive manner num num
0.35575834.12419707.html.plaintext.txt	194	former blocked gabaa receptor block latter ionotropic glutamate receptor block
0.35575834.12419707.html.plaintext.txt	195	rat superficial dorsal horn neuron orexin b mediated increase ipsc frequency inhibited glycine receptor block num
0.35575834.12419707.html.plaintext.txt	196	amplitude postsynaptic current potential also sometimes affected reported guinea pig ileal submucosal ganglion reduced excitatory postsynaptic potential epsp inhibitory postsynaptic potential ipsp amplitude ref
0.35575834.12419707.html.plaintext.txt	197	num mouse laterodorsal tegmental nucleus increased epsc amplitude ref
0.35575834.12419707.html.plaintext.txt	198	num rat arcuate nucleus increased ipsp amplitude ref
0.35575834.12419707.html.plaintext.txt	199	increased amplitude postsynaptic potential current specify pre postsynaptic mechanism case
0.35575834.12419707.html.plaintext.txt	200	depolarization inward current often measured response orexin application
0.35575834.12419707.html.plaintext.txt	201	depolarization also result investigated without exception increased action potential frequency often depolarization studied presence ttx block disturbance fig
0.35575834.12419707.html.plaintext.txt	202	depolarization maximum magnitude num num mv observedmainly free running electrodesin hypothalamus rat tuberomamillary nucleus paraventricular nucleus lateral hypothalamic glucose sensitive neuron ref
0.35575834.12419707.html.plaintext.txt	203	num num num num num brain stem rat locus ceruleus dorsal motor nucleus vagus ref
0.35575834.12419707.html.plaintext.txt	204	num num num num num spinal cord rat intermediolateral cell column ref
0.35575834.12419707.html.plaintext.txt	205	num periphery guinea pig ileal type submucosal neuron ref
0.35575834.12419707.html.plaintext.txt	206	inward current observed rat locus ceruleus num pa ref
0.35575834.12419707.html.plaintext.txt	207	num dorsal motor nucleus vagus num pa ref
0.35575834.12419707.html.plaintext.txt	208	num superficial dorsal horn num pa ref
0.35575834.12419707.html.plaintext.txt	209	num mouse laterodorsal tegmental nucleus num pa ref
0.35575834.12419707.html.plaintext.txt	210	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	211	orexin mediated increase action potential frequency depolarization b rat hypothalamic tuberomamillary nucleus neuron slice preparation
0.35575834.12419707.html.plaintext.txt	212	whole cell recording performed intracellular microelectrodes free running mode
0.35575834.12419707.html.plaintext.txt	213	cell stimulated num nm orexin indicated
0.35575834.12419707.html.plaintext.txt	214	experiment b performed presence num nm ttx
0.35575834.12419707.html.plaintext.txt	215	num copyright num society neuroscience
0.35575834.12419707.html.plaintext.txt	216	orexin stimulated increase current probably reflect direct effect orexin
0.35575834.12419707.html.plaintext.txt	217	evidence includes stable current lack effect ttx synaptic block kind elimination epscs
0.35575834.12419707.html.plaintext.txt	218	mechanism depolarization rat lateral hypothalamic glucose sensitive neuron locus ceruleus autonomic preganglionic neuron intermediolateral cell column dorsal motor nucleus vagus guinea pig ileal type submucosal neuron increased input resistance num num measured co occur depolarization num num num num num
0.35575834.12419707.html.plaintext.txt	219	suggests orexins may inhibit k channel also suggested reduced afterhyperpolarization amplitude observed rat locus ceruleus guinea pig ileal submucosal ganglion num num
0.35575834.12419707.html.plaintext.txt	220	also current voltage relationship measured suggests k channel inhibition rat locus ceruleus dorsal motor nucleus vagus ref
0.35575834.12419707.html.plaintext.txt	221	hand orexins may activate canum dependent k channel suggested mouse peritoneal macrophage num
0.35575834.12419707.html.plaintext.txt	222	interesting orexins instead inhibit slow afterhyperpolarization locus ceruleus thought depend canum activated k channel
0.35575834.12419707.html.plaintext.txt	223	possible orexins elevate canum site signal generated receptor activation counteract effect canum elevation
0.35575834.12419707.html.plaintext.txt	224	case reduced input resistance noise associated orexin induced depolarization
0.35575834.12419707.html.plaintext.txt	225	seen rat tuberomamillary nucleus num rat lumbar spinal cord num mouse laterodorsal tegmental nucleus num
0.35575834.12419707.html.plaintext.txt	226	hypothalamic histaminergic tuberomamillary nucleus orexin b depolarize increase firing rate num num num fig
0.35575834.12419707.html.plaintext.txt	227	depolarization abolished removal extracellular na virtually unaffected increase extracellular k num
0.35575834.12419707.html.plaintext.txt	228	pharmacological block nacanum exchanger reduces depolarization suggesting may mediated canum elevation induced activation electrogenic nacanum exchange
0.35575834.12419707.html.plaintext.txt	229	residual depolarization blocked ninum may suggest putatively underlying canum current also slightly depolarize cell
0.35575834.12419707.html.plaintext.txt	230	even rat dorsal motor nucleus vagus part current appears depend na remaining part may caused k channel block num
0.35575834.12419707.html.plaintext.txt	231	finally clear change input resistance may seen rat hypothalamic paraventricular nucleus num locus ceruleus num num intermediolateral cell column num
0.35575834.12419707.html.plaintext.txt	232	could occur increased conductance caused opening ion channel na canum compensated closure channel k orexins rather affected transporter
0.35575834.12419707.html.plaintext.txt	233	even single cell orexins may utilize several mechanism depolarization num num
0.35575834.12419707.html.plaintext.txt	234	summary orexin effect electrical activity neuron
0.35575834.12419707.html.plaintext.txt	235	thus orexins often increase neuronal activity via presynaptic effect increased transmitter release via unknown mechanism via postsynaptic depolarization block k channel activation cation channel electrogenic transporter
0.35575834.12419707.html.plaintext.txt	236	effect putative k channel inhibition typical gq coupled receptor see e
0.35575834.12419707.html.plaintext.txt	237	mechanism may secondary canum elevation may depend activation nonselective cation channel like trp channel
0.35575834.12419707.html.plaintext.txt	238	particular neuron orexins may also cause inhibition via increased inhibitory transmitter release via decreased postsynaptic effect excitatory transmitter
0.35575834.12419707.html.plaintext.txt	239	unclear direct indirect role canum transient play electrical response orexins much effort put investigation date
0.35575834.12419707.html.plaintext.txt	240	independent method measurement electrical activity effect orexins usually slow onset action num num min recovery even slower see e
0.35575834.12419707.html.plaintext.txt	241	num num num num num num num num num num num
0.35575834.12419707.html.plaintext.txt	242	study performed slice preparation perfusion orexins may slow
0.35575834.12419707.html.plaintext.txt	243	however rather superficial neuron patched obvious reason perfusate would reach neuron immediately
0.35575834.12419707.html.plaintext.txt	244	furthermore similar slow onset num num lag num min maximum delayed offset num min complete decay removal seen dissociated neuron num
0.35575834.12419707.html.plaintext.txt	245	therefore possible orexins affect ion channel via e
0.35575834.12419707.html.plaintext.txt	246	phosphorylation rather direct g protein interaction
0.35575834.12419707.html.plaintext.txt	247	result indicate involvement protein kinase c orexin response num num num
0.35575834.12419707.html.plaintext.txt	248	orexin b reported reduce n methyl d aspartate nmda induced current amplitude num enhance gaba induced current amplitude num dissociated rat nucleus accumbens cell num could also possibly phosphorylation dependent event
0.35575834.12419707.html.plaintext.txt	249	discussed increased synaptic activity orexins may increase transmitter release indicated increaseddecreased synaptic potential frequency
0.35575834.12419707.html.plaintext.txt	250	direct indication presynaptic effect orexins presence ttx rather certainly suggest presynaptic site orexin effect
0.35575834.12419707.html.plaintext.txt	251	inhibition k stimulated serotonin release orexin b rat hypothalamic synaptosomes also directly show presynaptic site action num
0.35575834.12419707.html.plaintext.txt	252	also indirect indication orexin stimulated transmitter release vitro slice norepinephrine rat cerebral cortex ref
0.35575834.12419707.html.plaintext.txt	253	num vivo microdialysis histamine rat anterior hypothalamus ref
0.35575834.12419707.html.plaintext.txt	254	case impossible tell whether orexins directly affect releasing neuron upstream neuron complex mechanism suggested delayed num min response rat cerebrocortical slice
0.35575834.12419707.html.plaintext.txt	255	camp elevation response orexin stimulation reported rat human adrenal cortex putatively via oxnum receptor num num
0.35575834.12419707.html.plaintext.txt	256	contrast primary culture rat hypothalamic neuron elevation camp seen num
0.35575834.12419707.html.plaintext.txt	257	elevation camp may occur several mechanism depending isoform adenylyl cyclase expressed
0.35575834.12419707.html.plaintext.txt	258	adenylyl cyclase isoforms differentially activated canum protein kinase c g protein subunit num expression adenylyl cyclase isoforms may different adrenal cortex hypothalamus
0.35575834.12419707.html.plaintext.txt	259	g protein might also expressed tissue specifically oxnum oxnum receptor could couple different g protein
0.35575834.12419707.html.plaintext.txt	260	oxnum receptor reported couple gi g go gq protein human fetal adrenal gland num gi g gq go protein adult human adrenal gland num measured gtp azidoanilide labeling method
0.35575834.12419707.html.plaintext.txt	261	orexin receptor may also couple protein kinase cascade involved cell growth differentiation death
0.35575834.12419707.html.plaintext.txt	262	effect clearly seen orexin receptor expressed cho cell
0.35575834.12419707.html.plaintext.txt	263	kukkonen unpublished observation
0.35575834.12419707.html.plaintext.txt	264	one immediate indication rapid activation mitogen activated protein kinase mapk pathway seen oxnum receptor stimulation fig
0.35575834.12419707.html.plaintext.txt	265	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	266	mitogen activated protein kinase mapk activation response oxnum receptor stimulation cho hoxnum cell
0.35575834.12419707.html.plaintext.txt	267	kukkonen unpublished observation
0.35575834.12419707.html.plaintext.txt	268	extracellular signal regulated kinase erknum num activation measured blotting respective phosphorylated specie specific antibody
0.35575834.12419707.html.plaintext.txt	269	num num nm orexin lead rapid num min activation mainly erknum response clearly decreased num min time point lower concentration
0.35575834.12419707.html.plaintext.txt	270	oxnum oxnum receptor already shown original study different binding affinity orexin b num
0.35575834.12419707.html.plaintext.txt	271	expressed recombinantly cho cell oxnum receptor num time higher affinity orexin orexin b whereas oxnum receptor bind orexin b equal affinity
0.35575834.12419707.html.plaintext.txt	272	selectivity seen respect canum elevation thus orexin activates oxnum receptor num time potently orexin b num num num
0.35575834.12419707.html.plaintext.txt	273	thus evidence selectivity oxnum receptor nonselectivity oxnum receptor orexin b based solely study canum elevation recombinant cho cell
0.35575834.12419707.html.plaintext.txt	274	difficult find exclusive expression one subtype tissue case support selectivity found orexin num
0.35575834.12419707.html.plaintext.txt	275	num fold potent increasing electrical activity rat locus ceruleus oxnum expression dominates num
0.35575834.12419707.html.plaintext.txt	276	isolated human adrenocortical cell oxnum mrna also predominantly found orexin orexin b stimulates cortisol secretion num
0.35575834.12419707.html.plaintext.txt	277	tissue oxnum expression dominates rat tuberomamillary nucleus orexin b essentially equipotent stimulating electrical activity
0.35575834.12419707.html.plaintext.txt	278	orexin b also equally potent releasing catecholamine human pheochromocytoma cell express oxnum mrna num
0.35575834.12419707.html.plaintext.txt	279	hand putatively oxnum mediated adrenocorticotropic hormone acth release num fold le sensitive orexin b orexin num num
0.35575834.12419707.html.plaintext.txt	280	generally dangerous rely called selective agonist efficacy dependent receptor g protein expression level
0.35575834.12419707.html.plaintext.txt	281	pharmacological reason chemical difference orexin b see genetics chemistry orexins conclusion receptor subtype involvement based potency orexin variant num num num num probably avoided
0.35575834.12419707.html.plaintext.txt	282	study report higher potency orexin b orexin respect response num num unexplainable basis recombinant pharmacology
0.35575834.12419707.html.plaintext.txt	283	even pharmacological selectivity respect interaction orexin b orexin receptor subtypes occur tissue physiological significance would unclear
0.35575834.12419707.html.plaintext.txt	284	molecular determinant required orexin peptide binding activation orexin receptor investigated cho cell
0.35575834.12419707.html.plaintext.txt	285	comparison structure activity orexin b suggests nhnum terminal amino acid le important receptor binding activation cooh terminal amino acid num
0.35575834.12419707.html.plaintext.txt	286	truncation orexin orexin anum num reduces potency oxnum oxnum receptor num num fold num num truncation successively abolishes canum response least oxnum num
0.35575834.12419707.html.plaintext.txt	287	mutation cystine forming cysteine alanine orexin reduces potency mutant peptide oxnum oxnum receptor num fold num
0.35575834.12419707.html.plaintext.txt	288	however difficult judge whether effect due lost disulfide bridge exchanged cysteine
0.35575834.12419707.html.plaintext.txt	289	one one replacement amino acid orexin anum num alanine alanine scan revealed region particular importance orexin activation oxnum receptor particular leucine num num cooh terminal aa num num seem great importance num
0.35575834.12419707.html.plaintext.txt	290	kukkonen unpublished observation oxnum oxnum receptor approximately equally sensitive nhnum terminal truncation alanine scan orexin peptide
0.35575834.12419707.html.plaintext.txt	291	amino acid importance largely described ref
0.35575834.12419707.html.plaintext.txt	292	changeremoval amino acid affect oxnum oxnum receptor interesting difference seen potency response
0.35575834.12419707.html.plaintext.txt	293	interestingly none mutated peptide without activity antagonist
0.35575834.12419707.html.plaintext.txt	294	xenopus orexin b proposed num fold higher affinity potency xenopus orexin human oxnum receptor expressed cho cell num
0.35575834.12419707.html.plaintext.txt	295	xenopus orexin b equipotent human oxnum receptor
0.35575834.12419707.html.plaintext.txt	296	synthetic peptide hcrt num hcrt num based originally described hypocretin sequence num shown numnum fold le potent corresponding orexin peptide respect canum elevation recombinant cho cell num
0.35575834.12419707.html.plaintext.txt	297	num study cellular response rather high concentration num nm orexins used evoke response
0.35575834.12419707.html.plaintext.txt	298	even ecnum value determined rather high e
0.35575834.12419707.html.plaintext.txt	299	num nm orexin rat locus ceruleus increased firing ref
0.35575834.12419707.html.plaintext.txt	300	hand even subnanomolar concentration evoke response e
0.35575834.12419707.html.plaintext.txt	301	canum response rat ventral tegmental neuron ref
0.35575834.12419707.html.plaintext.txt	302	resolve mechanical basis experiment could performed recombinant expression system different expression level measurement different response
0.35575834.12419707.html.plaintext.txt	303	another reason high concentration required tissue may use orexin b oxnum receptor use hypocretins based original sequence weak potency reported recombinant system hold true tissue see
0.35575834.12419707.html.plaintext.txt	304	moment reliable vivo selectivity obtained known orexin receptor agonist
0.35575834.12419707.html.plaintext.txt	305	recently synthesis orexin receptor subtype selective antagonist reported num num
0.35575834.12419707.html.plaintext.txt	306	antagonist sb num fig
0.35575834.12419707.html.plaintext.txt	307	numd display num fold higher affinity oxnum oxnum receptor
0.35575834.12419707.html.plaintext.txt	308	selectivity successfully utilized vivo experiment elucidate role oxnum receptor systemic effect orexins see systemic effect orexins
0.35575834.12419707.html.plaintext.txt	309	unfortunately antagonist able block oxnum receptor available
0.35575834.12419707.html.plaintext.txt	310	conclusion role oxnum receptor physiological process based solely sb num orexin receptor subtypes may overlapping interacting role
0.35575834.12419707.html.plaintext.txt	311	however sb num uniquely useful tool orexin receptor investigation
0.35575834.12419707.html.plaintext.txt	312	perspective unfortunate sb num widely available orexin receptor researcher
0.35575834.12419707.html.plaintext.txt	313	recently variety peptide transmitter including secretin npy variant reported inhibit orexin binding membrane preparation endogenous recombinant cell expressing oxnum receptor even nanomolar affinity num
0.35575834.12419707.html.plaintext.txt	314	result interpreted indicate interaction orexinergic npyergic system see connection orexinergic pathway feeding regulating transmittershormones could occur orexin receptor level
0.35575834.12419707.html.plaintext.txt	315	result binding could however verified functional experiment binding experiment intact cell num num
0.35575834.12419707.html.plaintext.txt	316	peptide secretin pituitary adenylate cyclase activating polypeptide pacap npy variant display detectable affinity activity oxnum oxnum receptor num num
0.35575834.12419707.html.plaintext.txt	317	num likely peptide affect intracellular process instance g protein binding receptor required high affinity agonist binding therefore reduce orexin binding particular preparation
0.35575834.12419707.html.plaintext.txt	318	therefore secretin used define specific orexin binding lead possibly erroneous conclusion num num
0.35575834.12419707.html.plaintext.txt	319	distribution orexinergic cell investigated molecular biological immunological method give rather similar result
0.35575834.12419707.html.plaintext.txt	320	main peptide investigated orexin comparison distribution orexin orexin b preproorexin suggests extensive colocalization
0.35575834.12419707.html.plaintext.txt	321	therefore data pooled
0.35575834.12419707.html.plaintext.txt	322	data orexin distribution originate rat investigated vertebrate specie given similar result
0.35575834.12419707.html.plaintext.txt	323	orexinergic cell body rat cns
0.35575834.12419707.html.plaintext.txt	324	rat brain orexinergic cell body found solely hypothalamus
0.35575834.12419707.html.plaintext.txt	325	within hypothalamus cell body reside bilaterally symmetrically lateral part probably abundantly perifornical area num num num num num num num num num num
0.35575834.12419707.html.plaintext.txt	326	orexinergic cell interspersed among melanocyte concentrating hormone mch ergic cell num num
0.35575834.12419707.html.plaintext.txt	327	however overlap area complete num mchergic cell clearly different orexinergic cell num num num num although otherwise share property orexinergic cell num num num
0.35575834.12419707.html.plaintext.txt	328	isolated orexinergic cell body also reported median eminence posterior dorsal dorsomedial hypothalamus arcuate subincertal nucleus num num num
0.35575834.12419707.html.plaintext.txt	329	orexinergic neuron variable size diameter cell body num num microm shape spherical fusiform multipolar num num num num assumed number numnum numnum whole rat brain num num
0.35575834.12419707.html.plaintext.txt	330	orexinergic cell shown project orexinergic cell within hypothalamus num might different population orexinergic cell within hypothalamus
0.35575834.12419707.html.plaintext.txt	331	preproorexin mrna protein even detected ependymal cell layer num num orexin found choroid plexi num
0.35575834.12419707.html.plaintext.txt	332	would interesting find whether expression occurs ependymal cell instance neuronal stem cell
0.35575834.12419707.html.plaintext.txt	333	orexinergic projection rat cns
0.35575834.12419707.html.plaintext.txt	334	orexinergic fiber visualized mainly using orexin immunohistochemistry
0.35575834.12419707.html.plaintext.txt	335	orexin smooth varicose fiber observed num num varicose fiber appear one often seen although result might also caused easier detection kind process
0.35575834.12419707.html.plaintext.txt	336	study investigating orexin b distribution report projection site similar orexin num num
0.35575834.12419707.html.plaintext.txt	337	despite low number orexinergic cell body hypothalamus orexinergic fiber project widely cns
0.35575834.12419707.html.plaintext.txt	338	important orexinergic projection area within hypothalamus two thalamic nucleus brain stem whole length spinal cord table num see also fig
0.35575834.12419707.html.plaintext.txt	339	interested reader recommended consult original paper detailed num num num num num num num num num num num num num
0.35575834.12419707.html.plaintext.txt	340	view table table num
0.35575834.12419707.html.plaintext.txt	341	orexin distribution rat central nervous system
0.35575834.12419707.html.plaintext.txt	342	orexins cns specie
0.35575834.12419707.html.plaintext.txt	343	study conducted specie rat
0.35575834.12419707.html.plaintext.txt	344	however study performed result seem good agreement study rat
0.35575834.12419707.html.plaintext.txt	345	several vertebrate specie table num orexinergic cell found hypothalamic area similar rat
0.35575834.12419707.html.plaintext.txt	346	cell assumed number numnum numnum numnum dog human brain respectively num num
0.35575834.12419707.html.plaintext.txt	347	projection area also appear similar rat specie table num however study limited area investigated making full conclusion impossible
0.35575834.12419707.html.plaintext.txt	348	also specie orexinergic neurites often determined varicose
0.35575834.12419707.html.plaintext.txt	349	view table table num
0.35575834.12419707.html.plaintext.txt	350	distribution orexinergic cell pathway specie
0.35575834.12419707.html.plaintext.txt	351	similarly orexins orexin receptor distribution investigated molecular biological immunological method
0.35575834.12419707.html.plaintext.txt	352	almost data originate rat
0.35575834.12419707.html.plaintext.txt	353	altogether orexin receptor found projection site orexinergic neuron see suggests orexinergic neuron contact many different transmitter system see
0.35575834.12419707.html.plaintext.txt	354	study specified whether expression seen neuron cell although electrophysiological measurement whenever performed indicate activation neuron
0.35575834.12419707.html.plaintext.txt	355	level orexin receptor necessarily fully follow density orexinergic innervation
0.35575834.12419707.html.plaintext.txt	356	case synaptic contact anatomically shown num num num num
0.35575834.12419707.html.plaintext.txt	357	localization orexinergic cellsprocesses close ventricular surface num num num num suggests orexins could act paracrine endocrine fashion
0.35575834.12419707.html.plaintext.txt	358	similar amount oxnum oxnum mrna found rat brain whole oxnum oxnum receptor mrna mostly show similar distribution although difference seen fig
0.35575834.12419707.html.plaintext.txt	359	interesting area essentially one subtype expressed num num
0.35575834.12419707.html.plaintext.txt	360	however mrna expression may directly correspond receptor protein expression discussed van den pol et al
0.35575834.12419707.html.plaintext.txt	361	correlation receptor distribution different function orexinergic system shown table num
0.35575834.12419707.html.plaintext.txt	362	article review study expression oxnum oxnum receptor protein rat cns published num num
0.35575834.12419707.html.plaintext.txt	363	particularly interesting finding expression oxnum receptor protein molecular granular layer cerebellum num earlier study failed detect orexin receptor mrna cerebellum although orexinergic fiber projecting cerebellum
0.35575834.12419707.html.plaintext.txt	364	otherwise immunohistochemical study suggest distribution generally similar mrna measurement although difference seen
0.35575834.12419707.html.plaintext.txt	365	instance greater overlap expression oxnum oxnum receptor suggested basis immunological study situ hybridization
0.35575834.12419707.html.plaintext.txt	366	discussed author difference may degree related fact mrna measurement visualize expressing cell body whereas immunohistochemistry indicates actual cellular localization protein
0.35575834.12419707.html.plaintext.txt	367	receptor mrna protein measurement semiquantitative rather quantitative allow absolute comparison subtype expression within site
0.35575834.12419707.html.plaintext.txt	368	view table table num
0.35575834.12419707.html.plaintext.txt	369	orexin receptor mrna distribution respect postulated function
0.35575834.12419707.html.plaintext.txt	370	coexpression connection orexins transmitter
0.35575834.12419707.html.plaintext.txt	371	despite partial overlap distribution orexinergic mchergic cell body coexpression peptide cell ref
0.35575834.12419707.html.plaintext.txt	372	contrast essentially orexin prodynorphin expression colocalizes lateral hypothalamus num num
0.35575834.12419707.html.plaintext.txt	373	orexinergic neuron may also coexpress transmitter galanin num glutamate num
0.35575834.12419707.html.plaintext.txt	374	view larger version numk fig
0.35575834.12419707.html.plaintext.txt	375	connection orexins appetite regulating transmittershormones hypothalamus
0.35575834.12419707.html.plaintext.txt	376	arrow marked indicate stimulation inhibition respectively neuronal activity release synthesis hormone affected site plus minus indicates either stimulatory inhibitory effect different condition toward similar cell different anatomic locus
0.35575834.12419707.html.plaintext.txt	377	unmarked arrow indicate connection unknown effect
0.35575834.12419707.html.plaintext.txt	378	indicated text orexinergic neuron may either respond glucose reciprocal connection glucose sensitive gsn glucose responding grn neuron
0.35575834.12419707.html.plaintext.txt	379	thus clear whether effect glucose neuron lh arcn direct mediated sensor neuron therefore glucose gsn grn grouped figure dotted line
0.35575834.12419707.html.plaintext.txt	380	solid line indicate anatomically defined hypothalamic area
0.35575834.12419707.html.plaintext.txt	381	vasoactive intestinal peptide vip vasopressin npy containing neuron innervate orexinergic neuron hypothalamus ref
0.35575834.12419707.html.plaintext.txt	382	hand orexinergic nerve lateral hypothalamus innervate neuronal circuit utilize many different transmitter instance norepinephrine dopamine serotonin histamine acetylcholine vasopressin vip somatostatin corticotropin releasing hormone crf npyagouti gene related peptide agrp proopiomelanocortin pomc cocaine amphetamine regulated transcript cart gaba mch glutamate fig
0.35575834.12419707.html.plaintext.txt	383	num num anatomy see e
0.35575834.12419707.html.plaintext.txt	384	num num num num num even functional response orexins shown site e
0.35575834.12419707.html.plaintext.txt	385	num num num num num num num num num num num num num num num num num see cellular response orexins
0.35575834.12419707.html.plaintext.txt	386	orexinergic neuron even make contact orexinergic neuron within hypothalamus num num
0.35575834.12419707.html.plaintext.txt	387	connection orexinergic pathway feeding regulating transmittershormones
0.35575834.12419707.html.plaintext.txt	388	orexins first isolated appetite increasing peptide although view later disputed
0.35575834.12419707.html.plaintext.txt	389	several hypothalamic site involved regulation feeding lateral hypothalamic area parvocellular paraventricular nucleus ventromedial nucleus arcuate nucleus innervated orexinergic fiber lateral hypothalamic area see e
0.35575834.12419707.html.plaintext.txt	390	oxnum oxnum receptor may expressed projection area num
0.35575834.12419707.html.plaintext.txt	391	abundant connection orexin feeding regulating transmittershormones leptin npy mch pomc cart galanin agrp fig
0.35575834.12419707.html.plaintext.txt	392	almost orexin positive cell also express leptin receptor even statnumthe leptin receptor activated promoter elementand orexin coexpressed ref
0.35575834.12419707.html.plaintext.txt	393	num see also effect orexins gastrointestinal tract organ feedingenergy metabolism
0.35575834.12419707.html.plaintext.txt	394	hand leptin receptor positive cell lateral hypothalamic area orexinergic cell body lie orexin positive num
0.35575834.12419707.html.plaintext.txt	395	cell express leptin receptor mchergic neuron lateral hypothalamus npy agrp pomc cartergic cell arcuate nucleus ref
0.35575834.12419707.html.plaintext.txt	396	orexinergic fiber project npy pomcergic cell arcuate nucleus num
0.35575834.12419707.html.plaintext.txt	397	hand npyagrp pomcergic fiber likely arcuate nucleus project orexin mchergic cell lateral hypothalamus num num num num num
0.35575834.12419707.html.plaintext.txt	398	orexinergic cell lateral hypothalamus also contain feeding regulating transmitter dynorphin galanin ref
0.35575834.12419707.html.plaintext.txt	399	num may enhance effect orexins feeding
0.35575834.12419707.html.plaintext.txt	400	response orexinergic cell feeding stimulus
0.35575834.12419707.html.plaintext.txt	401	hypoglycemia induced various mean shown increase c fo see orexin preproorexin mrna expression subpopulation orexinergic cell lateral hypothalamus num num num num num num num see also effect orexins gastrointestinal tract organ feedingenergy metabolism
0.35575834.12419707.html.plaintext.txt	402	fasting also abolishes circadian variation csf orexin level num
0.35575834.12419707.html.plaintext.txt	403	lateral hypothalamic area well hypothalamic region contains neuron activated decreased level glucose glucose sensitive neuron neuron activated elevated level glucose glucose responsive neuron ref
0.35575834.12419707.html.plaintext.txt	404	num almost half histochemically defined orexinergic neuron rat lateral hypothalamus directly responded lowering extracellular glucose increase cytosolic canum thus glucose sensitive neuron lateral hypothalamus may orexinergic
0.35575834.12419707.html.plaintext.txt	405	num identified glucose sensitive responsive indifferent population among rat hypothalamic neuron responded orexin stimulation depolarization increased firing rate
0.35575834.12419707.html.plaintext.txt	406	contrast orexin suppressed firing rate glucose responsive neuron rat ventromedial hypothalamic nucleus num
0.35575834.12419707.html.plaintext.txt	407	orexinergic neuron may also make contact andor contacted glucose sensitive responsive neuron brain area lateral hypothalamus ventromedial hypothalamus arcuate nucleus nucleus solitary tract ref
0.35575834.12419707.html.plaintext.txt	408	num see also anatomic study orexinergic projection
0.35575834.12419707.html.plaintext.txt	409	leptin thought one major negative regulator orexin expression hypothalamus see effect orexins feeding behavior probably directly via leptin receptor orexinergic cell via leptin receptor feeding controlling cell connected orexinergic cell see
0.35575834.12419707.html.plaintext.txt	410	attempt elucidate leptin orexin interaction measurement orexin orexin mrna level made rodent model system defective leptin signaling fafa zucker rat dbdb mouse devoid functional leptin receptor obob mouse devoid leptin reviewed ref
0.35575834.12419707.html.plaintext.txt	411	result however contradictory conclusion drawn leptin necessarily required keep orexin expression low
0.35575834.12419707.html.plaintext.txt	412	however also often knockout system difficult evaluate physiological role possible multiple disturbance redundancy signaling compensatory mechanism
0.35575834.12419707.html.plaintext.txt	413	orexins orexin receptor outside cns
0.35575834.12419707.html.plaintext.txt	414	orexin immunoreactivity preproorexin mrna found variety peripheral organ mainly rat
0.35575834.12419707.html.plaintext.txt	415	cell expressing orexins case identified include neuron endocrine cell
0.35575834.12419707.html.plaintext.txt	416	pituitary pineal gland may originate neuron hypothalamus peripheral neuron appear peripheral origin
0.35575834.12419707.html.plaintext.txt	417	orexin receptorsreceptor mrna mainly found organ orexins
0.35575834.12419707.html.plaintext.txt	418	cell type expressing orexin receptor might include least endocrine muscle nerve cell num num num num num
0.35575834.12419707.html.plaintext.txt	419	even periphery expression subtypes varies different tissue
0.35575834.12419707.html.plaintext.txt	420	orexin orexin receptor immunoreactivity found gastrointestinal tract pancreas rat guinea pig human ref
0.35575834.12419707.html.plaintext.txt	421	substantial level orexin b oxnum oxnum mrna protein found rat pituitary num num num johren et al
0.35575834.12419707.html.plaintext.txt	422	num found preproorexin oxnum mrna rat testis
0.35575834.12419707.html.plaintext.txt	423	oxnum mrna oxnum mrna immunoreactivity found rat human adrenal gland num num num num num although subtype expression different layer somewhat disputed may difference specie see e
0.35575834.12419707.html.plaintext.txt	424	oxnum mrna found kidney thyroid oxnum mrna lung num
0.35575834.12419707.html.plaintext.txt	425	orexinergic fiber extend cns toward rat pineal gland oxnum mrna detected pineal gland num
0.35575834.12419707.html.plaintext.txt	426	view table table num
0.35575834.12419707.html.plaintext.txt	427	view table table num
0.35575834.12419707.html.plaintext.txt	428	orexin receptor periphery
0.35575834.12419707.html.plaintext.txt	429	however expression preproorexin orexin receptor message stomach gut pancreas lung kidney pituitary adrenal gland disputed num num num
0.35575834.12419707.html.plaintext.txt	430	difference may explained le sensitive method northern blotting failing detect signal sensitive method pcr situ hybridization
0.35575834.12419707.html.plaintext.txt	431	contrast difficult explain opposite receptor subtype expression reported human adrenal cortex num num
0.35575834.12419707.html.plaintext.txt	432	location orexinergic cell projection contact transmitter system suggest role eating sleepwakefulness neuroendocrine autonomic function
0.35575834.12419707.html.plaintext.txt	433	sometimes difficult judge basis available experimental evidence whether particular systemic response orexins caused indirectly directly target organ
0.35575834.12419707.html.plaintext.txt	434	case direct effect orexins isolated organ even isolated cell demonstrated trying highlight kind evidence
0.35575834.12419707.html.plaintext.txt	435	effect orexins feeding behavior
0.35575834.12419707.html.plaintext.txt	436	original publication dealing orexins shown intracerebroventricular injection orexins induces feeding rat num
0.35575834.12419707.html.plaintext.txt	437	injected different hypothalamic site rat orexin effective narrow area perifornical area lateral hypothalamus dorsomedial paraventricular nucleus preoptic area arcuate ventromedial nucleus whereas orexin b inactive num num
0.35575834.12419707.html.plaintext.txt	438	hypothalamic nucleus possibly involved feeding response orexins listed table num
0.35575834.12419707.html.plaintext.txt	439	intraperitoneally injected oxnum receptor antagonist sb num inhibits baseline feeding normal weight gain feeding response orexin injection hypothalamus num num
0.35575834.12419707.html.plaintext.txt	440	feeding stimulating effect fasting blocked intracisternally administered anti orexin antibody num intraperitoneal sb num num
0.35575834.12419707.html.plaintext.txt	441	suggests least oxnum receptor involved natural regulation feeding orexin receptor subtypes expressed nucleus involved regulation feeding ref
0.35575834.12419707.html.plaintext.txt	442	orexin increase c fo expression area energy regulatory site within hypothalamus limbic region hindbrain num
0.35575834.12419707.html.plaintext.txt	443	mentioned see cellular response orexins orexins belong regulatory network peptide including npy mch agrp galanin pomc product cart dynorphin regulate feeding behavior
0.35575834.12419707.html.plaintext.txt	444	orexins appear act upstream npy antagonist npy ynum ynum receptor block orexin stimulated feeding num num
0.35575834.12419707.html.plaintext.txt	445	degree orexins regulate long term food intake subject debate data indicate rather orexin induced food intake acute effect evened compensatory decrease food intake within num h see e
0.35575834.12419707.html.plaintext.txt	446	speculated part orexin induced food intake secondary increased wakefulness activity therefore following increased energy expenditure
0.35575834.12419707.html.plaintext.txt	447	general view emerging different result orexins may participate short term regulation energy homeostasis initiating feeding response fall glucose subsequent increase glucose leptin visceral signal would decrease orexin turn would terminate behavior food ingestion ref
0.35575834.12419707.html.plaintext.txt	448	mapping orexinergic projection indicates orexins could also involved overall regulation feeding
0.35575834.12419707.html.plaintext.txt	449	instance nucleus solitary tract sensory trigeminal nucleus lamina num num sacral cord receive afferent mouth gastrointestinal tract dorsal motor nucleus vagus motor trigeminal nucleus intermediolateral cell column sacral parasympathetic nucleus give rise nerve innervate gastrointestinal tract muscle mastication num num num num num num num
0.35575834.12419707.html.plaintext.txt	450	therefore tempting suggest central orexinergic nerve could involved primary eating process via sensory motor innervation mouth passage food gastrointestinal tract via sensory motor secretomotor innervation intestine
0.35575834.12419707.html.plaintext.txt	451	peripheral orexinergic neuron endocrine release orexins e
0.35575834.12419707.html.plaintext.txt	452	enterochromaffin cell could affect intestinal motility endo exocrine secretion uptake sensory signaling gastrointestinal tract see effect orexins gastrointestinal tract organ feedingenergy metabolism
0.35575834.12419707.html.plaintext.txt	453	direct data num num num num num num indirect observation narcoleptic patient animal model num num num num suggest orexins may affect metabolic rate heat loss related process
0.35575834.12419707.html.plaintext.txt	454	overall role energy metabolism also suggested effect orexins release hormone especially adrenal steroid see orexins autonomicendocrine function
0.35575834.12419707.html.plaintext.txt	455	involvement orexins sleepwakefulness
0.35575834.12419707.html.plaintext.txt	456	regulation sleepwakefulness well demonstrated systemic effect orexinergic pathway
0.35575834.12419707.html.plaintext.txt	457	anatomic level orexinergic neuron present project multitude nucleus different level cns involved sleeparousal
0.35575834.12419707.html.plaintext.txt	458	orexin receptorsreceptor mrna observed area
0.35575834.12419707.html.plaintext.txt	459	oxnum oxnum receptor mrna expression within area suggests receptor subtypes involved table num
0.35575834.12419707.html.plaintext.txt	460	injection orexin rat cerebral ventricle specific cns site rat cat increase wakefulness decrease sleep num num num num num num
0.35575834.12419707.html.plaintext.txt	461	markedly effect seen decreased rapid eye movement rem sleep slow wave sleep episode number duration
0.35575834.12419707.html.plaintext.txt	462	profound role histaminergic system process suggested result show effect orexin mouse blocked histamine hnum receptor antagonist gene disruption num num
0.35575834.12419707.html.plaintext.txt	463	narcoleptic dog disrupted oxnum receptor decreased brain histamine content num oxnum receptor seems responsible orexin effect tuberomamillary nucleus even rat num num
0.35575834.12419707.html.plaintext.txt	464	expression c fo shown increase mainly orexin positive cell hypothalamus time normal waking rat c fo expression also increased sleep deprivation antinarcoleptic drug metamphetamine mofanadil num num num
0.35575834.12419707.html.plaintext.txt	465	cellular response orexins observed area involved sleep
0.35575834.12419707.html.plaintext.txt	466	orexins excite neuron rat locus ceruleus num num num num dorsal raphe nucleus num tuberomamillary nucleus num num mouse laterodorsal tegmental nucleus num see cellular response orexins
0.35575834.12419707.html.plaintext.txt	467	even area oxnum oxnum receptor seem overlapping role
0.35575834.12419707.html.plaintext.txt	468	orexinergic system sleep wakefulness well knockout phenotype discussed narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	469	orexins autonomicendocrine function
0.35575834.12419707.html.plaintext.txt	470	orexinergic efferent project particular area brain stem spinal cord suggest direct involvement autonomic afferent efferent pain transmission num num num num num
0.35575834.12419707.html.plaintext.txt	471	autonomic effect manifested increased blood pressure heart rate intestinal motility see gastric acid secretion num num sympathetic nerve activity num num num response intracerebroventricular orexin
0.35575834.12419707.html.plaintext.txt	472	administered intravenously orexin induces analgesia thermal nociception paradigm num
0.35575834.12419707.html.plaintext.txt	473	effect orexin blocked oxnum receptor antagonist sb numeven baselinebut naloxone suggesting opiate independent mechanism
0.35575834.12419707.html.plaintext.txt	474	orexins may affect water balance via effect drinking watersalt homeostasis mechanism involved blood pressure regulation suggested anatomy projection num num num num num num num num num num num num
0.35575834.12419707.html.plaintext.txt	475	fact intracerebroventricular orexin b increase water intake rat num num
0.35575834.12419707.html.plaintext.txt	476	injection orexin b particular brain stem site increase mean arterial pressure heart rate rat num num num num
0.35575834.12419707.html.plaintext.txt	477	extent effect may mediated increased release hormone norepinephrine num num
0.35575834.12419707.html.plaintext.txt	478	release many hormone hypothalamus shown affected orexins
0.35575834.12419707.html.plaintext.txt	479	orexins may regulate hypothalamo hypophysial hormone secretion indirectly via neuronal circuit even direct effect hypophysis possible orexins found median eminence num num mrna orexin receptor subtypes found anterior intermediate hypophysial lobe num
0.35575834.12419707.html.plaintext.txt	480	num identify coexpression growth hormone oxnum receptor acidophil cell adenohypophysis coexpression acth oxnum receptor par intermedia basophil cell adenohypophysis
0.35575834.12419707.html.plaintext.txt	481	orexins orexin receptor also found low level posterior hypophysial lobe
0.35575834.12419707.html.plaintext.txt	482	altogether oxnum oxnum mrna expressed area involved neuroendocrine regulation num
0.35575834.12419707.html.plaintext.txt	483	stimulatory effect release multiple level hypothalamo hypophysio adrenal axis reported see orexinergic regulation hypothalamo hypophysio adrenal axis stress response
0.35575834.12419707.html.plaintext.txt	484	orexin injected intravenously directly hypothalamic paraventricular nucleus decrease tsh release rat num num change seen plasma level thyroid hormone num num
0.35575834.12419707.html.plaintext.txt	485	intracerebroventricular orexin decrease growth hormone release rat num
0.35575834.12419707.html.plaintext.txt	486	effect release hormone also reported result equivocal
0.35575834.12419707.html.plaintext.txt	487	release effect shown hypothalamic explants vitro orexin stimulates release neurotensin npy vip somatostatin luteinizing hormone releasing hormone lhrh decrease release trh effect release dopamine vasopressin mch num num num
0.35575834.12419707.html.plaintext.txt	488	orexinergic regulation hypothalamo hypophysio adrenal axis stress response
0.35575834.12419707.html.plaintext.txt	489	intracerebroventricular administration orexin increase plasma level crf acth corticosterone vasopressin epinephrine rat num num num num num num num num
0.35575834.12419707.html.plaintext.txt	490	crf release suggested mediated elevated npy acting ynum receptor num num placing npy downstream orexins even system
0.35575834.12419707.html.plaintext.txt	491	orexin even stimulate crf release vitro num
0.35575834.12419707.html.plaintext.txt	492	crf receptor antagonist reported block orexin stimulated plasma corticosterone elevation rat num num hand orexins reported inhibit crf stimulated acth release cultured rat adenohypophysial cell num
0.35575834.12419707.html.plaintext.txt	493	orexins also reported stimulate release corticosteronecortisol num num num aldosterone num num rat porcine human adrenal glandsadrenal cell vitro
0.35575834.12419707.html.plaintext.txt	494	release independent acth num num
0.35575834.12419707.html.plaintext.txt	495	corticosteronecortisol release determined co occur camp elevation probably depend rat num human num
0.35575834.12419707.html.plaintext.txt	496	together lack additivity orexin acth suggests peptide utilize mechanism glucocorticoid release num
0.35575834.12419707.html.plaintext.txt	497	contrast direct effect rat adrenal slice seen jaszberenyi et al
0.35575834.12419707.html.plaintext.txt	498	study long term num day exposure orexin orexin b plasma level aldosterone corticosterone crf acth elevated rat num
0.35575834.12419707.html.plaintext.txt	499	release epinephrine norepinephrine rat adrenal medulla increased intracerebroventricular orexins num similar although smaller effect seen cultured porcine adrenal medullar cell num
0.35575834.12419707.html.plaintext.txt	500	oxnum oxnum receptor mrna suggested expressed rat adrenal medulla num although study present opposing view num
0.35575834.12419707.html.plaintext.txt	501	orexin mediated increase crf acth corticosterone aldosterone vasopressin epinephrine release suggest orexins could mediate stress response
0.35575834.12419707.html.plaintext.txt	502	interesting context orexins increase particular stereotypic behavioral pattern grooming face washing burrowing may related activation stress response num num num num
0.35575834.12419707.html.plaintext.txt	503	orexin induced grooming inhibited oxnum receptor block sb num num crf receptor antagonist inhibits orexin induced face washing grooming num shift rest locomotor activity num num num
0.35575834.12419707.html.plaintext.txt	504	involvement complex pathway highlighted inhibitory effect dopamine serotonin receptor antagonist num num num
0.35575834.12419707.html.plaintext.txt	505	noted orexins increase wakefulness andor activity rat therefore important able separate effect stress response
0.35575834.12419707.html.plaintext.txt	506	effect orexins gastrointestinal tract organ feedingenergy metabolism
0.35575834.12419707.html.plaintext.txt	507	gastrointestinal tract neuron endocrine cell may express orexins num num
0.35575834.12419707.html.plaintext.txt	508	neuron orexin immunoreactivity seen submucosal myenteric plexi
0.35575834.12419707.html.plaintext.txt	509	orexinergic neuron plexi suggested sensory secretomotor basis coexpression marker vip choline acetyltransferase num num
0.35575834.12419707.html.plaintext.txt	510	neurites project orexin containing cell mucosa muscle layer submucosal blood vessel
0.35575834.12419707.html.plaintext.txt	511	guinea pig orexin positive neuron submucosal myenteric plexi express leptin receptor well num
0.35575834.12419707.html.plaintext.txt	512	fasting increase number orexin immunoreactive submucosal neuron guinea pig also become positive phospho camp response element binding protein pcreb num
0.35575834.12419707.html.plaintext.txt	513	similar c fo expression indicates activation neuron suggesting fasting activates central peripheral orexinergic system
0.35575834.12419707.html.plaintext.txt	514	also endocrine cell gut stomachsome enterochromaffin express serotonindisplay orexin immunoreactivity mouse rat guinea pig human num num
0.35575834.12419707.html.plaintext.txt	515	interestingly enterochromaffin cell rat also num express orexin receptor oxnum num localized close proximity orexinergic nerve fiber num
0.35575834.12419707.html.plaintext.txt	516	cellular level orexin induces electrical response guinea pig submucosal neuron see cellular response orexins
0.35575834.12419707.html.plaintext.txt	517	thus orexinergic neuron gastrointestinal tract could affect intestinal secretion uptake endocrine secretion sensory signaling intestinal motility
0.35575834.12419707.html.plaintext.txt	518	different effect intestinal motility pattern indeed measured mouse rat small intestine num num guinea pig distal colon num
0.35575834.12419707.html.plaintext.txt	519	different orexin receptor subtypes different distribution gastrointestinal tract oxnum receptor immunoreactivity solely expressed submucosal myenteric neuron whereas oxnum receptor immunoreactivity seen enterochromaffin cell rat num
0.35575834.12419707.html.plaintext.txt	520	energy metabolism regulated several hormone important pancreatic glucagon insulin hypophysial growth hormone glucocorticoid norepinephrine thyroid hormone
0.35575834.12419707.html.plaintext.txt	521	effect orexins glucocorticoid growth hormone release discussed
0.35575834.12419707.html.plaintext.txt	522	insulin release somewhat increased rat intracerebroventricular num subcutaneous num num injection orexin also rat pancreas vitro num
0.35575834.12419707.html.plaintext.txt	523	extrinsic neuron rat guinea pig pancreatic ganglion display orexin oxnum oxnum receptor immunoreactivity num
0.35575834.12419707.html.plaintext.txt	524	plasma leptin also increased subcutaneous injection orexin b rat although suggested occur via increased insulin release num
0.35575834.12419707.html.plaintext.txt	525	narcolepsy disorder orexinergic system
0.35575834.12419707.html.plaintext.txt	526	narcolepsy disorder short characterized abnormal inclusion rem sleep feature muscle paralysis hallucination waking state sleepwaking transition state
0.35575834.12419707.html.plaintext.txt	527	addition hypersomnia often observed
0.35575834.12419707.html.plaintext.txt	528	narcolepsy human usually sporadic disease strong association major histocompatibility complex antigen especially hla drbnumnum hla dqanumnum hla dqbnumnum long time suggested relate autoimmune process
0.35575834.12419707.html.plaintext.txt	529	yet autoantibody sign ongoing previous inflammation hard find reviewed ref
0.35575834.12419707.html.plaintext.txt	530	could however caused num fact postmortem narcoleptic brain usually investigated year disease onset num dispersed nature orexinergic cell
0.35575834.12419707.html.plaintext.txt	531	orexin undetectable csf human narcoleptic patient num num number orexinergic neuron postmortem narcoleptic brain much reduced num num even sign gliosis observed num
0.35575834.12419707.html.plaintext.txt	532	time mchergic neuron brain area present normal number num num
0.35575834.12419707.html.plaintext.txt	533	together animal model system see led hypothesis narcolepsy disease orexinergic neuron
0.35575834.12419707.html.plaintext.txt	534	support one clearly debilitating preproorexin orexin receptor mutation found human subject ref
0.35575834.12419707.html.plaintext.txt	535	mouse depletion hypothalamus orexins result narcoleptic phenotype
0.35575834.12419707.html.plaintext.txt	536	accomplished genetic disruption preproorexin gene orexin knockout mouse ref
0.35575834.12419707.html.plaintext.txt	537	num genetic destruction orexinergic cell preproorexin ataxin num knockin mouse num toxic destruction orexinergic cell hypothalamic injection orexin b saporin conjugate num
0.35575834.12419707.html.plaintext.txt	538	dog narcolepsy mainly familial disorder
0.35575834.12419707.html.plaintext.txt	539	recently familial canine narcolepsy doberman pinscher labrador retriever shown caused mutation oxnum receptor gene num
0.35575834.12419707.html.plaintext.txt	540	case mutation cause premature amino acid chain termination
0.35575834.12419707.html.plaintext.txt	541	expressed heterologously heknum cell mutant receptor mainly remain intracellular compartment neither bind orexin activate canum mobilization num
0.35575834.12419707.html.plaintext.txt	542	point mutation glunumlys nhnum terminusfirst transmembrane segment junction oxnum receptor also lead reduced orexin binding num fold reduced potency canum elevation expressed heknum cell num
0.35575834.12419707.html.plaintext.txt	543	num reported mutation preproorexin oxnum receptor gene thought represent benign polymorphism num
0.35575834.12419707.html.plaintext.txt	544	sporadic case canine narcolepsy suggested caused lack orexins num
0.35575834.12419707.html.plaintext.txt	545	oxnum oxnum receptor gene abnormality considered responsible human narcoleptic case num single base change num aa change found healthy narcoleptic human subject ref
0.35575834.12419707.html.plaintext.txt	546	num num see also genetics chemistry orexins intron coding region supposed represent benign polymorphism
0.35575834.12419707.html.plaintext.txt	547	one polymorphism concern reported sequence oxnum receptor aa num see genetics chemistry orexins although could sequencing error
0.35575834.12419707.html.plaintext.txt	548	one mutation leunumarg found num signal peptide region human preproorexin gene probably result early onset severe narcolepsy num
0.35575834.12419707.html.plaintext.txt	549	transiently expressed neuro numa cell mutated peptide apparently accumulated tubular network presumably smooth endoplasmic reticulum er contrast wild type preproorexin appeared vesicle
0.35575834.12419707.html.plaintext.txt	550	another point mutation num untranslated region may involved disease process presence particular type tissue antigen hla drnum ref
0.35575834.12419707.html.plaintext.txt	551	insertion adenosine num promoter region found one narcoleptic patient although effect pathogenicity unclear num
0.35575834.12419707.html.plaintext.txt	552	thus strong evidence narcolepsy caused reduced orexinergic signaling via either destruction orexinergic neuron defective orexin peptide receptor although larger population study necessary confirm
0.35575834.12419707.html.plaintext.txt	553	oxnum receptor appears especially involved dog would promote role nucleus relying receptor subtype tuberomamillary nucleus although possible oxnum oxnum receptor different distribution rat human compared dog
0.35575834.12419707.html.plaintext.txt	554	orexinergic disorder may also provide interesting information role orexins feeding
0.35575834.12419707.html.plaintext.txt	555	patient narcolepsy show somewhat increased body mass index compared healthy subject num
0.35575834.12419707.html.plaintext.txt	556	two previously described kind orexin transgenic mouse hypophagic preproorexin knockout mouse lean num opposed orexinergic neuron deficient mouse obese num
0.35575834.12419707.html.plaintext.txt	557	thus possible preproorexin knockout mouse develop compensatory mechanism weight regulation whereas orexinergic neuron deficient mouse lose orexinergic neuron postnatally see genetics chemistry orexins able
0.35575834.12419707.html.plaintext.txt	558	another interesting possibility recently proposed chou et al
0.35575834.12419707.html.plaintext.txt	559	essentially mouse lateral hypothalamic orexinergic neuron express dynorphin num num removal orexinergic neuron deficient mouse might responsible pronounced phenotype
0.35575834.12419707.html.plaintext.txt	560	although anatomic architecture orexinergic system cns well characterized several open question actual role orexins central peripheral function
0.35575834.12419707.html.plaintext.txt	561	mechanism action orexins cellular level orexin receptor identified presynaptic inhibitory orexin receptor brain limited access orexin responding neuron experimental problem
0.35575834.12419707.html.plaintext.txt	562	several limitation concerning method available characterization functional property cell slice preparation acutely isolated cell
0.35575834.12419707.html.plaintext.txt	563	model system based cultured neuron even neuronal stem cell might provide important improvement study orexin signaling
0.35575834.12419707.html.plaintext.txt	564	cho cell line available provided insight function orexinergic system enabled screening orexin receptor ligand data obtained may relevant nervous system
0.35575834.12419707.html.plaintext.txt	565	recombinant model based neuron neuronlike cell might therefore provide information signal pathway used orexins
0.35575834.12419707.html.plaintext.txt	566	role orexin cell play regulation feeding available information suggests least one population orexinergic cell lateral hypothalamus directly monitor responds change glucose concentration environment may also directly respond signal inhibiting feeding leptin
0.35575834.12419707.html.plaintext.txt	567	orexinergic cell one project area brain involved feeding behavior orexin receptor expressed high number several region within hypothalamus
0.35575834.12419707.html.plaintext.txt	568	regulate release feeding related neurotransmitter regulation feeding seems complex involving many neuropeptides seems gross redundancy system
0.35575834.12419707.html.plaintext.txt	569	blocking orexinergic system various mean reduce feeding permanent deletion orexinergic system marginal controversial effect
0.35575834.12419707.html.plaintext.txt	570	thus even increase rather expected decrease body mass may occur deletion different component orexinergic system
0.35575834.12419707.html.plaintext.txt	571	role orexins sleep seems clearer light connection narcoleptic phenotype orexin cell loss similar symptomatology occurring functional orexin orexin receptor loss
0.35575834.12419707.html.plaintext.txt	572	context also appears quite clear major part orexin effect mediated via monoaminergic system regulate cholinergic pathway involved initiation rem sleep reviewed e
0.35575834.12419707.html.plaintext.txt	573	yet unclear activity orexinergic cell regulated
0.35575834.12419707.html.plaintext.txt	574	use orexin antagonist hypnotic could prove rewarding many commonly used hypnotic interfere rem sleep cause tolerance addiction memory disturbance
0.35575834.12419707.html.plaintext.txt	575	interesting question whether overlap cell regulating feeding sleep lateral hypothalamus
0.35575834.12419707.html.plaintext.txt	576	instance feeding behavior associated arousal effect orexins possibility future devise better pharmacological method identification different orexinergic neuron well manipulating function hopefully give answer question
0.35575834.12419707.html.plaintext.txt	577	one intriguing question concern role orexins play periphery
0.35575834.12419707.html.plaintext.txt	578	act hormonesparacrine mediator presence orexins receptor many peripheral organ intestine endocrine pancreas adrenal pituitary suggests may case
0.35575834.12419707.html.plaintext.txt	579	could orexins even transmit signal periphery cns discussed study available suggest separate peripheral central orexinergic system
0.35575834.12419707.html.plaintext.txt	580	study change central orexin concentration reflected periphery narcoleptic devoid central orexins orexins still found plasma
0.35575834.12419707.html.plaintext.txt	581	may indicate plasma orexin level reflect peripherally produced orexins
0.35575834.12419707.html.plaintext.txt	582	peripheral orexin receptor similar central least adrenal cortical zona fasciculatareticularis orexin receptor appear couple camp elevation canum elevation
0.35575834.12419707.html.plaintext.txt	583	reflect different receptor subtypesas suggested studiesor coupling different signal pathway cell line primary culture peripheral tissue provide lot missing information context
0.35575834.12419707.html.plaintext.txt	584	acknowledge van den pol et al
0.35575834.12419707.html.plaintext.txt	585	num allowed reproduction fig
0.35575834.12419707.html.plaintext.txt	586	study supported european union contract qlgnum ct num num grant swedish medical research council cancer research fund sweden lars hierta foundation academy finland sigrid juselius foundation
0.35575834.12419707.html.plaintext.txt	587	address reprint request correspondence j
0.35575834.12419707.html.plaintext.txt	588	bmc po box num se num uppsala sweden e mail jkukkoneatfysiologi
0.35575834.12419707.html.plaintext.txt	589	abrahamson ee leak rk moore ry
0.35575834.12419707.html.plaintext.txt	590	suprachiasmatic nucleus project posterior hypothalamic arousal system
0.35575834.12419707.html.plaintext.txt	591	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	592	al barazanji ka wilson baker j jessop d harbuz m
0.35575834.12419707.html.plaintext.txt	593	central orexin activates hypothalamic pituitary adrenal axis stimulates hypothalamic corticotropin releasing factor arginine vasopressin neurones conscious rat
0.35575834.12419707.html.plaintext.txt	594	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	595	antunes vr brailoiu gc kwok eh scruggs p dun nj
0.35575834.12419707.html.plaintext.txt	596	orexinshypocretins excite rat sympathetic preganglionic neuron vivo vitro
0.35575834.12419707.html.plaintext.txt	597	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	598	arihara z takahashi k murakami o totsune k sone m satoh f ito hayashi y sasano h mouri
0.35575834.12419707.html.plaintext.txt	599	orexin human brain tumor tissue ganglioneuroblastoma neuroblastoma
0.35575834.12419707.html.plaintext.txt	600	peptide num num num numisimedline
0.35575834.12419707.html.plaintext.txt	601	backberg m hervieu g wilson meister b
0.35575834.12419707.html.plaintext.txt	602	orexin receptor num ox rnum immunoreactivity chemically identified neuron hypothalamus focus orexin target involved control food water intake
0.35575834.12419707.html.plaintext.txt	603	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	604	balasko m szelenyi z szekely m
0.35575834.12419707.html.plaintext.txt	605	central thermoregulatory effect neuropeptide y orexin rat
0.35575834.12419707.html.plaintext.txt	606	acta physiol hung num num num nummedline
0.35575834.12419707.html.plaintext.txt	607	receptor activated canum inflow animal cell variety pathway tailored meet different intracellular canum signalling requirement
0.35575834.12419707.html.plaintext.txt	608	biochem j num num num numisimedline
0.35575834.12419707.html.plaintext.txt	609	bayer l colard c nguyen nu risold py fellmann d griffond b
0.35575834.12419707.html.plaintext.txt	610	alteration expression hypocretin orexin gene num deoxyglucose rat lateral hypothalamic area
0.35575834.12419707.html.plaintext.txt	611	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	612	bayer l eggermann e serafin m saint mleux b machard d jones b muhlethaler m
0.35575834.12419707.html.plaintext.txt	613	orexins hypocretins directly excite tuberomammillary neuron
0.35575834.12419707.html.plaintext.txt	614	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	615	bayer l mairet coello g risold py griffond b
0.35575834.12419707.html.plaintext.txt	616	orexinhypocretin neuron chemical phenotype possible interaction melanin concentrating hormone neuron
0.35575834.12419707.html.plaintext.txt	617	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	618	bingham davey pt babbs aj irving ea sammons mj wyles m jeffrey p cutler l riba john porter ra upton n hunter aj parson aa
0.35575834.12419707.html.plaintext.txt	619	orexin hypothalamic peptide analgesic property
0.35575834.12419707.html.plaintext.txt	620	pain num num num numisimedline
0.35575834.12419707.html.plaintext.txt	621	blanco m garcia caballero fraga m gallego r cuevas j forteza j beira dieguez c
0.35575834.12419707.html.plaintext.txt	622	cellular localization orexin receptor human adrenal gland adrenocortical adenoma pheochromocytoma
0.35575834.12419707.html.plaintext.txt	623	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	624	blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beira
0.35575834.12419707.html.plaintext.txt	625	cellular localization orexin receptor human pituitary
0.35575834.12419707.html.plaintext.txt	626	j clin endocrinol metab num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	627	bonini ja jones ka adham n forray c artymyshyn r durkin mm smith ke tamm ja boteju lw lakhlani pp raddatz r yao wj ogozalek kl boyle n kouranova ev quan y vaysse pj wetzel jm branchek ta gerald c borowsky b
0.35575834.12419707.html.plaintext.txt	628	identification characterization two g protein coupled receptor neuropeptide ff
0.35575834.12419707.html.plaintext.txt	629	j biol chem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	630	bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l
0.35575834.12419707.html.plaintext.txt	631	hypocretin num modulates rapid eye movement sleep activation locus coeruleus neuron
0.35575834.12419707.html.plaintext.txt	632	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	633	briski kp sylvester pw
0.35575834.12419707.html.plaintext.txt	634	hypothalamic orexin immunopositive neuron express fo response central glucopenia
0.35575834.12419707.html.plaintext.txt	635	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	636	broberger c de lecea l sutcliffe jg hokfelt
0.35575834.12419707.html.plaintext.txt	637	hypocretinorexin melanin concentrating hormone expressing cell form distinct population rodent lateral hypothalamus relationship neuropeptide y agouti gene related protein system
0.35575834.12419707.html.plaintext.txt	638	j comp neurol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	639	brown re sergeeva o eriksson k haas hl
0.35575834.12419707.html.plaintext.txt	640	orexin excites serotonergic neuron dorsal raphe nucleus rat
0.35575834.12419707.html.plaintext.txt	641	neuropharmacology num num num numisimedline
0.35575834.12419707.html.plaintext.txt	642	burlet tyler cj leonard c
0.35575834.12419707.html.plaintext.txt	643	direct indirect excitation laterodorsal tegmental neuron hypocretinorexin peptide implication wakefulness narcolepsy
0.35575834.12419707.html.plaintext.txt	644	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	645	cai xj evans ml lister ca leslie ra arch jr wilson williams g
0.35575834.12419707.html.plaintext.txt	646	hypoglycemia activates orexin neuron selectively increase hypothalamic orexin b level response inhibited feeding possibly mediated nucleus solitary tract
0.35575834.12419707.html.plaintext.txt	647	diabetes num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	648	cai xj liu xh evans m clapham jc wilson arch jr morris r williams g
0.35575834.12419707.html.plaintext.txt	649	orexins feeding special occasion everyday occurrence regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	650	cai xj widdowson p harrold j wilson buckingham re arch jr tadayyon m clapham jc wilding j williams g
0.35575834.12419707.html.plaintext.txt	651	hypothalamic orexin expression modulation blood glucose feeding
0.35575834.12419707.html.plaintext.txt	652	diabetes num num num numabstract
0.35575834.12419707.html.plaintext.txt	653	chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m
0.35575834.12419707.html.plaintext.txt	654	narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.35575834.12419707.html.plaintext.txt	655	cell num num num numisimedline
0.35575834.12419707.html.plaintext.txt	656	chen ct dun sl kwok eh dun nj chang jk
0.35575834.12419707.html.plaintext.txt	657	orexin like immunoreactivity rat brain
0.35575834.12419707.html.plaintext.txt	658	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	659	chen ct hwang ll chang jk dun nj
0.35575834.12419707.html.plaintext.txt	660	pressor effect orexins injected intracisternally rostral ventrolateral medulla anesthetized rat
0.35575834.12419707.html.plaintext.txt	661	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	662	nature num num num numisimedline
0.35575834.12419707.html.plaintext.txt	663	chou tc lee ce lu j elmquist jk hara j willie jt beuckmann ct chemelli rm sakurai yanagisawa m saper cb scammell te
0.35575834.12419707.html.plaintext.txt	664	orexin hypocretin neuron contain dynorphin
0.35575834.12419707.html.plaintext.txt	665	j neurosci num rcnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	666	cikos gregor p koppel j
0.35575834.12419707.html.plaintext.txt	667	sequence tissue distribution novel g protein coupled receptor expressed prominently human placenta
0.35575834.12419707.html.plaintext.txt	668	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	669	clapham de runnel lw strubing c
0.35575834.12419707.html.plaintext.txt	670	nat rev neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	671	cluderay je harrison dc hervieu gj
0.35575834.12419707.html.plaintext.txt	672	protein distribution orexin num receptor rat central nervous system
0.35575834.12419707.html.plaintext.txt	673	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	674	cutler dj morris r sheridhar v wattam ta holmes patel arch jr wilson buckingham re evans ml leslie ra williams g
0.35575834.12419707.html.plaintext.txt	675	differential distribution orexin orexin b immunoreactivity rat brain spinal cord
0.35575834.12419707.html.plaintext.txt	676	peptide num num num numisimedline
0.35575834.12419707.html.plaintext.txt	677	dalal ma schuld haack m uhr m geisler p eisensehr noachtar pollmacher
0.35575834.12419707.html.plaintext.txt	678	normal plasma level orexin hypocretin num narcoleptic patient
0.35575834.12419707.html.plaintext.txt	679	neurology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	680	darker jg porter ra eggleston d smart d brough sj sabido david c jerman jc
0.35575834.12419707.html.plaintext.txt	681	structure activity analysis truncated orexin analogue orexin num receptor
0.35575834.12419707.html.plaintext.txt	682	bioorg med chem lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	683	date y mondal m matsukura nakazato m
0.35575834.12419707.html.plaintext.txt	684	distribution orexin orexin b hypocretins rat spinal cord
0.35575834.12419707.html.plaintext.txt	685	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	686	date y mondal m matsukura ueta y yamashita h kaiya h kangawa k nakazato m
0.35575834.12419707.html.plaintext.txt	687	distribution orexinhypocretin rat median eminence pituitary
0.35575834.12419707.html.plaintext.txt	688	brain re mol brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	689	date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m
0.35575834.12419707.html.plaintext.txt	690	orexins orexigenic hypothalamic peptide interact autonomic neuroendocrine neuroregulatory system
0.35575834.12419707.html.plaintext.txt	691	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	692	de lecea l kilduff t peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett f frankel wn van den pol bloom fe gautvik km sutcliffe jg
0.35575834.12419707.html.plaintext.txt	693	hypocretins hypothalamus specific peptide neuroexcitatory activity
0.35575834.12419707.html.plaintext.txt	694	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	695	dube mg horvath tl kalra p kalra sp
0.35575834.12419707.html.plaintext.txt	696	evidence npy ynum receptor involvement food intake elicited orexin sated rat
0.35575834.12419707.html.plaintext.txt	697	peptide num num num numisimedline
0.35575834.12419707.html.plaintext.txt	698	dube mg kalra sp kalra p
0.35575834.12419707.html.plaintext.txt	699	food intake elicited central administration orexinshypocretins identification hypothalamic site action
0.35575834.12419707.html.plaintext.txt	700	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	701	duxon m stretton j starr k jones dn holland v riley g jerman j brough smart d john chan w porter ra upton n
0.35575834.12419707.html.plaintext.txt	702	evidence orexin evoked grooming rat mediated orexin num oxnum receptor downstream num htnumc receptor involvement
0.35575834.12419707.html.plaintext.txt	703	psychopharmacology berl num num num nummedline
0.35575834.12419707.html.plaintext.txt	704	dyer cj touchette kj carroll ja allee gl matteri rl
0.35575834.12419707.html.plaintext.txt	705	cloning porcine prepro orexin cdna effect intramuscular injection synthetic porcine orexin b feed intake young pig
0.35575834.12419707.html.plaintext.txt	706	domest anim endocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	707	eggermann e serafin m bayer l machard d saint mleux b jones muhlethaler m
0.35575834.12419707.html.plaintext.txt	708	orexinshypocretins excite basal forebrain cholinergic neurones
0.35575834.12419707.html.plaintext.txt	709	neuroscience num num num numisimedline
0.35575834.12419707.html.plaintext.txt	710	elia cf saper cb maratos flier e tritos na lee c kelly j tatro jb hoffman ge ollmann mm barsh g sakurai yanagisawa m elmquist jk
0.35575834.12419707.html.plaintext.txt	711	chemically defined projection linking mediobasal hypothalamus lateral hypothalamic area
0.35575834.12419707.html.plaintext.txt	712	j comp neurol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	713	eriksson k sergeeva o brown re haas hl
0.35575834.12419707.html.plaintext.txt	714	orexinhypocretin excites histaminergic neuron tuberomammillary nucleus
0.35575834.12419707.html.plaintext.txt	715	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	716	espana ra baldo ba kelley ae berridge cw
0.35575834.12419707.html.plaintext.txt	717	wake promoting sleep suppressing action hypocretin orexin basal forebrain site action
0.35575834.12419707.html.plaintext.txt	718	neuroscience num num num numisimedline
0.35575834.12419707.html.plaintext.txt	719	estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te
0.35575834.12419707.html.plaintext.txt	720	fo expression orexin neuron varies behavioral state
0.35575834.12419707.html.plaintext.txt	721	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	722	fujiki n yoshida y ripley b honda k mignot e nishino
0.35575834.12419707.html.plaintext.txt	723	change csf hypocretin num orexin level rat across num hour response food deprivation
0.35575834.12419707.html.plaintext.txt	724	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	725	fung sj yamuy j sampogna morale fr chase mh
0.35575834.12419707.html.plaintext.txt	726	hypocretin orexin input trigeminal hypoglossal motoneuron cat double labeling immunohistochemical study
0.35575834.12419707.html.plaintext.txt	727	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	728	melanin concentrating hormone depresses synaptic activity glutamate gaba neuron rat lateral hypothalamus
0.35575834.12419707.html.plaintext.txt	729	j physiol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	730	gautvik km de lecea l gautvik vt danielson pe tranque p dopazo bloom fe sutcliffe jg
0.35575834.12419707.html.plaintext.txt	731	overview prevalent hypothalamus specific mrna identified directional tag pcr subtraction
0.35575834.12419707.html.plaintext.txt	732	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	733	gencik m dahmen n wieczorek kasten m bierbrauer j anghelescu szegedi menezes saecker epplen jt
0.35575834.12419707.html.plaintext.txt	734	prepro orexin gene polymorphism associated narcolepsy
0.35575834.12419707.html.plaintext.txt	735	neurology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	736	gerashchenko d kohl md greco m waleh n salin pascual r kilduff t lappi da shiromani pj
0.35575834.12419707.html.plaintext.txt	737	hypocretin num saporin lesion lateral hypothalamus produce narcoleptic like sleep behavior rat
0.35575834.12419707.html.plaintext.txt	738	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	739	griffond b risold py jacquemard c colard c fellmann d
0.35575834.12419707.html.plaintext.txt	740	insulin induced hypoglycemia increase preprohypocretin orexin mrna rat lateral hypothalamic area
0.35575834.12419707.html.plaintext.txt	741	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	742	grudt tj van den pol perl er
0.35575834.12419707.html.plaintext.txt	743	hypocretin num orexin b modulation superficial dorsal horn activity rat
0.35575834.12419707.html.plaintext.txt	744	j physiol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	745	guan jl saotome wang qp funahashi h hori tanaka shioda
0.35575834.12419707.html.plaintext.txt	746	orexinergic innervation pomc containing neuron rat arcuate nucleus
0.35575834.12419707.html.plaintext.txt	747	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	748	hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n
0.35575834.12419707.html.plaintext.txt	749	orexin activates locus coeruleus cell firing increase arousal rat
0.35575834.12419707.html.plaintext.txt	750	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	751	hakansson ml brown h ghilardi n skoda rc meister b
0.35575834.12419707.html.plaintext.txt	752	leptin receptor immunoreactivity chemically defined target neuron hypothalamus
0.35575834.12419707.html.plaintext.txt	753	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	754	hakansson m de lecea l sutcliffe jg yanagisawa m meister b
0.35575834.12419707.html.plaintext.txt	755	leptin receptor statnum immunoreactivities hypocretinorexin neurones lateral hypothalamus
0.35575834.12419707.html.plaintext.txt	756	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	757	hamilton se loose md qi m levey ai hille b mcknight g idzerda rl nathanson nm
0.35575834.12419707.html.plaintext.txt	758	disruption mnum receptor gene ablates muscarinic receptor dependent m current regulation seizure activity mouse
0.35575834.12419707.html.plaintext.txt	759	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	760	hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai
0.35575834.12419707.html.plaintext.txt	761	genetic ablation orexin neuron mouse result narcolepsy hypophagia obesity
0.35575834.12419707.html.plaintext.txt	762	neuron num num num numisimedline
0.35575834.12419707.html.plaintext.txt	763	harrison ta chen ct dun nj chang jk
0.35575834.12419707.html.plaintext.txt	764	hypothalamic orexin immunoreactive neuron project rat dorsal medulla
0.35575834.12419707.html.plaintext.txt	765	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	766	haynes ac jackson b chapman h tadayyon m john porter ra arch jr
0.35575834.12419707.html.plaintext.txt	767	selective orexin num receptor antagonist reduces food consumption male female rat
0.35575834.12419707.html.plaintext.txt	768	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	769	haynes ac jackson b overend p buckingham re wilson tadayyon m arch jr
0.35575834.12419707.html.plaintext.txt	770	effect single chronic intracerebroventricular administration orexins feeding rat
0.35575834.12419707.html.plaintext.txt	771	peptide num num num numisimedline
0.35575834.12419707.html.plaintext.txt	772	hervieu gj cluderay je harrison dc robert jc leslie ra
0.35575834.12419707.html.plaintext.txt	773	gene expression protein distribution orexin num receptor rat brain spinal cord
0.35575834.12419707.html.plaintext.txt	774	neuroscience num num num numisimedline
0.35575834.12419707.html.plaintext.txt	775	inhibition gi activated potassium channel girknumnum gq coupled mnum muscarinic acetylcholine receptor
0.35575834.12419707.html.plaintext.txt	776	j biol chem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	777	hirota k kushikata kudo m kudo lambert dg matsuki
0.35575834.12419707.html.plaintext.txt	778	orexin b evoke noradrenaline release rat cerebrocortical slice
0.35575834.12419707.html.plaintext.txt	779	br j pharmacol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	780	holmqvist akerman keo kukkonen jp
0.35575834.12419707.html.plaintext.txt	781	high specificity human orexin receptor orexins neuropeptide y neuropeptides
0.35575834.12419707.html.plaintext.txt	782	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	783	horn f weare j beukers mw horsch bairoch chen w edvardsen o campagne f vriend g
0.35575834.12419707.html.plaintext.txt	784	gpcrdb information system g protein coupled receptor
0.35575834.12419707.html.plaintext.txt	785	nucleic acid re num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	786	horvath tl diano van den pol
0.35575834.12419707.html.plaintext.txt	787	synaptic interaction hypocretin orexin neuropeptide y cell rodent primate hypothalamus novel circuit implicated metabolic endocrine regulation
0.35575834.12419707.html.plaintext.txt	788	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	789	horvath tl peyron c diano ivanov aston jones g kilduff t van den pol
0.35575834.12419707.html.plaintext.txt	790	hypocretin orexin activation synaptic innervation locus coeruleus noradrenergic system
0.35575834.12419707.html.plaintext.txt	791	j comp neurol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	792	horvath tl warden ch hajos m lombardi goglia f diano
0.35575834.12419707.html.plaintext.txt	793	brain uncoupling protein num uncoupled neuronal mitochondrion predict thermal synapsis homeostatic center
0.35575834.12419707.html.plaintext.txt	794	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	795	huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o
0.35575834.12419707.html.plaintext.txt	796	arousal effect orexin depends activation histaminergic system
0.35575834.12419707.html.plaintext.txt	797	proc natl acad sci usa num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	798	hungs m fan j lin l lin x maki ra mignot e
0.35575834.12419707.html.plaintext.txt	799	identification functional analysis mutation hypocretin orexin gene narcoleptic canine
0.35575834.12419707.html.plaintext.txt	800	genome re num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	801	hypocretinorexin sleep narcolepsy
0.35575834.12419707.html.plaintext.txt	802	bioessays num num num numisimedline
0.35575834.12419707.html.plaintext.txt	803	hwang ll chen ct dun nj
0.35575834.12419707.html.plaintext.txt	804	mechanism orexin induced depolarization rat dorsal motor nucleus vagus neurones vitro
0.35575834.12419707.html.plaintext.txt	805	j physiol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	806	ichinose m asai m sawada m sasaki k oomura y
0.35575834.12419707.html.plaintext.txt	807	induction outward current orexin b mouse peritoneal macrophage
0.35575834.12419707.html.plaintext.txt	808	feb lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	809	ida nakahara k katayama murakami n nakazato m
0.35575834.12419707.html.plaintext.txt	810	effect lateral cerebroventricular injection appetite stimulating neuropeptide orexin neuropeptide y various behavioral activity rat
0.35575834.12419707.html.plaintext.txt	811	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	812	ida nakahara k murakami hanada r nakazato m murakami n
0.35575834.12419707.html.plaintext.txt	813	possible involvement orexin stress reaction rat
0.35575834.12419707.html.plaintext.txt	814	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	815	ishizuka yamamoto y yamatodani
0.35575834.12419707.html.plaintext.txt	816	effect orexin b histamine release anterior hypothalamus rat
0.35575834.12419707.html.plaintext.txt	817	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	818	ivanov aston jones g
0.35575834.12419707.html.plaintext.txt	819	hypocretinorexin depolarizes decrease potassium conductance locus coeruleus neuron
0.35575834.12419707.html.plaintext.txt	820	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	821	jain mr horvath tl kalra p kalra sp
0.35575834.12419707.html.plaintext.txt	822	evidence npy ynum receptor involved stimulation feeding orexins hypocretins sated rat
0.35575834.12419707.html.plaintext.txt	823	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	824	jaszberenyi m bujdoso e pataki telegdy g
0.35575834.12419707.html.plaintext.txt	825	effect orexins hypothalamic pituitary adrenal system
0.35575834.12419707.html.plaintext.txt	826	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	827	jaszberenyi m bujdoso e telegdy g
0.35575834.12419707.html.plaintext.txt	828	role neuropeptide y orexin induced hypothalamic pituitary adrenal activation
0.35575834.12419707.html.plaintext.txt	829	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	830	johren o neidert sj kummer m dendorfer dominiak p
0.35575834.12419707.html.plaintext.txt	831	prepro orexin orexin receptor mrna differentially expressed peripheral tissue male female rat
0.35575834.12419707.html.plaintext.txt	832	endocrinology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	833	jones dn gartlon j parker f taylor sg routledge c hemmati p munton rp ashmeade te hatcher jp john porter ra hagan jj hunter aj upton n
0.35575834.12419707.html.plaintext.txt	834	effect centrally administered orexin b orexin role orexin num receptor orexin b induced hyperactivity
0.35575834.12419707.html.plaintext.txt	835	psychopharmacology berl num num num nummedline
0.35575834.12419707.html.plaintext.txt	836	kane jk parker sl matta sg fu y sharp bm li md
0.35575834.12419707.html.plaintext.txt	837	nicotine regulates expression orexin receptor rat brain
0.35575834.12419707.html.plaintext.txt	838	endocrinology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	839	kane jk tanaka h parker sl yanagisawa m li md
0.35575834.12419707.html.plaintext.txt	840	sensitivity orexin binding phospholipase c inhibitor neuropeptide y secretin
0.35575834.12419707.html.plaintext.txt	841	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	842	karteris e randeva h grammatopoulos dk jaffe rb hillhouse ew
0.35575834.12419707.html.plaintext.txt	843	expression coupling characteristic crh orexin type num receptor human fetal adrenal
0.35575834.12419707.html.plaintext.txt	844	j clin endocrinol metab num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	845	orexin orexin b rapidly enters brain blood simple diffusion
0.35575834.12419707.html.plaintext.txt	846	j pharmacol exp ther num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	847	hypocretinorexin ligand receptor system implication sleep sleep disorder
0.35575834.12419707.html.plaintext.txt	848	trend neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	849	kimura j miyamae noma
0.35575834.12419707.html.plaintext.txt	850	identification sodium calcium exchange current single ventricular cell guinea pig
0.35575834.12419707.html.plaintext.txt	851	j physiol num num num numabstract
0.35575834.12419707.html.plaintext.txt	852	orexin synthesis response gut
0.35575834.12419707.html.plaintext.txt	853	neuron num num num numisimedline
0.35575834.12419707.html.plaintext.txt	854	korotkova tm eriksson k haas hl brown re
0.35575834.12419707.html.plaintext.txt	855	selective excitation gabaergic neuron substantia nigra rat orexinhypocretin vitro
0.35575834.12419707.html.plaintext.txt	856	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	857	krahn le black jl silber mh
0.35575834.12419707.html.plaintext.txt	858	narcolepsy new understanding irresistible sleep
0.35575834.12419707.html.plaintext.txt	859	mayo clin proc num num num numisimedline
0.35575834.12419707.html.plaintext.txt	860	kreegipuu blom n brunak
0.35575834.12419707.html.plaintext.txt	861	phosphobase database phosphorylation site release num
0.35575834.12419707.html.plaintext.txt	862	nucleic acid re num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	863	kukkonen jp akerman keo orexin receptor couple canum channel different store operated canum channel
0.35575834.12419707.html.plaintext.txt	864	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	865	kummer m neidert sj johren o dominiak p
0.35575834.12419707.html.plaintext.txt	866	orexin hypocretin gene expression rat ependymal cell
0.35575834.12419707.html.plaintext.txt	867	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	868	kunii k yamanaka nambu matsuzaki goto k sakurai
0.35575834.12419707.html.plaintext.txt	869	orexinshypocretins regulate drinking behaviour
0.35575834.12419707.html.plaintext.txt	870	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	871	kurose ueta y yamamoto y serino r ozaki y saito j nagata yamashita h
0.35575834.12419707.html.plaintext.txt	872	effect restricted feeding activity hypothalamic orexin ox containing neuron oxnum receptor mrna level paraventricular nucleus rat
0.35575834.12419707.html.plaintext.txt	873	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	874	lee jh bang e chae kj kim jy lee dw lee w
0.35575834.12419707.html.plaintext.txt	875	solution structure new hypothalamic neuropeptide human hypocretin numorexin b
0.35575834.12419707.html.plaintext.txt	876	eur j biochem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	877	levin dunn meynell aa routh vh
0.35575834.12419707.html.plaintext.txt	878	brain glucose sensing body energy homeostasis role obesity diabetes
0.35575834.12419707.html.plaintext.txt	879	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	880	lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e
0.35575834.12419707.html.plaintext.txt	881	sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.35575834.12419707.html.plaintext.txt	882	cell num num num numisimedline
0.35575834.12419707.html.plaintext.txt	883	liu xh morris r spiller d white m williams g
0.35575834.12419707.html.plaintext.txt	884	orexin preferentially excites glucose sensitive neuron lateral hypothalamus rat vitro
0.35575834.12419707.html.plaintext.txt	885	diabetes num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	886	lopez m senaris r gallego r garcia caballero lago f seoane l casanueva f dieguez c
0.35575834.12419707.html.plaintext.txt	887	orexin receptor expressed adrenal medulla rat
0.35575834.12419707.html.plaintext.txt	888	endocrinology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	889	lopez m seoane l garcia mc lago f casanueva ff senaris r dieguez c
0.35575834.12419707.html.plaintext.txt	890	leptin regulation prepro orexin orexin receptor mrna level hypothalamus
0.35575834.12419707.html.plaintext.txt	891	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	892	lubkin m stricker krongrad
0.35575834.12419707.html.plaintext.txt	893	independent feeding metabolic action orexins mouse
0.35575834.12419707.html.plaintext.txt	894	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	895	lund pe shariatmadari r uustare detheux m parmentier m kukkonen jp akerman keo orexin oxnum receptor activates novel canum influx pathway necessary coupling phospholipase c
0.35575834.12419707.html.plaintext.txt	896	j biol chem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	897	malendowicz lk hochol ziolkowska nowak m gottardo l nussdorfer gg
0.35575834.12419707.html.plaintext.txt	898	prolonged orexin administration stimulates steroid hormone secretion acting directly rat adrenal gland
0.35575834.12419707.html.plaintext.txt	899	int j mol med num num num numisimedline
0.35575834.12419707.html.plaintext.txt	900	malendowicz lk jedrzejczak n belloni trejter m hochol nussdorfer gg
0.35575834.12419707.html.plaintext.txt	901	effect orexins b secretory proliferative activity immature regenerating rat adrenal gland
0.35575834.12419707.html.plaintext.txt	902	histol histopathol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	903	malendowicz lk tortorella c nussdorfer gg
0.35575834.12419707.html.plaintext.txt	904	orexins stimulate corticosterone secretion rat adrenocortical cell activation adenylate cyclase dependent signaling cascade
0.35575834.12419707.html.plaintext.txt	905	j steroid biochem mol biol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	906	marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk
0.35575834.12419707.html.plaintext.txt	907	differential expression orexin receptor num num rat brain
0.35575834.12419707.html.plaintext.txt	908	j comp neurol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	909	g protein mediated gating inward rectifier k channel
0.35575834.12419707.html.plaintext.txt	910	eur j biochem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	911	martin g fabre v siggins gr de lecea l
0.35575834.12419707.html.plaintext.txt	912	interaction hypocretins neurotransmitter nucleus accumbens
0.35575834.12419707.html.plaintext.txt	913	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	914	matsumura k tsuchihashi abe
0.35575834.12419707.html.plaintext.txt	915	central orexin augments sympathoadrenal outflow conscious rabbit
0.35575834.12419707.html.plaintext.txt	916	hypertension num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	917	matsuzaki sakurai kunii k nakamura yanagisawa m goto k
0.35575834.12419707.html.plaintext.txt	918	involvement serotonergic system orexin induced behavioral alteration rat
0.35575834.12419707.html.plaintext.txt	919	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	920	mazzocchi g malendowicz lk aragona f rebuffat p gottardo l nussdorfer gg
0.35575834.12419707.html.plaintext.txt	921	human pheochromocytoma express orexin receptor type num gene display vitro secretory response orexins b
0.35575834.12419707.html.plaintext.txt	922	j clin endocrinol metab num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	923	mazzocchi g malendowicz lk gottardo l aragona f nussdorfer gg
0.35575834.12419707.html.plaintext.txt	924	orexin stimulates cortisol secretion human adrenocortical cell activation adenylate cyclase dependent signaling cascade
0.35575834.12419707.html.plaintext.txt	925	j clin endocrinol metab num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	926	mcgranaghan pa piggins hd
0.35575834.12419707.html.plaintext.txt	927	orexin like immunoreactivity hypothalamus thalamus syrian hamster mesocricetus auratus siberian hamster phodopus sungorus special reference circadian structure
0.35575834.12419707.html.plaintext.txt	928	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	929	control food intake via leptin receptor hypothalamus
0.35575834.12419707.html.plaintext.txt	930	vitam horm num num num nummedline
0.35575834.12419707.html.plaintext.txt	931	methippara mm alam mn szymusiak r mcginty d
0.35575834.12419707.html.plaintext.txt	932	effect lateral preoptic area application orexin sleep wakefulness
0.35575834.12419707.html.plaintext.txt	933	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	934	mikkelsen jd hauser f delecea l sutcliffe jg kilduff t calgari c pevet p simonneaux v
0.35575834.12419707.html.plaintext.txt	935	hypocretin orexin rat pineal gland central transmitter effect noradrenaline induced release melatonin
0.35575834.12419707.html.plaintext.txt	936	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	937	mintz em van den pol casano aa albers
0.35575834.12419707.html.plaintext.txt	938	distribution hypocretin orexin immunoreactivity central nervous system syrian hamster mesocricetus auratus
0.35575834.12419707.html.plaintext.txt	939	j chem neuroanat num num num numisimedline
0.35575834.12419707.html.plaintext.txt	940	mitsuma hirooka y mori y kayama m adachi k rhue n ping j nogimori
0.35575834.12419707.html.plaintext.txt	941	effect orexin thyrotropin releasing hormone thyrotropin secretion rat
0.35575834.12419707.html.plaintext.txt	942	horm metab re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	943	monda m viggiano mondola p de luca v
0.35575834.12419707.html.plaintext.txt	944	inhibition prostaglandin synthesis reduces hyperthermic reaction induced hypocretin numorexin
0.35575834.12419707.html.plaintext.txt	945	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	946	mondal m nakazato m date y murakami n hanada r sakata matsukura
0.35575834.12419707.html.plaintext.txt	947	characterization orexin orexin b microdissected rat brain nucleus content two obese rat model
0.35575834.12419707.html.plaintext.txt	948	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	949	mondal m nakazato m date y murakami n yanagisawa m matsukura
0.35575834.12419707.html.plaintext.txt	950	widespread distribution orexin rat brain regulation upon fasting
0.35575834.12419707.html.plaintext.txt	951	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	952	moriguchi sakurai nambu yanagisawa m goto k
0.35575834.12419707.html.plaintext.txt	953	neuron containing orexin lateral hypothalamic area adult rat brain activated insulin induced acute hypoglycemia
0.35575834.12419707.html.plaintext.txt	954	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	955	mullett ma billington cj levine kotz cm
0.35575834.12419707.html.plaintext.txt	956	hypocretin lateral hypothalamus activates key feeding regulatory brain site
0.35575834.12419707.html.plaintext.txt	957	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	958	muroya uramura k sakurai takigawa m yada
0.35575834.12419707.html.plaintext.txt	959	lowering glucose concentration increase cytosolic canum orexin neuron rat lateral hypothalamus
0.35575834.12419707.html.plaintext.txt	960	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	961	nakamura uramura k nambu yada goto k yanagisawa m sakurai
0.35575834.12419707.html.plaintext.txt	962	orexin induced hyperlocomotion stereotypy mediated dopaminergic system
0.35575834.12419707.html.plaintext.txt	963	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	964	nambu sakurai mizukami k hosoya y yanagisawa m goto k
0.35575834.12419707.html.plaintext.txt	965	distribution orexin neuron adult rat brain
0.35575834.12419707.html.plaintext.txt	966	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	967	nanmoku isobe k sakurai yamanaka takekoshi k kawakami y goto k nakai
0.35575834.12419707.html.plaintext.txt	968	effect orexin cultured porcine adrenal medullary cortex cell
0.35575834.12419707.html.plaintext.txt	969	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	970	naslund e ehrstrom m ma j hellstrom pm kirchgessner al
0.35575834.12419707.html.plaintext.txt	971	localization effect orexin fasting motility rat duodenum
0.35575834.12419707.html.plaintext.txt	972	j physiol gastrointest liver physiol num gnum gnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	973	nishino fujiki n ripley b sakurai e kato m watanabe mignot e yanai k
0.35575834.12419707.html.plaintext.txt	974	decreased brain histamine content hypocretinorexin receptor num mutated narcoleptic dog
0.35575834.12419707.html.plaintext.txt	975	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	976	nishino ripley b overeem lammers gj mignot e
0.35575834.12419707.html.plaintext.txt	977	hypocretin orexin deficiency human narcolepsy
0.35575834.12419707.html.plaintext.txt	978	lancet num num num numisimedline
0.35575834.12419707.html.plaintext.txt	979	localization hypocretin like immunoreactivity brain diurnal rodent arvicanthis niloticus
0.35575834.12419707.html.plaintext.txt	980	j chem neuroanat num num num numisimedline
0.35575834.12419707.html.plaintext.txt	981	nowak kw mackowiak p switonska mm fabis m malendowicz lk
0.35575834.12419707.html.plaintext.txt	982	acute orexin effect insulin secretion rat vivo vitro study
0.35575834.12419707.html.plaintext.txt	983	life sci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	984	okumura takeuchi motomura w yamada h egashira si asahi kanatani ihara m kohgo y
0.35575834.12419707.html.plaintext.txt	985	requirement intact disulfide bond orexin induced stimulation gastric acid secretion mediated oxnum receptor activation
0.35575834.12419707.html.plaintext.txt	986	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	987	olafsdottir br rye db scammell te matheson jk stefansson k gulcher jr
0.35575834.12419707.html.plaintext.txt	988	polymorphism hypocretinorexin pathway gene narcolepsy
0.35575834.12419707.html.plaintext.txt	989	neurology num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	990	orlando g brunetti l di nisio c michelotto b recinella l ciabattoni g vacca m
0.35575834.12419707.html.plaintext.txt	991	effect cocaine amphetamine regulated transcript peptide leptin orexins hypothalamic serotonin release
0.35575834.12419707.html.plaintext.txt	992	eur j pharmacol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	993	overeem mignot e gert van dijk j lammers gj
0.35575834.12419707.html.plaintext.txt	994	narcolepsy clinical feature new pathophysiologic insight future perspective
0.35575834.12419707.html.plaintext.txt	995	j clin neurophysiol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	996	peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e
0.35575834.12419707.html.plaintext.txt	997	mutation case early onset narcolepsy generalized absence hypocretin peptide human narcoleptic brain
0.35575834.12419707.html.plaintext.txt	998	nat med num num num numisimedline
0.35575834.12419707.html.plaintext.txt	999	peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff t
0.35575834.12419707.html.plaintext.txt	1000	neuron containing hypocretin orexin project multiple neuronal system
0.35575834.12419707.html.plaintext.txt	1001	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1002	piper dc upton n smith mi hunter aj
0.35575834.12419707.html.plaintext.txt	1003	novel brain neuropeptide orexin modulates sleep wake cycle rat
0.35575834.12419707.html.plaintext.txt	1004	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1005	porter ra chan wn coulton john hadley m widdowson k jerman jc brough sj coldwell m smart d jewitt f jeffrey p austin n
0.35575834.12419707.html.plaintext.txt	1006	numnum biarylureas selective non peptide antagonist orexin num receptor
0.35575834.12419707.html.plaintext.txt	1007	bioorg med chem lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1008	randeva h karteris e grammatopoulos d hillhouse ew
0.35575834.12419707.html.plaintext.txt	1009	expression orexin functional orexin type num receptor human adult adrenal implication adrenal function energy homeostasis
0.35575834.12419707.html.plaintext.txt	1010	j clin endocrinol metab num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1011	rauch m riediger schmid ha simon e
0.35575834.12419707.html.plaintext.txt	1012	orexin activates leptin responsive neuron arcuate nucleus
0.35575834.12419707.html.plaintext.txt	1013	pflugers arch num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1014	ripley b fujiki n okura m mignot e nishino
0.35575834.12419707.html.plaintext.txt	1015	hypocretin level sporadic familial case canine narcolepsy
0.35575834.12419707.html.plaintext.txt	1016	neurobiol dis num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1017	rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr blundell je
0.35575834.12419707.html.plaintext.txt	1018	dose response effect orexin food intake behavioural satiety sequence rat
0.35575834.12419707.html.plaintext.txt	1019	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1020	rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr upton n porter ra john blundell je
0.35575834.12419707.html.plaintext.txt	1021	sb num selective orexin num receptor antagonist enhances behavioural satiety block hyperphagic effect orexin rat
0.35575834.12419707.html.plaintext.txt	1022	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1023	russell sh kim m small cj abbott cr morgan dg taheri murphy kg todd jf ghatei ma bloom sr
0.35575834.12419707.html.plaintext.txt	1024	central administration orexin suppresses basal domperidone stimulated plasma prolactin
0.35575834.12419707.html.plaintext.txt	1025	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1026	russell sh small cj dakin cl abbott cr morgan dg ghatei ma bloom sr
0.35575834.12419707.html.plaintext.txt	1027	central effect orexin hypothalamic pituitary adrenal axis vivo vitro male rat
0.35575834.12419707.html.plaintext.txt	1028	j neuroendocrinol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1029	russell sh small cj sunter d morgan dakin cl cohen ma bloom sr
0.35575834.12419707.html.plaintext.txt	1030	chronic intraparaventricular nuclear administration orexin male rat alter thyroid axis uncoupling protein num brown adipose tissue
0.35575834.12419707.html.plaintext.txt	1031	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1032	sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan r mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m
0.35575834.12419707.html.plaintext.txt	1033	orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.35575834.12419707.html.plaintext.txt	1034	cell num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1035	sakurai moriguchi furuya k kajiwara n nakamura yanagisawa m goto k
0.35575834.12419707.html.plaintext.txt	1036	structure function human prepro orexin gene
0.35575834.12419707.html.plaintext.txt	1037	j biol chem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1038	samson wk gosnell b chang jk resch zt murphy tc
0.35575834.12419707.html.plaintext.txt	1039	cardiovascular regulatory action hypocretins brain
0.35575834.12419707.html.plaintext.txt	1040	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1041	trend endocrinol metab num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1042	hypocretinorexin suppresses corticotroph responsiveness vitro
0.35575834.12419707.html.plaintext.txt	1043	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1044	samson wk taylor mm follwell m ferguson av
0.35575834.12419707.html.plaintext.txt	1045	orexin action hypothalamic paraventricular nucleus physiological consequence cellular correlate
0.35575834.12419707.html.plaintext.txt	1046	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1047	satoh y uchida m fujita nishio h takeuchi hata f
0.35575834.12419707.html.plaintext.txt	1048	possible role orexin nonadrenergic noncholinergic inhibitory response muscle mouse small intestine
0.35575834.12419707.html.plaintext.txt	1049	eur j pharmacol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1050	scammell te estabrooke iv mccarthy mt chemelli rm yanagisawa m miller m saper cb
0.35575834.12419707.html.plaintext.txt	1051	hypothalamic arousal region activated modafinil induced wakefulness
0.35575834.12419707.html.plaintext.txt	1052	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1053	schuld hebebrand j geller f pollmacher
0.35575834.12419707.html.plaintext.txt	1054	increased body mass index patient narcolepsy
0.35575834.12419707.html.plaintext.txt	1055	lancet num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1056	shibahara m sakurai nambu takenouchi iwaasa h egashira si ihara m goto k
0.35575834.12419707.html.plaintext.txt	1057	structure tissue distribution pharmacological characterization xenopus orexins
0.35575834.12419707.html.plaintext.txt	1058	peptide num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1059	shiraishi oomura y sasaki k wayner mj
0.35575834.12419707.html.plaintext.txt	1060	effect leptin orexin food intake feeding related hypothalamic neuron
0.35575834.12419707.html.plaintext.txt	1061	physiol behav num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1062	shirasaka miyahara kunitake jin qh kato k takasaki m kannan h
0.35575834.12419707.html.plaintext.txt	1063	orexin depolarizes rat hypothalamic paraventricular nucleus neuron
0.35575834.12419707.html.plaintext.txt	1064	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1065	shirasaka nakazato m matsukura takasaki m kannan h
0.35575834.12419707.html.plaintext.txt	1066	sympathetic cardiovascular action orexins conscious rat
0.35575834.12419707.html.plaintext.txt	1067	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1068	smart d jerman jc brough sj neville wa jewitt f porter ra
0.35575834.12419707.html.plaintext.txt	1069	hypocretins weak agonist recombinant human orexin num orexin num receptor
0.35575834.12419707.html.plaintext.txt	1070	br j pharmacol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1071	smart d jerman jc brough sj rushton sl murdock pr jewitt f elshourbagy na elli ce middlemiss dn brown f
0.35575834.12419707.html.plaintext.txt	1072	characterization recombinant human orexin receptor pharmacology chinese hamster ovary cell line using flipr
0.35575834.12419707.html.plaintext.txt	1073	br j pharmacol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1074	smart d sabido david c brough sj jewitt f john porter ra jerman jc
0.35575834.12419707.html.plaintext.txt	1075	sb num first selective orexin num receptor antagonist
0.35575834.12419707.html.plaintext.txt	1076	br j pharmacol num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1077	soffin em evans ml gill ch harries mh benham cd davy ch
0.35575834.12419707.html.plaintext.txt	1078	sb num antagonises orexin mediated excitation locus coeruleus
0.35575834.12419707.html.plaintext.txt	1079	neuropharmacology num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1080	sunahara rk dessauer cw gilman ag
0.35575834.12419707.html.plaintext.txt	1081	complexity diversity mammalian adenylyl cyclases
0.35575834.12419707.html.plaintext.txt	1082	annu rev pharmacol toxicol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1083	sutcliffe jg de lecea l
0.35575834.12419707.html.plaintext.txt	1084	hypocretins excitatory neuromodulatory peptide multiple homeostatic system including sleep feeding
0.35575834.12419707.html.plaintext.txt	1085	j neurosci re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1086	sweet dc levine billington cj kotz cm
0.35575834.12419707.html.plaintext.txt	1087	feeding response central orexins
0.35575834.12419707.html.plaintext.txt	1088	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1089	switonska mm kaczmarek p malendowicz lk nowak kw
0.35575834.12419707.html.plaintext.txt	1090	orexins adipoinsular axis function rat
0.35575834.12419707.html.plaintext.txt	1091	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1092	szekely m petervari e balasko m hernadi uzsoki b
0.35575834.12419707.html.plaintext.txt	1093	effect orexins energy balance thermoregulation
0.35575834.12419707.html.plaintext.txt	1094	regul pept num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1095	taheri sunter d dakin c moyes seal l gardiner j rossi m ghatei m bloom
0.35575834.12419707.html.plaintext.txt	1096	diurnal variation orexin immunoreactivity prepro orexin mrna rat central nervous system
0.35575834.12419707.html.plaintext.txt	1097	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1098	takahashi n okumura yamada h kohgo y
0.35575834.12419707.html.plaintext.txt	1099	stimulation gastric acid secretion centrally administered orexin conscious rat
0.35575834.12419707.html.plaintext.txt	1100	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1101	thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm
0.35575834.12419707.html.plaintext.txt	1102	reduced number hypocretin neuron human narcolepsy
0.35575834.12419707.html.plaintext.txt	1103	neuron num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1104	current concept etiology diagnosis treatment narcolepsy
0.35575834.12419707.html.plaintext.txt	1105	sleep med num num num nummedline
0.35575834.12419707.html.plaintext.txt	1106	trivedi p yu h macneil dj van der ploeg lh guan xm
0.35575834.12419707.html.plaintext.txt	1107	distribution orexin receptor mrna rat brain
0.35575834.12419707.html.plaintext.txt	1108	feb lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1109	uramura k funahashi h muroya shioda takigawa m yada
0.35575834.12419707.html.plaintext.txt	1110	orexin activates phospholipase c protein kinase c mediated canum signaling dopamine neuron ventral tegmental area
0.35575834.12419707.html.plaintext.txt	1111	neuroreport num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1112	hypothalamic hypocretin orexin robust innervation spinal cord
0.35575834.12419707.html.plaintext.txt	1113	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1114	van den pol gao xb obrietan k kilduff t belousov ab
0.35575834.12419707.html.plaintext.txt	1115	presynaptic postsynaptic action modulation neuroendocrine neuron new hypothalamic peptide hypocretinorexin
0.35575834.12419707.html.plaintext.txt	1116	j neurosci num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1117	van den pol patrylo pr ghosh pk gao xb
0.35575834.12419707.html.plaintext.txt	1118	lateral hypothalamus early developmental expression response hypocretin orexin
0.35575834.12419707.html.plaintext.txt	1119	j comp neurol num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1120	waleh n apte deshpande terao ding j kilduff t
0.35575834.12419707.html.plaintext.txt	1121	modulation promoter region prepro hypocretin alpha interferon
0.35575834.12419707.html.plaintext.txt	1122	gene num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1123	wang j osaka inoue
0.35575834.12419707.html.plaintext.txt	1124	energy expenditure intracerebroventricular administration orexin anesthetized rat
0.35575834.12419707.html.plaintext.txt	1125	neurosci lett num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1126	ion channel regulation g protein
0.35575834.12419707.html.plaintext.txt	1127	physiol rev num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1128	wieland ha soll rm doods hn stenkamp d hurnaus r lammle b beck sickinger ag
0.35575834.12419707.html.plaintext.txt	1129	sk n mc cell line express orexin binding site different recombinant orexin num type receptor
0.35575834.12419707.html.plaintext.txt	1130	eur j biochem num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1131	williams g harrold ja cutler dj
0.35575834.12419707.html.plaintext.txt	1132	hypothalamus regulation energy homeostasis lifting lid black box
0.35575834.12419707.html.plaintext.txt	1133	proc nutr soc num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1134	willie jt chemelli rm sinton cm yanagisawa m
0.35575834.12419707.html.plaintext.txt	1135	eat sleep orexin regulation feeding wakefulness
0.35575834.12419707.html.plaintext.txt	1136	annu rev neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1137	xi mc morale fr chase mh
0.35575834.12419707.html.plaintext.txt	1138	effect sleep wakefulness injection hypocretin num orexin laterodorsal tegmental nucleus cat
0.35575834.12419707.html.plaintext.txt	1139	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1140	yamada h okumura motomura w kobayashi y kohgo y
0.35575834.12419707.html.plaintext.txt	1141	inhibition food intake central injection anti orexin antibody fasted rat
0.35575834.12419707.html.plaintext.txt	1142	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1143	yamamoto y ueta y date y nakazato m hara y serino r nomura m shibuya matsukura yamashita h
0.35575834.12419707.html.plaintext.txt	1144	regulation prepro orexin gene expression genetically obese mouse
0.35575834.12419707.html.plaintext.txt	1145	brain re mol brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1146	yamanaka sakurai katsumoto yanagisawa m goto k
0.35575834.12419707.html.plaintext.txt	1147	chronic intracerebroventricular administration orexin rat increase food intake daytime effect body weight
0.35575834.12419707.html.plaintext.txt	1148	brain re num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1149	yamanaka tsujino n funahashi h honda k guan jl wang qp tominaga m goto k shioda sakurai
0.35575834.12419707.html.plaintext.txt	1150	orexins activate histaminergic neuron via orexin num receptor
0.35575834.12419707.html.plaintext.txt	1151	biochem biophys re commun num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1152	yoshida y fujiki n nakajima ripley b matsumura h yoneda h mignot e nishino
0.35575834.12419707.html.plaintext.txt	1153	fluctuation extracellular hypocretin num orexin level rat relation light dark cycle sleep wake activity
0.35575834.12419707.html.plaintext.txt	1154	eur j neurosci num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1155	yoshimichi g yoshimatsu h masaki sakata
0.35575834.12419707.html.plaintext.txt	1156	orexin regulates body temperature coordination arousal status
0.35575834.12419707.html.plaintext.txt	1157	exp biol med maywood num num num numabstractfree full text
0.35575834.12419707.html.plaintext.txt	1158	orexin b immunoreactive fiber terminal innervate sensory motor neuron jaw elevator muscle rat
0.35575834.12419707.html.plaintext.txt	1159	synapse num num num numisimedline
0.35575834.12419707.html.plaintext.txt	1160	j physiol cell physiol numnumcnum cnum num numnum num
0.35575834.12419707.html.plaintext.txt	1161	num copyright num american physiological society
0.358711.12485808.html.plaintext.txt	0	minireview side orexins endocrine metabolic action meghan m
0.358711.12485808.html.plaintext.txt	1	pharmacological physiological science st
0.358711.12485808.html.plaintext.txt	2	louis university school medicine st
0.358711.12485808.html.plaintext.txt	3	although clear orexinhypocretin peptide significant physiologically relevant role sleepwakefulness broader picture emerged indicating metabolic action may depend upon neural endocrine mechanism manifestation
0.358711.12485808.html.plaintext.txt	4	ability exogenous peptide activate sympathetic tone increase locomotor activity alter feeding behavior together observed alteration function knockout animal strongly suggests important neural action endogenous orexinshypocretins
0.358711.12485808.html.plaintext.txt	5	likewise action exogenously administered peptide alter endocrine function particular corticotropin release mirrored potential endocrinopathies knockout animal
0.358711.12485808.html.plaintext.txt	6	thus pluripotent peptide hold great potential treatment human narcolepsy also provide insight coordinated regulation multiple physiological system
0.358711.12485808.html.plaintext.txt	7	food intake autonomic nervous system narcolepsy corticotropin corticosterone
0.358711.12485808.html.plaintext.txt	8	remarkable convergence independent effort occurred early num la jolla dallas group simultaneously reported predicted num elucidated num structure two peptide would become named hypocretins num alternatively orexins num
0.358711.12485808.html.plaintext.txt	9	peptide known processed prohormone recognized produced brain remarkably circumscribed location lateral hypothalamusperifornical area region known important feeding behavior num
0.358711.12485808.html.plaintext.txt	10	axonal projection multiple brain site num num num num num num predicted diversity biological action clear beginning peptide exerted membrane effect similar recognized neurotransmitter num num num might significant role central nervous system cns regulation feeding behavior num num num
0.358711.12485808.html.plaintext.txt	11	simplicity peptide referred orexins
0.358711.12485808.html.plaintext.txt	12	orexin hypocretin num num amino acid peptide two internal disulfide linkage pyroglutamyl residue nhnum terminus amidated cooh terminus
0.358711.12485808.html.plaintext.txt	13	orexin b hypocretin num num amino acid length lack internal disulfide bond similarly amidated cooh terminus
0.358711.12485808.html.plaintext.txt	14	initial description orexins yanigisawas group sakurai et al
0.358711.12485808.html.plaintext.txt	15	num also identified two orexin receptor oxnumr oxnumr
0.358711.12485808.html.plaintext.txt	16	although g protein coupled receptor oxnumr appears couple via gqnum subclass heteromeric receptor oxnumr may couple either gqnum gio subclass num num
0.358711.12485808.html.plaintext.txt	17	clear oxnumr prefers orexin ligand whereas oxnumr bind orexin orexin b similar affinity num
0.358711.12485808.html.plaintext.txt	18	finally recognized addition broad projection field originating orexin producing neuron lateral hypothalamicperifornical area unique distribution oxnumr oxnumr subtypes exist num num num num establishing potential development pharmacological agent interact uniquely single subclass orexin receptor therefore act selective agonist antagonist specific biological action endogenous peptide
0.358711.12485808.html.plaintext.txt	19	although agreed exogenously applied orexin stimulate feeding orexin production determined metabolic state animal see review mieda yanagisawa ref
0.358711.12485808.html.plaintext.txt	20	num investigator recognize effect orexins le potent neuropeptide y npy see review smart et al
0.358711.12485808.html.plaintext.txt	21	however must recognized multiple peptide system interact control feeding response hierarchy within system clearly established
0.358711.12485808.html.plaintext.txt	22	pretreatment npy antagonist significantly decreased feeding response exogenously administered orexin num num suggesting npy neuron located downstream wiring diagram however evidence exist potential opposite true
0.358711.12485808.html.plaintext.txt	23	orexin neuron located farther downstream npy series circuit controlling feeding num
0.358711.12485808.html.plaintext.txt	24	strong evidence innervation npy neuron orexin terminal arcuate nucleus hypothalamus num num central administration dose orexin stimulated feeding significantly increased npy mrna nuclear group well num
0.358711.12485808.html.plaintext.txt	25	convincing evidence physiologically relevant role endogenous orexins cns control feeding come passive immunoneutralization study compromise bioactivity endogenous orexin num num neutralizing antibody reduced feeding response overnight fast
0.358711.12485808.html.plaintext.txt	26	least one group access compound observed decreased feeding response exogenously applied orexin fast induced feeding administration relatively selective nonpeptide oxnumr antagonist sb num num
0.358711.12485808.html.plaintext.txt	27	orexin knockout mouse preprohormone gene deletion ate le wild type littermates num suggesting physiologically relevant role endogenous orexin regulation appetite
0.358711.12485808.html.plaintext.txt	28	however mouse grew normally thus determinant growth body weight must compensate decreased feeding
0.358711.12485808.html.plaintext.txt	29	two excellent possibility motor activity metabolic state
0.358711.12485808.html.plaintext.txt	30	early recognized orexins stimulated motor activity apparently increased arousal state num num
0.358711.12485808.html.plaintext.txt	31	peptide also stimulate sympathetic nervous system activity num num num num thought increase feeding might actually secondary increased arousal state metabolic demand num
0.358711.12485808.html.plaintext.txt	32	clear locomotor activity time spent awake state increased animal administered orexin num
0.358711.12485808.html.plaintext.txt	33	thus addition stimulating feeding peptide stimulated energy expenditure num
0.358711.12485808.html.plaintext.txt	34	thing became much clearer yanagisawa colleague chemelli et al
0.358711.12485808.html.plaintext.txt	35	num demonstrated technical expertise developing orexin gene knockout mouse
0.358711.12485808.html.plaintext.txt	36	model proved importance endogenous orexin system sleepwakefulness time cast doubt physiological relevance observed effect peptide feeding behavior metabolism
0.358711.12485808.html.plaintext.txt	37	mouse displayed behavioral phenotype quite similar human canine model narcolepsy num num num distinct period behavioral arrest intrusion rapid eye movement rem sleep normal waking state
0.358711.12485808.html.plaintext.txt	38	primary function orexins control feeding metabolic rate pharmacological study suggested animal would expected display phenotypic change reflective loss activity
0.358711.12485808.html.plaintext.txt	39	however mouse reported otherwise phenotypically normal general metabolic state mirrored serum electrolyte glucose level similar wild type littermates num num wk age
0.358711.12485808.html.plaintext.txt	40	addition mouse fertile thus pharmacological effect previously reported reproductive hormone num num num num growth hormone num secretion appear physiological expression animal time studied
0.358711.12485808.html.plaintext.txt	41	although embryonic orexin gene knockout mouse provided key evidence pharmacological effect orexin sleepwakefulness potential physiological relevance drew attention investigator away endocrine metabolic effect peptide model entirely recapitulate pathology human narcolepsy num
0.358711.12485808.html.plaintext.txt	42	contrary recognized human narcolepsy almost case frank lack orexin gene expression throughout life instead gradual loss orexin producing neuron hypothalamus aging num num
0.358711.12485808.html.plaintext.txt	43	thus faithfully recreate mouse equivalent human model yanagisawa colleague hara et al
0.358711.12485808.html.plaintext.txt	44	num yet another brilliant series experiment created mouse harboring toxic ataxin num gene attached orexin promotor
0.358711.12485808.html.plaintext.txt	45	ataxin num gene encodes protein extended polyglutamine repeat caused apoptosis expressed transfected cell vitro num
0.358711.12485808.html.plaintext.txt	46	already num wk age expression transgene could detected orexin producing neuron num num wk age majority orexin producing neuron eliminated
0.358711.12485808.html.plaintext.txt	47	similarly num wk age ataxin num transgenic mouse preproorexin mrna could detected whereas expression two peptide known involved control feeding npy melanin concentrating hormone appeared normal num
0.358711.12485808.html.plaintext.txt	48	num wk age orexinataxin num mouse num observed display period behavioral arrest similar previously reported investigator orexin knockout animal num
0.358711.12485808.html.plaintext.txt	49	fragmentation sleepwakefulness characteristic orexin knockout animal also observed orexinataxin num mouse
0.358711.12485808.html.plaintext.txt	50	included increased frequency entry duration rem sleep
0.358711.12485808.html.plaintext.txt	51	thus mouse delayed onset compromise orexin producing neuron faithfully mirrored situation human narcolepsy characterized slowly progressive disease due dropping orexin neuron lateral hypothalamus num
0.358711.12485808.html.plaintext.txt	52	appearance alteration sleepwakefulness mouse predictable however additional observation made group investigator surprise provide important insight potential endocrine metabolic action endogenous orexins
0.358711.12485808.html.plaintext.txt	53	one might expected orexinataxin num mouse aged would lose weight compared wild type control due loss orexigenic action peptide
0.358711.12485808.html.plaintext.txt	54	instead even predicted decrease food intake became obese num
0.358711.12485808.html.plaintext.txt	55	obese phenotype might due fact orexinataxin num mouse displayed decreased spontaneous motor activity dark phase compared control thus energy expenditure might possibly le leading obesity
0.358711.12485808.html.plaintext.txt	56	would suggest ability exogenous peptide stimulate arousal sympathetic nervous system locomotor activity num num num num earlier pharmacological study physiological correlate
0.358711.12485808.html.plaintext.txt	57	intriguing finding reported hara et al
0.358711.12485808.html.plaintext.txt	58	num orexinataxin num mouse developed along obesity appeared late onset diabetes type num diabetes
0.358711.12485808.html.plaintext.txt	59	earlier work preproorexin gene knockout animal suggested alteration glucose homeostasis report direct effect orexin insulin secretion isolated pancreatic islet cell
0.358711.12485808.html.plaintext.txt	60	one report intravenous administration orexin elevates circulating insulin glucose level rat orexin stimulates insulin release vitro isolated perfused pancreas preparation num dos higher present gland circulation
0.358711.12485808.html.plaintext.txt	61	observed phenotype obesity diabetes orexinataxin num mouse resembles situation human narcoleptic patient num num
0.358711.12485808.html.plaintext.txt	62	also mirror situation cortisol excess obesity result combination fat redistribution due altered insulin sensitivity increased appetite
0.358711.12485808.html.plaintext.txt	63	hypothesis orexinataxin num mouse represent exactly pathology
0.358711.12485808.html.plaintext.txt	64	central administration orexin conscious rat resulted behavioral response similar stress response num num
0.358711.12485808.html.plaintext.txt	65	included increased grooming motor activity e
0.358711.12485808.html.plaintext.txt	66	injection also resulted increased sympathetic nervous system tone reflected increased heart rate blood pressure num num num
0.358711.12485808.html.plaintext.txt	67	known whether orexinataxin num mouse display reset depressed autonomic system important examine possibility
0.358711.12485808.html.plaintext.txt	68	similarly central administration orexin stimulated corticotropin acth corticosterone release num num num num vivo action blocked pretreatment animal corticotropin releasing factor crf antagonist num num
0.358711.12485808.html.plaintext.txt	69	crf recognized anorexigenicanxiogenic peptide num loss orexin neuron might predict decrease crf release hypothalamo pituitary portal vessel response stress also loss potential stimulatory action orexin crf neuron important shut feeding cue
0.358711.12485808.html.plaintext.txt	70	thus absence orexin le crf would released basal stimulated condition animal addition feeding longer period would become corticosterone deficient
0.358711.12485808.html.plaintext.txt	71	instead quite opposite observed
0.358711.12485808.html.plaintext.txt	72	animal ate le appeared experience corticosterone excess
0.358711.12485808.html.plaintext.txt	73	decreased feeding observed clearly might due loss orexigenic drive provided endogenous peptide might explain apparent corticosterone excess
0.358711.12485808.html.plaintext.txt	74	thought ability centrally administered orexin stimulate acth corticosterone release vivo num num num num reflection generalized stress effect exogenous peptide num num indication role endogenous orexin day day control hypothalamo pituitary adrenal axis
0.358711.12485808.html.plaintext.txt	75	instead identified direct anterior pituitary effect orexinshypocretins num potentially explain metabolic phenotype orexinataxin num mouse num
0.358711.12485808.html.plaintext.txt	76	orexin immunopositive nerve terminal exist external lamina median eminence num site diffusion neuroendocrine factor hypophysial portal vessel connecting hypothalamus anterior lobe pituitary gland
0.358711.12485808.html.plaintext.txt	77	addition oxnumr oxnumr subtypes exist anterior lobe oxnumr localized corticotrophs human gland num
0.358711.12485808.html.plaintext.txt	78	demonstrated significant inhibitory effect orexins crf stimulated acth release cultured anterior pituitary cell num
0.358711.12485808.html.plaintext.txt	79	effect appeared mediated oxnumr subtype pkc dependent mechanism suggesting activation gq initiated signaling pathway num
0.358711.12485808.html.plaintext.txt	80	recently demonstrated orexin stimulated transient elevation intracellular inositol trisphosphate level num ferguson samson
0.358711.12485808.html.plaintext.txt	81	samson unpublished observation observed calcium transient fura num labeled crf responsive pituitary cell vitro
0.358711.12485808.html.plaintext.txt	82	samson unpublished observation
0.358711.12485808.html.plaintext.txt	83	would suggest binding orexin oxnumr corticotrophs result activation phospholipase c subsequent formation inositol trisphosphate diacylglycerol dag
0.358711.12485808.html.plaintext.txt	84	blocked inhibitory action orexin crf induced acth release pkc inhibitor calphostin c hypothesize formation dag result activation potassium channel resulting hyperpolarization corticotroph right shift crf concentration response curve
0.358711.12485808.html.plaintext.txt	85	hypothesis supported demonstration pretreatment cell concentration potassium channel inhibitor glyburide alter basal crf stimulated hormone release resulted complete reversal inhibitory effect orexin num
0.358711.12485808.html.plaintext.txt	86	thus hypothesize significant physiologically relevant effect orexin hypothalamo pituitary adrenal axis exerted pituitary hypothalamic level
0.358711.12485808.html.plaintext.txt	87	loss physiologically relevant inhibitory effect peptide time orexin neuron degenerate would lead increased sensitivity corticotrophs crf resultant resetting corticosteroid release apparent corticosteroid excess
0.358711.12485808.html.plaintext.txt	88	might explain appearance diabetes reality situation decreased insulin sensitivity caused corticosterone excess
0.358711.12485808.html.plaintext.txt	89	certainly obese appearance mouse would support hypothesis
0.358711.12485808.html.plaintext.txt	90	absence readily available selective oxnumr oxnumr antagonist inherent problem encountered passive immunoneutralization approach resulted slow progress toward goal establishing physiological relevance described pharmacological action orexins endocrine system metabolism
0.358711.12485808.html.plaintext.txt	91	however observation study preproorexin gene knockout mouse suggested several observed endocrine action pharmacologically administered orexin likelihood without physiological correlate
0.358711.12485808.html.plaintext.txt	92	mouse fertile apparently grew normally exception decreased activity food intake addition alteration sleepwakefulness
0.358711.12485808.html.plaintext.txt	93	thus previously described effect exogenous peptide reproductive hormone growth hormone secretion reflected knockout mouse num
0.358711.12485808.html.plaintext.txt	94	metabolic alteration recognized however
0.358711.12485808.html.plaintext.txt	95	animal expressing orexinataxin num gene product followed adulthood clearer picture physiological relevance pharmacological effect exogenously administered orexin began appear
0.358711.12485808.html.plaintext.txt	96	mouse narcoleptic display decreased motor activity num
0.358711.12485808.html.plaintext.txt	97	addition obese diabetic
0.358711.12485808.html.plaintext.txt	98	model certainly provide additional insight control sleepwakefulness even importantly may provide information genesis form insulin resistant diabetes particular associated excess corticosteroid production e
0.358711.12485808.html.plaintext.txt	99	may also stimulate clinical researcher examine possibility subset human narcoleptic individual cushingoid
0.358711.12485808.html.plaintext.txt	100	finally mouse provide model examine unique concordant action peptide feeding energy utilization case orexin unlike orexigenic peptide num num positive food intake energy expenditure
0.358711.12485808.html.plaintext.txt	101	acknowledge financial support dean st
0.358711.12485808.html.plaintext.txt	102	louis university school medicine w
0.358711.12485808.html.plaintext.txt	103	samson chairman department pharmacological physiological science m
0.358711.12485808.html.plaintext.txt	104	taylor predoctoral fellow supported grant heartland affiliate american heart association
0.358711.12485808.html.plaintext.txt	105	address reprint request correspondence w
0.358711.12485808.html.plaintext.txt	106	samson pharmacological physiological science st
0.358711.12485808.html.plaintext.txt	107	school medicine num south grand blvd
0.358711.12485808.html.plaintext.txt	108	louis mo num e mail samsonwkatslu
0.358711.12485808.html.plaintext.txt	109	cost publication article defrayed part payment page charge
0.358711.12485808.html.plaintext.txt	110	article must therefore hereby marked advertisement accordance num u
0.358711.12485808.html.plaintext.txt	111	section num solely indicate fact
0.358711.12485808.html.plaintext.txt	112	blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casaneuva f dieguez c beira
0.358711.12485808.html.plaintext.txt	113	cellular localization orexin receptor human pituitary
0.358711.12485808.html.plaintext.txt	114	j clin endocrinol metab num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	115	chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong x kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m
0.358711.12485808.html.plaintext.txt	116	narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.358711.12485808.html.plaintext.txt	117	cell num num num numisimedline
0.358711.12485808.html.plaintext.txt	118	chen ct hwang ll chang jk dunn nj
0.358711.12485808.html.plaintext.txt	119	pressor effect orexins injected intracisternally rostral ventrolateral medulla anesthetized rat
0.358711.12485808.html.plaintext.txt	120	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.358711.12485808.html.plaintext.txt	121	date y mondal m matsukura ueta y yamashita h kaiya h kangawa k nakazato m
0.358711.12485808.html.plaintext.txt	122	distribution orexinhypocretin rat median eminence pituitary
0.358711.12485808.html.plaintext.txt	123	mol brain re num num num numisimedline
0.358711.12485808.html.plaintext.txt	124	date y ueta y yamashita h yamaguchi h matsukura kangawa k sakurai yanagisawa m nakazato m
0.358711.12485808.html.plaintext.txt	125	orexins orexigenic hypothalamic peptide interact autonomic neuroendocrine neuroregulatory system
0.358711.12485808.html.plaintext.txt	126	proc natl acad sci usa num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	127	de lecea l kilduff t peyron c gao xb foye pe danielson pe fukuhara c battenberg elf gautvik vt bartlett f frankel wn van den pol bloom fe gautvik km sutcliffe jg
0.358711.12485808.html.plaintext.txt	128	hypocretins hypothalamus specific peptide neuroexcitatory activity
0.358711.12485808.html.plaintext.txt	129	proc natl acad sci usa num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	130	dube mg horvath tl kalra p kalra sp
0.358711.12485808.html.plaintext.txt	131	evidence neuropeptide y ynum receptor involvement food intake elicited orexin sated rat
0.358711.12485808.html.plaintext.txt	132	peptide num num num numisi
0.358711.12485808.html.plaintext.txt	133	hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah aj hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n
0.358711.12485808.html.plaintext.txt	134	orexin activates locus coeruleus cell firing increase arousal rat
0.358711.12485808.html.plaintext.txt	135	proc natl acad sci usa num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	136	hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai
0.358711.12485808.html.plaintext.txt	137	genetic ablation orexin neuron mouse result narcolepsy hypophagia obesity
0.358711.12485808.html.plaintext.txt	138	neuron num num num numisimedline
0.358711.12485808.html.plaintext.txt	139	honda y doi y nimomiya r ninomiya c
0.358711.12485808.html.plaintext.txt	140	increased frequency non insulin diabetes mellitus among narcoleptic patient
0.358711.12485808.html.plaintext.txt	141	sleep num num num numisimedline
0.358711.12485808.html.plaintext.txt	142	horvath tl diano van den pol
0.358711.12485808.html.plaintext.txt	143	synaptic interaction hypocretin orexin neuropeptide y cell rodent primate hypothalamus novel circuit implicated metabolic endocrine regulation
0.358711.12485808.html.plaintext.txt	144	j neurosci num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	145	jasberenyi m bujdoso e pataki telegdy g
0.358711.12485808.html.plaintext.txt	146	effect orexin hypothalamic pituitary adrenal system
0.358711.12485808.html.plaintext.txt	147	j neuroendocrinol num num num numisimedline
0.358711.12485808.html.plaintext.txt	148	hypocretinorexin ligand receptor system implication sleep sleep disorder
0.358711.12485808.html.plaintext.txt	149	trend neurosci num num num numisimedline
0.358711.12485808.html.plaintext.txt	150	kuru m ueta y serino r nakazato m yamamoto y shibuya yamashita h
0.358711.12485808.html.plaintext.txt	151	centrally administered orexinhypocretin activates hpa axis rat
0.358711.12485808.html.plaintext.txt	152	neuroreport num num num numisimedline
0.358711.12485808.html.plaintext.txt	153	lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e
0.358711.12485808.html.plaintext.txt	154	sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.358711.12485808.html.plaintext.txt	155	cell num num num numisimedline
0.358711.12485808.html.plaintext.txt	156	lopez m seoane lm del carmen garcia m dieguez c senaris r
0.358711.12485808.html.plaintext.txt	157	neuropeptide y agouti related peptide melanin concentrating hormone target peptide orexin feeding action rat hypothalamus
0.358711.12485808.html.plaintext.txt	158	neuroendocrinology num num num numisimedline
0.358711.12485808.html.plaintext.txt	159	lu xy bagnol d burke akil h watson sj
0.358711.12485808.html.plaintext.txt	160	differential distribution oxnum oxnum orexinhypocretin receptor messenger rna brain upon fasting
0.358711.12485808.html.plaintext.txt	161	horm behav num num num numisimedline
0.358711.12485808.html.plaintext.txt	162	lubkin m stricker krongrad
0.358711.12485808.html.plaintext.txt	163	independent feeding metabolic action orexins mouse
0.358711.12485808.html.plaintext.txt	164	biochem biophys re commun num num num numisimedline
0.358711.12485808.html.plaintext.txt	165	marcus jn aschkenasi cj lee ce chemelli rm saper cb yanagisawa m elmquist jk
0.358711.12485808.html.plaintext.txt	166	differential expression orexin receptor num num rat brain
0.358711.12485808.html.plaintext.txt	167	j comp neurol num num num numisimedline
0.358711.12485808.html.plaintext.txt	168	sleep feeding neuropeptides role orexins orexin receptor
0.358711.12485808.html.plaintext.txt	169	curr opin neurobiol num num num numisimedline
0.358711.12485808.html.plaintext.txt	170	nambu sakurai mizukami k hosoya y yanagisawa m goto k
0.358711.12485808.html.plaintext.txt	171	distribution orexin neuron adult rat brain
0.358711.12485808.html.plaintext.txt	172	brain re num num num numisimedline
0.358711.12485808.html.plaintext.txt	173	niimi m sato m taminato
0.358711.12485808.html.plaintext.txt	174	neuropeptide y central control feeding interaction orexin leptin
0.358711.12485808.html.plaintext.txt	175	endocrine num num num numisimedline
0.358711.12485808.html.plaintext.txt	176	nowak kw mackowiak p switonska mm fabis m malendowicz lk
0.358711.12485808.html.plaintext.txt	177	acute orexin effect insulin secretion rat vivo vitro study
0.358711.12485808.html.plaintext.txt	178	life sci num num num numisimedline
0.358711.12485808.html.plaintext.txt	179	peyron c faraco j rogers w ripley b overeem charnay y nevismalov aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e
0.358711.12485808.html.plaintext.txt	180	mutation case early onset narcolepsy generalized absence hypocretin peptide human narcoleptic brain
0.358711.12485808.html.plaintext.txt	181	nature med num num num numisimedline
0.358711.12485808.html.plaintext.txt	182	peyron c tighe dk van den pol de lecea l heller hc sutcliffe jg kilduff t
0.358711.12485808.html.plaintext.txt	183	neuron containing hypocretin orexin project multiple neuronal system
0.358711.12485808.html.plaintext.txt	184	j neurosci num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	185	pu jain mr kalra p kalra sp
0.358711.12485808.html.plaintext.txt	186	orexins novel family hypothalamic neuropeptides modulate pituitary luteinizing hormone secretion ovarian steroid dependent manner
0.358711.12485808.html.plaintext.txt	187	regul pept num num num numisimedline
0.358711.12485808.html.plaintext.txt	188	rodgers rj halford jc nunes de souza rl canto de souza al piper dc arch jr upton n porter ra john blundell je
0.358711.12485808.html.plaintext.txt	189	sb num selective orexin num receptor antagonist enhances behavioural satiety block hyperphagic effect orexin rat
0.358711.12485808.html.plaintext.txt	190	eur j neurosci num num num numisimedline
0.358711.12485808.html.plaintext.txt	191	russell sh kim m small cj abbott cr morgan dga taheri murphy kg todd jf ghatei ma bloom sr
0.358711.12485808.html.plaintext.txt	192	central administration orexin suppresses basal domperidone stimulated plasma prolactin
0.358711.12485808.html.plaintext.txt	193	j neuroendocrinol num num num numisimedline
0.358711.12485808.html.plaintext.txt	194	sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan r mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m
0.358711.12485808.html.plaintext.txt	195	orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.358711.12485808.html.plaintext.txt	196	cell num num num numisimedline
0.358711.12485808.html.plaintext.txt	197	samson wk gosnell b chang jk resch zt murphy tc
0.358711.12485808.html.plaintext.txt	198	cardiovascular regulatory action hypocretins brain
0.358711.12485808.html.plaintext.txt	199	brain re num num num numisimedline
0.358711.12485808.html.plaintext.txt	200	trend endocrinol metab num num num numisimedline
0.358711.12485808.html.plaintext.txt	201	hypocretinorexin suppresses corticotroph responsiveness vitro
0.358711.12485808.html.plaintext.txt	202	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.358711.12485808.html.plaintext.txt	203	samson wk taylor mm anderson jw ferguson av
0.358711.12485808.html.plaintext.txt	204	orexin inhibition crh stimulated acth secretion possible role potassium channel activation abstract
0.358711.12485808.html.plaintext.txt	205	samson wk taylor mm folwell m ferguson av
0.358711.12485808.html.plaintext.txt	206	orexin action hypothalamic paraventricular nucleus physiological consequence cellular correlate
0.358711.12485808.html.plaintext.txt	207	regul pept num num num numisimedline
0.358711.12485808.html.plaintext.txt	208	schuld hebebrand j geller f pollmaecher
0.358711.12485808.html.plaintext.txt	209	increased body mass index patient narcolepsy
0.358711.12485808.html.plaintext.txt	210	lancet num num num numisimedline
0.358711.12485808.html.plaintext.txt	211	shirasaka nakazato m matsukura takasaki m kannan h
0.358711.12485808.html.plaintext.txt	212	sympathetic cardiovascular action orexins conscious rat
0.358711.12485808.html.plaintext.txt	213	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.358711.12485808.html.plaintext.txt	214	smart d haynes ac williams g arch jr orexins treatment obesity
0.358711.12485808.html.plaintext.txt	215	eur j pharmacol num num num numisimedline
0.358711.12485808.html.plaintext.txt	216	taheri mahmoodi sm opacka juffry j ghatei ma bloom sr
0.358711.12485808.html.plaintext.txt	217	distribution quantification immunoreactive orexin rat tissue
0.358711.12485808.html.plaintext.txt	218	feb lett num num num numisimedline
0.358711.12485808.html.plaintext.txt	219	tamura irahara m tezuka m kiyokawa m aono
0.358711.12485808.html.plaintext.txt	220	orexins orexigenic hypothalamic neuropeptides suppress pulsatile secretion luteinizing hormone ovariectomized female rat
0.358711.12485808.html.plaintext.txt	221	biochem biophys re commun num num num numisimedline
0.358711.12485808.html.plaintext.txt	222	thannickal tc moore ry nienhuis r ramanathan l gukyani aldrich m comford m siegel jm
0.358711.12485808.html.plaintext.txt	223	reduced number hypocretin neuron human narcolepsy
0.358711.12485808.html.plaintext.txt	224	neuron num num num numisimedline
0.358711.12485808.html.plaintext.txt	225	trivedi p yu h macneil dj van der ploeg lht guan xm
0.358711.12485808.html.plaintext.txt	226	distribution orexin receptor mrna rat brain
0.358711.12485808.html.plaintext.txt	227	feb lett num num num numisimedline
0.358711.12485808.html.plaintext.txt	228	van den pol gao xb obrietan k kilduff t belousov ab
0.358711.12485808.html.plaintext.txt	229	presynaptic postsynaptic action modulation neuroendocrine neuron new hypothalamic peptide hypocretinorexin
0.358711.12485808.html.plaintext.txt	230	j neurosci num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	231	yamada h okumura motomuran w kobayashi y kohgo y
0.358711.12485808.html.plaintext.txt	232	inhibition food intake central injection anti orexin antibody fasted rat
0.358711.12485808.html.plaintext.txt	233	biochem biophys re commun num num num numisimedline
0.358711.12485808.html.plaintext.txt	234	yamanaka kunii k nambu tsujino n sakai matsuzaki miwa y goto k sakurai
0.358711.12485808.html.plaintext.txt	235	orexin induced food intake involves neuropeptide y pathway
0.358711.12485808.html.plaintext.txt	236	brain re num num num numisimedline
0.358711.12485808.html.plaintext.txt	237	yoshimichi g yoshimatsu h masaki sakata
0.358711.12485808.html.plaintext.txt	238	orexin regulates body temperature coordination arousal status
0.358711.12485808.html.plaintext.txt	239	exp biol med num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	240	yoshizawa yamagishi y koseki n goto j yoshida h shibasaki f shoji kanazawa
0.358711.12485808.html.plaintext.txt	241	cell cycle arrest enhances vitro toxicity truncated machado joseph disease gene product expanded pyroglutamine stretch
0.358711.12485808.html.plaintext.txt	242	hum mol genet num num num numabstractfree full text
0.358711.12485808.html.plaintext.txt	243	j physiol endocrinol metab numnumenum enum num numnum num
0.358711.12485808.html.plaintext.txt	244	num copyright num american physiological society
0.4064973.15172887.html.plaintext.txt	0	pulsatile lh release diminished whereas fsh secretion normal hypocretin deficient narcoleptic men
0.4064973.15172887.html.plaintext.txt	1	department numgeneral internal medicine numendocrinology numneurology leiden university medical center num rc leiden netherlands
0.4064973.15172887.html.plaintext.txt	2	submitted num february num accepted final form num may num
0.4064973.15172887.html.plaintext.txt	3	orexin luteinizing hormone follicle stimulating hormone testosterone estradiol circadian rhythm deconvolution analysis
0.4064973.15172887.html.plaintext.txt	4	narcolepsy characterized excessive daytime sleepiness cataplexy hypnagogic hallucination sleep paralysis num
0.4064973.15172887.html.plaintext.txt	5	caused progressive loss hypocretin neuron brain num num
0.4064973.15172887.html.plaintext.txt	6	hypocretin neuronal cell body located exclusively lateral hypothalamusperifornical area num axonal projection throughout central nervous system predict diverse biological action num
0.4064973.15172887.html.plaintext.txt	7	indeed hypocretin peptide num num also called orexin b appear affect feeding behavior energy expenditure arousal autonomic outflow variety neuroendocrine ensemble num num num num
0.4064973.15172887.html.plaintext.txt	8	therefore apart well recognized neurological manifestation clinical syndrome hypocretin deficiency human may encompass broad spectrum behavioral endocrine metabolic anomaly
0.4064973.15172887.html.plaintext.txt	9	keeping postulate recently identified aberration pituitary adrenal somatotropic ensemble circulating leptin concentration hypocretin deficient narcoleptic men num num num
0.4064973.15172887.html.plaintext.txt	10	septal preoptic arcuate nucleus among many brain site receiving hypocretin input num num num num
0.4064973.15172887.html.plaintext.txt	11	nucleus involved control hypothalamo pituitary gonadal hpg axis num
0.4064973.15172887.html.plaintext.txt	12	furthermore intracerebroventricular administration hypocretins acutely induces lh release ovarian steroid primed ovariectomized rat num
0.4064973.15172887.html.plaintext.txt	13	also hypocretin num promotes gonadotropin releasing hormone gnrh release hypothalamic explants male rat num intracerebroventricular administration anti hypocretin antibody completely abolishes preovulatory lh surge intact female rat num
0.4064973.15172887.html.plaintext.txt	14	thus available data suggest endogenous hypocretin peptide stimulate lh release rodent
0.4064973.15172887.html.plaintext.txt	15	currently unknown whether peptide exert analogous effect human
0.4064973.15172887.html.plaintext.txt	16	far aware impact hypocretins fsh secretion investigated date
0.4064973.15172887.html.plaintext.txt	17	present study conducted evaluate role endogenous hypocretins regulation gonadotropin release human
0.4064973.15172887.html.plaintext.txt	18	specifically hypothesized hypocretin deficiency narcoleptic men would blunt spontaneous pituitary lh release
0.4064973.15172887.html.plaintext.txt	19	included seven male patient outpatient clinic department neurology leiden university
0.4064973.15172887.html.plaintext.txt	20	diagnosis narcolepsy cataplexy made clinical ground physician experienced narcolepsy g
0.4064973.15172887.html.plaintext.txt	21	also result multiple sleep latency test typical narcolepsy patient num
0.4064973.15172887.html.plaintext.txt	22	addition patient hla drnumdqbnumnum positive num lacked hypocretin num cerebrospinal fluid measurement previously described num
0.4064973.15172887.html.plaintext.txt	23	subject free medication num patient discontinued medication num wk study
0.4064973.15172887.html.plaintext.txt	24	two three narcoleptic subject used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine
0.4064973.15172887.html.plaintext.txt	25	weight height subject measured well waist hip circumference
0.4064973.15172887.html.plaintext.txt	26	waist hip ratio whr used relative measure abdominal fat mass
0.4064973.15172887.html.plaintext.txt	27	total body fat mass determined dual energy x ray absorptiometry hologic qdrnum waltham ma
0.4064973.15172887.html.plaintext.txt	28	seven male control subject recruited advertisement local newspaper
0.4064973.15172887.html.plaintext.txt	29	control matched age body mass index total fat mass whr since narcoleptic moderately obese num
0.4064973.15172887.html.plaintext.txt	30	subject eligible study exclusion hypertension defined repeated blood pressure measurement systolic num mmhg diastolic num mmhg known history pituitary disease recent body weight change num kg weight gain loss within previous num mo fasting blood glucose num
0.4064973.15172887.html.plaintext.txt	31	written informed consent obtained subject
0.4064973.15172887.html.plaintext.txt	32	study approved ethic committee leiden university medical center
0.4064973.15172887.html.plaintext.txt	33	subject admitted clinical research center morning
0.4064973.15172887.html.plaintext.txt	34	drawing blood performed standardized dark light alimentary condition
0.4064973.15172887.html.plaintext.txt	35	num h study occasion three standardized meal served num num num nutridrink num
0.4064973.15172887.html.plaintext.txt	36	num kcalml numnum numnum kcalday macronutrient composition per num ml num g protein num
0.4064973.15172887.html.plaintext.txt	37	num g carbohydrate nutricia zoetermeer netherlands
0.4064973.15172887.html.plaintext.txt	38	subject remained sedentary throughout study except bathroom visit
0.4064973.15172887.html.plaintext.txt	39	light switched num
0.4064973.15172887.html.plaintext.txt	40	upon arrival intravenous cannula inserted antecubital vein num h start blood sampling performed num min interval num h long line prevent sleep disturbance
0.4064973.15172887.html.plaintext.txt	41	sample allowed clot centrifuged num degree c num min serum frozen num degree c assay
0.4064973.15172887.html.plaintext.txt	42	sleep registration using portable electroencephalogram system porti twente medical system enschede netherlands confirmed abnormally distributed num h total sleep well rem sleep narcoleptic subject normal distribution sleep stage control subject
0.4064973.15172887.html.plaintext.txt	43	separate occasion blood drawn num overnight fast measurement lh fsh testosterone estradiol sex hormone binding globulin shbg concentration
0.4064973.15172887.html.plaintext.txt	44	subsequently gnrh test performed num whereby num microg gonadoreline aventis pharma hoevelaken netherlands given intravenous bolus serum lh concentration measured every num min num min thereafter
0.4064973.15172887.html.plaintext.txt	45	serum lh fsh concentration measured time resolved immunofluorometric assay wallac turku finland coefficient variation cv num
0.4064973.15172887.html.plaintext.txt	46	num concentration range num
0.4064973.15172887.html.plaintext.txt	47	num concentration range num
0.4064973.15172887.html.plaintext.txt	48	testosterone measured coated tube radioimmunoassay ria diagnostic product los angeles ca cv num
0.4064973.15172887.html.plaintext.txt	49	num concentration range num
0.4064973.15172887.html.plaintext.txt	50	shbg measured immunoradiometric assay spectria espoo finland serum estradiol ria diagnostic system laboratory webster tx
0.4064973.15172887.html.plaintext.txt	51	sample gonadotropin num h profile processed assay procedure
0.4064973.15172887.html.plaintext.txt	52	addition leptin concentration measured every num min sample ria linco research st
0.4064973.15172887.html.plaintext.txt	53	detection limit assay num
0.4064973.15172887.html.plaintext.txt	54	num concentration range num
0.4064973.15172887.html.plaintext.txt	55	detail leptin secretion narcolepsy previously published report num h mean leptin concentration relation lh parameter testosterone num
0.4064973.15172887.html.plaintext.txt	56	deconvolution analysis num used estimate four secretory clearance measure interest num number location secretory event num amplitude secretory burst num duration randomly dispersed lh fsh secretory burst num endogenous single component subject specific plasma half life lh fsh
0.4064973.15172887.html.plaintext.txt	57	assumed gonadotropin distribution volume lh fsh half life time concentration invariant
0.4064973.15172887.html.plaintext.txt	58	following parameter calculated half duration secretory burst duration secretory burst half maximal amplitude hormone half life burst frequency amplitude secretory burst maximal secretory rate attained within burst mass secreted per burst basal secretion rate lh pulsatile secretion rate product burst frequency mean burst mass total secretion sum basal pulsatile
0.4064973.15172887.html.plaintext.txt	59	based recent validation study men deconvolution analysis carried num joint statistical confidence interval calculated lh fsh amplitude num num
0.4064973.15172887.html.plaintext.txt	60	univariate approximate entropy apen statistic developed quantify degree irregularity disorderliness time series num
0.4064973.15172887.html.plaintext.txt	61	technically apen quantifies summed logarithmic likelihood template length m pattern data similar within r remain similar within tolerance r next incremental comparison formally defined elsewhere num
0.4064973.15172887.html.plaintext.txt	62	apen calculation provides single nonnegative number ensemble estimate relative process randomness wherein larger apen value denote greater irregularity
0.4064973.15172887.html.plaintext.txt	63	cross apen x apen quantifies joint pattern synchrony two separate parallel time series standardization z score transformation num num
0.4064973.15172887.html.plaintext.txt	64	present analysis calculated x apen assuming r num sd individual time series m num hence use designation x apen num num
0.4064973.15172887.html.plaintext.txt	65	parameter set affords sensitive valid statistically well replicated apen x apen metric assessing hormone time series length num num
0.4064973.15172887.html.plaintext.txt	66	apen x apen result reported ratio absolute value mean numnum randomly shuffled data series value approaching num
0.4064973.15172887.html.plaintext.txt	67	result expressed mean plus minus se unless stated otherwise
0.4064973.15172887.html.plaintext.txt	68	student one tailed test used evaluate priori hypothesis lh secretion reduced narcoleptic men
0.4064973.15172887.html.plaintext.txt	69	comparison statistically evaluated two tailed student test kolmogorov smirnov test two sample appropriate
0.4064973.15172887.html.plaintext.txt	70	statistical analysis performed using systat release num
0.4064973.15172887.html.plaintext.txt	71	narcoleptic patient n control c comparable age num
0.4064973.15172887.html.plaintext.txt	72	num c yr body mass index num
0.4064973.15172887.html.plaintext.txt	73	gonadal steroid hormone concentration similar narcoleptic control testosterone num
0.4064973.15172887.html.plaintext.txt	74	mean plasma lh concentration significantly lower narcoleptic patient num
0.4064973.15172887.html.plaintext.txt	75	num whereas fsh concentration similar group num
0.4064973.15172887.html.plaintext.txt	76	num show num h serum lh fsh concentration v
0.4064973.15172887.html.plaintext.txt	77	time narcoleptic subject control
0.4064973.15172887.html.plaintext.txt	78	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	79	serum lh concentration num narcoleptic subject num control
0.4064973.15172887.html.plaintext.txt	80	blood sample drawn every num min num h
0.4064973.15172887.html.plaintext.txt	81	data shown mean se
0.4064973.15172887.html.plaintext.txt	82	light num num
0.4064973.15172887.html.plaintext.txt	83	meal served num num num
0.4064973.15172887.html.plaintext.txt	84	deconvolution derived parameter estimate lh fsh secretion elimination given table num num respectively
0.4064973.15172887.html.plaintext.txt	85	pulsatile secretion lh diminished narcoleptic subject num
0.4064973.15172887.html.plaintext.txt	86	num c u l num num h num p num
0.4064973.15172887.html.plaintext.txt	87	num result concerted effect reduced burst frequency burst mass
0.4064973.15172887.html.plaintext.txt	88	total lh secretion also le narcoleptic patient p num
0.4064973.15172887.html.plaintext.txt	89	contrast feature fsh release similar narcoleptic control
0.4064973.15172887.html.plaintext.txt	90	also plasma lh fsh half life different group
0.4064973.15172887.html.plaintext.txt	91	representative num h lh fsh secretory profile calculated deconvolution analysis corresponding curve serum concentration data shown fig
0.4064973.15172887.html.plaintext.txt	92	deconvolution derived feature lh secretion
0.4064973.15172887.html.plaintext.txt	93	deconvolution derived feature fsh secretion
0.4064973.15172887.html.plaintext.txt	94	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	95	representative num h lh secretory profile c d corresponding plasma concentration series intrasample dose dependent standard deviation fitted curve calculated deconvolution b narcoleptic patient c matched control b d
0.4064973.15172887.html.plaintext.txt	96	note decreased pulsatile secretion narcoleptic patient
0.4064973.15172887.html.plaintext.txt	97	time depicted minute elapsed numst sample taken
0.4064973.15172887.html.plaintext.txt	98	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	99	representative num h fsh secretory profile c d corresponding plasma concentration series intrasample dose dependent standard deviation fitted curve calculated deconvolution b narcoleptic patient c matched control b d
0.4064973.15172887.html.plaintext.txt	100	time depicted minute elapsed first sample taken
0.4064973.15172887.html.plaintext.txt	101	basal serum gonadotropin level lh num
0.4064973.15172887.html.plaintext.txt	102	num maximal concentration response gnrh stimulation lh num
0.4064973.15172887.html.plaintext.txt	103	num similar group
0.4064973.15172887.html.plaintext.txt	104	individual lh fsh response displayed fig
0.4064973.15172887.html.plaintext.txt	105	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	106	individual lh tsh increase iv injection num microg lhrh num narcoleptic patient matched control
0.4064973.15172887.html.plaintext.txt	107	mean increase lh fsh respectively similar studied group
0.4064973.15172887.html.plaintext.txt	108	mean num h leptin concentration patient num
0.4064973.15172887.html.plaintext.txt	109	num microgl control num
0.4064973.15172887.html.plaintext.txt	110	significant correlation present num h lh secretion mean num h leptin concentration either combined group r num
0.4064973.15172887.html.plaintext.txt	111	num separately patient r num
0.4064973.15172887.html.plaintext.txt	112	num h leptin concentration serum testosterone significant inverse linear correlation found displayed fig
0.4064973.15172887.html.plaintext.txt	113	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	114	linear relationship mean num h leptin concentration num min sampling serum testosterone concentration
0.4064973.15172887.html.plaintext.txt	115	note inverse relationship measure
0.4064973.15172887.html.plaintext.txt	116	apen ratio value lh lower patient compared control denoting regular secretion n num
0.4064973.15172887.html.plaintext.txt	117	individual data displayed fig
0.4064973.15172887.html.plaintext.txt	118	similarly apen ratio fsh also smaller patient num
0.4064973.15172887.html.plaintext.txt	119	x apen ratio lh fsh concentration series lower patient control indicating increased synchrony hormone patient compared control n num
0.4064973.15172887.html.plaintext.txt	120	x apen ratio leptin concentration series num min data lh series num min data differ group n num
0.4064973.15172887.html.plaintext.txt	121	view larger version numk fig
0.4064973.15172887.html.plaintext.txt	122	aproximate entropy apen ratio lh fsh secretion cross apen ratio lh fsh series
0.4064973.15172887.html.plaintext.txt	123	lower value denote orderliness secretion
0.4064973.15172887.html.plaintext.txt	124	data suggest endogenous hypocretin peptide stimulate pulsatile lh release men
0.4064973.15172887.html.plaintext.txt	125	particular fact spontaneous lh secretion blunted whereas pituitary responsiveness gnrh stimulation intact narcoleptic subject suggests hypocretin deficiency primarily inhibits hypothalamic gnrh release
0.4064973.15172887.html.plaintext.txt	126	inference agrees study male rat showing hypocretin num promotes gnrh release hypothalamic explants num
0.4064973.15172887.html.plaintext.txt	127	moreover hypocretin input abundant preoptic area contains many gnrh neuron num coexpress hypocretin num receptor direct contact hypocretin fiber num
0.4064973.15172887.html.plaintext.txt	128	physiological anatomical observation obviously support notion hypocretin peptide involved regulation gnrh release
0.4064973.15172887.html.plaintext.txt	129	fact fsh secretion diminished whereas lh release narcoleptic subject may imply hypocretins specifically modulate gnrh burst frequency lh secretion particularly enhanced high frequency burst whereas low frequency burst predominantly promote fsh release num
0.4064973.15172887.html.plaintext.txt	130	apen quantitates relative orderliness reproducibility subordinate nonpulsatile secretory pattern neurohormone time series reflects feedforward feedback adjustment driven pathophysiological change interglandular communication
0.4064973.15172887.html.plaintext.txt	131	view unchanged testosterone feedback signal patient increased lh fsh regularity increased synchrony hormone might reflect diminished gnrh input signal unchanged pituitary responsiveness toward neurohormone num
0.4064973.15172887.html.plaintext.txt	132	alternatively hypoleptinemia may blunt lh release narcoleptic patient
0.4064973.15172887.html.plaintext.txt	133	previously shown num plasma leptin concentration considerably reduced narcoleptic men
0.4064973.15172887.html.plaintext.txt	134	leptin emerged important modulator hpg axis num
0.4064973.15172887.html.plaintext.txt	135	indeed leptin deficient obob mouse hypogonadotropic sterile recombinant leptin administration rescue defect obob male num female num
0.4064973.15172887.html.plaintext.txt	136	moreover circadian rhythm plasma leptin level synchronous lh concentration num reduction lh secretion induced fasting rat human reversed leptin administration num num num
0.4064973.15172887.html.plaintext.txt	137	data indicate leptin stimulates lh release genetic andor physiological alteration circulating leptin level impact pituitary gonadotropin release
0.4064973.15172887.html.plaintext.txt	138	context conceivable reduction plasma leptin concentration narcoleptic num involved diminution pituitary lh release patient mentioned could demonstrate linear correlation mean circulating leptin concentration lh production
0.4064973.15172887.html.plaintext.txt	139	notwithstanding diminished lh production testosterone concentration unchanged patient
0.4064973.15172887.html.plaintext.txt	140	recently become clear leptin involved local regulation testosterone synthesis secretion male rat gonad num
0.4064973.15172887.html.plaintext.txt	141	direct evidence action human available inverse relation serum testosterone leptin demonstrated num
0.4064973.15172887.html.plaintext.txt	142	therefore inhibitory effect leptin testosterone adrenal hormone secretion might relevant narcoleptic patient narcoleptic exhibit num reduction circulating leptin concentration may unleash gonadal testosterone secretion compensate diminished lh drive num
0.4064973.15172887.html.plaintext.txt	143	finding inverse relationship testosterone leptin subject reinforces view
0.4064973.15172887.html.plaintext.txt	144	prepro orexin mrna orexin receptor expressed various endocrine nonendocrine tissue num instance orexins modulate directly human porcine adrenal stereoidogenic function num num
0.4064973.15172887.html.plaintext.txt	145	relevant present investigation recent finding mrna expression oxnum oxnum receptor male rat gonad num
0.4064973.15172887.html.plaintext.txt	146	activation oxnum receptor stimulates testosterone secretion vivo vitro suggesting physiological modulating role orexin system concert leptin ghrelin testicular level num
0.4064973.15172887.html.plaintext.txt	147	significance finding human physiology need explored
0.4064973.15172887.html.plaintext.txt	148	however oxnum oxnum receptor expression demonstrated male human reproductive system including testis suggesting orexins directly impact gonadal hormone release human well rodent num
0.4064973.15172887.html.plaintext.txt	149	impact alteration hpg ensemble described fertility narcoleptic men remains definitely determined
0.4064973.15172887.html.plaintext.txt	150	early report suggested narcolepsy associated impaired fertility num since suggestion confirmed far aware
0.4064973.15172887.html.plaintext.txt	151	moreover clinical impression narcoleptic male patient le fertile gonadal hormone concentration plasma normal narcoleptic despite reduction lh level
0.4064973.15172887.html.plaintext.txt	152	thus seems unlikely partial hypogonadotropism observed clinical sequela
0.4064973.15172887.html.plaintext.txt	153	nevertheless view finding male warranted investigate narcoleptic female across menstrual cycle putative defect ovarian function
0.4064973.15172887.html.plaintext.txt	154	conclusion hypocretin deficient narcoleptic men reduced circulating lh level brought diminution pulsatile lh release
0.4064973.15172887.html.plaintext.txt	155	contrast fsh secretion normal patient
0.4064973.15172887.html.plaintext.txt	156	pituitary sensitivity gnrh stimulation normal narcoleptic suggests reduction hypothalamic gnrh release underlies blunted lh secretion accordance view increased orderliness secretion gonadotropin
0.4064973.15172887.html.plaintext.txt	157	hypocretin deficiency per se hypoleptinemia may involved change hpg axis narcoleptic male
0.4064973.15172887.html.plaintext.txt	158	acknowledgment gratefully acknowledge skillful assistance e
0.4064973.15172887.html.plaintext.txt	159	sierat van der steen study occasion
0.4064973.15172887.html.plaintext.txt	160	footnote address reprint request correspondence h
0.4064973.15172887.html.plaintext.txt	161	general internal medicine cnum rnum po box num num rc leiden netherlands e mail h
0.4064973.15172887.html.plaintext.txt	162	cost publication article defrayed part payment page charge
0.4064973.15172887.html.plaintext.txt	163	article must therefore hereby marked advertisement accordance num u
0.4064973.15172887.html.plaintext.txt	164	section num solely indicate fact
0.42022583.11842076.html.plaintext.txt	0	highlighted topic functional genomics sleep circadian rhythm invited review genetic dissection sleep mehdi taftinum paul frankennum
0.42022583.11842076.html.plaintext.txt	1	num biochemistry clinical neurophysiology unit department psychiatry university geneva ch num geneva switzerland num department biological science stanford university stanford california num
0.42022583.11842076.html.plaintext.txt	2	recent advance genomics open new avenue analysis complex behavior sleep
0.42022583.11842076.html.plaintext.txt	3	analysis mouse model specie choice amenable high throughput phenotype genotype analysis
0.42022583.11842076.html.plaintext.txt	4	use mouse model unprecedented progress understanding sleep physiology treatment sleep disorder awaited
0.42022583.11842076.html.plaintext.txt	5	review intended provide overview available method technique genetic dissection sleep mouse
0.42022583.11842076.html.plaintext.txt	6	limit advantage different approach discussed highlight necessity combining method avoid erroneous interpretation
0.42022583.11842076.html.plaintext.txt	7	gap understanding mechanism sleep function may bridged finding molecular base
0.42022583.11842076.html.plaintext.txt	8	quantitative trait locus quantitative trait nucleotide mutagenesis transgenic mouse gene knockout gene expression profiling gene translation regulation
0.42022583.11842076.html.plaintext.txt	9	sleep long standing question modern neuroscience still unable answer
0.42022583.11842076.html.plaintext.txt	10	however substantial progress made understanding mechanism underlying different aspect sleep physiology
0.42022583.11842076.html.plaintext.txt	11	know neuronal substrate neurochemical messenger regulatory process involved initiating maintaining sleep
0.42022583.11842076.html.plaintext.txt	12	understanding sleep toward function molecular genetics bring new insight first give historical perspective genetics sleep continue review available method genetic dissection sleep experimental approach used conjunction state art electrophysiological neuroanatomic pharmacological technique already used great success sleep research
0.42022583.11842076.html.plaintext.txt	13	also caution making premature interpretation molecular finding complex trait attempted within general physiology intact organism
0.42022583.11842076.html.plaintext.txt	14	introduction molecular biology genetic study trait phenotype based either observation resemblance related individual crossing experiment experimental individual carrying divergent phenotype
0.42022583.11842076.html.plaintext.txt	15	simple law discovered according simple monogenic autosomal recessive phenotype segregate inherited basis assumption molecular substrate
0.42022583.11842076.html.plaintext.txt	16	however type trait far le prevalent attributed influence single gene
0.42022583.11842076.html.plaintext.txt	17	nevertheless shortly introduction electroencephalography eeg vogel num one first notice even complex phenotype like eeg strong genetic control
0.42022583.11842076.html.plaintext.txt	18	segregation analysis pedigree carrying rare eeg variant concordant classical genetic law suggesting presence single gene effect num num
0.42022583.11842076.html.plaintext.txt	19	result twin study also indicated eeg pattern monozygotic mz twin much higher resemblance dizygotic dz twin unrelated subject num num num confirming highly complex functional brain phenotype might tightly controlled gene little affected environment
0.42022583.11842076.html.plaintext.txt	20	study genetics sleep approximately dated back publication geyer num num reported higher concordance sleep habit mz twin dz twin
0.42022583.11842076.html.plaintext.txt	21	gedda num reported rare case concordant long sleeper num h mz twin
0.42022583.11842076.html.plaintext.txt	22	gedda brenci num first estimated heritability percentage variance explained additive effect gene sleep duration num
0.42022583.11842076.html.plaintext.txt	23	author later confirmed sleep duration highly similar twin living apart num discounting influence possible environmental effect
0.42022583.11842076.html.plaintext.txt	24	recent observation twin indicated even pattern rapid eye movement present higher concordance mz dz twin num num num variance sleep duration presence sleep disorder accounted genetic effect num num
0.42022583.11842076.html.plaintext.txt	25	zung wilson num performed first polygraphic sleep recording twin num found temporal sequence sleep stage almost completely concordant mz twin
0.42022583.11842076.html.plaintext.txt	26	num num detailed polygraphic analysis performed twin study reported surprising similarity mz twin num num num num
0.42022583.11842076.html.plaintext.txt	27	experimental genetics sleep mouse pioneered valatx early nums
0.42022583.11842076.html.plaintext.txt	28	time span num year valatxs group num num conducted several crossing experiment recorded sleep hundred inbred recombinant inbred ri hybrid mouse mainly follow segregation paradoxical sleep p amount
0.42022583.11842076.html.plaintext.txt	29	study together diallelique reciprocal crossing several inbred strain sleep experiment mouse performed friedmann num clearly indicated although aspect sleep may follow simple segregation classical genetic law predict others
0.42022583.11842076.html.plaintext.txt	30	although classical genetic sleep study favor strong genetic basis sleep still clue possible molecular mechanism
0.42022583.11842076.html.plaintext.txt	31	first attempt identify molecular basis sleep based assumption must gene change expression according behavioral state sleep v
0.42022583.11842076.html.plaintext.txt	32	wake andor time spent particular state
0.42022583.11842076.html.plaintext.txt	33	closely related example come circadian field dramatic change expression several clock gene occur according strict circadian pattern reviewed ref
0.42022583.11842076.html.plaintext.txt	34	two process model sleep regulation num remarkable prediction homeostatic aspect sleep motivated first molecular investigation sleep
0.42022583.11842076.html.plaintext.txt	35	sleep need intensity homeostatically regulated deprivation sleep lead change expression gene product necessary recovery least involved sleep regulation
0.42022583.11842076.html.plaintext.txt	36	num performed first substractive hybridization sleep deprived v
0.42022583.11842076.html.plaintext.txt	37	control rat isolated several clone increased decreased relative expression among neurogranin dendrin later identified num num
0.42022583.11842076.html.plaintext.txt	38	sleep deprivation paradigm since become method choice gene expression experiment aimed uncovering molecular base sleep regulatory process reviewed ref
0.42022583.11842076.html.plaintext.txt	39	laboratory num already discussed several conceptual problem approach
0.42022583.11842076.html.plaintext.txt	40	summary two major limitation
0.42022583.11842076.html.plaintext.txt	41	first fact expression many gene varies vigilance state rather actively involved vigilance state regulation
0.42022583.11842076.html.plaintext.txt	42	weakness correlative gene expression overcome confirming involvement identified gene loss function gain function experiment
0.42022583.11842076.html.plaintext.txt	43	second high complexity mammalian brain mrna population technical limitation however overcome recent development gene expression profiling see
0.42022583.11842076.html.plaintext.txt	44	nevertheless identification cortistatin orexin num num specific action sleep show gene expression investigation highly successful
0.42022583.11842076.html.plaintext.txt	45	transgenic method based random gene integration homologous recombination gave rise strong hope uncover molecular base many phenotype including complex one
0.42022583.11842076.html.plaintext.txt	46	technique used address consequence overexpression ectopic expression time tissue specific expression gain loss function candidate gene
0.42022583.11842076.html.plaintext.txt	47	potential advantage problem addressed several review recent review see ref
0.42022583.11842076.html.plaintext.txt	48	exception orexinhypocretin system see best knowledge single gene manipulation performed specifically investigate consequence sleep
0.42022583.11842076.html.plaintext.txt	49	however many investigator field benefit availability transgenic model answer sleep related question
0.42022583.11842076.html.plaintext.txt	50	accumulated result indicate transgenic mouse study published thus far see table num report sleep related abnormality strongly suggesting either nonspecific effect gene manipulation andor complex integrative nature sleep make highly sensitive many physiological change
0.42022583.11842076.html.plaintext.txt	51	view table table num
0.42022583.11842076.html.plaintext.txt	52	effect gene manipulation sleep
0.42022583.11842076.html.plaintext.txt	53	straightforward approach consider candidate gene based previous evidence implication sleep
0.42022583.11842076.html.plaintext.txt	54	indicated sleep physiology pharmacology study identified essential system candidate gene chosen
0.42022583.11842076.html.plaintext.txt	55	use approach study differential expression tyrosine hydroxylase num growth hormone releasing hormone num interleukin num num somatostatin num brain derived neurotrophic factor num shown play potential role sleep
0.42022583.11842076.html.plaintext.txt	56	sleep study transgenic mouse table num also used approach
0.42022583.11842076.html.plaintext.txt	57	powerful approach also combined recent technique gene identification
0.42022583.11842076.html.plaintext.txt	58	major disadvantage approach obviously nothing new learned term sleep gene discovery
0.42022583.11842076.html.plaintext.txt	59	unique coincidental sleep related gene discovery concern orexin system
0.42022583.11842076.html.plaintext.txt	60	orexin b hypothalamic neuropeptides acting orexin num num receptor first thought involved feeding behavior num num
0.42022583.11842076.html.plaintext.txt	61	mignots group num identified linkage analysis positional cloning mutation orexin num receptor gene cause canine narcolepsy animal model human sleep disorder narcolepsy
0.42022583.11842076.html.plaintext.txt	62	independently almost simultaneously yanagisawas group num interested role orexins feeding behavior discovered mouse phenotype similar canine human narcolepsy targeted deletion preproorexin gene
0.42022583.11842076.html.plaintext.txt	63	recently orexin system also implicated etiology human narcolepsy narcoleptic patient undetectable orexin level cerebrospinal fluid num small number postmortem case dramatic reduction number orexin containing neuron observed hypothalamus num num
0.42022583.11842076.html.plaintext.txt	64	unexpected observation led sakurais group num generate first transgenic mouse specifically investigate role orexin system vigilance state
0.42022583.11842076.html.plaintext.txt	65	transgenic mouse carry promoter human preproorexin gene ligated truncated human ataxin num gene induce cell death
0.42022583.11842076.html.plaintext.txt	66	specific expression transgene construct orexin containing neuron induces apoptosis num num wk age
0.42022583.11842076.html.plaintext.txt	67	adult orexinataxin num mouse show narcolepsy hypophagia obesity num
0.42022583.11842076.html.plaintext.txt	68	however although causal implication orexin system narcolepsy established direct causal involvement normal sleep regulation often claimed num num num num num num num remains elucidated
0.42022583.11842076.html.plaintext.txt	69	systematic search gene affecting particular phenotype need cover whole genome organism
0.42022583.11842076.html.plaintext.txt	70	genome wide search mapping experiment make priori assumption gene system involved although approach may lead already known physiological mechanism strength unknown andor unexpected system may discovered
0.42022583.11842076.html.plaintext.txt	71	orexin success story canine narcolepsy unique best example approach field sleep research
0.42022583.11842076.html.plaintext.txt	72	therefore genome wide search constitutes method choice discover new sleep gene
0.42022583.11842076.html.plaintext.txt	73	fundamental basis approach linkage disequilibrium closely localized gene
0.42022583.11842076.html.plaintext.txt	74	gene affecting trait must addition gene genetic material tightly linked segregating generation generation together trait study
0.42022583.11842076.html.plaintext.txt	75	therefore instead testing gene organism check cosegregation trait linkage one need test small panel gene regular interval throughout genome obtain sufficient information large chromosomal piece transmitted single unit
0.42022583.11842076.html.plaintext.txt	76	follow segregation gene must polymorphic nucleotide variation individual individual may case sequence gene may unknown
0.42022583.11842076.html.plaintext.txt	77	powerful substitute provided highly polymorphic element restriction fragment length polymorphism rflps simple sequence length polymorphism sslps single nucleotide polymorphism snp forth mostly found noncoding genetic material
0.42022583.11842076.html.plaintext.txt	78	polymorphic marker tested accurate mapping
0.42022583.11842076.html.plaintext.txt	79	major question big effect gene detected
0.42022583.11842076.html.plaintext.txt	80	orexin num receptor produce remarkable change trait readily recognized e
0.42022583.11842076.html.plaintext.txt	81	monogenic autosomal recessive canine narcolepsy whereas natural variation gene controlling complex trait may subtle effect
0.42022583.11842076.html.plaintext.txt	82	therefore genome wide approach dissect complex trait highly sensitive detect gene variable effect trait
0.42022583.11842076.html.plaintext.txt	83	basically two major approach available mutagenesis quantitative trait locus qtl analysis
0.42022583.11842076.html.plaintext.txt	84	mutagenesis approach straightforward mutagen like n ethyl n nitrosurea used mutate random whole genome followed high throughput screening mutant offspring detect major effect given phenotype
0.42022583.11842076.html.plaintext.txt	85	dominant recessive mutation screened way single gene mutation pathological condition
0.42022583.11842076.html.plaintext.txt	86	mutated gene localized candidate gene positional cloning approach used identification ultimately functional analysis performed gain loss function
0.42022583.11842076.html.plaintext.txt	87	remarkable demonstration technique provided isolation clock one key mammalian circadian clock gene num num num
0.42022583.11842076.html.plaintext.txt	88	however genetic screen approach fully penetrant dominant recessive mutation therefore identify small effect sequence variation may turn essential aspect phenotype
0.42022583.11842076.html.plaintext.txt	89	addition currently available technology recording analyzing sleep thousand mouse mutant screen seem feasible least single academic laboratory
0.42022583.11842076.html.plaintext.txt	90	qtl analysis proposed powerful approach genetic dissection complex trait num num num
0.42022583.11842076.html.plaintext.txt	91	although natural allelic variation gene small effect mapped qtl analysis final identification sequence variant quantitative trait nucleotide qtns ref
0.42022583.11842076.html.plaintext.txt	92	num qtl region biologically significant effect phenotype may represent prohibitive effort term phenotyping genotyping
0.42022583.11842076.html.plaintext.txt	93	excellent example qtl analysis understanding complex trait recently provided takahashis group num circadian behavior mouse
0.42022583.11842076.html.plaintext.txt	94	although molecular machinery circadian timekeeping system discovered mainly direct molecular technique mutagenesis identified gene explain complexity observed circadian behavior
0.42022583.11842076.html.plaintext.txt	95	instance none clock gene found involved approximately num h difference free running period balbc cnumblnum inbred mouse strain
0.42022583.11842076.html.plaintext.txt	96	takahashis group num used qtl analysis balbc x cnumblnum cxb intercross discovered several new locus epistatic interaction
0.42022583.11842076.html.plaintext.txt	97	complex nature sleep reflected high intra interspecies phenotypic variability
0.42022583.11842076.html.plaintext.txt	98	instance num h amount sleep show highly significant difference inbred mouse strain num num num
0.42022583.11842076.html.plaintext.txt	99	shown akr mouse sleep num h dba mouse num h period num
0.42022583.11842076.html.plaintext.txt	100	difference period circadian rhythm single gene many gene complex interaction may found account difference
0.42022583.11842076.html.plaintext.txt	101	therefore initiated series experiment dissect different phenotypic aspect sleep mouse qtl analysis
0.42022583.11842076.html.plaintext.txt	102	table num summarizes main quantitative aspect sleep inbred strain mouse differed
0.42022583.11842076.html.plaintext.txt	103	note difference high low strain consistent two study performed num year apart usually difference two extreme strain expressed standard deviation twice large ref
0.42022583.11842076.html.plaintext.txt	104	num due smaller within strain standard deviation based repeated measure data ref
0.42022583.11842076.html.plaintext.txt	105	num based num day continuous recording instead single num h recording ref
0.42022583.11842076.html.plaintext.txt	106	view table table num
0.42022583.11842076.html.plaintext.txt	107	difference amount sw p extreme inbred mouse strain
0.42022583.11842076.html.plaintext.txt	108	qtl analysis performed several segregating mouse population including intercross backcross advanced intercross backcross ri heterogeneous stock num num
0.42022583.11842076.html.plaintext.txt	109	basically two inbred mouse strain differing trait interest crossed fnum offspring either intercrossed generate fnum backcrossed one progenitor strain generate backcross population
0.42022583.11842076.html.plaintext.txt	110	random intercross backcross generation performed generate advanced intercross backcross population
0.42022583.11842076.html.plaintext.txt	111	generate ri set fnum mouse brother x sister mated full homozygosity thereby fixing unique set recombination several inbred line
0.42022583.11842076.html.plaintext.txt	112	heterogeneous stock generated intercrossing several inbred mouse strain many generation therefore represent higher rate recombination polymorphism useful fine mapping num num
0.42022583.11842076.html.plaintext.txt	113	although ri usually suitable qtl mapping due limited progenitor strain number qtls large effect may provide significant mapping accuracy fourfold increase recombination compared fnum population num
0.42022583.11842076.html.plaintext.txt	114	also complex phenotype high variability use ri advantageous several individual per strain tested instead example single fnum animal
0.42022583.11842076.html.plaintext.txt	115	therefore first step performed qtl analysis two ri set
0.42022583.11842076.html.plaintext.txt	116	seven cxb ri qtls identified amount p chromosome num num num num num
0.42022583.11842076.html.plaintext.txt	117	toth williams num conducted similar study num cxb ri reported provisional qtls chromosome num num num amount p light period
0.42022583.11842076.html.plaintext.txt	118	small number cxb ri n num num none qtls identified could satisfy standard significance level num
0.42022583.11842076.html.plaintext.txt	119	also discrepancy two referenced work indicates linkage study replication needed especially finding based limited number animal andor strain recent review see also ref
0.42022583.11842076.html.plaintext.txt	120	qtl analysis num cnumblnum x dbanum bxd ri identified first significant qtl amount p num h light period chromosome num num
0.42022583.11842076.html.plaintext.txt	121	estimated bxd ri num num variance sleep amount accounted additive effect num num gene confirming polygenic basis difference sleep amount
0.42022583.11842076.html.plaintext.txt	122	quantitative eeg analysis mean fast fourier transform analysis robust technique evaluate functional change central nervous system including change vigilance state num
0.42022583.11842076.html.plaintext.txt	123	slow wave sleep characterized oscillation delta num num hz spindle num num hz frequency range whereas p especially rodent characterized theta oscillation num num hz
0.42022583.11842076.html.plaintext.txt	124	wakefulness encompasses variety behavior characteristic eeg pattern
0.42022583.11842076.html.plaintext.txt	125	waking eeg analysis twin demonstrated spectral profile among heritable trait human reviewed ref
0.42022583.11842076.html.plaintext.txt	126	num heritability estimate ranging num num num
0.42022583.11842076.html.plaintext.txt	127	shown several spectral characteristic sleep fig
0.42022583.11842076.html.plaintext.txt	128	num differ significantly inbred mouse strain num
0.42022583.11842076.html.plaintext.txt	129	among theta peak frequency p showed highest difference inbred strain num interstrain variability could attributed genetic effect
0.42022583.11842076.html.plaintext.txt	130	established intercross backcross cxb mouse single gene may explain phenotypic variance major gene num
0.42022583.11842076.html.plaintext.txt	131	high resolution qtl mapping needed localize underlying gene
0.42022583.11842076.html.plaintext.txt	132	view larger version numk fig
0.42022583.11842076.html.plaintext.txt	133	bottom num electroencephalogram eeg sample paradoxical sleep p left slow wave sleep sw right num representative mouse inbred strain eeg characteristic differed
0.42022583.11842076.html.plaintext.txt	134	ak akrj br cnumbrcdj c balbcbyj dnum dbanumj
0.42022583.11842076.html.plaintext.txt	135	p eeg dominated theta oscillation num num hz
0.42022583.11842076.html.plaintext.txt	136	sw eeg composed delta num num hz theta sigma num num hz oscillation
0.42022583.11842076.html.plaintext.txt	137	top relative contribution frequency eeg component quantified spectral analysis
0.42022583.11842076.html.plaintext.txt	138	average theta frequency p num
0.42022583.11842076.html.plaintext.txt	139	num hz faster br compared ak mouse
0.42022583.11842076.html.plaintext.txt	140	spectral profile sw eeg c dnum mouse display large difference relative contribution delta sigma frequency component
0.42022583.11842076.html.plaintext.txt	141	spectral profile based num epoch scored p sw baseline num h light period n numstrain
0.42022583.11842076.html.plaintext.txt	142	another aspect sleep eeg considerable importance homeostatic regulation change delta power
0.42022583.11842076.html.plaintext.txt	143	eeg power num num hz range function prior wakefulness duration
0.42022583.11842076.html.plaintext.txt	144	relative delta power used index sleep need sleep intensity mammalian specie studied far
0.42022583.11842076.html.plaintext.txt	145	sleep loss induces proportional predictable increase delta power differs significantly inbred mouse strain num num
0.42022583.11842076.html.plaintext.txt	146	used delta power rebound num h sleep deprivation map underlying gene bxd ri num
0.42022583.11842076.html.plaintext.txt	147	result confirmed rate sleep need accumulates varies greatly genotype
0.42022583.11842076.html.plaintext.txt	148	one significant qtl identified chromosome num accounted num genetic variance trait
0.42022583.11842076.html.plaintext.txt	149	two example suggest quantitative sleep eeg parameter stronger genetic control sleep amount therefore suitable quantitative genetic dissection
0.42022583.11842076.html.plaintext.txt	150	sleep amount mammal may approximated technique eeg use piezoelectric film would make high throughput genetic analysis feasible
0.42022583.11842076.html.plaintext.txt	151	however success may limited due highly polygenic nature sleep amount suggesting presence many gene small effect
0.42022583.11842076.html.plaintext.txt	152	hand quantitative eeg analysis dramatically limit wide range use involves implantation recovery adaptation cabling time intensive analysis may turn successful due limited number underlying gene presence major gene
0.42022583.11842076.html.plaintext.txt	153	qtl analysis map gene genetic effect large chromosomal region usually num num cm
0.42022583.11842076.html.plaintext.txt	154	large region may contain single major gene several gene small effect
0.42022583.11842076.html.plaintext.txt	155	also qtls may interact epistasis effect difficult detect qtl mapping experiment
0.42022583.11842076.html.plaintext.txt	156	first step make sure region contains qtls large enough effect
0.42022583.11842076.html.plaintext.txt	157	one possibility transfer qtl region one inbred strain background another inbred background repeated backcrossing selection make congenic strain
0.42022583.11842076.html.plaintext.txt	158	reviewed sleep amount data available eight congenic strain generated transferring minor histocompatibility gene inbred strain balbc inbred background cnumblnum num
0.42022583.11842076.html.plaintext.txt	159	almost case result indicated even transferred piece chromosome contained large effect qtl detected cxb ri clear effect could observed resulting congenic strain
0.42022583.11842076.html.plaintext.txt	160	finding strongly suggests num many gene involved num interaction epistasis num even major qtl identified effect may vary genetic background genetic background due action modifier gene num
0.42022583.11842076.html.plaintext.txt	161	qtl region verified next step finely map qtl smallest chromosomal region num num amenable candidate gene analysis
0.42022583.11842076.html.plaintext.txt	162	final identification functional qtns sequence variant difficult part since qtns may found every kilobases
0.42022583.11842076.html.plaintext.txt	163	therefore combination several approach necessary mapping candidate gene analysis
0.42022583.11842076.html.plaintext.txt	164	high resolution qtl mapping conjunction future development high throughput phenotyping genotyping availability whole genome sequence several major mouse strain identify candidate gene investigated
0.42022583.11842076.html.plaintext.txt	165	candidate gene mutated either classical homologous recombination knockout newly developed serial nested chromosomal deletion num
0.42022583.11842076.html.plaintext.txt	166	systematic cross increasing decreasing qtl allele complete set mutant physically identify functional qtn
0.42022583.11842076.html.plaintext.txt	167	qtns probably involved gene regulation rather mutation affecting protein function gene expression profiling high throughput genotyping technology e
0.42022583.11842076.html.plaintext.txt	168	microarray taqman gene translation posttranslational protein analysis used uncover molecular mechanism involved
0.42022583.11842076.html.plaintext.txt	169	note finding molecular basis mutagenesis experiment follows approximately time labor intensive procedure
0.42022583.11842076.html.plaintext.txt	170	challenge finding molecular base sleep requires demanding effort term genetic genomic resource also term future development high throughput phenotyping technique
0.42022583.11842076.html.plaintext.txt	171	enough effort financial resource given develop simplified automated sleep recording device major limitation overcome
0.42022583.11842076.html.plaintext.txt	172	high number qtl mutant screen experiment thus become feasible
0.42022583.11842076.html.plaintext.txt	173	entire mouse genome sequence becomes available genome wide assessment spatial temporal expression gene identification every conceivable sequence variation provide speedy molecular analysis complex trait sleep
0.42022583.11842076.html.plaintext.txt	174	genetics sleep may also complemented genetic analysis rest activity fly num
0.42022583.11842076.html.plaintext.txt	175	considering still know little molecular basis sleep ineffective current treatment common sleep disorder insomnia hypersomnia believe molecular genetic approach still best hope developing better therapy uncovering sleep function
0.42022583.11842076.html.plaintext.txt	176	review tried show many technique combination used answer basic question
0.42022583.11842076.html.plaintext.txt	177	however relying solely large effect gene revealed mutagenesis candidate gene approach may bring erroneous interpretation complex polygenic nature sleep mechanism
0.42022583.11842076.html.plaintext.txt	178	taftis laboratory supported swiss national science foundation grant num
0.42022583.11842076.html.plaintext.txt	179	national heart lung blood institute grant hl num supported p
0.42022583.11842076.html.plaintext.txt	180	address reprint request correspondence m
0.42022583.11842076.html.plaintext.txt	181	tafti hug belle idee biochemistry clinical neurophysiology unit chemin du petit bel air num ch num chene bourg switzerland e mail taftiatcmu
0.42022583.11842076.html.plaintext.txt	182	antoch mp song ej chang vitaterna mh zhao y wilsbacher ld sangoram king dp pinto lh takahashi j
0.42022583.11842076.html.plaintext.txt	183	functional identification mouse circadian clock gene transgenic bac rescue
0.42022583.11842076.html.plaintext.txt	184	cell num num num numisimedline
0.42022583.11842076.html.plaintext.txt	185	borbely aa baumann f brandeis d strauch lehmann d
0.42022583.11842076.html.plaintext.txt	186	sleep deprivation effect sleep stage eeg power density man
0.42022583.11842076.html.plaintext.txt	187	electroencephalogr clin neurophysiol num num num numisimedline
0.42022583.11842076.html.plaintext.txt	188	bourgin p huitron resendiz spier ad fabre v morte b criado jr sutcliffe jg henriksen sj de lecea l
0.42022583.11842076.html.plaintext.txt	189	hypocretin num modulates rapid eye movement sleep activation locus coeruleus neuron
0.42022583.11842076.html.plaintext.txt	190	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	191	boutrel b franc b hen r hamon m adrien j
0.42022583.11842076.html.plaintext.txt	192	key role num htnumb receptor regulation paradoxical sleep evidenced num htnumb knock mouse
0.42022583.11842076.html.plaintext.txt	193	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	194	bova r micheli mr qualadrucci p zucconi gg
0.42022583.11842076.html.plaintext.txt	195	bdnf trkb mrna oscillate rat brain light dark cycle
0.42022583.11842076.html.plaintext.txt	196	brain re mol brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	197	bredow taishi p obel f guha thakurta n krueger jm
0.42022583.11842076.html.plaintext.txt	198	hypothalamic growth hormone releasing hormone mrna varies across day rat
0.42022583.11842076.html.plaintext.txt	199	neuroreport num num num numisimedline
0.42022583.11842076.html.plaintext.txt	200	chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m
0.42022583.11842076.html.plaintext.txt	201	narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.42022583.11842076.html.plaintext.txt	202	cell num num num numisimedline
0.42022583.11842076.html.plaintext.txt	203	chouvet g blois r debilly g jouvet m
0.42022583.11842076.html.plaintext.txt	204	structure occurrence rapid eye movement paradoxical sleep similar homozygotic twin
0.42022583.11842076.html.plaintext.txt	205	cr seance acad sci iii num num num num
0.42022583.11842076.html.plaintext.txt	206	gene expression brain across sleep waking cycle
0.42022583.11842076.html.plaintext.txt	207	brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	208	daan beersma dg borbely aa
0.42022583.11842076.html.plaintext.txt	209	timing human sleep recovery process gated circadian pacemaker
0.42022583.11842076.html.plaintext.txt	210	j physiol regulatory integrative comp physiol num rnum rnum numabstractfree full text
0.42022583.11842076.html.plaintext.txt	211	experimental strategy genetic dissection complex trait animal model
0.42022583.11842076.html.plaintext.txt	212	nat genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	213	de lecea l criado jr prospero garcia o gautvik km schweitzer p danielson pe dunlop cl siggins gr henriksen sj sutcliffe jg
0.42022583.11842076.html.plaintext.txt	214	cortical neuropeptide neuronal depressant sleep modulating property
0.42022583.11842076.html.plaintext.txt	215	de lecea l kilduff t peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett f ii frankel wn van den pol bloom fe gautvik km sutcliffe jg
0.42022583.11842076.html.plaintext.txt	216	hypocretins hypothalamus specific peptide neuroexcitatory activity
0.42022583.11842076.html.plaintext.txt	217	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	218	estabrooke iv mccarthy mt ko e chou tc chemelli rm yanagisawa m saper cb scammell te
0.42022583.11842076.html.plaintext.txt	219	fo expression orexin neuron varies behavioral state
0.42022583.11842076.html.plaintext.txt	220	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	221	fang j wang y krueger jm
0.42022583.11842076.html.plaintext.txt	222	mouse lacking tnf num kda receptor fail sleep tnf treatment
0.42022583.11842076.html.plaintext.txt	223	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	224	fang j wang y krueger jm
0.42022583.11842076.html.plaintext.txt	225	effect interleukin num sleep mediated type receptor
0.42022583.11842076.html.plaintext.txt	226	j physiol regulatory integrative comp physiol num rnum rnum numabstractfree full text
0.42022583.11842076.html.plaintext.txt	227	finding molecular basis quantitative trait success pitfall
0.42022583.11842076.html.plaintext.txt	228	nat rev genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	229	franken p chollet d tafti m
0.42022583.11842076.html.plaintext.txt	230	homeostatic regulation sleep need genetic control
0.42022583.11842076.html.plaintext.txt	231	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	232	franken p lopez molina l marcacci l schibler u tafti m
0.42022583.11842076.html.plaintext.txt	233	transcription factor dbp affect circadian sleep consolidation rhythmic eeg activity
0.42022583.11842076.html.plaintext.txt	234	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	235	franken p malafosse tafti m
0.42022583.11842076.html.plaintext.txt	236	genetic variation eeg activity sleep inbred mouse
0.42022583.11842076.html.plaintext.txt	237	j physiol regulatory integrative comp physiol num rnum rnum numabstractfree full text
0.42022583.11842076.html.plaintext.txt	238	franken p malafosse tafti m
0.42022583.11842076.html.plaintext.txt	239	genetic determinant sleep regulation inbred mouse
0.42022583.11842076.html.plaintext.txt	240	sleep num num num numisimedline
0.42022583.11842076.html.plaintext.txt	241	diallel analysis genetic underpinnings mouse sleep
0.42022583.11842076.html.plaintext.txt	242	physiol behav num num num numisimedline
0.42022583.11842076.html.plaintext.txt	243	rome orizzonte medico num p
0.42022583.11842076.html.plaintext.txt	244	sleep dream characteristic twin
0.42022583.11842076.html.plaintext.txt	245	acta genet med gemellol rom num num num nummedline
0.42022583.11842076.html.plaintext.txt	246	twin living apart test progress report
0.42022583.11842076.html.plaintext.txt	247	acta genet med gemellol rom num num num nummedline
0.42022583.11842076.html.plaintext.txt	248	ueber den schlaf von zwillingen
0.42022583.11842076.html.plaintext.txt	249	z indukt abstamm verebungsl num num num num
0.42022583.11842076.html.plaintext.txt	250	greenspan rj tononi g cirelli c shaw pj
0.42022583.11842076.html.plaintext.txt	251	trend neurosci num num num numisimedline
0.42022583.11842076.html.plaintext.txt	252	hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n
0.42022583.11842076.html.plaintext.txt	253	orexin activates locus coeruleus cell firing increase arousal rat
0.42022583.11842076.html.plaintext.txt	254	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	255	hara j beuckmann ct nambu willie jt chemelli rm sinton cm sugiyama f yagami k goto k yanagisawa m sakurai
0.42022583.11842076.html.plaintext.txt	256	genetic ablation orexin neuron mouse result narcolepsy hypophagia obesity
0.42022583.11842076.html.plaintext.txt	257	neuron num num num numisimedline
0.42022583.11842076.html.plaintext.txt	258	heath kendler k eaves lj martin ng
0.42022583.11842076.html.plaintext.txt	259	evidence genetic influence sleep disturbance sleep pattern twin
0.42022583.11842076.html.plaintext.txt	260	sleep num num num numisimedline
0.42022583.11842076.html.plaintext.txt	261	sleep characteristic twin
0.42022583.11842076.html.plaintext.txt	262	jpn j psychiatry neurol num num num nummedline
0.42022583.11842076.html.plaintext.txt	263	huang zl qu wm li wd mochizuki eguchi n watanabe urade y hayaishi o
0.42022583.11842076.html.plaintext.txt	264	arousal effect orexin depends activation histaminergic system
0.42022583.11842076.html.plaintext.txt	265	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	266	juel nielsen n harvald b
0.42022583.11842076.html.plaintext.txt	267	electroencephalogram uniovular twin brought apart
0.42022583.11842076.html.plaintext.txt	268	acta genet basel num num num nummedline
0.42022583.11842076.html.plaintext.txt	269	hypocretinorexin ligand receptor system implication sleep sleep disorder
0.42022583.11842076.html.plaintext.txt	270	trend neurosci num num num numisimedline
0.42022583.11842076.html.plaintext.txt	271	king dp zhao y sangoram wilsbacher ld tanaka m antoch mp steeves td vitaterna mh kornhauser jm lowrey pl turek fw takahashi j
0.42022583.11842076.html.plaintext.txt	272	positional cloning mouse circadian clock gene
0.42022583.11842076.html.plaintext.txt	273	cell num num num numisimedline
0.42022583.11842076.html.plaintext.txt	274	mapping mendelian factor underlying quantitative trait using rflp linkage map
0.42022583.11842076.html.plaintext.txt	275	genetics num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	276	genetic dissection complex trait
0.42022583.11842076.html.plaintext.txt	277	science num num num numisimedline
0.42022583.11842076.html.plaintext.txt	278	lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e
0.42022583.11842076.html.plaintext.txt	279	sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.42022583.11842076.html.plaintext.txt	280	cell num num num numisimedline
0.42022583.11842076.html.plaintext.txt	281	j sleep re num supplnum num num numisimedline
0.42022583.11842076.html.plaintext.txt	282	linkowski p kerkhofs m hauspie r mendlewicz j
0.42022583.11842076.html.plaintext.txt	283	genetic determinant eeg sleep study twin living apart
0.42022583.11842076.html.plaintext.txt	284	electroencephalogr clin neurophysiol num num num numisimedline
0.42022583.11842076.html.plaintext.txt	285	linkowski p kerkhofs m hauspie r susanne c mendlewicz j
0.42022583.11842076.html.plaintext.txt	286	eeg sleep pattern man twin study
0.42022583.11842076.html.plaintext.txt	287	electroencephalogr clin neurophysiol num num num numisimedline
0.42022583.11842076.html.plaintext.txt	288	lyman rf lai c mackay tf
0.42022583.11842076.html.plaintext.txt	289	linkage disequilibrium mapping molecular polymorphism scabrous locus associated naturally occurring variation bristle number drosophila melanogaster
0.42022583.11842076.html.plaintext.txt	290	genet re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	291	mackiewicz m sollars pj ogilvie md pack ai
0.42022583.11842076.html.plaintext.txt	292	modulation il num gene expression rat cns sleep deprivation
0.42022583.11842076.html.plaintext.txt	293	neuroreport num num num numisimedline
0.42022583.11842076.html.plaintext.txt	294	mott r talbot cj turri mg collins ac flint j
0.42022583.11842076.html.plaintext.txt	295	new method fine mapping quantitative trait locus outbred animal stock
0.42022583.11842076.html.plaintext.txt	296	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	297	modifier gene mouse human
0.42022583.11842076.html.plaintext.txt	298	nat rev genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	299	naylor e bergmann bm krauski k zee pc takahashi j vitaterna mh turek fw
0.42022583.11842076.html.plaintext.txt	300	circadian clock mutation alters sleep homeostasis mouse
0.42022583.11842076.html.plaintext.txt	301	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	302	neuner jehle m denizot jp borbely aa mallet j
0.42022583.11842076.html.plaintext.txt	303	characterization sleep deprivation induced expression modulation dendrin novel dendritic protein rat brain neuron
0.42022583.11842076.html.plaintext.txt	304	j neurosci re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	305	neuner jehle m rhyner ta borbely aa
0.42022583.11842076.html.plaintext.txt	306	sleep deprivation differentially alters mrna protein level neurogranin rat brain
0.42022583.11842076.html.plaintext.txt	307	brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	308	nishino ripley b overeem lammers gj mignot e
0.42022583.11842076.html.plaintext.txt	309	hypocretin orexin deficiency human narcolepsy
0.42022583.11842076.html.plaintext.txt	310	lancet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	311	partinen m kaprio j koskenvuo m putkonen p langinvainio h
0.42022583.11842076.html.plaintext.txt	312	genetic environmental determination human sleep
0.42022583.11842076.html.plaintext.txt	313	sleep num num num numisimedline
0.42022583.11842076.html.plaintext.txt	314	peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e
0.42022583.11842076.html.plaintext.txt	315	mutation case early onset narcolepsy generalized absence hypocretin peptide human narcoleptic brain
0.42022583.11842076.html.plaintext.txt	316	nat med num num num numisimedline
0.42022583.11842076.html.plaintext.txt	317	pinzar e kanaoka y inui eguchi n urade y hayaishi o
0.42022583.11842076.html.plaintext.txt	318	prostaglandin d synthase gene involved regulation non rapid eye movement sleep
0.42022583.11842076.html.plaintext.txt	319	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	320	porkka heiskanen smith se taira urban jh levine je turek fw stenberg d
0.42022583.11842076.html.plaintext.txt	321	noradrenergic activity rat brain rapid eye movement sleep deprivation rebound sleep
0.42022583.11842076.html.plaintext.txt	322	j physiol regulatory integrative comp physiol num rnum rnum numabstractfree full text
0.42022583.11842076.html.plaintext.txt	323	rhyner ta biguet nf berrard borbely aa mallet j
0.42022583.11842076.html.plaintext.txt	324	efficient approach selective isolation specific transcript complex brain mrna population
0.42022583.11842076.html.plaintext.txt	325	j neurosci re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	326	sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan r mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m
0.42022583.11842076.html.plaintext.txt	327	orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.42022583.11842076.html.plaintext.txt	328	cell num num num numisimedline
0.42022583.11842076.html.plaintext.txt	329	molecular approach towards isolation sleep related gene
0.42022583.11842076.html.plaintext.txt	330	j sleep re num suppl num num num num
0.42022583.11842076.html.plaintext.txt	331	shimomura k low zeddies s king dp steeves td whiteley kushla j zemenides pd lin vitaterna mh churchill ga takahashi j
0.42022583.11842076.html.plaintext.txt	332	genome wide epistatic interaction analysis reveals complex genetic determinant circadian behavior mouse
0.42022583.11842076.html.plaintext.txt	333	genome re num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	334	shiromani pj basheer r thakkar j wagner d greco ma charness
0.42022583.11842076.html.plaintext.txt	335	sleep wakefulness c fo fo b gene knockout mouse
0.42022583.11842076.html.plaintext.txt	336	brain re mol brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	337	su h wang x bradley
0.42022583.11842076.html.plaintext.txt	338	nested chromosomal deletion induced retroviral vector mouse
0.42022583.11842076.html.plaintext.txt	339	nat genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	340	tafti m chollet d valatx jl franken p
0.42022583.11842076.html.plaintext.txt	341	quantitative trait locus approach genetics sleep recombinant inbred mouse
0.42022583.11842076.html.plaintext.txt	342	j sleep re num suppl num num num numisimedline
0.42022583.11842076.html.plaintext.txt	343	tafti m franken p kitahama k malafosse jouvet m valatx jl
0.42022583.11842076.html.plaintext.txt	344	localization candidate genomic region influencing paradoxical sleep mouse
0.42022583.11842076.html.plaintext.txt	345	neuroreport num num num numisimedline
0.42022583.11842076.html.plaintext.txt	346	tafti m malafosse franken p
0.42022583.11842076.html.plaintext.txt	347	genetic determinant theta rhythm mouse
0.42022583.11842076.html.plaintext.txt	348	j sleep re num supplnum num num
0.42022583.11842076.html.plaintext.txt	349	talbot cj nicod cherny s fulker dw collins ac flint j
0.42022583.11842076.html.plaintext.txt	350	high resolution mapping quantitative trait locus outbred mouse
0.42022583.11842076.html.plaintext.txt	351	nat genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	352	terao peyron c ding j wurts sw edgar dm heller hc kilduff t
0.42022583.11842076.html.plaintext.txt	353	prepro hypocretin prepro orexin expression unaffected short term sleep deprivation rat mouse
0.42022583.11842076.html.plaintext.txt	354	sleep num num num numisimedline
0.42022583.11842076.html.plaintext.txt	355	thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm
0.42022583.11842076.html.plaintext.txt	356	reduced number hypocretin neuron human narcolepsy
0.42022583.11842076.html.plaintext.txt	357	neuron num num num numisimedline
0.42022583.11842076.html.plaintext.txt	358	tobler gaus se deboer achermann p fischer m rulicke moser m oesch b mcbride pa manson jc
0.42022583.11842076.html.plaintext.txt	359	altered circadian activity rhythm sleep mouse devoid prion protein
0.42022583.11842076.html.plaintext.txt	360	nature num num num numisimedline
0.42022583.11842076.html.plaintext.txt	361	tobler kopp c deboer rudolph u
0.42022583.11842076.html.plaintext.txt	362	diazepam induced change sleep role num gabaa receptor subtype
0.42022583.11842076.html.plaintext.txt	363	proc natl acad sci usa num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	364	toppila j alanko l asikainen m tobler stenberg d porkka heiskanen
0.42022583.11842076.html.plaintext.txt	365	sleep deprivation increase somatostatin growth hormone releasing hormone messenger rna rat hypothalamus
0.42022583.11842076.html.plaintext.txt	366	j sleep re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	367	identifying genetic influence sleep approach discovering mechanism sleep regulation
0.42022583.11842076.html.plaintext.txt	368	behav genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	369	cytokine microbially induced sleep response interleukin num deficient mouse
0.42022583.11842076.html.plaintext.txt	370	j physiol regulatory integrative comp physiol num rnum rnum numabstractfree full text
0.42022583.11842076.html.plaintext.txt	371	quantitative genetic analysis slow wave sleep rapid eye movement sleep cxb recombinant inbred mouse
0.42022583.11842076.html.plaintext.txt	372	behav genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	373	possible embryonic origin sleep interstrain difference mouse
0.42022583.11842076.html.plaintext.txt	374	maturation nervous system
0.42022583.11842076.html.plaintext.txt	375	prog brain re num num num nummedline
0.42022583.11842076.html.plaintext.txt	376	genetics model studying sleep waking cycle
0.42022583.11842076.html.plaintext.txt	377	exp brain re suppl num num num num
0.42022583.11842076.html.plaintext.txt	378	facteurs genetiques dans le determinisme du cycle veille sommeil chez la souris
0.42022583.11842076.html.plaintext.txt	379	brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	380	valatx jl bugat r jouvet m
0.42022583.11842076.html.plaintext.txt	381	genetic study sleep mouse
0.42022583.11842076.html.plaintext.txt	382	nature num num num numisimedline
0.42022583.11842076.html.plaintext.txt	383	valatx jl cespuglio r paut l bailey dw
0.42022583.11842076.html.plaintext.txt	384	etude genetique du sommeil paradoxal chez la souris
0.42022583.11842076.html.plaintext.txt	385	liaison possible avec le gene de coloration
0.42022583.11842076.html.plaintext.txt	386	waking sleeping num num num nummedline
0.42022583.11842076.html.plaintext.txt	387	valatx jl chouvet g kitahama k
0.42022583.11842076.html.plaintext.txt	388	genetics sleep learning process possible relationship
0.42022583.11842076.html.plaintext.txt	389	genetics environment intelligence edited oliverio
0.42022583.11842076.html.plaintext.txt	390	valatx jl douhet p bucchini d
0.42022583.11842076.html.plaintext.txt	391	human insulin gene insertion mouse
0.42022583.11842076.html.plaintext.txt	392	effect sleep wake cycle j sleep re num supplnum num num numisimedline
0.42022583.11842076.html.plaintext.txt	393	van beijsterveldt ce boomsma di
0.42022583.11842076.html.plaintext.txt	394	genetics human electroencephalogram eeg event related brain potential erps review
0.42022583.11842076.html.plaintext.txt	395	hum genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	396	van beijsterveldt ce molenaar pc de geus ej boomsma di
0.42022583.11842076.html.plaintext.txt	397	heritability human brain functioning assessed electroencephalography
0.42022583.11842076.html.plaintext.txt	398	j hum genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	399	vitaterna mh king dp chang kornhauser jm lowrey pl mcdonald jd dove wf pinto lh turek fw takahashi j
0.42022583.11842076.html.plaintext.txt	400	mutagenesis mapping mouse gene clock essential circadian behavior
0.42022583.11842076.html.plaintext.txt	401	science num num num numisimedline
0.42022583.11842076.html.plaintext.txt	402	uber die erblichkeit de normalen electroencephalogramms
0.42022583.11842076.html.plaintext.txt	403	stuttgart germany thieme num
0.42022583.11842076.html.plaintext.txt	404	genetic basis normal human electroencephalogram
0.42022583.11842076.html.plaintext.txt	405	humangenetik num num num numisimedline
0.42022583.11842076.html.plaintext.txt	406	zur genetischen grundlage fronto prazentraler b wellen gruppen im eeg de menschen
0.42022583.11842076.html.plaintext.txt	407	humangenetik num num num numisimedline
0.42022583.11842076.html.plaintext.txt	408	zur genetischen grundlage occipitaler langsamer b wellen gruppen im eeg de menschen
0.42022583.11842076.html.plaintext.txt	409	humangenetik num num num numisimedline
0.42022583.11842076.html.plaintext.txt	410	circadian rhythm genetics fly mouse human
0.42022583.11842076.html.plaintext.txt	411	nat genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	412	relationship sleep characteristic identical fraternal twin
0.42022583.11842076.html.plaintext.txt	413	arch gen psychiatry num num num numabstract
0.42022583.11842076.html.plaintext.txt	414	transgenic animal integrative biology approach interpretation outcome
0.42022583.11842076.html.plaintext.txt	415	j appl physiol num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	416	willie jt chemelli rm sinton cm yanagisawa m
0.42022583.11842076.html.plaintext.txt	417	eat sleep orexin regulation feeding wakefulness
0.42022583.11842076.html.plaintext.txt	418	annu rev neurosci num num num numisimedline
0.42022583.11842076.html.plaintext.txt	419	wisor jp nishino sora uhl gh mignot e edgar dm
0.42022583.11842076.html.plaintext.txt	420	dopaminergic role stimulant induced wakefulness
0.42022583.11842076.html.plaintext.txt	421	j neurosci num num num numabstractfree full text
0.42022583.11842076.html.plaintext.txt	422	xi m morale fr chase mh
0.42022583.11842076.html.plaintext.txt	423	effect sleep wakefulness injection hypocretin num orexin laterodorsal tegmental nucleus cat
0.42022583.11842076.html.plaintext.txt	424	brain re num num num numisimedline
0.42022583.11842076.html.plaintext.txt	425	young jp lader mh fenton gw
0.42022583.11842076.html.plaintext.txt	426	twin study genetic influence electroencephalogram
0.42022583.11842076.html.plaintext.txt	427	j med genet num num num numisimedline
0.42022583.11842076.html.plaintext.txt	428	zhang j obal f jr fang j collins bj krueger jm
0.42022583.11842076.html.plaintext.txt	429	non rapid eye movement sleep suppressed transgenic mouse deficiency somatotropic system
0.42022583.11842076.html.plaintext.txt	430	neurosci lett num num num numisimedline
0.42022583.11842076.html.plaintext.txt	431	sleep dream pattern twin
0.42022583.11842076.html.plaintext.txt	432	markov analysis genetic trait
0.42022583.11842076.html.plaintext.txt	433	rec adv biol psychiatry num num num num
0.42022583.11842076.html.plaintext.txt	434	j appl physiol numnumnum num num numnum num
0.42022583.11842076.html.plaintext.txt	435	num copyright num american physiological society
0.44176623.15625087.html.plaintext.txt	0	altered setting pituitary thyroid ensemble hypocretin deficient narcoleptic men simon w
0.44176623.15625087.html.plaintext.txt	1	koknum ferdinand roelfsemanum sebastiaan overeemnum gert jan lammersnum marijke frolichnum
0.44176623.15625087.html.plaintext.txt	2	edo meindersnum hanno pijlnum
0.44176623.15625087.html.plaintext.txt	3	department numgeneral internal medicine numendocrinology numneurology leiden university medical center leiden netherlands
0.44176623.15625087.html.plaintext.txt	4	submitted num july num accepted final form num december num
0.44176623.15625087.html.plaintext.txt	5	narcolepsy thyroid stimulating hormone orexin sleep entropy
0.44176623.15625087.html.plaintext.txt	6	narcolepsy neurological disorder characterized excessive daytime sleepiness ed hypnagogic hallucination cataplexy sleep paralysis num affect num num every numnum subject u europe num
0.44176623.15625087.html.plaintext.txt	7	disruption hypocretin orexin neurotransmission underlies disease animal human num num
0.44176623.15625087.html.plaintext.txt	8	hypocretins hypocretin num num also called orexin b produced small group neuron lateral hypothalamus project widely throughout central nervous system cns num num
0.44176623.15625087.html.plaintext.txt	9	paraventricular nucleus pvn among various brain site receive hypocretin input signal num
0.44176623.15625087.html.plaintext.txt	10	nucleus harbor neuron synthesize thyrotropin releasing hormone trh involved regulation hypothalamo pituitary thyroid hpt axis num
0.44176623.15625087.html.plaintext.txt	11	starvation thyroid hormone secretion suppressed num num whereas preprohypocretin mrna upregulated lateral hypothalamus num
0.44176623.15625087.html.plaintext.txt	12	led u hypothesize hypocretin neural circuit modulate activity hypothalamic trh neuron thereby impact hpt axis
0.44176623.15625087.html.plaintext.txt	13	study putative effect hypocretin peptide hpt axis animal incomplete result conflicting
0.44176623.15625087.html.plaintext.txt	14	single intravenous intracerebroventricular injection hypocretin num rat acutely decreased plasma tsh concentration hypothalamic trh release num
0.44176623.15625087.html.plaintext.txt	15	contrast several paper report hypocretin num measurable effect pituitary thyroid axis num num num num whereas circulating tsh shown increase response central administration hypocretin num num
0.44176623.15625087.html.plaintext.txt	16	thus although topography hypocretin thyrotrope neural circuit suggests trh neuronal activity governed hypocretin input nature signal
0.44176623.15625087.html.plaintext.txt	17	excitatory inhibitory remains unclear hypocretin num num may differential effect result distinct chemical structure
0.44176623.15625087.html.plaintext.txt	18	previously reported circulating leptin level low male narcoleptic patient num
0.44176623.15625087.html.plaintext.txt	19	leptin stimulatory effect hpt axis conceivable relative hypoleptinemia downregulates hpt axis activity narcolepsy
0.44176623.15625087.html.plaintext.txt	20	addition typical disruption sleep wake cycle associated narcolepsy may also impact tsh release sleep inhibits tsh secretion healthy subject num
0.44176623.15625087.html.plaintext.txt	21	gain insight regulation hpt axis hypocretin deficient human analyzed num h plasma tsh thyroid hormone concentration relation leptin sleep seven narcoleptic men seven healthy control
0.44176623.15625087.html.plaintext.txt	22	included seven male patient mean age num
0.44176623.15625087.html.plaintext.txt	23	num yr range num num yr outpatient clinic department neurology leiden university medical center
0.44176623.15625087.html.plaintext.txt	24	diagnosis narcolepsy cataplexy made clinical ground physician experienced narcolepsy g
0.44176623.15625087.html.plaintext.txt	25	multiple sleep latency testing showed result typical narcolepsy num
0.44176623.15625087.html.plaintext.txt	26	patient hla drnumdqbnumnum positive lacked hypocretin num cerebrospinal fluid measurement previously described num
0.44176623.15625087.html.plaintext.txt	27	subject free medication num patient discontinued medication num wk study
0.44176623.15625087.html.plaintext.txt	28	two patient used psychostimulants methylfenidate modafinil one tricyclic antidepressant clomipramine treatment narcolepsy
0.44176623.15625087.html.plaintext.txt	29	weight height subject measured well waist hip circumference
0.44176623.15625087.html.plaintext.txt	30	waist hip ratio whr used relative measure abdominal fat mass
0.44176623.15625087.html.plaintext.txt	31	total body fat mass determined dual energy x ray absorptiometry qdrnum hologic waltham ma
0.44176623.15625087.html.plaintext.txt	32	seven male control subject mean age num
0.44176623.15625087.html.plaintext.txt	33	num yr range num num yr recruited advertisement local newspaper
0.44176623.15625087.html.plaintext.txt	34	matched age body mass index bmi total fat mass whr since narcoleptic moderately obese num
0.44176623.15625087.html.plaintext.txt	35	subject eligible study exclusion hypertension defined repeated blood pressure measurement systolic num mmhg diastolic num mmhg known history pituitary disease recent weight change num kg weight gain loss within previous num mo fasting blood glucose num
0.44176623.15625087.html.plaintext.txt	36	written informed consent obtained subject
0.44176623.15625087.html.plaintext.txt	37	study approved ethic committee leiden university medical center
0.44176623.15625087.html.plaintext.txt	38	subject admitted clinical research center morning num h study occasion
0.44176623.15625087.html.plaintext.txt	39	num h study occasion three standardized meal served num num num nutridrink num
0.44176623.15625087.html.plaintext.txt	40	num kcalml numnum numnum kcalday macronutrient composition per num ml num g protein num
0.44176623.15625087.html.plaintext.txt	41	num g carbohydrate nutricia zoetermeer netherlands
0.44176623.15625087.html.plaintext.txt	42	subject remained sedentary throughout study except bathroom visit
0.44176623.15625087.html.plaintext.txt	43	light switched num
0.44176623.15625087.html.plaintext.txt	44	upon arrival intravenous cannula inserted antecubital vein num h start blood sampling
0.44176623.15625087.html.plaintext.txt	45	blood sample collected monovetten sarstedt etten leur netherlands three way stopcock attached num
0.44176623.15625087.html.plaintext.txt	46	num nacl heparin num uml infusion num mlnum h keep cannula clotting
0.44176623.15625087.html.plaintext.txt	47	blood collected num min interval num h
0.44176623.15625087.html.plaintext.txt	48	sampled long line prevent sleep disturbance investigative manipulation
0.44176623.15625087.html.plaintext.txt	49	sample clotted centrifuged num degree c num min serum frozen num degree c assay
0.44176623.15625087.html.plaintext.txt	50	plasma tsh concentration measured every sample
0.44176623.15625087.html.plaintext.txt	51	total thyroxine tnum triiodothyronine tnum concentration measured hourly relatively long plasma half life
0.44176623.15625087.html.plaintext.txt	52	plasma free tnum concentration measured morning
0.44176623.15625087.html.plaintext.txt	53	separate occasion trh stimulation test carried five patient five control
0.44176623.15625087.html.plaintext.txt	54	fasting state num microg trh injected intravenously blood sample taken num min interval num h
0.44176623.15625087.html.plaintext.txt	55	thyroid hormone assay performed automated system total tnum measured fluorescence immunoenzymometric assay fiema abbott diagnostics division hoofddorp netherlands tnum fluorescence enzymeimmunoassay feia abbott diagnostics division
0.44176623.15625087.html.plaintext.txt	56	free tnum concentration measured electrochemoluminescence immunoassay roche diagnostics nederland almere netherlands
0.44176623.15625087.html.plaintext.txt	57	tsh measured time resolved immunofluorometric assay wallac turku finland
0.44176623.15625087.html.plaintext.txt	58	detection limit tsh assay num
0.44176623.15625087.html.plaintext.txt	59	num mul interassay coefficient variation cv num
0.44176623.15625087.html.plaintext.txt	60	addition plasma leptin concentration measured every num min sample ria linco research st
0.44176623.15625087.html.plaintext.txt	61	detection limit assay num
0.44176623.15625087.html.plaintext.txt	62	num concentration range num
0.44176623.15625087.html.plaintext.txt	63	detailed description circulating leptin level narcoleptic men previously published num
0.44176623.15625087.html.plaintext.txt	64	correlated num h mean leptin concentration tsh secretion also num min leptin data relation reconstituted num min plasma tsh profile
0.44176623.15625087.html.plaintext.txt	65	num h sampling procedure sleep recorded polygraphically using porti num ambulant electroencephalogram recording system twente medical system international enschede netherlands scored eeg num review software nihon kohden tokyo japan
0.44176623.15625087.html.plaintext.txt	66	experienced technician blinded subject study visually scored sleep recording num epoch mean standardized criterion num
0.44176623.15625087.html.plaintext.txt	67	present study used distribution amount sleep across num h
0.44176623.15625087.html.plaintext.txt	68	cluster used detection discrete tsh peak
0.44176623.15625087.html.plaintext.txt	69	computerized pulse algorithm largely model free identifies statistically significant pulse relation dose dependent measurement error hormone time series
0.44176623.15625087.html.plaintext.txt	70	present analysis num x num test cluster configuration used two data point test nadir one test peak statistic num
0.44176623.15625087.html.plaintext.txt	71	num downstroke minimizes false positive false negative peak
0.44176623.15625087.html.plaintext.txt	72	location width significant concentration peak identified total number peak counted mean peak interval calculated minute
0.44176623.15625087.html.plaintext.txt	73	addition following pulse parameter determined peak height highest value attained within peak incremental peak amplitude difference peak height prepeak nadir area peak
0.44176623.15625087.html.plaintext.txt	74	interpulse valley identified region embracing nadir intervening upstroke
0.44176623.15625087.html.plaintext.txt	75	total area curve also calculated well summed pulse area num
0.44176623.15625087.html.plaintext.txt	76	num h tsh secretion rate calculated pulse
0.44176623.15625087.html.plaintext.txt	77	deconvolution method waveform independent used estimating hormone secretion rate time point well total num h rate num
0.44176623.15625087.html.plaintext.txt	78	method requires priori specification plasma half life
0.44176623.15625087.html.plaintext.txt	79	present analysis used two compartment model fast component num plus minus num min slow component num plus minus num min fractional contribution num
0.44176623.15625087.html.plaintext.txt	80	num slow component overall decay data kindly provided dr
0.44176623.15625087.html.plaintext.txt	81	veldhuis mayo clinic rochester mn
0.44176623.15625087.html.plaintext.txt	82	mass tsh released trh injection also calculated deconvolution
0.44176623.15625087.html.plaintext.txt	83	separarate occasion patient received num microg trh intravenously morning blood sample drawn injection num min interval num min
0.44176623.15625087.html.plaintext.txt	84	univariate approximate entropy apen statistic developed quantify degree irregularity disorderliness time series num num
0.44176623.15625087.html.plaintext.txt	85	technically apen quantifies summed logarithmic likelihood template length m pattern data similar within r remain similar within tolerance r next incremental comparison formally defined elsewhere num
0.44176623.15625087.html.plaintext.txt	86	apen calculation provides single nonnegative number ensemble estimate relative process randomness wherein larger apen value denote greater irregularity
0.44176623.15625087.html.plaintext.txt	87	cross apen x apen quantifies joint pattern synchrony two separate parallel time series standardization z score transformation num num
0.44176623.15625087.html.plaintext.txt	88	present analysis calculated x apen leptin tsh sleep tsh assuming r num sd individual time series m num hence use designation x apen num num
0.44176623.15625087.html.plaintext.txt	89	parameter set affords sensitive valid statistically well replicated apen x apen metric assessing hormone time series length num
0.44176623.15625087.html.plaintext.txt	90	apen x apen result reported absolute value ratio absolute value mean numnum randomly shuffled data series value approaching num
0.44176623.15625087.html.plaintext.txt	91	nyctohemeral num h rhythmicity
0.44176623.15625087.html.plaintext.txt	92	diurnal variation plasma tsh concentration calculated data fitted robust curve fitting algorithm num num
0.44176623.15625087.html.plaintext.txt	93	acrophase maximal value fitted curve
0.44176623.15625087.html.plaintext.txt	94	amplitude rhythm defined one half difference nocturnal zenith daytime nadir
0.44176623.15625087.html.plaintext.txt	95	relative amplitude maximal percent increase nadir value
0.44176623.15625087.html.plaintext.txt	96	relation sleep onset decrease tsh concentration quantified hypergeometric joint binomial distribution num
0.44176623.15625087.html.plaintext.txt	97	program calculates probability event pulse time series two occur randomly
0.44176623.15625087.html.plaintext.txt	98	result presented mean plus minus se unless stated otherwise
0.44176623.15625087.html.plaintext.txt	99	comparison made two tailed student test unpaired data necessary logarithmic transformation limit variability
0.44176623.15625087.html.plaintext.txt	100	addition used kolmogorov smirnov test
0.44176623.15625087.html.plaintext.txt	101	relation variable analyzed regression technique
0.44176623.15625087.html.plaintext.txt	102	calculation performed systat version num systat richmond ca
0.44176623.15625087.html.plaintext.txt	103	figure num show average num h serum tsh concentration v
0.44176623.15625087.html.plaintext.txt	104	time narcoleptic subject n matched control c
0.44176623.15625087.html.plaintext.txt	105	mean num h plasma tsh concentration significantly lower narcoleptic patient num
0.44176623.15625087.html.plaintext.txt	106	contrast mean hourly plasma total tnum tnum different patient control table num
0.44176623.15625087.html.plaintext.txt	107	also basal free tnum measurement similar group num
0.44176623.15625087.html.plaintext.txt	108	circadian plasma tnum tnum level display significant diurnal rhythm
0.44176623.15625087.html.plaintext.txt	109	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	110	twenty four hour thyroid stimulating hormone tsh concentration num narcoleptic patient num control
0.44176623.15625087.html.plaintext.txt	111	data shown mean se bar
0.44176623.15625087.html.plaintext.txt	112	mean num h serum tsh thyroid hormone concentration narcoleptic patient healthy control
0.44176623.15625087.html.plaintext.txt	113	result cluster analysis summarized table num
0.44176623.15625087.html.plaintext.txt	114	tsh pulse frequency mean pulse interval differ patient control
0.44176623.15625087.html.plaintext.txt	115	mean pulse area smaller patient control primarily caused diminution pulse height pulse amplitude
0.44176623.15625087.html.plaintext.txt	116	integrated total area tsh curve auc also lower patient control numnum plus minus num v
0.44176623.15625087.html.plaintext.txt	117	numnum plus minus num mul p num
0.44176623.15625087.html.plaintext.txt	118	mean nadir concentration num lower patient control
0.44176623.15625087.html.plaintext.txt	119	cluster analysis num h serum tsh concentration series narcolepsy control
0.44176623.15625087.html.plaintext.txt	120	acrophase time maximal tsh occurred num
0.44176623.15625087.html.plaintext.txt	121	nadir concentration reached num
0.44176623.15625087.html.plaintext.txt	122	amplitude rhythm smaller patient control num
0.44176623.15625087.html.plaintext.txt	123	num percent increase tsh concentration similar two group num plus minus num v
0.44176623.15625087.html.plaintext.txt	124	num plus minus num p num
0.44176623.15625087.html.plaintext.txt	125	example representative tsh profile fitted curve shown fig
0.44176623.15625087.html.plaintext.txt	126	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	127	plasma tsh concentration series num patient top num control bottom
0.44176623.15625087.html.plaintext.txt	128	locally weighted robust regression line data point also shown
0.44176623.15625087.html.plaintext.txt	129	percentage wakefulness calculated num min bin displayed top panel
0.44176623.15625087.html.plaintext.txt	130	different occasion response tsh trh investigated
0.44176623.15625087.html.plaintext.txt	131	total mass tsh released calculated deconvolution analysis num
0.44176623.15625087.html.plaintext.txt	132	maximal tsh value reached num num min trh injection different patient control num min p num
0.44176623.15625087.html.plaintext.txt	133	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	134	tsh increase injection num microg thyrotropin releasing hormone trh num narcoleptic patient num control
0.44176623.15625087.html.plaintext.txt	135	basal tsh concentration differed significantly p num
0.44176623.15625087.html.plaintext.txt	136	maximal value num num min different total tsh mass secreted similar patient control
0.44176623.15625087.html.plaintext.txt	137	data shown mean plus minus se
0.44176623.15625087.html.plaintext.txt	138	figure num show correlation leptin tsh concentration
0.44176623.15625087.html.plaintext.txt	139	synchronicity leptin tsh series similar patient control x apen score leptin leading tsh num
0.44176623.15625087.html.plaintext.txt	140	expressed ratio random series x apen ratio patient num
0.44176623.15625087.html.plaintext.txt	141	ratio differed significantly random series num sd
0.44176623.15625087.html.plaintext.txt	142	linear relation mean num h leptin concentration num h tsh secretion rate determined deconvolution analysis depicted fig
0.44176623.15625087.html.plaintext.txt	143	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	144	regression tsh leptin concentration num narcoleptic patient num control
0.44176623.15625087.html.plaintext.txt	145	data represent sample obtained num min interval num h study
0.44176623.15625087.html.plaintext.txt	146	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	147	linear regression mean num h leptin concentration tsh secretion estimated deconvolution analysis
0.44176623.15625087.html.plaintext.txt	148	narcoleptic patient shown circle control triangle
0.44176623.15625087.html.plaintext.txt	149	narcoleptic patient slept longer sampling protocol
0.44176623.15625087.html.plaintext.txt	150	num sleep pattern expressed percentage awake tsh concentration profile displayed two patient two control
0.44176623.15625087.html.plaintext.txt	151	patient control except one highly significant concordance sleep onset decrease tsh concentration present p value ranging num
0.44176623.15625087.html.plaintext.txt	152	total sleep duration correlated negatively num h tsh secretion rnum num
0.44176623.15625087.html.plaintext.txt	153	relation sleep tsh concentration also explored apen analysis
0.44176623.15625087.html.plaintext.txt	154	sleep apen num num apen num num ratio significantly increased compared control denoting increased sleep disorderliness narcoleptic patient fig
0.44176623.15625087.html.plaintext.txt	155	x apen analysis demonstrated coupling sleep tsh control patient mutual difference
0.44176623.15625087.html.plaintext.txt	156	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	157	approximate entropy apen cross apen x apen sleep joint synchrony sleep tsh num narcoleptic n patient num age body fat mass matched control c
0.44176623.15625087.html.plaintext.txt	158	statistical comparison made num tailed student test unpaired data
0.44176623.15625087.html.plaintext.txt	159	tsh synthesis secretion primarily regulated trh feedforward input feedback inhibition thyroid hormone
0.44176623.15625087.html.plaintext.txt	160	host hormone neurotransmitter including somatostatin catecholamine various cytokine leptin modulate neuroendocrine ensemble num num
0.44176623.15625087.html.plaintext.txt	161	addition sleep inhibitory effect tsh secretion num num
0.44176623.15625087.html.plaintext.txt	162	trh synthesized thyrotropic area pvn anterior pituitary act promote tsh secretion endocrine paracrine mechanism respectively num
0.44176623.15625087.html.plaintext.txt	163	although hypocretin neuronal cell body heavily project pvn num currently unknown whether hypocretin axon actually synapse trh neuron
0.44176623.15625087.html.plaintext.txt	164	therefore uncertain whether hypocretins directly modulate trh synthesis release thus affect tsh secretion
0.44176623.15625087.html.plaintext.txt	165	also experiment investigating impact exogenous hypocretin peptide tsh release rodent yielded inconclusive result
0.44176623.15625087.html.plaintext.txt	166	intracerebroventricular intravenous injection hypocretin num either reduced plasma tsh level showed effect tsh andor trh release num num num num
0.44176623.15625087.html.plaintext.txt	167	thus seems unlikely hypocretin deficiency per se inhibits trh secretion reduce tsh level narcoleptic human
0.44176623.15625087.html.plaintext.txt	168	num previously showed circulating leptin level num lower narcoleptic patient control matched age body fat mass
0.44176623.15625087.html.plaintext.txt	169	show circulating leptin level tsh secretion rate correlated positively narcoleptic men
0.44176623.15625087.html.plaintext.txt	170	study revealed leptin intimately involved regulation hpt axis
0.44176623.15625087.html.plaintext.txt	171	specifically reduction circulating leptin mediates inhibition hpt axis activity starvation num
0.44176623.15625087.html.plaintext.txt	172	leptin act primarily integrate activity neuronal circuit orchestrate energy balance num
0.44176623.15625087.html.plaintext.txt	173	context leptin activates melanocyte stimulating hormone msh cocaine amphetamine regulated transcript cart whereas inhibits neuropeptide y npy agouti related peptide agrp
0.44176623.15625087.html.plaintext.txt	174	trh neuron receive functional input neurotransmitter num num num num num npyagrp inhibit trh release num whereas mshcart promote trh secretion num num
0.44176623.15625087.html.plaintext.txt	175	addition leptin directly stimulate prepro trh mrna synthesis processing promote trh release via activation leptin receptor trh neuron num
0.44176623.15625087.html.plaintext.txt	176	moreover fact leptin leptin receptor expressed rodent anterior pituitary cell suggests leptin may also impact tsh secretion directly num
0.44176623.15625087.html.plaintext.txt	177	diurnal pulsatile leptin tsh level exhibit strong pattern synchrony healthy human whereas tsh release get disorganized circadian rhythm phase shifted leptin deficient human subject num
0.44176623.15625087.html.plaintext.txt	178	present study also demonstrate strong pattern synchrony leptin tsh patient control
0.44176623.15625087.html.plaintext.txt	179	data clearly suggest leptin involved regulation tsh release rodent human
0.44176623.15625087.html.plaintext.txt	180	thus fact tsh release rate positively correlated circulating leptin level present study support certainly prove contention hypoleptinemia blunts tsh secretion narcoleptic patient
0.44176623.15625087.html.plaintext.txt	181	diminished dopaminergic tone may also blunt tsh secretion narcoleptic subject diminution trh release
0.44176623.15625087.html.plaintext.txt	182	study using canine model narcolepsy suggest hypoactivity dopaminergic noradrenergic circuit among major pathophysiological mechanism narcolepsy num
0.44176623.15625087.html.plaintext.txt	183	recent vivo brain imaging study human support notion num disease currently treated symptomatically drug enhance monoaminergic
0.44176623.15625087.html.plaintext.txt	184	dopamine norepinephrine neurotransmissions num
0.44176623.15625087.html.plaintext.txt	185	vitro vivo study clearly show hypocretin peptide stimulate dopaminergic neuron various brain site num num also suggests hypocretin deficiency may silence dopaminergic circuit
0.44176623.15625087.html.plaintext.txt	186	dopamine promotes trh release via hypothalamic dopamine dnum receptor num
0.44176623.15625087.html.plaintext.txt	187	therefore hypocretin deficiency may blunt trh thereby tsh release diminution dopaminergic neurotransmission hypothalamus
0.44176623.15625087.html.plaintext.txt	188	however role dopamine regulation tsh secretion complex view fact monoamine inhibits tsh release level pituitary num num
0.44176623.15625087.html.plaintext.txt	189	observation implies reduced dopaminergic tone would lead increase circulating tsh narcoleptic subject
0.44176623.15625087.html.plaintext.txt	190	context seems important mention prolactin secretion also controlled dopamine pituitary level altered narcoleptic patient
0.44176623.15625087.html.plaintext.txt	191	thus role dopamine pathophysiology low plasma tsh level narcoleptic human remains uncertain
0.44176623.15625087.html.plaintext.txt	192	clinical feature narcolepsy also suggest trh deficiency hypoleptinemia unknown cause may involved pathophysiology disease
0.44176623.15625087.html.plaintext.txt	193	ed cataplexy reflection depressed activity cns
0.44176623.15625087.html.plaintext.txt	194	accordingly current option treatment narcolepsy include cns stimulant ed antidepressant cataplexy num
0.44176623.15625087.html.plaintext.txt	195	trh receptor distributed widely cns num trh diverse neuromodulating action num num
0.44176623.15625087.html.plaintext.txt	196	among many feature cns stimulant antidepressant effect num num
0.44176623.15625087.html.plaintext.txt	197	interestingly chronic administration trh analog increase wakefulness ameliorates cataplexy narcoleptic dog num may imply diminished trh tone involved pathogenesis narcoleptic symptom
0.44176623.15625087.html.plaintext.txt	198	however fact circulating prolactin level normal narcoleptic human unpublished observation argues exclude primary trh deficiency patient trh involved regulation prolactin release
0.44176623.15625087.html.plaintext.txt	199	sleep inhibitory effect tsh release demonstrated human normal light dark cycle sleep light dark cycle manipulation num num
0.44176623.15625087.html.plaintext.txt	200	underlying neuroendocrine mechanism known
0.44176623.15625087.html.plaintext.txt	201	present study sleep plasma tsh level inversely associated sleep period invariably followed reduction tsh concentration patient control suggesting hypocretins involved coupling sleep tsh release
0.44176623.15625087.html.plaintext.txt	202	present data also suggest fact patient slept longer control may contributed reduction tsh level
0.44176623.15625087.html.plaintext.txt	203	hypersensitivity thyroid gland tsh stimulation may also contribute alteration pituitary thyroid ensemble described
0.44176623.15625087.html.plaintext.txt	204	despite fact tsh level reduced narcoleptic subject plasma tnum tnum concentration similar healthy control completely within normal range
0.44176623.15625087.html.plaintext.txt	205	may imply thyroid sensitive tsh stimulation narcoleptic unfortunately study yield data support notion
0.44176623.15625087.html.plaintext.txt	206	thyroid hypersensitivity tsh may brought reduction sympathetic tone patient num tsh induced tnum release inhibited num adrenergic receptor stimulation num num
0.44176623.15625087.html.plaintext.txt	207	putative resetting pituitary thyroid axis could fully explain observation
0.44176623.15625087.html.plaintext.txt	208	case fact thyroid hormone level within normal range narcoleptic indicates patient euthyroid
0.44176623.15625087.html.plaintext.txt	209	however remains established whether ensemble act appropriately condition greater metabolic demand growth cold adaptation pregnancy
0.44176623.15625087.html.plaintext.txt	210	data clearly show apen statistic appropriately detect disorderliness sleep pattern narcoleptic human
0.44176623.15625087.html.plaintext.txt	211	thus conceivable application apen analysis sleep pattern effect drug therapy sleep disorder physiological study sleep related neuroendocrine phenomenon might contribute understanding complicated network involved
0.44176623.15625087.html.plaintext.txt	212	conclusion present study show circulating tsh concentration reduced face normal plasma thyroid hormone concentration hypocretin deficient narcoleptic human
0.44176623.15625087.html.plaintext.txt	213	hypoleptinemia disorderly sleep episode longer duration may involved pathophysiology neuroendocrine feature narcolepsy
0.44176623.15625087.html.plaintext.txt	214	view larger version numk fig
0.44176623.15625087.html.plaintext.txt	215	acknowledgment gratefully acknowledge work performed following collaborator e
0.44176623.15625087.html.plaintext.txt	216	sierat van der steen technical support m
0.44176623.15625087.html.plaintext.txt	217	haasnoot van der bent performing tsh tnum tnum assay
0.44176623.15625087.html.plaintext.txt	218	footnote address reprint request correspondence h
0.44176623.15625087.html.plaintext.txt	219	general internal medicine cnum rnum po box num num rc leiden netherlands e mail h
0.44176623.15625087.html.plaintext.txt	220	cost publication article defrayed part payment page charge
0.44176623.15625087.html.plaintext.txt	221	article must therefore hereby marked advertisement accordance num u
0.44176623.15625087.html.plaintext.txt	222	section num solely indicate fact
0.44176623.15625087.html.plaintext.txt	223	home help feedback subscription archive search table content visit aps journal online copyright num american physiological society
0.5774776.12453828.html.plaintext.txt	0	somatotropic axis hypocretin deficient narcoleptic human altered circadian distribution gh secretory event sebastiaan overeemnum simon w
0.5774776.12453828.html.plaintext.txt	1	koknum gert jan lammersnum alla
0.5774776.12453828.html.plaintext.txt	2	veinnum marijke frolichnum arend e
0.5774776.12453828.html.plaintext.txt	3	meindersnum ferdinand roelfsemanum hanno pijlnum
0.5774776.12453828.html.plaintext.txt	4	num department neurology clinical neurophysiology num department general internal medicine num department endocrinology leiden university medical center num rc leiden netherlands
0.5774776.12453828.html.plaintext.txt	5	narcolepsy sleep disorder caused impaired hypocretin orexin neurotransmission
0.5774776.12453828.html.plaintext.txt	6	growth hormone gh secretion may altered narcolepsy various reason
0.5774776.12453828.html.plaintext.txt	7	slow wave sleep episode closely associated gh secretory event randomly dispersed num h narcoleptic
0.5774776.12453828.html.plaintext.txt	8	furthermore hypocretins may inhibit pituitary gh release
0.5774776.12453828.html.plaintext.txt	9	assessed function somatotropic axis narcolepsy deconvolving num h num min sampling interval plasma gh concentration profile seven hypocretin deficient narcoleptic patient seven healthy control matched age sex body weight
0.5774776.12453828.html.plaintext.txt	10	basal pulsatile gh secretion rate secretagogue induced gh release similar patient control
0.5774776.12453828.html.plaintext.txt	11	however narcoleptic secreted num total production daytime whereas control secreted num day
0.5774776.12453828.html.plaintext.txt	12	also gh output pattern narcoleptic significantly le regular
0.5774776.12453828.html.plaintext.txt	13	propose hypocretin deficiency disrupts circadian distribution hypothalamic gh releasing hormone release narcoleptic patient simultaneously cause daytime gh release promote propensity fall asleep day
0.5774776.12453828.html.plaintext.txt	14	narcolepsy primarily affect organization regulation sleep wakefulness
0.5774776.12453828.html.plaintext.txt	15	main symptom excessive daytime sleepiness cataplexy fragmented nocturnal sleep num
0.5774776.12453828.html.plaintext.txt	16	narcolepsy caused disruption hypocretin orexin mediated neurotransmission num num num
0.5774776.12453828.html.plaintext.txt	17	vast majority human patient lack hypocretin cerebrospinal fluid csf num num num
0.5774776.12453828.html.plaintext.txt	18	autoimmune mediated destruction hypocretin neuron currently presumed principal cause narcolepsy human num num
0.5774776.12453828.html.plaintext.txt	19	sleep activity somatotropic axis intimately related num
0.5774776.12453828.html.plaintext.txt	20	particular slow wave sleep sw associated pituitary growth hormone gh release
0.5774776.12453828.html.plaintext.txt	21	healthy individual major gh secretory event occurs often shortly sleep onset close temporal association first period sw
0.5774776.12453828.html.plaintext.txt	22	conversely sleep deprivation consistently associated reduction circulating gh level age related decline sw accompanied marked decrease gh secretion num
0.5774776.12453828.html.plaintext.txt	23	sw episode randomly distributed num h narcoleptic patient healthy subject num num circadian distribution gh secretory event may altered hypocretin deficient narcoleptic human
0.5774776.12453828.html.plaintext.txt	24	moreover intracerebroventricular injection hypocretin num cause dose dependent reduction plasma gh rat num hypocretin deficiency may exert direct excitatory effect gh release narcoleptic
0.5774776.12453828.html.plaintext.txt	25	limited number study assessed status somatotropic axis narcoleptic human
0.5774776.12453828.html.plaintext.txt	26	general study suggested rise plasma gh concentration around sleep onset markedly dampened even absent narcolepsy num num num
0.5774776.12453828.html.plaintext.txt	27	hypothesized intrinsic disturbance sw andor frequent occurrence sleep onset rapid eye movement rem period underlies alteration gh secretion narcoleptic human num
0.5774776.12453828.html.plaintext.txt	28	however interpretation data obtained early study hampered methodological imperfection particularly respect selection control subject e
0.5774776.12453828.html.plaintext.txt	29	matched age andor body mass index bmi
0.5774776.12453828.html.plaintext.txt	30	moreover course time novel analytical technique deconvolution approximate entropy apen developed allow estimation pituitary gh secretion rate quantification orderliness release process basis frequently sampled plasma gh concentration time series num num num
0.5774776.12453828.html.plaintext.txt	31	evaluate impact disturbance circadian slow wave sleep distribution andor hypocretin deficiency various feature pulsatile gh secretion human deconvolved num h plasma gh concentration profile narcoleptic patient healthy control matched age sex bmi
0.5774776.12453828.html.plaintext.txt	32	specifically hypothesized circadian distribution peak trough plasma gh concentration would disrupted total daily gh production would increased narcoleptic patient
0.5774776.12453828.html.plaintext.txt	33	included seven male patient outpatient clinic department neurology
0.5774776.12453828.html.plaintext.txt	34	physician experienced narcolepsy g
0.5774776.12453828.html.plaintext.txt	35	lammers made clinical diagnosis narcolepsy cataplexy
0.5774776.12453828.html.plaintext.txt	36	diagnosis confirmed multiple sleep latency testing showed result typical narcolepsy num
0.5774776.12453828.html.plaintext.txt	37	patient hla dqbnumnum positive
0.5774776.12453828.html.plaintext.txt	38	confirmed patient hypocretin deficient hypocretin num undetectable csf direct radioimmunoassay ria previously described num
0.5774776.12453828.html.plaintext.txt	39	subject except three two using psychostimulants one using clomipramine discontinued medication num wk study free medication
0.5774776.12453828.html.plaintext.txt	40	weight height subject measured well waist hip circumference waist halfway lowest rib crista iliaca hip maximum circumference standing position
0.5774776.12453828.html.plaintext.txt	41	waist hip ratio whr used relative measure abdominal fat mass
0.5774776.12453828.html.plaintext.txt	42	total body fat mass determined dual energy x ray absorptiometry hologic qdrnum waltham ma num
0.5774776.12453828.html.plaintext.txt	43	recruited seven male control subject advertisement local newspaper
0.5774776.12453828.html.plaintext.txt	44	control matched age bmi total fat mass whr
0.5774776.12453828.html.plaintext.txt	45	control take medication history sleep disorder
0.5774776.12453828.html.plaintext.txt	46	subject eligible study exclusion hypertension defined repeated blood pressure measurement showing systolic pressure num mmhg diastolic pressure num mmhg known history endocrine disease recent weight change num kg weight gain loss within last num mo fasting blood glucose num
0.5774776.12453828.html.plaintext.txt	47	study protocol approved medical ethic committee leiden university medical center
0.5774776.12453828.html.plaintext.txt	48	subject gave written informed consent participate
0.5774776.12453828.html.plaintext.txt	49	investigation performed clinical research center crc department general internal medicine
0.5774776.12453828.html.plaintext.txt	50	subject admitted crc prepared sleep registration
0.5774776.12453828.html.plaintext.txt	51	num h study occasion three standardized meal served num num num nutridrink num
0.5774776.12453828.html.plaintext.txt	52	num kcalml num num kcalday macronutrient composition per num ml num g protein num
0.5774776.12453828.html.plaintext.txt	53	num g carbohydrate nutricia zoetermeer netherlands
0.5774776.12453828.html.plaintext.txt	54	subject remained sedentary throughout study except bathroom visit
0.5774776.12453828.html.plaintext.txt	55	light switched num
0.5774776.12453828.html.plaintext.txt	56	intravenous cannula inserted antecubital vein num h start blood sampling
0.5774776.12453828.html.plaintext.txt	57	blood sample taken three way stopcock attached extended line prevent sleep disturbance manipulation investigator
0.5774776.12453828.html.plaintext.txt	58	catheter kept patent num
0.5774776.12453828.html.plaintext.txt	59	num nacl heparin num uml drip num mlnum h
0.5774776.12453828.html.plaintext.txt	60	blood collected monovetten tube sarstedt etten leur netherlands num min interval num h allowed clot centrifuged num degree c num min within hour collection serum frozen num degree c assay performed
0.5774776.12453828.html.plaintext.txt	61	serum igf igf binding protein num igfbp num concentration measured early morning sample
0.5774776.12453828.html.plaintext.txt	62	num h sampling procedure num next morning num microg gh releasing hormone ghrh given intravenous bolus serum gh concentration measured blood sample taken every num min num min bolus injection num
0.5774776.12453828.html.plaintext.txt	63	serum gh concentration measured using sensitive time resolved immunofluorometric assay wallac turku finland
0.5774776.12453828.html.plaintext.txt	64	assay specific num kda gh isoform
0.5774776.12453828.html.plaintext.txt	65	human biosynthetic gh pharmacia uppsala sweden diluted bovine calf serum used standard calibrated world health organization first international reference preparation num num num microg num
0.5774776.12453828.html.plaintext.txt	66	detection limit assay defined value num sd mean value zero standard num
0.5774776.12453828.html.plaintext.txt	67	interassay coefficient variation varied num
0.5774776.12453828.html.plaintext.txt	68	num gh concentration range num
0.5774776.12453828.html.plaintext.txt	69	sample one subject measured assay
0.5774776.12453828.html.plaintext.txt	70	total serum igf igfbp num concentration measured ria previously described num
0.5774776.12453828.html.plaintext.txt	71	num h sampling procedure sleep recorded polygraphically using porti num ambulant electroencephalogram recording system twente medical system international enschede netherlands scored eeg num review software nihon kohden tokyo japan
0.5774776.12453828.html.plaintext.txt	72	experienced technician blinded subject study visually scored sleep recording num epoch mean standardized criterion num
0.5774776.12453828.html.plaintext.txt	73	nocturnal sleep onset identified first epoch stage ii iii iv rem sleep light provided subsequent interval scored wake
0.5774776.12453828.html.plaintext.txt	74	sleep period defined time sleep onset final awakening morning
0.5774776.12453828.html.plaintext.txt	75	sleep efficiency calculated percentage sleep period actually spent asleep
0.5774776.12453828.html.plaintext.txt	76	gh time series used multiple parameter deconvolution analysis estimate various specific measure pulsatile secretion half life basis simultaneous consideration serum hormone concentration dose dependent intrasample variance num num
0.5774776.12453828.html.plaintext.txt	77	result expressed milliunits per liter distribution volume muld
0.5774776.12453828.html.plaintext.txt	78	following parameter estimated gh series number secretory burst secretory burst half duration duration half maximal amplitude burst amplitude mean mass secreted per burst hormone half life pulsatile secretion rate basal secretion rate total secretion per num h
0.5774776.12453828.html.plaintext.txt	79	furthermore quantified amount gh secreted num num num num num h sleep onset first secretory burst sleep onset
0.5774776.12453828.html.plaintext.txt	80	quantified minute minute regularity serial orderliness gh secretion use apen statistic scale model independent metric num
0.5774776.12453828.html.plaintext.txt	81	apen estimate regularity subordinate nonpulsatile pattern data yield information complementary deconvolution technique num num
0.5774776.12453828.html.plaintext.txt	82	greater regularity yield smaller apen value whereas greater independence among sequential value time series yield larger apen value
0.5774776.12453828.html.plaintext.txt	83	applied normalized apen parameter m num r num intraseries sd previously validated gh series length num
0.5774776.12453828.html.plaintext.txt	84	apen ratio delineates orderliness concentration time series compared apen score associated maximal randomness time series estimated computer simulation
0.5774776.12453828.html.plaintext.txt	85	thus apen ratio equal num reflects maximal randomness time series study smaller apen ratio denote greater regularity
0.5774776.12453828.html.plaintext.txt	86	gh release response ghrh injection determined using deconvolution analysis see
0.5774776.12453828.html.plaintext.txt	87	unless otherwise stated result expressed mean plus minus se
0.5774776.12453828.html.plaintext.txt	88	median value shown parenthesis
0.5774776.12453828.html.plaintext.txt	89	comparison made using unpaired two tailed student test log transformation gh concentrationsecretion data
0.5774776.12453828.html.plaintext.txt	90	difference group considered significant p num
0.5774776.12453828.html.plaintext.txt	91	statistical calculation performed using spss window release num
0.5774776.12453828.html.plaintext.txt	92	num systat release num spss chicago il
0.5774776.12453828.html.plaintext.txt	93	clinical characteristic subject study shown table num
0.5774776.12453828.html.plaintext.txt	94	note mean bmi subject overweight range
0.5774776.12453828.html.plaintext.txt	95	num num kgmnum expected narcoleptic patient num
0.5774776.12453828.html.plaintext.txt	96	participant well matched anthropometric variable potentially influencing gh secretion including bmi body composition
0.5774776.12453828.html.plaintext.txt	97	view table table num
0.5774776.12453828.html.plaintext.txt	98	clinical characteristic study subject
0.5774776.12453828.html.plaintext.txt	99	duration sleep period differ patient num plus minus num min control num plus minus num min p num
0.5774776.12453828.html.plaintext.txt	100	group relatively low sleep efficiency narcolepsy num plus minus num
0.5774776.12453828.html.plaintext.txt	101	num control num plus minus num
0.5774776.12453828.html.plaintext.txt	102	num resulting num plus minus num min nocturnal sleep patient num plus minus num min control p num
0.5774776.12453828.html.plaintext.txt	103	however relative amount nocturnal stage sleep num higher narcoleptic num
0.5774776.12453828.html.plaintext.txt	104	num suggests fragmented nocturnal sleep
0.5774776.12453828.html.plaintext.txt	105	amount sw night differ patient control num
0.5774776.12453828.html.plaintext.txt	106	none control subject slept daytime
0.5774776.12453828.html.plaintext.txt	107	contrast narcoleptic took least two daytime nap average num
0.5774776.12453828.html.plaintext.txt	108	num min daytime sleep episode spent sw num
0.5774776.12453828.html.plaintext.txt	109	figure num illustrates num h sleep pattern patient individual control together concomitant serum gh concentration profile deconvolution based estimate gh secretion rate
0.5774776.12453828.html.plaintext.txt	110	num h mean serum concentration gh significantly different narcoleptic patient control num
0.5774776.12453828.html.plaintext.txt	111	likewise serum igf igfbp num concentration differ group data shown
0.5774776.12453828.html.plaintext.txt	112	view larger version numk fig
0.5774776.12453828.html.plaintext.txt	113	example num h growth hormone gh profile narcoleptic patient num yr old individual control num yr old b
0.5774776.12453828.html.plaintext.txt	114	plotted top bottom hypnogram pattern wakefulness sleep stage serum gh concentration conc
0.5774776.12453828.html.plaintext.txt	115	mul num min interval gh secretory rate secr
0.5774776.12453828.html.plaintext.txt	116	mu lnum minnum estimated multiparameter deconvolution
0.5774776.12453828.html.plaintext.txt	117	note occurrence num daytime nap patient
0.5774776.12453828.html.plaintext.txt	118	deconvolution derived num h gh secretion parameter summarized table num
0.5774776.12453828.html.plaintext.txt	119	patient narcolepsy differ control respect basal secretion rate total number gh peak peak amplitude area
0.5774776.12453828.html.plaintext.txt	120	consequently total production gh different two group fig
0.5774776.12453828.html.plaintext.txt	121	however distribution gh secretory event num h differed considerably group
0.5774776.12453828.html.plaintext.txt	122	narcoleptic secreted almost one half total pulsatile production day whereas control produced one quarter day pulsatile release daytime fraction total pulsatile release num
0.5774776.12453828.html.plaintext.txt	123	view table table num
0.5774776.12453828.html.plaintext.txt	124	secretory parameter num h serum gh narcolepsy patient control
0.5774776.12453828.html.plaintext.txt	125	view larger version numk fig
0.5774776.12453828.html.plaintext.txt	126	total num h gh secretion patient control
0.5774776.12453828.html.plaintext.txt	127	ld liter distribution volume
0.5774776.12453828.html.plaintext.txt	128	individual level shown together mean value
0.5774776.12453828.html.plaintext.txt	129	sleep onset gh secretion assessed determination gh production first num h sleep quantifying first gh pulse sleep onset
0.5774776.12453828.html.plaintext.txt	130	narcoleptic control secreted approximately one third total num h gh production first num h sleep num
0.5774776.12453828.html.plaintext.txt	131	amount secreted first secretory event sleep onset also similar group num
0.5774776.12453828.html.plaintext.txt	132	total amount gh released per day strongly correlated total num h amount sw control rnum num
0.5774776.12453828.html.plaintext.txt	133	relationship remained intact narcoleptic rnum num
0.5774776.12453828.html.plaintext.txt	134	contrast gh release correlated total amount rem sleep either group rnum num
0.5774776.12453828.html.plaintext.txt	135	num narcoleptic control respectively
0.5774776.12453828.html.plaintext.txt	136	view larger version numk fig
0.5774776.12453828.html.plaintext.txt	137	correlation total amount slow wave sleep num h total gh secretion patient control group combined
0.5774776.12453828.html.plaintext.txt	138	slope regression line significantly different group
0.5774776.12453828.html.plaintext.txt	139	gh secretion pattern le orderly narcoleptic patient may reflect disruption ghrh feedforward input see discussion
0.5774776.12453828.html.plaintext.txt	140	apennumnum value num
0.5774776.12453828.html.plaintext.txt	141	num increased patient group reflecting decrease serial orderliness gh secretion
0.5774776.12453828.html.plaintext.txt	142	narcoleptic patient responded ghrh injection secreting amount gh similar control subject
0.5774776.12453828.html.plaintext.txt	143	use multiparameter deconvolution gh secretion ghrh injection calculated num
0.5774776.12453828.html.plaintext.txt	144	num muld patient control respectively p num
0.5774776.12453828.html.plaintext.txt	145	assessed num h sleep pattern gh secretion profile conjointly well defined group narcoleptic patient control matched various confounding variable
0.5774776.12453828.html.plaintext.txt	146	patient several daytime nap including sw episode whereas sleep confined nighttime control
0.5774776.12453828.html.plaintext.txt	147	total daily gh production strongly correlated total time sw narcoleptic patient control alike fig
0.5774776.12453828.html.plaintext.txt	148	result dispersion gh secretory event slow wave sleep epoch num h altered concomitantly narcoleptic secreted larger fraction total gh production day num v
0.5774776.12453828.html.plaintext.txt	149	gh output pattern significantly le regular narcoleptic patient
0.5774776.12453828.html.plaintext.txt	150	expectation basal pulsatile gh production secretagogue induced gh release similar patient control fig
0.5774776.12453828.html.plaintext.txt	151	previous study examined plasma gh concentration patient narcolepsy
0.5774776.12453828.html.plaintext.txt	152	result study generally suggested gh release spontaneous num h secretagogue induced blunted narcoleptic num num num
0.5774776.12453828.html.plaintext.txt	153	however interpretation data obtained study hampered potential imperfection regarding selection control subject
0.5774776.12453828.html.plaintext.txt	154	example two study num num body weight participant reported third study num include healthy control subject
0.5774776.12453828.html.plaintext.txt	155	know narcoleptic patient tend obese num gh production profoundly reduced abdominally obese human num num
0.5774776.12453828.html.plaintext.txt	156	also age reported two study num num
0.5774776.12453828.html.plaintext.txt	157	one num narcoleptic patient num yr older control num v
0.5774776.12453828.html.plaintext.txt	158	num yr may also biased result num
0.5774776.12453828.html.plaintext.txt	159	present study control subject carefully matched respect age sex bmi body fat distribution preclude analogous bias
0.5774776.12453828.html.plaintext.txt	160	therefore believe data presented present paper conclusive previous study whether narcolepsy per se impact gh secretion
0.5774776.12453828.html.plaintext.txt	161	moreover narcoleptic patient present study confirmed hypocretin deficient possible determine previous study hypocretin peptide unknown time
0.5774776.12453828.html.plaintext.txt	162	thus present data pertain specifically hypocretin deficient narcoleptic human
0.5774776.12453828.html.plaintext.txt	163	result clearly argue reduction spontaneous secretagogue induced gh secretion human narcolepsy
0.5774776.12453828.html.plaintext.txt	164	learn regulation gh secretion sleep result study first onset nocturnal sleep remains important correlate gh release even numerous nap interrupted daytime wakefulness
0.5774776.12453828.html.plaintext.txt	165	narcoleptic control num total daily gh secretion occurred num h nocturnal sleep onset
0.5774776.12453828.html.plaintext.txt	166	second relationship sw gh release remains robust even sleep fragmented randomly dispersed num h
0.5774776.12453828.html.plaintext.txt	167	strong positive highly significant correlation variable observed narcoleptic control
0.5774776.12453828.html.plaintext.txt	168	third dispersion gh secretory event sleep epoch num h appears altered analogously narcoleptic patient slow wave sleep time gh secretion day
0.5774776.12453828.html.plaintext.txt	169	finally endogenous hypocretins significantly impact amount gh produced daily human
0.5774776.12453828.html.plaintext.txt	170	hypocretin peptide hypocretin num num also known orexin b produced exclusively small number neuron located perifornical area hypothalamus num num
0.5774776.12453828.html.plaintext.txt	171	hypocretin neuron connect nucleus within hypothalamus including arcuate nucleus pituitary num explain impact energy balance several neuroendocrine ensemble review see ref
0.5774776.12453828.html.plaintext.txt	172	intracerebroventricular administration hypocretin num cause dose dependent decrease plasma gh rat num
0.5774776.12453828.html.plaintext.txt	173	furthermore recently reported somatotropic cell human pituitary express hypocretin receptor num num
0.5774776.12453828.html.plaintext.txt	174	data suggest hypocretins directly blunt gh secretion
0.5774776.12453828.html.plaintext.txt	175	therefore hypothesized hypocretin deficiency would enhance total daily gh production narcoleptic human
0.5774776.12453828.html.plaintext.txt	176	result support contention narcoleptic patient produced normal total amount gh fig
0.5774776.12453828.html.plaintext.txt	177	however believe data support thesis hypocretin deficiency disrupts circadian dispersion hypothalamic ghrh release normally confines sleep gh secretion night
0.5774776.12453828.html.plaintext.txt	178	irregular gh output pattern found narcoleptic also support notion hypothalamic ghrh release may enhanced disorder
0.5774776.12453828.html.plaintext.txt	179	serial orderliness pulsatile gh release determined apen statistic reflects balance feedforward feedback input somatotropic neuroendocrine ensemble num
0.5774776.12453828.html.plaintext.txt	180	present study gh output irregular narcoleptic patient healthy control suggests negative feedback restraint somatotropic activity muted andor positive feedforward input enhanced narcolepsy num
0.5774776.12453828.html.plaintext.txt	181	conclusion study document irregular release normal amount gh hypocretin deficient narcoleptic human
0.5774776.12453828.html.plaintext.txt	182	addition circadian dispersion gh secretory event altered narcoleptic relatively large fraction total production occurs daytime
0.5774776.12453828.html.plaintext.txt	183	propose altered circadian distribution ghrh release brought hypocretin deficiency simultaneously cause increased daytime gh secretion enhanced daytime sleepiness narcolepsy
0.5774776.12453828.html.plaintext.txt	184	thank following effort completion study e
0.5774776.12453828.html.plaintext.txt	185	sierat van der steen technical support study occasion m
0.5774776.12453828.html.plaintext.txt	186	haasnoot van der bent performing gh measurement p
0.5774776.12453828.html.plaintext.txt	187	reijntjes technical assistance analysis visualization part data
0.5774776.12453828.html.plaintext.txt	188	address reprint request correspondence h
0.5774776.12453828.html.plaintext.txt	189	general internal medicine cnum rnum p
0.5774776.12453828.html.plaintext.txt	190	box num num rc leiden netherlands e mail h
0.5774776.12453828.html.plaintext.txt	191	cost publication article defrayed part payment page charge
0.5774776.12453828.html.plaintext.txt	192	article must therefore hereby marked advertisement accordance num u
0.5774776.12453828.html.plaintext.txt	193	section num solely indicate fact
0.5774776.12453828.html.plaintext.txt	194	first published november num numnum
0.5774776.12453828.html.plaintext.txt	195	received num october num accepted final form num november num
0.5774776.12453828.html.plaintext.txt	196	american sleep disorder association
0.5774776.12453828.html.plaintext.txt	197	international classification sleep disorder
0.5774776.12453828.html.plaintext.txt	198	diagnostic coding manual revised
0.5774776.12453828.html.plaintext.txt	199	rochester mn american sleep disorder association num
0.5774776.12453828.html.plaintext.txt	200	besset bonardet billiard m descomps b de paulet ac passouant p
0.5774776.12453828.html.plaintext.txt	201	circadian pattern growth hormone cortisol secretion narcoleptic patient
0.5774776.12453828.html.plaintext.txt	202	chronobiologia num num num numisimedline
0.5774776.12453828.html.plaintext.txt	203	technical principle dual energy x ray absorptiometry
0.5774776.12453828.html.plaintext.txt	204	semin nucl med num num num numisimedline
0.5774776.12453828.html.plaintext.txt	205	blanco m lopez m garcia caballero gallego r vazquez boquete morel g senaris r casanueva f dieguez c beira
0.5774776.12453828.html.plaintext.txt	206	cellular localization orexin receptor human pituitary
0.5774776.12453828.html.plaintext.txt	207	j clin endocrinol metab num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	208	broughton r dunham w newman j lutley k duschesne p river m
0.5774776.12453828.html.plaintext.txt	209	ambulatory num hour sleep wake monitoring narcolepsy cataplexy compared matched control
0.5774776.12453828.html.plaintext.txt	210	electroencephalogr clin neurophysiol num num num numisimedline
0.5774776.12453828.html.plaintext.txt	211	broughton r krupa boucher b river m mullington j
0.5774776.12453828.html.plaintext.txt	212	impaired circadian waking arousal narcolepsy cataplexy
0.5774776.12453828.html.plaintext.txt	213	online sleep re num num num num
0.5774776.12453828.html.plaintext.txt	214	chemelli rm willie jt sinton cm elmquist jk scammell lee c richardson ja williams sc xiong y kisanuki y fitch te nakazato m hammer re saper cb yanagisawa m
0.5774776.12453828.html.plaintext.txt	215	narcolepsy orexin knockout mouse molecular genetics sleep regulation
0.5774776.12453828.html.plaintext.txt	216	cell num num num numisimedline
0.5774776.12453828.html.plaintext.txt	217	clark rw schmidt h malarkey wb
0.5774776.12453828.html.plaintext.txt	218	disordered growth hormone prolactin secretion primary disorder sleep
0.5774776.12453828.html.plaintext.txt	219	neurology num num num numabstract
0.5774776.12453828.html.plaintext.txt	220	dahmen n bierbrauer j kasten m
0.5774776.12453828.html.plaintext.txt	221	increased prevalence obesity narcoleptic patient relative
0.5774776.12453828.html.plaintext.txt	222	eur arch psychiatry clin neurosci num num num numisimedline
0.5774776.12453828.html.plaintext.txt	223	de lecea l kilduff t peyron c gao x foye pe danielson pe fukuhara c battenberg el gautvik vt bartlett f frankel wn den pol bloom fe gautvik km sutcliffe jg
0.5774776.12453828.html.plaintext.txt	224	hypocretins hypothalamus specific peptide neuroexcitatory activity
0.5774776.12453828.html.plaintext.txt	225	proc natl acad sci usa num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	226	fujiki n yoshida y ripley b honda k mignot e nishino
0.5774776.12453828.html.plaintext.txt	227	change csf hypocretin num orexin level rat across num hour response food deprivation
0.5774776.12453828.html.plaintext.txt	228	neuroreport num num num numisimedline
0.5774776.12453828.html.plaintext.txt	229	giustina veldhuis jd
0.5774776.12453828.html.plaintext.txt	230	pathophysiology neuroregulation growth hormone secretion experimental animal human
0.5774776.12453828.html.plaintext.txt	231	endocr rev num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	232	hagan jj leslie ra patel evans ml wattam ta holmes benham cd taylor sg routledge c hemmati p munton rp ashmeade te shah hatcher jp hatcher pd jones dn smith mi piper dc hunter aj porter ra upton n
0.5774776.12453828.html.plaintext.txt	233	orexin activates locus coeruleus cell firing increase arousal rat
0.5774776.12453828.html.plaintext.txt	234	proc natl acad sci usa num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	235	hartman ml veldhuis jd thorner mo
0.5774776.12453828.html.plaintext.txt	236	normal control growth hormone secretion
0.5774776.12453828.html.plaintext.txt	237	horm re num num num numisimedline
0.5774776.12453828.html.plaintext.txt	238	higuchi takahashi y takahashi k niimi y miyasita
0.5774776.12453828.html.plaintext.txt	239	twenty four hour secretory pattern growth hormone prolactin cortisol narcolepsy
0.5774776.12453828.html.plaintext.txt	240	j clin endocrinol metab num num num numabstract
0.5774776.12453828.html.plaintext.txt	241	lin l faraco j li r kadotani h rogers w lin x qiu x de jong pj nishino mignot e
0.5774776.12453828.html.plaintext.txt	242	sleep disorder canine narcolepsy caused mutation hypocretin orexin receptor num gene
0.5774776.12453828.html.plaintext.txt	243	cell num num num numisimedline
0.5774776.12453828.html.plaintext.txt	244	nishino ripley b overeem lammers gj mignot e
0.5774776.12453828.html.plaintext.txt	245	hypocretin orexin deficiency human narcolepsy
0.5774776.12453828.html.plaintext.txt	246	lancet num num num numisimedline
0.5774776.12453828.html.plaintext.txt	247	nishino ripley b overeem nevsimalova lammers gj vankova j okun m rogers w brook mignot e
0.5774776.12453828.html.plaintext.txt	248	low cerebrospinal fluid hypocretin orexin altered energy homeostasis human narcolepsy
0.5774776.12453828.html.plaintext.txt	249	ann neurol num num num numisimedline
0.5774776.12453828.html.plaintext.txt	250	obal f jr fang j taishi p kacsoh b gardi j krueger jm
0.5774776.12453828.html.plaintext.txt	251	deficiency growth hormone releasing hormone signaling associated sleep alteration dwarf rat
0.5774776.12453828.html.plaintext.txt	252	j neurosci num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	253	overeem mignot e van dijk jg lammers gj
0.5774776.12453828.html.plaintext.txt	254	narcolepsy clinical feature new pathophysiologic insight future perspective
0.5774776.12453828.html.plaintext.txt	255	j clin neurophysiol num num num numisimedline
0.5774776.12453828.html.plaintext.txt	256	peyron c faraco j rogers w ripley b overeem charnay y nevsimalova aldrich m reynolds d albin r li r hungs m pedrazzoli m padigaru m kucherlapati m fan j maki r lammers gj bouras c kucherlapati r nishino mignot e
0.5774776.12453828.html.plaintext.txt	257	mutation case early onset narcolepsy generalized absence hypocretin peptide human narcoleptic brain
0.5774776.12453828.html.plaintext.txt	258	nat med num num num numisimedline
0.5774776.12453828.html.plaintext.txt	259	peyron c tighe dk den pol de lecea l heller hc sutcliffe jg kilduff t
0.5774776.12453828.html.plaintext.txt	260	neuron containing hypocretin orexin project multiple neuronal system
0.5774776.12453828.html.plaintext.txt	261	j neurosci num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	262	pijl h langendonk jg burggraaf j frolich m cohen af veldhuis jd meinders ae
0.5774776.12453828.html.plaintext.txt	263	altered neuroregulation gh secretion viscerally obese premenopausal woman
0.5774776.12453828.html.plaintext.txt	264	j clin endocrinol metab num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	265	approximate entropy measure system complexity
0.5774776.12453828.html.plaintext.txt	266	proc natl acad sci usa num num num numabstract
0.5774776.12453828.html.plaintext.txt	267	pincus sm gevers ef robinson ic van den bg roelfsema f hartman ml veldhuis jd
0.5774776.12453828.html.plaintext.txt	268	female secrete growth hormone process irregularity male human rat
0.5774776.12453828.html.plaintext.txt	269	j physiol endocrinol metab num enum enum numabstractfree full text
0.5774776.12453828.html.plaintext.txt	270	pincus sm hartman ml roelfsema f thorner mo veldhuis jd
0.5774776.12453828.html.plaintext.txt	271	hormone pulsatility discrimination via coarse short time sampling
0.5774776.12453828.html.plaintext.txt	272	j physiol endocrinol metab num enum enum numabstractfree full text
0.5774776.12453828.html.plaintext.txt	273	rechtschaffen kale
0.5774776.12453828.html.plaintext.txt	274	manual standardized terminology technique scoring system sleep stage human subject
0.5774776.12453828.html.plaintext.txt	275	los angeles ca ucla brain information servicebrain research institute num
0.5774776.12453828.html.plaintext.txt	276	ripley b overeem fujiki n nevsimalova uchino m yesavage j di monte d dohi k melberg lammers gj nishida y roelandse fw hungs m mignot e nishino
0.5774776.12453828.html.plaintext.txt	277	csf hypocretinorexin level narcolepsy neurological condition
0.5774776.12453828.html.plaintext.txt	278	neurology num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	279	sakurai amemiya ishii m matsuzaki chemelli rm tanaka h williams sc richardson ja kozlowski gp wilson arch jr buckingham re haynes ac carr sa annan r mcnulty de liu w terrett ja elshourbagy na bergsma dj yanagisawa m
0.5774776.12453828.html.plaintext.txt	280	orexins orexin receptor family hypothalamic neuropeptides g protein coupled receptor regulate feeding behavior
0.5774776.12453828.html.plaintext.txt	281	cell num num num numisimedline
0.5774776.12453828.html.plaintext.txt	282	thannickal tc moore ry nienhuis r ramanathan l gulyani aldrich m cornford m siegel jm
0.5774776.12453828.html.plaintext.txt	283	reduced number hypocretin neuron human narcolepsy
0.5774776.12453828.html.plaintext.txt	284	neuron num num num numisimedline
0.5774776.12453828.html.plaintext.txt	285	thorner mo vance ml evans w rogol ad rivier j vale w blizzard rm
0.5774776.12453828.html.plaintext.txt	286	clinical study ghrh man
0.5774776.12453828.html.plaintext.txt	287	horm re num num num numisimedline
0.5774776.12453828.html.plaintext.txt	288	van cauter e leproult r plat l
0.5774776.12453828.html.plaintext.txt	289	age related change slow wave sleep rem sleep relationship growth hormone cortisol level healthy men
0.5774776.12453828.html.plaintext.txt	290	jama num num num numabstractfree full text
0.5774776.12453828.html.plaintext.txt	291	van cauter e plat l copinschi g
0.5774776.12453828.html.plaintext.txt	292	interrelation sleep somatotropic axis
0.5774776.12453828.html.plaintext.txt	293	sleep num num num numisimedline
0.5774776.12453828.html.plaintext.txt	294	new modality understanding dynamic regulation somatotropic gh axis explication gender difference gh neuroregulation human
0.5774776.12453828.html.plaintext.txt	295	j pediatr endocrinol metab num supplnum num num numisimedline
0.5774776.12453828.html.plaintext.txt	296	veldhuis jd carlson ml johnson ml
0.5774776.12453828.html.plaintext.txt	297	pituitary gland secretes burst appraising nature glandular secretory impulse simultaneous multiple parameter deconvolution plasma hormone concentration
0.5774776.12453828.html.plaintext.txt	298	proc natl acad sci usa num num num numabstract
0.5774776.12453828.html.plaintext.txt	299	veldhuis jd iranmanesh ho kk water mj johnson ml lizarralde g
0.5774776.12453828.html.plaintext.txt	300	dual defect pulsatile growth hormone secretion clearance subserve hyposomatotropism obesity man
0.5774776.12453828.html.plaintext.txt	301	j clin endocrinol metab num num num numabstract
0.5774776.12453828.html.plaintext.txt	302	veldhuis jd johnson ml
0.5774776.12453828.html.plaintext.txt	303	deconvolution analysis hormone data
0.5774776.12453828.html.plaintext.txt	304	method enzymol num num num numisimedline
0.5774776.12453828.html.plaintext.txt	305	veldhuis jd johnson ml
0.5774776.12453828.html.plaintext.txt	306	analytical method evaluating episodic secretory activity within neuroendocrine ax
0.5774776.12453828.html.plaintext.txt	307	neurosci biobehav rev num num num numisimedline
0.5774776.12453828.html.plaintext.txt	308	orderliness hormone release pattern complementary measure conventional pulsatile circadian analysis
0.5774776.12453828.html.plaintext.txt	309	eur j endocrinol num num num numisimedline
0.5774776.12453828.html.plaintext.txt	310	veldhuis jd straume m iranmanesh mulligan jaffe c barkan johnson ml pincus
0.5774776.12453828.html.plaintext.txt	311	secretory process regularity monitor neuroendocrine feedback feedforward signaling strength human
0.5774776.12453828.html.plaintext.txt	312	j physiol regul integr comp physiol num rnum rnum numabstractfree full text
0.5774776.12453828.html.plaintext.txt	313	willie jt chemelli rm sinton cm yanagisawa m
0.5774776.12453828.html.plaintext.txt	314	eat sleep orexin regulation feeding wakefulness
0.5774776.12453828.html.plaintext.txt	315	annu rev neurosci num num num numisimedline
0.5774776.12453828.html.plaintext.txt	316	j physiol endocrinol metab numnumenum enum num numnum num
0.5774776.12453828.html.plaintext.txt	317	num copyright num american physiological society
